Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NM_024675.4(PALB2):c.*232G>T	PALB2		Fanconi anemia complementation group N	VCV000126567	16	23614548	16	23603227	126567	132077	rs180748355	NC_000016.10:23603226:C:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.*146A>G	PALB2		Breast-ovarian cancer, familial, susceptibility to, 2	VCV004073578	16	23614634	16	23603313	4073578	401463	rs1005933814	NC_000016.10:23603312:T:C	single nucleotide variant	3 prime UTR variant	Benign	Jul 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.*15A>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000629150	16	23614765	16	23603444	629150	618345	rs943559354	NC_000016.10:23603443:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Aug 31, 2018	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.*10A>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000921019	16	23614770	16	23603449	921019	913588	rs1966394024	NC_000016.10:23603448:T:A	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.*9A>G	PALB2		Familial cancer of breast	VCV003904767	16	23614771	16	23603450	3904767	4020639		NC_000016.10:23603449:T:C	single nucleotide variant	3 prime UTR variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.*7G>A	PALB2		Familial cancer of breast	VCV003903548	16	23614773	16	23603452	3903548	4019421		NC_000016.10:23603451:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.*6G>A	PALB2		Familial cancer of breast	VCV003903692	16	23614774	16	23603453	3903692	4019565		NC_000016.10:23603452:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.*4A>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000233562	16	23614776	16	23603455	233562	235147	rs876660491	NC_000016.10:23603454:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Aug 21, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.*2T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000628596	16	23614778	16	23603457	628596	618347	rs1567204901	NC_000016.10:23603456:A:C	single nucleotide variant	3 prime UTR variant	Likely benign	Jun 28, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.*1G>A	PALB2		Familial cancer of breast	VCV003903621	16	23614779	16	23603458	3903621	4019494		NC_000016.10:23603457:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3559T>C (p.Ter1187Gln)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000801241	16	23614782	16	23603461	801241	789599	rs1597061731	NC_000016.10:23603460:A:G	single nucleotide variant	stop lost	Uncertain significance	Aug 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3558A>T (p.Ser1186=)	PALB2		Familial cancer of breast	VCV003659656	16	23614783	16	23603462	3659656	3800604		NC_000016.10:23603461:T:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jul 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3558A>G (p.Ser1186=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001425698	16	23614783	16	23603462	1425698	1428072	rs1164709092	NC_000016.10:23603461:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3557C>G (p.Ser1186Ter)	PALB2	S1186*	Familial cancer of breast	VCV001361226	16	23614784	16	23603463	1361226	1383598	rs2142250676	NC_000016.10:23603462:G:C	single nucleotide variant	nonsense	Uncertain significance	Dec 29, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3555T>C (p.Tyr1185=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001732627	16	23614786	16	23603465	1732627	1786314	rs2142250730	NC_000016.10:23603464:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Sep 13, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3553T>G (p.Tyr1185Asp)	PALB2	Y1185D	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000496467	16	23614788	16	23603467	496467	487660	rs878855120	NC_000016.10:23603466:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3553T>C (p.Tyr1185His)	PALB2	Y1185H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000241566	16	23614788	16	23603467	241566	242346	rs878855120	NC_000016.10:23603466:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3552C>T (p.His1184=)	PALB2		Familial cancer of breast	VCV003904060	16	23614789	16	23603468	3904060	4019933		NC_000016.10:23603467:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3550C>A (p.His1184Asn)	PALB2	H1091N, H1105N, H1130N, H1160N, H1164N, H1184N, H362N, H588N, H810N, H835N, H889N	not provided	VCV003340220	16	23614791	16	23603470	3340220	3499478		NC_000016.10:23603469:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3550C>T (p.His1184Tyr)	PALB2	H1184Y	Hereditary cancer-predisposing syndrome	VCV000823914	16	23614791	16	23603470	823914	812639	rs770692850	NC_000016.10:23603469:G:A	single nucleotide variant	missense variant	Uncertain significance	May 17, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3549C>A (p.Tyr1183Ter)	PALB2	Y1183*	Familial cancer of breast	VCV000128144	16	23614792	16	23603471	128144	133601	rs118203998	NC_000016.10:23603470:G:T	single nucleotide variant	nonsense	Pathogenic	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.3549C>G (p.Tyr1183Ter)	PALB2	Y1183*	Inherited breast cancer and ovarian cancer|PALB2-related disorder|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Fanconi anemia complementation group N	VCV000001245	16	23614792	16	23603471	1245	16284	rs118203998	NC_000016.10:23603470:G:C	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3547T>G (p.Tyr1183Asp)	PALB2	Y1183D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000573435	16	23614794	16	23603473	573435	573902	rs1567204915	NC_000016.10:23603472:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2018	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3546A>G (p.Val1182=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000415978	16	23614795	16	23603474	415978	401464	rs1060504704	NC_000016.10:23603473:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3545T>C (p.Val1182Ala)	PALB2	V1182A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000187203	16	23614796	16	23603475	187203	184151	rs747149179	NC_000016.10:23603474:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3544G>T (p.Val1182Leu)	PALB2	V1162L, V887L, V1128L, V833L, V1103L, V1158L, V1182L, V586L, V808L, V1089L, V360L	Hereditary cancer-predisposing syndrome	VCV003413485	16	23614797	16	23603476	3413485	3574708		NC_000016.10:23603475:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3544G>C (p.Val1182Leu)	PALB2	V1182L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233540	16	23614797	16	23603476	233540	235148	rs876660474	NC_000016.10:23603475:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 8, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3542T>C (p.Phe1181Ser)	PALB2	F1181S	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000141728	16	23614799	16	23603478	141728	151442	rs587781968	NC_000016.10:23603477:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3541T>A (p.Phe1181Ile)	PALB2	F1181I, F585I, F886I, F1127I, F359I, F832I, F1102I, F1088I, F1157I, F1161I, F807I	Familial cancer of breast	VCV003658258	16	23614800	16	23603479	3658258	3800485		NC_000016.10:23603478:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3540A>G (p.Ile1180Met)	PALB2	I1180M	Breast and/or ovarian cancer	VCV000830210	16	23614801	16	23603480	830210	818444	rs1966395358	NC_000016.10:23603479:T:C	single nucleotide variant	missense variant	Uncertain significance	May 21, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3539T>C (p.Ile1180Thr)	PALB2	I1180T	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified	VCV000126747	16	23614802	16	23603481	126747	132257	rs180177139	NC_000016.10:23603480:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3538A>G (p.Ile1180Val)	PALB2	I1180V	not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not provided|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3	VCV000216757	16	23614803	16	23603482	216757	213149	rs863224788	NC_000016.10:23603481:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3537T>C (p.Asn1179=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001542068	16	23614804	16	23603483	1542068	1545822	rs1567204943	NC_000016.10:23603482:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3537T>A (p.Asn1179Lys)	PALB2	N1179K	Familial cancer of breast	VCV000566710	16	23614804	16	23603483	566710	573908	rs1567204943	NC_000016.10:23603482:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3536A>G (p.Asn1179Ser)	PALB2	N1179S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823900	16	23614805	16	23603484	823900	812641	rs1597061803	NC_000016.10:23603483:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3534A>T (p.Gly1178=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001732385	16	23614807	16	23603486	1732385	1786072	rs2506195305	NC_000016.10:23603485:T:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Sep 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3533G>C (p.Gly1178Ala)	PALB2	G1154A, G1158A, G804A, G883A, G1085A, G1099A, G1178A, G356A, G582A, G1124A, G829A	Familial cancer of breast	VCV002013915	16	23614808	16	23603487	2013915	2064128	rs1966395601	NC_000016.10:23603486:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3532G>T (p.Gly1178Ter)	PALB2	G1085*, G1099*, G1124*, G1154*, G1158*, G1178*, G356*, G582*, G804*, G829*, G883*	Familial cancer of breast	VCV004071447	16	23614809	16	23603488	4071447	4185294		NC_000016.10:23603487:C:A	single nucleotide variant	nonsense|3 prime UTR variant	Pathogenic	Jun 11, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3532G>A (p.Gly1178Arg)	PALB2	G1154R, G1158R, G1178R, G582R, G829R, G883R, G1099R, G1085R, G356R, G804R, G1124R	Familial cancer of breast	VCV002055034	16	23614809	16	23603488	2055034	2109035	rs2142251301	NC_000016.10:23603487:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3529G>A (p.Asp1177Asn)	PALB2	D1084N, D1098N, D1123N, D1153N, D882N, D355N, D1157N, D581N, D803N, D1177N, D828N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002773991	16	23614812	16	23603491	2773991	2934722	rs2506195372	NC_000016.10:23603490:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3526A>G (p.Lys1176Glu)	PALB2	K1083E, K1097E, K1122E, K1152E, K1156E, K1176E, K354E, K580E, K802E, K827E, K881E	Hereditary cancer-predisposing syndrome	VCV003228035	16	23614815	16	23603494	3228035	3387804	rs2142251404	NC_000016.10:23603493:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3525A>G (p.Gln1175=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000183868	16	23614816	16	23603495	183868	184152	rs763513849	NC_000016.10:23603494:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3524A>G (p.Gln1175Arg)	PALB2	Q1175R	Familial cancer of breast	VCV001023494	16	23614817	16	23603496	1023494	1012021	rs1966395750	NC_000016.10:23603495:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3523C>T (p.Gln1175Ter)	PALB2	Q1175*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530070	16	23614818	16	23603497	530070	529753	rs1555457841	NC_000016.10:23603496:G:A	single nucleotide variant	nonsense	Pathogenic	Jan 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3521G>T (p.Gly1174Val)	PALB2	G1174V	Familial cancer of breast	VCV001376126	16	23614820	16	23603499	1376126	1466659	rs1286090287	NC_000016.10:23603498:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3520G>A (p.Gly1174Arg)	PALB2	G1174R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000186939	16	23614821	16	23603500	186939	184153	rs786203339	NC_000016.10:23603499:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3518C>G (p.Ala1173Gly)	PALB2	A824G, A878G, A1080G, A1149G, A1153G, A1173G, A351G, A577G, A799G, A1094G, A1119G	Hereditary cancer-predisposing syndrome	VCV002587417	16	23614823	16	23603502	2587417	2754093	rs146659762	NC_000016.10:23603501:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3518C>A (p.Ala1173Asp)	PALB2	A1173D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484241	16	23614823	16	23603502	484241	478008	rs146659762	NC_000016.10:23603501:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3518C>T (p.Ala1173Val)	PALB2	A1173V	not specified|Familial cancer of breast|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000460999	16	23614823	16	23603502	460999	466164	rs146659762	NC_000016.10:23603501:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3517G>C (p.Ala1173Pro)	PALB2	A1080P, A1094P, A1119P, A1149P, A1153P, A1173P, A351P, A577P, A799P, A824P, A878P	Hereditary cancer-predisposing syndrome	VCV003228034	16	23614824	16	23603503	3228034	3387803	rs1555457844	NC_000016.10:23603502:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3517G>A (p.Ala1173Thr)	PALB2	A1173T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480273	16	23614824	16	23603503	480273	477533	rs1555457844	NC_000016.10:23603502:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3517G>T (p.Ala1173Ser)	PALB2	A1173S	not specified|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000439235	16	23614824	16	23603503	439235	432874	rs1555457844	NC_000016.10:23603502:C:A	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3515T>G (p.Leu1172Arg)	PALB2	L1172R	Familial cancer of breast	VCV001372173	16	23614826	16	23603505	1372173	1365682	rs1555457845	NC_000016.10:23603504:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3515T>C (p.Leu1172Pro)	PALB2	L1172P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484186	16	23614826	16	23603505	484186	477458	rs1555457845	NC_000016.10:23603504:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3514C>G (p.Leu1172Val)	PALB2	L1172V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000918833	16	23614827	16	23603506	918833	913589	rs1966396230	NC_000016.10:23603505:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3513G>A (p.Leu1171=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001732184	16	23614828	16	23603507	1732184	1789215	rs1221176559	NC_000016.10:23603506:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Oct 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3513G>C (p.Leu1171Phe)	PALB2	L1171F	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000801240	16	23614828	16	23603507	801240	789600	rs1221176559	NC_000016.10:23603506:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3512T>C (p.Leu1171Ser)	PALB2	L1171S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001062367	16	23614829	16	23603508	1062367	1049506	rs2142251737	NC_000016.10:23603507:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3510T>C (p.His1170=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001577515	16	23614831	16	23603510	1577515	1553551	rs1966396385	NC_000016.10:23603509:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3509A>C (p.His1170Pro)	PALB2	H1077P, H1091P, H1170P, H348P, H796P, H875P, H1146P, H1150P, H1116P, H574P, H821P	Hereditary cancer-predisposing syndrome	VCV001732133	16	23614832	16	23603511	1732133	1789164	rs2142251815	NC_000016.10:23603510:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3508C>A (p.His1170Asn)	PALB2	H1170N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410119	16	23614833	16	23603512	410119	400993	rs200283306	NC_000016.10:23603511:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 3, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3508C>T (p.His1170Tyr)	PALB2	H1170Y	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary breast ovarian cancer syndrome	VCV000141320	16	23614833	16	23603512	141320	151034	rs200283306	NC_000016.10:23603511:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3507T>C (p.Ser1169=)	PALB2		Familial cancer of breast	VCV003903740	16	23614834	16	23603513	3903740	4019613		NC_000016.10:23603512:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3506C>G (p.Ser1169Cys)	PALB2	S1169C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460998	16	23614835	16	23603514	460998	466097	rs1555457848	NC_000016.10:23603513:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3505T>A (p.Ser1169Thr)	PALB2	S1090T, S347T, S1145T, S573T, S820T, S1115T, S1076T, S1149T, S1169T, S795T, S874T	Familial cancer of breast	VCV001901623	16	23614836	16	23603515	1901623	1957115	rs2142251927	NC_000016.10:23603514:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3504C>A (p.Asp1168Glu)	PALB2	D1114E, D1168E, D1075E, D1089E, D1144E, D1148E, D346E, D794E, D819E, D572E, D873E	Hereditary cancer-predisposing syndrome	VCV001732095	16	23614837	16	23603516	1732095	1789126	rs1966396729	NC_000016.10:23603515:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3504C>T (p.Asp1168=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001103563	16	23614837	16	23603516	1103563	1103692	rs1966396729	NC_000016.10:23603515:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3504C>G (p.Asp1168Glu)	PALB2	D1168E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830209	16	23614837	16	23603516	830209	818445	rs1966396729	NC_000016.10:23603515:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3501A>G (p.Thr1167=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002453301	16	23614840	16	23603519	2453301	2430361	rs2506195792	NC_000016.10:23603518:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3500C>G (p.Thr1167Arg)	PALB2	T1167R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000490085	16	23614841	16	23603520	490085	482871	rs1308784980	NC_000016.10:23603519:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3500C>T (p.Thr1167Ile)	PALB2	T1167I	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000482010	16	23614841	16	23603520	482010	477469	rs1308784980	NC_000016.10:23603519:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3499A>G (p.Thr1167Ala)	PALB2	T1167A	Familial cancer of breast	VCV000640632	16	23614842	16	23603521	640632	644378	rs1597061878	NC_000016.10:23603520:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3498T>C (p.Gly1166=)	PALB2		Familial cancer of breast	VCV003904071	16	23614843	16	23603522	3904071	4019944		NC_000016.10:23603521:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3498T>A (p.Gly1166=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001549113	16	23614843	16	23603522	1549113	1573228	rs2142252267	NC_000016.10:23603521:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3497G>A (p.Gly1166Asp)	PALB2	G1166D, G871D, G1073D, G1142D, G792D, G1146D, G570D, G817D, G1087D, G1112D, G344D	Familial cancer of breast	VCV002766338	16	23614844	16	23603523	2766338	2932243	rs2142252321	NC_000016.10:23603522:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3496G>T (p.Gly1166Cys)	PALB2	G1142C, G1087C, G1166C, G1112C, G1146C, G570C, G792C, G1073C, G344C, G817C, G871C	Familial cancer of breast	VCV002955821	16	23614845	16	23603524	2955821	3122217	rs1966397121	NC_000016.10:23603523:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3496G>A (p.Gly1166Ser)	PALB2	G1166S	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000860740	16	23614845	16	23603524	860740	843551	rs1966397121	NC_000016.10:23603523:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3495G>C (p.Ser1165=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000507527	16	23614846	16	23603525	507527	235149	rs45439097	NC_000016.10:23603524:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.3:c.3495T>G	PALB2		Familial cancer of breast	VCV000225860	16	23614846	16	23603525	225860	227678			single nucleotide variant		Likely benign	Jun 1, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.3495G>A (p.Ser1165=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified|Fanconi anemia complementation group N|Breast and/or ovarian cancer	VCV000126745	16	23614846	16	23603525	126745	132255	rs45439097	NC_000016.10:23603524:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3494C>G (p.Ser1165Trp)	PALB2	S1086W, S1111W, S1145W, S816W, S870W, S1072W, S1141W, S1165W, S343W, S569W, S791W	Hereditary cancer-predisposing syndrome	VCV001731971	16	23614847	16	23603526	1731971	1789003	rs773829275	NC_000016.10:23603525:G:C	single nucleotide variant	missense variant	Uncertain significance	May 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3494C>A (p.Ser1165Ter)	PALB2	S1165*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530199	16	23614847	16	23603526	530199	529827	rs773829275	NC_000016.10:23603525:G:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Sep 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3494C>T (p.Ser1165Leu)	PALB2	S1165L	Fanconi anemia complementation group N|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000232781	16	23614847	16	23603526	232781	235150	rs773829275	NC_000016.10:23603525:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3493T>C (p.Ser1165Pro)	PALB2	S1165P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460997	16	23614848	16	23603527	460997	466098	rs763591645	NC_000016.10:23603526:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3492G>A (p.Trp1164Ter)	PALB2	W1164*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000246354	16	23614849	16	23603528	246354	244943	rs587782217	NC_000016.10:23603527:C:T	single nucleotide variant	nonsense	Pathogenic	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3492G>T (p.Trp1164Cys)	PALB2	W1164C	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Familial cancer of breast	VCV000142079	16	23614849	16	23603528	142079	151793	rs587782217	NC_000016.10:23603527:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3491G>A (p.Trp1164Ter)	PALB2	W1164*	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000246129	16	23614850	16	23603529	246129	244944	rs879254113	NC_000016.10:23603528:C:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3490T>A (p.Trp1164Arg)	PALB2	W1164R	Hereditary cancer-predisposing syndrome	VCV000631109	16	23614851	16	23603530	631109	618348	rs751979432	NC_000016.10:23603529:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3490T>C (p.Trp1164Arg)	PALB2	W1164R	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000484211	16	23614851	16	23603530	484211	477420	rs751979432	NC_000016.10:23603529:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3488A>T (p.Lys1163Ile)	PALB2	K1163I	Hereditary cancer-predisposing syndrome	VCV000230169	16	23614853	16	23603532	230169	235151	rs876658426	NC_000016.10:23603531:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3487A>G (p.Lys1163Glu)	PALB2	K1163E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823829	16	23614854	16	23603533	823829	812642	rs145369260	NC_000016.10:23603532:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3486G>A (p.Val1162=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823828	16	23614855	16	23603534	823828	812643	rs1597061958	NC_000016.10:23603533:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3484G>A (p.Val1162Met)	PALB2	V1162M	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000410133	16	23614857	16	23603536	410133	401730	rs1060502752	NC_000016.10:23603535:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3483T>A (p.Phe1161Leu)	PALB2	F1068L, F1107L, F1137L, F1161L, F812L, F1082L, F1141L, F866L, F787L, F339L, F565L	Familial cancer of breast	VCV001953404	16	23614858	16	23603537	1953404	2010964	rs372686500	NC_000016.10:23603536:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3483T>C (p.Phe1161=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|not provided	VCV000126744	16	23614858	16	23603537	126744	132254	rs372686500	NC_000016.10:23603536:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3482T>C (p.Phe1161Ser)	PALB2	F1068S, F1082S, F1107S, F1137S, F1141S, F1161S, F339S, F565S, F787S, F812S, F866S	Familial cancer of breast	VCV003240017	16	23614859	16	23603538	3240017	3399005	rs2142252792	NC_000016.10:23603537:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 29, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3481T>G (p.Phe1161Val)	PALB2	F1161V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001415377	16	23614860	16	23603539	1415377	1374884	rs2142252804	NC_000016.10:23603538:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3479C>G (p.Ser1160Cys)	PALB2	S1067C, S1081C, S1106C, S1136C, S1140C, S1160C, S338C, S564C, S786C, S811C, S865C	Familial cancer of breast	VCV003617772	16	23614862	16	23603541	3617772	3746156		NC_000016.10:23603540:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3479C>T (p.Ser1160Phe)	PALB2	S1106F, S338F, S786F, S1081F, S1136F, S564F, S865F, S1067F, S1140F, S1160F, S811F	Hereditary cancer-predisposing syndrome	VCV002453303	16	23614862	16	23603541	2453303	2430363	rs2142252828	NC_000016.10:23603540:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 26, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3478T>G (p.Ser1160Ala)	PALB2	S1081A, S1106A, S564A, S1067A, S1140A, S1160A, S786A, S1136A, S338A, S811A, S865A	Hereditary cancer-predisposing syndrome	VCV001731808	16	23614863	16	23603542	1731808	1792711	rs2142252844	NC_000016.10:23603541:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3477G>A (p.Trp1159Ter)	PALB2	W1159*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000655696	16	23614864	16	23603543	655696	644379	rs1597061983	NC_000016.10:23603542:C:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3476G>T (p.Trp1159Leu)	PALB2	W1159L	not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000460996	16	23614865	16	23603544	460996	466165	rs587782050	NC_000016.10:23603543:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 8, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3476G>A (p.Trp1159Ter)	PALB2	W1159*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000141841	16	23614865	16	23603544	141841	151555	rs587782050	NC_000016.10:23603543:C:T	single nucleotide variant	nonsense	Pathogenic	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3475T>G (p.Trp1159Gly)	PALB2	W1159G	Familial cancer of breast	VCV001349050	16	23614866	16	23603545	1349050	1479061	rs876660792	NC_000016.10:23603544:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3475T>C (p.Trp1159Arg)	PALB2	W1159R	not specified|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000234009	16	23614866	16	23603545	234009	235153	rs876660792	NC_000016.10:23603544:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3474T>C (p.His1158=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000378321	16	23614867	16	23603546	378321	375246	rs730881896	NC_000016.10:23603545:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3474T>A (p.His1158Gln)	PALB2	H1158Q	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000182777	16	23614867	16	23603546	182777	180706	rs730881896	NC_000016.10:23603545:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3473A>G (p.His1158Arg)	PALB2	H1158R	Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000216756	16	23614868	16	23603547	216756	213150	rs45505500	NC_000016.10:23603546:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3472C>T (p.His1158Tyr)	PALB2	H1079Y, H784Y, H1134Y, H562Y, H863Y, H1158Y, H336Y, H809Y, H1065Y, H1104Y, H1138Y	Hereditary cancer-predisposing syndrome	VCV001731750	16	23614869	16	23603548	1731750	1792654	rs2142253005	NC_000016.10:23603547:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3471A>G (p.Gln1157=)	PALB2		Familial cancer of breast	VCV000853255	16	23614870	16	23603549	853255	843552	rs876659978	NC_000016.10:23603548:T:C	single nucleotide variant	synonymous variant	Likely benign	May 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3471A>C (p.Gln1157His)	PALB2	Q1157H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823812	16	23614870	16	23603549	823812	812644	rs876659978	NC_000016.10:23603548:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3471A>T (p.Gln1157His)	PALB2	Q1157H	Hereditary cancer-predisposing syndrome	VCV000232766	16	23614870	16	23603549	232766	235154	rs876659978	NC_000016.10:23603548:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.3470A>G (p.Gln1157Arg)	PALB2	Q1078R, Q1137R, Q1103R, Q1133R, Q561R, Q335R, Q783R, Q808R, Q862R, Q1064R, Q1157R	Hereditary cancer-predisposing syndrome	VCV002453312	16	23614871	16	23603550	2453312	2430372	rs1567205033	NC_000016.10:23603549:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 21, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3470A>C (p.Gln1157Pro)	PALB2	Q1157P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000628293	16	23614871	16	23603550	628293	618349	rs1567205033	NC_000016.10:23603549:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3469C>G (p.Gln1157Glu)	PALB2	Q1157E	Familial cancer of breast	VCV000839370	16	23614872	16	23603551	839370	843553	rs1597062038	NC_000016.10:23603550:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3469C>T (p.Gln1157Ter)	PALB2	Q1157*	Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Familial cancer of breast	VCV000823806	16	23614872	16	23603551	823806	812645	rs1597062038	NC_000016.10:23603550:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3465T>C (p.Ser1155=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823803	16	23614876	16	23603555	823803	812646	rs1597062045	NC_000016.10:23603554:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3464C>T (p.Ser1155Phe)	PALB2	S1062F, S1076F, S1155F, S559F, S860F, S1101F, S333F, S781F, S806F, S1135F, S1131F	Hereditary cancer-predisposing syndrome	VCV001731664	16	23614877	16	23603556	1731664	1792568	rs755609496	NC_000016.10:23603555:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3464C>G (p.Ser1155Cys)	PALB2	S1155C	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000402308	16	23614877	16	23603556	402308	389257	rs755609496	NC_000016.10:23603555:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3463T>A (p.Ser1155Thr)	PALB2	S1155T, S1062T, S1135T, S333T, S559T, S1076T, S1131T, S1101T, S781T, S806T, S860T	Familial cancer of breast	VCV002001602	16	23614878	16	23603557	2001602	2054803	rs1555457858	NC_000016.10:23603556:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3463T>C (p.Ser1155Pro)	PALB2	S1155P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530110	16	23614878	16	23603557	530110	529757	rs1555457858	NC_000016.10:23603556:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3461T>C (p.Val1154Ala)	PALB2	V1154A	Familial cancer of breast	VCV000940689	16	23614880	16	23603559	940689	937354	rs1966399348	NC_000016.10:23603558:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3460G>A (p.Val1154Ile)	PALB2	V1154I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823800	16	23614881	16	23603560	823800	812647	rs1597062059	NC_000016.10:23603559:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 16, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3459T>A (p.Pro1153=)	PALB2		Familial cancer of breast	VCV003680889	16	23614882	16	23603561	3680889	3818511		NC_000016.10:23603560:A:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Sep 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3459T>C (p.Pro1153=)	PALB2		Familial cancer of breast	VCV002730993	16	23614882	16	23603561	2730993	2893614	rs2142253354	NC_000016.10:23603560:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Sep 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3458C>G (p.Pro1153Arg)	PALB2	P1153R	Hereditary cancer-predisposing syndrome	VCV000823793	16	23614883	16	23603562	823793	812648	rs1567205039	NC_000016.10:23603561:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3458C>A (p.Pro1153His)	PALB2	P1153H	Hereditary cancer-predisposing syndrome	VCV000823792	16	23614883	16	23603562	823792	812649	rs1567205039	NC_000016.10:23603561:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3458C>T (p.Pro1153Leu)	PALB2	P1153L	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000628354	16	23614883	16	23603562	628354	618350	rs1567205039	NC_000016.10:23603561:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3457C>G (p.Pro1153Ala)	PALB2	P1060A, P1074A, P1099A, P1129A, P1133A, P1153A, P331A, P557A, P779A, P804A, P858A	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV002503305	16	23614884	16	23603563	2503305	2668486	rs1966399624	NC_000016.10:23603562:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Nov 29, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3457C>T (p.Pro1153Ser)	PALB2	P1153S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000836390	16	23614884	16	23603563	836390	843554	rs1966399624	NC_000016.10:23603562:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3456A>C (p.Pro1152=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003894022	16	23614885	16	23603564	3894022	4009903		NC_000016.10:23603563:T:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Aug 12, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3456A>G (p.Pro1152=)	PALB2		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV001658193	16	23614885	16	23603564	1658193	1594194	rs2142253411	NC_000016.10:23603563:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 14, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3455C>T (p.Pro1152Leu)	PALB2	P1152L	Hereditary cancer-predisposing syndrome	VCV000484202	16	23614886	16	23603565	484202	477471	rs1555457860	NC_000016.10:23603564:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.3454C>T (p.Pro1152Ser)	PALB2	P1059S, P1098S, P1073S, P556S, P1132S, P330S, P803S, P1128S, P1152S, P778S, P857S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002453287	16	23614887	16	23603566	2453287	2430347	rs2142253457	NC_000016.10:23603565:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3454C>A (p.Pro1152Thr)	PALB2	P1152T	Familial cancer of breast	VCV001462693	16	23614887	16	23603566	1462693	1433095	rs2142253457	NC_000016.10:23603565:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3453C>T (p.Leu1151=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830207	16	23614888	16	23603567	830207	818447	rs777315394	NC_000016.10:23603566:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3453C>G (p.Leu1151=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000230002	16	23614888	16	23603567	230002	235155	rs777315394	NC_000016.10:23603566:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3452T>A (p.Leu1151His)	PALB2	L1151H	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000182776	16	23614889	16	23603568	182776	180707	rs730881895	NC_000016.10:23603567:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3451C>T (p.Leu1151Phe)	PALB2	L1151F	Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000187089	16	23614890	16	23603569	187089	184154	rs786203462	NC_000016.10:23603568:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3450C>T (p.Leu1150=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001662185	16	23614891	16	23603570	1662185	1577067	rs2142253555	NC_000016.10:23603569:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3449T>C (p.Leu1150Pro)	PALB2	L1057P, L1071P, L1126P, L1150P, L554P, L801P, L855P, L1096P, L1130P, L328P, L776P	Hereditary cancer-predisposing syndrome	VCV001731530	16	23614892	16	23603571	1731530	1792435	rs45566737	NC_000016.10:23603570:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3449T>G (p.Leu1150Arg)	PALB2	L1150R	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000141936	16	23614892	16	23603571	141936	151650	rs45566737	NC_000016.10:23603570:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3448C>T (p.Leu1150Phe)	PALB2	L1150F	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000216755	16	23614893	16	23603572	216755	213151	rs863224787	NC_000016.10:23603571:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3447C>T (p.Ala1149=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823780	16	23614894	16	23603573	823780	812650	rs1555457863	NC_000016.10:23603572:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3447C>G (p.Ala1149=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460995	16	23614894	16	23603573	460995	466346	rs1555457863	NC_000016.10:23603572:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3445G>T (p.Ala1149Ser)	PALB2	A1095S, A1125S, A553S, A775S, A800S, A1149S, A1056S, A1129S, A327S, A854S, A1070S	Hereditary cancer-predisposing syndrome	VCV002567564	16	23614896	16	23603575	2567564	2731206	rs2142253674	NC_000016.10:23603574:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 3, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3445G>A (p.Ala1149Thr)	PALB2	A1056T, A1070T, A1129T, A327T, A775T, A1125T, A800T, A1095T, A1149T, A553T, A854T	Hereditary cancer-predisposing syndrome	VCV001731507	16	23614896	16	23603575	1731507	1792412	rs2142253674	NC_000016.10:23603574:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3444T>G (p.Thr1148=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001731500	16	23614897	16	23603576	1731500	1792405	rs778512231	NC_000016.10:23603575:A:C	single nucleotide variant	3 prime UTR variant|synonymous variant	Likely benign	Sep 12, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3444T>C (p.Thr1148=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000511935	16	23614897	16	23603576	511935	505718	rs778512231	NC_000016.10:23603575:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3443C>T (p.Thr1148Ile)	PALB2	T1148I	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001378609	16	23614898	16	23603577	1378609	1493039	rs2142253712	NC_000016.10:23603576:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3442A>G (p.Thr1148Ala)	PALB2	T1055A, T1124A, T774A, T1094A, T1069A, T1128A, T1148A, T326A, T552A, T799A, T853A	Familial cancer of breast	VCV002761043	16	23614899	16	23603578	2761043	2918337	rs2142253737	NC_000016.10:23603577:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3441T>A (p.Cys1147Ter)	PALB2	C1147*	Malignant tumor of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Familial cancer of breast	VCV000546008	16	23614900	16	23603579	546008	536456	rs1555457867	NC_000016.10:23603578:A:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3440G>A (p.Cys1147Tyr)	PALB2	C551Y, C1068Y, C1093Y, C1127Y, C1147Y, C325Y, C798Y, C1054Y, C1123Y, C773Y, C852Y	Hereditary cancer-predisposing syndrome	VCV003885182	16	23614901	16	23603580	3885182	4005504		NC_000016.10:23603579:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 3, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3439T>G (p.Cys1147Gly)	PALB2	C1068G, C1093G, C798G, C1054G, C1127G, C1147G, C773G, C1123G, C325G, C852G, C551G	Hereditary cancer-predisposing syndrome	VCV001731438	16	23614902	16	23603581	1731438	1795811	rs1433737234	NC_000016.10:23603580:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3439T>C (p.Cys1147Arg)	PALB2	C1147R	Hereditary cancer-predisposing syndrome	VCV000484208	16	23614902	16	23603581	484208	477535	rs1433737234	NC_000016.10:23603580:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3438G>T (p.Gln1146His)	PALB2	Q1126H, Q1146H, Q1067H, Q1122H, Q772H, Q324H, Q550H, Q797H, Q1053H, Q1092H, Q851H	Familial cancer of breast	VCV002850420	16	23614903	16	23603582	2850420	3016028	rs771827859	NC_000016.10:23603581:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3438G>A (p.Gln1146=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001731430	16	23614903	16	23603582	1731430	1795803	rs771827859	NC_000016.10:23603581:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3437A>T (p.Gln1146Leu)	PALB2	Q1146L	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV001050209	16	23614904	16	23603583	1050209	1038413	rs587780219	NC_000016.10:23603582:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3437A>G (p.Gln1146Arg)	PALB2	Q1146R	not provided	VCV000128141	16	23614904	16	23603583	128141	133598	rs587780219	NC_000016.10:23603582:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2013	criteria provided, single submitter							
NM_024675.4(PALB2):c.3436C>T (p.Gln1146Ter)	PALB2	Q1146*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460994	16	23614905	16	23603584	460994	466104	rs879254033	NC_000016.10:23603583:G:A	single nucleotide variant	nonsense	Pathogenic	Sep 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3436C>G (p.Gln1146Glu)	PALB2	Q1146E	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000246373	16	23614905	16	23603584	246373	244945	rs879254033	NC_000016.10:23603583:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3436C>A (p.Gln1146Lys)	PALB2	Q1146K	Hereditary cancer-predisposing syndrome|not provided|not specified|Familial cancer of breast	VCV000245984	16	23614905	16	23603584	245984	244946	rs879254033	NC_000016.10:23603583:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3434G>T (p.Gly1145Val)	PALB2	G1052V, G1066V, G1091V, G1125V, G1145V, G323V, G850V, G1121V, G549V, G771V, G796V	Hereditary cancer-predisposing syndrome	VCV001731405	16	23614907	16	23603586	1731405	1795778	rs1442377872	NC_000016.10:23603585:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3434G>A (p.Gly1145Asp)	PALB2	G1145D	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000823769	16	23614907	16	23603586	823769	812651	rs1442377872	NC_000016.10:23603585:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3433G>T (p.Gly1145Cys)	PALB2	G1145C	Hereditary cancer-predisposing syndrome|PALB2-related disorder|Familial cancer of breast	VCV000571430	16	23614908	16	23603587	571430	569921	rs180177137	NC_000016.10:23603586:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3433G>A (p.Gly1145Ser)	PALB2	G1145S	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000186101	16	23614908	16	23603587	186101	184155	rs180177137	NC_000016.10:23603586:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3433G>C (p.Gly1145Arg)	PALB2	G1145R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126742	16	23614908	16	23603587	126742	132252	rs180177137	NC_000016.10:23603586:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3432C>A (p.Leu1144=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000681706	16	23614909	16	23603588	681706	656357	rs748363227	NC_000016.10:23603587:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3432C>T (p.Leu1144=)	PALB2		not provided|not specified|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000415976	16	23614909	16	23603588	415976	401733	rs748363227	NC_000016.10:23603587:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Apr 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3432C>G (p.Leu1144=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000390708	16	23614909	16	23603588	390708	377358	rs748363227	NC_000016.10:23603587:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3431T>C (p.Leu1144Pro)	PALB2	L1144P	Hereditary cancer-predisposing syndrome	VCV000628361	16	23614910	16	23603589	628361	618351	rs1567205096	NC_000016.10:23603588:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3430C>A (p.Leu1144Ile)	PALB2	L1144I	Familial cancer of breast	VCV001369336	16	23614911	16	23603590	1369336	1414350	rs1966401863	NC_000016.10:23603589:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3430C>G (p.Leu1144Val)	PALB2	L1144V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000999967	16	23614911	16	23603590	999967	996783	rs1966401863	NC_000016.10:23603589:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3428T>G (p.Leu1143Arg)	PALB2	L1064R, L1089R, L321R, L769R, L848R, L1050R, L794R, L1119R, L1123R, L1143R, L547R	Hereditary cancer-predisposing syndrome	VCV003885211	16	23614913	16	23603592	3885211	4005533		NC_000016.10:23603591:A:C	single nucleotide variant	3 prime UTR variant|missense variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3428T>C (p.Leu1143Pro)	PALB2	L1143P	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000126741	16	23614913	16	23603592	126741	132251	rs62625284	NC_000016.10:23603591:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3428T>A (p.Leu1143His)	PALB2	L1143H	Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|not specified|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not provided	VCV000126740	16	23614913	16	23603592	126740	132250	rs62625284	NC_000016.10:23603591:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3427C>T (p.Leu1143Phe)	PALB2	L1143F, L769F, L794F, L1064F, L1123F, L1119F, L547F, L1050F, L1089F, L321F, L848F	Familial cancer of breast	VCV001987690	16	23614914	16	23603593	1987690	2040337	rs368694141	NC_000016.10:23603592:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3427C>G (p.Leu1143Val)	PALB2	L1143V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000650948	16	23614914	16	23603593	650948	644382	rs368694141	NC_000016.10:23603592:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3425T>G (p.Leu1142Ter)	PALB2	L1142*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000944864	16	23614916	16	23603595	944864	927699	rs1555457878	NC_000016.10:23603594:A:C	single nucleotide variant	nonsense	Pathogenic	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3425T>A (p.Leu1142Ter)	PALB2	L1142*	Familial cancer of breast|not provided	VCV000546010	16	23614916	16	23603595	546010	536457	rs1555457878	NC_000016.10:23603594:A:T	single nucleotide variant	nonsense	Pathogenic	Aug 29, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3423C>T (p.Asp1141=)	PALB2		Familial cancer of breast	VCV002719616	16	23614918	16	23603597	2719616	2870252	rs2142254174	NC_000016.10:23603596:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jun 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3422A>T (p.Asp1141Val)	PALB2	D1048V, D1062V, D1087V, D1117V, D1121V, D1141V, D319V, D545V, D767V, D792V, D846V	Breast-ovarian cancer, familial, susceptibility to, 5	VCV003780092	16	23614919	16	23603598	3780092	3896059		NC_000016.10:23603597:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3422A>G (p.Asp1141Gly)	PALB2	D1087G, D1121G, D1141G, D1048G, D545G, D767G, D792G, D846G, D1062G, D1117G, D319G	Hereditary cancer-predisposing syndrome	VCV001731284	16	23614919	16	23603598	1731284	1795657	rs2142254190	NC_000016.10:23603597:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3421G>C (p.Asp1141His)	PALB2	D1141H	Hereditary cancer-predisposing syndrome	VCV000490084	16	23614920	16	23603599	490084	482877	rs1064795975	NC_000016.10:23603598:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3421G>A (p.Asp1141Asn)	PALB2	D1141N	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000422752	16	23614920	16	23603599	422752	409510	rs1064795975	NC_000016.10:23603598:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3420G>T (p.Trp1140Cys)	PALB2	W1061C, W1086C, W1120C, W791C, W1140C, W318C, W766C, W1047C, W544C, W845C, W1116C	Hereditary cancer-predisposing syndrome	VCV001731271	16	23614921	16	23603600	1731271	1795644	rs878855118	NC_000016.10:23603599:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3420G>A (p.Trp1140Ter)	PALB2	W1140*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000241564	16	23614921	16	23603600	241564	242347	rs878855118	NC_000016.10:23603599:C:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jan 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3419G>A (p.Trp1140Ter)	PALB2	W1047*, W1061*, W1086*, W1116*, W1120*, W1140*, W318*, W544*, W766*, W791*, W845*	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5	VCV002673887	16	23614922	16	23603601	2673887	2841385	rs1060502809	NC_000016.10:23603600:C:T	single nucleotide variant	nonsense|3 prime UTR variant	Pathogenic/Likely pathogenic	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3419G>C (p.Trp1140Ser)	PALB2	W1140S	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000410219	16	23614922	16	23603601	410219	401470	rs1060502809	NC_000016.10:23603600:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3418T>C (p.Trp1140Arg)	PALB2	W1140R	Familial cancer of breast|not specified	VCV001425379	16	23614923	16	23603602	1425379	1431618	rs62625283	NC_000016.10:23603601:A:G	single nucleotide variant	missense variant	Uncertain significance	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3418T>A (p.Trp1140Arg)	PALB2	W1140R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000849533	16	23614923	16	23603602	849533	843555	rs62625283	NC_000016.10:23603601:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3418T>G (p.Trp1140Gly)	PALB2	W1140G	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000183828	16	23614923	16	23603602	183828	184157	rs62625283	NC_000016.10:23603601:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3417T>C (p.Ile1139=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001731225	16	23614924	16	23603603	1731225	1795598	rs876659632	NC_000016.10:23603602:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 3, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3417T>G (p.Ile1139Met)	PALB2	I1139M	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000232225	16	23614924	16	23603603	232225	235156	rs876659632	NC_000016.10:23603602:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3416T>C (p.Ile1139Thr)	PALB2	I790T, I1115T, I1119T, I1139T, I844T, I1046T, I1060T, I1085T, I317T, I543T, I765T	Familial cancer of breast	VCV002093470	16	23614925	16	23603604	2093470	2156550	rs2142254321	NC_000016.10:23603603:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3415A>G (p.Ile1139Val)	PALB2	I1139V	Familial cancer of breast|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000823746	16	23614926	16	23603605	823746	812652	rs1249960937	NC_000016.10:23603604:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3415A>T (p.Ile1139Phe)	PALB2	I1139F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530122	16	23614926	16	23603605	530122	530108	rs1249960937	NC_000016.10:23603604:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3415A>C (p.Ile1139Leu)	PALB2	I1139L	Familial cancer of breast	VCV000530116	16	23614926	16	23603605	530116	529762	rs1249960937	NC_000016.10:23603604:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.3414C>T (p.Ala1138=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001083446	16	23614927	16	23603606	1083446	1081878	rs2142254371	NC_000016.10:23603605:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3413C>G (p.Ala1138Gly)	PALB2	A1138G	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV001036197	16	23614928	16	23603607	1036197	1032508	rs1966403381	NC_000016.10:23603606:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3412G>A (p.Ala1138Thr)	PALB2	A1138T	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000231889	16	23614929	16	23603608	231889	235157	rs577651839	NC_000016.10:23603607:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3410T>A (p.Ile1137Asn)	PALB2	I1113N, I541N, I1044N, I1117N, I1137N, I763N, I842N, I1058N, I1083N, I315N, I788N	Familial cancer of breast	VCV002730716	16	23614931	16	23603610	2730716	2883451	rs868258231	NC_000016.10:23603609:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3410T>C (p.Ile1137Thr)	PALB2	I1137T	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000841057	16	23614931	16	23603610	841057	843556	rs868258231	NC_000016.10:23603609:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3409A>G (p.Ile1137Val)	PALB2	I1044V, I1058V, I1083V, I1113V, I1117V, I1137V, I315V, I541V, I763V, I788V, I842V	not provided	VCV003363690	16	23614932	16	23603611	3363690	3522899		NC_000016.10:23603610:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3409A>C (p.Ile1137Leu)	PALB2	I1058L, I315L, I1044L, I1083L, I1113L, I1137L, I788L, I1117L, I763L, I541L, I842L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001731145	16	23614932	16	23603611	1731145	1795519	rs2142254480	NC_000016.10:23603610:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3407C>T (p.Thr1136Ile)	PALB2	T1136I	Hereditary cancer-predisposing syndrome	VCV000928412	16	23614934	16	23603613	928412	913590	rs1966403655	NC_000016.10:23603612:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3406A>G (p.Thr1136Ala)	PALB2	T1082A, T1112A, T1057A, T762A, T1116A, T314A, T540A, T1043A, T1136A, T787A, T841A	Hereditary cancer-predisposing syndrome	VCV003303983	16	23614935	16	23603614	3303983	3470150		NC_000016.10:23603613:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Mar 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3404G>T (p.Gly1135Val)	PALB2	G1135V	Familial cancer of breast	VCV001007382	16	23614937	16	23603616	1007382	996784	rs730881894	NC_000016.10:23603615:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3404G>C (p.Gly1135Ala)	PALB2	G1135A	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000484212	16	23614937	16	23603616	484212	477473	rs730881894	NC_000016.10:23603615:C:G	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3404G>A (p.Gly1135Glu)	PALB2	G1135E	Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000182775	16	23614937	16	23603616	182775	180708	rs730881894	NC_000016.10:23603615:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 25, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3403G>A (p.Gly1135Arg)	PALB2	G1081R, G1135R, G761R, G1111R, G1115R, G840R, G1056R, G539R, G786R, G1042R, G313R	Familial cancer of breast	VCV002855788	16	23614938	16	23603617	2855788	3010869	rs2142254584	NC_000016.10:23603616:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3403G>T (p.Gly1135Ter)	PALB2	G1042*, G1056*, G1081*, G1111*, G1115*, G1135*, G313*, G539*, G761*, G786*, G840*	Familial cancer of breast	VCV002674130	16	23614938	16	23603617	2674130	2841620	rs2142254584	NC_000016.10:23603616:C:A	single nucleotide variant	nonsense|3 prime UTR variant	Pathogenic	Sep 15, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3402T>C (p.Ser1134=)	PALB2		Familial cancer of breast	VCV002027703	16	23614939	16	23603618	2027703	2077914	rs1966403904	NC_000016.10:23603617:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Feb 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3402T>A (p.Ser1134=)	PALB2		Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000888368	16	23614939	16	23603618	888368	874991	rs1966403904	NC_000016.10:23603617:A:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3401C>G (p.Ser1134Cys)	PALB2	S1041C, S1055C, S1080C, S1110C, S1114C, S1134C, S312C, S538C, S760C, S785C, S839C	not provided	VCV003027112	16	23614940	16	23603619	3027112	3187421	rs2142254621	NC_000016.10:23603618:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 1, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3401C>A (p.Ser1134Tyr)	PALB2	S1114Y, S312Y, S760Y, S1080Y, S1110Y, S1055Y, S1134Y, S538Y, S1041Y, S785Y, S839Y	Hereditary cancer-predisposing syndrome	VCV001731073	16	23614940	16	23603619	1731073	1795447	rs2142254621	NC_000016.10:23603618:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3399T>C (p.Thr1133=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000485997	16	23614942	16	23603621	485997	477427	rs1555457883	NC_000016.10:23603620:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.3397A>T (p.Thr1133Ser)	PALB2	T1054S, T311S, T1079S, T1113S, T784S, T1040S, T537S, T759S, T838S, T1109S, T1133S	Familial cancer of breast	VCV002762083	16	23614944	16	23603623	2762083	2930579	rs2142254680	NC_000016.10:23603622:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3397A>G (p.Thr1133Ala)	PALB2	T1113A, T1133A, T537A, T784A, T1109A, T838A, T1040A, T1079A, T759A, T1054A, T311A	Hereditary cancer-predisposing syndrome	VCV001730951	16	23614944	16	23603623	1730951	1785939	rs2142254680	NC_000016.10:23603622:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3396G>A (p.Leu1132=)	PALB2		Familial cancer of breast	VCV003903827	16	23614945	16	23603624	3903827	4019700		NC_000016.10:23603623:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3396G>C (p.Leu1132Phe)	PALB2	L1078F, L1039F, L1132F, L310F, L536F, L837F, L1053F, L1108F, L1112F, L758F, L783F	Hereditary cancer-predisposing syndrome	VCV003413488	16	23614945	16	23603624	3413488	3574711		NC_000016.10:23603623:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3395T>C (p.Leu1132Ser)	PALB2	L1132S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001478871	16	23614946	16	23603625	1478871	1430106	rs1597062296	NC_000016.10:23603624:A:G	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3395T>A (p.Leu1132Ter)	PALB2	L1132*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823717	16	23614946	16	23603625	823717	812653	rs1597062296	NC_000016.10:23603624:A:T	single nucleotide variant	nonsense	Pathogenic	Sep 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3394T>C (p.Leu1132=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N	VCV000460993	16	23614947	16	23603626	460993	466348	rs1282821765	NC_000016.10:23603625:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3392T>C (p.Ile1131Thr)	PALB2	I1131T	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not provided	VCV000229790	16	23614949	16	23603628	229790	235160	rs876658196	NC_000016.10:23603627:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3391A>G (p.Ile1131Val)	PALB2	I1131V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Familial cancer of breast|not specified	VCV000410163	16	23614950	16	23603629	410163	401480	rs774517454	NC_000016.10:23603628:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3389C>T (p.Ala1130Val)	PALB2	A1106V, A534V, A835V, A1037V, A1076V, A1130V, A308V, A756V, A1110V, A1051V, A781V	Familial cancer of breast	VCV002858150	16	23614952	16	23603631	2858150	3018196	rs2142254891	NC_000016.10:23603630:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3388G>C (p.Ala1130Pro)	PALB2	A1037P, A534P, A756P, A835P, A1130P, A308P, A1106P, A781P, A1051P, A1076P, A1110P	Hereditary cancer-predisposing syndrome	VCV001730868	16	23614953	16	23603632	1730868	1785856	rs2142254906	NC_000016.10:23603631:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3386C>A (p.Ala1129Glu)	PALB2	A1129E	Familial cancer of breast	VCV001483004	16	23614955	16	23603634	1483004	1464987	rs1567205179	NC_000016.10:23603633:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3386C>T (p.Ala1129Val)	PALB2	A1129V	Familial cancer of breast|not provided	VCV000560876	16	23614955	16	23603634	560876	551913	rs1567205179	NC_000016.10:23603633:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3385G>C (p.Ala1129Pro)	PALB2	A1129P	Familial cancer of breast	VCV001465292	16	23614956	16	23603635	1465292	1511116	rs1966404823	NC_000016.10:23603634:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3385G>A (p.Ala1129Thr)	PALB2	A1129T	Familial cancer of breast	VCV001352446	16	23614956	16	23603635	1352446	1505656	rs1966404823	NC_000016.10:23603634:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3385G>T (p.Ala1129Ser)	PALB2	A1129S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000923808	16	23614956	16	23603635	923808	913592	rs1966404823	NC_000016.10:23603634:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3384A>C (p.Ala1128=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001172405	16	23614957	16	23603636	1172405	1161310	rs2142254978	NC_000016.10:23603635:T:G	single nucleotide variant	synonymous variant	Likely benign	Jun 22, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3383C>G (p.Ala1128Gly)	PALB2	A1128G	Familial cancer of breast	VCV000845423	16	23614958	16	23603637	845423	843557	rs1966404870	NC_000016.10:23603636:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3381T>G (p.Cys1127Trp)	PALB2	C1034W, C1048W, C1073W, C1103W, C1107W, C1127W, C305W, C531W, C753W, C778W, C832W	Familial cancer of breast	VCV001720453	16	23614960	16	23603639	1720453	1776635	rs2142255050	NC_000016.10:23603638:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3380G>A (p.Cys1127Tyr)	PALB2	C1048Y, C1073Y, C753Y, C778Y, C305Y, C531Y, C1107Y, C832Y, C1034Y, C1103Y, C1127Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001730821	16	23614961	16	23603640	1730821	1785809	rs759944815	NC_000016.10:23603639:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 16, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3379T>C (p.Cys1127Arg)	PALB2	C1127R	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Ovarian cancer|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Hereditary breast ovarian cancer syndrome|not provided	VCV000490083	16	23614962	16	23603641	490083	482916	rs767830005	NC_000016.10:23603640:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3378C>T (p.His1126=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002773992	16	23614963	16	23603642	2773992	2934723	rs2506197725	NC_000016.10:23603641:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3377A>G (p.His1126Arg)	PALB2	H1126R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001465799	16	23614964	16	23603643	1465799	1354031	rs752373316	NC_000016.10:23603642:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3377A>T (p.His1126Leu)	PALB2	H1126L	Hereditary cancer-predisposing syndrome	VCV000923632	16	23614964	16	23603643	923632	913593	rs752373316	NC_000016.10:23603642:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3377A>C (p.His1126Pro)	PALB2	H1126P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000229867	16	23614964	16	23603643	229867	235161	rs752373316	NC_000016.10:23603642:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3376C>G (p.His1126Asp)	PALB2	H1102D, H1106D, H304D, H831D, H1047D, H777D, H1126D, H1033D, H1072D, H530D, H752D	Hereditary cancer-predisposing syndrome	VCV003927447	16	23614965	16	23603644	3927447	4047080		NC_000016.10:23603643:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3376C>T (p.His1126Tyr)	PALB2	H1126Y, H530Y, H1072Y, H831Y, H1047Y, H304Y, H752Y, H1033Y, H1102Y, H1106Y, H777Y	Hereditary cancer-predisposing syndrome	VCV002567571	16	23614965	16	23603644	2567571	2731213	rs2142255133	NC_000016.10:23603643:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3375T>A (p.Asp1125Glu)	PALB2	D1046E, D529E, D830E, D1101E, D1105E, D303E, D776E, D1125E, D751E, D1032E, D1071E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002117473	16	23614966	16	23603645	2117473	2183114	rs1555457887	NC_000016.10:23603644:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3375T>C (p.Asp1125=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000485996	16	23614966	16	23603645	485996	477431	rs1555457887	NC_000016.10:23603644:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3374A>C (p.Asp1125Ala)	PALB2	D1032A, D1046A, D1071A, D529A, D1105A, D303A, D830A, D1101A, D1125A, D751A, D776A	Hereditary cancer-predisposing syndrome	VCV003413505	16	23614967	16	23603646	3413505	3574728		NC_000016.10:23603645:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3374A>T (p.Asp1125Val)	PALB2	D1125V	Familial cancer of breast	VCV000957342	16	23614967	16	23603646	957342	949300	rs1966405277	NC_000016.10:23603645:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3373G>A (p.Asp1125Asn)	PALB2	D1105N, D751N, D1101N, D303N, D529N, D1071N, D1032N, D1046N, D1125N, D776N, D830N	Hereditary cancer-predisposing syndrome	VCV003413413	16	23614968	16	23603647	3413413	3574636		NC_000016.10:23603646:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Nov 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3373G>C (p.Asp1125His)	PALB2	D1125H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000629852	16	23614968	16	23603647	629852	618352	rs146444298	NC_000016.10:23603646:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3373G>T (p.Asp1125Tyr)	PALB2	D1125Y	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000220669	16	23614968	16	23603647	220669	222454	rs146444298	NC_000016.10:23603646:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3372A>G (p.Lys1124=)	PALB2		Familial cancer of breast	VCV003903625	16	23614969	16	23603648	3903625	4019498		NC_000016.10:23603647:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3369G>C (p.Val1123=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628660	16	23614972	16	23603651	628660	618353	rs753357848	NC_000016.10:23603650:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3369G>A (p.Val1123=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460992	16	23614972	16	23603651	460992	466105	rs753357848	NC_000016.10:23603650:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3367G>T (p.Val1123Leu)	PALB2	V774L, V301L, V527L, V749L, V1044L, V1123L, V828L, V1030L, V1069L, V1099L, V1103L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003413453	16	23614974	16	23603653	3413453	3574676		NC_000016.10:23603652:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3367G>C (p.Val1123Leu)	PALB2	V1123L	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV001337182	16	23614974	16	23603653	1337182	1328192	rs757118000	NC_000016.10:23603652:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3367G>A (p.Val1123Met)	PALB2	V1123M	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|not provided	VCV000185518	16	23614974	16	23603653	185518	184158	rs757118000	NC_000016.10:23603652:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3366C>A (p.Asp1122Glu)	PALB2	D1122E	Familial cancer of breast	VCV000225857	16	23614975	16	23603654	225857	227661	rs373783514	NC_000016.10:23603653:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.3366C>T (p.Asp1122=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000136137	16	23614975	16	23603654	136137	139849	rs373783514	NC_000016.10:23603653:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3365A>T (p.Asp1122Val)	PALB2	D1122V	not provided	VCV000449880	16	23614976	16	23603655	449880	445543	rs1555457892	NC_000016.10:23603654:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.3364G>A (p.Asp1122Asn)	PALB2	D1029N, D1043N, D1068N, D1098N, D1102N, D1122N, D300N, D526N, D748N, D773N, D827N	Familial cancer of breast	VCV001719430	16	23614977	16	23603656	1719430	1774734	rs540276838	NC_000016.10:23603655:C:T	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Oct 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3362G>A (p.Gly1121Asp)	PALB2	G1121D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000576760	16	23614979	16	23603658	576760	567936	rs62625282	NC_000016.10:23603657:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3361G>A (p.Gly1121Ser)	PALB2	G1121S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823663	16	23614980	16	23603659	823663	812654	rs1597062387	NC_000016.10:23603658:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3358G>C (p.Glu1120Gln)	PALB2	E1120Q	Familial cancer of breast	VCV001360580	16	23614983	16	23603662	1360580	1360146	rs876658773	NC_000016.10:23603661:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3358G>A (p.Glu1120Lys)	PALB2	E1120K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000482046	16	23614983	16	23603662	482046	477536	rs876658773	NC_000016.10:23603661:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3358G>T (p.Glu1120Ter)	PALB2	E1120*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000230789	16	23614983	16	23603662	230789	235162	rs876658773	NC_000016.10:23603661:C:A	single nucleotide variant	nonsense	Pathogenic	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3357G>A (p.Leu1119=)	PALB2		Familial cancer of breast	VCV001609031	16	23614984	16	23603663	1609031	1573901	rs1966406468	NC_000016.10:23603662:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3356T>C (p.Leu1119Pro)	PALB2	L1119P	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3	VCV000126738	16	23614985	16	23603664	126738	132248	rs515726116	NC_000016.10:23603663:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3355C>G (p.Leu1119Val)	PALB2	L1026V, L1040V, L1065V, L1095V, L1099V, L1119V, L297V, L523V, L745V, L770V, L824V, P1015R, P1069R, P473R, P774R	Hereditary cancer-predisposing syndrome	VCV003894023	16	23614986	16	23603665	3894023	4009904		NC_000016.10:23603664:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3355C>T (p.Leu1119=)	PALB2		Familial cancer of breast	VCV000241563	16	23614986	16	23603665	241563	242348	rs748338957	NC_000016.10:23603664:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3354C>T (p.Phe1118=)	PALB2	P1069S, P473S, P1015S, P774S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001988520	16	23614987	16	23603666	1988520	2047668	rs2142255608	NC_000016.10:23603665:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Aug 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3353T>A (p.Phe1118Tyr)	PALB2	F1118Y	Familial cancer of breast	VCV000951112	16	23614988	16	23603667	951112	927700	rs1966406795	NC_000016.10:23603666:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3351G>C (p.Arg1117Ser)	PALB2	R1024S, R1063S, R1117S, R521S, R768S, V773L, W1038C, R1093S, V1014L, R295S, V1068L, V472L, W743C, R1097S, R822S	Familial cancer of breast	VCV002125362	16	23614990	16	23603669	2125362	2177963	rs1966406887	NC_000016.10:23603668:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3351G>A (p.Arg1117=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001053913	16	23614990	16	23603669	1053913	1049507	rs1966406887	NC_000016.10:23603668:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 9, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3351-1G>A	PALB2		Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV001072355	16	23614991	16	23603670	1072355	1063565	rs1597062406	NC_000016.10:23603669:C:T	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Jun 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-1G>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823650	16	23614991	16	23603670	823650	815622	rs1597062406	NC_000016.10:23603669:C:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-2A>T	PALB2		not provided|Hereditary cancer-predisposing syndrome	VCV001713229	16	23614992	16	23603671	1713229	1770742	rs1060502764	NC_000016.10:23603670:T:A	single nucleotide variant	splice acceptor variant	Conflicting classifications of pathogenicity	Nov 1, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3351-2A>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000410152	16	23614992	16	23603671	410152	401481	rs1060502764	NC_000016.10:23603670:T:C	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-3C>G	PALB2		not provided	VCV003367432	16	23614993	16	23603672	3367432	3526631		NC_000016.10:23603671:G:C	single nucleotide variant	intron variant	Uncertain significance	Dec 31, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3351-4T>A	PALB2		Hereditary cancer-predisposing syndrome	VCV000823651	16	23614994	16	23603673	823651	815623	rs777945799	NC_000016.10:23603672:A:T	single nucleotide variant	intron variant	Uncertain significance	Oct 31, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3351-4T>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460991	16	23614994	16	23603673	460991	466351	rs777945799	NC_000016.10:23603672:A:G	single nucleotide variant	intron variant	Likely benign	Apr 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-5A>G	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481026	16	23614995	16	23603674	481026	477433	rs749386551	NC_000016.10:23603673:T:C	single nucleotide variant	intron variant	Likely benign	Mar 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-5A>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000186020	16	23614995	16	23603674	186020	184159	rs749386551	NC_000016.10:23603673:T:G	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-6T>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530236	16	23614996	16	23603675	530236	529834	rs770987416	NC_000016.10:23603674:A:G	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-7C>T	PALB2		Familial cancer of breast	VCV001698828	16	23614997	16	23603676	1698828	1691204	rs2142255767	NC_000016.10:23603675:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3351-9T>C	PALB2		not specified|Familial cancer of breast	VCV000391935	16	23614999	16	23603678	391935	377361	rs1057524295	NC_000016.10:23603677:A:G	single nucleotide variant	intron variant	Likely benign	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-10A>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000926571	16	23615000	16	23603679	926571	916409	rs1057517611	NC_000016.10:23603678:T:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 18, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3351-10A>G	PALB2		Familial cancer of breast	VCV000371998	16	23615000	16	23603679	371998	358900	rs1057517611	NC_000016.10:23603678:T:C	single nucleotide variant	intron variant	Likely benign	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-12G>C	PALB2		Familial cancer of breast	VCV003904309	16	23615002	16	23603681	3904309	4020181		NC_000016.10:23603680:C:G	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3351-12G>A	PALB2		Familial cancer of breast	VCV003639667	16	23615002	16	23603681	3639667	3765012		NC_000016.10:23603680:C:T	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-13T>C	PALB2		Familial cancer of breast	VCV003903953	16	23615003	16	23603682	3903953	4019826		NC_000016.10:23603681:A:G	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3351-16C>T	PALB2		Familial cancer of breast	VCV002718269	16	23615006	16	23603685	2718269	2880512	rs1424095743	NC_000016.10:23603684:G:A	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-19C>T	PALB2		Familial cancer of breast	VCV003904287	16	23615009	16	23603688	3904287	4020160		NC_000016.10:23603687:G:A	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3351-19C>G	PALB2		Familial cancer of breast	VCV002703511	16	23615009	16	23603688	2703511	2859802	rs1260530091	NC_000016.10:23603687:G:C	single nucleotide variant	intron variant	Likely benign	Dec 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3351-19C>A	PALB2		Hereditary cancer-predisposing syndrome	VCV000921787	16	23615009	16	23603688	921787	916414	rs1260530091	NC_000016.10:23603687:G:T	single nucleotide variant	intron variant	Likely benign	Feb 25, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3351-20T>A	PALB2		Familial cancer of breast	VCV002727677	16	23615010	16	23603689	2727677	2892883	rs2506198199	NC_000016.10:23603688:A:T	single nucleotide variant	intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3351-41G>A	PALB2		not specified	VCV001697751	16	23615031	16	23603710	1697751	1690135	rs372107434	NC_000016.10:23603709:C:T	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3351-48G>T	PALB2		not provided|Familial cancer of breast	VCV000803230	16	23615038	16	23603717	803230	791563	rs201335445	NC_000016.10:23603716:C:A	single nucleotide variant	intron variant	Benign/Likely benign	Aug 11, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3350+50T>C	PALB2		Hereditary breast ovarian cancer syndrome	VCV001678965	16	23619135	16	23607814	1678965	1670759	rs1387953876	NC_000016.10:23607813:A:G	single nucleotide variant	intron variant	Likely benign	Apr 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3350+39C>G	PALB2		not specified	VCV001697752	16	23619146	16	23607825	1697752	1690136	rs568248665	NC_000016.10:23607824:G:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3350+19T>A	PALB2		Hereditary cancer-predisposing syndrome	VCV000923729	16	23619166	16	23607845	923729	916417	rs1966504406	NC_000016.10:23607844:A:T	single nucleotide variant	intron variant	Likely benign	Aug 7, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3350+16T>G	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3	VCV000126736	16	23619169	16	23607848	126736	132246	rs515726115	NC_000016.10:23607847:A:C	single nucleotide variant	intron variant	Likely benign	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3350+15C>T	PALB2		Familial cancer of breast	VCV001667542	16	23619170	16	23607849	1667542	1656826	rs2142270880	NC_000016.10:23607848:G:A	single nucleotide variant	intron variant	Likely benign	Dec 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3350+14A>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628455	16	23619171	16	23607850	628455	619521	rs749584711	NC_000016.10:23607849:T:C	single nucleotide variant	intron variant	Likely benign	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3350+11A>C	PALB2		Familial cancer of breast	VCV001668243	16	23619174	16	23607853	1668243	1570108	rs515726114	NC_000016.10:23607852:T:G	single nucleotide variant	intron variant	Likely benign	Jun 17, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3350+11A>G	PALB2		Familial cancer of breast|not specified|Fanconi anemia complementation group N	VCV000126735	16	23619174	16	23607853	126735	132245	rs515726114	NC_000016.10:23607852:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3350+9G>C	PALB2		not specified	VCV001172894	16	23619176	16	23607855	1172894	1162081	rs1966504683	NC_000016.10:23607854:C:G	single nucleotide variant	intron variant	Uncertain significance	May 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3350+9G>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000927309	16	23619176	16	23607855	927309	916700	rs1966504683	NC_000016.10:23607854:C:T	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3350+8T>A	PALB2		Familial cancer of breast	VCV002993429	16	23619177	16	23607856	2993429	3144747	rs2142270964	NC_000016.10:23607855:A:T	single nucleotide variant	intron variant	Likely benign	May 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3350+7G>A	PALB2		Familial cancer of breast	VCV003903975	16	23619178	16	23607857	3903975	4019848		NC_000016.10:23607856:C:T	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3350+7G>C	PALB2		Familial cancer of breast	VCV001158292	16	23619178	16	23607857	1158292	1145997	rs2142270979	NC_000016.10:23607856:C:G	single nucleotide variant	intron variant	Likely benign	Jun 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3350+6T>C	PALB2		Familial cancer of breast	VCV000581074	16	23619179	16	23607858	581074	569926	rs1567206733	NC_000016.10:23607857:A:G	single nucleotide variant	intron variant	Pathogenic	Nov 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3350+5G>A	PALB2		Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast	VCV000142586	16	23619180	16	23607859	142586	152300	rs587782566	NC_000016.10:23607858:C:T	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3350+4A>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482036	16	23619181	16	23607860	482036	477542	rs180177136	NC_000016.10:23607859:T:G	single nucleotide variant	intron variant	Likely pathogenic	Jul 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3350+4A>G	PALB2		Familial cancer of breast	VCV000126737	16	23619181	16	23607860	126737	132247	rs180177136	NC_000016.10:23607859:T:C	single nucleotide variant	intron variant	Likely pathogenic	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.3350+2C>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002673828	16	23619183	16	23607862	2673828	2841331	rs1555458171	NC_000016.10:23607861:G:T	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3350+2C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001730510	16	23619183	16	23607862	1730510	1788844	rs1555458171	NC_000016.10:23607861:G:A	single nucleotide variant	intron variant|splice donor variant	Conflicting classifications of pathogenicity	Dec 19, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3350+2C>G	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492218	16	23619183	16	23607862	492218	484796	rs1555458171	NC_000016.10:23607861:G:C	single nucleotide variant	intron variant|splice donor variant	Likely pathogenic	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3350+1G>C	PALB2		not provided|Familial cancer of breast	VCV003337433	16	23619184	16	23607863	3337433	3496095		NC_000016.10:23607862:C:G	single nucleotide variant	intron variant|splice donor variant	Likely pathogenic	Dec 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3350+1G>A	PALB2		Familial cancer of breast	VCV000219641	16	23619184	16	23607863	219641	222455	rs864622192	NC_000016.10:23607862:C:T	single nucleotide variant	intron variant|splice donor variant	Pathogenic/Likely pathogenic	Dec 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3350G>A (p.Arg1117Lys)	PALB2	R1117K	Familial cancer of breast	VCV000232594	16	23619185	16	23607864	232594	235163	rs876659859	NC_000016.10:23607863:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.3349A>G (p.Arg1117Gly)	PALB2	R1117G, R768G, R1063G, R295G, R822G, R1024G, R1093G, R1097G, R521G	Hereditary cancer-predisposing syndrome	VCV001730484	16	23619186	16	23607865	1730484	1788818	rs2142271079	NC_000016.10:23607864:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3348C>T (p.Gly1116=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001050999	16	23619187	16	23607866	1050999	1049508	rs746346966	NC_000016.10:23607865:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3347G>A (p.Gly1116Asp)	PALB2	G1116D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000656676	16	23619188	16	23607867	656676	644383	rs1597066554	NC_000016.10:23607866:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3346G>A (p.Gly1116Ser)	PALB2	G1062S, G1092S, G1116S, G1096S, G294S, G520S, G767S, G1023S, G821S	Familial cancer of breast|not specified	VCV002853557	16	23619189	16	23607868	2853557	3013356	rs2142271126	NC_000016.10:23607867:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3344C>T (p.Ala1115Val)	PALB2	A1115V	Familial cancer of breast	VCV000947931	16	23619191	16	23607870	947931	927701	rs1203633436	NC_000016.10:23607869:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3343G>T (p.Ala1115Ser)	PALB2	A1022S, A1061S, A1115S, A766S, A1095S, A293S, A519S, A1091S, A820S	Hereditary cancer-predisposing syndrome	VCV002562471	16	23619192	16	23607871	2562471	2717313	rs1567206747	NC_000016.10:23607870:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 9, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3343G>A (p.Ala1115Thr)	PALB2	A1115T	Familial cancer of breast	VCV000649602	16	23619192	16	23607871	649602	644384	rs1567206747	NC_000016.10:23607870:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3343G>C (p.Ala1115Pro)	PALB2	A1115P	Hereditary cancer-predisposing syndrome	VCV000629280	16	23619192	16	23607871	629280	618354	rs1567206747	NC_000016.10:23607870:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3342G>C (p.Gln1114His)	PALB2	Q1114H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000582957	16	23619193	16	23607872	582957	573910	rs1567206753	NC_000016.10:23607871:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3341A>T (p.Gln1114Leu)	PALB2	Q1060L, Q1094L, Q1114L, Q1090L, Q518L, Q765L, Q1021L, Q292L, Q819L	Hereditary cancer-predisposing syndrome	VCV003885219	16	23619194	16	23607873	3885219	4005541		NC_000016.10:23607872:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 2, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3340C>T (p.Gln1114Ter)	PALB2	Q1114*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000577564	16	23619195	16	23607874	577564	567937	rs1567206756	NC_000016.10:23607873:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3339G>T (p.Gly1113=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001730378	16	23619196	16	23607875	1730378	1788712	rs1555458175	NC_000016.10:23607874:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 24, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3339G>A (p.Gly1113=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480260	16	23619196	16	23607875	480260	477475	rs1555458175	NC_000016.10:23607874:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 16, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3337G>C (p.Gly1113Arg)	PALB2	G1020R, G1059R, G1089R, G1093R, G1113R, G291R, G517R, G764R, G818R	Hereditary cancer-predisposing syndrome	VCV003893760	16	23619198	16	23607877	3893760	4009641		NC_000016.10:23607876:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3337G>A (p.Gly1113Arg)	PALB2	G1020R, G1059R, G1089R, G1093R, G1113R, G291R, G517R, G764R, G818R	Breast-ovarian cancer, familial, susceptibility to, 5	VCV003393439	16	23619198	16	23607877	3393439	3552515		NC_000016.10:23607876:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3334C>A (p.Pro1112Thr)	PALB2	P290T, P516T, P1088T, P1092T, P1112T, P763T, P817T, P1019T, P1058T	Hereditary cancer-predisposing syndrome	VCV003413452	16	23619201	16	23607880	3413452	3574675		NC_000016.10:23607879:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 12, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3334C>T (p.Pro1112Ser)	PALB2	P1112S	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001396504	16	23619201	16	23607880	1396504	1418255	rs2142271325	NC_000016.10:23607879:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3333T>A (p.Pro1111=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000759716	16	23619202	16	23607881	759716	770766	rs1597066587	NC_000016.10:23607880:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3332C>T (p.Pro1111Leu)	PALB2	P1111L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Fanconi anemia complementation group N	VCV000665824	16	23619203	16	23607882	665824	644385	rs772480747	NC_000016.10:23607881:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3331C>T (p.Pro1111Ser)	PALB2	P1111S	Familial cancer of breast	VCV001063569	16	23619204	16	23607883	1063569	1049509	rs864622193	NC_000016.10:23607882:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3331C>G (p.Pro1111Ala)	PALB2	P1111A	Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000219647	16	23619204	16	23607883	219647	222456	rs864622193	NC_000016.10:23607882:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3328C>G (p.Leu1110Val)	PALB2	L1110V	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000241561	16	23619207	16	23607886	241561	242349	rs878855117	NC_000016.10:23607885:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3327T>A (p.Cys1109Ter)	PALB2	C1016*, C1055*, C1085*, C1089*, C1109*, C287*, C513*, C760*, C814*	Hereditary breast ovarian cancer syndrome	VCV002687483	16	23619208	16	23607887	2687483	2848519	rs2142271504	NC_000016.10:23607886:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jan 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3327T>C (p.Cys1109=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001332574	16	23619208	16	23607887	1332574	1323292	rs2142271504	NC_000016.10:23607886:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3326G>A (p.Cys1109Tyr)	PALB2	C1109Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823610	16	23619209	16	23607888	823610	812655	rs1597066628	NC_000016.10:23607887:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3325T>C (p.Cys1109Arg)	PALB2	C1109R	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000410196	16	23619210	16	23607889	410196	400995	rs911734555	NC_000016.10:23607888:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3324C>T (p.Tyr1108=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000921295	16	23619211	16	23607890	921295	913594	rs1218512317	NC_000016.10:23607889:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3324C>G (p.Tyr1108Ter)	PALB2	Y1108*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000460990	16	23619211	16	23607890	460990	466111	rs1218512317	NC_000016.10:23607889:G:C	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3324C>A (p.Tyr1108Ter)	PALB2	Y1108*	Hereditary cancer-predisposing syndrome|not provided	VCV000450256	16	23619211	16	23607890	450256	445544	rs1218512317	NC_000016.10:23607889:G:T	single nucleotide variant	nonsense	Likely pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3321G>A (p.Leu1107=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126733	16	23619214	16	23607893	126733	132243	rs515726113	NC_000016.10:23607892:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3320T>C (p.Leu1107Pro)	PALB2	L1107P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|not specified|Familial cancer of breast	VCV000142465	16	23619215	16	23607894	142465	152179	rs149194681	NC_000016.10:23607893:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3318G>A (p.Met1106Ile)	PALB2	M1013I, M1052I, M811I, M284I, M757I, M1082I, M1086I, M1106I, M510I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003019194	16	23619217	16	23607896	3019194	3175558	rs2142271677	NC_000016.10:23607895:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3317T>C (p.Met1106Thr)	PALB2	M1106T	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000460989	16	23619218	16	23607897	460989	466173	rs769065406	NC_000016.10:23607896:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3315G>A (p.Val1105=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001730129	16	23619220	16	23607899	1730129	1792335	rs2142271728	NC_000016.10:23607898:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3314T>C (p.Val1105Ala)	PALB2	V1105A	Familial cancer of breast	VCV001521309	16	23619221	16	23607900	1521309	1446962	rs2142271779	NC_000016.10:23607899:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3312T>G (p.Gly1104=)	PALB2		Familial cancer of breast	VCV003903521	16	23619223	16	23607902	3903521	4019394		NC_000016.10:23607901:A:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3312T>C (p.Gly1104=)	PALB2		Familial cancer of breast|not provided	VCV000681024	16	23619223	16	23607902	681024	656358	rs1199973644	NC_000016.10:23607901:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3311G>C (p.Gly1104Ala)	PALB2	G1050A, G1080A, G1084A, G1011A, G1104A, G809A, G508A, G282A, G755A	Familial cancer of breast	VCV003730191	16	23619224	16	23607903	3730191	3862261		NC_000016.10:23607902:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 12, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3311G>A (p.Gly1104Asp)	PALB2	G1104D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460988	16	23619224	16	23607903	460988	466114	rs1060502798	NC_000016.10:23607902:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3311G>T (p.Gly1104Val)	PALB2	G1104V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410203	16	23619224	16	23607903	410203	400997	rs1060502798	NC_000016.10:23607902:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3310G>T (p.Gly1104Cys)	PALB2	G1104C	Familial cancer of breast	VCV001521445	16	23619225	16	23607904	1521445	1347340	rs188254555	NC_000016.10:23607903:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3310G>A (p.Gly1104Ser)	PALB2	G1104S	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000220948	16	23619225	16	23607904	220948	222457	rs188254555	NC_000016.10:23607903:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3309G>T (p.Val1103=)	PALB2		Familial cancer of breast	VCV003903655	16	23619226	16	23607905	3903655	4019528		NC_000016.10:23607904:C:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3308T>G (p.Val1103Gly)	PALB2	V1103G	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV001320743	16	23619227	16	23607906	1320743	1310988	rs1966506776	NC_000016.10:23607905:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3307G>T (p.Val1103Leu)	PALB2	V1103L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000955759	16	23619228	16	23607907	955759	949301	rs201657283	NC_000016.10:23607906:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 11, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3307G>C (p.Val1103Leu)	PALB2	V1103L	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Ovarian cancer|not specified|Breast and/or ovarian cancer|not provided|Familial cancer of breast	VCV000141974	16	23619228	16	23607907	141974	151688	rs201657283	NC_000016.10:23607906:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 5, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3307G>A (p.Val1103Met)	PALB2	V1103M	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000126732	16	23619228	16	23607907	126732	132242	rs201657283	NC_000016.10:23607906:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3306C>T (p.Ser1102=)	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000230327	16	23619229	16	23607908	230327	235164	rs515726112	NC_000016.10:23607907:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3306C>G (p.Ser1102Arg)	PALB2	S1102R	Familial cancer of breast|not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000126731	16	23619229	16	23607908	126731	132241	rs515726112	NC_000016.10:23607907:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3305G>T (p.Ser1102Ile)	PALB2	S1102I	Familial cancer of breast	VCV001484364	16	23619230	16	23607909	1484364	1455294	rs2142272071	NC_000016.10:23607908:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3303C>T (p.Leu1101=)	PALB2		Familial cancer of breast	VCV002110249	16	23619232	16	23607911	2110249	2160369	rs2506215064	NC_000016.10:23607910:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3302T>G (p.Leu1101Arg)	PALB2	L1101R	Familial cancer of breast	VCV000460987	16	23619233	16	23607912	460987	466120	rs1555458188	NC_000016.10:23607911:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.3301C>G (p.Leu1101Val)	PALB2	L1047V, L505V, L1008V, L1101V, L752V, L1077V, L1081V, L279V, L806V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002567590	16	23619234	16	23607913	2567590	2731232	rs1966507273	NC_000016.10:23607912:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3301C>T (p.Leu1101Phe)	PALB2	L1101F	Familial cancer of breast	VCV000830203	16	23619234	16	23607913	830203	818450	rs1966507273	NC_000016.10:23607912:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3300T>C (p.Thr1100=)	PALB2		Familial cancer of breast|not provided	VCV002672623	16	23619235	16	23607914	2672623	2840143	rs45516100	NC_000016.10:23607913:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3300T>A (p.Thr1100=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482013	16	23619235	16	23607914	482013	477439	rs45516100	NC_000016.10:23607913:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3300T>G (p.Thr1100=)	PALB2		Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary breast ovarian cancer syndrome|not provided	VCV000126730	16	23619235	16	23607914	126730	132240	rs45516100	NC_000016.10:23607913:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3299C>G (p.Thr1100Ser)	PALB2	T751S, T1046S, T805S, T1007S, T1080S, T504S, T1076S, T1100S, T278S	Familial cancer of breast	VCV004056278	16	23619236	16	23607915	4056278	4170216		NC_000016.10:23607914:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3298A>G (p.Thr1100Ala)	PALB2	T1100A	Familial cancer of breast	VCV001041270	16	23619237	16	23607916	1041270	1032509	rs1966507619	NC_000016.10:23607915:T:C	single nucleotide variant	missense variant	Uncertain significance	May 13, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3297G>T (p.Thr1099=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000823480	16	23619238	16	23607917	823480	812656	rs45565738	NC_000016.10:23607916:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 18, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3297G>C (p.Thr1099=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492217	16	23619238	16	23607917	492217	484800	rs45565738	NC_000016.10:23607916:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3297G>A (p.Thr1099=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Familial ovarian cancer|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not provided	VCV000184415	16	23619238	16	23607917	184415	184160	rs45565738	NC_000016.10:23607916:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3296C>A (p.Thr1099Lys)	PALB2	T750K, T804K, T1045K, T1075K, T277K, T1006K, T1099K, T1079K, T503K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001729887	16	23619239	16	23607918	1729887	1792094	rs142132127	NC_000016.10:23607917:G:T	single nucleotide variant	missense variant	Uncertain significance	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3296C>T (p.Thr1099Met)	PALB2	T1099M	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast	VCV000410162	16	23619239	16	23607918	410162	401043	rs142132127	NC_000016.10:23607917:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3296C>G (p.Thr1099Arg)	PALB2	T1099R	Familial cancer of breast|not provided|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000142504	16	23619239	16	23607918	142504	152218	rs142132127	NC_000016.10:23607917:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 7, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3295A>G (p.Thr1099Ala)	PALB2	T1006A, T1045A, T1075A, T1079A, T1099A, T277A, T503A, T750A, T804A	Familial cancer of breast	VCV001717218	16	23619240	16	23607919	1717218	1776043	rs2142272338	NC_000016.10:23607918:T:C	single nucleotide variant	missense variant	Uncertain significance	May 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3294G>C (p.Lys1098Asn)	PALB2	K502N, K749N, K803N, K1044N, K1078N, K1074N, K1005N, K1098N, K276N	Hereditary cancer-predisposing syndrome	VCV002587413	16	23619241	16	23607920	2587413	2754089	rs875989796	NC_000016.10:23607919:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3294G>A (p.Lys1098=)	PALB2		Familial cancer of breast	VCV000225859	16	23619241	16	23607920	225859	227662	rs875989796	NC_000016.10:23607919:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3293A>C (p.Lys1098Thr)	PALB2	K1005T, K1044T, K1074T, K1078T, K1098T, K276T, K502T, K749T, K803T	not specified	VCV002691964	16	23619242	16	23607921	2691964	2852967	rs2142272388	NC_000016.10:23607920:T:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3292A>G (p.Lys1098Glu)	PALB2	K1098E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001446392	16	23619243	16	23607922	1446392	1387343	rs2142272407	NC_000016.10:23607921:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3291T>G (p.Pro1097=)	PALB2		Familial cancer of breast	VCV003032310	16	23619244	16	23607923	3032310	3198232	rs767472685	NC_000016.10:23607922:A:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3290C>A (p.Pro1097His)	PALB2	P1073H, P1043H, P802H, P1097H, P275H, P748H, P1004H, P1077H, P501H	Hereditary cancer-predisposing syndrome	VCV001729846	16	23619245	16	23607924	1729846	1792053	rs587781308	NC_000016.10:23607923:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3290C>T (p.Pro1097Leu)	PALB2	P1097L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000944865	16	23619245	16	23607924	944865	927704	rs587781308	NC_000016.10:23607923:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3290C>G (p.Pro1097Arg)	PALB2	P1097R	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000140834	16	23619245	16	23607924	140834	150548	rs587781308	NC_000016.10:23607923:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3289C>A (p.Pro1097Thr)	PALB2	P1004T, P1077T, P748T, P1043T, P501T, P275T, P1073T, P1097T, P802T	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome	VCV002151559	16	23619246	16	23607925	2151559	1881726	rs1966508272	NC_000016.10:23607924:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3289C>T (p.Pro1097Ser)	PALB2	P1097S	Familial cancer of breast	VCV001005193	16	23619246	16	23607925	1005193	996785	rs1966508272	NC_000016.10:23607924:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3288C>A (p.Asn1096Lys)	PALB2	N1096K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830201	16	23619247	16	23607926	830201	818452	rs1597066782	NC_000016.10:23607925:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3288C>T (p.Asn1096=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000758461	16	23619247	16	23607926	758461	770767	rs1597066782	NC_000016.10:23607925:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3287A>T (p.Asn1096Ile)	PALB2	N1003I, N1042I, N1072I, N1076I, N1096I, N274I, N500I, N747I, N801I	Hereditary cancer-predisposing syndrome	VCV003228029	16	23619248	16	23607927	3228029	3387798	rs786201142	NC_000016.10:23607926:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3287A>C (p.Asn1096Thr)	PALB2	N1003T, N1042T, N1072T, N1076T, N1096T, N274T, N500T, N747T, N801T	not specified	VCV002691965	16	23619248	16	23607927	2691965	2852968	rs786201142	NC_000016.10:23607926:T:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3287A>G (p.Asn1096Ser)	PALB2	N1096S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000183891	16	23619248	16	23607927	183891	184161	rs786201142	NC_000016.10:23607926:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3286A>G (p.Asn1096Asp)	PALB2	N1096D	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000422428	16	23619249	16	23607928	422428	409511	rs62625281	NC_000016.10:23607927:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3285T>A (p.Ile1095=)	PALB2		not specified	VCV002691966	16	23619250	16	23607929	2691966	2852969	rs2142272585	NC_000016.10:23607928:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3285T>C (p.Ile1095=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001729788	16	23619250	16	23607929	1729788	1791995	rs2142272585	NC_000016.10:23607928:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 7, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3284T>C (p.Ile1095Thr)	PALB2	I1095T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000945384	16	23619251	16	23607930	945384	927705	rs1966508816	NC_000016.10:23607929:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3283A>G (p.Ile1095Val)	PALB2	I1041V, I1075V, I499V, I746V, I1071V, I273V, I1002V, I1095V, I800V	Hereditary cancer-predisposing syndrome	VCV001729765	16	23619252	16	23607931	1729765	1791972	rs2142272628	NC_000016.10:23607930:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3282G>C (p.Val1094=)	PALB2		Familial cancer of breast	VCV003904495	16	23619253	16	23607932	3904495	4020367		NC_000016.10:23607931:C:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3282G>T (p.Val1094=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001729759	16	23619253	16	23607932	1729759	1791966	rs747861082	NC_000016.10:23607931:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3282G>A (p.Val1094=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000184242	16	23619253	16	23607932	184242	184162	rs747861082	NC_000016.10:23607931:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3280G>A (p.Val1094Met)	PALB2	V1094M	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000823413	16	23619255	16	23607934	823413	812657	rs1597066796	NC_000016.10:23607933:C:T	single nucleotide variant	missense variant	Uncertain significance	May 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3279T>C (p.Ile1093=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000480251	16	23619256	16	23607935	480251	477543	rs1555458198	NC_000016.10:23607934:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 30, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.3278T>C (p.Ile1093Thr)	PALB2	I1093T	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000182774	16	23619257	16	23607936	182774	180709	rs45616636	NC_000016.10:23607935:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3277A>G (p.Ile1093Val)	PALB2	I1093V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000639359	16	23619258	16	23607937	639359	644386	rs1597066812	NC_000016.10:23607936:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 19, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3276C>A (p.Leu1092=)	PALB2		Familial cancer of breast	VCV003658613	16	23619259	16	23607938	3658613	3797034		NC_000016.10:23607937:G:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3276C>G (p.Leu1092=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000921103	16	23619259	16	23607938	921103	913596	rs779003246	NC_000016.10:23607937:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3276C>T (p.Leu1092=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000229871	16	23619259	16	23607938	229871	235165	rs779003246	NC_000016.10:23607937:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3275T>C (p.Leu1092Pro)	PALB2	L1092P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823385	16	23619260	16	23607939	823385	812659	rs1597066815	NC_000016.10:23607938:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3273G>A (p.Gln1091=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001729643	16	23619262	16	23607941	1729643	1795318	rs1555458200	NC_000016.10:23607940:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3273G>C (p.Gln1091His)	PALB2	Q1091H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492216	16	23619262	16	23607941	492216	484973	rs1555458200	NC_000016.10:23607940:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3272A>G (p.Gln1091Arg)	PALB2	Q1091R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000823371	16	23619263	16	23607942	823371	812660	rs1597066825	NC_000016.10:23607941:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3271C>T (p.Gln1091Ter)	PALB2	Q1091*	not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast	VCV000219518	16	23619264	16	23607943	219518	222459	rs864622138	NC_000016.10:23607942:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3269T>G (p.Phe1090Cys)	PALB2	F1090C	Hereditary cancer-predisposing syndrome	VCV000823355	16	23619266	16	23607945	823355	812661	rs1597066832	NC_000016.10:23607944:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3268T>C (p.Phe1090Leu)	PALB2	F1090L	Familial cancer of breast	VCV000657777	16	23619267	16	23607946	657777	644387	rs1597066839	NC_000016.10:23607945:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3267G>C (p.Val1089=)	PALB2		Familial cancer of breast	VCV003904353	16	23619268	16	23607947	3904353	4020225		NC_000016.10:23607946:C:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3265G>T (p.Val1089Leu)	PALB2	V1089L	Familial cancer of breast	VCV001446295	16	23619270	16	23607949	1446295	1387246	rs1966509780	NC_000016.10:23607948:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3265G>A (p.Val1089Met)	PALB2	V1089M	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000919796	16	23619270	16	23607949	919796	913597	rs1966509780	NC_000016.10:23607948:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3264T>C (p.Pro1088=)	PALB2		Familial cancer of breast	VCV002810471	16	23619271	16	23607950	2810471	2965145	rs2506216952	NC_000016.10:23607949:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 31, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3263C>A (p.Pro1088His)	PALB2	P1088H	Familial cancer of breast	VCV001363989	16	23619272	16	23607951	1363989	1389809	rs1966509842	NC_000016.10:23607950:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3263C>G (p.Pro1088Arg)	PALB2	P1088R	Familial cancer of breast	VCV000933324	16	23619272	16	23607951	933324	937355	rs1966509842	NC_000016.10:23607950:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3262C>T (p.Pro1088Ser)	PALB2	P1088S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000570698	16	23619273	16	23607952	570698	567939	rs1060502777	NC_000016.10:23607951:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3262C>G (p.Pro1088Ala)	PALB2	P1088A	Familial cancer of breast	VCV000410173	16	23619273	16	23607952	410173	401051	rs1060502777	NC_000016.10:23607951:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3261C>T (p.Ser1087=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000232722	16	23619274	16	23607953	232722	235166	rs876659947	NC_000016.10:23607952:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3260G>A (p.Ser1087Asn)	PALB2	S1087N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000216754	16	23619275	16	23607954	216754	213152	rs863224786	NC_000016.10:23607953:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 11, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3258A>T (p.Arg1086=)	PALB2		Familial cancer of breast	VCV000753865	16	23619277	16	23607956	753865	770768	rs1597066871	NC_000016.10:23607955:T:A	single nucleotide variant	synonymous variant	Likely benign	Mar 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3257G>A (p.Arg1086Gln)	PALB2	R1086Q	Hereditary breast ovarian cancer syndrome|not provided|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000142035	16	23619278	16	23607957	142035	151749	rs146377793	NC_000016.10:23607956:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3256C>A (p.Arg1086=)	PALB2		Familial cancer of breast	VCV001134324	16	23619279	16	23607958	1134324	1125107	rs587776527	NC_000016.10:23607957:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 6, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3256C>G (p.Arg1086Gly)	PALB2	R1086G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial pancreatic carcinoma|Familial cancer of breast|not specified|not provided	VCV000410187	16	23619279	16	23607958	410187	401491	rs587776527	NC_000016.10:23607957:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3256C>T (p.Arg1086Ter)	PALB2	R1086*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|PALB2-related disorder|Breast-ovarian cancer, familial, susceptibility to, 5|Breast and/or ovarian cancer|Familial cancer of breast|not provided|Malignant tumor of breast	VCV000126729	16	23619279	16	23607958	126729	132239	rs587776527	NC_000016.10:23607957:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3255G>A (p.Leu1085=)	PALB2		Familial cancer of breast	VCV002918003	16	23619280	16	23607959	2918003	3072202	rs45486891	NC_000016.10:23607958:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3255G>T (p.Leu1085Phe)	PALB2	L1031F, L1085F, L1061F, L489F, L992F, L1065F, L736F, L790F, L263F	Familial cancer of breast	VCV002845318	16	23619280	16	23607959	2845318	3014773	rs45486891	NC_000016.10:23607958:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3254T>A (p.Leu1085Ter)	PALB2	L1061*, L1065*, L1085*, L736*, L790*, L263*, L489*, L992*, L1031*	Hereditary cancer-predisposing syndrome	VCV002453309	16	23619281	16	23607960	2453309	2430369	rs780524136	NC_000016.10:23607959:A:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Mar 1, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3254T>C (p.Leu1085Ser)	PALB2	L1085S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000936179	16	23619281	16	23607960	936179	937356	rs780524136	NC_000016.10:23607959:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3253T>C (p.Leu1085=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480254	16	23619282	16	23607961	480254	477477	rs1555458206	NC_000016.10:23607960:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3252G>T (p.Ser1084=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002850033	16	23619283	16	23607962	2850033	3005988	rs141570833	NC_000016.10:23607961:C:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 4, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3252G>C (p.Ser1084=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000925036	16	23619283	16	23607962	925036	913598	rs141570833	NC_000016.10:23607961:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3252G>A (p.Ser1084=)	PALB2		Familial cancer of breast|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000126728	16	23619283	16	23607962	126728	132238	rs141570833	NC_000016.10:23607961:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3251C>A (p.Ser1084Ter)	PALB2	S1084*	Malignant tumor of breast	VCV000933181	16	23619284	16	23607963	933181	921485	rs62625271	NC_000016.10:23607962:G:T	single nucleotide variant	nonsense	Likely pathogenic	Jun 22, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3251C>T (p.Ser1084Leu)	PALB2	S1084L	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not specified|Fanconi anemia complementation group N|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126727	16	23619284	16	23607963	126727	132237	rs62625271	NC_000016.10:23607962:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3249G>A (p.Glu1083=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001729372	16	23619286	16	23607965	1729372	1795048	rs147045425	NC_000016.10:23607964:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3249G>C (p.Glu1083Asp)	PALB2	E1083D	Familial cancer of breast	VCV000126726	16	23619286	16	23607965	126726	132236	rs147045425	NC_000016.10:23607964:C:G	single nucleotide variant	missense variant	Benign	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.3248A>T (p.Glu1083Val)	PALB2	E1029V, E1059V, E1063V, E1083V, E261V, E487V, E734V, E788V, E990V	Familial cancer of breast	VCV003240018	16	23619287	16	23607966	3240018	3399006	rs2142273459	NC_000016.10:23607965:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3248A>G (p.Glu1083Gly)	PALB2	E1083G	not provided	VCV001315646	16	23619287	16	23607966	1315646	1305906	rs2142273459	NC_000016.10:23607965:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3247G>A (p.Glu1083Lys)	PALB2	E1083K	not provided|not specified|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|See cases|Hereditary cancer-predisposing syndrome	VCV000216753	16	23619288	16	23607967	216753	213153	rs747785029	NC_000016.10:23607966:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3246T>G (p.Ser1082Arg)	PALB2	S1082R	Familial cancer of breast	VCV001360160	16	23619289	16	23607968	1360160	1363606	rs1064795472	NC_000016.10:23607967:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3246T>A (p.Ser1082Arg)	PALB2	S1082R	not provided|Familial cancer of breast	VCV000421959	16	23619289	16	23607968	421959	409512	rs1064795472	NC_000016.10:23607967:A:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3244A>G (p.Ser1082Gly)	PALB2	S1082G	Familial cancer of breast|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000186946	16	23619291	16	23607970	186946	184163	rs786203345	NC_000016.10:23607969:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 25, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3243G>A (p.Glu1081=)	PALB2		Familial cancer of breast	VCV002122677	16	23619292	16	23607971	2122677	2184437	rs1966511593	NC_000016.10:23607970:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3243G>C (p.Glu1081Asp)	PALB2	E1081D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000920670	16	23619292	16	23607971	920670	913599	rs1966511593	NC_000016.10:23607970:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3242A>G (p.Glu1081Gly)	PALB2	E1081G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000582313	16	23619293	16	23607972	582313	570158	rs1363812475	NC_000016.10:23607971:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3241G>C (p.Glu1081Gln)	PALB2	E1061Q, E786Q, E1027Q, E1081Q, E988Q, E1057Q, E732Q, E259Q, E485Q	Hereditary cancer-predisposing syndrome	VCV003304002	16	23619294	16	23607973	3304002	3470169		NC_000016.10:23607972:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3241G>T (p.Glu1081Ter)	PALB2	E1027*, E1057*, E1061*, E1081*, E259*, E485*, E732*, E786*, E988*	Familial cancer of breast	VCV002674080	16	23619294	16	23607973	2674080	2841570	rs2142273676	NC_000016.10:23607972:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3241G>A (p.Glu1081Lys)	PALB2	E1081K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001367363	16	23619294	16	23607973	1367363	1405083	rs2142273676	NC_000016.10:23607972:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3239A>G (p.Lys1080Arg)	PALB2	K1080R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460985	16	23619296	16	23607975	460985	465439	rs1441163505	NC_000016.10:23607974:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3238A>T (p.Lys1080Ter)	PALB2	K1026*, K1056*, K1060*, K1080*, K258*, K484*, K731*, K785*, K987*	Familial cancer of breast	VCV002673863	16	23619297	16	23607976	2673863	2841364	rs1966511830	NC_000016.10:23607975:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3238A>G (p.Lys1080Glu)	PALB2	K1080E	Hereditary cancer-predisposing syndrome	VCV000924013	16	23619297	16	23607976	924013	913600	rs1966511830	NC_000016.10:23607975:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3237C>G (p.Ala1079=)	PALB2		Familial cancer of breast	VCV003904155	16	23619298	16	23607977	3904155	4020028		NC_000016.10:23607976:G:C	single nucleotide variant	intron variant|synonymous variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3236C>T (p.Ala1079Val)	PALB2	A1079V	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000460984	16	23619299	16	23607978	460984	466355	rs769342316	NC_000016.10:23607977:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3235G>A (p.Ala1079Thr)	PALB2	A1079T, A483T, A730T, A784T, A986T, A1025T, A1055T, A1059T, A257T	Hereditary cancer-predisposing syndrome	VCV002567570	16	23619300	16	23607979	2567570	2731212	rs730881878	NC_000016.10:23607978:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3235G>T (p.Ala1079Ser)	PALB2	A1079S	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000182756	16	23619300	16	23607979	182756	180710	rs730881878	NC_000016.10:23607978:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3234T>C (p.Cys1078=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000631279	16	23619301	16	23607980	631279	618356	rs886039634	NC_000016.10:23607979:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 6, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3234T>A (p.Cys1078Ter)	PALB2	C1078*	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000265571	16	23619301	16	23607980	265571	260095	rs886039634	NC_000016.10:23607979:A:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Sep 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3233G>A (p.Cys1078Tyr)	PALB2	C729Y, C1054Y, C256Y, C783Y, C1078Y, C1024Y, C1058Y, C482Y, C985Y	Hereditary cancer-predisposing syndrome	VCV002567567	16	23619302	16	23607981	2567567	2731209	rs1567206945	NC_000016.10:23607980:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3233G>C (p.Cys1078Ser)	PALB2	C1078S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000584900	16	23619302	16	23607981	584900	575956	rs1567206945	NC_000016.10:23607980:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3232T>C (p.Cys1078Arg)	PALB2	C1058R, C256R, C1054R, C729R, C783R, C985R, C1024R, C1078R, C482R	Familial cancer of breast	VCV002133967	16	23619303	16	23607982	2133967	2188513	rs876659587	NC_000016.10:23607981:A:G	single nucleotide variant	missense variant	Uncertain significance	May 5, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3232T>A (p.Cys1078Ser)	PALB2	C1078S	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified	VCV000232150	16	23619303	16	23607982	232150	235168	rs876659587	NC_000016.10:23607981:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3231C>T (p.Pro1077=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492215	16	23619304	16	23607983	492215	484801	rs772714719	NC_000016.10:23607982:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 31, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3231C>A (p.Pro1077=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460983	16	23619304	16	23607983	460983	466358	rs772714719	NC_000016.10:23607982:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3230C>T (p.Pro1077Leu)	PALB2	P1023L, P1053L, P1057L, P1077L, P255L, P481L, P728L, P782L, P984L	Hereditary cancer-predisposing syndrome	VCV003228028	16	23619305	16	23607984	3228028	3387797	rs2142273874	NC_000016.10:23607983:G:A	single nucleotide variant	intron variant|missense variant	Uncertain significance	Dec 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3229C>G (p.Pro1077Ala)	PALB2	P1077A	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000128140	16	23619306	16	23607985	128140	133597	rs587780218	NC_000016.10:23607984:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3228T>A (p.His1076Gln)	PALB2	H1022Q, H1052Q, H1056Q, H1076Q, H254Q, H480Q, H727Q, H781Q, H983Q	Hereditary cancer-predisposing syndrome	VCV003893993	16	23619307	16	23607986	3893993	4009874		NC_000016.10:23607985:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 23, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3228T>G (p.His1076Gln)	PALB2	H1076Q	Familial cancer of breast	VCV001516714	16	23619307	16	23607986	1516714	1495487	rs762367769	NC_000016.10:23607985:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3226C>T (p.His1076Tyr)	PALB2	H1076Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000492213	16	23619309	16	23607988	492213	484716	rs1555458224	NC_000016.10:23607987:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3225T>C (p.Ser1075=)	PALB2		not specified	VCV003063790	16	23619310	16	23607989	3063790	3223999	rs202222149	NC_000016.10:23607988:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3225T>A (p.Ser1075Arg)	PALB2	S1075R	Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000230775	16	23619310	16	23607989	230775	235169	rs202222149	NC_000016.10:23607988:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 7, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3224G>A (p.Ser1075Asn)	PALB2	S1075N	Familial cancer of breast	VCV001390358	16	23619311	16	23607990	1390358	1396531	rs2142274025	NC_000016.10:23607989:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3222G>T (p.Leu1074=)	PALB2		Hereditary cancer-predisposing syndrome	VCV002447310	16	23619313	16	23607992	2447310	2422432	rs2142274073	NC_000016.10:23607991:C:A	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Dec 26, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3222G>C (p.Leu1074=)	PALB2		Familial cancer of breast	VCV002036921	16	23619313	16	23607992	2036921	2101288	rs2142274073	NC_000016.10:23607991:C:G	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3221T>C (p.Leu1074Pro)	PALB2	L1020P, L1050P, L1054P, L1074P, L252P, L478P, L725P, L779P, L981P	Hereditary cancer-predisposing syndrome	VCV003228027	16	23619314	16	23607993	3228027	3387796	rs1966512549	NC_000016.10:23607992:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3221T>G (p.Leu1074Arg)	PALB2	L1074R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001044157	16	23619314	16	23607993	1044157	1032510	rs1966512549	NC_000016.10:23607992:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3220C>G (p.Leu1074Val)	PALB2	L1074V	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000421293	16	23619315	16	23607994	421293	409513	rs1057523330	NC_000016.10:23607993:G:C	single nucleotide variant	missense variant	Uncertain significance	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3220C>T (p.Leu1074=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000389104	16	23619315	16	23607994	389104	375247	rs1057523330	NC_000016.10:23607993:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3219C>A (p.Val1073=)	PALB2		Familial cancer of breast	VCV002810955	16	23619316	16	23607995	2810955	2975468	rs876658924	NC_000016.10:23607994:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 31, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3219C>G (p.Val1073=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000231048	16	23619316	16	23607995	231048	235170	rs876658924	NC_000016.10:23607994:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3218T>A (p.Val1073Asp)	PALB2	V1019D, V1049D, V1053D, V980D, V1073D, V251D, V477D, V724D, V778D	Hereditary cancer-predisposing syndrome	VCV003413435	16	23619317	16	23607996	3413435	3574658		NC_000016.10:23607995:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3217G>A (p.Val1073Ile)	PALB2	V1019I, V1053I, V1073I, V251I, V724I, V778I, V980I, V1049I, V477I	Hereditary cancer-predisposing syndrome	VCV001729006	16	23619318	16	23607997	1729006	1785296	rs1555458226	NC_000016.10:23607996:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3217G>T (p.Val1073Phe)	PALB2	V1073F	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000460982	16	23619318	16	23607997	460982	466131	rs1555458226	NC_000016.10:23607996:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3216T>G (p.Ile1072Met)	PALB2	I476M, I1048M, I1052M, I1072M, I723M, I979M, I777M, I1018M, I250M	Familial cancer of breast	VCV003643049	16	23619319	16	23607998	3643049	3775921		NC_000016.10:23607997:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3215T>C (p.Ile1072Thr)	PALB2	I1072T	Familial cancer of breast	VCV001364301	16	23619320	16	23607999	1364301	1386240	rs2142274254	NC_000016.10:23607998:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3213T>C (p.Phe1071=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460981	16	23619322	16	23608001	460981	465440	rs774412039	NC_000016.10:23608000:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3211T>C (p.Phe1071Leu)	PALB2	F1071L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460980	16	23619324	16	23608003	460980	466184	rs1555458228	NC_000016.10:23608002:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3210C>T (p.Leu1070=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000516317	16	23619325	16	23608004	516317	505495	rs876659540	NC_000016.10:23608003:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3210C>G (p.Leu1070=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000232079	16	23619325	16	23608004	232079	235171	rs876659540	NC_000016.10:23608003:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3209T>C (p.Leu1070Pro)	PALB2	L1070P	Breast and/or ovarian cancer|not provided|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000216752	16	23619326	16	23608005	216752	213154	rs863224785	NC_000016.10:23608004:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3208C>T (p.Leu1070Phe)	PALB2	L775F, L977F, L1016F, L474F, L1046F, L1050F, L1070F, L248F, L721F	Familial cancer of breast	VCV003653431	16	23619327	16	23608006	3653431	3788864		NC_000016.10:23608005:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3207T>C (p.Leu1069=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002916878	16	23619328	16	23608007	2916878	3076940	rs2506219382	NC_000016.10:23608006:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Mar 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3206T>C (p.Leu1069Pro)	PALB2	L1069P	Familial cancer of breast	VCV001368579	16	23619329	16	23608008	1368579	1340171	rs2142274393	NC_000016.10:23608007:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3205C>T (p.Leu1069Phe)	PALB2	L774F, L1049F, L247F, L473F, L1045F, L1069F, L720F, L1015F, L976F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001728860	16	23619330	16	23608009	1728860	1788495	rs2506219457	NC_000016.10:23608008:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3204G>C (p.Gly1068=)	PALB2		Familial cancer of breast	VCV003904092	16	23619331	16	23608010	3904092	4019965		NC_000016.10:23608009:C:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3204G>T (p.Gly1068=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000233338	16	23619331	16	23608010	233338	235172	rs786203475	NC_000016.10:23608009:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3204G>A (p.Gly1068=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000187105	16	23619331	16	23608010	187105	184165	rs786203475	NC_000016.10:23608009:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3203G>A (p.Gly1068Glu)	PALB2	G1068E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000490082	16	23619332	16	23608011	490082	482928	rs759587160	NC_000016.10:23608010:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3203G>C (p.Gly1068Ala)	PALB2	G1068A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000185957	16	23619332	16	23608011	185957	184166	rs759587160	NC_000016.10:23608010:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3202G>A (p.Gly1068Arg)	PALB2	G1014R, G1044R, G1048R, G1068R, G246R, G472R, G719R, G773R, G975R	Hereditary cancer-predisposing syndrome	VCV003228026	16	23619333	16	23608012	3228026	3387795	rs1567207006	NC_000016.10:23608011:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 15, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202G>T (p.Gly1068Trp)	PALB2	G1068W	Hereditary cancer-predisposing syndrome	VCV000630819	16	23619333	16	23608012	630819	618357	rs1567207006	NC_000016.10:23608011:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202-1G>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not provided|Familial cancer of breast	VCV000371966	16	23619334	16	23608013	371966	358902	rs515726111	NC_000016.10:23608012:C:T	single nucleotide variant	intron variant|splice acceptor variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3202-1G>C	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000126723	16	23619334	16	23608013	126723	132233	rs515726111	NC_000016.10:23608012:C:G	single nucleotide variant	intron variant|splice acceptor variant	Pathogenic/Likely pathogenic	Feb 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3202-2A>G	PALB2		Familial cancer of breast	VCV000938626	16	23619335	16	23608014	938626	940355	rs1060499827	NC_000016.10:23608013:T:C	single nucleotide variant	intron variant|splice acceptor variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3202-2A>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000402306	16	23619335	16	23608014	402306	389259	rs1060499827	NC_000016.10:23608013:T:G	single nucleotide variant	intron variant|splice acceptor variant	Pathogenic/Likely pathogenic	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3202-3T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV003228025	16	23619336	16	23608015	3228025	3387794	rs2142274515	NC_000016.10:23608014:A:C	single nucleotide variant	intron variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202-4T>C	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000823181	16	23619337	16	23608016	823181	815624	rs1597067067	NC_000016.10:23608015:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3202-5A>G	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410126	16	23619338	16	23608017	410126	401736	rs1060502746	NC_000016.10:23608016:T:C	single nucleotide variant	intron variant	Uncertain significance	Apr 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3202-6A>C	PALB2		Familial cancer of breast	VCV002018757	16	23619339	16	23608018	2018757	2068993	rs2142274548	NC_000016.10:23608017:T:G	single nucleotide variant	intron variant	Likely benign	Jun 3, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202-8G>T	PALB2		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast and/or ovarian cancer|not specified|not provided	VCV000182750	16	23619341	16	23608020	182750	180711	rs367979106	NC_000016.10:23608019:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3202-8G>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000182749	16	23619341	16	23608020	182749	180712	rs367979106	NC_000016.10:23608019:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 28, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3202-9C>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001973652	16	23619342	16	23608021	1973652	2026351	rs757444247	NC_000016.10:23608020:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3202-9C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified	VCV000215936	16	23619342	16	23608021	215936	213155	rs757444247	NC_000016.10:23608020:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3202-10C>T	PALB2		Familial cancer of breast	VCV003903959	16	23619343	16	23608022	3903959	4019832		NC_000016.10:23608021:G:A	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202-10C>G	PALB2		Familial cancer of breast	VCV002086430	16	23619343	16	23608022	2086430	2144345	rs2142274595	NC_000016.10:23608021:G:C	single nucleotide variant	intron variant	Uncertain significance	Feb 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202-13T>C	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV002692687	16	23619346	16	23608025	2692687	2863514	rs2142274636	NC_000016.10:23608024:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3202-14T>G	PALB2		Familial cancer of breast	VCV002858162	16	23619347	16	23608026	2858162	3018208	rs2506219848	NC_000016.10:23608025:A:C	single nucleotide variant	intron variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202-17T>G	PALB2		not provided	VCV003390151	16	23619350	16	23608029	3390151	3549274		NC_000016.10:23608028:A:C	single nucleotide variant	intron variant	Uncertain significance	Nov 1, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202-17T>A	PALB2		Familial cancer of breast	VCV001586295	16	23619350	16	23608029	1586295	1562454	rs2142274677	NC_000016.10:23608028:A:T	single nucleotide variant	intron variant	Likely benign	Mar 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202-18A>G	PALB2		Familial cancer of breast	VCV002700136	16	23619351	16	23608030	2700136	2858988	rs2142274695	NC_000016.10:23608029:T:C	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3202-20T>C	PALB2		not specified|Familial cancer of breast	VCV002823687	16	23619353	16	23608032	2823687	2982201	rs2142274718	NC_000016.10:23608031:A:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3202-34T>C	PALB2		not specified	VCV002691967	16	23619367	16	23608046	2691967	2852970	rs2142274872	NC_000016.10:23608045:A:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202-40T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV003885188	16	23619373	16	23608052	3885188	4005510		NC_000016.10:23608051:A:C	single nucleotide variant	intron variant	Uncertain significance	Dec 23, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3202-83G>C	PALB2		not provided	VCV000675487	16	23619416	16	23608095	675487	667444	rs77090069	NC_000016.10:23608094:C:G	single nucleotide variant	intron variant	Likely benign	Jun 18, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3201+101A>G	PALB2		not provided|Hereditary breast ovarian cancer syndrome	VCV001292399	16	23625224	16	23613903	1292399	1282205	rs249935	NC_000016.10:23613902:T:C	single nucleotide variant	intron variant	Benign	Apr 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+96G>A	PALB2		Hereditary breast ovarian cancer syndrome|not provided	VCV000126722	16	23625229	16	23613908	126722	132232	rs373044186	NC_000016.10:23613907:C:T	single nucleotide variant	intron variant	Likely benign	Apr 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+95C>T	PALB2		Hereditary breast ovarian cancer syndrome|not provided	VCV001294214	16	23625230	16	23613909	1294214	1284012	rs76918977	NC_000016.10:23613908:G:A	single nucleotide variant	intron variant	Benign	Apr 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+36A>G	PALB2		not specified	VCV003765312	16	23625289	16	23613968	3765312	3881481		NC_000016.10:23613967:T:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3201+20G>A	PALB2		Familial cancer of breast	VCV001612640	16	23625305	16	23613984	1612640	1601723	rs774029323	NC_000016.10:23613983:C:T	single nucleotide variant	intron variant	Likely benign	Aug 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3201+20G>T	PALB2		Familial cancer of breast|not specified	VCV000371952	16	23625305	16	23613984	371952	358903	rs774029323	NC_000016.10:23613983:C:A	single nucleotide variant	intron variant	Likely benign	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+18G>A	PALB2		Familial cancer of breast	VCV002096302	16	23625307	16	23613986	2096302	2146453	rs2142298301	NC_000016.10:23613985:C:T	single nucleotide variant	intron variant	Likely benign	Feb 11, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3201+15G>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000629189	16	23625310	16	23613989	629189	619472	rs1314617288	NC_000016.10:23613988:C:A	single nucleotide variant	intron variant	Likely benign	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+10G>A	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000382164	16	23625315	16	23613994	382164	377362	rs759499251	NC_000016.10:23613993:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+9T>A	PALB2		Familial cancer of breast	VCV001578701	16	23625316	16	23613995	1578701	1652383	rs2142298416	NC_000016.10:23613994:A:T	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+8A>G	PALB2		Familial cancer of breast	VCV001088198	16	23625317	16	23613996	1088198	1081879	rs1966633439	NC_000016.10:23613995:T:C	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+7A>G	PALB2		Familial cancer of breast	VCV002733369	16	23625318	16	23613997	2733369	2890828	rs2506264018	NC_000016.10:23613996:T:C	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+6T>C	PALB2		Familial cancer of breast	VCV001427566	16	23625319	16	23613998	1427566	1441100	rs1567209787	NC_000016.10:23613997:A:G	single nucleotide variant	intron variant	Uncertain significance	Jul 16, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3201+6T>A	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000628207	16	23625319	16	23613998	628207	619556	rs1567209787	NC_000016.10:23613997:A:T	single nucleotide variant	intron variant	Uncertain significance	May 26, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+5G>A	PALB2		Hereditary cancer-predisposing syndrome	VCV001728820	16	23625320	16	23613999	1728820	1788455	rs1597073208	NC_000016.10:23613998:C:T	single nucleotide variant	intron variant	Uncertain significance	May 2, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3201+5G>T	PALB2		Hereditary breast ovarian cancer syndrome	VCV000632616	16	23625320	16	23613999	632616	621048	rs1597073208	NC_000016.10:23613998:C:A	single nucleotide variant	intron variant	Likely pathogenic	Mar 1, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3201+4A>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630056	16	23625321	16	23614000	630056	619604	rs1226634357	NC_000016.10:23613999:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 11, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3201+3A>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001036851	16	23625322	16	23614001	1036851	1032512	rs876660215	NC_000016.10:23614000:T:C	single nucleotide variant	intron variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+3A>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233131	16	23625322	16	23614001	233131	235173	rs876660215	NC_000016.10:23614000:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3201+1G>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002673833	16	23625324	16	23614003	2673833	2841336	rs587776423	NC_000016.10:23614002:C:T	single nucleotide variant	intron variant|splice donor variant	Pathogenic/Likely pathogenic	Jun 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+1G>C	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000143972	16	23625324	16	23614003	143972	153702	rs587776423	NC_000016.10:23614002:C:G	single nucleotide variant	intron variant|splice donor variant	Pathogenic/Likely pathogenic	Nov 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201+1G>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000141501	16	23625324	16	23614003	141501	151215	rs587776423	NC_000016.10:23614002:C:A	single nucleotide variant	intron variant|splice donor variant	Pathogenic/Likely pathogenic	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3201G>A (p.Met1067Ile)	PALB2	M1067I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484178	16	23625325	16	23614004	484178	477547	rs1555458809	NC_000016.10:23614003:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 24, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3199A>C (p.Met1067Leu)	PALB2	M1067L	Familial cancer of breast	VCV000998559	16	23625327	16	23614006	998559	996786	rs1966634088	NC_000016.10:23614005:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3196G>A (p.Glu1066Lys)	PALB2	E1066K	Familial cancer of breast	VCV001063905	16	23625330	16	23614009	1063905	1049510	rs2142298635	NC_000016.10:23614008:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3194C>T (p.Ser1065Phe)	PALB2	S1065F	Familial cancer of breast	VCV000830197	16	23625332	16	23614011	830197	818456	rs1347982621	NC_000016.10:23614010:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3194C>G (p.Ser1065Cys)	PALB2	S1065C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480249	16	23625332	16	23614011	480249	478015	rs1347982621	NC_000016.10:23614010:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3192T>C (p.Tyr1064=)	PALB2		Familial cancer of breast	VCV003903797	16	23625334	16	23614013	3903797	4019670		NC_000016.10:23614012:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3191A>T (p.Tyr1064Phe)	PALB2	Y1064F	Hereditary cancer-predisposing syndrome|not provided	VCV001172175	16	23625335	16	23614014	1172175	1161311	rs730881893	NC_000016.10:23614013:T:A	single nucleotide variant	missense variant	Uncertain significance	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3191A>G (p.Tyr1064Cys)	PALB2	Y1064C	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000182773	16	23625335	16	23614014	182773	180713	rs730881893	NC_000016.10:23614013:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3189C>G (p.Ala1063=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001728610	16	23625337	16	23614016	1728610	1788245	rs2142298779	NC_000016.10:23614015:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3184A>G (p.Lys1062Glu)	PALB2	K1062E	Familial cancer of breast	VCV000584901	16	23625342	16	23614021	584901	575957	rs1567209813	NC_000016.10:23614020:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3183C>A (p.His1061Gln)	PALB2	H1037Q, H465Q, H712Q, H968Q, H1061Q, H1007Q, H1041Q, H766Q, H239Q	Familial cancer of breast	VCV001986074	16	23625343	16	23614022	1986074	2040025	rs1966634454	NC_000016.10:23614021:G:T	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3182A>G (p.His1061Arg)	PALB2	H1061R	Familial cancer of breast|not provided	VCV001026404	16	23625344	16	23614023	1026404	1012022	rs1966634515	NC_000016.10:23614022:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3180T>A (p.Cys1060Ter)	PALB2	C1060*	Familial cancer of breast	VCV001453938	16	23625346	16	23614025	1453938	1451462	rs2142298948	NC_000016.10:23614024:A:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3179G>A (p.Cys1060Tyr)	PALB2	C1060Y	Hereditary cancer-predisposing syndrome	VCV000927505	16	23625347	16	23614026	927505	913601	rs116967702	NC_000016.10:23614025:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3179G>C (p.Cys1060Ser)	PALB2	C1060S	Familial cancer of breast	VCV000241560	16	23625347	16	23614026	241560	242350	rs116967702	NC_000016.10:23614025:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.3177C>T (p.Val1059=)	PALB2		Familial cancer of breast	VCV002897456	16	23625349	16	23614028	2897456	3056931	rs1597073260	NC_000016.10:23614027:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3177C>G (p.Val1059=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000823082	16	23625349	16	23614028	823082	812662	rs1597073260	NC_000016.10:23614027:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3175G>T (p.Val1059Phe)	PALB2	V1005F, V710F, V237F, V463F, V764F, V1035F, V966F, V1039F, V1059F	Familial cancer of breast	VCV002862007	16	23625351	16	23614030	2862007	3029369	rs587780217	NC_000016.10:23614029:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3175G>A (p.Val1059Ile)	PALB2	V1059I	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000128139	16	23625351	16	23614030	128139	133596	rs587780217	NC_000016.10:23614029:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3174A>G (p.Ser1058=)	PALB2		Familial cancer of breast	VCV001143037	16	23625352	16	23614031	1143037	1145998	rs1597073268	NC_000016.10:23614030:T:C	single nucleotide variant	synonymous variant	Likely benign	May 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3174A>C (p.Ser1058=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823076	16	23625352	16	23614031	823076	812664	rs1597073268	NC_000016.10:23614030:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3173C>A (p.Ser1058Ter)	PALB2	S1004*, S1038*, S1058*, S462*, S236*, S709*, S763*, S1034*, S965*	Familial cancer of breast	VCV003727835	16	23625353	16	23614032	3727835	3858458		NC_000016.10:23614031:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 23, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3172T>G (p.Ser1058Ala)	PALB2	S1058A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000216751	16	23625354	16	23614033	216751	213156	rs863224784	NC_000016.10:23614032:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3171T>C (p.Ala1057=)	PALB2		Familial cancer of breast	VCV003652079	16	23625355	16	23614034	3652079	3785359		NC_000016.10:23614033:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3171T>G (p.Ala1057=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003303994	16	23625355	16	23614034	3303994	3470161		NC_000016.10:23614033:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3171T>A (p.Ala1057=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001728438	16	23625355	16	23614034	1728438	1791838	rs2142299162	NC_000016.10:23614033:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3170C>G (p.Ala1057Gly)	PALB2	A1057G, A964G, A762G, A1003G, A1033G, A1037G, A708G, A235G, A461G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002818665	16	23625356	16	23614035	2818665	2981037	rs2142299183	NC_000016.10:23614034:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3170C>A (p.Ala1057Asp)	PALB2	A1037D, A1057D, A708D, A1003D, A762D, A964D, A461D, A1033D, A235D	Hereditary cancer-predisposing syndrome	VCV001728429	16	23625356	16	23614035	1728429	1791829	rs2142299183	NC_000016.10:23614034:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3169G>A (p.Ala1057Thr)	PALB2	A461T, A1003T, A235T, A964T, A1033T, A1037T, A762T, A1057T, A708T	Familial cancer of breast	VCV002781068	16	23625357	16	23614036	2781068	2937466	rs2142299202	NC_000016.10:23614035:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3168A>G (p.Gln1056=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001728383	16	23625358	16	23614037	1728383	1791783	rs2142299226	NC_000016.10:23614036:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3168A>C (p.Gln1056His)	PALB2	Q1056H	Hereditary cancer-predisposing syndrome	VCV001691952	16	23625358	16	23614037	1691952	1684394	rs2142299226	NC_000016.10:23614036:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3166C>G (p.Gln1056Glu)	PALB2	Q1056E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001469711	16	23625360	16	23614039	1469711	1475659	rs1021662947	NC_000016.10:23614038:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3166C>T (p.Gln1056Ter)	PALB2	Q1056*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000492212	16	23625360	16	23614039	492212	484718	rs1021662947	NC_000016.10:23614038:G:A	single nucleotide variant	nonsense	Pathogenic	Mar 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3165C>G (p.Tyr1055Ter)	PALB2	Y1055*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480263	16	23625361	16	23614040	480263	477440	rs876658157	NC_000016.10:23614039:G:C	single nucleotide variant	nonsense	Pathogenic	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3165C>A (p.Tyr1055Ter)	PALB2	Y1055*	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000229713	16	23625361	16	23614040	229713	235174	rs876658157	NC_000016.10:23614039:G:T	single nucleotide variant	nonsense	Pathogenic	Feb 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3164A>G (p.Tyr1055Cys)	PALB2	Y1055C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000651654	16	23625362	16	23614041	651654	644388	rs1297371446	NC_000016.10:23614040:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3163T>C (p.Tyr1055His)	PALB2	Y1055H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530074	16	23625363	16	23614042	530074	530321	rs1319433657	NC_000016.10:23614041:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3161C>T (p.Ser1054Phe)	PALB2	S1054F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000843245	16	23625365	16	23614044	843245	843558	rs1227213725	NC_000016.10:23614043:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3159T>G (p.Asp1053Glu)	PALB2	D1053E	Familial cancer of breast	VCV001524245	16	23625367	16	23614046	1524245	1382807	rs1555458816	NC_000016.10:23614045:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3159T>C (p.Asp1053=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484200	16	23625367	16	23614046	484200	477549	rs1555458816	NC_000016.10:23614045:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3157G>C (p.Asp1053His)	PALB2	D457H, D960H, D231H, D704H, D1029H, D1033H, D1053H, D758H, D999H	Familial cancer of breast	VCV003665819	16	23625369	16	23614048	3665819	3795692		NC_000016.10:23614047:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3157G>T (p.Asp1053Tyr)	PALB2	D1053Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001053174	16	23625369	16	23614048	1053174	1049511	rs967436311	NC_000016.10:23614047:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3156T>C (p.Asp1052=)	PALB2		Familial cancer of breast	VCV001127282	16	23625370	16	23614049	1127282	1125108	rs2142299487	NC_000016.10:23614048:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3155A>T (p.Asp1052Val)	PALB2	D1052V	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000492211	16	23625371	16	23614050	492211	484803	rs775290401	NC_000016.10:23614049:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3154G>C (p.Asp1052His)	PALB2	D1028H, D1032H, D1052H, D230H, D456H, D703H, D757H, D959H, D998H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003240019	16	23625372	16	23614051	3240019	3399007	rs878855116	NC_000016.10:23614050:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3154G>A (p.Asp1052Asn)	PALB2	D1052N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000241559	16	23625372	16	23614051	241559	242351	rs878855116	NC_000016.10:23614050:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3153T>C (p.Ile1051=)	PALB2		Familial cancer of breast	VCV001145468	16	23625373	16	23614052	1145468	1145999	rs1168676309	NC_000016.10:23614051:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3153T>G (p.Ile1051Met)	PALB2	I1051M	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000574559	16	23625373	16	23614052	574559	567940	rs1168676309	NC_000016.10:23614051:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3152T>A (p.Ile1051Asn)	PALB2	I1051N	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480229	16	23625374	16	23614053	480229	477442	rs760373091	NC_000016.10:23614052:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3152T>C (p.Ile1051Thr)	PALB2	I1051T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410154	16	23625374	16	23614053	410154	400998	rs760373091	NC_000016.10:23614052:A:G	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3151A>G (p.Ile1051Val)	PALB2	I1051V	Familial cancer of breast	VCV000410125	16	23625375	16	23614054	410125	401055	rs1060502745	NC_000016.10:23614053:T:C	single nucleotide variant	missense variant	Uncertain significance	May 13, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3150C>T (p.His1050=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001728188	16	23625376	16	23614055	1728188	1791588	rs2142299652	NC_000016.10:23614054:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3148C>T (p.His1050Tyr)	PALB2	H1050Y	not provided|Familial cancer of breast	VCV001481678	16	23625378	16	23614057	1481678	1367196	rs2142299692	NC_000016.10:23614056:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3147G>A (p.Met1049Ile)	PALB2	M1049I, M227I, M453I, M956I, M1029I, M1025I, M700I, M995I, M754I	Familial cancer of breast	VCV003650506	16	23625379	16	23614058	3650506	3785081		NC_000016.10:23614057:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3146T>G (p.Met1049Arg)	PALB2	M1049R	Familial cancer of breast	VCV001003282	16	23625380	16	23614059	1003282	996787	rs138273800	NC_000016.10:23614058:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3146T>C (p.Met1049Thr)	PALB2	M1049T	Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|not specified|Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not provided	VCV000141785	16	23625380	16	23614059	141785	151499	rs138273800	NC_000016.10:23614058:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3144G>A (p.Lys1048=)	PALB2		Familial cancer of breast	VCV002026748	16	23625382	16	23614061	2026748	2084668	rs2142299759	NC_000016.10:23614060:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3143A>G (p.Lys1048Arg)	PALB2	K1048R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126717	16	23625383	16	23614062	126717	132227	rs515726107	NC_000016.10:23614061:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3141A>G (p.Lys1047=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV001097869	16	23625385	16	23614064	1097869	1081880	rs2142299817	NC_000016.10:23614063:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3139A>T (p.Lys1047Ter)	PALB2	K1023*, K1027*, K1047*, K225*, K451*, K698*, K752*, K954*, K993*	Familial cancer of breast	VCV002674035	16	23625387	16	23614066	2674035	2841527	rs2506266710	NC_000016.10:23614065:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3139A>G (p.Lys1047Glu)	PALB2	K1027E, K698E, K993E, K225E, K954E, K1023E, K1047E, K752E, K451E	Familial cancer of breast	VCV002064999	16	23625387	16	23614066	2064999	2125110	rs2506266710	NC_000016.10:23614065:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3138G>A (p.Leu1046=)	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000484215	16	23625388	16	23614067	484215	477447	rs1555458824	NC_000016.10:23614066:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3137T>G (p.Leu1046Arg)	PALB2	L450R, L697R, L953R, L1022R, L1026R, L751R, L1046R, L224R, L992R	Hereditary cancer-predisposing syndrome	VCV003885205	16	23625389	16	23614068	3885205	4005527		NC_000016.10:23614067:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 11, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3137T>C (p.Leu1046Pro)	PALB2	L1026P, L450P, L992P, L1046P, L697P, L751P, L224P, L1022P, L953P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002585207	16	23625389	16	23614068	2585207	2752769	rs1966636283	NC_000016.10:23614067:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance		criteria provided, single submitter							
NM_024675.4(PALB2):c.3137T>A (p.Leu1046Gln)	PALB2	L1022Q, L1026Q, L1046Q, L224Q, L450Q, L697Q, L751Q, L953Q, L992Q	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001718729	16	23625389	16	23614068	1718729	1776233	rs1966636283	NC_000016.10:23614067:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3136C>T (p.Leu1046=)	PALB2		Familial cancer of breast	VCV001117825	16	23625390	16	23614069	1117825	1103693	rs750579753	NC_000016.10:23614068:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3134T>C (p.Leu1045Pro)	PALB2	L1021P, L1025P, L1045P, L223P, L449P, L750P, L696P, L952P, L991P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001727997	16	23625392	16	23614071	1727997	1794865	rs1966636462	NC_000016.10:23614070:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3133C>T (p.Leu1045Phe)	PALB2	L1045F	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000575265	16	23625393	16	23614072	575265	573912	rs1567209904	NC_000016.10:23614071:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3132A>G (p.Gln1044=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000822962	16	23625394	16	23614073	822962	812665	rs587780216	NC_000016.10:23614072:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3132A>T (p.Gln1044His)	PALB2	Q1044H	Familial cancer of breast|PALB2-related disorder|Hereditary cancer-predisposing syndrome	VCV000460977	16	23625394	16	23614073	460977	466145	rs587780216	NC_000016.10:23614072:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3132A>C (p.Gln1044His)	PALB2	Q1044H	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000128138	16	23625394	16	23614073	128138	133595	rs587780216	NC_000016.10:23614072:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3130C>A (p.Gln1044Lys)	PALB2	Q1044K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000643388	16	23625396	16	23614075	643388	644389	rs766394024	NC_000016.10:23614074:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3130C>T (p.Gln1044Ter)	PALB2	Q1044*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480290	16	23625396	16	23614075	480290	478020	rs766394024	NC_000016.10:23614074:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3129T>G (p.Gly1043=)	PALB2		Familial cancer of breast	VCV001133648	16	23625397	16	23614076	1133648	1125109	rs1567209919	NC_000016.10:23614075:A:C	single nucleotide variant	synonymous variant	Likely benign	Sep 17, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3129T>C (p.Gly1043=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000628487	16	23625397	16	23614076	628487	618358	rs1567209919	NC_000016.10:23614075:A:G	single nucleotide variant	synonymous variant	Likely benign	May 29, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3128G>T (p.Gly1043Val)	PALB2	G950V, G1023V, G221V, G694V, G989V, G447V, G1019V, G1043V, G748V	Familial cancer of breast	VCV002781528	16	23625398	16	23614077	2781528	2947425	rs377713277	NC_000016.10:23614076:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3128G>A (p.Gly1043Asp)	PALB2	G1043D	Hereditary cancer-predisposing syndrome	VCV000922719	16	23625398	16	23614077	922719	913602	rs377713277	NC_000016.10:23614076:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3128G>C (p.Gly1043Ala)	PALB2	G1043A	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not specified	VCV000126716	16	23625398	16	23614077	126716	132226	rs377713277	NC_000016.10:23614076:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3127G>A (p.Gly1043Ser)	PALB2	G1043S	Familial cancer of breast	VCV001347549	16	23625399	16	23614078	1347549	1465979	rs2142300078	NC_000016.10:23614077:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3126T>A (p.Thr1042=)	PALB2		Hereditary breast ovarian cancer syndrome	VCV003362808	16	23625400	16	23614079	3362808	3522015		NC_000016.10:23614078:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3126T>C (p.Thr1042=)	PALB2		Familial cancer of breast	VCV002023358	16	23625400	16	23614079	2023358	2083839	rs566549034	NC_000016.10:23614078:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 10, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3126T>G (p.Thr1042=)	PALB2		Familial cancer of breast	VCV001557410	16	23625400	16	23614079	1557410	1627853	rs566549034	NC_000016.10:23614078:A:C	single nucleotide variant	synonymous variant	Likely benign	May 7, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3125C>G (p.Thr1042Ser)	PALB2	T1042S	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000128137	16	23625401	16	23614080	128137	133594	rs587780215	NC_000016.10:23614079:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3123A>T (p.Lys1041Asn)	PALB2	K692N, K948N, K1017N, K219N, K445N, K1021N, K1041N, K746N, K987N	Hereditary cancer-predisposing syndrome	VCV003413486	16	23625403	16	23614082	3413486	3574709		NC_000016.10:23614081:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3122A>C (p.Lys1041Thr)	PALB2	K1041T	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000422560	16	23625404	16	23614083	422560	409514	rs781663559	NC_000016.10:23614082:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3121A>G (p.Lys1041Glu)	PALB2	K1041E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484237	16	23625405	16	23614084	484237	477552	rs1175812630	NC_000016.10:23614083:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3119T>G (p.Leu1040Ter)	PALB2	L1016*, L1020*, L1040*, L218*, L444*, L691*, L745*, L947*, L986*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002674102	16	23625407	16	23614086	2674102	2841592	rs2142300225	NC_000016.10:23614085:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3119T>A (p.Leu1040Ter)	PALB2	L1016*, L1020*, L1040*, L218*, L444*, L691*, L745*, L947*, L986*	Familial cancer of breast	VCV002674059	16	23625407	16	23614086	2674059	2841549	rs2142300225	NC_000016.10:23614085:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3116A>C (p.Asn1039Thr)	PALB2	N1039T	Familial cancer of breast|not provided	VCV000449863	16	23625410	16	23614089	449863	445545	rs1555458829	NC_000016.10:23614088:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3114G>A (p.Trp1038Ter)	PALB2	W1038*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000231919	16	23625412	16	23614091	231919	235175	rs778345761	NC_000016.10:23614090:C:T	single nucleotide variant	nonsense	Pathogenic	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3114-1G>C	PALB2		Breast and/or ovarian cancer	VCV001329323	16	23625413	16	23614092	1329323	1320010	rs886039619	NC_000016.10:23614091:C:G	single nucleotide variant	intron variant|splice acceptor variant	Likely pathogenic	Jul 2, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-1G>A	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3	VCV000265552	16	23625413	16	23614092	265552	260096	rs886039619	NC_000016.10:23614091:C:T	single nucleotide variant	intron variant|splice acceptor variant	Pathogenic/Likely pathogenic	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3114-2A>C	PALB2		Hereditary cancer-predisposing syndrome	VCV003413489	16	23625414	16	23614093	3413489	3574712		NC_000016.10:23614092:T:G	single nucleotide variant	intron variant|splice acceptor variant	Likely pathogenic	Nov 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-2A>G	PALB2		Familial cancer of breast	VCV002673830	16	23625414	16	23614093	2673830	2841333	rs2142300348	NC_000016.10:23614092:T:C	single nucleotide variant	intron variant|splice acceptor variant	Likely pathogenic	Sep 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3114-3A>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000410183	16	23625415	16	23614094	410183	401495	rs1060502784	NC_000016.10:23614093:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3114-4T>A	PALB2		Familial cancer of breast	VCV003005433	16	23625416	16	23614095	3005433	3161847	rs2506267855	NC_000016.10:23614094:A:T	single nucleotide variant	intron variant	Likely benign	Jan 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-5C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000187727	16	23625417	16	23614096	187727	184168	rs753307725	NC_000016.10:23614095:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3114-6T>A	PALB2		Familial cancer of breast	VCV002011715	16	23625418	16	23614097	2011715	2070944	rs1064794886	NC_000016.10:23614096:A:T	single nucleotide variant	intron variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-6T>C	PALB2		not provided|Familial cancer of breast	VCV000421067	16	23625418	16	23614097	421067	409515	rs1064794886	NC_000016.10:23614096:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3114-7A>T	PALB2		Familial cancer of breast	VCV000792259	16	23625419	16	23614098	792259	788043	rs1597073440	NC_000016.10:23614097:T:A	single nucleotide variant	intron variant	Likely benign	Oct 16, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-10G>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002109370	16	23625422	16	23614101	2109370	2167235	rs756415176	NC_000016.10:23614100:C:G	single nucleotide variant	intron variant	Likely benign	Oct 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3114-10G>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000927506	16	23625422	16	23614101	927506	916387	rs756415176	NC_000016.10:23614100:C:T	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3114-12T>A	PALB2		Familial cancer of breast	VCV001993528	16	23625424	16	23614103	1993528	2049315	rs2506268032	NC_000016.10:23614102:A:T	single nucleotide variant	intron variant	Uncertain significance	May 12, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-14T>C	PALB2		Familial cancer of breast	VCV002021911	16	23625426	16	23614105	2021911	2083672	rs2506268099	NC_000016.10:23614104:A:G	single nucleotide variant	intron variant	Likely benign	Aug 6, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-15T>G	PALB2		Familial cancer of breast	VCV002732424	16	23625427	16	23614106	2732424	2883867	rs2142300467	NC_000016.10:23614105:A:C	single nucleotide variant	intron variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-15T>C	PALB2		Familial cancer of breast	VCV001550092	16	23625427	16	23614106	1550092	1659028	rs2142300467	NC_000016.10:23614105:A:G	single nucleotide variant	intron variant	Likely benign	Jun 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-16A>G	PALB2		Familial cancer of breast	VCV003903819	16	23625428	16	23614107	3903819	4019692		NC_000016.10:23614106:T:C	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-16A>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000627672	16	23625428	16	23614107	627672	619525	rs778244808	NC_000016.10:23614106:T:A	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3114-20A>G	PALB2		Familial cancer of breast	VCV001547044	16	23625432	16	23614111	1547044	1571587	rs770731003	NC_000016.10:23614110:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Mar 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3114-51=	PALB2		not provided	VCV000126714	16	23625463	16	23614142	126714	132224	rs249936	NC_000016.10:23614141:T:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3114-130A>C	PALB2		Familial cancer of breast	VCV000931344	16	23625542	16	23614221	931344	920359	rs1304034435	NC_000016.10:23614220:T:G	single nucleotide variant	intron variant	Uncertain significance	Nov 8, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-172A>G	PALB2		not provided	VCV001219724	16	23625584	16	23614263	1219724	1209702	rs146773703	NC_000016.10:23614262:T:C	single nucleotide variant	intron variant	Likely benign	Jun 26, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3114-239A>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002156281	16	23625651	16	23614330	2156281	1885953	rs2506269944	NC_000016.10:23614329:T:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 21, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3113+1376C>G	PALB2		not specified|not provided	VCV000830193	16	23631307	16	23619986	830193	818460	rs369444	NC_000016.10:23619985:G:C	single nucleotide variant	intron variant	Benign	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3113+1375G>A	PALB2		Hereditary cancer-predisposing syndrome	VCV001691951	16	23631308	16	23619987	1691951	1684393	rs2142321003	NC_000016.10:23619986:C:T	single nucleotide variant	intron variant	Uncertain significance	Dec 22, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+325A>G	PALB2		not provided	VCV001289409	16	23632358	16	23621037	1289409	1279240	rs8061190	NC_000016.10:23621036:T:C	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+204G>A	PALB2		not provided	VCV001181215	16	23632479	16	23621158	1181215	1172827	rs8060124	NC_000016.10:23621157:C:T	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+196A>G	PALB2		not provided	VCV000677010	16	23632487	16	23621166	677010	668257	rs113616057	NC_000016.10:23621165:T:C	single nucleotide variant	intron variant	Likely benign	Jun 15, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+34T>C	PALB2		not specified	VCV001697753	16	23632649	16	23621328	1697753	1690137	rs201387125	NC_000016.10:23621327:A:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+28C>T	PALB2		Hereditary breast ovarian cancer syndrome	VCV001678966	16	23632655	16	23621334	1678966	1670760	rs145973806	NC_000016.10:23621333:G:A	single nucleotide variant	intron variant	Likely benign	Apr 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+17G>A	PALB2		Familial cancer of breast	VCV002697028	16	23632666	16	23621345	2697028	2854598	rs1451806881	NC_000016.10:23621344:C:T	single nucleotide variant	intron variant	Likely benign	Nov 18, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+17G>T	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492210	16	23632666	16	23621345	492210	484804	rs1451806881	NC_000016.10:23621344:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3113+16A>G	PALB2		Familial cancer of breast	VCV001534072	16	23632667	16	23621346	1534072	1647640	rs1966767265	NC_000016.10:23621345:T:C	single nucleotide variant	intron variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+14C>T	PALB2		Familial cancer of breast	VCV001586220	16	23632669	16	23621348	1586220	1593865	rs2142325783	NC_000016.10:23621347:G:A	single nucleotide variant	intron variant	Likely benign	Oct 17, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+12C>G	PALB2		Familial cancer of breast	VCV001615960	16	23632671	16	23621350	1615960	1613680	rs1057523380	NC_000016.10:23621349:G:C	single nucleotide variant	intron variant	Likely benign	Jul 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+12C>A	PALB2		not specified|PALB2-related cancer predisposition	VCV000389265	16	23632671	16	23621350	389265	374917	rs1057523380	NC_000016.10:23621349:G:T	single nucleotide variant	intron variant	Likely benign	Oct 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3113+11C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000384662	16	23632672	16	23621351	384662	377364	rs1057522029	NC_000016.10:23621350:G:A	single nucleotide variant	intron variant	Likely benign	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3113+10C>T	PALB2		Familial cancer of breast|not specified	VCV000514169	16	23632673	16	23621352	514169	505501	rs1030025333	NC_000016.10:23621351:G:A	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3113+9T>C	PALB2		Familial cancer of breast	VCV003903836	16	23632674	16	23621353	3903836	4019709		NC_000016.10:23621352:A:G	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+9T>G	PALB2		Familial cancer of breast	VCV001102915	16	23632674	16	23621353	1102915	1103694	rs2142325832	NC_000016.10:23621352:A:C	single nucleotide variant	intron variant	Likely benign	Jan 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+8T>C	PALB2		Familial cancer of breast	VCV002752770	16	23632675	16	23621354	2752770	2913511	rs2142325841	NC_000016.10:23621353:A:G	single nucleotide variant	intron variant	Likely benign	Aug 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+7T>C	PALB2		Familial cancer of breast	VCV003624620	16	23632676	16	23621355	3624620	3757759		NC_000016.10:23621354:A:G	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3113+6C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002773994	16	23632677	16	23621356	2773994	2934725	rs764320763	NC_000016.10:23621355:G:A	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3113+6C>A	PALB2		Familial cancer of breast	VCV002127738	16	23632677	16	23621356	2127738	2185615	rs764320763	NC_000016.10:23621355:G:T	single nucleotide variant	intron variant	Uncertain significance	Apr 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113+5G>A	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000663588	16	23632678	16	23621357	663588	652718	rs876659463	NC_000016.10:23621356:C:T	single nucleotide variant	intron variant	Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3113+5G>C	PALB2		Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome	VCV000231961	16	23632678	16	23621357	231961	235176	rs876659463	NC_000016.10:23621356:C:G	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3113+1G>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001727771	16	23632682	16	23621361	1727771	1794639	rs1597079557	NC_000016.10:23621360:C:G	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3113+1G>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822928	16	23632682	16	23621361	822928	815625	rs1597079557	NC_000016.10:23621360:C:T	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3113G>C (p.Trp1038Ser)	PALB2	W1014S, W1018S, W1038S, W216S, W442S, W689S, W743S, W984S	Familial cancer of breast	VCV002673836	16	23632683	16	23621362	2673836	2841338	rs180177132	NC_000016.10:23621361:C:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Sep 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3113G>A (p.Trp1038Ter)	PALB2	W1038*	Familial cancer of breast	VCV000126711	16	23632683	16	23621362	126711	132221	rs180177132	NC_000016.10:23621361:C:T	single nucleotide variant	nonsense	Pathogenic	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.3112T>C (p.Trp1038Arg)	PALB2	W442R, W984R, W1038R, W216R, W689R, W1014R, W743R, W1018R	Familial cancer of breast	VCV003722036	16	23632684	16	23621363	3722036	3860140		NC_000016.10:23621362:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3111T>C (p.Ile1037=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000234178	16	23632685	16	23621364	234178	235177	rs876660903	NC_000016.10:23621363:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3110T>A (p.Ile1037Asn)	PALB2	I1017N, I1037N, I742N, I1013N, I215N, I441N, I688N, I983N	Hereditary cancer-predisposing syndrome	VCV001727750	16	23632686	16	23621365	1727750	1794618	rs1555459356	NC_000016.10:23621364:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3110T>C (p.Ile1037Thr)	PALB2	I1037T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484219	16	23632686	16	23621365	484219	478027	rs1555459356	NC_000016.10:23621364:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3109A>G (p.Ile1037Val)	PALB2	I1037V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001018016	16	23632687	16	23621366	1018016	1012023	rs1966767854	NC_000016.10:23621365:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3108T>C (p.Val1036=)	PALB2		Familial cancer of breast	VCV003903733	16	23632688	16	23621367	3903733	4019606		NC_000016.10:23621366:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3108T>A (p.Val1036=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001612958	16	23632688	16	23621367	1612958	1663109	rs2142326024	NC_000016.10:23621366:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3107T>G (p.Val1036Gly)	PALB2	V1016G, V440G, V741G, V1012G, V1036G, V214G, V687G, V982G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001727702	16	23632689	16	23621368	1727702	1794570	rs1555459357	NC_000016.10:23621367:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3107T>C (p.Val1036Ala)	PALB2	V1036A	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000490081	16	23632689	16	23621368	490081	482878	rs1555459357	NC_000016.10:23621367:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3106G>C (p.Val1036Leu)	PALB2	V1036L	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000188131	16	23632690	16	23621369	188131	186210	rs756906403	NC_000016.10:23621368:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 12, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3105T>G (p.Ile1035Met)	PALB2	I1035M	Hereditary cancer-predisposing syndrome	VCV001691950	16	23632691	16	23621370	1691950	1684392	rs1251984558	NC_000016.10:23621369:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3104T>C (p.Ile1035Thr)	PALB2	I1035T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530174	16	23632692	16	23621371	530174	529836	rs1555459362	NC_000016.10:23621370:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3103A>T (p.Ile1035Phe)	PALB2	I1035F	Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000219857	16	23632693	16	23621372	219857	222460	rs863224783	NC_000016.10:23621371:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3103A>G (p.Ile1035Val)	PALB2	I1035V	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000216750	16	23632693	16	23621372	216750	213157	rs863224783	NC_000016.10:23621371:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3102C>T (p.Asn1034=)	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome	VCV000822897	16	23632694	16	23621373	822897	812666	rs1282500498	NC_000016.10:23621372:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3101A>T (p.Asn1034Ile)	PALB2	N1014I, N212I, N685I, N1034I, N438I, N739I, N1010I, N980I	Hereditary cancer-predisposing syndrome	VCV003304006	16	23632695	16	23621374	3304006	3470173		NC_000016.10:23621373:T:A	single nucleotide variant	missense variant|intron variant	Likely benign	May 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3101A>G (p.Asn1034Ser)	PALB2	N1034S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001349670	16	23632695	16	23621374	1349670	1394433	rs2142326183	NC_000016.10:23621373:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 17, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3099C>A (p.Asn1033Lys)	PALB2	N1033K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410132	16	23632697	16	23621376	410132	401741	rs1057523064	NC_000016.10:23621375:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3099C>T (p.Asn1033=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000388304	16	23632697	16	23621376	388304	374922	rs1057523064	NC_000016.10:23621375:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3096G>T (p.Met1032Ile)	PALB2	M683I, M1032I, M436I, M1012I, M210I, M737I, M978I, M1008I	Hereditary cancer-predisposing syndrome	VCV003413430	16	23632700	16	23621379	3413430	3574653		NC_000016.10:23621378:C:A	single nucleotide variant	missense variant|intron variant	Likely benign	Jun 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3096G>C (p.Met1032Ile)	PALB2	M1032I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000232245	16	23632700	16	23621379	232245	235178	rs778705498	NC_000016.10:23621378:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 11, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3095T>C (p.Met1032Thr)	PALB2	M436T, M737T, M1008T, M1012T, M1032T, M210T, M683T, M978T	Hereditary cancer-predisposing syndrome	VCV001727505	16	23632701	16	23621380	1727505	1784985	rs745562326	NC_000016.10:23621379:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3095T>G (p.Met1032Arg)	PALB2	M1032R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233610	16	23632701	16	23621380	233610	235179	rs745562326	NC_000016.10:23621379:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3094A>T (p.Met1032Leu)	PALB2	M1032L	Hereditary cancer-predisposing syndrome	VCV000830191	16	23632702	16	23621381	830191	818462	rs1555459367	NC_000016.10:23621380:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.3094A>G (p.Met1032Val)	PALB2	M1032V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481034	16	23632702	16	23621381	481034	477448	rs1555459367	NC_000016.10:23621380:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3093T>C (p.Ile1031=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001727487	16	23632703	16	23621382	1727487	1784967	rs2506317513	NC_000016.10:23621381:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3092T>C (p.Ile1031Thr)	PALB2	I1031T	Familial cancer of breast	VCV000857356	16	23632704	16	23621383	857356	843560	rs1966768570	NC_000016.10:23621382:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3091A>G (p.Ile1031Val)	PALB2	I1031V	Hereditary cancer-predisposing syndrome	VCV000482057	16	23632705	16	23621384	482057	477558	rs757946618	NC_000016.10:23621383:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3089C>G (p.Thr1030Ser)	PALB2	T1006S, T1030S, T976S, T208S, T434S, T681S, T735S, T1010S	Hereditary cancer-predisposing syndrome	VCV002453285	16	23632707	16	23621386	2453285	2430345	rs876660109	NC_000016.10:23621385:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3089C>A (p.Thr1030Asn)	PALB2	T1030N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000864137	16	23632707	16	23621386	864137	843561	rs876660109	NC_000016.10:23621385:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3089C>T (p.Thr1030Ile)	PALB2	T1030I	Familial cancer of breast	VCV000232977	16	23632707	16	23621386	232977	235180	rs876660109	NC_000016.10:23621385:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.3088A>C (p.Thr1030Pro)	PALB2	T1006P, T208P, T434P, T976P, T1010P, T1030P, T681P, T735P	Hereditary cancer-predisposing syndrome	VCV003303999	16	23632708	16	23621387	3303999	3470166		NC_000016.10:23621386:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3088A>G (p.Thr1030Ala)	PALB2	T1030A	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000830190	16	23632708	16	23621387	830190	818463	rs1040452708	NC_000016.10:23621386:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3087T>C (p.Thr1029=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001727411	16	23632709	16	23621388	1727411	1784891	rs2142326440	NC_000016.10:23621387:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3087T>A (p.Thr1029=)	PALB2		Familial cancer of breast	VCV001550243	16	23632709	16	23621388	1550243	1659179	rs2142326440	NC_000016.10:23621387:A:T	single nucleotide variant	synonymous variant	Likely benign	Apr 12, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3086C>G (p.Thr1029Ser)	PALB2	T1005S, T1009S, T1029S, T207S, T433S, T680S, T734S, T975S	not provided	VCV003365379	16	23632710	16	23621389	3365379	3524586		NC_000016.10:23621388:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3086C>T (p.Thr1029Ile)	PALB2	T1029I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000856643	16	23632710	16	23621389	856643	843562	rs1966768882	NC_000016.10:23621388:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3085A>G (p.Thr1029Ala)	PALB2	T1029A	Familial cancer of breast	VCV000584902	16	23632711	16	23621390	584902	575958	rs1567212837	NC_000016.10:23621389:T:C	single nucleotide variant	missense variant	Uncertain significance	May 28, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3084T>C (p.Gly1028=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001727395	16	23632712	16	23621391	1727395	1784875	rs2142326500	NC_000016.10:23621390:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3083G>A (p.Gly1028Asp)	PALB2	G1028D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000956986	16	23632713	16	23621392	956986	949302	rs779642624	NC_000016.10:23621391:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3083G>T (p.Gly1028Val)	PALB2	G1028V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000663510	16	23632713	16	23621392	663510	644390	rs779642624	NC_000016.10:23621391:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3082G>C (p.Gly1028Arg)	PALB2	G974R, G1008R, G679R, G1028R, G1004R, G206R, G432R, G733R	Familial cancer of breast	VCV002780338	16	23632714	16	23621393	2780338	2944078	rs2142326566	NC_000016.10:23621392:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3082G>T (p.Gly1028Cys)	PALB2	G1004C, G1008C, G1028C, G206C, G432C, G679C, G733C, G974C	Familial cancer of breast	VCV001714932	16	23632714	16	23621393	1714932	1777933	rs2142326566	NC_000016.10:23621392:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3080T>G (p.Leu1027Arg)	PALB2	L1003R, L1007R, L1027R, L431R, L732R, L973R, L205R, L678R	Familial cancer of breast	VCV002745949	16	23632716	16	23621395	2745949	2904142	rs2142326618	NC_000016.10:23621394:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3080T>C (p.Leu1027Pro)	PALB2	L1027P	Familial cancer of breast	VCV001415439	16	23632716	16	23621395	1415439	1374946	rs2142326618	NC_000016.10:23621394:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3079C>T (p.Leu1027Phe)	PALB2	L1027F	Familial cancer of breast	VCV000956346	16	23632717	16	23621396	956346	949303	rs1966769057	NC_000016.10:23621395:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3079C>G (p.Leu1027Val)	PALB2	L1027V	Hereditary cancer-predisposing syndrome	VCV000922481	16	23632717	16	23621396	922481	913603	rs1966769057	NC_000016.10:23621395:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3078G>A (p.Leu1026=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486022	16	23632718	16	23621397	486022	477560	rs1555459373	NC_000016.10:23621396:C:T	single nucleotide variant	synonymous variant	Likely benign	May 21, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3076C>T (p.Leu1026=)	PALB2		Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000508248	16	23632720	16	23621399	508248	506204	rs1555459377	NC_000016.10:23621398:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3075T>G (p.Ala1025=)	PALB2		Familial cancer of breast	VCV003660735	16	23632721	16	23621400	3660735	3794450		NC_000016.10:23621399:A:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3075T>C (p.Ala1025=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000822813	16	23632721	16	23621400	822813	812667	rs1597079664	NC_000016.10:23621399:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3074C>A (p.Ala1025Asp)	PALB2	A203D, A676D, A971D, A1001D, A429D, A1005D, A1025D, A730D	Hereditary cancer-predisposing syndrome	VCV002773995	16	23632722	16	23621401	2773995	2934726	rs1555459378	NC_000016.10:23621400:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3074C>T (p.Ala1025Val)	PALB2	A1025V	Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486000	16	23632722	16	23621401	486000	477449	rs1555459378	NC_000016.10:23621400:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3073G>T (p.Ala1025Ser)	PALB2	A429S, A1005S, A1025S, A971S, A1001S, A203S, A676S, A730S	Hereditary cancer-predisposing syndrome	VCV001727283	16	23632723	16	23621402	1727283	1784763	rs746872839	NC_000016.10:23621401:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3073G>A (p.Ala1025Thr)	PALB2	A1025T	Breast and/or ovarian cancer|not provided|not specified|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000217917	16	23632723	16	23621402	217917	214572	rs746872839	NC_000016.10:23621401:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3071A>C (p.Glu1024Ala)	PALB2	E1024A, E729A, E970A, E1000A, E1004A, E202A, E428A, E675A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003413462	16	23632725	16	23621404	3413462	3574685		NC_000016.10:23621403:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3071A>T (p.Glu1024Val)	PALB2	E1024V, E970V, E1000V, E675V, E1004V, E202V, E729V, E428V	Familial cancer of breast	VCV002806391	16	23632725	16	23621404	2806391	2971323	rs2506318360	NC_000016.10:23621403:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3069A>G (p.Gln1023=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000184257	16	23632727	16	23621406	184257	184169	rs786201363	NC_000016.10:23621405:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3067C>T (p.Gln1023Ter)	PALB2	Q1023*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492209	16	23632729	16	23621408	492209	484638	rs1555459386	NC_000016.10:23621407:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Nov 19, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3066G>T (p.Met1022Ile)	PALB2	M1022I	Familial cancer of breast	VCV001495793	16	23632730	16	23621409	1495793	1362708	rs1220966608	NC_000016.10:23621408:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3066G>A (p.Met1022Ile)	PALB2	M1022I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000633345	16	23632730	16	23621409	633345	621528	rs1220966608	NC_000016.10:23621408:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3066G>C (p.Met1022Ile)	PALB2	M1022I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460976	16	23632730	16	23621409	460976	466361	rs1220966608	NC_000016.10:23621408:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3064A>G (p.Met1022Val)	PALB2	M1022V	Familial cancer of breast	VCV000410197	16	23632732	16	23621411	410197	401003	rs1060502792	NC_000016.10:23621410:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.3063G>A (p.Gly1021=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001799397	16	23632733	16	23621412	1799397	1855005	rs1966769912	NC_000016.10:23621411:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 18, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3062G>A (p.Gly1021Glu)	PALB2	G1021E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822770	16	23632734	16	23621413	822770	812668	rs1597079719	NC_000016.10:23621412:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3061G>A (p.Gly1021Arg)	PALB2	G1021R	not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|not provided|Familial cancer of breast	VCV000230665	16	23632735	16	23621414	230665	235181	rs143808171	NC_000016.10:23621413:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3060A>G (p.Gln1020=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484207	16	23632736	16	23621415	484207	477482	rs1555459389	NC_000016.10:23621414:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3059A>T (p.Gln1020Leu)	PALB2	Q1020L	Hereditary cancer-predisposing syndrome	VCV001332425	16	23632737	16	23621416	1332425	1323143	rs776221283	NC_000016.10:23621415:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3059A>G (p.Gln1020Arg)	PALB2	Q1020R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000220010	16	23632737	16	23621416	220010	222461	rs776221283	NC_000016.10:23621415:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3058C>T (p.Gln1020Ter)	PALB2	Q1020*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001068533	16	23632738	16	23621417	1068533	1063573	rs2142327117	NC_000016.10:23621416:G:A	single nucleotide variant	nonsense	Pathogenic	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3057C>G (p.Val1019=)	PALB2		Familial cancer of breast	VCV002008861	16	23632739	16	23621418	2008861	2062934	rs2142327149	NC_000016.10:23621417:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3057C>A (p.Val1019=)	PALB2		Familial cancer of breast	VCV001568630	16	23632739	16	23621418	1568630	1634231	rs2142327149	NC_000016.10:23621417:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3057C>T (p.Val1019=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001153446	16	23632739	16	23621418	1153446	1146000	rs2142327149	NC_000016.10:23621417:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3056T>A (p.Val1019Asp)	PALB2	V423D, V965D, V995D, V999D, V1019D, V197D, V670D, V724D	Familial cancer of breast	VCV002750119	16	23632740	16	23621419	2750119	2919077	rs376619846	NC_000016.10:23621418:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3056T>C (p.Val1019Ala)	PALB2	V1019A	not provided|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000126709	16	23632740	16	23621419	126709	132219	rs376619846	NC_000016.10:23621418:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 16, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3054G>T (p.Glu1018Asp)	PALB2	E1018D	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000420826	16	23632742	16	23621421	420826	409517	rs183489969	NC_000016.10:23621420:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3054G>A (p.Glu1018=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000383013	16	23632742	16	23621421	383013	374246	rs183489969	NC_000016.10:23621420:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3054G>C (p.Glu1018Asp)	PALB2	E1018D	Familial cancer of breast	VCV000126708	16	23632742	16	23621421	126708	132218	rs183489969	NC_000016.10:23621420:C:G	single nucleotide variant	missense variant	Benign	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.3053A>C (p.Glu1018Ala)	PALB2	E1018A	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000576952	16	23632743	16	23621422	576952	573914	rs1567212910	NC_000016.10:23621421:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3052G>A (p.Glu1018Lys)	PALB2	E1018K	Hereditary cancer-predisposing syndrome	VCV000921437	16	23632744	16	23621423	921437	913604	rs1966770468	NC_000016.10:23621422:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3051T>G (p.Ala1017=)	PALB2		Familial cancer of breast	VCV003002247	16	23632745	16	23621424	3002247	3157424	rs774535249	NC_000016.10:23621423:A:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3050C>G (p.Ala1017Gly)	PALB2	A1017G	Familial cancer of breast	VCV001500797	16	23632746	16	23621425	1500797	1501720	rs2142327332	NC_000016.10:23621424:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3049G>T (p.Ala1017Ser)	PALB2	A963S, A195S, A421S, A1017S, A668S, A997S, A722S, A993S	Familial cancer of breast	VCV002107323	16	23632747	16	23621426	2107323	2170377	rs759795184	NC_000016.10:23621425:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3049G>A (p.Ala1017Thr)	PALB2	A1017T	Familial cancer of breast	VCV000830187	16	23632747	16	23621426	830187	818466	rs759795184	NC_000016.10:23621425:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.3049G>C (p.Ala1017Pro)	PALB2	A1017P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000822716	16	23632747	16	23621426	822716	812669	rs759795184	NC_000016.10:23621425:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3048T>C (p.Phe1016=)	PALB2		Familial cancer of breast	VCV002130980	16	23632748	16	23621427	2130980	2186275	rs1567212918	NC_000016.10:23621426:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3048T>G (p.Phe1016Leu)	PALB2	F1016L	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3	VCV000560875	16	23632748	16	23621427	560875	551914	rs1567212918	NC_000016.10:23621426:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3047T>C (p.Phe1016Ser)	PALB2	F1016S	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000420578	16	23632749	16	23621428	420578	409518	rs879254154	NC_000016.10:23621427:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3047T>G (p.Phe1016Cys)	PALB2	F1016C	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000246209	16	23632749	16	23621428	246209	244949	rs879254154	NC_000016.10:23621427:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3045T>C (p.Thr1015=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001799196	16	23632751	16	23621430	1799196	1854805	rs2142327487	NC_000016.10:23621429:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 13, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3044C>A (p.Thr1015Asn)	PALB2	T1015N	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV001447999	16	23632752	16	23621431	1447999	1403885	rs367840862	NC_000016.10:23621430:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3044C>G (p.Thr1015Ser)	PALB2	T1015S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000642904	16	23632752	16	23621431	642904	644393	rs367840862	NC_000016.10:23621430:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3044C>T (p.Thr1015Ile)	PALB2	T1015I	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000141554	16	23632752	16	23621431	141554	151268	rs367840862	NC_000016.10:23621430:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3043A>G (p.Thr1015Ala)	PALB2	T193A, T419A, T961A, T666A, T995A, T1015A, T720A, T991A	Hereditary cancer-predisposing syndrome	VCV003885186	16	23632753	16	23621432	3885186	4005508		NC_000016.10:23621431:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3043A>C (p.Thr1015Pro)	PALB2	T1015P	Familial cancer of breast	VCV000947626	16	23632753	16	23621432	947626	927707	rs1966771031	NC_000016.10:23621431:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3041T>C (p.Leu1014Pro)	PALB2	L1014P	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000232100	16	23632755	16	23621434	232100	235182	rs876659554	NC_000016.10:23621433:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3040C>A (p.Leu1014Ile)	PALB2	L1014I	Familial cancer of breast	VCV000968978	16	23632756	16	23621435	968978	957694	rs1966771258	NC_000016.10:23621434:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.3039A>G (p.Ile1013Met)	PALB2	I417M, I664M, I718M, I959M, I1013M, I989M, I993M, I191M	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002561288	16	23632757	16	23621436	2561288	2728054	rs1966771316	NC_000016.10:23621435:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3038T>C (p.Ile1013Thr)	PALB2	I1013T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000574607	16	23632758	16	23621437	574607	567947	rs775666266	NC_000016.10:23621436:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3037A>C (p.Ile1013Leu)	PALB2	I664L, I989L, I1013L, I718L, I959L, I191L, I417L, I993L	Hereditary cancer-predisposing syndrome	VCV001799095	16	23632759	16	23621438	1799095	1856363	rs1567212950	NC_000016.10:23621437:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3037A>G (p.Ile1013Val)	PALB2	I1013V	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3	VCV000574028	16	23632759	16	23621438	574028	570161	rs1567212950	NC_000016.10:23621437:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 12, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3036T>C (p.Thr1012=)	PALB2		Familial cancer of breast	VCV003903583	16	23632760	16	23621439	3903583	4019456		NC_000016.10:23621438:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3036T>G (p.Thr1012=)	PALB2		Familial cancer of breast	VCV000765068	16	23632760	16	23621439	765068	770769	rs1597079832	NC_000016.10:23621438:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3035C>T (p.Thr1012Ile)	PALB2	T1012I	not provided|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome	VCV000410122	16	23632761	16	23621440	410122	401004	rs761032954	NC_000016.10:23621439:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.3035C>G (p.Thr1012Ser)	PALB2	T1012S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233356	16	23632761	16	23621440	233356	235183	rs761032954	NC_000016.10:23621439:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3034A>C (p.Thr1012Pro)	PALB2	T1012P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000928296	16	23632762	16	23621441	928296	913605	rs1966771666	NC_000016.10:23621440:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3032A>T (p.Glu1011Val)	PALB2	E1011V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001343343	16	23632764	16	23621443	1343343	1335010	rs1597079845	NC_000016.10:23621442:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3032A>G (p.Glu1011Gly)	PALB2	E1011G	Hereditary cancer-predisposing syndrome	VCV000822662	16	23632764	16	23621443	822662	812670	rs1597079845	NC_000016.10:23621442:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.3031G>A (p.Glu1011Lys)	PALB2	E1011K	Familial cancer of breast	VCV001050013	16	23632765	16	23621444	1050013	1038416	rs1302512878	NC_000016.10:23621443:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3030G>C (p.Glu1010Asp)	PALB2	E1010D, E715D, E990D, E414D, E661D, E956D, E986D, E188D	Familial cancer of breast	VCV002115923	16	23632766	16	23621445	2115923	2182862	rs2142327851	NC_000016.10:23621444:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3029A>T (p.Glu1010Val)	PALB2	E661V, E956V, E990V, E414V, E1010V, E188V, E715V, E986V	Hereditary cancer-predisposing syndrome	VCV002567563	16	23632767	16	23621446	2567563	2731205	rs1228569190	NC_000016.10:23621445:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 1, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3029A>G (p.Glu1010Gly)	PALB2	E1010G	Familial cancer of breast	VCV001498534	16	23632767	16	23621446	1498534	1395435	rs1228569190	NC_000016.10:23621445:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3029A>C (p.Glu1010Ala)	PALB2	E1010A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000822650	16	23632767	16	23621446	822650	812671	rs1228569190	NC_000016.10:23621445:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3028G>A (p.Glu1010Lys)	PALB2	E1010K	Hereditary cancer-predisposing syndrome	VCV001171563	16	23632768	16	23621447	1171563	1161312	rs1966771907	NC_000016.10:23621446:C:T	single nucleotide variant	missense variant	Uncertain significance	May 11, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3028G>T (p.Glu1010Ter)	PALB2	E1010*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000858309	16	23632768	16	23621447	858309	843563	rs1966771907	NC_000016.10:23621446:C:A	single nucleotide variant	nonsense	Pathogenic	Dec 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3027T>C (p.Pro1009=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000231804	16	23632769	16	23621448	231804	235184	rs876659376	NC_000016.10:23621447:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3026C>T (p.Pro1009Leu)	PALB2	P1009L	Familial cancer of breast	VCV000830185	16	23632770	16	23621449	830185	818468	rs552354535	NC_000016.10:23621448:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3025C>T (p.Pro1009Ser)	PALB2	P1009S	PALB2-related disorder|Familial cancer of breast|not provided|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome	VCV000419928	16	23632771	16	23621450	419928	409519	rs764669864	NC_000016.10:23621449:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3024C>G (p.Pro1008=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001102595	16	23632772	16	23621451	1102595	1103695	rs180177130	NC_000016.10:23621450:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3024C>T (p.Pro1008=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000126705	16	23632772	16	23621451	126705	132215	rs180177130	NC_000016.10:23621450:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3023C>G (p.Pro1008Arg)	PALB2	P1008R, P186R, P412R, P659R, P713R, P954R, P984R, P988R	Familial cancer of breast	VCV002677446	16	23632773	16	23621452	2677446	2836317	rs1060502736	NC_000016.10:23621451:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3023C>A (p.Pro1008His)	PALB2	P412H, P659H, P984H, P954H, P988H, P1008H, P713H, P186H	Hereditary cancer-predisposing syndrome	VCV001798940	16	23632773	16	23621452	1798940	1856209	rs1060502736	NC_000016.10:23621451:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3023C>T (p.Pro1008Leu)	PALB2	P1008L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410113	16	23632773	16	23621452	410113	401056	rs1060502736	NC_000016.10:23621451:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3022C>T (p.Pro1008Ser)	PALB2	P1008S	Familial cancer of breast	VCV001493385	16	23632774	16	23621453	1493385	1355583	rs1555459407	NC_000016.10:23621452:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3022C>A (p.Pro1008Thr)	PALB2	P1008T	Familial cancer of breast	VCV000530113	16	23632774	16	23621453	530113	529766	rs1555459407	NC_000016.10:23621452:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3021G>T (p.Met1007Ile)	PALB2	M1007I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000921102	16	23632775	16	23621454	921102	913606	rs1443207976	NC_000016.10:23621453:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3021G>A (p.Met1007Ile)	PALB2	M1007I	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000460974	16	23632775	16	23621454	460974	466154	rs1443207976	NC_000016.10:23621453:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3020T>C (p.Met1007Thr)	PALB2	M1007T, M185T, M411T, M658T, M712T, M953T, M983T, M987T	Hereditary cancer-predisposing syndrome	VCV003894455	16	23632776	16	23621455	3894455	4010335		NC_000016.10:23621454:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3019A>T (p.Met1007Leu)	PALB2	M1007L, M658L, M983L, M712L, M953L, M185L, M411L, M987L	Familial cancer of breast	VCV003010965	16	23632777	16	23621456	3010965	3169999	rs2142328121	NC_000016.10:23621455:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3019A>G (p.Met1007Val)	PALB2	M1007V	Familial cancer of breast	VCV001418578	16	23632777	16	23621456	1418578	1490174	rs2142328121	NC_000016.10:23621455:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.3018G>C (p.Leu1006Phe)	PALB2	L657F, L986F, L1006F, L184F, L711F, L410F, L982F, L952F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003642342	16	23632778	16	23621457	3642342	3769199		NC_000016.10:23621456:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3018G>A (p.Leu1006=)	PALB2		Familial cancer of breast	VCV001139828	16	23632778	16	23621457	1139828	1125110	rs1597079904	NC_000016.10:23621456:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3018G>T (p.Leu1006Phe)	PALB2	L1006F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000664544	16	23632778	16	23621457	664544	644395	rs1597079904	NC_000016.10:23621456:C:A	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3017T>C (p.Leu1006Ser)	PALB2	L1006S, L711S, L982S, L184S, L952S, L986S, L410S, L657S	Hereditary cancer-predisposing syndrome	VCV003927423	16	23632779	16	23621458	3927423	4047056		NC_000016.10:23621457:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 31, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3016T>A (p.Leu1006Met)	PALB2	L410M, L952M, L982M, L1006M, L184M, L657M, L711M, L986M	Hereditary cancer-predisposing syndrome	VCV001798863	16	23632780	16	23621459	1798863	1856132	rs1447096272	NC_000016.10:23621458:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3016T>C (p.Leu1006=)	PALB2		Familial cancer of breast	VCV001089813	16	23632780	16	23621459	1089813	1081882	rs1447096272	NC_000016.10:23621458:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.3015T>C (p.Phe1005=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002453290	16	23632781	16	23621460	2453290	2430350	rs2506320531	NC_000016.10:23621459:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3014T>C (p.Phe1005Ser)	PALB2	F1005S	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000246461	16	23632782	16	23621461	246461	244950	rs879254268	NC_000016.10:23621460:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3013T>A (p.Phe1005Ile)	PALB2	F1005I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484239	16	23632783	16	23621462	484239	477451	rs1555459414	NC_000016.10:23621461:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3012A>G (p.Gln1004=)	PALB2		Familial cancer of breast	VCV003903542	16	23632784	16	23621463	3903542	4019415		NC_000016.10:23621462:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.3011A>C (p.Gln1004Pro)	PALB2	Q1004P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484232	16	23632785	16	23621464	484232	477565	rs1555459415	NC_000016.10:23621463:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3010C>T (p.Gln1004Ter)	PALB2	Q1004*, Q182*, Q408*, Q655*, Q709*, Q950*, Q980*, Q984*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002673849	16	23632786	16	23621465	2673849	2841351	rs2142328321	NC_000016.10:23621464:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3010C>G (p.Gln1004Glu)	PALB2	Q655E, Q408E, Q950E, Q980E, Q709E, Q1004E, Q182E, Q984E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001798809	16	23632786	16	23621465	1798809	1856078	rs2142328321	NC_000016.10:23621464:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3009C>A (p.Asn1003Lys)	PALB2	N1003K, N181K, N407K, N654K, N708K, N949K, N979K, N983K	Familial cancer of breast	VCV001717157	16	23632787	16	23621466	1717157	1775982	rs1555459417	NC_000016.10:23621465:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3009C>T (p.Asn1003=)	PALB2		Familial cancer of breast	VCV000530223	16	23632787	16	23621466	530223	529837	rs1555459417	NC_000016.10:23621465:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3008A>C (p.Asn1003Thr)	PALB2	N1003T, N181T, N407T, N949T, N979T, N983T, N708T, N654T	Hereditary cancer-predisposing syndrome	VCV002447307	16	23632788	16	23621467	2447307	2422429	rs2142328358	NC_000016.10:23621466:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.3008A>G (p.Asn1003Ser)	PALB2	N181S, N983S, N1003S, N654S, N708S, N949S, N979S, N407S	Hereditary cancer-predisposing syndrome	VCV001798760	16	23632788	16	23621467	1798760	1856029	rs2142328358	NC_000016.10:23621466:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.3006A>G (p.Glu1002=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000923700	16	23632790	16	23621469	923700	913607	rs1966773103	NC_000016.10:23621468:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3004G>T (p.Glu1002Ter)	PALB2	E653*, E1002*, E978*, E982*, E180*, E406*, E707*, E948*	Familial cancer of breast	VCV002123068	16	23632792	16	23621471	2123068	2180962	rs2142328421	NC_000016.10:23621470:C:A	single nucleotide variant	nonsense	Pathogenic	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3003A>G (p.Lys1001=)	PALB2		Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV003891902	16	23632793	16	23621472	3891902	4007791		NC_000016.10:23621471:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3002A>T (p.Lys1001Ile)	PALB2	K1001I, K179I, K405I, K652I, K706I, K947I, K977I, K981I	Hereditary cancer-predisposing syndrome	VCV003228024	16	23632794	16	23621473	3228024	3387793	rs2142328448	NC_000016.10:23621472:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2999G>T (p.Gly1000Val)	PALB2	G1000V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000952324	16	23632797	16	23621476	952324	927708	rs1597079946	NC_000016.10:23621475:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2999G>A (p.Gly1000Asp)	PALB2	G1000D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822480	16	23632797	16	23621476	822480	812672	rs1597079946	NC_000016.10:23621475:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2998G>C (p.Gly1000Arg)	PALB2	G1000R	Familial cancer of breast|not specified	VCV001062828	16	23632798	16	23621477	1062828	1049512	rs1966773345	NC_000016.10:23621476:C:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2998G>A (p.Gly1000Ser)	PALB2	G1000S	Familial cancer of breast	VCV000835767	16	23632798	16	23621477	835767	843564	rs1966773345	NC_000016.10:23621476:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997A>G (p.Gly999=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001798584	16	23632799	16	23621478	1798584	1856723	rs1966773406	NC_000016.10:23621477:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 6, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997-1G>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003254153	16	23632800	16	23621479	3254153	3412932	rs754465466	NC_000016.10:23621478:C:G	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2997-1G>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822478	16	23632800	16	23621479	822478	815626	rs754465466	NC_000016.10:23621478:C:T	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2997-2A>G	PALB2		Familial cancer of breast	VCV002673824	16	23632801	16	23621480	2673824	2841328	rs1555459421	NC_000016.10:23621479:T:C	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Sep 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997-2A>T	PALB2		Hereditary cancer-predisposing syndrome	VCV000926193	16	23632801	16	23621480	926193	915932	rs1555459421	NC_000016.10:23621479:T:A	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Mar 9, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997-2A>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482065	16	23632801	16	23621480	482065	477460	rs1555459421	NC_000016.10:23621479:T:G	single nucleotide variant	splice acceptor variant|intron variant	Uncertain significance	Oct 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2997-3C>G	PALB2		Familial cancer of breast	VCV000847928	16	23632802	16	23621481	847928	852810	rs1966773531	NC_000016.10:23621480:G:C	single nucleotide variant	intron variant	Uncertain significance	Mar 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997-8A>G	PALB2		Familial cancer of breast	VCV003903867	16	23632807	16	23621486	3903867	4019740		NC_000016.10:23621485:T:C	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997-9T>A	PALB2		Familial cancer of breast	VCV003661299	16	23632808	16	23621487	3661299	3790958		NC_000016.10:23621486:A:T	single nucleotide variant	intron variant	Likely benign	Oct 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997-9T>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000215935	16	23632808	16	23621487	215935	213158	rs765733708	NC_000016.10:23621486:A:G	single nucleotide variant	intron variant	Likely benign	Feb 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2997-13G>A	PALB2		Familial cancer of breast	VCV002119236	16	23632812	16	23621491	2119236	2183583	rs2142328665	NC_000016.10:23621490:C:T	single nucleotide variant	intron variant	Likely benign	Mar 29, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997-14T>C	PALB2		Familial cancer of breast	VCV002095791	16	23632813	16	23621492	2095791	2149708	rs2506321286	NC_000016.10:23621491:A:G	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2997-15C>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000928276	16	23632814	16	23621493	928276	916394	rs1966773679	NC_000016.10:23621492:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2997-16A>G	PALB2		Familial cancer of breast	VCV001949438	16	23632815	16	23621494	1949438	2007006	rs2142328706	NC_000016.10:23621493:T:C	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2997-18A>T	PALB2		Familial cancer of breast|not specified	VCV002576367	16	23632817	16	23621496	2576367	2741263	rs750052146	NC_000016.10:23621495:T:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2997-18A>G	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000630874	16	23632817	16	23621496	630874	619606	rs750052146	NC_000016.10:23621495:T:C	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2997-18A>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000508253	16	23632817	16	23621496	508253	505263	rs750052146	NC_000016.10:23621495:T:G	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2997-19C>T	PALB2		Familial cancer of breast	VCV003903799	16	23632818	16	23621497	3903799	4019672		NC_000016.10:23621496:G:A	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997-28C>T	PALB2		not specified	VCV001697754	16	23632827	16	23621506	1697754	1690138	rs1031537530	NC_000016.10:23621505:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997-34A>C	PALB2		not specified	VCV001697755	16	23632833	16	23621512	1697755	1690139	rs200676448	NC_000016.10:23621511:T:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2997-44G>A	PALB2		not specified	VCV003765313	16	23632843	16	23621522	3765313	3881482		NC_000016.10:23621521:C:T	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+264T>C	PALB2		not provided	VCV001263636	16	23634026	16	23622705	1263636	1250963	rs420259	NC_000016.10:23622704:A:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+145C>T	PALB2		not provided	VCV001198435	16	23634145	16	23622824	1198435	1188347	rs115175469	NC_000016.10:23622823:G:A	single nucleotide variant	intron variant	Likely benign	Jun 26, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+18T>C	PALB2		Familial cancer of breast	VCV002040896	16	23634272	16	23622951	2040896	2098789	rs1966797272	NC_000016.10:23622950:A:G	single nucleotide variant	intron variant	Likely benign	Jul 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+17T>C	PALB2		Hereditary cancer-predisposing syndrome|not specified|Breast and/or ovarian cancer|not provided|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000126701	16	23634273	16	23622952	126701	132211	rs180177128	NC_000016.10:23622951:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2996+16A>G	PALB2		Familial cancer of breast	VCV002773105	16	23634274	16	23622953	2773105	2930383	rs1966797376	NC_000016.10:23622952:T:C	single nucleotide variant	intron variant	Likely benign	Nov 1, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+14T>C	PALB2		Familial cancer of breast	VCV002778886	16	23634276	16	23622955	2778886	2943923	rs1407045774	NC_000016.10:23622954:A:G	single nucleotide variant	intron variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+14T>A	PALB2		Familial cancer of breast	VCV002694651	16	23634276	16	23622955	2694651	2860790	rs1407045774	NC_000016.10:23622954:A:T	single nucleotide variant	intron variant	Likely benign	Nov 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+14T>G	PALB2		PALB2-related cancer predisposition|Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome	VCV000492207	16	23634276	16	23622955	492207	484720	rs1407045774	NC_000016.10:23622954:A:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 3, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2996+13T>C	PALB2		Familial cancer of breast	VCV001542606	16	23634277	16	23622956	1542606	1610142	rs2142334023	NC_000016.10:23622955:A:G	single nucleotide variant	intron variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+11C>T	PALB2		Familial cancer of breast	VCV002147461	16	23634279	16	23622958	2147461	1880651	rs2142334043	NC_000016.10:23622957:G:A	single nucleotide variant	intron variant	Likely benign	Jul 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+10G>C	PALB2		Familial cancer of breast	VCV001653082	16	23634280	16	23622959	1653082	1579581	rs773023007	NC_000016.10:23622958:C:G	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2996+10G>A	PALB2		Familial cancer of breast	VCV001618231	16	23634280	16	23622959	1618231	1527553	rs773023007	NC_000016.10:23622958:C:T	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2996+10G>T	PALB2		Familial cancer of breast	VCV001088624	16	23634280	16	23622959	1088624	1081883	rs773023007	NC_000016.10:23622958:C:A	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2996+9A>G	PALB2		Familial cancer of breast	VCV000742659	16	23634281	16	23622960	742659	760472	rs1168172644	NC_000016.10:23622959:T:C	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2996+8A>G	PALB2		Familial cancer of breast	VCV001610261	16	23634282	16	23622961	1610261	1519615	rs2142334083	NC_000016.10:23622960:T:C	single nucleotide variant	intron variant	Likely benign	Oct 13, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+8A>C	PALB2		Familial cancer of breast	VCV001083627	16	23634282	16	23622961	1083627	1081884	rs2142334083	NC_000016.10:23622960:T:G	single nucleotide variant	intron variant	Likely benign	Apr 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+5G>T	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000246286	16	23634285	16	23622964	246286	244951	rs879254193	NC_000016.10:23622963:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2996+4A>G	PALB2		Hereditary breast ovarian cancer syndrome	VCV002687484	16	23634286	16	23622965	2687484	2848520	rs2142334123	NC_000016.10:23622964:T:C	single nucleotide variant	intron variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996+3A>C	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000566995	16	23634287	16	23622966	566995	567952	rs876659931	NC_000016.10:23622965:T:G	single nucleotide variant	intron variant	Uncertain significance	Dec 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2996+3A>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000232697	16	23634287	16	23622966	232697	235186	rs876659931	NC_000016.10:23622965:T:C	single nucleotide variant	intron variant	Uncertain significance	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2996+2T>C	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome	VCV000987831	16	23634288	16	23622967	987831	975830	rs1966797789	NC_000016.10:23622966:A:G	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2996+1G>T	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000265562	16	23634289	16	23622968	265562	260099	rs886039626	NC_000016.10:23622967:C:A	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2996G>A (p.Gly999Glu)	PALB2	G999E	Familial cancer of breast	VCV000853174	16	23634290	16	23622969	853174	843565	rs1597081049	NC_000016.10:23622968:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2996G>C (p.Gly999Ala)	PALB2	G999A	Familial cancer of breast	VCV000642929	16	23634290	16	23622969	642929	644397	rs1597081049	NC_000016.10:23622968:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2995G>T (p.Gly999Ter)	PALB2	G650*, G704*, G945*, G999*, G177*, G403*, G975*, G979*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002567579	16	23634291	16	23622970	2567579	2731221	rs1269970394	NC_000016.10:23622969:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2995G>C (p.Gly999Arg)	PALB2	G403R, G177R, G650R, G704R, G945R, G975R, G979R, G999R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001798570	16	23634291	16	23622970	1798570	1856709	rs1269970394	NC_000016.10:23622969:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2995G>A (p.Gly999Arg)	PALB2	G999R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484172	16	23634291	16	23622970	484172	477488	rs1269970394	NC_000016.10:23622969:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2994A>C (p.Gly998=)	PALB2		Familial cancer of breast	VCV002752485	16	23634292	16	23622971	2752485	2916251	rs2142334227	NC_000016.10:23622970:T:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2994A>G (p.Gly998=)	PALB2		not specified	VCV001301374	16	23634292	16	23622971	1301374	1291657	rs2142334227	NC_000016.10:23622970:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 2, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2993G>C (p.Gly998Ala)	PALB2	G998A	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000379870	16	23634293	16	23622972	379870	377365	rs45551636	NC_000016.10:23622971:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2993G>A (p.Gly998Glu)	PALB2	G998E	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not specified|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Fanconi anemia complementation group N	VCV000126699	16	23634293	16	23622972	126699	132209	rs45551636	NC_000016.10:23622971:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2992G>T (p.Gly998Ter)	PALB2	G176*, G974*, G978*, G998*, G402*, G649*, G703*, G944*	Familial cancer of breast	VCV002860689	16	23634294	16	23622973	2860689	3025617	rs1039184417	NC_000016.10:23622972:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2992G>A (p.Gly998Arg)	PALB2	G998R	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000379831	16	23634294	16	23622973	379831	375250	rs1039184417	NC_000016.10:23622972:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2990A>T (p.Asp997Val)	PALB2	D175V, D702V, D973V, D997V, D401V, D943V, D648V, D977V	Familial cancer of breast	VCV001950749	16	23634296	16	23622975	1950749	2017352	rs1567213572	NC_000016.10:23622974:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2990A>G (p.Asp997Gly)	PALB2	D997G	Hereditary cancer-predisposing syndrome	VCV000628557	16	23634296	16	23622975	628557	618360	rs1567213572	NC_000016.10:23622974:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2989G>A (p.Asp997Asn)	PALB2	D997N	Hereditary cancer-predisposing syndrome	VCV001691949	16	23634297	16	23622976	1691949	1684391	rs1555459513	NC_000016.10:23622975:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2989G>T (p.Asp997Tyr)	PALB2	D997Y	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000530176	16	23634297	16	23622976	530176	529842	rs1555459513	NC_000016.10:23622975:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2988A>G (p.Glu996=)	PALB2		Familial cancer of breast	VCV003903895	16	23634298	16	23622977	3903895	4019768		NC_000016.10:23622976:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2986G>T (p.Glu996Ter)	PALB2	E996*	Malignant tumor of breast|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000187492	16	23634300	16	23622979	187492	184171	rs786203775	NC_000016.10:23622978:C:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2985A>C (p.Ala995=)	PALB2		Familial cancer of breast	VCV003903862	16	23634301	16	23622980	3903862	4019735		NC_000016.10:23622979:T:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2985A>T (p.Ala995=)	PALB2		Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|not provided|Familial cancer of breast	VCV000186365	16	23634301	16	23622980	186365	184172	rs786202892	NC_000016.10:23622979:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2984C>G (p.Ala995Gly)	PALB2	A173G, A399G, A646G, A700G, A941G, A971G, A975G, A995G	Familial cancer of breast	VCV001720071	16	23634302	16	23622981	1720071	1779110	rs1567213581	NC_000016.10:23622980:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2984C>T (p.Ala995Val)	PALB2	A995V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000565617	16	23634302	16	23622981	565617	569937	rs1567213581	NC_000016.10:23622980:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2983G>A (p.Ala995Thr)	PALB2	A995T	Familial cancer of breast	VCV001524653	16	23634303	16	23622982	1524653	1463127	rs2142334456	NC_000016.10:23622981:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2983G>T (p.Ala995Ser)	PALB2	A995S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001512389	16	23634303	16	23622982	1512389	1478639	rs2142334456	NC_000016.10:23622981:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2982T>A (p.Phe994Leu)	PALB2	F994L	Familial cancer of breast	VCV000460973	16	23634304	16	23622983	460973	466373	rs1555459516	NC_000016.10:23622982:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2981T>C (p.Phe994Ser)	PALB2	F994S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000232244	16	23634305	16	23622984	232244	235187	rs876659645	NC_000016.10:23622983:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2979G>A (p.Thr993=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481167	16	23634307	16	23622986	481167	477567	rs772357409	NC_000016.10:23622985:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2978C>T (p.Thr993Met)	PALB2	T993M	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not provided|Familial cancer of breast	VCV000232056	16	23634308	16	23622987	232056	235188	rs61756146	NC_000016.10:23622986:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2977A>G (p.Thr993Ala)	PALB2	T698A, T973A, T397A, T644A, T969A, T171A, T939A, T993A	Hereditary cancer-predisposing syndrome	VCV001798337	16	23634309	16	23622988	1798337	1856478	rs2142334618	NC_000016.10:23622987:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2975T>C (p.Met992Thr)	PALB2	M992T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001008588	16	23634311	16	23622990	1008588	996789	rs1597081111	NC_000016.10:23622989:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2975T>A (p.Met992Lys)	PALB2	M992K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000822401	16	23634311	16	23622990	822401	812673	rs1597081111	NC_000016.10:23622989:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2974A>G (p.Met992Val)	PALB2	M992V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484198	16	23634312	16	23622991	484198	477490	rs1555459522	NC_000016.10:23622990:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2973C>T (p.Val991=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001332143	16	23634313	16	23622992	1332143	1322863	rs2142334725	NC_000016.10:23622991:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2972T>C (p.Val991Ala)	PALB2	V991A	Familial cancer of breast	VCV000661496	16	23634314	16	23622993	661496	644398	rs1064796208	NC_000016.10:23622992:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2972T>G (p.Val991Gly)	PALB2	V991G	not provided|Hereditary cancer-predisposing syndrome	VCV000423073	16	23634314	16	23622993	423073	409520	rs1064796208	NC_000016.10:23622992:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2971G>T (p.Val991Phe)	PALB2	V991F	not provided|not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000231886	16	23634315	16	23622994	231886	235189	rs765175665	NC_000016.10:23622993:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2970A>G (p.Glu990=)	PALB2		Familial cancer of breast	VCV001160021	16	23634316	16	23622995	1160021	1146001	rs2142334792	NC_000016.10:23622994:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2968G>C (p.Glu990Gln)	PALB2	E990Q	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000530026	16	23634318	16	23622997	530026	530322	rs876659036	NC_000016.10:23622996:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 3, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2968G>T (p.Glu990Ter)	PALB2	E990*	Breast neoplasm|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000231227	16	23634318	16	23622997	231227	235190	rs876659036	NC_000016.10:23622996:C:A	single nucleotide variant	nonsense	Pathogenic	Jan 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2967A>G (p.Val989=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000981106	16	23634319	16	23622998	981106	969183	rs1966799199	NC_000016.10:23622997:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2965G>A (p.Val989Ile)	PALB2	V989I	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000230356	16	23634321	16	23623000	230356	235191	rs764140747	NC_000016.10:23622999:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2964A>G (p.Gln988=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|not specified	VCV000241557	16	23634322	16	23623001	241557	242352	rs777244673	NC_000016.10:23623000:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 10, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2963A>C (p.Gln988Pro)	PALB2	Q988P	not provided|Familial cancer of breast	VCV001318682	16	23634323	16	23623002	1318682	1307194	rs1966799521	NC_000016.10:23623001:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2962C>T (p.Gln988Ter)	PALB2	Q988*	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000001246	16	23634324	16	23623003	1246	16285	rs118203999	NC_000016.10:23623002:G:A	single nucleotide variant	nonsense	Pathogenic	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2961A>G (p.Gln987=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492206	16	23634325	16	23623004	492206	484805	rs1555459530	NC_000016.10:23623003:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2960A>G (p.Gln987Arg)	PALB2	Q391R, Q692R, Q933R, Q963R, Q165R, Q967R, Q987R, Q638R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003413449	16	23634326	16	23623005	3413449	3574672		NC_000016.10:23623004:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2959C>T (p.Gln987Ter)	PALB2	Q165*, Q391*, Q638*, Q692*, Q933*, Q963*, Q967*, Q987*	Hereditary cancer-predisposing syndrome	VCV003774408	16	23634327	16	23623006	3774408	3890555		NC_000016.10:23623005:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 23, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2959C>A (p.Gln987Lys)	PALB2	Q165K, Q391K, Q967K, Q692K, Q963K, Q638K, Q933K, Q987K	Hereditary cancer-predisposing syndrome	VCV002567587	16	23634327	16	23623006	2567587	2731229	rs2142335181	NC_000016.10:23623005:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2959C>G (p.Gln987Glu)	PALB2	Q391E, Q638E, Q165E, Q933E, Q692E, Q963E, Q967E, Q987E	Hereditary cancer-predisposing syndrome	VCV001798136	16	23634327	16	23623006	1798136	1853754	rs2142335181	NC_000016.10:23623005:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2958T>C (p.Asp986=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001798132	16	23634328	16	23623007	1798132	1853750	rs1966799873	NC_000016.10:23623006:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 10, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2957A>T (p.Asp986Val)	PALB2	D164V, D390V, D637V, D691V, D932V, D962V, D966V, D986V	Familial cancer of breast	VCV002419557	16	23634329	16	23623008	2419557	1938379	rs2142335218	NC_000016.10:23623007:T:A	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2957A>C (p.Asp986Ala)	PALB2	D986A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001473096	16	23634329	16	23623008	1473096	1501341	rs2142335218	NC_000016.10:23623007:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2955T>C (p.Ser985=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830183	16	23634331	16	23623010	830183	818470	rs765643734	NC_000016.10:23623009:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 23, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2955T>G (p.Ser985=)	PALB2		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000184129	16	23634331	16	23623010	184129	184173	rs765643734	NC_000016.10:23623009:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2953T>C (p.Ser985Pro)	PALB2	S985P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484162	16	23634333	16	23623012	484162	477503	rs139726856	NC_000016.10:23623011:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 8, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2952T>C (p.Leu984=)	PALB2		Familial cancer of breast	VCV003903802	16	23634334	16	23623013	3903802	4019675		NC_000016.10:23623012:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2950C>T (p.Leu984Phe)	PALB2	L635F, L930F, L960F, L964F, L162F, L388F, L689F, L984F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001798054	16	23634336	16	23623015	1798054	1853673	rs2506333920	NC_000016.10:23623014:G:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2949C>T (p.Thr983=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492205	16	23634337	16	23623016	492205	484721	rs1250153779	NC_000016.10:23623015:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2949C>G (p.Thr983=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000481062	16	23634337	16	23623016	481062	477569	rs1250153779	NC_000016.10:23623015:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2947A>G (p.Thr983Ala)	PALB2	T983A	Hereditary cancer-predisposing syndrome	VCV000485998	16	23634339	16	23623018	485998	478034	rs587782211	NC_000016.10:23623017:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2947A>T (p.Thr983Ser)	PALB2	T983S	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000142070	16	23634339	16	23623018	142070	151784	rs587782211	NC_000016.10:23623017:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2946G>T (p.Gly982=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410103	16	23634340	16	23623019	410103	401058	rs1060502731	NC_000016.10:23623018:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2943T>C (p.Ser981=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000797151	16	23634343	16	23623022	797151	785216	rs775585445	NC_000016.10:23623021:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2943T>G (p.Ser981Arg)	PALB2	S981R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530050	16	23634343	16	23623022	530050	530111	rs775585445	NC_000016.10:23623021:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2942G>T (p.Ser981Ile)	PALB2	S981I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000822336	16	23634344	16	23623023	822336	812675	rs1597081224	NC_000016.10:23623022:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2942G>A (p.Ser981Asn)	PALB2	S981N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000650595	16	23634344	16	23623023	650595	644399	rs1597081224	NC_000016.10:23623022:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 29, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2941A>C (p.Ser981Arg)	PALB2	S981R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000935594	16	23634345	16	23623024	935594	937357	rs1460156504	NC_000016.10:23623023:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2941A>G (p.Ser981Gly)	PALB2	S981G	Familial cancer of breast	VCV000830182	16	23634345	16	23623024	830182	818471	rs1460156504	NC_000016.10:23623023:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2940C>T (p.Ser980=)	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000415975	16	23634346	16	23623025	415975	401011	rs766049739	NC_000016.10:23623024:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2938A>C (p.Ser980Arg)	PALB2	S158R, S685R, S926R, S980R, S956R, S960R, S384R, S631R	Familial cancer of breast	VCV002704937	16	23634348	16	23623027	2704937	2863349	rs2142335614	NC_000016.10:23623026:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2937T>C (p.Ser979=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484231	16	23634349	16	23623028	484231	478040	rs1555459542	NC_000016.10:23623027:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2936G>A (p.Ser979Asn)	PALB2	S955N, S979N, S157N, S383N, S630N, S925N, S684N, S959N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001797865	16	23634350	16	23623029	1797865	1853484	rs1417567084	NC_000016.10:23623028:C:T	single nucleotide variant	missense variant	Uncertain significance	May 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2936G>T (p.Ser979Ile)	PALB2	S979I	Hereditary cancer-predisposing syndrome	VCV000918664	16	23634350	16	23623029	918664	913609	rs1417567084	NC_000016.10:23623028:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2935A>C (p.Ser979Arg)	PALB2	S979R	Familial cancer of breast	VCV000216749	16	23634351	16	23623030	216749	213160	rs751227032	NC_000016.10:23623029:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.2932G>A (p.Val978Ile)	PALB2	V978I	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000999247	16	23634354	16	23623033	999247	996790	rs1966801130	NC_000016.10:23623032:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2931A>G (p.Leu977=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001411714	16	23634355	16	23623034	1411714	1448163	rs2142335769	NC_000016.10:23623033:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2930T>A (p.Leu977Gln)	PALB2	L628Q, L953Q, L381Q, L682Q, L957Q, L977Q, L155Q, L923Q	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001797817	16	23634356	16	23623035	1797817	1853436	rs1060499825	NC_000016.10:23623034:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2930T>C (p.Leu977Pro)	PALB2	L977P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000402304	16	23634356	16	23623035	402304	389261	rs1060499825	NC_000016.10:23623034:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2928G>C (p.Arg976Ser)	PALB2	R154S, R380S, R627S, R681S, R922S, R952S, R956S, R976S	Hereditary cancer-predisposing syndrome	VCV003228023	16	23634358	16	23623037	3228023	3387792	rs878855115	NC_000016.10:23623036:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2928G>T (p.Arg976Ser)	PALB2	R976S	Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460971	16	23634358	16	23623037	460971	465446	rs878855115	NC_000016.10:23623036:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2928G>A (p.Arg976=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000241556	16	23634358	16	23623037	241556	242353	rs878855115	NC_000016.10:23623036:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2927G>C (p.Arg976Thr)	PALB2	R976T	Hereditary cancer-predisposing syndrome	VCV000584904	16	23634359	16	23623038	584904	575960	rs1567213697	NC_000016.10:23623037:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2926A>C (p.Arg976=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001078684	16	23634360	16	23623039	1078684	1081885	rs2142335890	NC_000016.10:23623038:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2925G>C (p.Arg975Ser)	PALB2	R626S, R680S, R955S, R379S, R951S, R975S, R153S, R921S	Hereditary cancer-predisposing syndrome	VCV003413463	16	23634361	16	23623040	3413463	3574686		NC_000016.10:23623039:C:G	single nucleotide variant	missense variant|intron variant	Likely benign	Sep 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2924G>T (p.Arg975Met)	PALB2	R975M	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001470618	16	23634362	16	23623041	1470618	1372579	rs2142335927	NC_000016.10:23623040:C:A	single nucleotide variant	missense variant	Uncertain significance	May 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2922G>C (p.Lys974Asn)	PALB2	K974N	Familial cancer of breast	VCV000853378	16	23634364	16	23623043	853378	843567	rs730881892	NC_000016.10:23623042:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2922G>T (p.Lys974Asn)	PALB2	K974N	not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000182772	16	23634364	16	23623043	182772	180714	rs730881892	NC_000016.10:23623042:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2920A>G (p.Lys974Glu)	PALB2	K974E	Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484159	16	23634366	16	23623045	484159	477464	rs1418709183	NC_000016.10:23623044:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 3, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2919A>T (p.Thr973=)	PALB2		Familial cancer of breast	VCV000530229	16	23634367	16	23623046	530229	529768	rs876659945	NC_000016.10:23623045:T:A	single nucleotide variant	synonymous variant	Likely benign	Sep 6, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2919A>G (p.Thr973=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000232717	16	23634367	16	23623046	232717	235192	rs876659945	NC_000016.10:23623045:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2918C>A (p.Thr973Lys)	PALB2	T973K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001004903	16	23634368	16	23623047	1004903	996791	rs1465745143	NC_000016.10:23623046:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2918C>T (p.Thr973Ile)	PALB2	T973I	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484218	16	23634368	16	23623047	484218	477465	rs1465745143	NC_000016.10:23623046:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2018	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2917A>G (p.Thr973Ala)	PALB2	T973A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000229706	16	23634369	16	23623048	229706	235193	rs876658154	NC_000016.10:23623047:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2916G>A (p.Leu972=)	PALB2		Familial cancer of breast	VCV001997720	16	23634370	16	23623049	1997720	2056940	rs2142336103	NC_000016.10:23623048:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2916G>C (p.Leu972=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001797632	16	23634370	16	23623049	1797632	1854550	rs2142336103	NC_000016.10:23623048:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2915T>C (p.Leu972Pro)	PALB2	L972P	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000421267	16	23634371	16	23623050	421267	409521	rs1064795021	NC_000016.10:23623049:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2914C>T (p.Leu972=)	PALB2		Familial cancer of breast	VCV003904131	16	23634372	16	23623051	3904131	4020004		NC_000016.10:23623050:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2913C>T (p.Gly971=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460969	16	23634373	16	23623052	460969	466159	rs786201384	NC_000016.10:23623051:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2913C>A (p.Gly971=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000184294	16	23634373	16	23623052	184294	184174	rs786201384	NC_000016.10:23623051:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2912G>A (p.Gly971Asp)	PALB2	G947D, G971D, G375D, G951D, G149D, G676D, G917D, G622D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001797596	16	23634374	16	23623053	1797596	1854514	rs1060502754	NC_000016.10:23623052:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2912G>T (p.Gly971Val)	PALB2	G971V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410137	16	23634374	16	23623053	410137	401498	rs1060502754	NC_000016.10:23623052:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2911G>A (p.Gly971Ser)	PALB2	G375S, G622S, G917S, G947S, G951S, G149S, G676S, G971S	Familial cancer of breast	VCV004056280	16	23634375	16	23623054	4056280	4170218		NC_000016.10:23623053:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 23, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2911G>C (p.Gly971Arg)	PALB2	G971R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000482035	16	23634375	16	23623054	482035	478047	rs1555459556	NC_000016.10:23623053:C:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2910T>C (p.Leu970=)	PALB2		Familial cancer of breast	VCV001158620	16	23634376	16	23623055	1158620	1146002	rs1555459558	NC_000016.10:23623054:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2910T>G (p.Leu970=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480292	16	23634376	16	23623055	480292	477572	rs1555459558	NC_000016.10:23623054:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2909T>C (p.Leu970Pro)	PALB2	L970P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001483868	16	23634377	16	23623056	1483868	1458651	rs2142336251	NC_000016.10:23623055:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2908C>T (p.Leu970Phe)	PALB2	L621F, L946F, L374F, L916F, L970F, L675F, L950F, L148F	Hereditary cancer-predisposing syndrome	VCV001797532	16	23634378	16	23623057	1797532	1854450	rs2142336277	NC_000016.10:23623056:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2907G>A (p.Val969=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460967	16	23634379	16	23623058	460967	466385	rs1555459560	NC_000016.10:23623057:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2906T>A (p.Val969Glu)	PALB2	V969E	Familial cancer of breast	VCV000530067	16	23634380	16	23623059	530067	529843	rs1555459561	NC_000016.10:23623058:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2906T>C (p.Val969Ala)	PALB2	V969A	Hereditary cancer-predisposing syndrome	VCV000482050	16	23634380	16	23623059	482050	477467	rs1555459561	NC_000016.10:23623058:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2905G>A (p.Val969Met)	PALB2	V969M	Hereditary cancer-predisposing syndrome	VCV000490080	16	23634381	16	23623060	490080	482933	rs1555459562	NC_000016.10:23623059:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2904T>G (p.Ala968=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001666103	16	23634382	16	23623061	1666103	1655832	rs876658818	NC_000016.10:23623060:A:C	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2904T>C (p.Ala968=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000230871	16	23634382	16	23623061	230871	235194	rs876658818	NC_000016.10:23623060:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2903C>T (p.Ala968Val)	PALB2	A968V	Familial cancer of breast	VCV000639071	16	23634383	16	23623062	639071	644400	rs369132015	NC_000016.10:23623061:G:A	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2903C>G (p.Ala968Gly)	PALB2	A968G	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|not specified	VCV000126695	16	23634383	16	23623062	126695	132205	rs369132015	NC_000016.10:23623061:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2902G>A (p.Ala968Thr)	PALB2	A968T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000186261	16	23634384	16	23623063	186261	184175	rs786202813	NC_000016.10:23623062:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2901A>G (p.Lys967=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000390061	16	23634385	16	23623064	390061	377368	rs1057523633	NC_000016.10:23623063:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2899A>G (p.Lys967Glu)	PALB2	K967E	Familial cancer of breast	VCV000566942	16	23634387	16	23623066	566942	570163	rs864622525	NC_000016.10:23623065:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2899A>C (p.Lys967Gln)	PALB2	K967Q	Familial cancer of breast	VCV000220436	16	23634387	16	23623066	220436	222462	rs864622525	NC_000016.10:23623065:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2898A>G (p.Ile966Met)	PALB2	I966M	Hereditary cancer-predisposing syndrome	VCV000920166	16	23634388	16	23623067	920166	913610	rs1555459563	NC_000016.10:23623066:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2898A>T (p.Ile966=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000492203	16	23634388	16	23623067	492203	484723	rs1555459563	NC_000016.10:23623066:T:A	single nucleotide variant	synonymous variant	Likely benign	Jul 20, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2897T>G (p.Ile966Arg)	PALB2	I966R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV001369767	16	23634389	16	23623068	1369767	1437473	rs587780214	NC_000016.10:23623067:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2897T>A (p.Ile966Lys)	PALB2	I966K	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3	VCV000860553	16	23634389	16	23623068	860553	843568	rs587780214	NC_000016.10:23623067:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2897T>C (p.Ile966Thr)	PALB2	I966T	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|not provided|not specified|Familial cancer of breast	VCV000128136	16	23634389	16	23623068	128136	133593	rs587780214	NC_000016.10:23623067:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 25, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2896A>T (p.Ile966Leu)	PALB2	I966L	Familial cancer of breast	VCV000460966	16	23634390	16	23623069	460966	466386	rs786204248	NC_000016.10:23623068:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2896A>G (p.Ile966Val)	PALB2	I966V	not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3	VCV000188387	16	23634390	16	23623069	188387	186212	rs786204248	NC_000016.10:23623068:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2895T>C (p.Asn965=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460965	16	23634391	16	23623070	460965	466186	rs1555459569	NC_000016.10:23623069:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2894A>C (p.Asn965Thr)	PALB2	N670T, N945T, N143T, N616T, N911T, N369T, N941T, N965T	Familial cancer of breast	VCV002753397	16	23634392	16	23623071	2753397	2909395	rs2142336619	NC_000016.10:23623070:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2892A>G (p.Gly964=)	PALB2		Familial cancer of breast|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000482015	16	23634394	16	23623073	482015	477574	rs762772267	NC_000016.10:23623072:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2892A>C (p.Gly964=)	PALB2		Familial cancer of breast	VCV000460964	16	23634394	16	23623073	460964	465449	rs762772267	NC_000016.10:23623072:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2891G>C (p.Gly964Ala)	PALB2	G368A, G964A, G142A, G615A, G910A, G940A, G669A, G944A	Hereditary cancer-predisposing syndrome	VCV001797315	16	23634395	16	23623074	1797315	1855889	rs2142336660	NC_000016.10:23623073:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2890G>A (p.Gly964Arg)	PALB2	G964R	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000140789	16	23634396	16	23623075	140789	150503	rs587781280	NC_000016.10:23623074:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2887T>C (p.Ser963Pro)	PALB2	S963P	Familial cancer of breast	VCV001060019	16	23634399	16	23623078	1060019	1049513	rs2142336778	NC_000016.10:23623077:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2886G>A (p.Lys962=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002587412	16	23634400	16	23623079	2587412	2754088	rs2142336806	NC_000016.10:23623078:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2883G>A (p.Leu961=)	PALB2		Familial cancer of breast	VCV003903807	16	23634403	16	23623082	3903807	4019680		NC_000016.10:23623081:C:T	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2882T>C (p.Leu961Pro)	PALB2	L961P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000186824	16	23634404	16	23623083	186824	184176	rs786203248	NC_000016.10:23623082:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2881C>A (p.Leu961Met)	PALB2	L961M	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000241554	16	23634405	16	23623084	241554	242354	rs61755166	NC_000016.10:23623083:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2881C>T (p.Leu961=)	PALB2		not specified|Fanconi anemia complementation group N|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|not provided	VCV000186696	16	23634405	16	23623084	186696	184177	rs61755166	NC_000016.10:23623083:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2880A>G (p.Leu960=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000378320	16	23634406	16	23623085	378320	377374	rs1057520342	NC_000016.10:23623084:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2879T>C (p.Leu960Pro)	PALB2	L364P, L138P, L611P, L936P, L940P, L960P, L665P, L906P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002163813	16	23634407	16	23623086	2163813	1905525	rs1966803595	NC_000016.10:23623085:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2878C>T (p.Leu960=)	PALB2		not provided|Familial cancer of breast	VCV000993120	16	23634408	16	23623087	993120	981148	rs1966803657	NC_000016.10:23623086:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 4, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2877A>G (p.Val959=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492202	16	23634409	16	23623088	492202	484644	rs1060504710	NC_000016.10:23623087:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2877A>T (p.Val959=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000415986	16	23634409	16	23623088	415986	401742	rs1060504710	NC_000016.10:23623087:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2876T>G (p.Val959Gly)	PALB2	V363G, V939G, V137G, V664G, V959G, V610G, V905G, V935G	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3	VCV003891901	16	23634410	16	23623089	3891901	4007790		NC_000016.10:23623088:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 6, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2876T>C (p.Val959Ala)	PALB2	V959A	Familial cancer of breast	VCV001691512	16	23634410	16	23623089	1691512	1683991	rs2142337057	NC_000016.10:23623088:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2875G>A (p.Val959Ile)	PALB2	V959I	Hereditary cancer-predisposing syndrome	VCV000921396	16	23634411	16	23623090	921396	913611	rs1064793658	NC_000016.10:23623089:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2875G>T (p.Val959Leu)	PALB2	V959L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000419120	16	23634411	16	23623090	419120	409523	rs1064793658	NC_000016.10:23623089:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2874A>G (p.Gln958=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480227	16	23634412	16	23623091	480227	478051	rs1555459577	NC_000016.10:23623090:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2873A>G (p.Gln958Arg)	PALB2	Q958R	not provided	VCV001329813	16	23634413	16	23623092	1329813	1320497	rs876659693	NC_000016.10:23623091:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2873A>C (p.Gln958Pro)	PALB2	Q958P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000232317	16	23634413	16	23623092	232317	235195	rs876659693	NC_000016.10:23623091:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2872C>T (p.Gln958Ter)	PALB2	Q958*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000920797	16	23634414	16	23623093	920797	913612	rs1567213829	NC_000016.10:23623092:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2872C>G (p.Gln958Glu)	PALB2	Q958E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628430	16	23634414	16	23623093	628430	618361	rs1567213829	NC_000016.10:23623092:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2871G>A (p.Lys957=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000628260	16	23634415	16	23623094	628260	618362	rs1567213833	NC_000016.10:23623093:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2870A>G (p.Lys957Arg)	PALB2	K957R	Familial cancer of breast	VCV001431902	16	23634416	16	23623095	1431902	1405973	rs2142337222	NC_000016.10:23623094:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2869A>T (p.Lys957Ter)	PALB2	K957*	Familial cancer of breast	VCV000530052	16	23634417	16	23623096	530052	530333	rs515726103	NC_000016.10:23623095:T:A	single nucleotide variant	nonsense	Pathogenic	Dec 21, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2869A>C (p.Lys957Gln)	PALB2	K957Q	not specified|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000126694	16	23634417	16	23623096	126694	132204	rs515726103	NC_000016.10:23623095:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2868A>G (p.Glu956=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001797009	16	23634418	16	23623097	1797009	1855583	rs2142337268	NC_000016.10:23623096:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2867A>G (p.Glu956Gly)	PALB2	E956G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001352175	16	23634419	16	23623098	1352175	1482711	rs2142337289	NC_000016.10:23623097:T:C	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2866G>T (p.Glu956Ter)	PALB2	E956*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628431	16	23634420	16	23623099	628431	618363	rs1219715328	NC_000016.10:23623098:C:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2866G>A (p.Glu956Lys)	PALB2	E956K	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000460963	16	23634420	16	23623099	460963	466394	rs1219715328	NC_000016.10:23623098:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2865T>C (p.Ser955=)	PALB2		Familial cancer of breast	VCV003904115	16	23634421	16	23623100	3904115	4019988		NC_000016.10:23623099:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2864G>A (p.Ser955Asn)	PALB2	S955N	Hereditary cancer-predisposing syndrome	VCV000480286	16	23634422	16	23623101	480286	477468	rs1555459580	NC_000016.10:23623100:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2863A>G (p.Ser955Gly)	PALB2	S133G, S660G, S931G, S955G, S935G, S359G, S606G, S901G	Familial cancer of breast	VCV002716733	16	23634423	16	23623102	2716733	2876431	rs2142337388	NC_000016.10:23623101:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2861A>G (p.Glu954Gly)	PALB2	E954G	not provided|Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast	VCV000530081	16	23634425	16	23623104	530081	529780	rs375942535	NC_000016.10:23623103:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2860G>A (p.Glu954Lys)	PALB2	E954K	Familial cancer of breast	VCV000578165	16	23634426	16	23623105	578165	569942	rs879254015	NC_000016.10:23623104:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2860G>T (p.Glu954Ter)	PALB2	E954*	not provided|Familial cancer of breast	VCV000245957	16	23634426	16	23623105	245957	244953	rs879254015	NC_000016.10:23623104:C:A	single nucleotide variant	nonsense	Pathogenic	Jun 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2859T>C (p.Asp953=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000126692	16	23634427	16	23623106	126692	132202	rs515726101	NC_000016.10:23623105:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2858A>G (p.Asp953Gly)	PALB2	D953G	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000481097	16	23634428	16	23623107	481097	477504	rs1555459583	NC_000016.10:23623106:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 11, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2857G>A (p.Asp953Asn)	PALB2	D953N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480244	16	23634429	16	23623108	480244	477577	rs1555459584	NC_000016.10:23623107:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2856T>G (p.Asp952Glu)	PALB2	D952E	Familial cancer of breast	VCV000963144	16	23634430	16	23623109	963144	949305	rs1966804681	NC_000016.10:23623108:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2855A>G (p.Asp952Gly)	PALB2	D130G, D356G, D603G, D657G, D898G, D928G, D932G, D952G	Hereditary cancer-predisposing syndrome	VCV003228022	16	23634431	16	23623110	3228022	3387791	rs373280855	NC_000016.10:23623109:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2855A>T (p.Asp952Val)	PALB2	D952V	Familial cancer of breast	VCV000659777	16	23634431	16	23623110	659777	644401	rs373280855	NC_000016.10:23623109:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2854G>T (p.Asp952Tyr)	PALB2	D130Y, D356Y, D603Y, D657Y, D898Y, D928Y, D932Y, D952Y	Hereditary cancer-predisposing syndrome	VCV003893903	16	23634432	16	23623111	3893903	4009784		NC_000016.10:23623110:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2854G>A (p.Asp952Asn)	PALB2	D603N, D928N, D952N, D356N, D130N, D657N, D898N, D932N	Hereditary cancer-predisposing syndrome	VCV001796880	16	23634432	16	23623111	1796880	1855455	rs2142337544	NC_000016.10:23623110:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2852C>T (p.Ser951Phe)	PALB2	S951F	Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Familial cancer of breast	VCV000143008	16	23634434	16	23623113	143008	152722	rs587782889	NC_000016.10:23623112:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2851T>C (p.Ser951Pro)	PALB2	S951P	Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|not specified	VCV000126691	16	23634435	16	23623114	126691	132201	rs149522412	NC_000016.10:23623113:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2850C>A (p.Ser950=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001796826	16	23634436	16	23623115	1796826	1855401	rs876660352	NC_000016.10:23623114:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 10, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2850C>T (p.Ser950=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233355	16	23634436	16	23623115	233355	235196	rs876660352	NC_000016.10:23623114:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2849C>T (p.Ser950Phe)	PALB2	S950F	not specified|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000231438	16	23634437	16	23623116	231438	235197	rs876659160	NC_000016.10:23623115:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2847T>C (p.Cys949=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492201	16	23634439	16	23623118	492201	484807	rs1555459591	NC_000016.10:23623117:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2846G>C (p.Cys949Ser)	PALB2	C353S, C654S, C127S, C600S, C929S, C895S, C925S, C949S	Familial cancer of breast	VCV002842765	16	23634440	16	23623119	2842765	2997471	rs587778588	NC_000016.10:23623118:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2846G>T (p.Cys949Phe)	PALB2	C949F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000821894	16	23634440	16	23623119	821894	812676	rs587778588	NC_000016.10:23623118:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2846G>A (p.Cys949Tyr)	PALB2	C949Y	Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000128135	16	23634440	16	23623119	128135	133592	rs587778588	NC_000016.10:23623118:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 4, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2844T>G (p.Phe948Leu)	PALB2	F352L, F894L, F948L, F599L, F653L, F126L, F924L, F928L	Familial cancer of breast	VCV003656893	16	23634442	16	23623121	3656893	3789749		NC_000016.10:23623120:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2843T>C (p.Phe948Ser)	PALB2	F599S, F653S, F928S, F126S, F352S, F924S, F948S, F894S	Hereditary cancer-predisposing syndrome	VCV003927438	16	23634443	16	23623122	3927438	4047071		NC_000016.10:23623121:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	May 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2842T>C (p.Phe948Leu)	PALB2	F126L, F599L, F894L, F352L, F924L, F653L, F928L, F948L	Hereditary cancer-predisposing syndrome	VCV001796738	16	23634444	16	23623123	1796738	1855313	rs1060502810	NC_000016.10:23623122:A:G	single nucleotide variant	missense variant	Likely benign	Oct 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2842T>A (p.Phe948Ile)	PALB2	F948I	Familial cancer of breast	VCV000410220	16	23634444	16	23623123	410220	401500	rs1060502810	NC_000016.10:23623122:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2841G>A (p.Leu947=)	PALB2		Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5	VCV003780089	16	23634445	16	23623124	3780089	3896056		NC_000016.10:23623123:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2841G>C (p.Leu947Phe)	PALB2	L947F	Familial cancer of breast	VCV000657666	16	23634445	16	23623124	657666	644403	rs45525135	NC_000016.10:23623123:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2840T>C (p.Leu947Ser)	PALB2	L947S	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|not specified|Hereditary cancer-predisposing syndrome|Inherited breast cancer and ovarian cancer	VCV000241553	16	23634446	16	23623125	241553	242355	rs45464500	NC_000016.10:23623124:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2838A>G (p.Ala946=)	PALB2		Familial cancer of breast	VCV003637473	16	23634448	16	23623127	3637473	3767757		NC_000016.10:23623126:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2838A>C (p.Ala946=)	PALB2		Familial cancer of breast	VCV002845314	16	23634448	16	23623127	2845314	3014769	rs2142337886	NC_000016.10:23623126:T:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2838A>T (p.Ala946=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001796668	16	23634448	16	23623127	1796668	1855243	rs2142337886	NC_000016.10:23623126:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 13, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2836G>C (p.Ala946Pro)	PALB2	A350P, A651P, A892P, A922P, A926P, A124P, A597P, A946P	Familial cancer of breast	VCV002770050	16	23634450	16	23623129	2770050	2929919	rs878855113	NC_000016.10:23623128:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2836G>A (p.Ala946Thr)	PALB2	A946T	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000421893	16	23634450	16	23623129	421893	409524	rs878855113	NC_000016.10:23623128:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2836G>T (p.Ala946Ser)	PALB2	A946S	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000241552	16	23634450	16	23623129	241552	242356	rs878855113	NC_000016.10:23623128:C:A	single nucleotide variant	missense variant	Uncertain significance	May 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835G>A (p.Arg945=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000232774	16	23634451	16	23623130	232774	235198	rs876659983	NC_000016.10:23623129:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2835-1G>A	PALB2		PALB2-related disorder|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000188163	16	23634452	16	23623131	188163	186213	rs515726099	NC_000016.10:23623130:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835-1G>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3	VCV000126688	16	23634452	16	23623131	126688	132198	rs515726099	NC_000016.10:23623130:C:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835-2A>G	PALB2		Familial cancer of breast|Fanconi anemia complementation group N	VCV002584866	16	23634453	16	23623132	2584866	2752428	rs886039613	NC_000016.10:23623131:T:C	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835-2A>C	PALB2		Familial cancer of breast|not provided	VCV000265544	16	23634453	16	23623132	265544	260100	rs886039613	NC_000016.10:23623131:T:G	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835-3T>C	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410200	16	23634454	16	23623133	410200	401501	rs1060502795	NC_000016.10:23623132:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2835-4T>C	PALB2		Hereditary cancer-predisposing syndrome	VCV000484229	16	23634455	16	23623134	484229	477474	rs1555459604	NC_000016.10:23623133:A:G	single nucleotide variant	intron variant	Uncertain significance	Apr 24, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-5C>G	PALB2		Familial cancer of breast	VCV000530099	16	23634456	16	23623135	530099	529782	rs1555459605	NC_000016.10:23623134:G:C	single nucleotide variant	intron variant	Uncertain significance	Oct 12, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-5C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484173	16	23634456	16	23623135	484173	477580	rs1555459605	NC_000016.10:23623134:G:A	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835-5C>A	PALB2		Familial cancer of breast	VCV000460962	16	23634456	16	23623135	460962	466160	rs1555459605	NC_000016.10:23623134:G:T	single nucleotide variant	intron variant	Likely benign	Mar 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-6G>T	PALB2		Familial cancer of breast	VCV001632532	16	23634457	16	23623136	1632532	1631058	rs2142338070	NC_000016.10:23623135:C:A	single nucleotide variant	intron variant	Likely benign	Oct 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-7G>A	PALB2		Familial cancer of breast	VCV000410214	16	23634458	16	23623137	410214	401018	rs1060502806	NC_000016.10:23623136:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 14, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-9T>G	PALB2		Familial cancer of breast	VCV002107346	16	23634460	16	23623139	2107346	2166510	rs1597081630	NC_000016.10:23623138:A:C	single nucleotide variant	intron variant	Uncertain significance	Dec 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-9T>C	PALB2		Familial cancer of breast|not provided	VCV000682811	16	23634460	16	23623139	682811	668440	rs1597081630	NC_000016.10:23623138:A:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835-11A>G	PALB2		Hereditary cancer-predisposing syndrome|not specified|PALB2-related cancer predisposition|Familial cancer of breast|not provided	VCV000381771	16	23634462	16	23623141	381771	374252	rs747232850	NC_000016.10:23623140:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835-12T>C	PALB2		Familial cancer of breast	VCV003903465	16	23634463	16	23623142	3903465	4019339		NC_000016.10:23623141:A:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-12T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV003885206	16	23634463	16	23623142	3885206	4005528		NC_000016.10:23623141:A:C	single nucleotide variant	intron variant	Uncertain significance	Jan 31, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-13A>G	PALB2		Familial cancer of breast	VCV002813117	16	23634464	16	23623143	2813117	2972919	rs1478108462	NC_000016.10:23623142:T:C	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835-15T>C	PALB2		Familial cancer of breast	VCV003903555	16	23634466	16	23623145	3903555	4019428		NC_000016.10:23623144:A:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-15T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000492200	16	23634466	16	23623145	492200	484645	rs1555459607	NC_000016.10:23623144:A:C	single nucleotide variant	intron variant	Likely benign	Nov 17, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-16C>T	PALB2		Familial cancer of breast	VCV003671498	16	23634467	16	23623146	3671498	3803636		NC_000016.10:23623145:G:A	single nucleotide variant	intron variant	Likely benign	Dec 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2835-18T>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000925911	16	23634469	16	23623148	925911	915934	rs1966806281	NC_000016.10:23623147:A:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835-27C>T	PALB2		not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000126689	16	23634478	16	23623157	126689	132199	rs199757736	NC_000016.10:23623156:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2835-299G>T	PALB2		not provided	VCV001279800	16	23634750	16	23623429	1279800	1268376	rs12926135	NC_000016.10:23623428:C:A	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+104A>T	PALB2		not provided	VCV001201027	16	23635226	16	23623905	1201027	1191787	rs116722618	NC_000016.10:23623904:T:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+28T>C	PALB2		not specified	VCV002576369	16	23635302	16	23623981	2576369	2741265	rs1966822122	NC_000016.10:23623980:A:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+20T>C	PALB2		Familial cancer of breast	VCV001566679	16	23635310	16	23623989	1566679	1569203	rs515726097	NC_000016.10:23623988:A:G	single nucleotide variant	intron variant	Likely benign	Sep 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+20T>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000919654	16	23635310	16	23623989	919654	916396	rs515726097	NC_000016.10:23623988:A:T	single nucleotide variant	intron variant	Likely benign	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+20T>G	PALB2		Familial cancer of breast	VCV000126686	16	23635310	16	23623989	126686	132196	rs515726097	NC_000016.10:23623988:A:C	single nucleotide variant	intron variant	Likely benign	Jun 17, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+19G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628093	16	23635311	16	23623990	628093	619473	rs1167305954	NC_000016.10:23623989:C:T	single nucleotide variant	intron variant	Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+18A>T	PALB2		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|not specified	VCV000138576	16	23635312	16	23623991	138576	142279	rs114491776	NC_000016.10:23623990:T:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+17G>A	PALB2		Familial cancer of breast	VCV001671943	16	23635313	16	23623992	1671943	1636871	rs1389763153	NC_000016.10:23623991:C:T	single nucleotide variant	intron variant	Likely benign	Jul 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+16G>T	PALB2		not specified|Familial cancer of breast	VCV001802885	16	23635314	16	23623993	1802885	1859916	rs1218761844	NC_000016.10:23623992:C:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+16G>A	PALB2		Familial cancer of breast|not specified	VCV000516438	16	23635314	16	23623993	516438	505722	rs1218761844	NC_000016.10:23623992:C:T	single nucleotide variant	intron variant	Likely benign	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+15A>G	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not specified	VCV000378319	16	23635315	16	23623994	378319	374255	rs149791114	NC_000016.10:23623993:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+13C>G	PALB2		Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000925492	16	23635317	16	23623996	925492	915936	rs551516577	NC_000016.10:23623995:G:C	single nucleotide variant	intron variant	Likely benign	Mar 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+13C>A	PALB2		not specified|Familial cancer of breast|Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000516437	16	23635317	16	23623996	516437	505727	rs551516577	NC_000016.10:23623995:G:T	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+12C>T	PALB2		Familial cancer of breast	VCV000126685	16	23635318	16	23623997	126685	132195	rs515726096	NC_000016.10:23623996:G:A	single nucleotide variant	intron variant	Likely benign	May 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+11C>G	PALB2		Familial cancer of breast	VCV001615671	16	23635319	16	23623998	1615671	1547613	rs755983937	NC_000016.10:23623997:G:C	single nucleotide variant	intron variant	Likely benign	Jun 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+11C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000918281	16	23635319	16	23623998	918281	916399	rs755983937	NC_000016.10:23623997:G:A	single nucleotide variant	intron variant	Likely benign	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+10T>G	PALB2		Familial cancer of breast	VCV000530252	16	23635320	16	23623999	530252	530116	rs1555459700	NC_000016.10:23623998:A:C	single nucleotide variant	intron variant	Likely benign	Aug 24, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+9T>C	PALB2		Familial cancer of breast	VCV003903871	16	23635321	16	23624000	3903871	4019744		NC_000016.10:23623999:A:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+8A>C	PALB2		Familial cancer of breast	VCV003904253	16	23635322	16	23624001	3904253	4020126		NC_000016.10:23624000:T:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+8A>G	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530221	16	23635322	16	23624001	530221	530123	rs1378802379	NC_000016.10:23624000:T:C	single nucleotide variant	intron variant	Likely benign	Jan 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+7A>T	PALB2		Familial cancer of breast	VCV001993928	16	23635323	16	23624002	1993928	2059590	rs1468310581	NC_000016.10:23624001:T:A	single nucleotide variant	intron variant	Likely benign	May 13, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+7A>G	PALB2		Familial cancer of breast	VCV001111312	16	23635323	16	23624002	1111312	1103696	rs1468310581	NC_000016.10:23624001:T:C	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+6T>C	PALB2		Familial cancer of breast	VCV003727724	16	23635324	16	23624003	3727724	3858347		NC_000016.10:23624002:A:G	single nucleotide variant	intron variant	Uncertain significance	Dec 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+5G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530057	16	23635325	16	23624004	530057	529784	rs570455216	NC_000016.10:23624003:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2834+4T>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484228	16	23635326	16	23624005	484228	477507	rs982643702	NC_000016.10:23624004:A:G	single nucleotide variant	intron variant	Uncertain significance	May 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+3A>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410155	16	23635327	16	23624006	410155	401025	rs1060502766	NC_000016.10:23624005:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 6, 2022	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2834+2T>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002673834	16	23635328	16	23624007	2673834	2836339	rs864622481	NC_000016.10:23624006:A:T	single nucleotide variant	splice donor variant	Likely pathogenic	Oct 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+2T>C	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000821873	16	23635328	16	23624007	821873	815627	rs864622481	NC_000016.10:23624006:A:G	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+2T>G	PALB2		Familial cancer of breast	VCV000220338	16	23635328	16	23624007	220338	222463	rs864622481	NC_000016.10:23624006:A:C	single nucleotide variant	splice donor variant	Pathogenic	Jun 2, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834+1G>C	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000482048	16	23635329	16	23624008	482048	478055	rs587776419	NC_000016.10:23624007:C:G	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Feb 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+1G>A	PALB2		Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Malignant tumor of breast	VCV000182771	16	23635329	16	23624008	182771	180715	rs587776419	NC_000016.10:23624007:C:T	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834+1G>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not provided	VCV000143968	16	23635329	16	23624008	143968	153698	rs587776419	NC_000016.10:23624007:C:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Apr 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2834G>A (p.Arg945Lys)	PALB2	R945K	Hereditary cancer-predisposing syndrome	VCV001691948	16	23635330	16	23624009	1691948	1684390	rs1966823330	NC_000016.10:23624008:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2834G>C (p.Arg945Thr)	PALB2	R945T	Familial cancer of breast	VCV000860213	16	23635330	16	23624009	860213	843569	rs1966823330	NC_000016.10:23624008:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2833A>G (p.Arg945Gly)	PALB2	R123G, R945G, R349G, R891G, R925G, R596G, R650G, R921G	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Diffuse midline glioma, H3 K27-altered	VCV001796612	16	23635331	16	23624010	1796612	1855187	rs1330055409	NC_000016.10:23624009:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2832C>T (p.Ile944=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003304005	16	23635332	16	23624011	3304005	3470172		NC_000016.10:23624010:G:A	single nucleotide variant	synonymous variant	Likely benign	May 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2832C>G (p.Ile944Met)	PALB2	I944M	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530134	16	23635332	16	23624011	530134	529785	rs1555459704	NC_000016.10:23624010:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2831T>G (p.Ile944Ser)	PALB2	I944S	Familial cancer of breast	VCV000973769	16	23635333	16	23624012	973769	962061	rs201817103	NC_000016.10:23624011:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2831T>A (p.Ile944Asn)	PALB2	I944N	Familial cancer of breast	VCV000187262	16	23635333	16	23624012	187262	184178	rs201817103	NC_000016.10:23624011:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.2829G>C (p.Glu943Asp)	PALB2	E943D	Familial cancer of breast	VCV001021178	16	23635335	16	23624014	1021178	1012025	rs1555459706	NC_000016.10:23624013:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2829G>A (p.Glu943=)	PALB2		Familial cancer of breast	VCV000530261	16	23635335	16	23624014	530261	529851	rs1555459706	NC_000016.10:23624013:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2828A>C (p.Glu943Ala)	PALB2	E943A	Familial cancer of breast	VCV000530185	16	23635336	16	23624015	530185	529858	rs1555459707	NC_000016.10:23624014:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2827G>C (p.Glu943Gln)	PALB2	E121Q, E347Q, E594Q, E648Q, E889Q, E919Q, E923Q, E943Q	not provided|Familial cancer of breast	VCV003067659	16	23635337	16	23624016	3067659	3226954	rs1567214295	NC_000016.10:23624015:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2827G>A (p.Glu943Lys)	PALB2	E943K	Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3	VCV000629080	16	23635337	16	23624016	629080	618364	rs1567214295	NC_000016.10:23624015:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2826A>G (p.Arg942=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000921221	16	23635338	16	23624017	921221	913613	rs1966823909	NC_000016.10:23624016:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 11, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2824A>T (p.Arg942Ter)	PALB2	R942*	Hereditary cancer-predisposing syndrome	VCV000821860	16	23635340	16	23624019	821860	812677	rs757055720	NC_000016.10:23624018:T:A	single nucleotide variant	nonsense	Pathogenic	Jul 31, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2824A>G (p.Arg942Gly)	PALB2	R942G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000570859	16	23635340	16	23624019	570859	573918	rs757055720	NC_000016.10:23624018:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2823C>A (p.Ile941=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000126684	16	23635341	16	23624020	126684	132194	rs515726095	NC_000016.10:23624019:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 7, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2822T>G (p.Ile941Ser)	PALB2	I119S, I345S, I592S, I646S, I887S, I917S, I921S, I941S	not provided	VCV003361143	16	23635342	16	23624021	3361143	3520354		NC_000016.10:23624020:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2821A>G (p.Ile941Val)	PALB2	I941V	Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000460961	16	23635343	16	23624022	460961	466188	rs778602038	NC_000016.10:23624021:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2819A>G (p.Glu940Gly)	PALB2	E344G, E645G, E916G, E920G, E118G, E591G, E886G, E940G	Familial cancer of breast	VCV002730719	16	23635345	16	23624024	2730719	2883454	rs2506348855	NC_000016.10:23624023:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2818G>A (p.Glu940Lys)	PALB2	E886K, E920K, E591K, E940K, E118K, E344K, E645K, E916K	Hereditary cancer-predisposing syndrome	VCV001796397	16	23635346	16	23624025	1796397	1852832	rs2142342958	NC_000016.10:23624024:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2817G>A (p.Leu939=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003228020	16	23635347	16	23624026	3228020	3387789	rs1555459710	NC_000016.10:23624025:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2817G>C (p.Leu939Phe)	PALB2	L939F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000490079	16	23635347	16	23624026	490079	482936	rs1555459710	NC_000016.10:23624025:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2816T>C (p.Leu939Ser)	PALB2	L117S, L590S, L644S, L343S, L939S, L885S, L915S, L919S	Familial cancer of breast	VCV003652897	16	23635348	16	23624027	3652897	3778286		NC_000016.10:23624026:A:G	single nucleotide variant	missense variant	Uncertain significance	May 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2816T>G (p.Leu939Trp)	PALB2	L939W	Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|not specified|Fanconi anemia complementation group N|Familial cancer of breast|not provided|Hereditary breast ovarian cancer syndrome	VCV000126683	16	23635348	16	23624027	126683	132193	rs45478192	NC_000016.10:23624026:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2815T>C (p.Leu939=)	PALB2		Familial cancer of breast	VCV000800117	16	23635349	16	23624028	800117	785217	rs876658742	NC_000016.10:23624027:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2815T>G (p.Leu939Val)	PALB2	L939V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000230745	16	23635349	16	23624028	230745	235199	rs876658742	NC_000016.10:23624027:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2813A>G (p.Asn938Ser)	PALB2	N938S	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000584543	16	23635351	16	23624030	584543	575599	rs1567214357	NC_000016.10:23624029:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 4, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2811A>G (p.Gly937=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000821838	16	23635353	16	23624032	821838	812678	rs876660486	NC_000016.10:23624031:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2811A>C (p.Gly937=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233554	16	23635353	16	23624032	233554	235200	rs876660486	NC_000016.10:23624031:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2810G>C (p.Gly937Ala)	PALB2	G917A, G937A, G115A, G341A, G588A, G642A, G883A, G913A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001913733	16	23635354	16	23624033	1913733	1970064	rs786202641	NC_000016.10:23624032:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2810G>A (p.Gly937Glu)	PALB2	G937E	Hereditary cancer-predisposing syndrome|Familial pancreatic carcinoma|Familial cancer of breast	VCV000186029	16	23635354	16	23624033	186029	184179	rs786202641	NC_000016.10:23624032:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2809G>C (p.Gly937Arg)	PALB2	G937R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530131	16	23635355	16	23624034	530131	529793	rs1555459712	NC_000016.10:23624033:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2809G>A (p.Gly937Arg)	PALB2	G937R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484164	16	23635355	16	23624034	484164	477481	rs1555459712	NC_000016.10:23624033:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2808G>T (p.Leu936Phe)	PALB2	L114F, L340F, L587F, L641F, L882F, L912F, L916F, L936F	Hereditary cancer-predisposing syndrome	VCV003228019	16	23635356	16	23624035	3228019	3387788	rs2142343235	NC_000016.10:23624034:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2807T>G (p.Leu936Trp)	PALB2	L882W, L114W, L340W, L587W, L916W, L936W, L641W, L912W	Hereditary cancer-predisposing syndrome	VCV003927435	16	23635357	16	23624036	3927435	4047068		NC_000016.10:23624035:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2807T>C (p.Leu936Ser)	PALB2	L936S	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000128134	16	23635357	16	23624036	128134	133591	rs587780213	NC_000016.10:23624035:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2806T>G (p.Leu936Val)	PALB2	L340V, L936V, L114V, L587V, L912V, L641V, L882V, L916V	Familial cancer of breast	VCV003702771	16	23635358	16	23624037	3702771	3838822		NC_000016.10:23624036:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2806T>C (p.Leu936=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV001151297	16	23635358	16	23624037	1151297	1146003	rs2142343280	NC_000016.10:23624036:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 5, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2805T>G (p.Ala935=)	PALB2		Familial cancer of breast	VCV001583578	16	23635359	16	23624038	1583578	1601273	rs2142343292	NC_000016.10:23624037:A:C	single nucleotide variant	synonymous variant	Likely benign	Nov 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2804C>G (p.Ala935Gly)	PALB2	A935G	Pancreatic cancer, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast	VCV000530124	16	23635360	16	23624039	530124	529806	rs769009609	NC_000016.10:23624038:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2804C>T (p.Ala935Val)	PALB2	A935V	Familial cancer of breast|not provided	VCV000410146	16	23635360	16	23624039	410146	401059	rs769009609	NC_000016.10:23624038:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2803G>A (p.Ala935Thr)	PALB2	A586T, A113T, A915T, A935T, A339T, A881T, A911T, A640T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002179889	16	23635361	16	23624040	2179889	1916409	rs2142343363	NC_000016.10:23624039:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2802A>G (p.Val934=)	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000484165	16	23635362	16	23624041	484165	477509	rs1555459718	NC_000016.10:23624040:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2801T>G (p.Val934Gly)	PALB2	V934G	Familial cancer of breast	VCV001431189	16	23635363	16	23624042	1431189	1467865	rs2142343417	NC_000016.10:23624041:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2800G>C (p.Val934Leu)	PALB2	V934L	Familial cancer of breast	VCV001390313	16	23635364	16	23624043	1390313	1396486	rs370243279	NC_000016.10:23624042:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2799T>C (p.Cys933=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000415992	16	23635365	16	23624044	415992	401505	rs748232940	NC_000016.10:23624043:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2798G>C (p.Cys933Ser)	PALB2	C933S	Hereditary cancer-predisposing syndrome	VCV001332294	16	23635366	16	23624045	1332294	1323013	rs730881891	NC_000016.10:23624044:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2798G>A (p.Cys933Tyr)	PALB2	C933Y	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000182770	16	23635366	16	23624045	182770	180716	rs730881891	NC_000016.10:23624044:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2797T>A (p.Cys933Ser)	PALB2	C111S, C909S, C933S, C638S, C879S, C337S, C584S, C913S	Familial cancer of breast	VCV002843435	16	23635367	16	23624046	2843435	3004090	rs1295650692	NC_000016.10:23624045:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2797T>G (p.Cys933Gly)	PALB2	C933G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000655185	16	23635367	16	23624046	655185	644404	rs1295650692	NC_000016.10:23624045:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2796G>A (p.Val932=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000492199	16	23635368	16	23624047	492199	484809	rs1555459719	NC_000016.10:23624046:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2795T>G (p.Val932Gly)	PALB2	V110G, V637G, V912G, V583G, V908G, V336G, V878G, V932G	Familial cancer of breast	VCV002015591	16	23635369	16	23624048	2015591	2068389	rs2506350142	NC_000016.10:23624047:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2794G>A (p.Val932Met)	PALB2	V932M	Breast and/or ovarian cancer|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|Fanconi anemia complementation group N|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|not specified|Hereditary cancer-predisposing syndrome	VCV000126682	16	23635370	16	23624049	126682	132192	rs45624036	NC_000016.10:23624048:C:T	single nucleotide variant	missense variant	Benign/Likely benign	May 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2793C>A (p.Leu931=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003303987	16	23635371	16	23624050	3303987	3470154		NC_000016.10:23624049:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2793C>G (p.Leu931=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002773997	16	23635371	16	23624050	2773997	2934728	rs1039677524	NC_000016.10:23624049:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2793C>T (p.Leu931=)	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000415993	16	23635371	16	23624050	415993	401027	rs1039677524	NC_000016.10:23624049:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2792T>C (p.Leu931Pro)	PALB2	L931P	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000241550	16	23635372	16	23624051	241550	242358	rs773831304	NC_000016.10:23624050:A:G	single nucleotide variant	missense variant	Uncertain significance	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2792T>G (p.Leu931Arg)	PALB2	L931R	not specified|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000186840	16	23635372	16	23624051	186840	184180	rs773831304	NC_000016.10:23624050:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2791C>T (p.Leu931Phe)	PALB2	L931F	Familial cancer of breast	VCV000410188	16	23635373	16	23624052	410188	401509	rs1060502786	NC_000016.10:23624051:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2789A>C (p.Asn930Thr)	PALB2	N930T	Familial cancer of breast	VCV001350191	16	23635375	16	23624054	1350191	1473014	rs1966825680	NC_000016.10:23624053:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2789A>G (p.Asn930Ser)	PALB2	N930S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000925038	16	23635375	16	23624054	925038	913614	rs1966825680	NC_000016.10:23624053:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2788A>G (p.Asn930Asp)	PALB2	N930D	Familial cancer of breast	VCV001491888	16	23635376	16	23624055	1491888	1446119	rs1227325413	NC_000016.10:23624054:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2788A>T (p.Asn930Tyr)	PALB2	N930Y	not specified|not provided|Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460960	16	23635376	16	23624055	460960	466190	rs1227325413	NC_000016.10:23624054:T:A	single nucleotide variant	missense variant	Uncertain significance	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2787T>G (p.Tyr929Ter)	PALB2	Y929*	Hereditary cancer-predisposing syndrome	VCV000484195	16	23635377	16	23624056	484195	477519	rs876660669	NC_000016.10:23624055:A:C	single nucleotide variant	nonsense	Pathogenic	Jul 28, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2787T>C (p.Tyr929=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000233829	16	23635377	16	23624056	233829	235201	rs876660669	NC_000016.10:23624055:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2786A>G (p.Tyr929Cys)	PALB2	Y909C, Y333C, Y634C, Y875C, Y580C, Y929C, Y107C, Y905C	Hereditary cancer-predisposing syndrome	VCV002773998	16	23635378	16	23624057	2773998	2934729	rs1249404804	NC_000016.10:23624056:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 11, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2786A>T (p.Tyr929Phe)	PALB2	Y333F, Y875F, Y107F, Y580F, Y905F, Y929F, Y634F, Y909F	Hereditary cancer-predisposing syndrome	VCV001795982	16	23635378	16	23624057	1795982	1853341	rs1249404804	NC_000016.10:23624056:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2785T>A (p.Tyr929Asn)	PALB2	Y107N, Y333N, Y905N, Y580N, Y909N, Y929N, Y634N, Y875N	Hereditary cancer-predisposing syndrome	VCV002447308	16	23635379	16	23624058	2447308	2422430	rs1966826141	NC_000016.10:23624057:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2785T>C (p.Tyr929His)	PALB2	Y929H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001402534	16	23635379	16	23624058	1402534	1476961	rs1966826141	NC_000016.10:23624057:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2784G>T (p.Val928=)	PALB2		Familial cancer of breast|not provided	VCV001212569	16	23635380	16	23624059	1212569	1202563	rs763411245	NC_000016.10:23624058:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2784G>A (p.Val928=)	PALB2		Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460959	16	23635380	16	23624059	460959	465450	rs763411245	NC_000016.10:23624058:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2783T>G (p.Val928Gly)	PALB2	V928G	Hereditary cancer-predisposing syndrome	VCV000821806	16	23635381	16	23624060	821806	812679	rs1597082810	NC_000016.10:23624059:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2782G>T (p.Val928Leu)	PALB2	V106L, V332L, V904L, V633L, V908L, V579L, V874L, V928L	Hereditary cancer-predisposing syndrome	VCV003303990	16	23635382	16	23624061	3303990	3470157		NC_000016.10:23624060:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2782G>C (p.Val928Leu)	PALB2	V633L, V332L, V874L, V908L, V106L, V579L, V904L, V928L	Familial cancer of breast	VCV002822429	16	23635382	16	23624061	2822429	2978389	rs771288520	NC_000016.10:23624060:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2782G>A (p.Val928Met)	PALB2	V928M	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000185678	16	23635382	16	23624061	185678	184181	rs771288520	NC_000016.10:23624060:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2781T>C (p.Asp927=)	PALB2		Familial cancer of breast	VCV001083247	16	23635383	16	23624062	1083247	1081886	rs1373766717	NC_000016.10:23624061:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2781T>A (p.Asp927Glu)	PALB2	D927E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000821804	16	23635383	16	23624062	821804	812680	rs1373766717	NC_000016.10:23624061:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2780A>C (p.Asp927Ala)	PALB2	D927A	Familial cancer of breast	VCV001391988	16	23635384	16	23624063	1391988	1386786	rs62625280	NC_000016.10:23624062:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2780A>G (p.Asp927Gly)	PALB2	D927G	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000422729	16	23635384	16	23624063	422729	409527	rs62625280	NC_000016.10:23624062:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2780A>T (p.Asp927Val)	PALB2	D927V	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000421641	16	23635384	16	23624063	421641	409526	rs62625280	NC_000016.10:23624062:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2779G>C (p.Asp927His)	PALB2	D105H, D903H, D578H, D907H, D331H, D927H, D632H, D873H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001795889	16	23635385	16	23624064	1795889	1853248	rs1567214436	NC_000016.10:23624063:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2779G>A (p.Asp927Asn)	PALB2	D927N	Hereditary cancer-predisposing syndrome	VCV000627863	16	23635385	16	23624064	627863	618366	rs1567214436	NC_000016.10:23624063:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2777C>T (p.Pro926Leu)	PALB2	P926L	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N	VCV000530106	16	23635387	16	23624066	530106	529809	rs1555459732	NC_000016.10:23624065:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2776C>T (p.Pro926Ser)	PALB2	P104S, P330S, P577S, P631S, P872S, P902S, P906S, P926S	Familial cancer of breast	VCV002677447	16	23635388	16	23624067	2677447	2836318	rs2142344116	NC_000016.10:23624066:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2775G>A (p.Val925=)	PALB2		Familial cancer of breast	VCV001118567	16	23635389	16	23624068	1118567	1103697	rs1210285949	NC_000016.10:23624067:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 3, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2774T>C (p.Val925Ala)	PALB2	V925A	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3	VCV000460958	16	23635390	16	23624069	460958	466398	rs1555459734	NC_000016.10:23624068:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2773G>T (p.Val925Leu)	PALB2	V329L, V901L, V925L, V103L, V576L, V871L, V905L, V630L	Familial cancer of breast	VCV002755715	16	23635391	16	23624070	2755715	2916887	rs180177125	NC_000016.10:23624069:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2773G>A (p.Val925Met)	PALB2	V925M	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000651937	16	23635391	16	23624070	651937	644407	rs180177125	NC_000016.10:23624069:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 14, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2773G>C (p.Val925Leu)	PALB2	V925L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not provided|Breast and/or ovarian cancer	VCV000126681	16	23635391	16	23624070	126681	132191	rs180177125	NC_000016.10:23624069:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 24, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2772A>C (p.Pro924=)	PALB2		Familial cancer of breast	VCV003903866	16	23635392	16	23624071	3903866	4019739		NC_000016.10:23624070:T:G	single nucleotide variant	synonymous variant	Benign	Jan 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2771C>T (p.Pro924Leu)	PALB2	P924L	Hereditary cancer-predisposing syndrome	VCV000628659	16	23635393	16	23624072	628659	618367	rs1567214451	NC_000016.10:23624071:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2770C>G (p.Pro924Ala)	PALB2	P900A, P328A, P102A, P575A, P629A, P870A, P904A, P924A	Hereditary cancer-predisposing syndrome	VCV003927430	16	23635394	16	23624073	3927430	4047063		NC_000016.10:23624072:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2769T>C (p.Val923=)	PALB2		Familial cancer of breast	VCV003904489	16	23635395	16	23624074	3904489	4020361		NC_000016.10:23624073:A:G	single nucleotide variant	synonymous variant	Benign	Jan 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2768T>G (p.Val923Gly)	PALB2	V923G	Familial cancer of breast	VCV000638155	16	23635396	16	23624075	638155	625976	rs1597082876	NC_000016.10:23624074:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2767G>A (p.Val923Ile)	PALB2	V101I, V327I, V574I, V628I, V869I, V899I, V903I, V923I	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV001715990	16	23635397	16	23624076	1715990	1771287	rs767165391	NC_000016.10:23624075:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2767G>C (p.Val923Leu)	PALB2	V923L	Familial cancer of breast	VCV001432361	16	23635397	16	23624076	1432361	1484472	rs767165391	NC_000016.10:23624075:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2767G>T (p.Val923Phe)	PALB2	V923F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000918282	16	23635397	16	23624076	918282	913615	rs767165391	NC_000016.10:23624075:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2766A>C (p.Ile922=)	PALB2		Familial cancer of breast	VCV002010886	16	23635398	16	23624077	2010886	2063676	rs1597082882	NC_000016.10:23624076:T:G	single nucleotide variant	synonymous variant	Likely benign	Jun 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2766A>G (p.Ile922Met)	PALB2	I922M	Familial cancer of breast	VCV000940362	16	23635398	16	23624077	940362	937359	rs1597082882	NC_000016.10:23624076:T:C	single nucleotide variant	missense variant	Uncertain significance	May 18, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2766A>T (p.Ile922=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000821779	16	23635398	16	23624077	821779	812681	rs1597082882	NC_000016.10:23624076:T:A	single nucleotide variant	synonymous variant	Likely benign	Sep 25, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2765T>G (p.Ile922Arg)	PALB2	I627R, I898R, I573R, I902R, I922R, I100R, I326R, I868R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001997276	16	23635399	16	23624078	1997276	2060358	rs1060499822	NC_000016.10:23624077:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2765T>C (p.Ile922Thr)	PALB2	I922T	Hereditary cancer-predisposing syndrome|not provided	VCV000920268	16	23635399	16	23624078	920268	913616	rs1060499822	NC_000016.10:23624077:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2765T>A (p.Ile922Lys)	PALB2	I922K	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000402301	16	23635399	16	23624078	402301	389264	rs1060499822	NC_000016.10:23624077:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2764A>G (p.Ile922Val)	PALB2	I922V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480281	16	23635400	16	23624079	480281	477484	rs1555459736	NC_000016.10:23624078:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2763G>C (p.Gln921His)	PALB2	Q921H	Familial cancer of breast	VCV000216748	16	23635401	16	23624080	216748	213161	rs372931676	NC_000016.10:23624079:C:G	single nucleotide variant	missense variant	Uncertain significance	May 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2762A>C (p.Gln921Pro)	PALB2	Q921P	Familial cancer of breast	VCV000856222	16	23635402	16	23624081	856222	843571	rs1966827421	NC_000016.10:23624080:T:G	single nucleotide variant	missense variant	Uncertain significance	May 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2761C>A (p.Gln921Lys)	PALB2	Q921K	Familial cancer of breast	VCV001351096	16	23635403	16	23624082	1351096	1407446	rs180177124	NC_000016.10:23624081:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2761C>T (p.Gln921Ter)	PALB2	Q921*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126680	16	23635403	16	23624082	126680	132190	rs180177124	NC_000016.10:23624081:G:A	single nucleotide variant	nonsense	Pathogenic	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2759T>G (p.Leu920Ter)	PALB2	L920*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000632929	16	23635405	16	23624084	632929	621529	rs1567214493	NC_000016.10:23624083:A:C	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2758T>C (p.Leu920=)	PALB2		Familial cancer of breast	VCV002860142	16	23635406	16	23624085	2860142	3028779	rs2506351721	NC_000016.10:23624084:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2757A>G (p.Val919=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001669626	16	23635407	16	23624086	1669626	1665880	rs2142344557	NC_000016.10:23624085:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2756T>C (p.Val919Ala)	PALB2	V919A	Familial cancer of breast	VCV001486246	16	23635408	16	23624087	1486246	1468723	rs886041103	NC_000016.10:23624086:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2755G>T (p.Val919Leu)	PALB2	V919L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000922142	16	23635409	16	23624088	922142	913617	rs775193384	NC_000016.10:23624087:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2755G>C (p.Val919Leu)	PALB2	V919L	Familial cancer of breast	VCV000857464	16	23635409	16	23624088	857464	843572	rs775193384	NC_000016.10:23624087:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2755G>A (p.Val919Ile)	PALB2	V919I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|not specified|not provided|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000225856	16	23635409	16	23624088	225856	227664	rs775193384	NC_000016.10:23624087:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 11, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2754A>G (p.Pro918=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001629602	16	23635410	16	23624089	1629602	1532385	rs2142344640	NC_000016.10:23624088:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2753C>A (p.Pro918Gln)	PALB2	P918Q	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000136136	16	23635411	16	23624090	136136	139848	rs587780822	NC_000016.10:23624089:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2752C>A (p.Pro918Thr)	PALB2	P918T	Familial cancer of breast	VCV000645317	16	23635412	16	23624091	645317	644408	rs515726094	NC_000016.10:23624090:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2752C>T (p.Pro918Ser)	PALB2	P918S	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000126679	16	23635412	16	23624091	126679	132189	rs515726094	NC_000016.10:23624090:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 4, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2751T>C (p.Val917=)	PALB2		Familial cancer of breast	VCV002700477	16	23635413	16	23624092	2700477	2855476	rs2506351953	NC_000016.10:23624091:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2750T>C (p.Val917Ala)	PALB2	V917A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000231633	16	23635414	16	23624093	231633	235203	rs763645981	NC_000016.10:23624092:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2749G>C (p.Val917Leu)	PALB2	V568L, V917L, V863L, V893L, V95L, V622L, V897L, V321L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002562469	16	23635415	16	23624094	2562469	2717311	rs753767237	NC_000016.10:23624093:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2749G>A (p.Val917Ile)	PALB2	V917I	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000659049	16	23635415	16	23624094	659049	644409	rs753767237	NC_000016.10:23624093:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 29, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2749-1G>A	PALB2		Familial cancer of breast	VCV000964073	16	23635416	16	23624095	964073	960150	rs1060502804	NC_000016.10:23624094:C:T	single nucleotide variant	splice acceptor variant	Likely pathogenic	Oct 29, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-1G>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492198	16	23635416	16	23624095	492198	484979	rs1060502804	NC_000016.10:23624094:C:A	single nucleotide variant	splice acceptor variant	Likely pathogenic	Mar 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2749-1G>C	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410212	16	23635416	16	23624095	410212	401061	rs1060502804	NC_000016.10:23624094:C:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Mar 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2749-2A>G	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001068245	16	23635417	16	23624096	1068245	1056300	rs1555459747	NC_000016.10:23624095:T:C	single nucleotide variant	splice acceptor variant	Likely pathogenic	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2749-2A>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480275	16	23635417	16	23624096	480275	477525	rs1555459747	NC_000016.10:23624095:T:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2749-3T>A	PALB2		Hereditary cancer-predisposing syndrome	VCV001795514	16	23635418	16	23624097	1795514	1854173	rs2142344782	NC_000016.10:23624096:A:T	single nucleotide variant	intron variant	Uncertain significance	Mar 18, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-3T>G	PALB2		Familial cancer of breast	VCV001384059	16	23635418	16	23624097	1384059	1447655	rs2142344782	NC_000016.10:23624096:A:C	single nucleotide variant	intron variant	Uncertain significance	Oct 8, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-4T>G	PALB2		Familial cancer of breast	VCV000662261	16	23635419	16	23624098	662261	652979	rs1597082952	NC_000016.10:23624097:A:C	single nucleotide variant	intron variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-5T>G	PALB2		Familial cancer of breast	VCV002020355	16	23635420	16	23624099	2020355	2079540	rs1966828330	NC_000016.10:23624098:A:C	single nucleotide variant	intron variant	Uncertain significance	Nov 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-5T>C	PALB2		not specified|Familial cancer of breast	VCV000933164	16	23635420	16	23624099	933164	921510	rs1966828330	NC_000016.10:23624098:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2749-8T>C	PALB2		Familial cancer of breast	VCV001547868	16	23635423	16	23624102	1547868	1537686	rs2142344832	NC_000016.10:23624101:A:G	single nucleotide variant	intron variant	Likely benign	Apr 5, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-8T>G	PALB2		Familial cancer of breast	VCV001159730	16	23635423	16	23624102	1159730	1146004	rs2142344832	NC_000016.10:23624101:A:C	single nucleotide variant	intron variant	Likely benign	Oct 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-13T>C	PALB2		Familial cancer of breast	VCV002198506	16	23635428	16	23624107	2198506	1933731	rs2506352257	NC_000016.10:23624106:A:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2749-15C>G	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000926112	16	23635430	16	23624109	926112	915938	rs1567214528	NC_000016.10:23624108:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 28, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2749-15C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000628349	16	23635430	16	23624109	628349	619607	rs1567214528	NC_000016.10:23624108:G:A	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2749-16G>C	PALB2		Familial cancer of breast	VCV003904434	16	23635431	16	23624110	3904434	4020306		NC_000016.10:23624109:C:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-16G>A	PALB2		Familial cancer of breast	VCV003662082	16	23635431	16	23624110	3662082	3797947		NC_000016.10:23624109:C:T	single nucleotide variant	intron variant	Likely benign	Aug 12, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-16G>T	PALB2		Familial cancer of breast	VCV002772611	16	23635431	16	23624110	2772611	2933763	rs2142344912	NC_000016.10:23624109:C:A	single nucleotide variant	intron variant	Likely benign	Oct 29, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-17T>C	PALB2		Familial cancer of breast	VCV003903734	16	23635432	16	23624111	3903734	4019607		NC_000016.10:23624110:A:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-17T>G	PALB2		Familial cancer of breast	VCV002033488	16	23635432	16	23624111	2033488	2100420	rs2506352328	NC_000016.10:23624110:A:C	single nucleotide variant	intron variant	Likely benign	Sep 30, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-18C>T	PALB2		Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided|Hereditary breast ovarian cancer syndrome	VCV000126678	16	23635433	16	23624112	126678	132188	rs182194007	NC_000016.10:23624111:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2749-19G>C	PALB2		Familial cancer of breast	VCV002132257	16	23635434	16	23624113	2132257	2188098	rs2142344937	NC_000016.10:23624112:C:G	single nucleotide variant	intron variant	Likely benign	Apr 30, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2749-19G>A	PALB2		Familial cancer of breast	VCV001926765	16	23635434	16	23624113	1926765	1990830	rs2142344937	NC_000016.10:23624112:C:T	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2749-20G>T	PALB2		Familial cancer of breast	VCV003661038	16	23635435	16	23624114	3661038	3790697		NC_000016.10:23624113:C:A	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2748+306C>G	PALB2		not provided	VCV001232695	16	23637251	16	23625930	1232695	1224402	rs703776	NC_000016.10:23625929:G:C	single nucleotide variant	intron variant	Benign	Mar 6, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2748+20T>C	PALB2		Familial cancer of breast	VCV001627519	16	23637537	16	23626216	1627519	1616544	rs777746899	NC_000016.10:23626215:A:G	single nucleotide variant	intron variant	Likely benign	Feb 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2748+16G>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630764	16	23637541	16	23626220	630764	619529	rs730881873	NC_000016.10:23626219:C:G	single nucleotide variant	intron variant	Likely benign	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2748+16G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000182748	16	23637541	16	23626220	182748	180717	rs730881873	NC_000016.10:23626219:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2748+15C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000492197	16	23637542	16	23626221	492197	484814	rs749756493	NC_000016.10:23626220:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2748+13C>A	PALB2		Hereditary cancer-predisposing syndrome	VCV000918557	16	23637544	16	23626223	918557	916418	rs771355581	NC_000016.10:23626222:G:T	single nucleotide variant	intron variant	Likely benign	Jul 18, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2748+13C>G	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000372046	16	23637544	16	23626223	372046	358904	rs771355581	NC_000016.10:23626222:G:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2748+8G>A	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530258	16	23637549	16	23626228	530258	529870	rs1188895680	NC_000016.10:23626227:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2748+7G>T	PALB2		Familial cancer of breast	VCV001105842	16	23637550	16	23626229	1105842	1103698	rs2142352787	NC_000016.10:23626228:C:A	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2748+3A>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000628992	16	23637554	16	23626233	628992	619560	rs1567215302	NC_000016.10:23626232:T:C	single nucleotide variant	intron variant	Uncertain significance	May 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2748+2T>A	PALB2		Familial cancer of breast	VCV002673825	16	23637555	16	23626234	2673825	2841329	rs1060499821	NC_000016.10:23626233:A:T	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Sep 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2748+2T>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000402300	16	23637555	16	23626234	402300	389265	rs1060499821	NC_000016.10:23626233:A:G	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2748+1G>A	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484205	16	23637556	16	23626235	484205	477582	rs753153576	NC_000016.10:23626234:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	May 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2748+1G>C	PALB2		Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome	VCV000372056	16	23637556	16	23626235	372056	358905	rs753153576	NC_000016.10:23626234:C:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Aug 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2748+1G>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000186035	16	23637556	16	23626235	186035	184183	rs753153576	NC_000016.10:23626234:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2748G>A (p.Glu916=)	PALB2		Familial cancer of breast	VCV002865529	16	23637557	16	23626236	2865529	3026602	rs2142352915	NC_000016.10:23626235:C:T	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	May 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2747A>G (p.Glu916Gly)	PALB2	E320G, E621G, E892G, E896G, E916G, E94G	Familial cancer of breast	VCV002755054	16	23637558	16	23626237	2755054	2909753	rs2142352942	NC_000016.10:23626236:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2744C>T (p.Ala915Val)	PALB2	A915V	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV001320442	16	23637561	16	23626240	1320442	1310687	rs1459102959	NC_000016.10:23626239:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2743G>C (p.Ala915Pro)	PALB2	A620P, A915P, A93P, A319P, A891P, A895P	not provided	VCV003572311	16	23637562	16	23626241	3572311	3731211		NC_000016.10:23626240:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2743G>A (p.Ala915Thr)	PALB2	A915T	Breast-ovarian cancer, familial, susceptibility to, 5|Diffuse midline glioma, H3 K27-altered|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000141109	16	23637562	16	23626241	141109	150823	rs374736398	NC_000016.10:23626240:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2742C>G (p.Phe914Leu)	PALB2	F619L, F894L, F914L, F890L, F92L, F318L	Hereditary cancer-predisposing syndrome	VCV001795451	16	23637563	16	23626242	1795451	1854110	rs115759702	NC_000016.10:23626241:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2742C>A (p.Phe914Leu)	PALB2	F914L	Familial cancer of breast	VCV001035283	16	23637563	16	23626242	1035283	1032513	rs115759702	NC_000016.10:23626241:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2742C>T (p.Phe914=)	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Fanconi anemia complementation group N|Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000138575	16	23637563	16	23626242	138575	142278	rs115759702	NC_000016.10:23626241:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2740T>A (p.Phe914Ile)	PALB2	F890I, F92I, F619I, F894I, F914I, F318I	Familial cancer of breast	VCV003019485	16	23637565	16	23626244	3019485	3171993	rs2142353067	NC_000016.10:23626243:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2740T>C (p.Phe914Leu)	PALB2	F890L, F894L, F318L, F619L, F92L, F914L	Familial cancer of breast	VCV003017063	16	23637565	16	23626244	3017063	3178581	rs2142353067	NC_000016.10:23626243:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 9, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2739C>T (p.His913=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001795384	16	23637566	16	23626245	1795384	1854045	rs876660557	NC_000016.10:23626244:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2739C>G (p.His913Gln)	PALB2	H913Q	Hereditary cancer-predisposing syndrome	VCV000233664	16	23637566	16	23626245	233664	235204	rs876660557	NC_000016.10:23626244:G:C	single nucleotide variant	missense variant	Uncertain significance	May 6, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2738A>T (p.His913Leu)	PALB2	H913L	Hereditary cancer-predisposing syndrome	VCV000821743	16	23637567	16	23626246	821743	812682	rs760363440	NC_000016.10:23626245:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2737C>T (p.His913Tyr)	PALB2	H913Y	Familial cancer of breast	VCV000530041	16	23637568	16	23626247	530041	529872	rs1555459923	NC_000016.10:23626246:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2736G>A (p.Trp912Ter)	PALB2	W912*	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000821738	16	23637569	16	23626248	821738	812683	rs1555459925	NC_000016.10:23626247:C:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2736G>C (p.Trp912Cys)	PALB2	W912C	Familial cancer of breast	VCV000530047	16	23637569	16	23626248	530047	530335	rs1555459925	NC_000016.10:23626247:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2735G>C (p.Trp912Ser)	PALB2	W888S, W912S, W316S, W617S, W892S, W90S	Familial cancer of breast	VCV003657231	16	23637570	16	23626249	3657231	3793510		NC_000016.10:23626248:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2735G>A (p.Trp912Ter)	PALB2	W316*, W617*, W888*, W892*, W90*, W912*	Familial cancer of breast	VCV002673860	16	23637570	16	23626249	2673860	2841361	rs2142353165	NC_000016.10:23626248:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2734T>G (p.Trp912Gly)	PALB2	W316G, W617G, W888G, W892G, W90G, W912G	Familial cancer of breast	VCV002498117	16	23637571	16	23626250	2498117	2473199	rs1597084930	NC_000016.10:23626249:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.2734T>C (p.Trp912Arg)	PALB2	W912R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000821734	16	23637571	16	23626250	821734	812684	rs1597084930	NC_000016.10:23626249:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2733C>G (p.Thr911=)	PALB2		Familial cancer of breast	VCV001615462	16	23637572	16	23626251	1615462	1547404	rs1555459927	NC_000016.10:23626250:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 13, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2733C>T (p.Thr911=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV001130788	16	23637572	16	23626251	1130788	1125112	rs1555459927	NC_000016.10:23626250:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2733C>A (p.Thr911=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530220	16	23637572	16	23626251	530220	529879	rs1555459927	NC_000016.10:23626250:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2732C>G (p.Thr911Ser)	PALB2	T911S	Hereditary cancer-predisposing syndrome	VCV000920727	16	23637573	16	23626252	920727	913618	rs180177123	NC_000016.10:23626251:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2732C>A (p.Thr911Asn)	PALB2	T911N	not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000482014	16	23637573	16	23626252	482014	477584	rs180177123	NC_000016.10:23626251:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2732C>T (p.Thr911Ile)	PALB2	T911I	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126676	16	23637573	16	23626252	126676	132186	rs180177123	NC_000016.10:23626251:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2730T>C (p.Tyr910=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV001136238	16	23637575	16	23626254	1136238	1125113	rs995629797	NC_000016.10:23626253:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2730T>A (p.Tyr910Ter)	PALB2	Y910*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not provided	VCV000410165	16	23637575	16	23626254	410165	401064	rs995629797	NC_000016.10:23626253:A:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2728T>C (p.Tyr910His)	PALB2	Y910H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001479436	16	23637577	16	23626256	1479436	1439159	rs2142353327	NC_000016.10:23626255:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2727T>G (p.Leu909=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000796616	16	23637578	16	23626257	796616	785218	rs1597084949	NC_000016.10:23626256:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2725C>G (p.Leu909Val)	PALB2	L909V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410116	16	23637580	16	23626259	410116	401744	rs1060502739	NC_000016.10:23626258:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 6, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2724A>C (p.Lys908Asn)	PALB2	K312N, K613N, K86N, K884N, K888N, K908N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003413470	16	23637581	16	23626260	3413470	3574693		NC_000016.10:23626259:T:G	single nucleotide variant	missense variant|intron variant	Likely benign	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2724A>T (p.Lys908Asn)	PALB2	K908N	Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530036	16	23637581	16	23626260	530036	529811	rs1555459932	NC_000016.10:23626259:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2722A>C (p.Lys908Gln)	PALB2	K908Q	Familial cancer of breast	VCV001022006	16	23637583	16	23626262	1022006	1012026	rs1966842344	NC_000016.10:23626261:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2721A>T (p.Glu907Asp)	PALB2	E887D, E311D, E612D, E907D, E85D, E883D	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3	VCV003891900	16	23637584	16	23626263	3891900	4007789		NC_000016.10:23626262:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 17, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2721A>G (p.Glu907=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000821714	16	23637584	16	23626263	821714	812685	rs1597084962	NC_000016.10:23626262:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 27, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2720A>C (p.Glu907Ala)	PALB2	E311A, E612A, E85A, E907A, E883A, E887A	Hereditary cancer-predisposing syndrome	VCV003927454	16	23637585	16	23626264	3927454	4047087		NC_000016.10:23626263:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 31, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2720A>G (p.Glu907Gly)	PALB2	E907G	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410156	16	23637585	16	23626264	410156	401028	rs45504298	NC_000016.10:23626263:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2719G>A (p.Glu907Lys)	PALB2	E907K	not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484182	16	23637586	16	23626265	484182	477527	rs1555459933	NC_000016.10:23626264:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2718G>A (p.Trp906Ter)	PALB2	W906*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary breast ovarian cancer syndrome|not provided	VCV000126675	16	23637587	16	23626266	126675	132185	rs180177122	NC_000016.10:23626265:C:T	single nucleotide variant	nonsense	Pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2717G>A (p.Trp906Ter)	PALB2	W310*, W611*, W84*, W882*, W886*, W906*	Familial cancer of breast	VCV002189976	16	23637588	16	23626267	2189976	1918726	rs2142353580	NC_000016.10:23626266:C:T	single nucleotide variant	nonsense	Pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2716T>G (p.Trp906Gly)	PALB2	W906G	Familial cancer of breast	VCV000936625	16	23637589	16	23626268	936625	937360	rs587782815	NC_000016.10:23626267:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2716T>C (p.Trp906Arg)	PALB2	W906R	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000142914	16	23637589	16	23626268	142914	152628	rs587782815	NC_000016.10:23626267:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2715G>C (p.Gln905His)	PALB2	Q309H, Q881H, Q885H, Q905H, Q610H, Q83H	Hereditary cancer-predisposing syndrome	VCV003885228	16	23637590	16	23626269	3885228	4005550		NC_000016.10:23626268:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 2, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2715G>A (p.Gln905=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492196	16	23637590	16	23626269	492196	484732	rs1555459937	NC_000016.10:23626268:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2714A>G (p.Gln905Arg)	PALB2	Q309R, Q610R, Q83R, Q881R, Q885R, Q905R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001719711	16	23637591	16	23626270	1719711	1772367	rs2142353649	NC_000016.10:23626269:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2713C>A (p.Gln905Lys)	PALB2	Q905K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460955	16	23637592	16	23626271	460955	466196	rs1555459939	NC_000016.10:23626270:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2712G>A (p.Trp904Ter)	PALB2	W904*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000141053	16	23637593	16	23626272	141053	150767	rs587781457	NC_000016.10:23626271:C:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2711G>A (p.Trp904Ter)	PALB2	W904*	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000410087	16	23637594	16	23626273	410087	401513	rs1060502726	NC_000016.10:23626272:C:T	single nucleotide variant	nonsense	Pathogenic	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2710T>G (p.Trp904Gly)	PALB2	W308G, W609G, W884G, W904G, W82G, W880G	Hereditary cancer-predisposing syndrome	VCV003927467	16	23637595	16	23626274	3927467	4047100		NC_000016.10:23626273:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 19, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2708C>T (p.Ala903Val)	PALB2	A307V, A608V, A81V, A879V, A883V, A903V	Breast-ovarian cancer, familial, susceptibility to, 5	VCV003780088	16	23637597	16	23626276	3780088	3896055		NC_000016.10:23626275:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2707G>A (p.Ala903Thr)	PALB2	A903T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001036981	16	23637598	16	23626277	1036981	1032514	rs1324636666	NC_000016.10:23626276:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 22, 2022	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2707G>C (p.Ala903Pro)	PALB2	A903P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000841940	16	23637598	16	23626277	841940	843574	rs1324636666	NC_000016.10:23626276:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2707G>T (p.Ala903Ser)	PALB2	A903S	Hereditary cancer-predisposing syndrome	VCV000630421	16	23637598	16	23626277	630421	618368	rs1324636666	NC_000016.10:23626276:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2706T>C (p.Asp902=)	PALB2		Familial cancer of breast	VCV000460954	16	23637599	16	23626278	460954	466169	rs1555459944	NC_000016.10:23626277:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 30, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2705A>T (p.Asp902Val)	PALB2	D902V	Hereditary cancer-predisposing syndrome	VCV000140983	16	23637600	16	23626279	140983	150697	rs587781415	NC_000016.10:23626278:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2014	criteria provided, single submitter							
NM_024675.4(PALB2):c.2703G>C (p.Leu901=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003413456	16	23637602	16	23626281	3413456	3574679		NC_000016.10:23626280:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2703G>A (p.Leu901=)	PALB2		Familial cancer of breast	VCV001609320	16	23637602	16	23626281	1609320	1638833	rs1278315369	NC_000016.10:23626280:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2702T>C (p.Leu901Pro)	PALB2	L901P	Familial cancer of breast	VCV001525896	16	23637603	16	23626282	1525896	1395952	rs2142353922	NC_000016.10:23626281:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2701C>G (p.Leu901Val)	PALB2	L901V	Hereditary cancer-predisposing syndrome	VCV000186534	16	23637604	16	23626283	186534	184184	rs786203022	NC_000016.10:23626282:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2014	criteria provided, single submitter							
NM_024675.4(PALB2):c.2699C>G (p.Ala900Gly)	PALB2	A900G, A304G, A876G, A880G, A605G, A78G	Familial cancer of breast	VCV002761268	16	23637606	16	23626285	2761268	2925034	rs730881890	NC_000016.10:23626284:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2699C>T (p.Ala900Val)	PALB2	A900V	Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Familial cancer of breast	VCV000182769	16	23637606	16	23626285	182769	180719	rs730881890	NC_000016.10:23626284:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 28, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2698G>C (p.Ala900Pro)	PALB2	A900P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000570425	16	23637607	16	23626286	570425	570167	rs1555459946	NC_000016.10:23626285:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 3, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2698G>A (p.Ala900Thr)	PALB2	A900T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460953	16	23637607	16	23626286	460953	466399	rs1555459946	NC_000016.10:23626285:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2697A>G (p.Lys899=)	PALB2		Familial cancer of breast	VCV003903694	16	23637608	16	23626287	3903694	4019567		NC_000016.10:23626286:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2697A>T (p.Lys899Asn)	PALB2	K899N, K303N, K875N, K879N, K604N, K77N	Familial cancer of breast	VCV003656545	16	23637608	16	23626287	3656545	3779355		NC_000016.10:23626286:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2695A>C (p.Lys899Gln)	PALB2	K879Q, K303Q, K77Q, K875Q, K899Q, K604Q	Familial cancer of breast	VCV002848653	16	23637610	16	23626289	2848653	3015550	rs2506370492	NC_000016.10:23626288:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2694G>T (p.Trp898Cys)	PALB2	W302C, W603C, W878C, W76C, W874C, W898C	Hereditary cancer-predisposing syndrome	VCV003927433	16	23637611	16	23626290	3927433	4047066		NC_000016.10:23626289:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 12, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2694G>A (p.Trp898Ter)	PALB2	W898*	Familial cancer of breast	VCV000530097	16	23637611	16	23626290	530097	529816	rs1555459949	NC_000016.10:23626289:C:T	single nucleotide variant	nonsense	Pathogenic	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2693G>T (p.Trp898Leu)	PALB2	W874L, W302L, W603L, W76L, W878L, W898L	Familial cancer of breast	VCV002012602	16	23637612	16	23626291	2012602	2064108	rs876658983	NC_000016.10:23626290:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2693G>A (p.Trp898Ter)	PALB2	W898*	Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Familial cancer of breast	VCV000231147	16	23637612	16	23626291	231147	235205	rs876658983	NC_000016.10:23626290:C:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Apr 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2692T>C (p.Trp898Arg)	PALB2	W898R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000662356	16	23637613	16	23626292	662356	644410	rs776016200	NC_000016.10:23626291:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2690T>C (p.Leu897Pro)	PALB2	L897P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000951464	16	23637615	16	23626294	951464	927711	rs876660377	NC_000016.10:23626293:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2690T>G (p.Leu897Arg)	PALB2	L897R	Hereditary cancer-predisposing syndrome	VCV000233395	16	23637615	16	23626294	233395	235206	rs876660377	NC_000016.10:23626293:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2689C>T (p.Leu897Phe)	PALB2	L897F	Hereditary cancer-predisposing syndrome	VCV000821665	16	23637616	16	23626295	821665	812686	rs761739493	NC_000016.10:23626294:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2687C>T (p.Ser896Phe)	PALB2	S896F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001393373	16	23637618	16	23626297	1393373	1399225	rs1597085085	NC_000016.10:23626296:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2687C>G (p.Ser896Cys)	PALB2	S896C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000821664	16	23637618	16	23626297	821664	812687	rs1597085085	NC_000016.10:23626296:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2686T>C (p.Ser896Pro)	PALB2	S896P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000922037	16	23637619	16	23626298	922037	913619	rs1966842504	NC_000016.10:23626297:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2683G>A (p.Val895Ile)	PALB2	V871I, V875I, V299I, V73I, V895I, V600I	Hereditary cancer-predisposing syndrome	VCV001794700	16	23637622	16	23626301	1794700	1852445	rs1597085101	NC_000016.10:23626300:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2683G>T (p.Val895Phe)	PALB2	V895F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000646015	16	23637622	16	23626301	646015	644411	rs1597085101	NC_000016.10:23626300:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2682A>C (p.Val894=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000753211	16	23637623	16	23626302	753211	770770	rs1555459959	NC_000016.10:23626301:T:G	single nucleotide variant	synonymous variant	Likely benign	Mar 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2682A>G (p.Val894=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480278	16	23637623	16	23626302	480278	477529	rs1555459959	NC_000016.10:23626301:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2680G>C (p.Val894Leu)	PALB2	V599L, V870L, V72L, V874L, V298L, V894L	Hereditary cancer-predisposing syndrome	VCV002567578	16	23637625	16	23626304	2567578	2731220	rs1483164486	NC_000016.10:23626303:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2679T>C (p.Asp893=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000757941	16	23637626	16	23626305	757941	770771	rs1597085114	NC_000016.10:23626304:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2678A>G (p.Asp893Gly)	PALB2	D893G	Familial cancer of breast	VCV001045297	16	23637627	16	23626306	1045297	1032515	rs1060502783	NC_000016.10:23626305:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2678A>T (p.Asp893Val)	PALB2	D893V	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000619887	16	23637627	16	23626306	619887	611217	rs1060502783	NC_000016.10:23626305:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2678A>C (p.Asp893Ala)	PALB2	D893A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410182	16	23637627	16	23626306	410182	401516	rs1060502783	NC_000016.10:23626305:T:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2677G>C (p.Asp893His)	PALB2	D297H, D869H, D598H, D71H, D873H, D893H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002107067	16	23637628	16	23626307	2107067	2170121	rs765077104	NC_000016.10:23626306:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2677G>T (p.Asp893Tyr)	PALB2	D893Y	not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410135	16	23637628	16	23626307	410135	401070	rs765077104	NC_000016.10:23626306:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2676A>G (p.Glu892=)	PALB2		Familial cancer of breast	VCV000955139	16	23637629	16	23626308	955139	949306	rs1966842547	NC_000016.10:23626307:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2674G>T (p.Glu892Ter)	PALB2	E892*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Inherited breast cancer and ovarian cancer	VCV000233122	16	23637631	16	23626310	233122	235207	rs45476495	NC_000016.10:23626309:C:A	single nucleotide variant	nonsense	Pathogenic	Feb 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2674G>A (p.Glu892Lys)	PALB2	E892K	not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|not provided|Familial cancer of breast	VCV000126672	16	23637631	16	23626310	126672	132182	rs45476495	NC_000016.10:23626309:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2673C>G (p.Cys891Trp)	PALB2	C295W, C596W, C69W, C867W, C871W, C891W	Familial pancreatic carcinoma	VCV003780087	16	23637632	16	23626311	3780087	3896054		NC_000016.10:23626310:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2673C>A (p.Cys891Ter)	PALB2	C891*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492195	16	23637632	16	23626311	492195	484982	rs78179744	NC_000016.10:23626310:G:T	single nucleotide variant	nonsense	Pathogenic	Jun 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2673C>T (p.Cys891=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|not specified|Familial cancer of breast	VCV000230867	16	23637632	16	23626311	230867	235208	rs78179744	NC_000016.10:23626310:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2671T>C (p.Cys891Arg)	PALB2	C69R, C871R, C891R, C867R, C295R, C596R	Familial cancer of breast	VCV002054257	16	23637634	16	23626313	2054257	2116007	rs786204208	NC_000016.10:23626312:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2671T>A (p.Cys891Ser)	PALB2	C891S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000188308	16	23637634	16	23626313	188308	186214	rs786204208	NC_000016.10:23626312:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2670T>C (p.Ala890=)	PALB2		Familial cancer of breast	VCV001621939	16	23637635	16	23626314	1621939	1593142	rs1597085149	NC_000016.10:23626313:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2670T>A (p.Ala890=)	PALB2		Familial cancer of breast	VCV000795347	16	23637635	16	23626314	795347	785219	rs1597085149	NC_000016.10:23626313:A:T	single nucleotide variant	synonymous variant	Likely benign	Jun 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2669C>G (p.Ala890Gly)	PALB2	A294G, A595G, A68G, A866G, A870G, A890G	Hereditary cancer-predisposing syndrome	VCV003228017	16	23637636	16	23626315	3228017	3387786	rs1966842597	NC_000016.10:23626314:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2669C>T (p.Ala890Val)	PALB2	A890V	Familial cancer of breast	VCV001020026	16	23637636	16	23626315	1020026	1012027	rs1966842597	NC_000016.10:23626314:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2668G>C (p.Ala890Pro)	PALB2	A890P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000581155	16	23637637	16	23626316	581155	573919	rs1555459971	NC_000016.10:23626315:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2668G>A (p.Ala890Thr)	PALB2	A890T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486011	16	23637637	16	23626316	486011	477489	rs1555459971	NC_000016.10:23626315:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2667T>A (p.Thr889=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N	VCV000231558	16	23637638	16	23626317	231558	235209	rs876659224	NC_000016.10:23626316:A:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2666C>G (p.Thr889Ser)	PALB2	T293S, T594S, T67S, T865S, T869S, T889S	Hereditary cancer-predisposing syndrome	VCV003228016	16	23637639	16	23626318	3228016	3387785	rs2142354728	NC_000016.10:23626317:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2666C>T (p.Thr889Ile)	PALB2	T889I	Familial cancer of breast	VCV001502869	16	23637639	16	23626318	1502869	1404462	rs2142354728	NC_000016.10:23626317:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2665A>G (p.Thr889Ala)	PALB2	T889A	Familial cancer of breast	VCV001045730	16	23637640	16	23626319	1045730	1032516	rs1966842608	NC_000016.10:23626318:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2663T>C (p.Ile888Thr)	PALB2	I292T, I593T, I66T, I864T, I868T, I888T	Familial cancer of breast|not provided	VCV002646325	16	23637642	16	23626321	2646325	2807740	rs2142354807	NC_000016.10:23626320:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2662A>C (p.Ile888Leu)	PALB2	I888L	Hereditary cancer-predisposing syndrome	VCV000922032	16	23637643	16	23626322	922032	913620	rs786202468	NC_000016.10:23626321:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2662A>G (p.Ile888Val)	PALB2	I888V	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000801239	16	23637643	16	23626322	801239	789601	rs786202468	NC_000016.10:23626321:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2662A>T (p.Ile888Leu)	PALB2	I888L	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000185801	16	23637643	16	23626322	185801	184185	rs786202468	NC_000016.10:23626321:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2661C>G (p.Ile887Met)	PALB2	I65M, I867M, I291M, I592M, I863M, I887M	Hereditary cancer-predisposing syndrome	VCV002587408	16	23637644	16	23626323	2587408	2754084	rs180177120	NC_000016.10:23626322:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2661C>T (p.Ile887=)	PALB2		Familial cancer of breast	VCV001569209	16	23637644	16	23626323	1569209	1603757	rs180177120	NC_000016.10:23626322:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2660T>A (p.Ile887Asn)	PALB2	I291N, I592N, I65N, I863N, I867N, I887N	Hereditary cancer-predisposing syndrome	VCV001794445	16	23637645	16	23626324	1794445	1852191	rs45550935	NC_000016.10:23626323:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2660T>G (p.Ile887Ser)	PALB2	I887S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484201	16	23637645	16	23626324	484201	477493	rs45550935	NC_000016.10:23626323:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2659A>G (p.Ile887Val)	PALB2	I887V	Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000576302	16	23637646	16	23626325	576302	570169	rs533814557	NC_000016.10:23626324:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2658T>A (p.Cys886Ter)	PALB2	C290*, C591*, C64*, C862*, C866*, C886*	Familial cancer of breast	VCV002674050	16	23637647	16	23626326	2674050	2841541	rs2142354911	NC_000016.10:23626325:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2656T>C (p.Cys886Arg)	PALB2	C886R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000565851	16	23637649	16	23626328	565851	570171	rs1555459977	NC_000016.10:23626327:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2656T>A (p.Cys886Ser)	PALB2	C886S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484187	16	23637649	16	23626328	484187	478069	rs1555459977	NC_000016.10:23626327:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2655A>G (p.Pro885=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000391506	16	23637650	16	23626329	391506	374923	rs1057524113	NC_000016.10:23626328:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2654C>T (p.Pro885Leu)	PALB2	P289L, P590L, P63L, P861L, P865L, P885L	Hereditary cancer-predisposing syndrome	VCV003228015	16	23637651	16	23626330	3228015	3387784	rs2142355016	NC_000016.10:23626329:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2653C>T (p.Pro885Ser)	PALB2	P289S, P590S, P63S, P861S, P865S, P885S	Inherited breast cancer and ovarian cancer|Hereditary cancer-predisposing syndrome	VCV003228014	16	23637652	16	23626331	3228014	3387783	rs878855111	NC_000016.10:23626330:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 17, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2653C>A (p.Pro885Thr)	PALB2	P885T	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000241549	16	23637652	16	23626331	241549	242359	rs878855111	NC_000016.10:23626330:G:T	single nucleotide variant	missense variant	Uncertain significance	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2652G>A (p.Glu884=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000387647	16	23637653	16	23626332	387647	375253	rs1057522856	NC_000016.10:23626331:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2651A>C (p.Glu884Ala)	PALB2	E288A, E62A, E860A, E884A, E589A, E864A	Familial cancer of breast	VCV002857497	16	23637654	16	23626333	2857497	3021394	rs2142355108	NC_000016.10:23626332:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2650G>A (p.Glu884Lys)	PALB2	E884K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000925785	16	23637655	16	23626334	925785	913621	rs1304351755	NC_000016.10:23626333:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2650G>T (p.Glu884Ter)	PALB2	E884*	Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000530158	16	23637655	16	23626334	530158	529818	rs1304351755	NC_000016.10:23626333:C:A	single nucleotide variant	nonsense	Pathogenic	Apr 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2650G>C (p.Glu884Gln)	PALB2	E884Q	Familial cancer of breast	VCV000530066	16	23637655	16	23626334	530066	530348	rs1304351755	NC_000016.10:23626333:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2649A>G (p.Lys883=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000186414	16	23637656	16	23626335	186414	184186	rs786202932	NC_000016.10:23626334:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2647A>T (p.Lys883Ter)	PALB2	K287*, K588*, K61*, K859*, K863*, K883*	Familial cancer of breast	VCV002674135	16	23637658	16	23626337	2674135	2841625	rs1966842668	NC_000016.10:23626336:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2647A>G (p.Lys883Glu)	PALB2	K883E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001007192	16	23637658	16	23626337	1007192	996792	rs1966842668	NC_000016.10:23626336:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2646T>G (p.Cys882Trp)	PALB2	C882W	Hereditary cancer-predisposing syndrome	VCV001172072	16	23637659	16	23626338	1172072	1161314	rs1966842673	NC_000016.10:23626337:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2645G>A (p.Cys882Tyr)	PALB2	C882Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001001911	16	23637660	16	23626339	1001911	996793	rs45486906	NC_000016.10:23626338:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2645G>C (p.Cys882Ser)	PALB2	C882S	Hereditary cancer-predisposing syndrome	VCV000924364	16	23637660	16	23626339	924364	913622	rs45486906	NC_000016.10:23626338:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2645G>T (p.Cys882Phe)	PALB2	C882F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000581150	16	23637660	16	23626339	581150	573924	rs45486906	NC_000016.10:23626338:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2644T>C (p.Cys882Arg)	PALB2	C882R	Hereditary cancer-predisposing syndrome	VCV000922412	16	23637661	16	23626340	922412	913623	rs1966842679	NC_000016.10:23626339:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2643T>C (p.Gly881=)	PALB2		Familial cancer of breast	VCV003903708	16	23637662	16	23626341	3903708	4019581		NC_000016.10:23626340:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2642G>C (p.Gly881Ala)	PALB2	G285A, G59A, G861A, G586A, G857A, G881A	Familial cancer of breast	VCV002720314	16	23637663	16	23626342	2720314	2880825	rs772499138	NC_000016.10:23626341:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2642G>A (p.Gly881Asp)	PALB2	G881D	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000460952	16	23637663	16	23626342	460952	466176	rs772499138	NC_000016.10:23626341:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2641G>T (p.Gly881Cys)	PALB2	G857C, G586C, G59C, G861C, G881C, G285C	Hereditary cancer-predisposing syndrome	VCV003413442	16	23637664	16	23626343	3413442	3574665		NC_000016.10:23626342:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2641G>C (p.Gly881Arg)	PALB2	G285R, G586R, G59R, G857R, G861R, G881R	Hereditary cancer-predisposing syndrome	VCV003228013	16	23637664	16	23626343	3228013	3387782	rs766315705	NC_000016.10:23626342:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2641G>A (p.Gly881Ser)	PALB2	G881S	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000460951	16	23637664	16	23626343	460951	466178	rs766315705	NC_000016.10:23626342:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2640C>G (p.Ala880=)	PALB2		Familial cancer of breast	VCV000830177	16	23637665	16	23626344	830177	818475	rs752928633	NC_000016.10:23626343:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2640C>A (p.Ala880=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000821616	16	23637665	16	23626344	821616	812688	rs752928633	NC_000016.10:23626343:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2640C>T (p.Ala880=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3	VCV000215932	16	23637665	16	23626344	215932	213163	rs752928633	NC_000016.10:23626343:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2639C>A (p.Ala880Asp)	PALB2	A880D	Familial cancer of breast	VCV000658731	16	23637666	16	23626345	658731	644412	rs1597085237	NC_000016.10:23626344:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2638G>A (p.Ala880Thr)	PALB2	A880T	Familial cancer of breast	VCV000946773	16	23637667	16	23626346	946773	927712	rs1966842713	NC_000016.10:23626345:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2635A>T (p.Arg879Ter)	PALB2	R859*, R879*, R283*, R584*, R57*, R855*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001794108	16	23637670	16	23626349	1794108	1842388	rs1555459994	NC_000016.10:23626348:T:A	single nucleotide variant	nonsense	Pathogenic	Jun 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2635A>G (p.Arg879Gly)	PALB2	R879G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484226	16	23637670	16	23626349	484226	477588	rs1555459994	NC_000016.10:23626348:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2634A>G (p.Glu878=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003885203	16	23637671	16	23626350	3885203	4005525		NC_000016.10:23626349:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2632G>T (p.Glu878Ter)	PALB2	E878*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484176	16	23637673	16	23626352	484176	477589	rs1555459999	NC_000016.10:23626351:C:A	single nucleotide variant	nonsense	Pathogenic	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2631G>A (p.Trp877Ter)	PALB2	W877*	Familial cancer of breast	VCV001074369	16	23637674	16	23626353	1074369	1063577	rs2142355636	NC_000016.10:23626352:C:T	single nucleotide variant	nonsense	Pathogenic	Jul 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2630G>T (p.Trp877Leu)	PALB2	W877L, W582L, W281L, W853L, W55L, W857L	Hereditary cancer-predisposing syndrome	VCV003885224	16	23637675	16	23626354	3885224	4005546		NC_000016.10:23626353:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2630G>A (p.Trp877Ter)	PALB2	W877*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000233842	16	23637675	16	23626354	233842	235211	rs876660678	NC_000016.10:23626353:C:T	single nucleotide variant	nonsense	Pathogenic	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2629T>G (p.Trp877Gly)	PALB2	W281G, W55G, W582G, W857G, W853G, W877G	Hereditary cancer-predisposing syndrome	VCV003927466	16	23637676	16	23626355	3927466	4047099		NC_000016.10:23626354:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2629T>C (p.Trp877Arg)	PALB2	W877R	Familial cancer of breast	VCV000830176	16	23637676	16	23626355	830176	818476	rs1966842747	NC_000016.10:23626354:A:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2628T>C (p.Phe876=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460950	16	23637677	16	23626356	460950	466410	rs876659584	NC_000016.10:23626355:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2628T>G (p.Phe876Leu)	PALB2	F876L	Hereditary cancer-predisposing syndrome	VCV000232145	16	23637677	16	23626356	232145	235212	rs876659584	NC_000016.10:23626355:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.2625G>A (p.Met875Ile)	PALB2	M875I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000861476	16	23637680	16	23626359	861476	843575	rs1966842758	NC_000016.10:23626358:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2624T>A (p.Met875Lys)	PALB2	M875K	Hereditary cancer-predisposing syndrome	VCV000923485	16	23637681	16	23626360	923485	913624	rs878855110	NC_000016.10:23626359:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2624T>C (p.Met875Thr)	PALB2	M875T	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000241548	16	23637681	16	23626360	241548	242360	rs878855110	NC_000016.10:23626359:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2623A>G (p.Met875Val)	PALB2	M875V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000662060	16	23637682	16	23626361	662060	644413	rs1060502750	NC_000016.10:23626360:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2623A>T (p.Met875Leu)	PALB2	M875L	Familial cancer of breast	VCV000410130	16	23637682	16	23626361	410130	401082	rs1060502750	NC_000016.10:23626360:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2622C>T (p.Ala874=)	PALB2		Familial cancer of breast	VCV003650712	16	23637683	16	23626362	3650712	3781442		NC_000016.10:23626361:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2621C>A (p.Ala874Asp)	PALB2	A874D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480294	16	23637684	16	23626363	480294	477530	rs1440952139	NC_000016.10:23626362:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2620G>A (p.Ala874Thr)	PALB2	A278T, A52T, A579T, A850T, A854T, A874T	Breast-ovarian cancer, familial, susceptibility to, 5	VCV002683910	16	23637685	16	23626364	2683910	2844947	rs2142355885	NC_000016.10:23626363:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2620G>T (p.Ala874Ser)	PALB2	A854S, A579S, A52S, A278S, A850S, A874S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001793949	16	23637685	16	23626364	1793949	1842229	rs2142355885	NC_000016.10:23626363:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2619T>A (p.Ser873Arg)	PALB2	S873R	Hereditary cancer-predisposing syndrome	VCV000482062	16	23637686	16	23626365	482062	477592	rs587782387	NC_000016.10:23626364:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2619T>G (p.Ser873Arg)	PALB2	S873R	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000142328	16	23637686	16	23626365	142328	152042	rs587782387	NC_000016.10:23626364:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2616G>T (p.Val872=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000632931	16	23637689	16	23626368	632931	621530	rs1567215519	NC_000016.10:23626367:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2615T>C (p.Val872Ala)	PALB2	V872A	not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000182755	16	23637690	16	23626369	182755	180721	rs730881877	NC_000016.10:23626368:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2614G>A (p.Val872Met)	PALB2	V872M	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000419080	16	23637691	16	23626370	419080	409530	rs1064793628	NC_000016.10:23626369:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2613T>C (p.Asp871=)	PALB2		Familial cancer of breast	VCV002842979	16	23637692	16	23626371	2842979	2993851	rs1555460011	NC_000016.10:23626370:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2613T>A (p.Asp871Glu)	PALB2	D871E	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480276	16	23637692	16	23626371	480276	477494	rs1555460011	NC_000016.10:23626370:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2612A>T (p.Asp871Val)	PALB2	D871V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530168	16	23637693	16	23626372	530168	530128	rs515726090	NC_000016.10:23626371:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2612A>G (p.Asp871Gly)	PALB2	D871G	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000126670	16	23637693	16	23626372	126670	132180	rs515726090	NC_000016.10:23626371:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2611G>A (p.Asp871Asn)	PALB2	D275N, D49N, D576N, D847N, D851N, D871N	Familial cancer of breast	VCV003615740	16	23637694	16	23626373	3615740	3749571		NC_000016.10:23626372:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2610A>G (p.Val870=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003894456	16	23637695	16	23626374	3894456	4010336		NC_000016.10:23626373:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2609T>G (p.Val870Gly)	PALB2	V870G	Familial cancer of breast	VCV001521467	16	23637696	16	23626375	1521467	1347362	rs876659819	NC_000016.10:23626374:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2609T>C (p.Val870Ala)	PALB2	V870A	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000232522	16	23637696	16	23626375	232522	235213	rs876659819	NC_000016.10:23626374:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2608G>C (p.Val870Leu)	PALB2	V870L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000652162	16	23637697	16	23626376	652162	644414	rs376641234	NC_000016.10:23626375:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2608G>T (p.Val870Leu)	PALB2	V870L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460949	16	23637697	16	23626376	460949	466187	rs376641234	NC_000016.10:23626375:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2608G>A (p.Val870Ile)	PALB2	V870I	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000142746	16	23637697	16	23626376	142746	152460	rs376641234	NC_000016.10:23626375:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2607C>G (p.Ser869=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003228012	16	23637698	16	23626377	3228012	3387781	rs45542234	NC_000016.10:23626376:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2607C>A (p.Ser869=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000182747	16	23637698	16	23626377	182747	180722	rs45542234	NC_000016.10:23626376:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2607C>T (p.Ser869=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|not specified	VCV000136135	16	23637698	16	23626377	136135	139847	rs45542234	NC_000016.10:23626376:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2606C>A (p.Ser869Tyr)	PALB2	S869Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480245	16	23637699	16	23626378	480245	477595	rs779279139	NC_000016.10:23626377:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2606C>T (p.Ser869Phe)	PALB2	S869F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|not provided	VCV000420725	16	23637699	16	23626378	420725	409531	rs779279139	NC_000016.10:23626377:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2606C>G (p.Ser869Cys)	PALB2	S869C	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000225855	16	23637699	16	23626378	225855	227665	rs779279139	NC_000016.10:23626377:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2605T>C (p.Ser869Pro)	PALB2	S869P	Familial cancer of breast	VCV001396415	16	23637700	16	23626379	1396415	1418166	rs2142356352	NC_000016.10:23626378:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2604T>A (p.Cys868Ter)	PALB2	C272*, C46*, C573*, C844*, C848*, C868*	Familial cancer of breast	VCV002674083	16	23637701	16	23626380	2674083	2841573	rs2142356386	NC_000016.10:23626379:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2604T>C (p.Cys868=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001793714	16	23637701	16	23626380	1793714	1845839	rs2142356386	NC_000016.10:23626379:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2603G>A (p.Cys868Tyr)	PALB2	C868Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530091	16	23637702	16	23626381	530091	529820	rs772398814	NC_000016.10:23626380:C:T	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2602T>C (p.Cys868Arg)	PALB2	C868R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000821557	16	23637703	16	23626382	821557	812689	rs1555460026	NC_000016.10:23626381:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2602T>G (p.Cys868Gly)	PALB2	C868G	Familial cancer of breast	VCV000460948	16	23637703	16	23626382	460948	466189	rs1555460026	NC_000016.10:23626381:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2601C>T (p.Ser867=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000184006	16	23637704	16	23626383	184006	184187	rs786201218	NC_000016.10:23626382:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2600C>G (p.Ser867Cys)	PALB2	S867C	Familial cancer of breast	VCV001447606	16	23637705	16	23626384	1447606	1403493	rs2142356460	NC_000016.10:23626383:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2599T>C (p.Ser867Pro)	PALB2	S572P, S843P, S867P, S45P, S847P, S271P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001793607	16	23637706	16	23626385	1793607	1845732	rs2142356482	NC_000016.10:23626384:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2598T>C (p.Gly866=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001793595	16	23637707	16	23626386	1793595	1845720	rs1966842870	NC_000016.10:23626385:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 5, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2597G>T (p.Gly866Val)	PALB2	G866V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000188058	16	23637708	16	23626387	188058	186215	rs62625279	NC_000016.10:23626386:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2597G>A (p.Gly866Asp)	PALB2	G866D	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000186848	16	23637708	16	23626387	186848	184188	rs62625279	NC_000016.10:23626386:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2596G>A (p.Gly866Ser)	PALB2	G866S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001019265	16	23637709	16	23626388	1019265	1012028	rs780415750	NC_000016.10:23626387:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2596G>T (p.Gly866Cys)	PALB2	G866C	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000460947	16	23637709	16	23626388	460947	465455	rs780415750	NC_000016.10:23626387:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2595A>G (p.Ser865=)	PALB2		Familial cancer of breast	VCV001154549	16	23637710	16	23626389	1154549	1146005	rs1597085400	NC_000016.10:23626388:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2595A>T (p.Ser865=)	PALB2		Familial cancer of breast	VCV000749008	16	23637710	16	23626389	749008	755027	rs1597085400	NC_000016.10:23626388:T:A	single nucleotide variant	synonymous variant	Uncertain significance	Sep 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2594C>G (p.Ser865Ter)	PALB2	S865*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000241547	16	23637711	16	23626390	241547	242361	rs746604683	NC_000016.10:23626389:G:C	single nucleotide variant	nonsense	Pathogenic	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2592T>C (p.Pro864=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000821456	16	23637713	16	23626392	821456	812690	rs1597085410	NC_000016.10:23626391:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2591C>T (p.Pro864Leu)	PALB2	P268L, P844L, P569L, P864L, P42L, P840L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002453295	16	23637714	16	23626393	2453295	2430355	rs2142356686	NC_000016.10:23626392:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2591C>A (p.Pro864His)	PALB2	P864H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001691947	16	23637714	16	23626393	1691947	1684389	rs2142356686	NC_000016.10:23626392:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2590C>A (p.Pro864Thr)	PALB2	P864T	Familial cancer of breast	VCV000572654	16	23637715	16	23626394	572654	567953	rs45568339	NC_000016.10:23626393:G:T	single nucleotide variant	missense variant	Uncertain significance	May 2, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2590C>T (p.Pro864Ser)	PALB2	P864S	Breast and/or ovarian cancer|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|not provided|not specified|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000126669	16	23637715	16	23626394	126669	132179	rs45568339	NC_000016.10:23626393:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Apr 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2588A>C (p.Asn863Thr)	PALB2	N267T, N41T, N843T, N568T, N839T, N863T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002453284	16	23637717	16	23626396	2453284	2430344	rs2142356743	NC_000016.10:23626395:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587A>G (p.Asn863Asp)	PALB2	N863D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000837393	16	23637718	16	23626397	837393	843576	rs776407568	NC_000016.10:23626396:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587-1G>A	PALB2		Familial cancer of breast	VCV002673823	16	23637719	16	23626398	2673823	2841327	rs761214886	NC_000016.10:23626397:C:T	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Sep 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-1G>C	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000584905	16	23637719	16	23626398	584905	575961	rs761214886	NC_000016.10:23626397:C:G	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications							
NC_000016.10:g.23626399T>C	PALB2		Familial cancer of breast	VCV001513849	16	23637720	16	23626399	1513849	622658	rs1060502787	NC_000016.10:23626398:T:C	single nucleotide variant		Conflicting classifications of pathogenicity	Sep 13, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2587-2A>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410189	16	23637720	16	23626399	410189	401749	rs1060502787	NC_000016.10:23626398:T:G	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Sep 13, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2587-3C>T	PALB2		Hereditary cancer-predisposing syndrome	VCV001793436	16	23637721	16	23626400	1793436	1848949	rs1264528297	NC_000016.10:23626399:G:A	single nucleotide variant	intron variant	Uncertain significance	May 2, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-4T>C	PALB2		Familial cancer of breast	VCV001136734	16	23637722	16	23626401	1136734	1125114	rs1597085437	NC_000016.10:23626400:A:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-4T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000821529	16	23637722	16	23626401	821529	815628	rs1597085437	NC_000016.10:23626400:A:C	single nucleotide variant	intron variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-5G>A	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000384744	16	23637723	16	23626402	384744	374259	rs1057522036	NC_000016.10:23626401:C:T	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587-6T>C	PALB2		Familial cancer of breast	VCV000569805	16	23637724	16	23626403	569805	567957	rs1567215608	NC_000016.10:23626402:A:G	single nucleotide variant	intron variant	Uncertain significance	May 22, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-7G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000530028	16	23637725	16	23626404	530028	529880	rs932395531	NC_000016.10:23626403:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2587-8T>G	PALB2		Hereditary cancer-predisposing syndrome|PALB2-related cancer predisposition|not provided|Familial cancer of breast	VCV000942775	16	23637726	16	23626405	942775	940356	rs1489345430	NC_000016.10:23626404:A:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2587-8T>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000630759	16	23637726	16	23626405	630759	619477	rs1489345430	NC_000016.10:23626404:A:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587-9T>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000631341	16	23637727	16	23626406	631341	619612	rs1567215613	NC_000016.10:23626405:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2587-10A>T	PALB2		Hereditary cancer-predisposing syndrome	VCV000492192	16	23637728	16	23626407	492192	484990	rs1060504711	NC_000016.10:23626406:T:A	single nucleotide variant	intron variant	Likely benign	Dec 19, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-10A>G	PALB2		Familial cancer of breast	VCV000415988	16	23637728	16	23626407	415988	401751	rs1060504711	NC_000016.10:23626406:T:C	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587-11C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000925995	16	23637729	16	23626408	925995	915940	rs1966842946	NC_000016.10:23626407:G:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587-12C>A	PALB2		Hereditary cancer-predisposing syndrome	VCV002774001	16	23637730	16	23626409	2774001	2934732	rs1266683395	NC_000016.10:23626408:G:T	single nucleotide variant	intron variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-12C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3	VCV001617787	16	23637730	16	23626409	1617787	1614640	rs1266683395	NC_000016.10:23626408:G:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587-13G>C	PALB2		Familial cancer of breast	VCV003904320	16	23637731	16	23626410	3904320	4020192		NC_000016.10:23626409:C:G	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-13G>T	PALB2		Familial cancer of breast	VCV002843228	16	23637731	16	23626410	2843228	2994099	rs2506375640	NC_000016.10:23626409:C:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587-15T>C	PALB2		Familial cancer of breast	VCV002170952	16	23637733	16	23626412	2170952	1903604	rs2142356956	NC_000016.10:23626411:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2587-16G>T	PALB2		Familial cancer of breast	VCV001539528	16	23637734	16	23626413	1539528	1660454	rs1057522563	NC_000016.10:23626412:C:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587-16G>A	PALB2		not specified|Familial cancer of breast	VCV000386651	16	23637734	16	23626413	386651	374269	rs1057522563	NC_000016.10:23626412:C:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587-17T>C	PALB2		Familial cancer of breast	VCV003903675	16	23637735	16	23626414	3903675	4019548		NC_000016.10:23626413:A:G	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-19A>C	PALB2		Familial cancer of breast	VCV003645105	16	23637737	16	23626416	3645105	3783520		NC_000016.10:23626415:T:G	single nucleotide variant	intron variant	Likely benign	Mar 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-19A>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630101	16	23637737	16	23626416	630101	619616	rs1178447858	NC_000016.10:23626415:T:C	single nucleotide variant	intron variant	Likely benign	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2587-20A>T	PALB2		Familial cancer of breast	VCV003904078	16	23637738	16	23626417	3904078	4019951		NC_000016.10:23626416:T:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-22A>G	PALB2		Familial cancer of breast	VCV002677444	16	23637740	16	23626419	2677444	2836315	rs769394881	NC_000016.10:23626418:T:C	single nucleotide variant	intron variant	Uncertain significance	Oct 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-24A>C	PALB2		not specified	VCV002576371	16	23637742	16	23626421	2576371	2741267	rs1049057913	NC_000016.10:23626420:T:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-29C>T	PALB2		not specified	VCV002691968	16	23637747	16	23626426	2691968	2852971	rs766229559	NC_000016.10:23626425:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-38C>G	PALB2		not specified	VCV000126666	16	23637756	16	23626435	126666	132176	rs180177119	NC_000016.10:23626434:G:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-47A>G	PALB2		not specified	VCV001697756	16	23637765	16	23626444	1697756	1690140	rs2142357318	NC_000016.10:23626443:T:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2587-48A>C	PALB2		not specified	VCV001697757	16	23637766	16	23626445	1697757	1690141	rs1260047262	NC_000016.10:23626444:T:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+81C>T	PALB2		Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000126664	16	23640444	16	23629123	126664	132174	rs114710547	NC_000016.10:23629122:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2586+79A>G	PALB2		Hereditary breast ovarian cancer syndrome	VCV001678968	16	23640446	16	23629125	1678968	1670762	rs2142366978	NC_000016.10:23629124:T:C	single nucleotide variant	intron variant	Likely benign	Apr 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+58C>T	PALB2		not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000126663	16	23640467	16	23629146	126663	132173	rs249954	NC_000016.10:23629145:G:A	single nucleotide variant	intron variant	Benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2586+40T>C	PALB2		not specified	VCV001802886	16	23640485	16	23629164	1802886	1859917	rs1236573041	NC_000016.10:23629163:A:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+30G>A	PALB2		Hereditary breast ovarian cancer syndrome|not specified	VCV001678969	16	23640495	16	23629174	1678969	1670763	rs769118926	NC_000016.10:23629173:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2586+27C>T	PALB2		not specified	VCV003765315	16	23640498	16	23629177	3765315	3881484		NC_000016.10:23629176:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+21C>T	PALB2		not specified	VCV003765316	16	23640504	16	23629183	3765316	3881485		NC_000016.10:23629182:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+20C>T	PALB2		Familial cancer of breast	VCV001639720	16	23640505	16	23629184	1639720	1571140	rs2142367431	NC_000016.10:23629183:G:A	single nucleotide variant	intron variant	Likely benign	Mar 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+19T>A	PALB2		Familial cancer of breast	VCV001570924	16	23640506	16	23629185	1570924	1646152	rs2142367445	NC_000016.10:23629184:A:T	single nucleotide variant	intron variant	Likely benign	Jan 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+18T>C	PALB2		Familial cancer of breast	VCV002124538	16	23640507	16	23629186	2124538	2184999	rs1210189291	NC_000016.10:23629185:A:G	single nucleotide variant	intron variant	Likely benign	Apr 11, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+17C>T	PALB2		Familial cancer of breast	VCV003672298	16	23640508	16	23629187	3672298	3805355		NC_000016.10:23629186:G:A	single nucleotide variant	intron variant	Likely benign	Jul 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+15C>G	PALB2		Familial cancer of breast	VCV002861998	16	23640510	16	23629189	2861998	3029360	rs144625889	NC_000016.10:23629188:G:C	single nucleotide variant	intron variant	Likely benign	May 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+15C>A	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000630591	16	23640510	16	23629189	630591	619485	rs144625889	NC_000016.10:23629188:G:T	single nucleotide variant	intron variant	Benign/Likely benign	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2586+12A>G	PALB2		Familial cancer of breast	VCV001566245	16	23640513	16	23629192	1566245	1656183	rs2142367499	NC_000016.10:23629191:T:C	single nucleotide variant	intron variant	Likely benign	Jun 28, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+11T>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492191	16	23640514	16	23629193	492191	484735	rs1555460208	NC_000016.10:23629192:A:G	single nucleotide variant	intron variant	Likely benign	Sep 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2586+10A>C	PALB2		Familial cancer of breast	VCV003727440	16	23640515	16	23629194	3727440	3861665		NC_000016.10:23629193:T:G	single nucleotide variant	intron variant	Likely benign	Dec 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+10A>G	PALB2		Familial cancer of breast|not specified|not provided|Breast and/or ovarian cancer|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome	VCV000126661	16	23640515	16	23629194	126661	132171	rs373321719	NC_000016.10:23629193:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2586+8G>C	PALB2		Familial cancer of breast	VCV001117828	16	23640517	16	23629196	1117828	1103699	rs1060504708	NC_000016.10:23629195:C:G	single nucleotide variant	intron variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2586+8G>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000918824	16	23640517	16	23629196	918824	916422	rs1060504708	NC_000016.10:23629195:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2586+8G>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000415983	16	23640517	16	23629196	415983	401029	rs1060504708	NC_000016.10:23629195:C:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2586+7A>G	PALB2		Familial cancer of breast	VCV001549574	16	23640518	16	23629197	1549574	1637041	rs2142367551	NC_000016.10:23629196:T:C	single nucleotide variant	intron variant	Likely benign	May 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+6A>T	PALB2		Familial cancer of breast	VCV001503886	16	23640519	16	23629198	1503886	1424290	rs1966853543	NC_000016.10:23629197:T:A	single nucleotide variant	intron variant	Uncertain significance	Nov 12, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+6A>G	PALB2		Familial cancer of breast	VCV001006556	16	23640519	16	23629198	1006556	996794	rs1966853543	NC_000016.10:23629197:T:C	single nucleotide variant	intron variant	Uncertain significance	May 6, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+4A>C	PALB2		Familial cancer of breast	VCV002627091	16	23640521	16	23629200	2627091	2794611	rs1966853555	NC_000016.10:23629199:T:G	single nucleotide variant	intron variant	Uncertain significance	Oct 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+4A>T	PALB2		Hereditary cancer-predisposing syndrome	VCV000927993	16	23640521	16	23629200	927993	915942	rs1966853555	NC_000016.10:23629199:T:A	single nucleotide variant	intron variant	Uncertain significance	Sep 4, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+3C>G	PALB2		Familial cancer of breast	VCV000949944	16	23640522	16	23629201	949944	941130	rs1597088078	NC_000016.10:23629200:G:C	single nucleotide variant	intron variant	Uncertain significance	Apr 26, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586+3C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000821525	16	23640522	16	23629201	821525	815629	rs1597088078	NC_000016.10:23629200:G:A	single nucleotide variant	intron variant	Likely benign	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2586+1G>A	PALB2		not provided|Familial cancer of breast	VCV002137799	16	23640524	16	23629203	2137799	1871408	rs1375713365	NC_000016.10:23629202:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2586+1G>T	PALB2		Familial cancer of breast	VCV000949945	16	23640524	16	23629203	949945	941131	rs1375713365	NC_000016.10:23629202:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Apr 26, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2586G>A (p.Lys862=)	PALB2		Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Hereditary cancer-predisposing syndrome	VCV003370311	16	23640525	16	23629204	3370311	3529502		NC_000016.10:23629203:C:T	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2586G>C (p.Lys862Asn)	PALB2	K862N	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast and/or ovarian cancer	VCV000229932	16	23640525	16	23629204	229932	235214	rs876658279	NC_000016.10:23629203:C:G	single nucleotide variant	missense variant	Uncertain significance	May 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2583A>G (p.Leu861=)	PALB2		Familial cancer of breast	VCV003903764	16	23640528	16	23629207	3903764	4019637		NC_000016.10:23629206:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2583A>T (p.Leu861Phe)	PALB2	L861F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001024265	16	23640528	16	23629207	1024265	1012029	rs1966853602	NC_000016.10:23629206:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2582T>G (p.Leu861Ter)	PALB2	L566*, L265*, L39*, L841*, L861*	Familial cancer of breast	VCV002858976	16	23640529	16	23629208	2858976	3025191	rs2142367705	NC_000016.10:23629207:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2581T>G (p.Leu861Val)	PALB2	L861V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410150	16	23640530	16	23629209	410150	401755	rs1060502763	NC_000016.10:23629208:A:C	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2580G>A (p.Glu860=)	PALB2		Familial cancer of breast	VCV002853525	16	23640531	16	23629210	2853525	3013324	rs1348398121	NC_000016.10:23629209:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2580G>C (p.Glu860Asp)	PALB2	E264D, E38D, E565D, E840D, E860D	Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Hereditary cancer-predisposing syndrome	VCV002682036	16	23640531	16	23629210	2682036	2843069	rs1348398121	NC_000016.10:23629209:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2580G>T (p.Glu860Asp)	PALB2	E860D	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000484223	16	23640531	16	23629210	484223	477496	rs1348398121	NC_000016.10:23629209:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2579A>G (p.Glu860Gly)	PALB2	E840G, E860G, E38G, E565G, E264G	Familial cancer of breast	VCV002099309	16	23640532	16	23629211	2099309	2150630	rs2506395600	NC_000016.10:23629210:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2578G>A (p.Glu860Lys)	PALB2	E38K, E860K, E264K, E565K, E840K	Familial cancer of breast|not specified	VCV002708468	16	23640533	16	23629212	2708468	2870759	rs1966853670	NC_000016.10:23629211:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2578G>T (p.Glu860Ter)	PALB2	E38*, E264*, E565*, E840*, E860*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002062838	16	23640533	16	23629212	2062838	2128113	rs1966853670	NC_000016.10:23629211:C:A	single nucleotide variant	nonsense	Pathogenic	Sep 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2577A>T (p.Ser859=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001793322	16	23640534	16	23629213	1793322	1848835	rs1567216795	NC_000016.10:23629212:T:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2577A>G (p.Ser859=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001793319	16	23640534	16	23629213	1793319	1848832	rs1567216795	NC_000016.10:23629212:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 16, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2576C>A (p.Ser859Ter)	PALB2	S859*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000371797	16	23640535	16	23629214	371797	358906	rs1057517539	NC_000016.10:23629213:G:T	single nucleotide variant	nonsense	Pathogenic	Oct 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2575T>C (p.Ser859Pro)	PALB2	S859P, S263P, S839P, S564P, S37P	Hereditary cancer-predisposing syndrome	VCV001793307	16	23640536	16	23629215	1793307	1848820	rs2142367840	NC_000016.10:23629214:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2575T>A (p.Ser859Thr)	PALB2	S263T, S839T, S564T, S37T, S859T	Hereditary cancer-predisposing syndrome	VCV001793304	16	23640536	16	23629215	1793304	1848817	rs2142367840	NC_000016.10:23629214:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2573T>A (p.Val858Asp)	PALB2	V838D, V858D, V36D, V262D, V563D	Hereditary cancer-predisposing syndrome	VCV001793279	16	23640538	16	23629217	1793279	1848792	rs2142367883	NC_000016.10:23629216:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2572G>C (p.Val858Leu)	PALB2	V858L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000821507	16	23640539	16	23629218	821507	812691	rs1597088111	NC_000016.10:23629217:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2571G>A (p.Leu857=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000136134	16	23640540	16	23629219	136134	139846	rs587780821	NC_000016.10:23629218:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2569T>C (p.Leu857=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000184722	16	23640542	16	23629221	184722	184189	rs786201642	NC_000016.10:23629220:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2568A>G (p.Gln856=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000774256	16	23640543	16	23629222	774256	703567	rs587781708	NC_000016.10:23629221:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2568A>C (p.Gln856His)	PALB2	Q856H	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000141385	16	23640543	16	23629222	141385	151099	rs587781708	NC_000016.10:23629221:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2566C>G (p.Gln856Glu)	PALB2	Q856E	Familial cancer of breast	VCV001037908	16	23640545	16	23629224	1037908	1032517	rs770996884	NC_000016.10:23629223:G:C	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2566C>A (p.Gln856Lys)	PALB2	Q856K	Familial cancer of breast	VCV000946682	16	23640545	16	23629224	946682	927714	rs770996884	NC_000016.10:23629223:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2566C>T (p.Gln856Ter)	PALB2	Q856*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000659155	16	23640545	16	23629224	659155	644415	rs770996884	NC_000016.10:23629223:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2565A>G (p.Leu855=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001653354	16	23640546	16	23629225	1653354	1547927	rs1375921468	NC_000016.10:23629224:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2564T>C (p.Leu855Pro)	PALB2	L855P	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000641098	16	23640547	16	23629226	641098	644416	rs774497779	NC_000016.10:23629225:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2563C>A (p.Leu855Ile)	PALB2	L259I, L33I, L560I, L855I, L835I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001793138	16	23640548	16	23629227	1793138	1848651	rs1555460212	NC_000016.10:23629226:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2563C>T (p.Leu855=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000798954	16	23640548	16	23629227	798954	785220	rs1555460212	NC_000016.10:23629226:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2563C>G (p.Leu855Val)	PALB2	L855V	Hereditary cancer-predisposing syndrome	VCV000492190	16	23640548	16	23629227	492190	484818	rs1555460212	NC_000016.10:23629226:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2562C>G (p.Asn854Lys)	PALB2	N854K	Familial cancer of breast	VCV001008299	16	23640549	16	23629228	1008299	996795	rs1966853809	NC_000016.10:23629227:G:C	single nucleotide variant	missense variant	Uncertain significance	May 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2562C>T (p.Asn854=)	PALB2		Familial cancer of breast|not provided	VCV000830172	16	23640549	16	23629228	830172	818478	rs1966853809	NC_000016.10:23629227:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2561A>T (p.Asn854Ile)	PALB2	N559I, N854I, N32I, N834I, N258I	Hereditary cancer-predisposing syndrome	VCV001793117	16	23640550	16	23629229	1793117	1848630	rs146455175	NC_000016.10:23629228:T:A	single nucleotide variant	missense variant	Likely benign	Jul 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2561A>G (p.Asn854Ser)	PALB2	N854S	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000220808	16	23640550	16	23629229	220808	222464	rs146455175	NC_000016.10:23629228:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2560A>G (p.Asn854Asp)	PALB2	N258D, N559D, N32D, N834D, N854D	Hereditary cancer-predisposing syndrome	VCV001793108	16	23640551	16	23629230	1793108	1848621	rs1567216856	NC_000016.10:23629229:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.2560A>C (p.Asn854His)	PALB2	N854H	not provided	VCV000619886	16	23640551	16	23629230	619886	611218	rs1567216856	NC_000016.10:23629229:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2559C>G (p.Gly853=)	PALB2		Familial cancer of breast	VCV003903964	16	23640552	16	23629231	3903964	4019837		NC_000016.10:23629230:G:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2559C>T (p.Gly853=)	PALB2		Familial cancer of breast	VCV000126660	16	23640552	16	23629231	126660	132170	rs180177115	NC_000016.10:23629230:G:A	single nucleotide variant	synonymous variant	Likely pathogenic	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.2557G>C (p.Gly853Arg)	PALB2	G257R, G853R, G833R, G31R, G558R	Familial cancer of breast	VCV002794213	16	23640554	16	23629233	2794213	2957929	rs587782579	NC_000016.10:23629232:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2557G>A (p.Gly853Ser)	PALB2	G853S	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000142600	16	23640554	16	23629233	142600	152314	rs587782579	NC_000016.10:23629232:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2556A>G (p.Pro852=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492189	16	23640555	16	23629234	492189	484999	rs1256170688	NC_000016.10:23629233:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2555C>T (p.Pro852Leu)	PALB2	P30L, P256L, P832L, P852L, P557L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002110914	16	23640556	16	23629235	2110914	2167483	rs2142368283	NC_000016.10:23629234:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 22, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2554C>T (p.Pro852Ser)	PALB2	P852S, P30S, P832S, P256S, P557S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002161733	16	23640557	16	23629236	2161733	1887512	rs1457487266	NC_000016.10:23629235:G:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2553C>A (p.Asn851Lys)	PALB2	N851K	Familial cancer of breast	VCV001432389	16	23640558	16	23629237	1432389	1484500	rs2142368337	NC_000016.10:23629236:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2552A>G (p.Asn851Ser)	PALB2	N851S	Familial cancer of breast	VCV000643453	16	23640559	16	23629238	643453	644418	rs1597088176	NC_000016.10:23629237:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2550A>C (p.Ile850=)	PALB2		Familial cancer of breast	VCV001111746	16	23640561	16	23629240	1111746	1103700	rs2142368431	NC_000016.10:23629239:T:G	single nucleotide variant	synonymous variant	Likely benign	Aug 20, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2549T>G (p.Ile850Arg)	PALB2	I850R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000854740	16	23640562	16	23629241	854740	843577	rs1966853918	NC_000016.10:23629240:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2548A>G (p.Ile850Val)	PALB2	I555V, I830V, I850V, I254V, I28V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002042441	16	23640563	16	23629242	2042441	2099034	rs2142368490	NC_000016.10:23629241:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2546G>A (p.Ser849Asn)	PALB2	S253N, S554N, S27N, S829N, S849N	Familial cancer of breast	VCV002111069	16	23640565	16	23629244	2111069	2167638	rs2142368569	NC_000016.10:23629243:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2546G>T (p.Ser849Ile)	PALB2	S253I, S27I, S849I, S554I, S829I	Hereditary cancer-predisposing syndrome	VCV001792884	16	23640565	16	23629244	1792884	1851933	rs2142368569	NC_000016.10:23629243:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2545A>G (p.Ser849Gly)	PALB2	S849G	Familial cancer of breast	VCV001389443	16	23640566	16	23629245	1389443	1376923	rs2142368594	NC_000016.10:23629244:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2544T>A (p.Asp848Glu)	PALB2	D26E, D252E, D828E, D553E, D848E	Familial cancer of breast	VCV002109012	16	23640567	16	23629246	2109012	2170770	rs753978124	NC_000016.10:23629245:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2544T>G (p.Asp848Glu)	PALB2	D848E	Hereditary cancer-predisposing syndrome	VCV001171297	16	23640567	16	23629246	1171297	1161315	rs753978124	NC_000016.10:23629245:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2544T>C (p.Asp848=)	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530230	16	23640567	16	23629246	530230	530132	rs753978124	NC_000016.10:23629245:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2543A>G (p.Asp848Gly)	PALB2	D848G	Familial cancer of breast	VCV000216747	16	23640568	16	23629247	216747	213164	rs762129437	NC_000016.10:23629246:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2542G>C (p.Asp848His)	PALB2	D848H	Hereditary cancer-predisposing syndrome	VCV000490078	16	23640569	16	23629248	490078	482941	rs1555460219	NC_000016.10:23629247:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2540C>T (p.Ser847Phe)	PALB2	S847F	Familial cancer of breast	VCV000830170	16	23640571	16	23629250	830170	818480	rs1567216902	NC_000016.10:23629249:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2540C>G (p.Ser847Cys)	PALB2	S847C	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3	VCV000566330	16	23640571	16	23629250	566330	567959	rs1567216902	NC_000016.10:23629249:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 5, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2535T>C (p.Pro845=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000921718	16	23640576	16	23629255	921718	913625	rs1567216906	NC_000016.10:23629254:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2535T>A (p.Pro845=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000821411	16	23640576	16	23629255	821411	812692	rs1567216906	NC_000016.10:23629254:A:T	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2534C>T (p.Pro845Leu)	PALB2	P845L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000648923	16	23640577	16	23629256	648923	644419	rs1597088217	NC_000016.10:23629255:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2533C>G (p.Pro845Ala)	PALB2	P845A, P249A, P550A, P23A, P825A	Familial cancer of breast	VCV003665038	16	23640578	16	23629257	3665038	3802160		NC_000016.10:23629256:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 7, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2533C>T (p.Pro845Ser)	PALB2	P845S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460946	16	23640578	16	23629257	460946	466198	rs1167924094	NC_000016.10:23629256:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2531T>C (p.Leu844Pro)	PALB2	L844P	Familial cancer of breast	VCV000569260	16	23640580	16	23629259	569260	570173	rs375713631	NC_000016.10:23629258:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2531T>G (p.Leu844Arg)	PALB2	L844R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530069	16	23640580	16	23629259	530069	529823	rs375713631	NC_000016.10:23629258:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2530C>T (p.Leu844Phe)	PALB2	L844F	Familial cancer of breast	VCV001513953	16	23640581	16	23629260	1513953	1469140	rs2142368906	NC_000016.10:23629259:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2529G>C (p.Glu843Asp)	PALB2	E548D, E843D, E21D, E823D, E247D	Familial cancer of breast	VCV001977019	16	23640582	16	23629261	1977019	2027138	rs2142368926	NC_000016.10:23629260:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2529G>A (p.Glu843=)	PALB2		Familial cancer of breast	VCV001670991	16	23640582	16	23629261	1670991	1529881	rs2142368926	NC_000016.10:23629260:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2528A>G (p.Glu843Gly)	PALB2	E843G, E823G, E21G, E247G, E548G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002075909	16	23640583	16	23629262	2075909	2141582	rs1966854027	NC_000016.10:23629261:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2528A>T (p.Glu843Val)	PALB2	E843V	Familial cancer of breast	VCV000847018	16	23640583	16	23629262	847018	843578	rs1966854027	NC_000016.10:23629261:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2527G>A (p.Glu843Lys)	PALB2	E21K, E247K, E548K, E823K, E843K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002131494	16	23640584	16	23629263	2131494	2189482	rs2142368965	NC_000016.10:23629262:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2525C>T (p.Ala842Val)	PALB2	A822V, A20V, A547V, A246V, A842V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003413432	16	23640586	16	23629265	3413432	3574655		NC_000016.10:23629264:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2524G>A (p.Ala842Thr)	PALB2	A842T	Hereditary cancer-predisposing syndrome	VCV000919589	16	23640587	16	23629266	919589	913626	rs1966854044	NC_000016.10:23629265:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2522C>T (p.Thr841Ile)	PALB2	T841I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000628741	16	23640589	16	23629268	628741	618369	rs1373085553	NC_000016.10:23629267:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 4, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2521A>G (p.Thr841Ala)	PALB2	T841A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000141890	16	23640590	16	23629269	141890	151604	rs368990417	NC_000016.10:23629268:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2520A>G (p.Glu840=)	PALB2		Familial cancer of breast	VCV001618189	16	23640591	16	23629270	1618189	1527511	rs2142369096	NC_000016.10:23629269:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2519A>G (p.Glu840Gly)	PALB2	E840G	Familial cancer of breast	VCV001525812	16	23640592	16	23629271	1525812	1395868	rs2142369107	NC_000016.10:23629270:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2518G>T (p.Glu840Ter)	PALB2	E18*, E244*, E545*, E820*, E840*	Hereditary cancer-predisposing syndrome	VCV003906174	16	23640593	16	23629272	3906174	4022046		NC_000016.10:23629271:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2517T>C (p.Thr839=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001792485	16	23640594	16	23629273	1792485	1842073	rs1555460224	NC_000016.10:23629272:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 9, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2517T>G (p.Thr839=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492188	16	23640594	16	23629273	492188	484650	rs1555460224	NC_000016.10:23629272:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2515A>C (p.Thr839Pro)	PALB2	T819P, T839P, T17P, T243P, T544P	Familial cancer of breast	VCV002694641	16	23640596	16	23629275	2694641	2860780	rs2142369190	NC_000016.10:23629274:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2515A>G (p.Thr839Ala)	PALB2	T243A, T544A, T819A, T839A, T17A	Familial cancer of breast	VCV002001038	16	23640596	16	23629275	2001038	2057678	rs2142369190	NC_000016.10:23629274:T:C	single nucleotide variant	missense variant	Uncertain significance	May 30, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2515-1G>A	PALB2		Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Breast cancer, susceptibility to|Hereditary cancer-predisposing syndrome	VCV000582926	16	23640597	16	23629276	582926	569950	rs587776417	NC_000016.10:23629275:C:T	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Apr 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2515-1G>C	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000216006	16	23640597	16	23629276	216006	213165	rs587776417	NC_000016.10:23629275:C:G	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
PALB2:c.2515-1G>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126657	16	23640597	16	23629276	126657	132167	rs587776417	NC_000016.10:23629275:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Mar 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2515-2A>C	PALB2		Familial cancer of breast	VCV003721293	16	23640598	16	23629277	3721293	3853660		NC_000016.10:23629276:T:G	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Oct 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2515-3C>A	PALB2		Hereditary cancer-predisposing syndrome	VCV000821386	16	23640599	16	23629278	821386	815630	rs957106428	NC_000016.10:23629277:G:T	single nucleotide variant	intron variant	Uncertain significance	Feb 18, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2515-3C>G	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000630725	16	23640599	16	23629278	630725	619487	rs957106428	NC_000016.10:23629277:G:C	single nucleotide variant	intron variant	Uncertain significance	Dec 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2515-3C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000460945	16	23640599	16	23629278	460945	466200	rs957106428	NC_000016.10:23629277:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 1, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2515-6T>C	PALB2		not specified|Familial cancer of breast	VCV000799384	16	23640602	16	23629281	799384	788189	rs1597088273	NC_000016.10:23629280:A:G	single nucleotide variant	intron variant	Likely benign	Apr 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2515-7T>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492187	16	23640603	16	23629282	492187	484819	rs1555460231	NC_000016.10:23629281:A:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2515-9T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000927008	16	23640605	16	23629284	927008	916424	rs1966854149	NC_000016.10:23629283:A:C	single nucleotide variant	intron variant	Uncertain significance	Oct 12, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2515-11T>C	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000560874	16	23640607	16	23629286	560874	551915	rs780521904	NC_000016.10:23629285:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2515-12T>C	PALB2		not specified|Familial cancer of breast	VCV000507434	16	23640608	16	23629287	507434	505505	rs1555460234	NC_000016.10:23629286:A:G	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2515-13T>C	PALB2		Familial cancer of breast	VCV003903562	16	23640609	16	23629288	3903562	4019435		NC_000016.10:23629287:A:G	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2515-14T>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000629853	16	23640610	16	23629289	629853	619490	rs752108348	NC_000016.10:23629288:A:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2515-15C>G	PALB2		Familial cancer of breast	VCV002969994	16	23640611	16	23629290	2969994	3129085	rs1966854193	NC_000016.10:23629289:G:C	single nucleotide variant	intron variant	Likely benign	Dec 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2515-16A>G	PALB2		Familial cancer of breast|not specified	VCV000511358	16	23640612	16	23629291	511358	506205	rs1555460241	NC_000016.10:23629290:T:C	single nucleotide variant	intron variant	Likely benign	Oct 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2515-17G>C	PALB2		Familial cancer of breast	VCV001603275	16	23640613	16	23629292	1603275	1524349	rs1966854210	NC_000016.10:23629291:C:G	single nucleotide variant	intron variant	Likely benign	Sep 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2515-18T>C	PALB2		Familial cancer of breast	VCV002822763	16	23640614	16	23629293	2822763	2978721	rs2142369375	NC_000016.10:23629292:A:G	single nucleotide variant	intron variant	Likely benign	Dec 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2515-19G>A	PALB2		Familial cancer of breast	VCV002145187	16	23640615	16	23629294	2145187	1870132	rs1966854220	NC_000016.10:23629293:C:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2515-20T>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000629245	16	23640616	16	23629295	629245	619532	rs1567216962	NC_000016.10:23629294:A:G	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2515-46A>G	PALB2		not specified	VCV001697758	16	23640642	16	23629321	1697758	1690142	rs138588349	NC_000016.10:23629320:T:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+136T>C	PALB2		not provided	VCV000223896	16	23640825	16	23629504	223896	225624	rs187008421	NC_000016.10:23629503:A:G	single nucleotide variant	intron variant	Likely benign	Jun 18, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+95C>T	PALB2		not provided	VCV001190711	16	23640866	16	23629545	1190711	1181357	rs141593714	NC_000016.10:23629544:G:A	single nucleotide variant	intron variant	Likely benign	Jul 23, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+20T>C	PALB2		Familial cancer of breast|not specified	VCV000511139	16	23640941	16	23629620	511139	505517	rs1555460289	NC_000016.10:23629619:A:G	single nucleotide variant	intron variant	Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2514+19G>A	PALB2		Familial cancer of breast	VCV002010435	16	23640942	16	23629621	2010435	2067099	rs2142371068	NC_000016.10:23629620:C:T	single nucleotide variant	intron variant	Likely benign	Jun 25, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+18T>A	PALB2		Familial cancer of breast	VCV002147786	16	23640943	16	23629622	2147786	1877098	rs1057521010	NC_000016.10:23629621:A:T	single nucleotide variant	intron variant	Likely benign	May 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+18T>G	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000381294	16	23640943	16	23629622	381294	377378	rs1057521010	NC_000016.10:23629621:A:C	single nucleotide variant	intron variant	Likely benign	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2514+17C>T	PALB2		Familial cancer of breast	VCV003645932	16	23640944	16	23629623	3645932	3780507		NC_000016.10:23629622:G:A	single nucleotide variant	intron variant	Likely benign	Mar 14, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+15C>G	PALB2		Familial cancer of breast	VCV002088782	16	23640946	16	23629625	2088782	2137548	rs2142371115	NC_000016.10:23629624:G:C	single nucleotide variant	intron variant	Likely benign	Jan 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+14C>A	PALB2		Familial cancer of breast	VCV001543560	16	23640947	16	23629626	1543560	1557716	rs1192734360	NC_000016.10:23629625:G:T	single nucleotide variant	intron variant	Likely benign	May 9, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+10A>G	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000492186	16	23640951	16	23629630	492186	485000	rs1032636199	NC_000016.10:23629629:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2514+9C>T	PALB2		Familial cancer of breast	VCV000415996	16	23640952	16	23629631	415996	401756	rs762994288	NC_000016.10:23629630:G:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2514+8C>G	PALB2		Familial cancer of breast	VCV001567005	16	23640953	16	23629632	1567005	1622647	rs1060504706	NC_000016.10:23629631:G:C	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2514+8C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000415980	16	23640953	16	23629632	415980	401084	rs1060504706	NC_000016.10:23629631:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2514+7T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV001691946	16	23640954	16	23629633	1691946	1684388	rs2142371207	NC_000016.10:23629632:A:C	single nucleotide variant	intron variant	Uncertain significance	Sep 11, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+5A>G	PALB2		not specified|Familial cancer of breast	VCV000928610	16	23640956	16	23629635	928610	917540	rs1966855329	NC_000016.10:23629634:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2514+4C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000656338	16	23640957	16	23629636	656338	652992	rs1597088645	NC_000016.10:23629635:G:A	single nucleotide variant	intron variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2514+3A>T	PALB2		Hereditary cancer-predisposing syndrome	VCV001792431	16	23640958	16	23629637	1792431	1842019	rs515726088	NC_000016.10:23629636:T:A	single nucleotide variant	intron variant	Uncertain significance	Jan 31, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+3A>G	PALB2		not provided|Breast and/or ovarian cancer|Familial pancreatic carcinoma|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126655	16	23640958	16	23629637	126655	132165	rs515726088	NC_000016.10:23629636:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2514+1G>T	PALB2		Hereditary cancer-predisposing syndrome	VCV002453311	16	23640960	16	23629639	2453311	2430371	rs886039729	NC_000016.10:23629638:C:A	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Mar 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514+1G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000862466	16	23640960	16	23629639	862466	852813	rs886039729	NC_000016.10:23629638:C:T	single nucleotide variant	intron variant|splice donor variant	Likely pathogenic	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2514+1G>C	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000265684	16	23640960	16	23629639	265684	260101	rs886039729	NC_000016.10:23629638:C:G	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2514G>C (p.Gln838His)	PALB2	Q543H, Q818H, Q838H, Q242H	Hereditary cancer-predisposing syndrome	VCV001792445	16	23640961	16	23629640	1792445	1842033	rs1064794902	NC_000016.10:23629639:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514G>T (p.Gln838His)	PALB2	Q838H	Familial cancer of breast	VCV001372590	16	23640961	16	23629640	1372590	1443834	rs1064794902	NC_000016.10:23629639:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2514G>A (p.Gln838=)	PALB2		Hereditary cancer-predisposing syndrome|not provided	VCV000421088	16	23640961	16	23629640	421088	409534	rs1064794902	NC_000016.10:23629639:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Aug 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2513A>G (p.Gln838Arg)	PALB2	Q838R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000482045	16	23640962	16	23629641	482045	477597	rs1555460298	NC_000016.10:23629640:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2512C>T (p.Gln838Ter)	PALB2	Q838*	Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000484190	16	23640963	16	23629642	484190	478077	rs750650768	NC_000016.10:23629641:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2512C>G (p.Gln838Glu)	PALB2	Q838E	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000230460	16	23640963	16	23629642	230460	235215	rs750650768	NC_000016.10:23629641:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2509G>C (p.Glu837Gln)	PALB2	E837Q	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000482038	16	23640966	16	23629645	482038	477497	rs587778587	NC_000016.10:23629644:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2509G>T (p.Glu837Ter)	PALB2	E837*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Hereditary breast ovarian cancer syndrome	VCV000241546	16	23640966	16	23629645	241546	242362	rs587778587	NC_000016.10:23629644:C:A	single nucleotide variant	nonsense	Pathogenic	Aug 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2509G>A (p.Glu837Lys)	PALB2	E837K	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|not specified|not provided|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome	VCV000128133	16	23640966	16	23629645	128133	133590	rs587778587	NC_000016.10:23629644:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2508C>A (p.Val836=)	PALB2		Familial cancer of breast	VCV003904041	16	23640967	16	23629646	3904041	4019914		NC_000016.10:23629645:G:T	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2508C>T (p.Val836=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000241545	16	23640967	16	23629646	241545	242363	rs786203603	NC_000016.10:23629645:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2508C>G (p.Val836=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified	VCV000187271	16	23640967	16	23629646	187271	184191	rs786203603	NC_000016.10:23629645:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2507T>C (p.Val836Ala)	PALB2	V836A	Hereditary cancer-predisposing syndrome	VCV000928360	16	23640968	16	23629647	928360	913627	rs1060502793	NC_000016.10:23629646:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2507T>A (p.Val836Asp)	PALB2	V836D	Familial cancer of breast	VCV000410198	16	23640968	16	23629647	410198	401761	rs1060502793	NC_000016.10:23629646:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2506G>A (p.Val836Ile)	PALB2	V836I	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000231442	16	23640969	16	23629648	231442	235217	rs536644825	NC_000016.10:23629647:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2506G>C (p.Val836Leu)	PALB2	V836L	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)|Hereditary cancer-predisposing syndrome	VCV000231405	16	23640969	16	23629648	231405	235216	rs536644825	NC_000016.10:23629647:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2506G>T (p.Val836Phe)	PALB2	V836F	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000216746	16	23640969	16	23629648	216746	213166	rs536644825	NC_000016.10:23629647:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 28, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2505C>G (p.Ser835=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001792306	16	23640970	16	23629649	1792306	1841894	rs756502783	NC_000016.10:23629648:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2505C>A (p.Ser835=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460944	16	23640970	16	23629649	460944	466202	rs756502783	NC_000016.10:23629648:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2505C>T (p.Ser835=)	PALB2		not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000197859	16	23640970	16	23629649	197859	195020	rs756502783	NC_000016.10:23629648:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2504C>G (p.Ser835Cys)	PALB2	S540C, S239C, S815C, S835C	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3	VCV003580034	16	23640971	16	23629650	3580034	3711626		NC_000016.10:23629649:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2504C>T (p.Ser835Phe)	PALB2	S835F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233364	16	23640971	16	23629650	233364	235218	rs876660357	NC_000016.10:23629649:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2503T>G (p.Ser835Ala)	PALB2	S835A	Familial cancer of breast	VCV000946016	16	23640972	16	23629651	946016	927716	rs1343435250	NC_000016.10:23629650:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2503T>A (p.Ser835Thr)	PALB2	S835T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482047	16	23640972	16	23629651	482047	478079	rs1343435250	NC_000016.10:23629650:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 8, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2502T>C (p.His834=)	PALB2		Familial cancer of breast	VCV000415977	16	23640973	16	23629652	415977	401762	rs1060504703	NC_000016.10:23629651:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2501A>G (p.His834Arg)	PALB2	H834R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001035885	16	23640974	16	23629653	1035885	1032518	rs1966855645	NC_000016.10:23629652:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2500C>T (p.His834Tyr)	PALB2	H834Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000490077	16	23640975	16	23629654	490077	482946	rs1555460308	NC_000016.10:23629653:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2499A>G (p.Lys833=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001792158	16	23640976	16	23629655	1792158	1841746	rs1567217151	NC_000016.10:23629654:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 10, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2499A>T (p.Lys833Asn)	PALB2	K833N	Familial cancer of breast	VCV000580920	16	23640976	16	23629655	580920	570175	rs1567217151	NC_000016.10:23629654:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2498A>C (p.Lys833Thr)	PALB2	K237T, K833T, K538T, K813T	Hereditary cancer-predisposing syndrome	VCV002611404	16	23640977	16	23629656	2611404	2773396	rs2142371753	NC_000016.10:23629655:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2496T>C (p.His832=)	PALB2		Familial cancer of breast	VCV002750104	16	23640979	16	23629658	2750104	2919062	rs777555497	NC_000016.10:23629657:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2495A>G (p.His832Arg)	PALB2	H236R, H537R, H812R, H832R	Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001722089	16	23640980	16	23629659	1722089	1779807	rs2506403078	NC_000016.10:23629658:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2494C>T (p.His832Tyr)	PALB2	H832Y	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000481183	16	23640981	16	23629660	481183	478080	rs901786175	NC_000016.10:23629659:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 15, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2493G>T (p.Leu831=)	PALB2		Familial cancer of breast	VCV003903876	16	23640982	16	23629661	3903876	4019749		NC_000016.10:23629660:C:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2493G>C (p.Leu831=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003894458	16	23640982	16	23629661	3894458	4010338		NC_000016.10:23629660:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2493G>A (p.Leu831=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001131315	16	23640982	16	23629661	1131315	1125115	rs749001322	NC_000016.10:23629660:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2492T>C (p.Leu831Pro)	PALB2	L235P, L536P, L811P, L831P	Familial cancer of breast	VCV003658837	16	23640983	16	23629662	3658837	3793834		NC_000016.10:23629661:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2491C>T (p.Leu831=)	PALB2		Familial cancer of breast	VCV003903941	16	23640984	16	23629663	3903941	4019814		NC_000016.10:23629662:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2491C>A (p.Leu831Met)	PALB2	L831M	Familial cancer of breast	VCV001407023	16	23640984	16	23629663	1407023	1487081	rs2142371841	NC_000016.10:23629662:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2491C>G (p.Leu831Val)	PALB2	L831V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001402719	16	23640984	16	23629663	1402719	1477145	rs2142371841	NC_000016.10:23629662:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2490G>A (p.Glu830=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001691945	16	23640985	16	23629664	1691945	1684387	rs2142371875	NC_000016.10:23629663:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 24, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2489A>G (p.Glu830Gly)	PALB2	E830G	Familial cancer of breast	VCV001476417	16	23640986	16	23629665	1476417	1339190	rs756800333	NC_000016.10:23629664:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2486A>C (p.Gln829Pro)	PALB2	Q233P, Q829P, Q534P, Q809P	Familial cancer of breast	VCV003653063	16	23640989	16	23629668	3653063	3778452		NC_000016.10:23629667:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 12, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2485C>T (p.Gln829Ter)	PALB2	Q829*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000845553	16	23640990	16	23629669	845553	843579	rs1966855759	NC_000016.10:23629668:G:A	single nucleotide variant	nonsense	Pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2484C>G (p.Cys828Trp)	PALB2	C828W	not provided	VCV000624100	16	23640991	16	23629670	624100	613029	rs875989798	NC_000016.10:23629669:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2484C>T (p.Cys828=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000225864	16	23640991	16	23629670	225864	227666	rs875989798	NC_000016.10:23629669:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2483G>A (p.Cys828Tyr)	PALB2	C533Y, C808Y, C828Y, C232Y	Hereditary cancer-predisposing syndrome	VCV002774002	16	23640992	16	23629671	2774002	2934733	rs1966855796	NC_000016.10:23629670:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2482T>A (p.Cys828Ser)	PALB2	C232S, C828S, C533S, C808S	Hereditary cancer-predisposing syndrome	VCV002611415	16	23640993	16	23629672	2611415	2773407	rs876660545	NC_000016.10:23629671:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2482T>C (p.Cys828Arg)	PALB2	C828R	not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233646	16	23640993	16	23629672	233646	235221	rs876660545	NC_000016.10:23629671:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2481A>G (p.Thr827=)	PALB2		Familial cancer of breast	VCV003903825	16	23640994	16	23629673	3903825	4019698		NC_000016.10:23629672:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2481A>C (p.Thr827=)	PALB2		Familial cancer of breast	VCV000763517	16	23640994	16	23629673	763517	770772	rs876658885	NC_000016.10:23629672:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2481A>T (p.Thr827=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000230985	16	23640994	16	23629673	230985	235222	rs876658885	NC_000016.10:23629672:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2480C>G (p.Thr827Arg)	PALB2	T532R, T827R, T807R, T231R	Hereditary cancer-predisposing syndrome	VCV001791913	16	23640995	16	23629674	1791913	1845346	rs1597088802	NC_000016.10:23629673:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2480C>A (p.Thr827Lys)	PALB2	T532K, T827K, T807K, T231K	Hereditary cancer-predisposing syndrome	VCV001791911	16	23640995	16	23629674	1791911	1845344	rs1597088802	NC_000016.10:23629673:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2480C>T (p.Thr827Ile)	PALB2	T827I	not provided|Familial cancer of breast	VCV000663260	16	23640995	16	23629674	663260	644420	rs1597088802	NC_000016.10:23629673:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2479A>G (p.Thr827Ala)	PALB2	T827A	Hereditary cancer-predisposing syndrome	VCV000821340	16	23640996	16	23629675	821340	812695	rs1324538307	NC_000016.10:23629674:T:C	single nucleotide variant	missense variant	Uncertain significance	May 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2478C>T (p.Asn826=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000185041	16	23640997	16	23629676	185041	184192	rs786201885	NC_000016.10:23629675:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2477A>G (p.Asn826Ser)	PALB2	N826S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001381842	16	23640998	16	23629677	1381842	1341801	rs2142372189	NC_000016.10:23629676:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2475A>G (p.Arg825=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003413483	16	23641000	16	23629679	3413483	3574706		NC_000016.10:23629678:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 19, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2474G>C (p.Arg825Thr)	PALB2	R825T	Hereditary cancer-predisposing syndrome|Endometrial carcinoma|Familial cancer of breast|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000185630	16	23641001	16	23629680	185630	184193	rs146218439	NC_000016.10:23629679:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2473A>G (p.Arg825Gly)	PALB2	R825G	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3	VCV000402299	16	23641002	16	23629681	402299	389266	rs745747228	NC_000016.10:23629680:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2472T>C (p.Cys824=)	PALB2		Familial cancer of breast	VCV003903713	16	23641003	16	23629682	3903713	4019586		NC_000016.10:23629681:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2472T>A (p.Cys824Ter)	PALB2	C228*, C529*, C804*, C824*	Breast-ovarian cancer, familial, susceptibility to, 5	VCV003780086	16	23641003	16	23629682	3780086	3896053		NC_000016.10:23629681:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2471G>C (p.Cys824Ser)	PALB2	C228S, C804S, C529S, C824S	Hereditary cancer-predisposing syndrome	VCV003885189	16	23641004	16	23629683	3885189	4005511		NC_000016.10:23629682:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2471G>A (p.Cys824Tyr)	PALB2	C824Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000821343	16	23641004	16	23629683	821343	812696	rs1597088831	NC_000016.10:23629682:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2470T>C (p.Cys824Arg)	PALB2	C228R, C529R, C824R, C804R	Familial cancer of breast	VCV003652181	16	23641005	16	23629684	3652181	3785461		NC_000016.10:23629683:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2469C>T (p.Leu823=)	PALB2		Familial cancer of breast	VCV003903896	16	23641006	16	23629685	3903896	4019769		NC_000016.10:23629684:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2469C>G (p.Leu823=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000220617	16	23641006	16	23629685	220617	222465	rs515726087	NC_000016.10:23629684:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2469C>A (p.Leu823=)	PALB2		Familial cancer of breast	VCV000126654	16	23641006	16	23629685	126654	132164	rs515726087	NC_000016.10:23629684:G:T	single nucleotide variant	synonymous variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2468T>C (p.Leu823Pro)	PALB2	L823P	Hereditary cancer-predisposing syndrome	VCV000821238	16	23641007	16	23629686	821238	812697	rs1034192699	NC_000016.10:23629685:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2467C>T (p.Leu823Phe)	PALB2	L823F	Hereditary cancer-predisposing syndrome	VCV000482039	16	23641008	16	23629687	482039	477538	rs1555460320	NC_000016.10:23629686:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2466G>C (p.Gln822His)	PALB2	Q226H, Q822H, Q527H, Q802H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001791691	16	23641009	16	23629688	1791691	1848508	rs1157451265	NC_000016.10:23629687:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2466G>A (p.Gln822=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000509481	16	23641009	16	23629688	509481	506207	rs1157451265	NC_000016.10:23629687:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2466G>T (p.Gln822His)	PALB2	Q822H	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000492185	16	23641009	16	23629688	492185	484651	rs1157451265	NC_000016.10:23629687:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2465A>C (p.Gln822Pro)	PALB2	Q822P, Q527P, Q226P, Q802P	Hereditary cancer-predisposing syndrome	VCV003885190	16	23641010	16	23629689	3885190	4005512		NC_000016.10:23629688:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2465A>G (p.Gln822Arg)	PALB2	Q822R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001442411	16	23641010	16	23629689	1442411	1475276	rs1299917568	NC_000016.10:23629688:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2464C>A (p.Gln822Lys)	PALB2	Q802K, Q226K, Q527K, Q822K	Hereditary cancer-predisposing syndrome	VCV002567572	16	23641011	16	23629690	2567572	2731214	rs1555460323	NC_000016.10:23629689:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2464C>T (p.Gln822Ter)	PALB2	Q822*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000492184	16	23641011	16	23629690	492184	485008	rs1555460323	NC_000016.10:23629689:G:A	single nucleotide variant	nonsense	Pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2463T>C (p.Asn821=)	PALB2		Familial cancer of breast	VCV002816114	16	23641012	16	23629691	2816114	2976784	rs2506404390	NC_000016.10:23629690:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2461A>C (p.Asn821His)	PALB2	N821H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000919993	16	23641014	16	23629693	919993	913628	rs958566673	NC_000016.10:23629692:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2461A>T (p.Asn821Tyr)	PALB2	N821Y	not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480228	16	23641014	16	23629693	480228	477599	rs958566673	NC_000016.10:23629692:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2458G>C (p.Glu820Gln)	PALB2	E224Q, E525Q, E800Q, E820Q	Hereditary cancer-predisposing syndrome	VCV001791576	16	23641017	16	23629696	1791576	1848394	rs772048795	NC_000016.10:23629695:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2458G>A (p.Glu820Lys)	PALB2	E820K	PALB2-related disorder|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000574699	16	23641017	16	23629696	574699	570176	rs772048795	NC_000016.10:23629695:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2457A>G (p.Lys819=)	PALB2		Familial cancer of breast	VCV002747361	16	23641018	16	23629697	2747361	2904254	rs2142372647	NC_000016.10:23629696:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2456A>C (p.Lys819Thr)	PALB2	K799T, K223T, K524T, K819T	Hereditary cancer-predisposing syndrome	VCV002774003	16	23641019	16	23629698	2774003	2934734	rs587778585	NC_000016.10:23629697:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 31, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2456A>G (p.Lys819Arg)	PALB2	K819R	Familial cancer of breast|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000134995	16	23641019	16	23629698	134995	138734	rs587778585	NC_000016.10:23629697:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2454T>A (p.Phe818Leu)	PALB2	F523L, F798L, F818L, F222L	Hereditary cancer-predisposing syndrome	VCV003885191	16	23641021	16	23629700	3885191	4005513		NC_000016.10:23629699:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2454T>C (p.Phe818=)	PALB2		Familial cancer of breast	VCV002755477	16	23641021	16	23629700	2755477	2920548	rs2142372682	NC_000016.10:23629699:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2453T>G (p.Phe818Cys)	PALB2	F523C, F222C, F798C, F818C	Hereditary cancer-predisposing syndrome	VCV003885192	16	23641022	16	23629701	3885192	4005514		NC_000016.10:23629700:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2453T>A (p.Phe818Tyr)	PALB2	F818Y, F222Y, F798Y, F523Y	Familial cancer of breast	VCV003642694	16	23641022	16	23629701	3642694	3765465		NC_000016.10:23629700:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2453T>C (p.Phe818Ser)	PALB2	F818S	Familial cancer of breast|not provided|Hereditary cancer|Hereditary cancer-predisposing syndrome	VCV000183712	16	23641022	16	23629701	183712	184194	rs370908330	NC_000016.10:23629700:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2452T>A (p.Phe818Ile)	PALB2	F818I	Familial cancer of breast	VCV001470381	16	23641023	16	23629702	1470381	1372343	rs1555460328	NC_000016.10:23629701:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2452T>C (p.Phe818Leu)	PALB2	F818L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460943	16	23641023	16	23629702	460943	466412	rs1555460328	NC_000016.10:23629701:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2451T>A (p.Thr817=)	PALB2		Hereditary cancer-predisposing syndrome	VCV002567588	16	23641024	16	23629703	2567588	2731230	rs2142372740	NC_000016.10:23629702:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2451T>G (p.Thr817=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001574547	16	23641024	16	23629703	1574547	1659732	rs2142372740	NC_000016.10:23629702:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2450C>G (p.Thr817Ser)	PALB2	T817S, T221S, T797S, T522S	Hereditary cancer-predisposing syndrome	VCV001791479	16	23641025	16	23629704	1791479	1848298	rs2142372754	NC_000016.10:23629703:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2449A>G (p.Thr817Ala)	PALB2	T817A, T221A, T522A, T797A	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV001791437	16	23641026	16	23629705	1791437	1848257	rs2142372771	NC_000016.10:23629704:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2449A>C (p.Thr817Pro)	PALB2	T797P, T221P, T817P, T522P	Hereditary cancer-predisposing syndrome	VCV001791435	16	23641026	16	23629705	1791435	1848255	rs2142372771	NC_000016.10:23629704:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2448C>T (p.Phe816=)	PALB2		Familial cancer of breast	VCV001078750	16	23641027	16	23629706	1078750	1081887	rs876659879	NC_000016.10:23629705:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2448C>A (p.Phe816Leu)	PALB2	F816L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481139	16	23641027	16	23629706	481139	477602	rs876659879	NC_000016.10:23629705:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2448C>G (p.Phe816Leu)	PALB2	F816L	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000232620	16	23641027	16	23629706	232620	235224	rs876659879	NC_000016.10:23629705:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 8, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2447T>A (p.Phe816Tyr)	PALB2	F220Y, F521Y, F796Y, F816Y	Hereditary cancer-predisposing syndrome	VCV003228009	16	23641028	16	23629707	3228009	3387778	rs1966856156	NC_000016.10:23629706:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2446T>A (p.Phe816Ile)	PALB2	F220I, F521I, F816I, F796I	Familial cancer of breast	VCV002848655	16	23641029	16	23629708	2848655	3015552	rs1567217251	NC_000016.10:23629707:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2446T>C (p.Phe816Leu)	PALB2	F816L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630081	16	23641029	16	23629708	630081	618370	rs1567217251	NC_000016.10:23629707:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2445A>T (p.Ser815=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003885200	16	23641030	16	23629709	3885200	4005522		NC_000016.10:23629708:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 6, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2445A>G (p.Ser815=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000631179	16	23641030	16	23629709	631179	618371	rs1567217255	NC_000016.10:23629708:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2444C>A (p.Ser815Ter)	PALB2	S219*, S520*, S795*, S815*	Familial cancer of breast	VCV002674088	16	23641031	16	23629710	2674088	2841578	rs879254068	NC_000016.10:23629709:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2444C>G (p.Ser815Ter)	PALB2	S219*, S520*, S795*, S815*	Familial cancer of breast	VCV002673858	16	23641031	16	23629710	2673858	2841360	rs879254068	NC_000016.10:23629709:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2444C>T (p.Ser815Leu)	PALB2	S815L	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000246052	16	23641031	16	23629710	246052	244954	rs879254068	NC_000016.10:23629709:G:A	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2443T>G (p.Ser815Ala)	PALB2	S815A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000921075	16	23641032	16	23629711	921075	913629	rs746802428	NC_000016.10:23629710:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2442G>A (p.Glu814=)	PALB2		Familial cancer of breast|Breast and/or ovarian cancer|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000126653	16	23641033	16	23629712	126653	132163	rs140776736	NC_000016.10:23629711:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2441A>G (p.Glu814Gly)	PALB2	E814G	Familial cancer of breast	VCV000835192	16	23641034	16	23629713	835192	843580	rs1567217273	NC_000016.10:23629712:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2441A>T (p.Glu814Val)	PALB2	E814V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628199	16	23641034	16	23629713	628199	618372	rs1567217273	NC_000016.10:23629712:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2440G>A (p.Glu814Lys)	PALB2	E218K, E814K, E519K, E794K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002561282	16	23641035	16	23629714	2561282	2728048	rs2142372947	NC_000016.10:23629713:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2439T>C (p.Ile813=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003903674	16	23641036	16	23629715	3903674	4019547		NC_000016.10:23629714:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2438T>C (p.Ile813Thr)	PALB2	I813T	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410141	16	23641037	16	23629716	410141	401764	rs763191051	NC_000016.10:23629715:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2437A>C (p.Ile813Leu)	PALB2	I813L	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000492183	16	23641038	16	23629717	492183	485009	rs766396469	NC_000016.10:23629716:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 6, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2437A>G (p.Ile813Val)	PALB2	I813V	Hereditary cancer-predisposing syndrome	VCV000231753	16	23641038	16	23629717	231753	235225	rs766396469	NC_000016.10:23629716:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 3, 2016	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2435C>G (p.Pro812Arg)	PALB2	P812R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001011479	16	23641040	16	23629719	1011479	996796	rs774502617	NC_000016.10:23629718:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2435C>T (p.Pro812Leu)	PALB2	P812L	Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not provided|not specified|Familial cancer of breast	VCV000246424	16	23641040	16	23629719	246424	244955	rs774502617	NC_000016.10:23629718:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2434C>A (p.Pro812Thr)	PALB2	P792T, P812T, P517T, P216T	Familial cancer of breast	VCV002783488	16	23641041	16	23629720	2783488	2948087	rs1060502751	NC_000016.10:23629719:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2434C>T (p.Pro812Ser)	PALB2	P812S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410131	16	23641041	16	23629720	410131	401032	rs1060502751	NC_000016.10:23629719:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2433A>G (p.Pro811=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001791191	16	23641042	16	23629721	1791191	1851552	rs2142373104	NC_000016.10:23629720:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 17, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2433A>C (p.Pro811=)	PALB2		Familial cancer of breast	VCV001584800	16	23641042	16	23629721	1584800	1560951	rs2142373104	NC_000016.10:23629720:T:G	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2432C>A (p.Pro811Gln)	PALB2	P215Q, P791Q, P811Q, P516Q	Familial cancer of breast	VCV003645163	16	23641043	16	23629722	3645163	3783578		NC_000016.10:23629721:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2431C>T (p.Pro811Ser)	PALB2	P811S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000490076	16	23641044	16	23629723	490076	482881	rs866520250	NC_000016.10:23629722:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2429C>T (p.Pro810Leu)	PALB2	P810L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460942	16	23641046	16	23629725	460942	466415	rs1555460335	NC_000016.10:23629724:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2428C>T (p.Pro810Ser)	PALB2	P810S	Hereditary cancer-predisposing syndrome|not provided	VCV000496465	16	23641047	16	23629726	496465	487777	rs759894786	NC_000016.10:23629725:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2427A>C (p.Thr809=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000241544	16	23641048	16	23629727	241544	242364	rs768064297	NC_000016.10:23629726:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2425A>G (p.Thr809Ala)	PALB2	T809A	Familial cancer of breast	VCV000803233	16	23641050	16	23629729	803233	791566	rs753204710	NC_000016.10:23629728:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2425A>T (p.Thr809Ser)	PALB2	T809S	Hereditary cancer-predisposing syndrome	VCV000484191	16	23641050	16	23629729	484191	477499	rs753204710	NC_000016.10:23629728:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2424A>G (p.Gly808=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000486004	16	23641051	16	23629730	486004	477500	rs1060504714	NC_000016.10:23629729:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2424A>C (p.Gly808=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000415991	16	23641051	16	23629730	415991	401517	rs1060504714	NC_000016.10:23629729:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2422G>T (p.Gly808Ter)	PALB2	G808*	Familial cancer of breast	VCV000649138	16	23641053	16	23629732	649138	644421	rs1064795507	NC_000016.10:23629731:C:A	single nucleotide variant	nonsense	Pathogenic	Dec 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2422G>A (p.Gly808Arg)	PALB2	G808R	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000422025	16	23641053	16	23629732	422025	409535	rs1064795507	NC_000016.10:23629731:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2421A>G (p.Pro807=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001791020	16	23641054	16	23629733	1791020	1851381	rs2506406483	NC_000016.10:23629732:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2420C>G (p.Pro807Arg)	PALB2	P211R, P787R, P512R, P807R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002567595	16	23641055	16	23629734	2567595	2731237	rs2142373343	NC_000016.10:23629733:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2418G>T (p.Pro806=)	PALB2		not provided|not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460941	16	23641057	16	23629736	460941	466203	rs577076372	NC_000016.10:23629735:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2418G>A (p.Pro806=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000183914	16	23641057	16	23629736	183914	184195	rs577076372	NC_000016.10:23629735:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2417C>G (p.Pro806Arg)	PALB2	P806R	Familial cancer of breast	VCV001059738	16	23641058	16	23629737	1059738	1049514	rs45464991	NC_000016.10:23629736:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2417C>A (p.Pro806Gln)	PALB2	P806Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000821148	16	23641058	16	23629737	821148	812698	rs45464991	NC_000016.10:23629736:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2417C>T (p.Pro806Leu)	PALB2	P806L	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000141063	16	23641058	16	23629737	141063	150777	rs45464991	NC_000016.10:23629736:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 12, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2416C>A (p.Pro806Thr)	PALB2	P210T, P511T, P786T, P806T	Familial cancer of breast	VCV002765308	16	23641059	16	23629738	2765308	2926055	rs1966856450	NC_000016.10:23629737:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2415C>T (p.Val805=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492182	16	23641060	16	23629739	492182	484824	rs756996540	NC_000016.10:23629738:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2414T>A (p.Val805Asp)	PALB2	V805D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628338	16	23641061	16	23629740	628338	618373	rs1567217364	NC_000016.10:23629739:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2413G>A (p.Val805Ile)	PALB2	V805I	Familial cancer of breast	VCV000847508	16	23641062	16	23629741	847508	843581	rs876659475	NC_000016.10:23629740:C:T	single nucleotide variant	missense variant	Uncertain significance	May 16, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2413G>T (p.Val805Phe)	PALB2	V805F	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000231985	16	23641062	16	23629741	231985	235226	rs876659475	NC_000016.10:23629740:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2412T>A (p.Ser804=)	PALB2		Familial cancer of breast	VCV003904066	16	23641063	16	23629742	3904066	4019939		NC_000016.10:23629741:A:T	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2412T>C (p.Ser804=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480238	16	23641063	16	23629742	480238	477541	rs1555460341	NC_000016.10:23629741:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2411C>G (p.Ser804Cys)	PALB2	S804C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460940	16	23641064	16	23629743	460940	466210	rs149836639	NC_000016.10:23629742:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2411C>T (p.Ser804Phe)	PALB2	S804F	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|not provided|Hereditary cancer-predisposing syndrome	VCV000418604	16	23641064	16	23629743	418604	409536	rs149836639	NC_000016.10:23629742:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2410T>C (p.Ser804Pro)	PALB2	S804P	Hereditary cancer-predisposing syndrome	VCV000484225	16	23641065	16	23629744	484225	477604	rs1555460347	NC_000016.10:23629743:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2407G>T (p.Asp803Tyr)	PALB2	D803Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001045696	16	23641068	16	23629747	1045696	1032519	rs1966856576	NC_000016.10:23629746:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2406T>C (p.Cys802=)	PALB2		Familial cancer of breast	VCV002035645	16	23641069	16	23629748	2035645	2097429	rs1966856594	NC_000016.10:23629747:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2406T>G (p.Cys802Trp)	PALB2	C802W	Familial cancer of breast	VCV000942963	16	23641069	16	23629748	942963	937361	rs1966856594	NC_000016.10:23629747:A:C	single nucleotide variant	missense variant	Uncertain significance	May 31, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2405G>A (p.Cys802Tyr)	PALB2	C507Y, C802Y, C206Y, C782Y	Familial cancer of breast	VCV002863264	16	23641070	16	23629749	2863264	3019451	rs2142373717	NC_000016.10:23629748:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2404T>A (p.Cys802Ser)	PALB2	C802S	Familial cancer of breast	VCV001000214	16	23641071	16	23629750	1000214	996797	rs1966856613	NC_000016.10:23629749:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2403C>G (p.Asp801Glu)	PALB2	D801E	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000231788	16	23641072	16	23629751	231788	235228	rs876659364	NC_000016.10:23629750:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2402A>G (p.Asp801Gly)	PALB2	D801G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482008	16	23641073	16	23629752	482008	477611	rs1555460348	NC_000016.10:23629751:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2401G>A (p.Asp801Asn)	PALB2	D801N	Hereditary cancer-predisposing syndrome|See cases|Familial cancer of breast|not provided	VCV000142850	16	23641074	16	23629753	142850	152564	rs587782765	NC_000016.10:23629752:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2400T>A (p.Cys800Ter)	PALB2	C204*, C505*, C780*, C800*	Familial cancer of breast	VCV002811154	16	23641075	16	23629754	2811154	2975667	rs2142373865	NC_000016.10:23629753:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jan 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2399G>A (p.Cys800Tyr)	PALB2	C204Y, C780Y, C800Y, C505Y	Familial cancer of breast	VCV003687362	16	23641076	16	23629755	3687362	3830623		NC_000016.10:23629754:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2399G>C (p.Cys800Ser)	PALB2	C800S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000834576	16	23641076	16	23629755	834576	843582	rs757899898	NC_000016.10:23629754:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2398T>A (p.Cys800Ser)	PALB2	C800S	Familial cancer of breast	VCV000584906	16	23641077	16	23629756	584906	575962	rs1567217401	NC_000016.10:23629755:A:T	single nucleotide variant	missense variant	Uncertain significance	May 28, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2397C>G (p.Thr799=)	PALB2		Familial cancer of breast	VCV001558232	16	23641078	16	23629757	1558232	1594821	rs2142373917	NC_000016.10:23629756:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2397C>T (p.Thr799=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001117060	16	23641078	16	23629757	1117060	1103701	rs2142373917	NC_000016.10:23629756:G:A	single nucleotide variant	synonymous variant	Likely benign	May 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2396C>G (p.Thr799Ser)	PALB2	T504S, T779S, T203S, T799S	Familial cancer of breast	VCV003654761	16	23641079	16	23629758	3654761	3778856		NC_000016.10:23629757:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2396C>A (p.Thr799Asn)	PALB2	T799N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000821209	16	23641079	16	23629758	821209	812699	rs1597089093	NC_000016.10:23629757:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2395A>C (p.Thr799Pro)	PALB2	T799P	not provided	VCV000128132	16	23641080	16	23629759	128132	133589	rs587780212	NC_000016.10:23629758:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2394T>A (p.Pro798=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003228008	16	23641081	16	23629760	3228008	3387777	rs61756018	NC_000016.10:23629759:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2391A>C (p.Gln797His)	PALB2	Q797H, Q201H, Q777H, Q502H	Hereditary cancer-predisposing syndrome	VCV002447309	16	23641084	16	23629763	2447309	2422431	rs780015674	NC_000016.10:23629762:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2391A>G (p.Gln797=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000389595	16	23641084	16	23629763	389595	375254	rs780015674	NC_000016.10:23629762:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2390A>G (p.Gln797Arg)	PALB2	Q502R, Q777R, Q201R, Q797R	Hereditary cancer-predisposing syndrome	VCV002453305	16	23641085	16	23629764	2453305	2430365	rs2142374138	NC_000016.10:23629763:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2389C>T (p.Gln797Ter)	PALB2	Q797*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000821194	16	23641086	16	23629765	821194	812700	rs1060502768	NC_000016.10:23629764:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2389C>A (p.Gln797Lys)	PALB2	Q797K	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410158	16	23641086	16	23629765	410158	401085	rs1060502768	NC_000016.10:23629764:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2388A>G (p.Gly796=)	PALB2		Familial cancer of breast	VCV001655246	16	23641087	16	23629766	1655246	1549819	rs2142374175	NC_000016.10:23629765:T:C	single nucleotide variant	synonymous variant	Likely benign	May 3, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2387G>C (p.Gly796Ala)	PALB2	G200A, G776A, G796A, G501A	Familial cancer of breast	VCV003661948	16	23641088	16	23629767	3661948	3797813		NC_000016.10:23629766:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2386G>A (p.Gly796Arg)	PALB2	G776R, G796R, G200R, G501R	Hereditary cancer-predisposing syndrome	VCV003885215	16	23641089	16	23629768	3885215	4005537		NC_000016.10:23629767:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Feb 12, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2386G>T (p.Gly796Ter)	PALB2	G796*	Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000126649	16	23641089	16	23629768	126649	132159	rs180177112	NC_000016.10:23629767:C:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Mar 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2383C>T (p.Gln795Ter)	PALB2	Q795*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001454050	16	23641092	16	23629771	1454050	1366658	rs1966856854	NC_000016.10:23629770:G:A	single nucleotide variant	nonsense	Pathogenic	Apr 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2383C>G (p.Gln795Glu)	PALB2	Q795E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000930580	16	23641092	16	23629771	930580	919635	rs1966856854	NC_000016.10:23629770:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 2, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2382G>T (p.Arg794Ser)	PALB2	R794S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484163	16	23641093	16	23629772	484163	477544	rs786203837	NC_000016.10:23629771:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2382G>A (p.Arg794=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000187577	16	23641093	16	23629772	187577	184196	rs786203837	NC_000016.10:23629771:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2381G>A (p.Arg794Lys)	PALB2	R198K, R499K, R774K, R794K	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV002682035	16	23641094	16	23629773	2682035	2843068	rs2142374327	NC_000016.10:23629772:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2379C>A (p.Gly793=)	PALB2		Familial cancer of breast	VCV003904249	16	23641096	16	23629775	3904249	4020122		NC_000016.10:23629774:G:T	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2379C>G (p.Gly793=)	PALB2		Familial cancer of breast	VCV002092273	16	23641096	16	23629775	2092273	2148783	rs377626805	NC_000016.10:23629774:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2379C>T (p.Gly793=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|not provided|not specified	VCV000128130	16	23641096	16	23629775	128130	133587	rs377626805	NC_000016.10:23629774:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2377G>A (p.Gly793Ser)	PALB2	G793S	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000241543	16	23641098	16	23629777	241543	242365	rs878855109	NC_000016.10:23629776:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2376A>T (p.Ser792=)	PALB2		Familial cancer of breast	VCV003904052	16	23641099	16	23629778	3904052	4019925		NC_000016.10:23629777:T:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2375C>G (p.Ser792Ter)	PALB2	S792*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N	VCV000410128	16	23641100	16	23629779	410128	401769	rs1060502748	NC_000016.10:23629778:G:C	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	May 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2371G>A (p.Val791Met)	PALB2	V791M	Hereditary cancer-predisposing syndrome	VCV000631288	16	23641104	16	23629783	631288	618374	rs1567217463	NC_000016.10:23629782:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2370A>C (p.Gln790His)	PALB2	Q194H, Q495H, Q770H, Q790H	Hereditary cancer-predisposing syndrome	VCV002774005	16	23641105	16	23629784	2774005	2934736	rs1555460368	NC_000016.10:23629783:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2370A>G (p.Gln790=)	PALB2		Familial cancer of breast	VCV000460939	16	23641105	16	23629784	460939	466418	rs1555460368	NC_000016.10:23629783:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2369A>C (p.Gln790Pro)	PALB2	Q194P, Q495P, Q770P, Q790P	Hereditary cancer-predisposing syndrome	VCV003894147	16	23641106	16	23629785	3894147	4010028		NC_000016.10:23629784:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2369A>G (p.Gln790Arg)	PALB2	Q790R	Familial cancer of breast	VCV000946864	16	23641106	16	23629785	946864	927717	rs1966856999	NC_000016.10:23629784:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2368C>T (p.Gln790Ter)	PALB2	Q790*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000265329	16	23641107	16	23629786	265329	260102	rs886039480	NC_000016.10:23629785:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Nov 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2367G>C (p.Leu789=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000821160	16	23641108	16	23629787	821160	812701	rs780985758	NC_000016.10:23629786:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2367G>A (p.Leu789=)	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000795236	16	23641108	16	23629787	795236	785221	rs780985758	NC_000016.10:23629786:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2365C>A (p.Leu789Met)	PALB2	L789M, L769M, L193M, L494M	Hereditary cancer-predisposing syndrome	VCV001790206	16	23641110	16	23629789	1790206	1844951	rs145805054	NC_000016.10:23629788:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2365C>T (p.Leu789=)	PALB2		not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000126648	16	23641110	16	23629789	126648	132158	rs145805054	NC_000016.10:23629788:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2364C>A (p.Thr788=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000794816	16	23641111	16	23629790	794816	785222	rs1597089226	NC_000016.10:23629789:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2363C>T (p.Thr788Ile)	PALB2	T788I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001478144	16	23641112	16	23629791	1478144	1351651	rs1567217501	NC_000016.10:23629790:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2363C>A (p.Thr788Asn)	PALB2	T788N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000572452	16	23641112	16	23629791	572452	567963	rs1567217501	NC_000016.10:23629790:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2361C>T (p.Thr787=)	PALB2		Familial cancer of breast	VCV003903885	16	23641114	16	23629793	3903885	4019758		NC_000016.10:23629792:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2360C>G (p.Thr787Ser)	PALB2	T787S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000921076	16	23641115	16	23629794	921076	913630	rs201042302	NC_000016.10:23629793:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 28, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2360C>T (p.Thr787Ile)	PALB2	T787I	not specified|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000216745	16	23641115	16	23629794	216745	213168	rs201042302	NC_000016.10:23629793:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2359A>G (p.Thr787Ala)	PALB2	T787A	Hereditary cancer-predisposing syndrome	VCV000629174	16	23641116	16	23629795	629174	618375	rs1567217510	NC_000016.10:23629794:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2358T>A (p.His786Gln)	PALB2	H766Q, H786Q, H190Q, H491Q	Familial cancer of breast	VCV002849485	16	23641117	16	23629796	2849485	3009274	rs912615354	NC_000016.10:23629795:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 26, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2358T>C (p.His786=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001122783	16	23641117	16	23629796	1122783	1125116	rs912615354	NC_000016.10:23629795:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2357A>G (p.His786Arg)	PALB2	H786R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000460938	16	23641118	16	23629797	460938	466425	rs774503574	NC_000016.10:23629796:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2356C>T (p.His786Tyr)	PALB2	H786Y	not specified|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|not provided	VCV000187278	16	23641119	16	23629798	187278	184197	rs786203608	NC_000016.10:23629797:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2355A>G (p.Pro785=)	PALB2		Familial cancer of breast	VCV003903445	16	23641120	16	23629799	3903445	4019319		NC_000016.10:23629798:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2353C>A (p.Pro785Thr)	PALB2	P189T, P490T, P765T, P785T	Hereditary cancer-predisposing syndrome	VCV003303982	16	23641122	16	23629801	3303982	3470149		NC_000016.10:23629800:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2353C>T (p.Pro785Ser)	PALB2	P785S	not provided|Hereditary cancer-predisposing syndrome|Hereditary cancer|Familial cancer of breast	VCV000182768	16	23641122	16	23629801	182768	180723	rs730881889	NC_000016.10:23629800:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2351A>C (p.Lys784Thr)	PALB2	K489T, K764T, K784T, K188T	Familial cancer of breast	VCV002735184	16	23641124	16	23629803	2735184	2905092	rs2142374974	NC_000016.10:23629802:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2350A>G (p.Lys784Glu)	PALB2	K188E, K489E, K764E, K784E	Hereditary cancer-predisposing syndrome	VCV003228007	16	23641125	16	23629804	3228007	3387776	rs1833331932	NC_000016.10:23629803:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2350A>T (p.Lys784Ter)	PALB2	K784*	Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast	VCV001455414	16	23641125	16	23629804	1455414	1464530	rs1833331932	NC_000016.10:23629803:T:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2350A>C (p.Lys784Gln)	PALB2	K784Q	Familial cancer of breast	VCV001419559	16	23641125	16	23629804	1419559	1409779	rs1833331932	NC_000016.10:23629803:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2349A>G (p.Ala783=)	PALB2		Familial cancer of breast	VCV001151255	16	23641126	16	23629805	1151255	1146006	rs2142375025	NC_000016.10:23629804:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2348C>T (p.Ala783Val)	PALB2	A783V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001063980	16	23641127	16	23629806	1063980	1049515	rs1473991269	NC_000016.10:23629805:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 1, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2348C>A (p.Ala783Glu)	PALB2	A783E	Familial cancer of breast	VCV001060312	16	23641127	16	23629806	1060312	1049516	rs1473991269	NC_000016.10:23629805:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2346A>G (p.Pro782=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003927462	16	23641129	16	23629808	3927462	4047095		NC_000016.10:23629807:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 8, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2346A>C (p.Pro782=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001171447	16	23641129	16	23629808	1171447	1161316	rs2142375080	NC_000016.10:23629807:T:G	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2345C>T (p.Pro782Leu)	PALB2	P782L	Familial cancer of breast	VCV000830164	16	23641130	16	23629809	830164	818486	rs772095244	NC_000016.10:23629808:G:A	single nucleotide variant	missense variant	Uncertain significance	May 13, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2345C>A (p.Pro782Gln)	PALB2	P782Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530133	16	23641130	16	23629809	530133	529826	rs772095244	NC_000016.10:23629808:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2344C>T (p.Pro782Ser)	PALB2	P782S	not specified|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000186885	16	23641131	16	23629810	186885	184198	rs786203296	NC_000016.10:23629809:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2343C>T (p.Ser781=)	PALB2		Familial cancer of breast	VCV002866414	16	23641132	16	23629811	2866414	3020022	rs1060499820	NC_000016.10:23629810:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 26, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2343C>A (p.Ser781Arg)	PALB2	S781R	Hereditary cancer-predisposing syndrome	VCV000402298	16	23641132	16	23629811	402298	389267	rs1060499820	NC_000016.10:23629810:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2014	criteria provided, single submitter							
NM_024675.4(PALB2):c.2342G>A (p.Ser781Asn)	PALB2	S781N	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000245658	16	23641133	16	23629812	245658	244956	rs761298847	NC_000016.10:23629811:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2341A>C (p.Ser781Arg)	PALB2	S185R, S486R, S761R, S781R	Hereditary cancer-predisposing syndrome	VCV002562466	16	23641134	16	23629813	2562466	2717308	rs2142375203	NC_000016.10:23629812:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2340C>G (p.Gly780=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000627729	16	23641135	16	23629814	627729	618376	rs1064794853	NC_000016.10:23629813:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2340C>T (p.Gly780=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000421016	16	23641135	16	23629814	421016	409537	rs1064794853	NC_000016.10:23629813:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 16, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2339G>T (p.Gly780Val)	PALB2	G780V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001354480	16	23641136	16	23629815	1354480	1341598	rs1966857283	NC_000016.10:23629814:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2338G>T (p.Gly780Cys)	PALB2	G780C	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000486027	16	23641137	16	23629816	486027	478085	rs1555460392	NC_000016.10:23629815:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2337A>T (p.Ser779=)	PALB2		Familial cancer of breast	VCV003904243	16	23641138	16	23629817	3904243	4020116		NC_000016.10:23629816:T:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2337A>C (p.Ser779=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000184735	16	23641138	16	23629817	184735	184199	rs786201651	NC_000016.10:23629816:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2336C>T (p.Ser779Leu)	PALB2	S779L	Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000628628	16	23641139	16	23629818	628628	618377	rs764509489	NC_000016.10:23629817:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2336C>G (p.Ser779Ter)	PALB2	S779*	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|PALB2-related disorder|Familial cancer of breast	VCV000186458	16	23641139	16	23629818	186458	184200	rs764509489	NC_000016.10:23629817:G:C	single nucleotide variant	nonsense	Pathogenic	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2335T>C (p.Ser779Pro)	PALB2	S183P, S484P, S759P, S779P	Familial cancer of breast	VCV002091265	16	23641140	16	23629819	2091265	2145304	rs1064793640	NC_000016.10:23629818:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2335T>G (p.Ser779Ala)	PALB2	S779A	not provided|Familial cancer of breast	VCV000419096	16	23641140	16	23629819	419096	409538	rs1064793640	NC_000016.10:23629818:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2334T>C (p.Ser778=)	PALB2		Familial cancer of breast	VCV002704965	16	23641141	16	23629820	2704965	2863377	rs2142375349	NC_000016.10:23629819:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2333G>A (p.Ser778Asn)	PALB2	S483N, S182N, S778N, S758N	Hereditary cancer-predisposing syndrome	VCV002567558	16	23641142	16	23629821	2567558	2731200	rs2142375387	NC_000016.10:23629820:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 29, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2332A>G (p.Ser778Gly)	PALB2	S778G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000569637	16	23641143	16	23629822	569637	573926	rs1567217583	NC_000016.10:23629821:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2330A>T (p.Asp777Val)	PALB2	D181V, D482V, D757V, D777V	Hereditary cancer-predisposing syndrome	VCV003774409	16	23641145	16	23629824	3774409	3890556		NC_000016.10:23629823:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2329G>T (p.Asp777Tyr)	PALB2	D777Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000655721	16	23641146	16	23629825	655721	644422	rs148026749	NC_000016.10:23629824:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 28, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2329G>A (p.Asp777Asn)	PALB2	D777N	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000182767	16	23641146	16	23629825	182767	180724	rs148026749	NC_000016.10:23629824:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2328C>A (p.Phe776Leu)	PALB2	F776L	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000410211	16	23641147	16	23629826	410211	401521	rs45508997	NC_000016.10:23629825:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2328C>T (p.Phe776=)	PALB2		not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000225863	16	23641147	16	23629826	225863	227667	rs45508997	NC_000016.10:23629825:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2326T>C (p.Phe776Leu)	PALB2	F776L	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000419746	16	23641149	16	23629828	419746	409539	rs764925691	NC_000016.10:23629827:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 12, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2325A>G (p.Gln775=)	PALB2		Familial cancer of breast	VCV000944284	16	23641150	16	23629829	944284	927718	rs750089867	NC_000016.10:23629828:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2325A>T (p.Gln775His)	PALB2	Q775H	Familial cancer of breast	VCV000935625	16	23641150	16	23629829	935625	937363	rs750089867	NC_000016.10:23629828:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2325A>C (p.Gln775His)	PALB2	Q775H	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000230141	16	23641150	16	23629829	230141	235229	rs750089867	NC_000016.10:23629828:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2323C>T (p.Gln775Ter)	PALB2	Q775*	Hereditary cancer-predisposing syndrome|Malignant tumor of breast|not provided|Familial cancer of breast	VCV000126646	16	23641152	16	23629831	126646	132156	rs180177111	NC_000016.10:23629830:G:A	single nucleotide variant	nonsense	Pathogenic	Jan 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2322A>G (p.Lys774=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003228006	16	23641153	16	23629832	3228006	3387775	rs2142375613	NC_000016.10:23629831:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2320A>G (p.Lys774Glu)	PALB2	K774E	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000964993	16	23641155	16	23629834	964993	957697	rs757892044	NC_000016.10:23629833:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2320A>C (p.Lys774Gln)	PALB2	K774Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000946372	16	23641155	16	23629834	946372	927719	rs757892044	NC_000016.10:23629833:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2319T>C (p.Thr773=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000460937	16	23641156	16	23629835	460937	466215	rs562168734	NC_000016.10:23629834:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2319T>G (p.Thr773=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000391941	16	23641156	16	23629835	391941	377380	rs562168734	NC_000016.10:23629834:A:C	single nucleotide variant	synonymous variant	Likely benign	Mar 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2318C>G (p.Thr773Ser)	PALB2	T478S, T753S, T773S, T177S	Familial cancer of breast	VCV003654141	16	23641157	16	23629836	3654141	3782292		NC_000016.10:23629835:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2317A>T (p.Thr773Ser)	PALB2	T773S	Familial cancer of breast	VCV001511059	16	23641158	16	23629837	1511059	1377874	rs1567217632	NC_000016.10:23629836:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2317A>C (p.Thr773Pro)	PALB2	T773P	Hereditary cancer-predisposing syndrome	VCV000629960	16	23641158	16	23629837	629960	618379	rs1567217632	NC_000016.10:23629836:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2317A>G (p.Thr773Ala)	PALB2	T773A	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000628192	16	23641158	16	23629837	628192	618378	rs1567217632	NC_000016.10:23629836:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2316T>G (p.Asp772Glu)	PALB2	D772E	Familial cancer of breast	VCV001000769	16	23641159	16	23629838	1000769	996798	rs1555460406	NC_000016.10:23629837:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2316T>C (p.Asp772=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000484217	16	23641159	16	23629838	484217	477613	rs1555460406	NC_000016.10:23629837:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 25, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2315A>T (p.Asp772Val)	PALB2	D477V, D176V, D772V, D752V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003413469	16	23641160	16	23629839	3413469	3574692		NC_000016.10:23629838:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2315A>G (p.Asp772Gly)	PALB2	D176G, D477G, D752G, D772G	Hereditary cancer-predisposing syndrome	VCV003228005	16	23641160	16	23629839	3228005	3387774	rs2142375780	NC_000016.10:23629838:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2314G>A (p.Asp772Asn)	PALB2	D772N	Familial cancer of breast	VCV000658166	16	23641161	16	23629840	658166	644423	rs1597089401	NC_000016.10:23629839:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2313T>G (p.Ser771Arg)	PALB2	S751R, S175R, S476R, S771R	Hereditary cancer-predisposing syndrome	VCV003885208	16	23641162	16	23629841	3885208	4005530		NC_000016.10:23629840:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 19, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2312G>A (p.Ser771Asn)	PALB2	S175N, S751N, S771N, S476N	Hereditary cancer-predisposing syndrome	VCV001789458	16	23641163	16	23629842	1789458	1851128	rs2142375855	NC_000016.10:23629841:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2311A>G (p.Ser771Gly)	PALB2	S771G	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000186302	16	23641164	16	23629843	186302	184201	rs786202846	NC_000016.10:23629842:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2310C>T (p.Ala770=)	PALB2		Familial cancer of breast	VCV003903706	16	23641165	16	23629844	3903706	4019579		NC_000016.10:23629843:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2309C>T (p.Ala770Val)	PALB2	A770V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001332596	16	23641166	16	23629845	1332596	1323314	rs2142375912	NC_000016.10:23629844:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2308G>T (p.Ala770Ser)	PALB2	A750S, A770S, A174S, A475S	Hereditary cancer-predisposing syndrome	VCV001789391	16	23641167	16	23629846	1789391	1851061	rs2142375936	NC_000016.10:23629845:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2304T>C (p.Cys768=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000923723	16	23641171	16	23629850	923723	913631	rs1966857656	NC_000016.10:23629849:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2303G>A (p.Cys768Tyr)	PALB2	C768Y	Familial cancer of breast	VCV001045609	16	23641172	16	23629851	1045609	1032520	rs1060502770	NC_000016.10:23629850:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2303G>C (p.Cys768Ser)	PALB2	C768S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410160	16	23641172	16	23629851	410160	401524	rs1060502770	NC_000016.10:23629850:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 22, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2302T>C (p.Cys768Arg)	PALB2	C768R	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000808018	16	23641173	16	23629852	808018	797288	rs1597089419	NC_000016.10:23629851:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2301C>A (p.Val767=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000126645	16	23641174	16	23629853	126645	132155	rs515726084	NC_000016.10:23629852:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2299G>A (p.Val767Ile)	PALB2	V767I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001514737	16	23641176	16	23629855	1514737	1485780	rs1312270645	NC_000016.10:23629854:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2299G>C (p.Val767Leu)	PALB2	V767L	not provided|Familial cancer of breast	VCV000574121	16	23641176	16	23629855	574121	567965	rs1312270645	NC_000016.10:23629854:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2298A>T (p.Ser766=)	PALB2		Familial cancer of breast	VCV003904402	16	23641177	16	23629856	3904402	4020274		NC_000016.10:23629855:T:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2298A>G (p.Ser766=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492181	16	23641177	16	23629856	492181	484657	rs754921518	NC_000016.10:23629855:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2297C>A (p.Ser766Ter)	PALB2	S170*, S471*, S746*, S766*	Familial cancer of breast	VCV002674043	16	23641178	16	23629857	2674043	2841534	rs1555460410	NC_000016.10:23629856:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2297C>G (p.Ser766Ter)	PALB2	S170*, S471*, S766*, S746*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001789186	16	23641178	16	23629857	1789186	1850857	rs1555460410	NC_000016.10:23629856:G:C	single nucleotide variant	nonsense	Pathogenic	Sep 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2297C>T (p.Ser766Leu)	PALB2	S766L	Hereditary cancer-predisposing syndrome	VCV000484194	16	23641178	16	23629857	484194	477615	rs1555460410	NC_000016.10:23629856:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2296T>C (p.Ser766Pro)	PALB2	S766P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000821020	16	23641179	16	23629858	821020	812703	rs1597089461	NC_000016.10:23629857:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2295C>G (p.Asp765Glu)	PALB2	D169E, D470E, D745E, D765E	Hereditary cancer-predisposing syndrome	VCV001789159	16	23641180	16	23629859	1789159	1850830	rs2142376232	NC_000016.10:23629858:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2295C>T (p.Asp765=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001148940	16	23641180	16	23629859	1148940	1146007	rs2142376232	NC_000016.10:23629858:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2294A>G (p.Asp765Gly)	PALB2	D169G, D470G, D765G, D745G	Hereditary cancer-predisposing syndrome	VCV001789147	16	23641181	16	23629860	1789147	1850818	rs2142376265	NC_000016.10:23629859:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2291A>G (p.Lys764Arg)	PALB2	K764R	not provided	VCV001320417	16	23641184	16	23629863	1320417	1310662	rs2142376326	NC_000016.10:23629862:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2290A>G (p.Lys764Glu)	PALB2	K764E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460936	16	23641185	16	23629864	460936	466217	rs573744591	NC_000016.10:23629863:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2289G>C (p.Leu763Phe)	PALB2	L763F	not specified|Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000136133	16	23641186	16	23629865	136133	139845	rs373478248	NC_000016.10:23629864:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2288T>G (p.Leu763Trp)	PALB2	L743W, L763W, L167W, L468W	Hereditary cancer-predisposing syndrome	VCV003885201	16	23641187	16	23629866	3885201	4005523		NC_000016.10:23629865:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2287T>A (p.Leu763Met)	PALB2	L167M, L468M, L763M, L743M	Familial cancer of breast	VCV002717130	16	23641188	16	23629867	2717130	2872956	rs2142376414	NC_000016.10:23629866:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2286T>C (p.His762=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000821032	16	23641189	16	23629868	821032	812704	rs1597089487	NC_000016.10:23629867:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2285A>C (p.His762Pro)	PALB2	H467P, H166P, H742P, H762P	Familial cancer of breast	VCV003661329	16	23641190	16	23629869	3661329	3790988		NC_000016.10:23629868:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2285A>G (p.His762Arg)	PALB2	H762R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000927068	16	23641190	16	23629869	927068	913632	rs1238274171	NC_000016.10:23629868:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2284C>T (p.His762Tyr)	PALB2	H166Y, H467Y, H742Y, H762Y	Familial cancer of breast	VCV002727965	16	23641191	16	23629870	2727965	2889303	rs2142376472	NC_000016.10:23629869:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2283T>C (p.Ala761=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003413461	16	23641192	16	23629871	3413461	3574684		NC_000016.10:23629870:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2282C>A (p.Ala761Asp)	PALB2	A761D	Familial cancer of breast	VCV000651916	16	23641193	16	23629872	651916	644426	rs878855108	NC_000016.10:23629871:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2282C>T (p.Ala761Val)	PALB2	A761V	Familial cancer of breast	VCV000241542	16	23641193	16	23629872	241542	242366	rs878855108	NC_000016.10:23629871:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2281G>A (p.Ala761Thr)	PALB2	A165T, A741T, A466T, A761T	Familial cancer of breast	VCV002159962	16	23641194	16	23629873	2159962	1887040	rs2142376559	NC_000016.10:23629872:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2280T>G (p.Leu760=)	PALB2		Familial cancer of breast	VCV001126504	16	23641195	16	23629874	1126504	1125117	rs2142376591	NC_000016.10:23629873:A:C	single nucleotide variant	synonymous variant	Likely benign	Sep 16, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2278C>G (p.Leu760Val)	PALB2	L740V, L164V, L760V, L465V	Familial cancer of breast	VCV003657600	16	23641197	16	23629876	3657600	3779555		NC_000016.10:23629875:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2278C>A (p.Leu760Ile)	PALB2	L760I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000921077	16	23641197	16	23629876	921077	913633	rs769634658	NC_000016.10:23629875:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 30, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2278C>T (p.Leu760Phe)	PALB2	L760F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000568917	16	23641197	16	23629876	568917	569956	rs769634658	NC_000016.10:23629875:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2277A>T (p.Gln759His)	PALB2	Q464H, Q739H, Q163H, Q759H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002013892	16	23641198	16	23629877	2013892	2067975	rs786202524	NC_000016.10:23629876:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2277A>C (p.Gln759His)	PALB2	Q759H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000821009	16	23641198	16	23629877	821009	812705	rs786202524	NC_000016.10:23629876:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2277A>G (p.Gln759=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Fanconi anemia complementation group N|Familial cancer of breast|Breast and/or ovarian cancer	VCV000185872	16	23641198	16	23629877	185872	184202	rs786202524	NC_000016.10:23629876:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2276A>T (p.Gln759Leu)	PALB2	Q759L	Familial cancer of breast	VCV001436450	16	23641199	16	23629878	1436450	1340841	rs1555460421	NC_000016.10:23629877:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2276A>G (p.Gln759Arg)	PALB2	Q759R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484174	16	23641199	16	23629878	484174	477550	rs1555460421	NC_000016.10:23629877:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2275C>T (p.Gln759Ter)	PALB2	Q759*	Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV001319617	16	23641200	16	23629879	1319617	1309868	rs515726083	NC_000016.10:23629878:G:A	single nucleotide variant	nonsense	Pathogenic	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2274C>G (p.Pro758=)	PALB2		Familial cancer of breast	VCV003903891	16	23641201	16	23629880	3903891	4019764		NC_000016.10:23629879:G:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2274C>T (p.Pro758=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000233151	16	23641201	16	23629880	233151	235234	rs183322618	NC_000016.10:23629879:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2273C>T (p.Pro758Leu)	PALB2	P758L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|PALB2-related disorder	VCV000577747	16	23641202	16	23629881	577747	570178	rs746117401	NC_000016.10:23629880:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 5, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2273C>G (p.Pro758Arg)	PALB2	P758R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not provided	VCV000230502	16	23641202	16	23629881	230502	235235	rs746117401	NC_000016.10:23629880:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2272C>A (p.Pro758Thr)	PALB2	P758T	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000419741	16	23641203	16	23629882	419741	409541	rs1064794078	NC_000016.10:23629881:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2271A>G (p.Thr757=)	PALB2		Familial cancer of breast|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000185160	16	23641204	16	23629883	185160	184203	rs786201971	NC_000016.10:23629882:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2270C>T (p.Thr757Ile)	PALB2	T757I	Hereditary cancer-predisposing syndrome|not provided	VCV001204896	16	23641205	16	23629884	1204896	1195048	rs1966858072	NC_000016.10:23629883:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2268C>T (p.Cys756=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3	VCV000627918	16	23641207	16	23629886	627918	618380	rs1567217721	NC_000016.10:23629885:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2267G>A (p.Cys756Tyr)	PALB2	C756Y	Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000530136	16	23641208	16	23629887	530136	530133	rs925044785	NC_000016.10:23629886:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 10, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2266T>C (p.Cys756Arg)	PALB2	C756R	not provided|Familial cancer of breast	VCV000421313	16	23641209	16	23629888	421313	409542	rs1064795052	NC_000016.10:23629887:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2265C>A (p.Cys755Ter)	PALB2	C755*	Hereditary cancer-predisposing syndrome	VCV000926204	16	23641210	16	23629889	926204	913634	rs1966858159	NC_000016.10:23629888:G:T	single nucleotide variant	nonsense	Pathogenic	Mar 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2263T>C (p.Cys755Arg)	PALB2	C755R	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000410199	16	23641212	16	23629891	410199	401770	rs1060502794	NC_000016.10:23629890:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2262T>G (p.Thr754=)	PALB2		Familial cancer of breast	VCV002070690	16	23641213	16	23629892	2070690	2129915	rs775456479	NC_000016.10:23629891:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2262T>C (p.Thr754=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000481137	16	23641213	16	23629892	481137	477556	rs775456479	NC_000016.10:23629891:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 17, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2261C>G (p.Thr754Ser)	PALB2	T459S, T734S, T158S, T754S	Hereditary cancer-predisposing syndrome	VCV001788638	16	23641214	16	23629893	1788638	1840852	rs1966858206	NC_000016.10:23629892:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2261C>T (p.Thr754Ile)	PALB2	T158I, T459I, T734I, T754I	Familial cancer of breast	VCV001719408	16	23641214	16	23629893	1719408	1774712	rs1966858206	NC_000016.10:23629892:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2259A>G (p.Arg753=)	PALB2		Familial cancer of breast	VCV003659129	16	23641216	16	23629895	3659129	3794126		NC_000016.10:23629894:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2258G>A (p.Arg753Gln)	PALB2	R753Q	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000134996	16	23641217	16	23629896	134996	138735	rs587778586	NC_000016.10:23629895:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2257C>A (p.Arg753=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000231071	16	23641218	16	23629897	231071	235236	rs180177110	NC_000016.10:23629896:G:T	single nucleotide variant	synonymous variant	Likely benign	Mar 20, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.2257C>T (p.Arg753Ter)	PALB2	R753*	Fanconi anemia complementation group N|Familial cancer of breast|Malignant tumor of breast|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000142403	16	23641218	16	23629897	142403	152117	rs180177110	NC_000016.10:23629896:G:A	single nucleotide variant	nonsense	Pathogenic	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2256A>T (p.Gly752=)	PALB2		Familial cancer of breast	VCV003904339	16	23641219	16	23629898	3904339	4020211		NC_000016.10:23629897:T:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2256A>G (p.Gly752=)	PALB2		not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000126642	16	23641219	16	23629898	126642	132152	rs147120218	NC_000016.10:23629897:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2255G>T (p.Gly752Val)	PALB2	G732V, G156V, G457V, G752V	Hereditary cancer-predisposing syndrome	VCV001788514	16	23641220	16	23629899	1788514	1844574	rs2142377194	NC_000016.10:23629898:C:A	single nucleotide variant	missense variant	Likely benign	Jun 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2254G>A (p.Gly752Arg)	PALB2	G752R	Familial cancer of breast	VCV001003988	16	23641221	16	23629900	1003988	996799	rs1966858306	NC_000016.10:23629899:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2253T>C (p.Ala751=)	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000183792	16	23641222	16	23629901	183792	184204	rs138514571	NC_000016.10:23629900:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2252C>G (p.Ala751Gly)	PALB2	A731G, A155G, A751G, A456G	Hereditary cancer-predisposing syndrome	VCV003303995	16	23641223	16	23629902	3303995	3470162		NC_000016.10:23629901:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2250T>A (p.Val750=)	PALB2		Familial cancer of breast	VCV003903890	16	23641225	16	23629904	3903890	4019763		NC_000016.10:23629903:A:T	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2249T>C (p.Val750Ala)	PALB2	V750A	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000492179	16	23641226	16	23629905	492179	484827	rs1555460430	NC_000016.10:23629904:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2248G>C (p.Val750Leu)	PALB2	V730L, V455L, V154L, V750L	Hereditary cancer-predisposing syndrome	VCV001788369	16	23641227	16	23629906	1788369	1844431	rs1567217769	NC_000016.10:23629905:C:G	single nucleotide variant	missense variant	Uncertain significance	May 21, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2248G>A (p.Val750Ile)	PALB2	V750I	Hereditary cancer-predisposing syndrome	VCV000630481	16	23641227	16	23629906	630481	618381	rs1567217769	NC_000016.10:23629905:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2246A>G (p.Glu749Gly)	PALB2	E454G, E153G, E729G, E749G	Familial cancer of breast	VCV002844408	16	23641229	16	23629908	2844408	3008049	rs2142377384	NC_000016.10:23629907:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 9, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2245G>A (p.Glu749Lys)	PALB2	E153K, E454K, E729K, E749K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001788336	16	23641230	16	23629909	1788336	1844398	rs1555460431	NC_000016.10:23629908:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2245G>T (p.Glu749Ter)	PALB2	E749*	Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000482051	16	23641230	16	23629909	482051	477505	rs1555460431	NC_000016.10:23629908:C:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2244A>G (p.Thr748=)	PALB2		Familial cancer of breast|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000183967	16	23641231	16	23629910	183967	184205	rs750048627	NC_000016.10:23629909:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2243C>T (p.Thr748Ile)	PALB2	T152I, T453I, T728I, T748I	Hereditary cancer-predisposing syndrome|not provided	VCV002506787	16	23641232	16	23629911	2506787	2671759	rs762533408	NC_000016.10:23629910:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2242A>G (p.Thr748Ala)	PALB2	T748A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830162	16	23641233	16	23629912	830162	818488	rs1279823900	NC_000016.10:23629911:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 13, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2241T>A (p.Ser747=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001788289	16	23641234	16	23629913	1788289	1844352	rs2142377488	NC_000016.10:23629912:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 27, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2240C>G (p.Ser747Cys)	PALB2	S747C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460934	16	23641235	16	23629914	460934	466431	rs1373451258	NC_000016.10:23629913:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2239T>C (p.Ser747Pro)	PALB2	S747P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000820937	16	23641236	16	23629915	820937	812706	rs1189203530	NC_000016.10:23629914:A:G	single nucleotide variant	missense variant	Uncertain significance	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2238A>G (p.Ala746=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820936	16	23641237	16	23629916	820936	812707	rs1597089677	NC_000016.10:23629915:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2236G>A (p.Ala746Thr)	PALB2	A746T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000490074	16	23641239	16	23629918	490074	482918	rs1555460433	NC_000016.10:23629917:C:T	single nucleotide variant	missense variant	Uncertain significance	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2235A>G (p.Lys745=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000509245	16	23641240	16	23629919	509245	506211	rs765854776	NC_000016.10:23629918:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2234A>C (p.Lys745Thr)	PALB2	K149T, K450T, K725T, K745T	Familial cancer of breast	VCV003689618	16	23641241	16	23629920	3689618	3823533		NC_000016.10:23629919:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2234A>G (p.Lys745Arg)	PALB2	K745R	not provided|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480232	16	23641241	16	23629920	480232	477616	rs142343372	NC_000016.10:23629919:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2233A>G (p.Lys745Glu)	PALB2	K745E	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000141860	16	23641242	16	23629921	141860	151574	rs587782064	NC_000016.10:23629920:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2232A>G (p.Glu744=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV001150471	16	23641243	16	23629922	1150471	1146008	rs1047622969	NC_000016.10:23629921:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2231A>G (p.Glu744Gly)	PALB2	E744G	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000410178	16	23641244	16	23629923	410178	401093	rs1060502779	NC_000016.10:23629922:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2230G>A (p.Glu744Lys)	PALB2	E744K	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000128129	16	23641245	16	23629924	128129	133586	rs62625278	NC_000016.10:23629923:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2229T>C (p.Tyr743=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000215931	16	23641246	16	23629925	215931	213169	rs730881888	NC_000016.10:23629924:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2229T>A (p.Tyr743Ter)	PALB2	Y743*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000182766	16	23641246	16	23629925	182766	180725	rs730881888	NC_000016.10:23629924:A:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2228A>T (p.Tyr743Phe)	PALB2	Y743F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000185182	16	23641247	16	23629926	185182	184206	rs141749524	NC_000016.10:23629925:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 18, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2228A>G (p.Tyr743Cys)	PALB2	Y743C	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|not specified|Breast and/or ovarian cancer|Familial pancreatic carcinoma|Hereditary breast ovarian cancer syndrome	VCV000184708	16	23641247	16	23629926	184708	184207	rs141749524	NC_000016.10:23629925:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2226C>T (p.Ser742=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003413478	16	23641249	16	23629928	3413478	3574701		NC_000016.10:23629927:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 14, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2226C>A (p.Ser742=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001787996	16	23641249	16	23629928	1787996	1847439	rs2142377848	NC_000016.10:23629927:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 21, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2225C>G (p.Ser742Cys)	PALB2	S742C	Hereditary cancer-predisposing syndrome	VCV000628009	16	23641250	16	23629929	628009	618382	rs1555460437	NC_000016.10:23629928:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2225C>T (p.Ser742Phe)	PALB2	S742F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460932	16	23641250	16	23629929	460932	465461	rs1555460437	NC_000016.10:23629928:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2224T>C (p.Ser742Pro)	PALB2	S447P, S722P, S146P, S742P	Familial cancer of breast	VCV001914924	16	23641251	16	23629930	1914924	1973848	rs752682542	NC_000016.10:23629929:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2224T>G (p.Ser742Ala)	PALB2	S742A	Familial cancer of breast	VCV001009669	16	23641251	16	23629930	1009669	996800	rs752682542	NC_000016.10:23629929:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2223C>T (p.Gly741=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001787962	16	23641252	16	23629931	1787962	1847405	rs2142377927	NC_000016.10:23629930:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 26, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2222G>A (p.Gly741Asp)	PALB2	G741D, G721D, G145D, G446D	Familial cancer of breast	VCV002702677	16	23641253	16	23629932	2702677	2866228	rs755907224	NC_000016.10:23629931:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2222G>C (p.Gly741Ala)	PALB2	G145A, G721A, G446A, G741A	Hereditary cancer-predisposing syndrome	VCV001787956	16	23641253	16	23629932	1787956	1847399	rs755907224	NC_000016.10:23629931:C:G	single nucleotide variant	missense variant	Likely benign	Jul 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2222G>T (p.Gly741Val)	PALB2	G741V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480295	16	23641253	16	23629932	480295	477619	rs755907224	NC_000016.10:23629931:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2221G>A (p.Gly741Ser)	PALB2	G741S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484177	16	23641254	16	23629933	484177	477559	rs1555460440	NC_000016.10:23629932:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 7, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2220A>C (p.Gln740His)	PALB2	Q740H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000836868	16	23641255	16	23629934	836868	843585	rs1057523562	NC_000016.10:23629933:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2220A>G (p.Gln740=)	PALB2		not specified	VCV000389872	16	23641255	16	23629934	389872	375255	rs1057523562	NC_000016.10:23629933:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2218C>G (p.Gln740Glu)	PALB2	Q740E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000656741	16	23641257	16	23629936	656741	644427	rs1555460445	NC_000016.10:23629935:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2218C>T (p.Gln740Ter)	PALB2	Q740*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000481035	16	23641257	16	23629936	481035	477506	rs1555460445	NC_000016.10:23629935:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2217T>A (p.Pro739=)	PALB2		Familial cancer of breast	VCV002755726	16	23641258	16	23629937	2755726	2916898	rs876660727	NC_000016.10:23629936:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2217T>C (p.Pro739=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000233910	16	23641258	16	23629937	233910	235237	rs876660727	NC_000016.10:23629936:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2216C>T (p.Pro739Leu)	PALB2	P739L	Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|Familial cancer of breast	VCV001012396	16	23641259	16	23629938	1012396	1000929	rs1966858909	NC_000016.10:23629937:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2215C>T (p.Pro739Ser)	PALB2	P739S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001349418	16	23641260	16	23629939	1349418	1394181	rs2142378149	NC_000016.10:23629938:G:A	single nucleotide variant	missense variant	Uncertain significance	May 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2214C>A (p.Gly738=)	PALB2		Familial cancer of breast	VCV002036266	16	23641261	16	23629940	2036266	2090322	rs1555460448	NC_000016.10:23629939:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2214C>T (p.Gly738=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484240	16	23641261	16	23629940	484240	477513	rs1555460448	NC_000016.10:23629939:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2213G>A (p.Gly738Asp)	PALB2	G738D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484238	16	23641262	16	23629941	484238	478095	rs1555460450	NC_000016.10:23629940:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2210T>G (p.Phe737Cys)	PALB2	F737C	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000662223	16	23641265	16	23629944	662223	644428	rs1597089763	NC_000016.10:23629943:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2208C>T (p.Ala736=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000751185	16	23641267	16	23629946	751185	770773	rs369113809	NC_000016.10:23629945:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2208C>A (p.Ala736=)	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000185271	16	23641267	16	23629946	185271	184208	rs369113809	NC_000016.10:23629945:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2207C>A (p.Ala736Asp)	PALB2	A716D, A441D, A736D, A140D	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3	VCV003891899	16	23641268	16	23629947	3891899	4007788		NC_000016.10:23629946:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2207C>G (p.Ala736Gly)	PALB2	A736G	not provided|Familial cancer of breast	VCV000936242	16	23641268	16	23629947	936242	937364	rs746056001	NC_000016.10:23629946:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2207C>T (p.Ala736Val)	PALB2	A736V	Familial cancer of breast|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000530104	16	23641268	16	23629947	530104	530135	rs746056001	NC_000016.10:23629946:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2205A>G (p.Pro735=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000126641	16	23641270	16	23629949	126641	132151	rs515726082	NC_000016.10:23629948:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2204C>T (p.Pro735Leu)	PALB2	P735L	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000246252	16	23641271	16	23629950	246252	244958	rs199743500	NC_000016.10:23629949:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2203C>A (p.Pro735Thr)	PALB2	P735T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000820878	16	23641272	16	23629951	820878	812709	rs1597089790	NC_000016.10:23629950:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2202T>A (p.Thr734=)	PALB2		Familial cancer of breast	VCV003904029	16	23641273	16	23629952	3904029	4019902		NC_000016.10:23629951:A:T	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2202T>C (p.Thr734=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000703019	16	23641273	16	23629952	703019	693829	rs1278216949	NC_000016.10:23629951:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2202T>G (p.Thr734=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486007	16	23641273	16	23629952	486007	477514	rs1278216949	NC_000016.10:23629951:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2201C>A (p.Thr734Asn)	PALB2	T734N	not provided|Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|not specified	VCV000241541	16	23641274	16	23629953	241541	242367	rs878855107	NC_000016.10:23629952:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2200A>T (p.Thr734Ser)	PALB2	T734S	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000126640	16	23641275	16	23629954	126640	132150	rs45543843	NC_000016.10:23629953:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2199T>C (p.Thr733=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000229835	16	23641276	16	23629955	229835	235238	rs876658227	NC_000016.10:23629954:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2014	criteria provided, single submitter							
NM_024675.4(PALB2):c.2198C>G (p.Thr733Ser)	PALB2	T438S, T713S, T137S, T733S	Familial cancer of breast	VCV003708473	16	23641277	16	23629956	3708473	3836750		NC_000016.10:23629955:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2197A>G (p.Thr733Ala)	PALB2	T733A	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not specified|not provided	VCV000246024	16	23641278	16	23629957	246024	244959	rs879254051	NC_000016.10:23629956:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2193A>G (p.Leu731=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000923720	16	23641282	16	23629961	923720	913635	rs1966859238	NC_000016.10:23629960:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 13, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2192T>G (p.Leu731Ter)	PALB2	L731*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000617779	16	23641283	16	23629962	617779	609176	rs1567217898	NC_000016.10:23629961:A:C	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2191T>C (p.Leu731=)	PALB2		Familial cancer of breast	VCV001636947	16	23641284	16	23629963	1636947	1612236	rs2142378686	NC_000016.10:23629962:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 28, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2190C>T (p.Ile730=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003667678	16	23641285	16	23629964	3667678	3796254		NC_000016.10:23629963:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2190C>G (p.Ile730Met)	PALB2	I435M, I730M, I134M, I710M	Hereditary cancer-predisposing syndrome	VCV002774006	16	23641285	16	23629964	2774006	2934737	rs958771546	NC_000016.10:23629963:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 3, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2190C>A (p.Ile730=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001787416	16	23641285	16	23629964	1787416	1850397	rs958771546	NC_000016.10:23629963:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 1, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2189T>C (p.Ile730Thr)	PALB2	I730T	not provided|Familial cancer of breast	VCV001524491	16	23641286	16	23629965	1524491	1462965	rs2142378728	NC_000016.10:23629964:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2188A>G (p.Ile730Val)	PALB2	I730V	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|not specified	VCV000410110	16	23641287	16	23629966	410110	401094	rs1060502735	NC_000016.10:23629965:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2187C>T (p.Pro729=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000820846	16	23641288	16	23629967	820846	812710	rs1597089834	NC_000016.10:23629966:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2184C>T (p.Phe728=)	PALB2		Familial cancer of breast	VCV003903597	16	23641291	16	23629970	3903597	4019470		NC_000016.10:23629969:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2181T>A (p.Ala727=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001787282	16	23641294	16	23629973	1787282	1840802	rs1555460458	NC_000016.10:23629972:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2181T>G (p.Ala727=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000629278	16	23641294	16	23629973	629278	618384	rs1555460458	NC_000016.10:23629972:A:C	single nucleotide variant	synonymous variant	Likely benign	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2181T>C (p.Ala727=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530262	16	23641294	16	23629973	530262	529883	rs1555460458	NC_000016.10:23629972:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2180C>T (p.Ala727Val)	PALB2	A131V, A432V, A707V, A727V	Familial cancer of breast	VCV002150992	16	23641295	16	23629974	2150992	1888488	rs2142378959	NC_000016.10:23629973:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2179G>C (p.Ala727Pro)	PALB2	A727P	Hereditary cancer-predisposing syndrome	VCV000484185	16	23641296	16	23629975	484185	478097	rs1555460459	NC_000016.10:23629974:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2178T>C (p.Pro726=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000215930	16	23641297	16	23629976	215930	213170	rs863224429	NC_000016.10:23629975:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2177C>T (p.Pro726Leu)	PALB2	P726L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460930	16	23641298	16	23629977	460930	465469	rs1555460461	NC_000016.10:23629976:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2176C>T (p.Pro726Ser)	PALB2	P726S	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast	VCV000216744	16	23641299	16	23629978	216744	213171	rs566813395	NC_000016.10:23629977:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2175A>T (p.Ser725=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002696602	16	23641300	16	23629979	2696602	2858021	rs2142379081	NC_000016.10:23629978:T:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Sep 2, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2174C>G (p.Ser725Ter)	PALB2	S129*, S430*, S705*, S725*	Familial cancer of breast	VCV002674119	16	23641301	16	23629980	2674119	2841609	rs1567217931	NC_000016.10:23629979:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2174C>T (p.Ser725Leu)	PALB2	S725L	Hereditary cancer-predisposing syndrome	VCV000629584	16	23641301	16	23629980	629584	618385	rs1567217931	NC_000016.10:23629979:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2173T>C (p.Ser725Pro)	PALB2	S725P	Familial cancer of breast|not provided	VCV001320906	16	23641302	16	23629981	1320906	1311150	rs2142379132	NC_000016.10:23629980:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2172T>G (p.Cys724Trp)	PALB2	C704W, C724W, C128W, C429W	Familial cancer of breast	VCV003709960	16	23641303	16	23629982	3709960	3836938		NC_000016.10:23629981:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2172T>C (p.Cys724=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001171146	16	23641303	16	23629982	1171146	1161317	rs2142379156	NC_000016.10:23629981:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2171G>A (p.Cys724Tyr)	PALB2	C429Y, C704Y, C128Y, C724Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002567569	16	23641304	16	23629983	2567569	2731211	rs2142379180	NC_000016.10:23629982:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2170T>G (p.Cys724Gly)	PALB2	C724G	Familial cancer of breast	VCV000964032	16	23641305	16	23629984	964032	949307	rs1597089875	NC_000016.10:23629983:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2170T>C (p.Cys724Arg)	PALB2	C724R	Familial cancer of breast	VCV000652333	16	23641305	16	23629984	652333	644430	rs1597089875	NC_000016.10:23629983:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2169G>A (p.Met723Ile)	PALB2	M127I, M428I, M703I, M723I	Hereditary cancer-predisposing syndrome	VCV002774007	16	23641306	16	23629985	2774007	2934738	rs2142379245	NC_000016.10:23629984:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2167A>G (p.Met723Val)	PALB2	M723V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233695	16	23641308	16	23629987	233695	235240	rs876660336	NC_000016.10:23629986:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 9, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2167A>T (p.Met723Leu)	PALB2	M723L	Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000233328	16	23641308	16	23629987	233328	235239	rs876660336	NC_000016.10:23629986:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2166C>T (p.Asp722=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001786985	16	23641309	16	23629988	1786985	1840506	rs768901359	NC_000016.10:23629987:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2166C>G (p.Asp722Glu)	PALB2	D722E	Hereditary cancer-predisposing syndrome	VCV000629854	16	23641309	16	23629988	629854	618386	rs768901359	NC_000016.10:23629987:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2165A>C (p.Asp722Ala)	PALB2	D427A, D702A, D722A, D126A	Breast-ovarian cancer, familial, susceptibility to, 5	VCV004056111	16	23641310	16	23629989	4056111	4170051		NC_000016.10:23629988:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2165A>G (p.Asp722Gly)	PALB2	D722G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000820827	16	23641310	16	23629989	820827	812711	rs941888035	NC_000016.10:23629988:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2164G>C (p.Asp722His)	PALB2	D126H, D427H, D702H, D722H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001786964	16	23641311	16	23629990	1786964	1840485	rs1555460464	NC_000016.10:23629989:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2164G>A (p.Asp722Asn)	PALB2	D722N	Hereditary cancer-predisposing syndrome	VCV000481006	16	23641311	16	23629990	481006	478104	rs1555460464	NC_000016.10:23629989:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2163A>G (p.Thr721=)	PALB2		Familial cancer of breast	VCV002738995	16	23641312	16	23629991	2738995	2902359	rs587781105	NC_000016.10:23629990:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2163A>C (p.Thr721=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000138574	16	23641312	16	23629991	138574	142277	rs587781105	NC_000016.10:23629990:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2162C>G (p.Thr721Arg)	PALB2	T701R, T721R, T125R, T426R	Hereditary cancer-predisposing syndrome	VCV002567585	16	23641313	16	23629992	2567585	2731227	rs2142379467	NC_000016.10:23629991:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2160C>A (p.Thr720=)	PALB2		Familial cancer of breast	VCV003904262	16	23641315	16	23629994	3904262	4020135		NC_000016.10:23629993:G:T	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2160C>T (p.Thr720=)	PALB2		Familial cancer of breast	VCV000830159	16	23641315	16	23629994	830159	818491	rs1430544638	NC_000016.10:23629993:G:A	single nucleotide variant	synonymous variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2160C>G (p.Thr720=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000742730	16	23641315	16	23629994	742730	755028	rs1430544638	NC_000016.10:23629993:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2159C>T (p.Thr720Ile)	PALB2	T700I, T124I, T720I, T425I	Hereditary cancer-predisposing syndrome	VCV003413444	16	23641316	16	23629995	3413444	3574667		NC_000016.10:23629994:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Aug 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2158A>C (p.Thr720Pro)	PALB2	T720P	Hereditary cancer-predisposing syndrome	VCV000480257	16	23641317	16	23629996	480257	477517	rs1555460466	NC_000016.10:23629995:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2157T>A (p.Pro719=)	PALB2		Familial cancer of breast	VCV002041671	16	23641318	16	23629997	2041671	2091832	rs2142379569	NC_000016.10:23629996:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 3, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2157T>C (p.Pro719=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001786835	16	23641318	16	23629997	1786835	1844204	rs2142379569	NC_000016.10:23629996:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2156C>G (p.Pro719Arg)	PALB2	P719R	Hereditary cancer-predisposing syndrome	VCV000484206	16	23641319	16	23629998	484206	477573	rs1555460467	NC_000016.10:23629997:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.2155C>G (p.Pro719Ala)	PALB2	P719A	Familial cancer of breast	VCV001462578	16	23641320	16	23629999	1462578	1432981	rs2142379642	NC_000016.10:23629998:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2155C>T (p.Pro719Ser)	PALB2	P719S	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV001055669	16	23641320	16	23629999	1055669	1049517	rs2142379642	NC_000016.10:23629998:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2154G>C (p.Arg718Ser)	PALB2	R698S, R718S, R423S, R122S	Hereditary cancer-predisposing syndrome	VCV003927437	16	23641321	16	23630000	3927437	4047070		NC_000016.10:23629999:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 20, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2154G>A (p.Arg718=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003927422	16	23641321	16	23630000	3927422	4047055		NC_000016.10:23629999:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 8, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2152A>G (p.Arg718Gly)	PALB2	R122G, R423G, R698G, R718G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001786772	16	23641323	16	23630002	1786772	1844141	rs2142379727	NC_000016.10:23630001:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2150A>G (p.Asp717Gly)	PALB2	D717G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000631042	16	23641325	16	23630004	631042	618387	rs1555460469	NC_000016.10:23630003:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2150A>T (p.Asp717Val)	PALB2	D717V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530175	16	23641325	16	23630004	530175	529890	rs1555460469	NC_000016.10:23630003:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2149G>A (p.Asp717Asn)	PALB2	D717N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482030	16	23641326	16	23630005	482030	477575	rs748692809	NC_000016.10:23630004:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2148T>C (p.Asn716=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000751424	16	23641327	16	23630006	751424	770774	rs770145849	NC_000016.10:23630005:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2148T>A (p.Asn716Lys)	PALB2	N716K	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000245657	16	23641327	16	23630006	245657	244960	rs770145849	NC_000016.10:23630005:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2147A>G (p.Asn716Ser)	PALB2	N716S	Hereditary cancer-predisposing syndrome|not specified|Papillary thyroid carcinoma|not provided|Familial cancer of breast	VCV000232654	16	23641328	16	23630007	232654	235242	rs148335539	NC_000016.10:23630006:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2146A>G (p.Asn716Asp)	PALB2	N716D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001422282	16	23641329	16	23630008	1422282	1416054	rs2142379886	NC_000016.10:23630007:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2145T>C (p.Asp715=)	PALB2		Familial cancer of breast	VCV003903540	16	23641330	16	23630009	3903540	4019413		NC_000016.10:23630008:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2143G>A (p.Asp715Asn)	PALB2	D715N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001372305	16	23641332	16	23630011	1372305	1443550	rs2142379989	NC_000016.10:23630010:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2140G>A (p.Asp714Asn)	PALB2	D714N	Familial pancreatic carcinoma|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000216743	16	23641335	16	23630014	216743	213172	rs45537237	NC_000016.10:23630013:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2139T>A (p.Pro713=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001786524	16	23641336	16	23630015	1786524	1843894	rs2142380112	NC_000016.10:23630014:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2137C>A (p.Pro713Thr)	PALB2	P693T, P713T, P117T, P418T	Hereditary cancer-predisposing syndrome	VCV001786492	16	23641338	16	23630017	1786492	1843862	rs1555460475	NC_000016.10:23630016:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2137C>T (p.Pro713Ser)	PALB2	P713S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530065	16	23641338	16	23630017	530065	529891	rs1555460475	NC_000016.10:23630016:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2136G>T (p.Ala712=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000993083	16	23641339	16	23630018	993083	981150	rs905951607	NC_000016.10:23630017:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2136G>C (p.Ala712=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000629935	16	23641339	16	23630018	629935	618389	rs905951607	NC_000016.10:23630017:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2136G>A (p.Ala712=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000628834	16	23641339	16	23630018	628834	618390	rs905951607	NC_000016.10:23630017:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2135C>T (p.Ala712Val)	PALB2	A712V	Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|not specified	VCV000126637	16	23641340	16	23630019	126637	132147	rs141458731	NC_000016.10:23630018:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2134G>C (p.Ala712Pro)	PALB2	A712P	Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|Familial cancer of breast	VCV000186485	16	23641341	16	23630020	186485	184209	rs765942523	NC_000016.10:23630019:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 24, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2133T>C (p.Val711=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001786445	16	23641342	16	23630021	1786445	1847194	rs2142380275	NC_000016.10:23630020:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 13, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2133T>G (p.Val711=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001105535	16	23641342	16	23630021	1105535	1103702	rs2142380275	NC_000016.10:23630020:A:C	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2131G>T (p.Val711Phe)	PALB2	V711F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000642689	16	23641344	16	23630023	642689	644431	rs1555460478	NC_000016.10:23630022:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2131G>A (p.Val711Ile)	PALB2	V711I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460929	16	23641344	16	23630023	460929	466219	rs1555460478	NC_000016.10:23630022:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2130G>T (p.Thr710=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001786400	16	23641345	16	23630024	1786400	1847150	rs774049060	NC_000016.10:23630023:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2130G>A (p.Thr710=)	PALB2		not specified|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000184275	16	23641345	16	23630024	184275	184210	rs774049060	NC_000016.10:23630023:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2129C>T (p.Thr710Met)	PALB2	T710M	not provided|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410177	16	23641346	16	23630025	410177	401773	rs759024828	NC_000016.10:23630024:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2128A>G (p.Thr710Ala)	PALB2	T710A	Hereditary cancer-predisposing syndrome|PALB2-related disorder|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|not provided|not specified	VCV000182765	16	23641347	16	23630026	182765	180727	rs730881887	NC_000016.10:23630025:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2127T>G (p.Asn709Lys)	PALB2	N113K, N414K, N689K, N709K	Hereditary cancer-predisposing syndrome	VCV003894086	16	23641348	16	23630027	3894086	4009967		NC_000016.10:23630026:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2127T>C (p.Asn709=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000794944	16	23641348	16	23630027	794944	785223	rs1597090047	NC_000016.10:23630026:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2126A>G (p.Asn709Ser)	PALB2	N709S	Hereditary cancer-predisposing syndrome	VCV000480280	16	23641349	16	23630028	480280	477630	rs1555460485	NC_000016.10:23630027:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2125A>T (p.Asn709Tyr)	PALB2	N709Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000490073	16	23641350	16	23630029	490073	482922	rs1286704342	NC_000016.10:23630028:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2124A>G (p.Leu708=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003885204	16	23641351	16	23630030	3885204	4005526		NC_000016.10:23630029:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 11, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2124A>T (p.Leu708Phe)	PALB2	L708F	Familial cancer of breast	VCV000640163	16	23641351	16	23630030	640163	644432	rs1597090058	NC_000016.10:23630029:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2123T>A (p.Leu708Ter)	PALB2	L708*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820761	16	23641352	16	23630031	820761	812714	rs1597090059	NC_000016.10:23630030:A:T	single nucleotide variant	nonsense	Pathogenic	Jun 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2121T>C (p.Pro707=)	PALB2		Familial cancer of breast	VCV003904068	16	23641354	16	23630033	3904068	4019941		NC_000016.10:23630032:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2120C>T (p.Pro707Leu)	PALB2	P707L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530038	16	23641355	16	23630034	530038	530349	rs1363384297	NC_000016.10:23630033:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2119C>T (p.Pro707Ser)	PALB2	P707S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001466297	16	23641356	16	23630035	1466297	1449122	rs2142380644	NC_000016.10:23630034:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2118T>C (p.Thr706=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003927427	16	23641357	16	23630036	3927427	4047060		NC_000016.10:23630035:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 26, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2118T>G (p.Thr706=)	PALB2		Familial cancer of breast	VCV003903844	16	23641357	16	23630036	3903844	4019717		NC_000016.10:23630035:A:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2117C>T (p.Thr706Ile)	PALB2	T706I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000229718	16	23641358	16	23630037	229718	235244	rs587780209	NC_000016.10:23630036:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2117C>G (p.Thr706Ser)	PALB2	T706S	Hereditary cancer-predisposing syndrome|not provided	VCV000128127	16	23641358	16	23630037	128127	133584	rs587780209	NC_000016.10:23630036:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2116A>G (p.Thr706Ala)	PALB2	T706A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000803235	16	23641359	16	23630038	803235	791568	rs767056829	NC_000016.10:23630037:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2115T>C (p.Tyr705=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482069	16	23641360	16	23630039	482069	477631	rs1370808088	NC_000016.10:23630038:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2113T>C (p.Tyr705His)	PALB2	Y705H	not specified|not provided	VCV001318515	16	23641362	16	23630041	1318515	1308299	rs2142380766	NC_000016.10:23630040:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2112T>G (p.Leu704=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001786137	16	23641363	16	23630042	1786137	1846889	rs876659598	NC_000016.10:23630041:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 5, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2112T>A (p.Leu704=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000232174	16	23641363	16	23630042	232174	235245	rs876659598	NC_000016.10:23630041:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2111T>C (p.Leu704Pro)	PALB2	L409P, L684P, L704P, L108P	Hereditary cancer-predisposing syndrome	VCV003927455	16	23641364	16	23630043	3927455	4047088		NC_000016.10:23630042:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 31, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2111T>A (p.Leu704His)	PALB2	L704H	Hereditary cancer-predisposing syndrome	VCV001332366	16	23641364	16	23630043	1332366	1323084	rs1555460489	NC_000016.10:23630042:A:T	single nucleotide variant	missense variant	Uncertain significance	May 18, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2111T>G (p.Leu704Arg)	PALB2	L704R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460928	16	23641364	16	23630043	460928	466432	rs1555460489	NC_000016.10:23630042:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2110C>T (p.Leu704Phe)	PALB2	L704F	not provided	VCV001320835	16	23641365	16	23630044	1320835	1311079	rs2142380865	NC_000016.10:23630043:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2109A>G (p.Leu703=)	PALB2		Familial cancer of breast	VCV003904108	16	23641366	16	23630045	3904108	4019981		NC_000016.10:23630044:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2109A>C (p.Leu703Phe)	PALB2	L703F	Familial cancer of breast	VCV000844093	16	23641366	16	23630045	844093	843586	rs1966860376	NC_000016.10:23630044:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2108T>C (p.Leu703Ser)	PALB2	L107S, L408S, L683S, L703S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002103761	16	23641367	16	23630046	2103761	2169411	rs752592662	NC_000016.10:23630045:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2108T>G (p.Leu703Ter)	PALB2	L703*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000233463	16	23641367	16	23630046	233463	235246	rs752592662	NC_000016.10:23630045:A:C	single nucleotide variant	nonsense	Pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2107T>G (p.Leu703Val)	PALB2	L107V, L408V, L683V, L703V	Familial cancer of breast	VCV004056295	16	23641368	16	23630047	4056295	4170233		NC_000016.10:23630046:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2107T>C (p.Leu703=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482022	16	23641368	16	23630047	482022	477523	rs756030419	NC_000016.10:23630046:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2106A>G (p.Ile702Met)	PALB2	I702M	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000182764	16	23641369	16	23630048	182764	180728	rs730881886	NC_000016.10:23630047:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 11, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2105T>A (p.Ile702Lys)	PALB2	I702K, I407K, I106K, I682K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001785983	16	23641370	16	23630049	1785983	1850240	rs2142381022	NC_000016.10:23630048:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2104A>G (p.Ile702Val)	PALB2	I702V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001037237	16	23641371	16	23630050	1037237	1032521	rs587781888	NC_000016.10:23630049:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2104A>C (p.Ile702Leu)	PALB2	I702L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000141625	16	23641371	16	23630050	141625	151339	rs587781888	NC_000016.10:23630049:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2103C>T (p.Ser701=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000402297	16	23641372	16	23630051	402297	389268	rs753583700	NC_000016.10:23630050:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2102C>G (p.Ser701Cys)	PALB2	S701C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000629312	16	23641373	16	23630052	629312	618392	rs1429929576	NC_000016.10:23630051:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2101T>C (p.Ser701Pro)	PALB2	S701P	Familial cancer of breast	VCV000957676	16	23641374	16	23630053	957676	949308	rs1966860532	NC_000016.10:23630052:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2100A>C (p.Ser700=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002784445	16	23641375	16	23630054	2784445	2941703	rs757145884	NC_000016.10:23630053:T:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2100A>G (p.Ser700=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001130651	16	23641375	16	23630054	1130651	1125118	rs757145884	NC_000016.10:23630053:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2100A>T (p.Ser700=)	PALB2		Fanconi anemia complementation group N|not provided|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000184830	16	23641375	16	23630054	184830	184211	rs757145884	NC_000016.10:23630053:T:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2099C>G (p.Ser700Ter)	PALB2	S700*	Hereditary cancer-predisposing syndrome	VCV000820710	16	23641376	16	23630055	820710	812715	rs1597090146	NC_000016.10:23630054:G:C	single nucleotide variant	nonsense	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2098T>C (p.Ser700Pro)	PALB2	S700P, S405P, S680P, S104P	Familial cancer of breast	VCV002832862	16	23641377	16	23630056	2832862	2991406	rs2142381220	NC_000016.10:23630055:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2097T>C (p.Ser699=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820708	16	23641378	16	23630057	820708	812716	rs1597090151	NC_000016.10:23630056:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2096C>T (p.Ser699Phe)	PALB2	S699F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000566302	16	23641379	16	23630058	566302	573927	rs780397699	NC_000016.10:23630057:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2096C>G (p.Ser699Cys)	PALB2	S699C	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000231670	16	23641379	16	23630058	231670	235247	rs780397699	NC_000016.10:23630057:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2095T>A (p.Ser699Thr)	PALB2	S699T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000487036	16	23641380	16	23630059	487036	478109	rs1555460493	NC_000016.10:23630058:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2093T>C (p.Leu698Pro)	PALB2	L698P	Familial cancer of breast	VCV000830157	16	23641382	16	23630061	830157	818493	rs1966860685	NC_000016.10:23630060:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2091C>T (p.Gly697=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001117855	16	23641384	16	23630063	1117855	1103703	rs875989797	NC_000016.10:23630062:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2091C>A (p.Gly697=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000225862	16	23641384	16	23630063	225862	227668	rs875989797	NC_000016.10:23630062:G:T	single nucleotide variant	synonymous variant	Likely benign	May 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2090G>A (p.Gly697Asp)	PALB2	G101D, G402D, G677D, G697D	Familial cancer of breast	VCV001720136	16	23641385	16	23630064	1720136	1779175	rs2142381427	NC_000016.10:23630063:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2089G>T (p.Gly697Cys)	PALB2	G677C, G697C, G402C, G101C	Hereditary cancer-predisposing syndrome	VCV001785693	16	23641386	16	23630065	1785693	1849951	rs1567218116	NC_000016.10:23630064:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2089G>C (p.Gly697Arg)	PALB2	G677R, G101R, G402R, G697R	Hereditary cancer-predisposing syndrome	VCV001785688	16	23641386	16	23630065	1785688	1849946	rs1567218116	NC_000016.10:23630064:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2089G>A (p.Gly697Ser)	PALB2	G697S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000576843	16	23641386	16	23630065	576843	573928	rs1567218116	NC_000016.10:23630064:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2088G>C (p.Thr696=)	PALB2		Familial cancer of breast	VCV002763634	16	23641387	16	23630066	2763634	2925673	rs747270311	NC_000016.10:23630065:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2088G>A (p.Thr696=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460927	16	23641387	16	23630066	460927	466223	rs747270311	NC_000016.10:23630065:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2087C>A (p.Thr696Lys)	PALB2	T696K	Familial cancer of breast	VCV001061301	16	23641388	16	23630067	1061301	1049518	rs587780820	NC_000016.10:23630066:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2087C>T (p.Thr696Met)	PALB2	T696M	Familial cancer of breast|PALB2-related disorder|Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000136131	16	23641388	16	23630067	136131	139843	rs587780820	NC_000016.10:23630066:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2086A>G (p.Thr696Ala)	PALB2	T696A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000820686	16	23641389	16	23630068	820686	812717	rs1195275297	NC_000016.10:23630067:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2084A>G (p.Lys695Arg)	PALB2	K675R, K400R, K99R, K695R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001785608	16	23641391	16	23630070	1785608	1840405	rs1406659804	NC_000016.10:23630069:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2083A>T (p.Lys695Ter)	PALB2	K695*	Familial cancer of breast	VCV000830155	16	23641392	16	23630071	830155	818495	rs1567218141	NC_000016.10:23630070:T:A	single nucleotide variant	nonsense	Pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2083A>G (p.Lys695Glu)	PALB2	K695E	Familial cancer of breast	VCV000577388	16	23641392	16	23630071	577388	573932	rs1567218141	NC_000016.10:23630070:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2082A>G (p.Thr694=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|not specified|not provided	VCV000183889	16	23641393	16	23630072	183889	184212	rs781440401	NC_000016.10:23630071:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2081C>G (p.Thr694Arg)	PALB2	T694R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000643070	16	23641394	16	23630073	643070	644433	rs1439027692	NC_000016.10:23630072:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2081C>A (p.Thr694Lys)	PALB2	T694K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482061	16	23641394	16	23630073	482061	477578	rs1439027692	NC_000016.10:23630072:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2080A>G (p.Thr694Ala)	PALB2	T694A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000579046	16	23641395	16	23630074	579046	569960	rs1567218150	NC_000016.10:23630073:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2079T>C (p.His693=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486010	16	23641396	16	23630075	486010	478113	rs1433680345	NC_000016.10:23630074:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2078A>T (p.His693Leu)	PALB2	H693L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000820667	16	23641397	16	23630076	820667	812718	rs587780208	NC_000016.10:23630075:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2078A>G (p.His693Arg)	PALB2	H693R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000128126	16	23641397	16	23630076	128126	133583	rs587780208	NC_000016.10:23630075:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 28, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2077C>A (p.His693Asn)	PALB2	H693N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820664	16	23641398	16	23630077	820664	812719	rs150585579	NC_000016.10:23630076:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2076G>T (p.Gln692His)	PALB2	Q692H	Hereditary cancer-predisposing syndrome	VCV000820663	16	23641399	16	23630078	820663	812720	rs876660531	NC_000016.10:23630077:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.2076G>A (p.Gln692=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000796970	16	23641399	16	23630078	796970	785224	rs876660531	NC_000016.10:23630077:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2076G>C (p.Gln692His)	PALB2	Q692H	Hereditary cancer-predisposing syndrome	VCV000233626	16	23641399	16	23630078	233626	235248	rs876660531	NC_000016.10:23630077:C:G	single nucleotide variant	missense variant	Uncertain significance	May 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2075A>C (p.Gln692Pro)	PALB2	Q397P, Q672P, Q692P, Q96P	Familial cancer of breast	VCV001717224	16	23641400	16	23630079	1717224	1776049	rs1555460499	NC_000016.10:23630078:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2075A>G (p.Gln692Arg)	PALB2	Q692R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481126	16	23641400	16	23630079	481126	477633	rs1555460499	NC_000016.10:23630078:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2074C>T (p.Gln692Ter)	PALB2	Q692*	Familial cancer of breast	VCV000143966	16	23641401	16	23630080	143966	153696	rs587776415	NC_000016.10:23630079:G:A	single nucleotide variant	nonsense	Likely pathogenic	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.2073C>A (p.Ser691Arg)	PALB2	S671R, S691R, S95R, S396R	Hereditary cancer-predisposing syndrome	VCV001785426	16	23641402	16	23630081	1785426	1840223	rs1567218173	NC_000016.10:23630080:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2073C>G (p.Ser691Arg)	PALB2	S691R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000631393	16	23641402	16	23630081	631393	618393	rs1567218173	NC_000016.10:23630080:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2072G>A (p.Ser691Asn)	PALB2	S691N	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000460926	16	23641403	16	23630082	460926	465472	rs1555460502	NC_000016.10:23630081:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2071A>T (p.Ser691Cys)	PALB2	S396C, S671C, S691C, S95C	Hereditary cancer-predisposing syndrome	VCV001785397	16	23641404	16	23630083	1785397	1840194	rs1555460504	NC_000016.10:23630082:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2071A>G (p.Ser691Gly)	PALB2	S691G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480256	16	23641404	16	23630083	480256	477524	rs1555460504	NC_000016.10:23630082:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2068C>T (p.Gln690Ter)	PALB2	Q395*, Q670*, Q690*, Q94*	Familial cancer of breast	VCV002673847	16	23641407	16	23630086	2673847	2841349	rs1555460505	NC_000016.10:23630085:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2068C>G (p.Gln690Glu)	PALB2	Q690E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530153	16	23641407	16	23630086	530153	530353	rs1555460505	NC_000016.10:23630085:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2067G>T (p.Ser689=)	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000241538	16	23641408	16	23630087	241538	242369	rs371149159	NC_000016.10:23630086:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2067G>A (p.Ser689=)	PALB2		Fanconi anemia complementation group N|not provided|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000185889	16	23641408	16	23630087	185889	184213	rs371149159	NC_000016.10:23630086:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2066C>A (p.Ser689Ter)	PALB2	S689*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000246056	16	23641409	16	23630088	246056	244961	rs749602688	NC_000016.10:23630087:G:T	single nucleotide variant	nonsense	Pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2066C>T (p.Ser689Leu)	PALB2	S689L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000241537	16	23641409	16	23630088	241537	242370	rs749602688	NC_000016.10:23630087:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2065T>G (p.Ser689Ala)	PALB2	S689A	not specified|Familial cancer of breast	VCV001321380	16	23641410	16	23630089	1321380	1311664	rs2142382088	NC_000016.10:23630088:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2064C>T (p.Asn688=)	PALB2		Familial cancer of breast	VCV001657337	16	23641411	16	23630090	1657337	1628501	rs2142382120	NC_000016.10:23630089:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2062A>G (p.Asn688Asp)	PALB2	N688D, N393D, N92D, N668D	Hereditary cancer-predisposing syndrome	VCV003413445	16	23641413	16	23630092	3413445	3574668		NC_000016.10:23630091:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2062A>C (p.Asn688His)	PALB2	N393H, N668H, N688H, N92H	not provided	VCV001809570	16	23641413	16	23630092	1809570	1866574	rs2142382154	NC_000016.10:23630091:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2060C>G (p.Pro687Arg)	PALB2	P687R, P392R, P667R, P91R	Familial cancer of breast	VCV002830401	16	23641415	16	23630094	2830401	2997879	rs2142382172	NC_000016.10:23630093:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2058G>C (p.Arg686Ser)	PALB2	R391S, R666S, R686S, R90S	Hereditary cancer-predisposing syndrome|not provided	VCV002429692	16	23641417	16	23630096	2429692	2403190	rs771376636	NC_000016.10:23630095:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2058G>T (p.Arg686Ser)	PALB2	R686S	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000241536	16	23641417	16	23630096	241536	242371	rs771376636	NC_000016.10:23630095:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2057G>A (p.Arg686Lys)	PALB2	R686K	PALB2-related disorder|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000080060	16	23641418	16	23630097	80060	90951	rs267604470	NC_000016.10:23630096:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2055A>C (p.Lys685Asn)	PALB2	K390N, K665N, K685N, K89N	Familial cancer of breast	VCV001713725	16	23641420	16	23630099	1713725	1777620	rs1597090304	NC_000016.10:23630098:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2055A>G (p.Lys685=)	PALB2		Familial cancer of breast	VCV000756887	16	23641420	16	23630099	756887	770775	rs1597090304	NC_000016.10:23630098:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2054A>G (p.Lys685Arg)	PALB2	K685R	Familial cancer of breast	VCV000665746	16	23641421	16	23630100	665746	644434	rs1597090309	NC_000016.10:23630099:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2053A>C (p.Lys685Gln)	PALB2	K685Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000245754	16	23641422	16	23630101	245754	244962	rs876660397	NC_000016.10:23630100:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2053A>G (p.Lys685Glu)	PALB2	K685E	not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233422	16	23641422	16	23630101	233422	235249	rs876660397	NC_000016.10:23630100:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2052C>T (p.Pro684=)	PALB2		Familial cancer of breast	VCV001107371	16	23641423	16	23630102	1107371	1103704	rs2142382363	NC_000016.10:23630101:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 6, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2051C>G (p.Pro684Arg)	PALB2	P684R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001051072	16	23641424	16	23630103	1051072	1049519	rs2142382405	NC_000016.10:23630102:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2050C>T (p.Pro684Ser)	PALB2	P389S, P664S, P684S, P88S	Familial cancer of breast	VCV002744060	16	23641425	16	23630104	2744060	2903537	rs2142382431	NC_000016.10:23630103:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2050C>A (p.Pro684Thr)	PALB2	P664T, P389T, P684T, P88T	Hereditary cancer-predisposing syndrome	VCV001785066	16	23641425	16	23630104	1785066	1843711	rs2142382431	NC_000016.10:23630103:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2048A>G (p.His683Arg)	PALB2	H683R, H388R, H663R, H87R	Familial cancer of breast	VCV003667606	16	23641427	16	23630106	3667606	3796182		NC_000016.10:23630105:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2047C>T (p.His683Tyr)	PALB2	H683Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492175	16	23641428	16	23630107	492175	484660	rs1555460511	NC_000016.10:23630106:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2046A>G (p.Ser682=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000759431	16	23641429	16	23630108	759431	770776	rs1442566697	NC_000016.10:23630107:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2045C>A (p.Ser682Ter)	PALB2	S387*, S662*, S682*, S86*	Hereditary cancer-predisposing syndrome	VCV003413431	16	23641430	16	23630109	3413431	3574654		NC_000016.10:23630108:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jul 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2045C>T (p.Ser682Leu)	PALB2	S682L	Hereditary cancer-predisposing syndrome	VCV000820578	16	23641430	16	23630109	820578	812722	rs1597090341	NC_000016.10:23630108:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2043A>G (p.Lys681=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000392625	16	23641432	16	23630111	392625	374270	rs1057524569	NC_000016.10:23630110:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2042A>G (p.Lys681Arg)	PALB2	K681R, K85R, K386R, K661R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002002808	16	23641433	16	23630112	2002808	2058168	rs1555460514	NC_000016.10:23630111:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2042A>C (p.Lys681Thr)	PALB2	K681T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480250	16	23641433	16	23630112	480250	477638	rs1555460514	NC_000016.10:23630111:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 22, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2041A>C (p.Lys681Gln)	PALB2	K386Q, K681Q, K85Q, K661Q	Familial cancer of breast	VCV002698540	16	23641434	16	23630113	2698540	2858680	rs2142382651	NC_000016.10:23630112:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2041A>G (p.Lys681Glu)	PALB2	K681E	Familial cancer of breast	VCV001408933	16	23641434	16	23630113	1408933	1496722	rs2142382651	NC_000016.10:23630112:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2041A>T (p.Lys681Ter)	PALB2	K681*	Familial cancer of breast	VCV001074762	16	23641434	16	23630113	1074762	1063587	rs2142382651	NC_000016.10:23630112:T:A	single nucleotide variant	nonsense	Pathogenic	Sep 9, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2040A>C (p.Gly680=)	PALB2		Familial cancer of breast	VCV000798975	16	23641435	16	23630114	798975	785225	rs1597090358	NC_000016.10:23630113:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2039G>A (p.Gly680Glu)	PALB2	G680E	Familial cancer of breast	VCV001051916	16	23641436	16	23630115	1051916	1049520	rs759218890	NC_000016.10:23630114:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2038G>T (p.Gly680Ter)	PALB2	G385*, G660*, G680*, G84*	Familial cancer of breast|not provided	VCV002502659	16	23641437	16	23630116	2502659	2667765	rs1223755856	NC_000016.10:23630115:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic/Likely pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2038G>C (p.Gly680Arg)	PALB2	G385R, G680R, G660R, G84R	Hereditary cancer-predisposing syndrome	VCV001784851	16	23641437	16	23630116	1784851	1843496	rs1223755856	NC_000016.10:23630115:C:G	single nucleotide variant	missense variant	Uncertain significance	May 5, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.2038G>A (p.Gly680Arg)	PALB2	G680R	Familial cancer of breast	VCV000460925	16	23641437	16	23630116	460925	466205	rs1223755856	NC_000016.10:23630115:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.2035C>T (p.Pro679Ser)	PALB2	P384S, P83S, P659S, P679S	Hereditary cancer-predisposing syndrome	VCV001784811	16	23641440	16	23630119	1784811	1843456	rs2142382817	NC_000016.10:23630118:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2034A>T (p.Leu678=)	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast	VCV001095109	16	23641441	16	23630120	1095109	1081888	rs373796987	NC_000016.10:23630119:T:A	single nucleotide variant	synonymous variant	Likely benign	Apr 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2034A>G (p.Leu678=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000378318	16	23641441	16	23630120	378318	374274	rs373796987	NC_000016.10:23630119:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2032C>T (p.Leu678=)	PALB2		Familial cancer of breast|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000231579	16	23641443	16	23630122	231579	235250	rs376189676	NC_000016.10:23630121:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2031T>G (p.Val677=)	PALB2		Familial cancer of breast	VCV003651625	16	23641444	16	23630123	3651625	3788336		NC_000016.10:23630122:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2031T>C (p.Val677=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000221122	16	23641444	16	23630123	221122	222466	rs864622756	NC_000016.10:23630122:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2028T>C (p.Ile676=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820552	16	23641447	16	23630126	820552	812723	rs763937788	NC_000016.10:23630125:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2028T>G (p.Ile676Met)	PALB2	I676M	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410134	16	23641447	16	23630126	410134	401095	rs763937788	NC_000016.10:23630125:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2027T>C (p.Ile676Thr)	PALB2	I676T	Familial cancer of breast	VCV000142310	16	23641448	16	23630127	142310	152024	rs200875161	NC_000016.10:23630126:A:G	single nucleotide variant	missense variant	Benign	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.2026A>C (p.Ile676Leu)	PALB2	I676L	Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000484244	16	23641449	16	23630128	484244	477581	rs761478794	NC_000016.10:23630127:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 31, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2025T>A (p.Leu675=)	PALB2		Familial cancer of breast	VCV001635703	16	23641450	16	23630129	1635703	1524165	rs1597090426	NC_000016.10:23630128:A:T	single nucleotide variant	synonymous variant	Likely benign	Feb 21, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2025T>G (p.Leu675=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000925463	16	23641450	16	23630129	925463	913636	rs1597090426	NC_000016.10:23630128:A:C	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2025T>C (p.Leu675=)	PALB2		not provided	VCV000763337	16	23641450	16	23630129	763337	770777	rs1597090426	NC_000016.10:23630128:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 20, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2022C>T (p.Asp674=)	PALB2		Familial cancer of breast	VCV003618941	16	23641453	16	23630132	3618941	3759421		NC_000016.10:23630131:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2022C>A (p.Asp674Glu)	PALB2	D379E, D654E, D674E, D78E	Familial cancer of breast	VCV001722139	16	23641453	16	23630132	1722139	1777001	rs2142383191	NC_000016.10:23630131:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.2021A>C (p.Asp674Ala)	PALB2	D674A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001483842	16	23641454	16	23630133	1483842	1458625	rs1064793726	NC_000016.10:23630132:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2021A>T (p.Asp674Val)	PALB2	D674V	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000419213	16	23641454	16	23630133	419213	409543	rs1064793726	NC_000016.10:23630132:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2020G>T (p.Asp674Tyr)	PALB2	D674Y	not specified	VCV001697759	16	23641455	16	23630134	1697759	1690143	rs730881885	NC_000016.10:23630133:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2020G>A (p.Asp674Asn)	PALB2	D674N	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000182763	16	23641455	16	23630134	182763	180730	rs730881885	NC_000016.10:23630133:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 18, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2019G>A (p.Glu673=)	PALB2		Familial cancer of breast	VCV002765275	16	23641456	16	23630135	2765275	2926022	rs2142383305	NC_000016.10:23630134:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.2018A>G (p.Glu673Gly)	PALB2	E378G, E653G, E77G, E673G	Hereditary cancer-predisposing syndrome	VCV003885223	16	23641457	16	23630136	3885223	4005545		NC_000016.10:23630135:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2018A>C (p.Glu673Ala)	PALB2	E673A	Hereditary cancer-predisposing syndrome	VCV000820524	16	23641457	16	23630136	820524	812724	rs1597090441	NC_000016.10:23630135:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.2017G>A (p.Glu673Lys)	PALB2	E673K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460924	16	23641458	16	23630137	460924	465474	rs1236182341	NC_000016.10:23630136:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.2016A>G (p.Glu672=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001784468	16	23641459	16	23630138	1784468	1846528	rs2142383398	NC_000016.10:23630137:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2016A>C (p.Glu672Asp)	PALB2	E672D	Hereditary cancer-predisposing syndrome	VCV001691944	16	23641459	16	23630138	1691944	1684386	rs2142383398	NC_000016.10:23630137:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2015A>G (p.Glu672Gly)	PALB2	E652G, E672G, E377G, E76G	Hereditary cancer-predisposing syndrome	VCV001784459	16	23641460	16	23630139	1784459	1846519	rs2142383435	NC_000016.10:23630138:T:C	single nucleotide variant	missense variant	Uncertain significance	May 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2014G>T (p.Glu672Ter)	PALB2	E672*	Familial cancer of breast	VCV001445586	16	23641461	16	23630140	1445586	1490457	rs45532440	NC_000016.10:23630139:C:A	single nucleotide variant	nonsense	Pathogenic	Dec 12, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2014G>A (p.Glu672Lys)	PALB2	E672K	Familial cancer of breast|not provided	VCV000422427	16	23641461	16	23630140	422427	409544	rs45532440	NC_000016.10:23630139:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2014G>C (p.Glu672Gln)	PALB2	E672Q	Familial cancer of breast	VCV000126630	16	23641461	16	23630140	126630	132140	rs45532440	NC_000016.10:23630139:C:G	single nucleotide variant	missense variant	Benign	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.2013A>G (p.Leu671=)	PALB2		Familial cancer of breast	VCV003903881	16	23641462	16	23630141	3903881	4019754		NC_000016.10:23630140:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.2013A>C (p.Leu671Phe)	PALB2	L671F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001348697	16	23641462	16	23630141	1348697	1456085	rs2142383518	NC_000016.10:23630140:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2012T>C (p.Leu671Ser)	PALB2	L376S, L671S, L651S, L75S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002697505	16	23641463	16	23630142	2697505	2864902	rs755263466	NC_000016.10:23630141:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2012T>G (p.Leu671Ter)	PALB2	L671*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000632932	16	23641463	16	23630142	632932	621531	rs755263466	NC_000016.10:23630141:A:C	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2010C>G (p.Asp670Glu)	PALB2	D670E, D74E, D375E, D650E	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV002056250	16	23641465	16	23630144	2056250	2112833	rs2142383581	NC_000016.10:23630143:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2009A>G (p.Asp670Gly)	PALB2	D670G	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001430269	16	23641466	16	23630145	1430269	1393191	rs781352462	NC_000016.10:23630144:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2006A>G (p.Glu669Gly)	PALB2	E669G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000578598	16	23641469	16	23630148	578598	573937	rs1567218281	NC_000016.10:23630147:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2004G>T (p.Met668Ile)	PALB2	M668I	Familial cancer of breast	VCV001465331	16	23641471	16	23630150	1465331	1511155	rs2142383719	NC_000016.10:23630149:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.2003T>C (p.Met668Thr)	PALB2	M373T, M668T, M72T, M648T	Familial cancer of breast	VCV003658522	16	23641472	16	23630151	3658522	3796943		NC_000016.10:23630150:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.2002A>G (p.Met668Val)	PALB2	M72V, M373V, M648V, M668V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002051610	16	23641473	16	23630152	2051610	2108200	rs2142383760	NC_000016.10:23630151:T:C	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2001A>T (p.Glu667Asp)	PALB2	E667D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460923	16	23641474	16	23630153	460923	466206	rs1421924676	NC_000016.10:23630152:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1998A>G (p.Thr666=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001784083	16	23641477	16	23630156	1784083	1849642	rs2142383870	NC_000016.10:23630155:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1997C>T (p.Thr666Ile)	PALB2	T666I	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast	VCV000631241	16	23641478	16	23630157	631241	618394	rs1567218311	NC_000016.10:23630156:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1996A>G (p.Thr666Ala)	PALB2	T371A, T70A, T666A, T646A	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3	VCV003891898	16	23641479	16	23630158	3891898	4007787		NC_000016.10:23630157:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1994A>G (p.Asp665Gly)	PALB2	D665G, D69G, D645G, D370G	Familial cancer of breast	VCV002009016	16	23641481	16	23630160	2009016	2063089	rs1555460531	NC_000016.10:23630159:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1994A>T (p.Asp665Val)	PALB2	D665V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484166	16	23641481	16	23630160	484166	477640	rs1555460531	NC_000016.10:23630159:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 22, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1993G>A (p.Asp665Asn)	PALB2	D370N, D665N, D645N, D69N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001784015	16	23641482	16	23630161	1784015	1849574	rs2142383972	NC_000016.10:23630160:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1992G>A (p.Met664Ile)	PALB2	M664I, M68I, M369I, M644I	Familial cancer of breast	VCV002741617	16	23641483	16	23630162	2741617	2896369	rs2142383999	NC_000016.10:23630161:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 29, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1991T>A (p.Met664Lys)	PALB2	M644K, M664K, M68K, M369K	Hereditary cancer-predisposing syndrome	VCV001783979	16	23641484	16	23630163	1783979	1849538	rs945657254	NC_000016.10:23630162:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1991T>G (p.Met664Arg)	PALB2	M664R	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000560873	16	23641484	16	23630163	560873	551916	rs945657254	NC_000016.10:23630162:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 29, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1991T>C (p.Met664Thr)	PALB2	M664T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460922	16	23641484	16	23630163	460922	465480	rs945657254	NC_000016.10:23630162:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1990A>G (p.Met664Val)	PALB2	M664V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820473	16	23641485	16	23630164	820473	812725	rs752714298	NC_000016.10:23630163:T:C	single nucleotide variant	missense variant	Uncertain significance	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1990A>C (p.Met664Leu)	PALB2	M664L	Familial cancer of breast	VCV000460921	16	23641485	16	23630164	460921	465481	rs752714298	NC_000016.10:23630163:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1989C>T (p.Arg663=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000385459	16	23641486	16	23630165	385459	374925	rs1057522230	NC_000016.10:23630164:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1988G>A (p.Arg663His)	PALB2	R663H	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000856518	16	23641487	16	23630166	856518	843589	rs1462734899	NC_000016.10:23630165:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1988G>T (p.Arg663Leu)	PALB2	R663L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530061	16	23641487	16	23630166	530061	529830	rs1462734899	NC_000016.10:23630165:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1987C>A (p.Arg663Ser)	PALB2	R368S, R67S, R643S, R663S	Hereditary cancer-predisposing syndrome	VCV001783886	16	23641488	16	23630167	1783886	1849445	rs62625277	NC_000016.10:23630166:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1987C>T (p.Arg663Cys)	PALB2	R663C	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided|Familial pancreatic carcinoma	VCV000128125	16	23641488	16	23630167	128125	133582	rs62625277	NC_000016.10:23630166:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 24, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1985A>G (p.Lys662Arg)	PALB2	K662R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486014	16	23641490	16	23630169	486014	478122	rs1441798714	NC_000016.10:23630168:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1984A>T (p.Lys662Ter)	PALB2	K662*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530125	16	23641491	16	23630170	530125	529895	rs1555460533	NC_000016.10:23630169:T:A	single nucleotide variant	nonsense	Pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1983T>G (p.Pro661=)	PALB2		Familial cancer of breast	VCV002749960	16	23641492	16	23630171	2749960	2918918	rs2142384272	NC_000016.10:23630170:A:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1982C>T (p.Pro661Leu)	PALB2	P366L, P641L, P65L, P661L	Hereditary cancer-predisposing syndrome	VCV003228000	16	23641493	16	23630172	3228000	3387769	rs71379822	NC_000016.10:23630171:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Nov 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1982C>G (p.Pro661Arg)	PALB2	P661R	Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not provided|not specified|Familial cancer of breast	VCV000232550	16	23641493	16	23630172	232550	235251	rs71379822	NC_000016.10:23630171:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1981C>T (p.Pro661Ser)	PALB2	P661S, P366S, P641S, P65S	Hereditary cancer-predisposing syndrome	VCV001783817	16	23641494	16	23630173	1783817	1839913	rs2142384334	NC_000016.10:23630172:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1980T>C (p.Ser660=)	PALB2		not provided	VCV000668438	16	23641495	16	23630174	668438	656359	rs1597090541	NC_000016.10:23630173:A:G	single nucleotide variant	synonymous variant	Likely benign	May 14, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1978A>G (p.Ser660Gly)	PALB2	S660G	Familial cancer of breast	VCV001063289	16	23641497	16	23630176	1063289	1049521	rs2142384431	NC_000016.10:23630175:T:C	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1976T>C (p.Leu659Pro)	PALB2	L639P, L63P, L364P, L659P	Hereditary cancer-predisposing syndrome	VCV003304013	16	23641499	16	23630178	3304013	3470180		NC_000016.10:23630177:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1975C>A (p.Leu659Met)	PALB2	L364M, L639M, L63M, L659M	Familial cancer of breast	VCV003240006	16	23641500	16	23630179	3240006	3398994	rs906858995	NC_000016.10:23630178:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1975C>G (p.Leu659Val)	PALB2	L659V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000566045	16	23641500	16	23630179	566045	573939	rs906858995	NC_000016.10:23630178:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1974A>T (p.Glu658Asp)	PALB2	E658D	Hereditary cancer-predisposing syndrome	VCV000480293	16	23641501	16	23630180	480293	478124	rs1057522241	NC_000016.10:23630179:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1974A>C (p.Glu658Asp)	PALB2	E658D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460920	16	23641501	16	23630180	460920	466211	rs1057522241	NC_000016.10:23630179:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1974A>G (p.Glu658=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000385497	16	23641501	16	23630180	385497	374933	rs1057522241	NC_000016.10:23630179:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1972G>T (p.Glu658Ter)	PALB2	E658*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830154	16	23641503	16	23630182	830154	818496	rs1555460542	NC_000016.10:23630181:C:A	single nucleotide variant	nonsense	Pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1972G>A (p.Glu658Lys)	PALB2	E658K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460919	16	23641503	16	23630182	460919	466435	rs1555460542	NC_000016.10:23630181:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1971G>C (p.Glu657Asp)	PALB2	E61D, E657D, E362D, E637D	Hereditary cancer-predisposing syndrome	VCV003927434	16	23641504	16	23630183	3927434	4047067		NC_000016.10:23630182:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 12, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1971G>A (p.Glu657=)	PALB2		Familial cancer of breast|not specified	VCV000386545	16	23641504	16	23630183	386545	377383	rs1057522528	NC_000016.10:23630182:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 22, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1970A>G (p.Glu657Gly)	PALB2	E657G	Familial cancer of breast	VCV001387742	16	23641505	16	23630184	1387742	1374363	rs2142384653	NC_000016.10:23630183:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1969G>T (p.Glu657Ter)	PALB2	E657*, E362*, E61*, E637*	Hereditary cancer-predisposing syndrome	VCV001783571	16	23641506	16	23630185	1783571	1839667	rs2142384677	NC_000016.10:23630184:C:A	single nucleotide variant	nonsense	Pathogenic	Sep 18, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1969G>C (p.Glu657Gln)	PALB2	E657Q	Familial cancer of breast	VCV001356113	16	23641506	16	23630185	1356113	1354408	rs2142384677	NC_000016.10:23630184:C:G	single nucleotide variant	missense variant	Uncertain significance	May 25, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1968A>G (p.Pro656=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000922674	16	23641507	16	23630186	922674	913638	rs756275403	NC_000016.10:23630185:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1968A>T (p.Pro656=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000511458	16	23641507	16	23630186	511458	505266	rs756275403	NC_000016.10:23630185:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1967C>T (p.Pro656Leu)	PALB2	P656L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001380801	16	23641508	16	23630187	1380801	1421623	rs370360082	NC_000016.10:23630186:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 23, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1966C>G (p.Pro656Ala)	PALB2	P656A, P361A, P60A, P636A	Familial cancer of breast	VCV002097820	16	23641509	16	23630188	2097820	2146676	rs2506428614	NC_000016.10:23630187:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1966C>T (p.Pro656Ser)	PALB2	P361S, P60S, P636S, P656S	Familial cancer of breast|not provided	VCV001712209	16	23641509	16	23630188	1712209	1710631	rs2506428614	NC_000016.10:23630187:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1965T>A (p.Phe655Leu)	PALB2	F360L, F635L, F655L, F59L	not specified|Hereditary cancer-predisposing syndrome	VCV001783513	16	23641510	16	23630189	1783513	1839609	rs1555460565	NC_000016.10:23630188:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1965T>C (p.Phe655=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000486023	16	23641510	16	23630189	486023	477587	rs1555460565	NC_000016.10:23630188:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 22, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1962T>C (p.Ile654=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481080	16	23641513	16	23630192	481080	477642	rs1555460568	NC_000016.10:23630191:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1961T>C (p.Ile654Thr)	PALB2	I58T, I634T, I359T, I654T	Familial cancer of breast	VCV001999108	16	23641514	16	23630193	1999108	2060901	rs778119923	NC_000016.10:23630192:A:G	single nucleotide variant	missense variant	Uncertain significance	May 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1960A>G (p.Ile654Val)	PALB2	I654V	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|not specified|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000234115	16	23641515	16	23630194	234115	235252	rs749842477	NC_000016.10:23630193:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1959T>C (p.Cys653=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000820416	16	23641516	16	23630195	820416	812726	rs1597090610	NC_000016.10:23630194:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 25, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1958G>C (p.Cys653Ser)	PALB2	C653S	Familial cancer of breast	VCV000661805	16	23641517	16	23630196	661805	644436	rs771246748	NC_000016.10:23630195:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1958G>T (p.Cys653Phe)	PALB2	C653F	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000630507	16	23641517	16	23630196	630507	618395	rs771246748	NC_000016.10:23630195:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1958G>A (p.Cys653Tyr)	PALB2	C653Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000187730	16	23641517	16	23630196	187730	184214	rs771246748	NC_000016.10:23630195:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 21, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1956C>G (p.Ser652Arg)	PALB2	S56R, S357R, S632R, S652R	Familial cancer of breast	VCV003709923	16	23641519	16	23630198	3709923	3836901		NC_000016.10:23630197:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1956C>T (p.Ser652=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000820411	16	23641519	16	23630198	820411	812727	rs1597090632	NC_000016.10:23630197:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1955G>A (p.Ser652Asn)	PALB2	S652N	Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Hereditary breast ovarian cancer syndrome	VCV000141528	16	23641520	16	23630199	141528	151242	rs587781818	NC_000016.10:23630198:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 4, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1954A>G (p.Ser652Gly)	PALB2	S652G	Hereditary cancer-predisposing syndrome	VCV000628356	16	23641521	16	23630200	628356	618396	rs1567218401	NC_000016.10:23630199:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1953A>G (p.Gly651=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000482021	16	23641522	16	23630201	482021	478126	rs1555460575	NC_000016.10:23630200:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1952G>A (p.Gly651Glu)	PALB2	G651E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000233107	16	23641523	16	23630202	233107	235253	rs876660200	NC_000016.10:23630201:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1951G>T (p.Gly651Ter)	PALB2	G356*, G55*, G651*, G631*	Familial cancer of breast	VCV003662087	16	23641524	16	23630203	3662087	3797952		NC_000016.10:23630202:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 12, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1950G>A (p.Glu650=)	PALB2		Familial cancer of breast	VCV002772555	16	23641525	16	23630204	2772555	2933707	rs1966862866	NC_000016.10:23630203:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 29, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1950G>C (p.Glu650Asp)	PALB2	E54D, E630D, E355D, E650D	Hereditary cancer-predisposing syndrome	VCV001783230	16	23641525	16	23630204	1783230	1843175	rs1966862866	NC_000016.10:23630203:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1949A>T (p.Glu650Val)	PALB2	E54V, E355V, E630V, E650V	Hereditary cancer-predisposing syndrome	VCV003927448	16	23641526	16	23630205	3927448	4047081		NC_000016.10:23630204:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1949A>C (p.Glu650Ala)	PALB2	E650A	Hereditary cancer-predisposing syndrome	VCV000926435	16	23641526	16	23630205	926435	913639	rs1966862898	NC_000016.10:23630204:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1948G>T (p.Glu650Ter)	PALB2	E355*, E54*, E630*, E650*	Familial cancer of breast	VCV002673883	16	23641527	16	23630206	2673883	2841383	rs1597090662	NC_000016.10:23630205:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1948G>C (p.Glu650Gln)	PALB2	E650Q	Familial cancer of breast	VCV001508650	16	23641527	16	23630206	1508650	1439861	rs1597090662	NC_000016.10:23630205:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1948G>A (p.Glu650Lys)	PALB2	E650K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000659835	16	23641527	16	23630206	659835	644437	rs1597090662	NC_000016.10:23630205:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1946A>C (p.Lys649Thr)	PALB2	K649T	Hereditary cancer-predisposing syndrome|not provided	VCV000925698	16	23641529	16	23630208	925698	913640	rs1966863018	NC_000016.10:23630207:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1945A>T (p.Lys649Ter)	PALB2	K649*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000481029	16	23641530	16	23630209	481029	477531	rs1555460579	NC_000016.10:23630208:T:A	single nucleotide variant	nonsense	Pathogenic	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1944T>C (p.Leu648=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233163	16	23641531	16	23630210	233163	235254	rs200296117	NC_000016.10:23630209:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1942C>T (p.Leu648Phe)	PALB2	L648F	Familial cancer of breast	VCV000943934	16	23641533	16	23630212	943934	927722	rs1966863129	NC_000016.10:23630211:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1941T>C (p.His647=)	PALB2		not specified|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000619708	16	23641534	16	23630213	619708	611219	rs745467835	NC_000016.10:23630212:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1940A>T (p.His647Leu)	PALB2	H647L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000492174	16	23641535	16	23630214	492174	485029	rs1055533509	NC_000016.10:23630213:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1940A>G (p.His647Arg)	PALB2	H647R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492173	16	23641535	16	23630214	492173	484663	rs1055533509	NC_000016.10:23630213:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1939C>G (p.His647Asp)	PALB2	H647D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000629351	16	23641536	16	23630215	629351	618397	rs1555460583	NC_000016.10:23630214:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1939C>T (p.His647Tyr)	PALB2	H647Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000480266	16	23641536	16	23630215	480266	477647	rs1555460583	NC_000016.10:23630214:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1938A>C (p.Arg646Ser)	PALB2	R626S, R50S, R646S, R351S	Familial cancer of breast	VCV002696367	16	23641537	16	23630216	2696367	2861222	rs2142385536	NC_000016.10:23630215:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1938A>G (p.Arg646=)	PALB2		Familial cancer of breast	VCV002120036	16	23641537	16	23630216	2120036	2176532	rs2142385536	NC_000016.10:23630215:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1937G>C (p.Arg646Thr)	PALB2	R646T	Familial cancer of breast	VCV000961994	16	23641538	16	23630217	961994	949310	rs1966863262	NC_000016.10:23630216:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1937G>A (p.Arg646Lys)	PALB2	R646K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000946556	16	23641538	16	23630217	946556	927723	rs1966863262	NC_000016.10:23630216:C:T	single nucleotide variant	missense variant	Uncertain significance	May 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1937G>T (p.Arg646Ile)	PALB2	R646I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000926771	16	23641538	16	23630217	926771	913642	rs1966863262	NC_000016.10:23630216:C:A	single nucleotide variant	missense variant	Uncertain significance	May 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1936A>G (p.Arg646Gly)	PALB2	R646G	Familial cancer of breast	VCV000654835	16	23641539	16	23630218	654835	644438	rs1303399070	NC_000016.10:23630217:T:C	single nucleotide variant	missense variant	Uncertain significance	May 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1935G>A (p.Glu645=)	PALB2		Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|not provided|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|not specified	VCV000126627	16	23641540	16	23630219	126627	132137	rs141707455	NC_000016.10:23630218:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1932A>T (p.Gly644=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001782903	16	23641543	16	23630222	1782903	1846267	rs1567218470	NC_000016.10:23630221:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1932A>G (p.Gly644=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000920269	16	23641543	16	23630222	920269	913643	rs1567218470	NC_000016.10:23630221:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 20, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1932A>C (p.Gly644=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000629046	16	23641543	16	23630222	629046	618398	rs1567218470	NC_000016.10:23630221:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1931G>C (p.Gly644Ala)	PALB2	G349A, G48A, G624A, G644A	Hereditary cancer-predisposing syndrome	VCV003885214	16	23641544	16	23630223	3885214	4005536		NC_000016.10:23630222:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 25, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1931G>A (p.Gly644Glu)	PALB2	G644E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000225854	16	23641544	16	23630223	225854	227670	rs875989794	NC_000016.10:23630222:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1930G>T (p.Gly644Ter)	PALB2	G644*	Hereditary cancer-predisposing syndrome	VCV000185767	16	23641545	16	23630224	185767	184215	rs786202439	NC_000016.10:23630223:C:A	single nucleotide variant	nonsense	Pathogenic	Jul 7, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1929T>A (p.Phe643Leu)	PALB2	F348L, F643L, F47L, F623L	Familial cancer of breast	VCV002986124	16	23641546	16	23630225	2986124	3146440	rs995715653	NC_000016.10:23630224:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1929T>G (p.Phe643Leu)	PALB2	F47L, F623L, F643L, F348L	Hereditary cancer-predisposing syndrome	VCV001782825	16	23641546	16	23630225	1782825	1846189	rs995715653	NC_000016.10:23630224:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1929T>C (p.Phe643=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000415985	16	23641546	16	23630225	415985	401038	rs995715653	NC_000016.10:23630224:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1928T>C (p.Phe643Ser)	PALB2	F643S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820360	16	23641547	16	23630226	820360	812729	rs1567218485	NC_000016.10:23630225:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1926G>A (p.Met642Ile)	PALB2	M642I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820357	16	23641549	16	23630228	820357	812730	rs1597090741	NC_000016.10:23630227:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1925T>C (p.Met642Thr)	PALB2	M642T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233411	16	23641550	16	23630229	233411	235255	rs876660387	NC_000016.10:23630228:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1923A>G (p.Lys641=)	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000415981	16	23641552	16	23630231	415981	401778	rs775283927	NC_000016.10:23630230:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1920A>T (p.Ser640=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000184802	16	23641555	16	23630234	184802	184217	rs375575311	NC_000016.10:23630233:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1919C>T (p.Ser640Leu)	PALB2	S640L	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000801238	16	23641556	16	23630235	801238	789602	rs760094988	NC_000016.10:23630234:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 29, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1919C>G (p.Ser640Ter)	PALB2	S640*	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000618260	16	23641556	16	23630235	618260	610022	rs760094988	NC_000016.10:23630234:G:C	single nucleotide variant	nonsense	Pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1919C>A (p.Ser640Ter)	PALB2	S640*	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast	VCV000231394	16	23641556	16	23630235	231394	235256	rs760094988	NC_000016.10:23630234:G:T	single nucleotide variant	nonsense	Pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1918T>G (p.Ser640Ala)	PALB2	S640A	Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000232030	16	23641557	16	23630236	232030	235257	rs876659058	NC_000016.10:23630235:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1918T>A (p.Ser640Thr)	PALB2	S640T	Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome	VCV000231263	16	23641557	16	23630236	231263	235258	rs876659058	NC_000016.10:23630235:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 4, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1917G>T (p.Glu639Asp)	PALB2	E639D	Familial cancer of breast	VCV000803236	16	23641558	16	23630237	803236	791569	rs1597090787	NC_000016.10:23630236:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 12, 2019	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1917G>A (p.Glu639=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000701873	16	23641558	16	23630237	701873	688555	rs1597090787	NC_000016.10:23630236:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1915G>C (p.Glu639Gln)	PALB2	E639Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001018633	16	23641560	16	23630239	1018633	1012031	rs1555460592	NC_000016.10:23630238:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1915G>T (p.Glu639Ter)	PALB2	E639*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000820334	16	23641560	16	23630239	820334	812731	rs1555460592	NC_000016.10:23630238:C:A	single nucleotide variant	nonsense	Pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1915G>A (p.Glu639Lys)	PALB2	E639K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480267	16	23641560	16	23630239	480267	477539	rs1555460592	NC_000016.10:23630238:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1911C>G (p.Pro637=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000820325	16	23641564	16	23630243	820325	812732	rs1567218530	NC_000016.10:23630242:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1911C>T (p.Pro637=)	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000627829	16	23641564	16	23630243	627829	618399	rs1567218530	NC_000016.10:23630242:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1910C>A (p.Pro637His)	PALB2	P637H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830151	16	23641565	16	23630244	830151	818499	rs878855104	NC_000016.10:23630243:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1910C>G (p.Pro637Arg)	PALB2	P637R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410174	16	23641565	16	23630244	410174	401042	rs878855104	NC_000016.10:23630243:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1910C>T (p.Pro637Leu)	PALB2	P637L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000241535	16	23641565	16	23630244	241535	242372	rs878855104	NC_000016.10:23630243:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1909C>A (p.Pro637Thr)	PALB2	P617T, P41T, P342T, P637T	Familial cancer of breast	VCV002100922	16	23641566	16	23630245	2100922	2150942	rs768248338	NC_000016.10:23630244:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1909C>T (p.Pro637Ser)	PALB2	P637S	not provided|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000619707	16	23641566	16	23630245	619707	611220	rs768248338	NC_000016.10:23630244:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1908G>A (p.Glu636=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000798831	16	23641567	16	23630246	798831	785226	rs1392612467	NC_000016.10:23630245:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1908G>C (p.Glu636Asp)	PALB2	E636D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530059	16	23641567	16	23630246	530059	530139	rs1392612467	NC_000016.10:23630245:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1907A>G (p.Glu636Gly)	PALB2	E636G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830150	16	23641568	16	23630247	830150	818500	rs1966863975	NC_000016.10:23630246:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 25, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1906G>C (p.Glu636Gln)	PALB2	E341Q, E40Q, E616Q, E636Q	Hereditary cancer-predisposing syndrome	VCV003227999	16	23641569	16	23630248	3227999	3387768	rs2142386346	NC_000016.10:23630247:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1906G>A (p.Glu636Lys)	PALB2	E341K, E40K, E616K, E636K	Familial cancer of breast	VCV001721455	16	23641569	16	23630248	1721455	1772789	rs2142386346	NC_000016.10:23630247:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1905G>A (p.Val635=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830149	16	23641570	16	23630249	830149	818501	rs1966864000	NC_000016.10:23630248:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1903G>C (p.Val635Leu)	PALB2	V340L, V39L, V615L, V635L	Familial cancer of breast	VCV002778038	16	23641572	16	23630251	2778038	2937033	rs776389696	NC_000016.10:23630250:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1903G>T (p.Val635Leu)	PALB2	V635L	Familial cancer of breast	VCV001392442	16	23641572	16	23630251	1392442	1502345	rs776389696	NC_000016.10:23630250:C:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1903G>A (p.Val635Met)	PALB2	V635M	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460918	16	23641572	16	23630251	460918	466439	rs776389696	NC_000016.10:23630250:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1902A>G (p.Pro634=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000230779	16	23641573	16	23630252	230779	235259	rs876658768	NC_000016.10:23630251:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1901C>A (p.Pro634Gln)	PALB2	P339Q, P38Q, P614Q, P634Q	Familial cancer of breast	VCV002851075	16	23641574	16	23630253	2851075	3009577	rs761829458	NC_000016.10:23630252:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1901C>T (p.Pro634Leu)	PALB2	P38L, P614L, P339L, P634L	Familial cancer of breast	VCV002795315	16	23641574	16	23630253	2795315	2951265	rs761829458	NC_000016.10:23630252:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1900C>T (p.Pro634Ser)	PALB2	P634S	Familial cancer of breast	VCV001059984	16	23641575	16	23630254	1059984	1049522	rs2142386489	NC_000016.10:23630253:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1899A>G (p.Lys633=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000759325	16	23641576	16	23630255	759325	770778	rs765063761	NC_000016.10:23630254:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1898A>T (p.Lys633Ile)	PALB2	K633I	Familial cancer of breast	VCV001388299	16	23641577	16	23630256	1388299	1371040	rs1567218554	NC_000016.10:23630255:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1898A>G (p.Lys633Arg)	PALB2	K633R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000570923	16	23641577	16	23630256	570923	567967	rs1567218554	NC_000016.10:23630255:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1897A>G (p.Lys633Glu)	PALB2	K633E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482052	16	23641578	16	23630257	482052	477545	rs1555460599	NC_000016.10:23630256:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1896A>G (p.Glu632=)	PALB2		Familial cancer of breast	VCV001147434	16	23641579	16	23630258	1147434	1146009	rs2142386584	NC_000016.10:23630257:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1895A>C (p.Glu632Ala)	PALB2	E632A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000628589	16	23641580	16	23630259	628589	618400	rs1567218562	NC_000016.10:23630258:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1894G>A (p.Glu632Lys)	PALB2	E337K, E632K, E36K, E612K	Familial cancer of breast	VCV003650318	16	23641581	16	23630260	3650318	3784893		NC_000016.10:23630259:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1894G>T (p.Glu632Ter)	PALB2	E337*, E36*, E632*, E612*	Hereditary cancer-predisposing syndrome	VCV001782126	16	23641581	16	23630260	1782126	1835521	rs2142386640	NC_000016.10:23630259:C:A	single nucleotide variant	nonsense	Pathogenic	Sep 26, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1893A>C (p.Ser631=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003903585	16	23641582	16	23630261	3903585	4019458		NC_000016.10:23630260:T:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jun 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1893A>T (p.Ser631=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003413507	16	23641582	16	23630261	3413507	3574730		NC_000016.10:23630260:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1893A>G (p.Ser631=)	PALB2		Familial cancer of breast	VCV002116872	16	23641582	16	23630261	2116872	2172179	rs2506432081	NC_000016.10:23630260:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1892C>T (p.Ser631Leu)	PALB2	S611L, S631L, S336L, S35L	Familial cancer of breast	VCV003660141	16	23641583	16	23630262	3660141	3797282		NC_000016.10:23630261:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1892C>G (p.Ser631Ter)	PALB2	S336*, S35*, S611*, S631*	Familial cancer of breast	VCV002673876	16	23641583	16	23630262	2673876	2841376	rs2142386665	NC_000016.10:23630261:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1891T>C (p.Ser631Pro)	PALB2	S631P	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000486020	16	23641584	16	23630263	486020	477546	rs1555460600	NC_000016.10:23630262:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1890C>T (p.Cys630=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001782064	16	23641585	16	23630264	1782064	1835459	rs2142386736	NC_000016.10:23630263:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 24, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1889G>C (p.Cys630Ser)	PALB2	C630S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820274	16	23641586	16	23630265	820274	812733	rs1597090878	NC_000016.10:23630264:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1888T>C (p.Cys630Arg)	PALB2	C34R, C630R, C335R, C610R	Hereditary cancer-predisposing syndrome	VCV001782017	16	23641587	16	23630266	1782017	1835412	rs2142386793	NC_000016.10:23630265:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1887C>T (p.Ser629=)	PALB2		Familial cancer of breast	VCV001108134	16	23641588	16	23630267	1108134	1103705	rs1966864226	NC_000016.10:23630266:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1886C>G (p.Ser629Cys)	PALB2	S334C, S33C, S609C, S629C	Familial cancer of breast	VCV002760225	16	23641589	16	23630268	2760225	2911037	rs1169756751	NC_000016.10:23630267:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1886C>A (p.Ser629Tyr)	PALB2	S629Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001056308	16	23641589	16	23630268	1056308	1049523	rs1169756751	NC_000016.10:23630267:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1886C>T (p.Ser629Phe)	PALB2	S629F	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460916	16	23641589	16	23630268	460916	465487	rs1169756751	NC_000016.10:23630267:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1885T>G (p.Ser629Ala)	PALB2	S33A, S334A, S609A, S629A	Familial cancer of breast	VCV004056274	16	23641590	16	23630269	4056274	4170212		NC_000016.10:23630268:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1885T>C (p.Ser629Pro)	PALB2	S629P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000567009	16	23641590	16	23630269	567009	569977	rs1567218578	NC_000016.10:23630268:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1884G>A (p.Lys628=)	PALB2		Familial cancer of breast	VCV003903536	16	23641591	16	23630270	3903536	4019409		NC_000016.10:23630269:C:T	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1883A>T (p.Lys628Met)	PALB2	K628M	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001513418	16	23641592	16	23630271	1513418	1472473	rs954390684	NC_000016.10:23630270:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1883A>C (p.Lys628Thr)	PALB2	K628T	not provided|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000482068	16	23641592	16	23630271	482068	478128	rs954390684	NC_000016.10:23630270:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1882A>G (p.Lys628Glu)	PALB2	K32E, K333E, K608E, K628E	Hereditary cancer-predisposing syndrome	VCV003227998	16	23641593	16	23630272	3227998	3387767	rs1597090894	NC_000016.10:23630271:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 31, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1882A>T (p.Lys628Ter)	PALB2	K628*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820249	16	23641593	16	23630272	820249	812734	rs1597090894	NC_000016.10:23630271:T:A	single nucleotide variant	nonsense	Pathogenic	Sep 2, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1881G>A (p.Val627=)	PALB2		Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000187715	16	23641594	16	23630273	187715	184218	rs139362268	NC_000016.10:23630272:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1881G>T (p.Val627=)	PALB2		Breast and/or ovarian cancer|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not provided|not specified|Familial cancer of breast	VCV000126626	16	23641594	16	23630273	126626	132136	rs139362268	NC_000016.10:23630272:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1880T>C (p.Val627Ala)	PALB2	V31A, V332A, V607A, V627A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001781889	16	23641595	16	23630274	1781889	1835285	rs1597090905	NC_000016.10:23630273:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1880T>G (p.Val627Gly)	PALB2	V627G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000820237	16	23641595	16	23630274	820237	812736	rs1597090905	NC_000016.10:23630273:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1879G>C (p.Val627Leu)	PALB2	V31L, V607L, V332L, V627L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001781847	16	23641596	16	23630275	1781847	1835243	rs1567218614	NC_000016.10:23630274:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 9, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1879G>A (p.Val627Met)	PALB2	V627M	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000629420	16	23641596	16	23630275	629420	618401	rs1567218614	NC_000016.10:23630274:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1878A>G (p.Lys626=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000629557	16	23641597	16	23630276	629557	618402	rs1567218624	NC_000016.10:23630275:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 14, 2021	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1877A>G (p.Lys626Arg)	PALB2	K331R, K626R, K606R, K30R	Familial cancer of breast	VCV003634220	16	23641598	16	23630277	3634220	3767103		NC_000016.10:23630276:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1876A>T (p.Lys626Ter)	PALB2	K626*, K30*, K331*, K606*	Hereditary cancer-predisposing syndrome	VCV003927440	16	23641599	16	23630278	3927440	4047073		NC_000016.10:23630277:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	May 12, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1876A>C (p.Lys626Gln)	PALB2	K626Q	Familial cancer of breast	VCV001057032	16	23641599	16	23630278	1057032	1049524	rs2142387099	NC_000016.10:23630277:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1875A>G (p.Glu625=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460915	16	23641600	16	23630279	460915	465491	rs1555460606	NC_000016.10:23630278:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1874A>G (p.Glu625Gly)	PALB2	E625G	Familial cancer of breast	VCV000530154	16	23641601	16	23630280	530154	530357	rs1555460607	NC_000016.10:23630279:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1873G>T (p.Glu625Ter)	PALB2	E330*, E29*, E605*, E625*	Hereditary cancer-predisposing syndrome	VCV003413454	16	23641602	16	23630281	3413454	3574677		NC_000016.10:23630280:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1872T>G (p.Leu624=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003885225	16	23641603	16	23630282	3885225	4005547		NC_000016.10:23630281:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 28, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1872T>C (p.Leu624=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000629855	16	23641603	16	23630282	629855	618403	rs758409916	NC_000016.10:23630281:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1871T>C (p.Leu624Pro)	PALB2	L624P	Familial cancer of breast	VCV000410194	16	23641604	16	23630283	410194	401099	rs1060502791	NC_000016.10:23630282:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.1870C>A (p.Leu624Ile)	PALB2	L624I	Familial cancer of breast	VCV001019727	16	23641605	16	23630284	1019727	1012032	rs1555460610	NC_000016.10:23630283:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1870C>G (p.Leu624Val)	PALB2	L624V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001007413	16	23641605	16	23630284	1007413	996802	rs1555460610	NC_000016.10:23630283:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1870C>T (p.Leu624Phe)	PALB2	L624F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000481044	16	23641605	16	23630284	481044	477652	rs1555460610	NC_000016.10:23630283:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1869G>C (p.Lys623Asn)	PALB2	K623N	Familial cancer of breast	VCV000946162	16	23641606	16	23630285	946162	927724	rs1555460612	NC_000016.10:23630284:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1869G>A (p.Lys623=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460914	16	23641606	16	23630285	460914	466225	rs1555460612	NC_000016.10:23630284:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1868A>C (p.Lys623Thr)	PALB2	K27T, K328T, K603T, K623T	Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5	VCV003780083	16	23641607	16	23630286	3780083	3896050		NC_000016.10:23630285:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 20, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1867A>G (p.Lys623Glu)	PALB2	K623E	Familial cancer of breast	VCV000839925	16	23641608	16	23630287	839925	843591	rs1966864669	NC_000016.10:23630286:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1865T>C (p.Leu622Pro)	PALB2	L622P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001025812	16	23641610	16	23630289	1025812	1012033	rs753012991	NC_000016.10:23630288:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1863T>C (p.Pro621=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000136130	16	23641612	16	23630291	136130	139842	rs587780819	NC_000016.10:23630290:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1862C>T (p.Pro621Leu)	PALB2	P621L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000630453	16	23641613	16	23630292	630453	618404	rs1567218668	NC_000016.10:23630291:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1861C>G (p.Pro621Ala)	PALB2	P25A, P601A, P326A, P621A	Hereditary cancer-predisposing syndrome	VCV003413466	16	23641614	16	23630293	3413466	3574689		NC_000016.10:23630292:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1861C>T (p.Pro621Ser)	PALB2	P621S	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV001346049	16	23641614	16	23630293	1346049	1378338	rs756116550	NC_000016.10:23630292:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1861C>A (p.Pro621Thr)	PALB2	P621T	not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000245656	16	23641614	16	23630293	245656	244963	rs756116550	NC_000016.10:23630292:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1860A>T (p.Gly620=)	PALB2		not provided	VCV002682034	16	23641615	16	23630294	2682034	2843067	rs2506433406	NC_000016.10:23630293:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1859G>A (p.Gly620Glu)	PALB2	G620E	Hereditary cancer-predisposing syndrome	VCV000820203	16	23641616	16	23630295	820203	812737	rs1597090978	NC_000016.10:23630294:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1858G>T (p.Gly620Ter)	PALB2	G24*, G325*, G600*, G620*	Familial cancer of breast	VCV001997185	16	23641617	16	23630296	1997185	2060267	rs777940379	NC_000016.10:23630295:C:A	single nucleotide variant	nonsense	Pathogenic	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1858G>C (p.Gly620Arg)	PALB2	G620R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000460913	16	23641617	16	23630296	460913	466227	rs777940379	NC_000016.10:23630295:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1857T>C (p.Phe619=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000496462	16	23641618	16	23630297	496462	487878	rs1555460623	NC_000016.10:23630296:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1854C>A (p.Asp618Glu)	PALB2	D22E, D598E, D618E, D323E	Hereditary cancer-predisposing syndrome	VCV002567592	16	23641621	16	23630300	2567592	2731234	rs2142387653	NC_000016.10:23630299:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1852G>A (p.Asp618Asn)	PALB2	D618N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000186906	16	23641623	16	23630302	186906	184219	rs754252373	NC_000016.10:23630301:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1851A>G (p.Glu617=)	PALB2		Familial cancer of breast	VCV002112031	16	23641624	16	23630303	2112031	2160852	rs2142387734	NC_000016.10:23630302:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1849G>A (p.Glu617Lys)	PALB2	E617K	Familial cancer of breast	VCV001043852	16	23641626	16	23630305	1043852	1032522	rs1966864945	NC_000016.10:23630304:C:T	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1848T>C (p.Asp616=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000215929	16	23641627	16	23630306	215929	213173	rs863224428	NC_000016.10:23630305:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1847A>T (p.Asp616Val)	PALB2	D616V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001399923	16	23641628	16	23630307	1399923	1444013	rs876660063	NC_000016.10:23630306:T:A	single nucleotide variant	missense variant	Uncertain significance	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1847A>G (p.Asp616Gly)	PALB2	D616G	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000232905	16	23641628	16	23630307	232905	235260	rs876660063	NC_000016.10:23630306:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1846G>A (p.Asp616Asn)	PALB2	D616N	Familial cancer of breast	VCV001450545	16	23641629	16	23630308	1450545	1436425	rs786201907	NC_000016.10:23630307:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1846G>C (p.Asp616His)	PALB2	D616H	not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000185069	16	23641629	16	23630308	185069	184220	rs786201907	NC_000016.10:23630307:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1845T>C (p.Pro615=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001781238	16	23641630	16	23630309	1781238	1839506	rs2142387887	NC_000016.10:23630308:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1844C>T (p.Pro615Leu)	PALB2	P615L	Familial cancer of breast	VCV001419690	16	23641631	16	23630310	1419690	1409910	rs2142387910	NC_000016.10:23630309:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1843C>A (p.Pro615Thr)	PALB2	P615T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492171	16	23641632	16	23630311	492171	485030	rs1019525144	NC_000016.10:23630310:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1843C>G (p.Pro615Ala)	PALB2	P615A	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000485999	16	23641632	16	23630311	485999	477555	rs1019525144	NC_000016.10:23630310:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1843C>T (p.Pro615Ser)	PALB2	P615S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410120	16	23641632	16	23630311	410120	401780	rs1019525144	NC_000016.10:23630310:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1842A>G (p.Leu614=)	PALB2		Familial cancer of breast	VCV000800060	16	23641633	16	23630312	800060	785227	rs1597091040	NC_000016.10:23630311:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1841T>A (p.Leu614Ter)	PALB2	L18*, L319*, L594*, L614*	Familial cancer of breast	VCV002674174	16	23641634	16	23630313	2674174	2841664	rs1555460628	NC_000016.10:23630312:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 11, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1841T>C (p.Leu614Ser)	PALB2	L614S	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000480933	16	23641634	16	23630313	480933	477601	rs1555460628	NC_000016.10:23630312:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1839G>A (p.Gln613=)	PALB2		not specified|Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000215928	16	23641636	16	23630315	215928	213174	rs199682414	NC_000016.10:23630314:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1838A>T (p.Gln613Leu)	PALB2	Q17L, Q318L, Q593L, Q613L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003227997	16	23641637	16	23630316	3227997	3387766	rs1966865170	NC_000016.10:23630315:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 8, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1838A>G (p.Gln613Arg)	PALB2	Q613R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000968519	16	23641637	16	23630316	968519	957699	rs1966865170	NC_000016.10:23630315:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1837C>G (p.Gln613Glu)	PALB2	Q613E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000851993	16	23641638	16	23630317	851993	843593	rs1966865214	NC_000016.10:23630316:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1837C>T (p.Gln613Ter)	PALB2	Q613*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000830147	16	23641638	16	23630317	830147	818503	rs1966865214	NC_000016.10:23630316:G:A	single nucleotide variant	nonsense	Pathogenic	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1836T>C (p.Phe612=)	PALB2		Familial cancer of breast	VCV002736901	16	23641639	16	23630318	2736901	2905471	rs2142388126	NC_000016.10:23630317:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1833C>T (p.Asp611=)	PALB2		Familial cancer of breast	VCV000830146	16	23641642	16	23630321	830146	818504	rs779184831	NC_000016.10:23630320:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 26, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1833C>G (p.Asp611Glu)	PALB2	D611E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000664965	16	23641642	16	23630321	664965	644439	rs779184831	NC_000016.10:23630320:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1833C>A (p.Asp611Glu)	PALB2	D611E	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482066	16	23641642	16	23630321	482066	477656	rs779184831	NC_000016.10:23630320:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1832A>G (p.Asp611Gly)	PALB2	D316G, D15G, D611G, D591G	Familial cancer of breast	VCV001960038	16	23641643	16	23630322	1960038	2016294	rs2142388232	NC_000016.10:23630321:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1831G>T (p.Asp611Tyr)	PALB2	D15Y, D316Y, D591Y, D611Y	Familial cancer of breast	VCV003240011	16	23641644	16	23630323	3240011	3398999	rs2142388249	NC_000016.10:23630322:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1830A>G (p.Thr610=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000231998	16	23641645	16	23630324	231998	235261	rs876659484	NC_000016.10:23630323:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1829C>T (p.Thr610Ile)	PALB2	T14I, T315I, T590I, T610I	Hereditary cancer-predisposing syndrome	VCV003413504	16	23641646	16	23630325	3413504	3574727		NC_000016.10:23630324:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1828A>G (p.Thr610Ala)	PALB2	T610A	Familial cancer of breast	VCV001015701	16	23641647	16	23630326	1015701	1012034	rs1555460632	NC_000016.10:23630325:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1828A>C (p.Thr610Pro)	PALB2	T610P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480255	16	23641647	16	23630326	480255	477607	rs1555460632	NC_000016.10:23630325:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1826T>G (p.Ile609Ser)	PALB2	I609S, I589S, I13S, I314S	Hereditary cancer-predisposing syndrome	VCV003413477	16	23641649	16	23630328	3413477	3574700		NC_000016.10:23630327:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1826T>C (p.Ile609Thr)	PALB2	I314T, I13T, I609T, I589T	Hereditary cancer-predisposing syndrome	VCV003303984	16	23641649	16	23630328	3303984	3470151		NC_000016.10:23630327:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 31, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1825A>G (p.Ile609Val)	PALB2	I314V, I589V, I609V, I13V	Hereditary cancer-predisposing syndrome	VCV003927429	16	23641650	16	23630329	3927429	4047062		NC_000016.10:23630328:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 31, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1824T>G (p.Ser608Arg)	PALB2	S608R, S588R, S12R, S313R	Hereditary cancer-predisposing syndrome	VCV003413476	16	23641651	16	23630330	3413476	3574699		NC_000016.10:23630329:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1824T>C (p.Ser608=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001780821	16	23641651	16	23630330	1780821	1832116	rs374771688	NC_000016.10:23630329:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 13, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1823G>A (p.Ser608Asn)	PALB2	S12N, S313N, S588N, S608N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001780800	16	23641652	16	23630331	1780800	1832095	rs2142388424	NC_000016.10:23630330:C:T	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1822A>G (p.Ser608Gly)	PALB2	S608G	Familial cancer of breast	VCV000858160	16	23641653	16	23630332	858160	843594	rs1966865388	NC_000016.10:23630331:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1821C>T (p.Leu607=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480288	16	23641654	16	23630333	480288	477657	rs1555460634	NC_000016.10:23630332:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1819C>G (p.Leu607Val)	PALB2	L607V	Hereditary cancer-predisposing syndrome	VCV000820134	16	23641656	16	23630335	820134	812738	rs1567218740	NC_000016.10:23630334:G:C	single nucleotide variant	missense variant	Likely benign	Jul 26, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1819C>A (p.Leu607Ile)	PALB2	L607I	Familial cancer of breast	VCV000575726	16	23641656	16	23630335	575726	569979	rs1567218740	NC_000016.10:23630334:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1818T>C (p.Phe606=)	PALB2		Familial cancer of breast	VCV003903607	16	23641657	16	23630336	3903607	4019480		NC_000016.10:23630335:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1818T>G (p.Phe606Leu)	PALB2	F606L	not specified	VCV001337380	16	23641657	16	23630336	1337380	1328389	rs1484066130	NC_000016.10:23630335:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1815T>G (p.Ser605=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000920313	16	23641660	16	23630339	920313	913644	rs1597091095	NC_000016.10:23630338:A:C	single nucleotide variant	synonymous variant	Likely benign	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1815T>C (p.Ser605=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000794755	16	23641660	16	23630339	794755	785228	rs1597091095	NC_000016.10:23630338:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1814C>G (p.Ser605Cys)	PALB2	S605C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000820129	16	23641661	16	23630340	820129	812739	rs876658992	NC_000016.10:23630339:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1814C>T (p.Ser605Phe)	PALB2	S605F	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000231162	16	23641661	16	23630340	231162	235262	rs876658992	NC_000016.10:23630339:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1813T>C (p.Ser605Pro)	PALB2	S605P	Familial cancer of breast	VCV001515218	16	23641662	16	23630341	1515218	1482407	rs2142388635	NC_000016.10:23630340:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1813T>G (p.Ser605Ala)	PALB2	S605A	Familial cancer of breast	VCV001062042	16	23641662	16	23630341	1062042	1049525	rs2142388635	NC_000016.10:23630340:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1812G>A (p.Leu604=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000385597	16	23641663	16	23630342	385597	377385	rs1057522269	NC_000016.10:23630341:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1811T>C (p.Leu604Pro)	PALB2	L604P	Familial cancer of breast	VCV000460912	16	23641664	16	23630343	460912	466213	rs1555460637	NC_000016.10:23630342:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1810C>T (p.Leu604=)	PALB2		Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|not provided|Familial cancer of breast|not specified|Hereditary breast ovarian cancer syndrome	VCV000126625	16	23641665	16	23630344	126625	132135	rs144015319	NC_000016.10:23630343:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1809A>G (p.Leu603=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000241534	16	23641666	16	23630345	241534	242373	rs878855103	NC_000016.10:23630344:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1807C>A (p.Leu603Ile)	PALB2	L308I, L583I, L603I, L7I	Familial cancer of breast	VCV001715787	16	23641668	16	23630347	1715787	1773732	rs2142388797	NC_000016.10:23630346:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1806A>G (p.Gln602=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002774008	16	23641669	16	23630348	2774008	2934739	rs1597091128	NC_000016.10:23630347:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1805A>C (p.Gln602Pro)	PALB2	Q602P	Familial cancer of breast	VCV000578012	16	23641670	16	23630349	578012	570184	rs864622768	NC_000016.10:23630348:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1805A>T (p.Gln602Leu)	PALB2	Q602L	Familial cancer of breast	VCV000221170	16	23641670	16	23630349	221170	222467	rs864622768	NC_000016.10:23630348:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1804C>T (p.Gln602Ter)	PALB2	Q602*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001456181	16	23641671	16	23630350	1456181	1458121	rs876660475	NC_000016.10:23630349:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1804C>G (p.Gln602Glu)	PALB2	Q602E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000233541	16	23641671	16	23630350	233541	235263	rs876660475	NC_000016.10:23630349:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1803G>A (p.Lys601=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001083614	16	23641672	16	23630351	1083614	1081889	rs1555460643	NC_000016.10:23630350:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1803G>C (p.Lys601Asn)	PALB2	K601N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482044	16	23641672	16	23630351	482044	477561	rs1555460643	NC_000016.10:23630350:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1802A>G (p.Lys601Arg)	PALB2	K601R	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not specified|Hereditary cancer-predisposing syndrome	VCV000482037	16	23641673	16	23630352	482037	477661	rs1555460644	NC_000016.10:23630351:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1800A>G (p.Leu600=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000492170	16	23641675	16	23630354	492170	484741	rs139662375	NC_000016.10:23630353:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 5, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1800A>C (p.Leu600Phe)	PALB2	L600F	Hereditary cancer-predisposing syndrome	VCV000490072	16	23641675	16	23630354	490072	482889	rs139662375	NC_000016.10:23630353:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1799T>C (p.Leu600Ser)	PALB2	L4S, L580S, L600S, L305S	Familial cancer of breast	VCV002873501	16	23641676	16	23630355	2873501	3032216	rs1966865838	NC_000016.10:23630354:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 26, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1799T>G (p.Leu600Ter)	PALB2	L600*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001332564	16	23641676	16	23630355	1332564	1323282	rs1966865838	NC_000016.10:23630354:A:C	single nucleotide variant	nonsense	Pathogenic	Sep 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1798T>G (p.Leu600Val)	PALB2	L600V	Familial cancer of breast	VCV001505932	16	23641677	16	23630356	1505932	1339662	rs2142389006	NC_000016.10:23630355:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1797T>C (p.Ser599=)	PALB2		Familial cancer of breast	VCV001605098	16	23641678	16	23630357	1605098	1537426	rs2142389023	NC_000016.10:23630356:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 16, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1796G>C (p.Ser599Thr)	PALB2	S304T, S3T, S579T, S599T	not specified|Familial cancer of breast	VCV003068769	16	23641679	16	23630358	3068769	3228095	rs1486577055	NC_000016.10:23630357:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1794G>C (p.Leu598=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003303996	16	23641681	16	23630360	3303996	3470163		NC_000016.10:23630359:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1794G>A (p.Leu598=)	PALB2		Familial cancer of breast	VCV000219588	16	23641681	16	23630360	219588	222468	rs182494675	NC_000016.10:23630359:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.1793T>G (p.Leu598Arg)	PALB2	L598R, L2R, L303R, L578R	Familial cancer of breast	VCV003666368	16	23641682	16	23630361	3666368	3792172		NC_000016.10:23630360:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1793T>C (p.Leu598Pro)	PALB2	L2P, L598P, L303P, L578P	Familial cancer of breast	VCV002100370	16	23641682	16	23630361	2100370	2158267	rs2142389109	NC_000016.10:23630360:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1792C>T (p.Leu598=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|not specified	VCV000215927	16	23641683	16	23630362	215927	213175	rs746702349	NC_000016.10:23630361:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1791G>A (p.Met597Ile)	PALB2	M597I	Hereditary cancer-predisposing syndrome	VCV000629775	16	23641684	16	23630363	629775	618405	rs1567218807	NC_000016.10:23630362:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1790T>A (p.Met597Lys)	PALB2	M1K, M577K, M302K, M597K	Hereditary cancer-predisposing syndrome	VCV001780187	16	23641685	16	23630364	1780187	1834888	rs786203214	NC_000016.10:23630363:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1790T>C (p.Met597Thr)	PALB2	M597T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001436613	16	23641685	16	23630364	1436613	1341004	rs786203214	NC_000016.10:23630363:A:G	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1790T>G (p.Met597Arg)	PALB2	M597R	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000186779	16	23641685	16	23630364	186779	184221	rs786203214	NC_000016.10:23630363:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1788A>G (p.Gly596=)	PALB2		Familial cancer of breast	VCV003903761	16	23641687	16	23630366	3903761	4019634		NC_000016.10:23630365:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1786G>A (p.Gly596Arg)	PALB2	G576R, G301R, G596R	Familial cancer of breast	VCV003638312	16	23641689	16	23630368	3638312	3774607		NC_000016.10:23630367:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1786G>T (p.Gly596Ter)	PALB2	G596*	not provided|Familial cancer of breast	VCV000830145	16	23641689	16	23630368	830145	818505	rs1966866081	NC_000016.10:23630367:C:A	single nucleotide variant	nonsense	Pathogenic	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1785T>A (p.Asp595Glu)	PALB2	D595E	Familial cancer of breast	VCV001494919	16	23641690	16	23630369	1494919	1345061	rs1555460651	NC_000016.10:23630368:A:T	single nucleotide variant	missense variant	Uncertain significance	May 9, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1785T>C (p.Asp595=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000460911	16	23641690	16	23630369	460911	466216	rs1555460651	NC_000016.10:23630368:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1784A>C (p.Asp595Ala)	PALB2	D595A, D575A, D300A	Hereditary cancer-predisposing syndrome	VCV003927450	16	23641691	16	23630370	3927450	4047083		NC_000016.10:23630369:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Jun 6, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1784A>T (p.Asp595Val)	PALB2	D575V, D595V, D300V	Familial cancer of breast	VCV002092664	16	23641691	16	23630370	2092664	2145407	rs1555460652	NC_000016.10:23630369:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1784A>G (p.Asp595Gly)	PALB2	D595G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481021	16	23641691	16	23630370	481021	478130	rs1555460652	NC_000016.10:23630369:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1783G>T (p.Asp595Tyr)	PALB2	D300Y, D595Y, D575Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002832003	16	23641692	16	23630371	2832003	2998217	rs1555460653	NC_000016.10:23630370:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1783G>A (p.Asp595Asn)	PALB2	D595N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480234	16	23641692	16	23630371	480234	477570	rs1555460653	NC_000016.10:23630370:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 30, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1782G>A (p.Arg594=)	PALB2		Familial cancer of breast	VCV003903650	16	23641693	16	23630372	3903650	4019523		NC_000016.10:23630371:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1781G>C (p.Arg594Thr)	PALB2	R594T	Familial cancer of breast	VCV001041753	16	23641694	16	23630373	1041753	1032523	rs1597091217	NC_000016.10:23630372:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1781G>A (p.Arg594Lys)	PALB2	R594K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000641088	16	23641694	16	23630373	641088	644440	rs1597091217	NC_000016.10:23630372:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 20, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1780A>G (p.Arg594Gly)	PALB2	R574G, R299G, R594G	Hereditary cancer-predisposing syndrome	VCV003927441	16	23641695	16	23630374	3927441	4047074		NC_000016.10:23630373:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1779T>G (p.His593Gln)	PALB2	H298Q, H593Q, H573Q	Familial cancer of breast	VCV002585102	16	23641696	16	23630375	2585102	2752664	rs1475548158	NC_000016.10:23630374:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance		criteria provided, single submitter							
NM_024675.4(PALB2):c.1779T>C (p.His593=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000652679	16	23641696	16	23630375	652679	644441	rs1475548158	NC_000016.10:23630374:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1778A>G (p.His593Arg)	PALB2	H593R	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000439231	16	23641697	16	23630376	439231	432878	rs1555460654	NC_000016.10:23630375:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1775T>G (p.Phe592Cys)	PALB2	F592C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001378290	16	23641700	16	23630379	1378290	1492720	rs2142389552	NC_000016.10:23630378:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1773A>G (p.Pro591=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000750637	16	23641702	16	23630381	750637	755029	rs1597091237	NC_000016.10:23630380:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1772C>T (p.Pro591Leu)	PALB2	P296L, P571L, P591L	Familial cancer of breast	VCV001721943	16	23641703	16	23630382	1721943	1779661	rs761773470	NC_000016.10:23630381:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1772C>A (p.Pro591Gln)	PALB2	P591Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000490071	16	23641703	16	23630382	490071	482948	rs761773470	NC_000016.10:23630381:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1771C>G (p.Pro591Ala)	PALB2	P591A	Hereditary cancer-predisposing syndrome	VCV000231582	16	23641704	16	23630383	231582	235264	rs876659241	NC_000016.10:23630382:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.1770T>C (p.Ala590=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001779796	16	23641705	16	23630384	1779796	1838448	rs1413121157	NC_000016.10:23630383:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 2, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1769C>A (p.Ala590Asp)	PALB2	A295D, A570D, A590D	not provided	VCV001810143	16	23641706	16	23630385	1810143	1867146	rs1966866430	NC_000016.10:23630384:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1769C>G (p.Ala590Gly)	PALB2	A590G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001425617	16	23641706	16	23630385	1425617	1427992	rs1966866430	NC_000016.10:23630384:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1769C>T (p.Ala590Val)	PALB2	A590V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000961132	16	23641706	16	23630385	961132	949312	rs1966866430	NC_000016.10:23630384:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1767G>A (p.Thr589=)	PALB2		Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|not provided|not specified|PALB2-related disorder|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast	VCV000230075	16	23641708	16	23630387	230075	235265	rs769849072	NC_000016.10:23630386:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1766C>T (p.Thr589Met)	PALB2	T589M	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000187669	16	23641709	16	23630388	187669	184222	rs773340677	NC_000016.10:23630387:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1765A>C (p.Thr589Pro)	PALB2	T569P, T294P, T589P	Hereditary cancer-predisposing syndrome	VCV001779656	16	23641710	16	23630389	1779656	1838309	rs1437053825	NC_000016.10:23630388:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1765A>G (p.Thr589Ala)	PALB2	T589A	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000460910	16	23641710	16	23630389	460910	466226	rs1437053825	NC_000016.10:23630388:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1762T>C (p.Phe588Leu)	PALB2	F588L	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001024121	16	23641713	16	23630392	1024121	1012035	rs762820168	NC_000016.10:23630391:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1761T>G (p.Ala587=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001779597	16	23641714	16	23630393	1779597	1838250	rs1060504715	NC_000016.10:23630392:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 4, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1761T>C (p.Ala587=)	PALB2		Familial cancer of breast	VCV000415994	16	23641714	16	23630393	415994	401045	rs1060504715	NC_000016.10:23630392:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 7, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1760C>T (p.Ala587Val)	PALB2	A587V, A567V, A292V	Hereditary cancer-predisposing syndrome	VCV001779573	16	23641715	16	23630394	1779573	1838226	rs2506437614	NC_000016.10:23630393:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1759G>A (p.Ala587Thr)	PALB2	A587T	Familial cancer of breast|not provided|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000410106	16	23641716	16	23630395	410106	401785	rs1060502733	NC_000016.10:23630394:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1758T>C (p.Asp586=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000220529	16	23641717	16	23630396	220529	222469	rs864622567	NC_000016.10:23630395:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1757A>T (p.Asp586Val)	PALB2	D291V, D566V, D586V	Hereditary cancer-predisposing syndrome	VCV003227996	16	23641718	16	23630397	3227996	3387765	rs1278558296	NC_000016.10:23630396:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1757A>G (p.Asp586Gly)	PALB2	D586G	Hereditary cancer-predisposing syndrome	VCV000922276	16	23641718	16	23630397	922276	913646	rs1278558296	NC_000016.10:23630396:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1756G>T (p.Asp586Tyr)	PALB2	D586Y	Familial cancer of breast	VCV001515544	16	23641719	16	23630398	1515544	1505409	rs587781954	NC_000016.10:23630397:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1756G>A (p.Asp586Asn)	PALB2	D586N	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000141709	16	23641719	16	23630398	141709	151423	rs587781954	NC_000016.10:23630397:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1755T>C (p.Asp585=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000186568	16	23641720	16	23630399	186568	184223	rs786203049	NC_000016.10:23630398:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1754A>G (p.Asp585Gly)	PALB2	D585G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820009	16	23641721	16	23630400	820009	812740	rs1597091293	NC_000016.10:23630399:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1754A>C (p.Asp585Ala)	PALB2	D585A	Familial cancer of breast	VCV000644866	16	23641721	16	23630400	644866	644444	rs1597091293	NC_000016.10:23630399:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1753G>A (p.Asp585Asn)	PALB2	D585N	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000241533	16	23641722	16	23630401	241533	242374	rs878855102	NC_000016.10:23630400:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1752T>G (p.Asp584Glu)	PALB2	D584E	Familial cancer of breast	VCV001005671	16	23641723	16	23630402	1005671	996803	rs1060504717	NC_000016.10:23630401:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1752T>C (p.Asp584=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000415997	16	23641723	16	23630402	415997	401530	rs1060504717	NC_000016.10:23630401:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1751A>G (p.Asp584Gly)	PALB2	D584G	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001509210	16	23641724	16	23630403	1509210	1452327	rs2142390124	NC_000016.10:23630402:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1750G>A (p.Asp584Asn)	PALB2	D584N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001389054	16	23641725	16	23630404	1389054	1476634	rs1966866891	NC_000016.10:23630403:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1749G>A (p.Leu583=)	PALB2		Familial cancer of breast	VCV003904504	16	23641726	16	23630405	3904504	4020376		NC_000016.10:23630404:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1749G>C (p.Leu583Phe)	PALB2	L583F	Familial cancer of breast	VCV000967597	16	23641726	16	23630405	967597	957700	rs1966866916	NC_000016.10:23630404:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1748T>C (p.Leu583Ser)	PALB2	L583S	Familial cancer of breast|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000186581	16	23641727	16	23630406	186581	184224	rs587782151	NC_000016.10:23630405:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1748T>G (p.Leu583Trp)	PALB2	L583W	Familial cancer of breast	VCV000141972	16	23641727	16	23630406	141972	151686	rs587782151	NC_000016.10:23630405:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.1747T>C (p.Leu583=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003413447	16	23641728	16	23630407	3413447	3574670		NC_000016.10:23630406:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 31, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1746C>A (p.Ser582=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001779295	16	23641729	16	23630408	1779295	1828510	rs1057520985	NC_000016.10:23630407:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Aug 18, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1746C>T (p.Ser582=)	PALB2		not specified|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000381235	16	23641729	16	23630408	381235	374941	rs1057520985	NC_000016.10:23630407:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1745C>T (p.Ser582Phe)	PALB2	S582F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001045653	16	23641730	16	23630409	1045653	1032524	rs865777690	NC_000016.10:23630408:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 23, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1745C>G (p.Ser582Cys)	PALB2	S582C	Familial cancer of breast	VCV000948850	16	23641730	16	23630409	948850	927726	rs865777690	NC_000016.10:23630408:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1744T>G (p.Ser582Ala)	PALB2	S287A, S562A, S582A	Familial cancer of breast	VCV003648596	16	23641731	16	23630410	3648596	3784453		NC_000016.10:23630409:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 3, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1744T>C (p.Ser582Pro)	PALB2	S582P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000232171	16	23641731	16	23630410	232171	235266	rs876659597	NC_000016.10:23630409:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1743A>G (p.Leu581=)	PALB2		Breast and/or ovarian cancer|not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000126624	16	23641732	16	23630411	126624	132134	rs180177105	NC_000016.10:23630410:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1742T>C (p.Leu581Ser)	PALB2	L581S	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000410138	16	23641733	16	23630412	410138	401114	rs1060502755	NC_000016.10:23630411:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1741T>C (p.Leu581=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001779212	16	23641734	16	23630413	1779212	1828427	rs2142390373	NC_000016.10:23630412:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1740T>G (p.Tyr580Ter)	PALB2	Y285*, Y560*, Y580*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002587420	16	23641735	16	23630414	2587420	2754096	rs2142390387	NC_000016.10:23630413:A:C	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1738T>C (p.Tyr580His)	PALB2	Y285H, Y560H, Y580H	Familial cancer of breast	VCV003240012	16	23641737	16	23630416	3240012	3399000	rs2142390400	NC_000016.10:23630415:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1737T>A (p.Ala579=)	PALB2		Familial cancer of breast	VCV003904034	16	23641738	16	23630417	3904034	4019907		NC_000016.10:23630416:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1737T>G (p.Ala579=)	PALB2		Familial cancer of breast	VCV001091924	16	23641738	16	23630417	1091924	1081890	rs1597091336	NC_000016.10:23630416:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1737T>C (p.Ala579=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000819957	16	23641738	16	23630417	819957	812741	rs1597091336	NC_000016.10:23630416:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 6, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1736C>G (p.Ala579Gly)	PALB2	A284G, A579G, A559G	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3	VCV003891897	16	23641739	16	23630418	3891897	4007786		NC_000016.10:23630417:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1736C>T (p.Ala579Val)	PALB2	A579V	not provided|Familial cancer of breast|Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome	VCV000576094	16	23641739	16	23630418	576094	570188	rs1567218908	NC_000016.10:23630417:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1735G>T (p.Ala579Ser)	PALB2	A559S, A579S, A284S	Hereditary cancer-predisposing syndrome	VCV001779065	16	23641740	16	23630419	1779065	1831649	rs1567218910	NC_000016.10:23630418:C:A	single nucleotide variant	missense variant	Uncertain significance	May 25, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1735G>C (p.Ala579Pro)	PALB2	A579P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001404770	16	23641740	16	23630419	1404770	1405531	rs1567218910	NC_000016.10:23630418:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1735G>A (p.Ala579Thr)	PALB2	A579T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630485	16	23641740	16	23630419	630485	618406	rs1567218910	NC_000016.10:23630418:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1734T>C (p.Ser578=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000415987	16	23641741	16	23630420	415987	401535	rs757036149	NC_000016.10:23630419:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1733G>A (p.Ser578Asn)	PALB2	S283N, S558N, S578N	Familial cancer of breast	VCV003648389	16	23641742	16	23630421	3648389	3787668		NC_000016.10:23630420:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1733G>T (p.Ser578Ile)	PALB2	S578I	Familial cancer of breast|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not provided	VCV000128123	16	23641742	16	23630421	128123	133580	rs587780207	NC_000016.10:23630420:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1732A>T (p.Ser578Cys)	PALB2	S578C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819931	16	23641743	16	23630422	819931	812742	rs764023822	NC_000016.10:23630421:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1732A>G (p.Ser578Gly)	PALB2	S578G	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000229738	16	23641743	16	23630422	229738	235267	rs764023822	NC_000016.10:23630421:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1731T>C (p.Asn577=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480237	16	23641744	16	23630423	480237	477579	rs1555460678	NC_000016.10:23630422:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1730A>G (p.Asn577Ser)	PALB2	N577S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000638970	16	23641745	16	23630424	638970	644445	rs1597091371	NC_000016.10:23630423:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1729A>G (p.Asn577Asp)	PALB2	N577D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000628579	16	23641746	16	23630425	628579	618407	rs1567218928	NC_000016.10:23630424:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1727G>A (p.Ser576Asn)	PALB2	S576N	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000245702	16	23641748	16	23630427	245702	244964	rs879253907	NC_000016.10:23630426:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1726A>G (p.Ser576Gly)	PALB2	S281G, S556G, S576G	Familial cancer of breast	VCV002748067	16	23641749	16	23630428	2748067	2912278	rs1555460681	NC_000016.10:23630427:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 29, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1726A>T (p.Ser576Cys)	PALB2	S576C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481141	16	23641749	16	23630428	481141	478134	rs1555460681	NC_000016.10:23630427:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1725G>T (p.Trp575Cys)	PALB2	W575C, W280C, W555C	Familial cancer of breast	VCV002832384	16	23641750	16	23630429	2832384	2994768	rs2142390682	NC_000016.10:23630428:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1725G>A (p.Trp575Ter)	PALB2	W555*, W575*, W280*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001778852	16	23641750	16	23630429	1778852	1831436	rs2142390682	NC_000016.10:23630428:C:T	single nucleotide variant	nonsense	Pathogenic	Jul 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1724G>A (p.Trp575Ter)	PALB2	W575*	Fanconi anemia complementation group N|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000182754	16	23641751	16	23630430	182754	180732	rs730881876	NC_000016.10:23630429:C:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1722T>C (p.Ser574=)	PALB2		Familial cancer of breast	VCV001079458	16	23641753	16	23630432	1079458	1081891	rs2142390779	NC_000016.10:23630431:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1721C>T (p.Ser574Phe)	PALB2	S574F	Hereditary cancer-predisposing syndrome	VCV000819910	16	23641754	16	23630433	819910	812743	rs1597091399	NC_000016.10:23630432:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1720T>C (p.Ser574Pro)	PALB2	S574P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001007445	16	23641755	16	23630434	1007445	996804	rs1214293842	NC_000016.10:23630433:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1719T>A (p.Leu573=)	PALB2		Familial cancer of breast	VCV003903900	16	23641756	16	23630435	3903900	4019773		NC_000016.10:23630434:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1719T>C (p.Leu573=)	PALB2		Familial cancer of breast	VCV003903463	16	23641756	16	23630435	3903463	4019337		NC_000016.10:23630434:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1716C>T (p.Ser572=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001143306	16	23641759	16	23630438	1143306	1146010	rs2142390847	NC_000016.10:23630437:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1715C>T (p.Ser572Phe)	PALB2	S572F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000185787	16	23641760	16	23630439	185787	184225	rs757397623	NC_000016.10:23630438:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1712A>T (p.Asp571Val)	PALB2	D571V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819885	16	23641763	16	23630442	819885	812744	rs1597091418	NC_000016.10:23630441:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1711G>A (p.Asp571Asn)	PALB2	D276N, D551N, D571N	Familial cancer of breast	VCV003625311	16	23641764	16	23630443	3625311	3755258		NC_000016.10:23630442:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1710G>C (p.Glu570Asp)	PALB2	E570D	Hereditary cancer-predisposing syndrome	VCV001332237	16	23641765	16	23630444	1332237	1322956	rs1555460688	NC_000016.10:23630443:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1710G>A (p.Glu570=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000482060	16	23641765	16	23630444	482060	477617	rs1555460688	NC_000016.10:23630443:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1708G>C (p.Glu570Gln)	PALB2	E570Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000460909	16	23641767	16	23630446	460909	465498	rs786203747	NC_000016.10:23630445:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1708G>A (p.Glu570Lys)	PALB2	E570K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000187454	16	23641767	16	23630446	187454	184226	rs786203747	NC_000016.10:23630445:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1707A>C (p.Lys569Asn)	PALB2	K549N, K569N, K274N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001778465	16	23641768	16	23630447	1778465	1834437	rs2506439250	NC_000016.10:23630446:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1706A>C (p.Lys569Thr)	PALB2	K569T	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000835141	16	23641769	16	23630448	835141	843595	rs1966867586	NC_000016.10:23630447:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1704A>T (p.Gln568His)	PALB2	Q273H, Q568H, Q548H	Familial cancer of breast	VCV002755031	16	23641771	16	23630450	2755031	2909730	rs876658676	NC_000016.10:23630449:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1704A>G (p.Gln568=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492169	16	23641771	16	23630450	492169	484830	rs876658676	NC_000016.10:23630449:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1704A>C (p.Gln568His)	PALB2	Q568H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000230634	16	23641771	16	23630450	230634	235268	rs876658676	NC_000016.10:23630449:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1703A>G (p.Gln568Arg)	PALB2	Q273R, Q548R, Q568R	Familial cancer of breast	VCV002135273	16	23641772	16	23630451	2135273	2190681	rs2506439396	NC_000016.10:23630450:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1702C>G (p.Gln568Glu)	PALB2	Q273E, Q548E, Q568E	Familial cancer of breast	VCV003672316	16	23641773	16	23630452	3672316	3805373		NC_000016.10:23630451:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1702C>T (p.Gln568Ter)	PALB2	Q568*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460907	16	23641773	16	23630452	460907	466443	rs876659354	NC_000016.10:23630451:G:A	single nucleotide variant	nonsense	Pathogenic	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1702C>A (p.Gln568Lys)	PALB2	Q568K	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not specified	VCV000231775	16	23641773	16	23630452	231775	235269	rs876659354	NC_000016.10:23630451:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1701T>C (p.His567=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002777787	16	23641774	16	23630453	2777787	2936783	rs1966867674	NC_000016.10:23630452:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1700A>T (p.His567Leu)	PALB2	H272L, H547L, H567L	Hereditary cancer-predisposing syndrome	VCV003413508	16	23641775	16	23630454	3413508	3574731		NC_000016.10:23630453:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1700A>C (p.His567Pro)	PALB2	H272P, H567P, H547P	Hereditary cancer-predisposing syndrome	VCV002567591	16	23641775	16	23630454	2567591	2731233	rs765722926	NC_000016.10:23630453:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1700A>G (p.His567Arg)	PALB2	H567R	not provided|Familial cancer of breast	VCV001002604	16	23641775	16	23630454	1002604	996805	rs765722926	NC_000016.10:23630453:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1699C>A (p.His567Asn)	PALB2	H567N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000819803	16	23641776	16	23630455	819803	812745	rs370422990	NC_000016.10:23630454:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1699C>T (p.His567Tyr)	PALB2	H567Y	Hereditary cancer-predisposing syndrome|not specified|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Familial cancer of breast	VCV000126622	16	23641776	16	23630455	126622	132132	rs370422990	NC_000016.10:23630454:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1698T>C (p.Arg566=)	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486021	16	23641777	16	23630456	486021	477623	rs373141871	NC_000016.10:23630455:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1697G>T (p.Arg566Leu)	PALB2	R566L	Familial cancer of breast	VCV000849544	16	23641778	16	23630457	849544	843596	rs144617793	NC_000016.10:23630456:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1697G>C (p.Arg566Pro)	PALB2	R566P	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|not provided|Hereditary cancer-predisposing syndrome	VCV000140894	16	23641778	16	23630457	140894	150608	rs144617793	NC_000016.10:23630456:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1697G>A (p.Arg566His)	PALB2	R566H	Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 2	VCV000128122	16	23641778	16	23630457	128122	133579	rs144617793	NC_000016.10:23630456:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1696C>A (p.Arg566Ser)	PALB2	R271S, R546S, R566S	Hereditary cancer-predisposing syndrome	VCV001778228	16	23641779	16	23630458	1778228	1838160	rs746582620	NC_000016.10:23630457:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1696C>T (p.Arg566Cys)	PALB2	R566C	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410109	16	23641779	16	23630458	410109	401542	rs746582620	NC_000016.10:23630457:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 31, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1695T>C (p.Ser565=)	PALB2		Familial cancer of breast	VCV003903588	16	23641780	16	23630459	3903588	4019461		NC_000016.10:23630458:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1695T>A (p.Ser565Arg)	PALB2	S545R, S565R, S270R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001778225	16	23641780	16	23630459	1778225	1838157	rs2506439748	NC_000016.10:23630458:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1694G>T (p.Ser565Ile)	PALB2	S565I	not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not specified	VCV000420453	16	23641781	16	23630460	420453	409545	rs876659914	NC_000016.10:23630459:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1694G>A (p.Ser565Asn)	PALB2	S565N	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000232674	16	23641781	16	23630460	232674	235270	rs876659914	NC_000016.10:23630459:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1693A>G (p.Ser565Gly)	PALB2	S565G	Hereditary cancer-predisposing syndrome	VCV001331807	16	23641782	16	23630461	1331807	1322527	rs2142391276	NC_000016.10:23630460:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1692A>G (p.Lys564=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000184985	16	23641783	16	23630462	184985	184227	rs786201842	NC_000016.10:23630461:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1691A>G (p.Lys564Arg)	PALB2	K564R	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000186382	16	23641784	16	23630463	186382	184228	rs62625276	NC_000016.10:23630462:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1689G>C (p.Lys563Asn)	PALB2	K268N, K543N, K563N	Hereditary cancer-predisposing syndrome	VCV003227995	16	23641786	16	23630465	3227995	3387764	rs2142391318	NC_000016.10:23630464:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1689G>T (p.Lys563Asn)	PALB2	K268N, K563N, K543N	Hereditary cancer-predisposing syndrome	VCV001778085	16	23641786	16	23630465	1778085	1838017	rs2142391318	NC_000016.10:23630464:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1688A>T (p.Lys563Met)	PALB2	K268M, K563M, K543M	Hereditary cancer-predisposing syndrome	VCV001778051	16	23641787	16	23630466	1778051	1837983	rs1396029242	NC_000016.10:23630465:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1688A>C (p.Lys563Thr)	PALB2	K563T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819821	16	23641787	16	23630466	819821	812747	rs1396029242	NC_000016.10:23630465:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1687A>G (p.Lys563Glu)	PALB2	K543E, K268E, K563E	Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV001778035	16	23641788	16	23630467	1778035	1837967	rs2142391353	NC_000016.10:23630466:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1686G>T (p.Gly562=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001778019	16	23641789	16	23630468	1778019	1837951	rs1555460700	NC_000016.10:23630467:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 16, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1686G>A (p.Gly562=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530255	16	23641789	16	23630468	530255	529899	rs1555460700	NC_000016.10:23630467:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 17, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1685G>A (p.Gly562Glu)	PALB2	G562E	Familial cancer of breast	VCV001478385	16	23641790	16	23630469	1478385	1351892	rs2142391406	NC_000016.10:23630468:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-1G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628561	16	23641791	16	23630470	628561	619492	rs1057520645	NC_000016.10:23630469:C:T	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Dec 6, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1685-1G>C	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000379566	16	23641791	16	23630470	379566	375259	rs1057520645	NC_000016.10:23630469:C:G	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Mar 22, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1685-2A>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001042118	16	23641792	16	23630471	1042118	1032525	rs754660432	NC_000016.10:23630470:T:G	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1685-2A>G	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|PALB2-related disorder|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000449968	16	23641792	16	23630471	449968	445546	rs754660432	NC_000016.10:23630470:T:C	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1685-3T>G	PALB2		Familial cancer of breast	VCV000578091	16	23641793	16	23630472	578091	567985	rs1254059410	NC_000016.10:23630471:A:C	single nucleotide variant	intron variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-3T>C	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000530233	16	23641793	16	23630472	530233	529901	rs1254059410	NC_000016.10:23630471:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1685-4T>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819827	16	23641794	16	23630473	819827	815632	rs1597091527	NC_000016.10:23630472:A:G	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1685-5T>C	PALB2		Familial cancer of breast	VCV003667623	16	23641795	16	23630474	3667623	3796199		NC_000016.10:23630473:A:G	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1685-5T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV003413465	16	23641795	16	23630474	3413465	3574688		NC_000016.10:23630473:A:C	single nucleotide variant	intron variant	Uncertain significance	Sep 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-5T>A	PALB2		Hereditary cancer-predisposing syndrome	VCV003413433	16	23641795	16	23630474	3413433	3574656		NC_000016.10:23630473:A:T	single nucleotide variant	intron variant	Uncertain significance	Jul 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-6C>T	PALB2		Familial cancer of breast	VCV002035144	16	23641796	16	23630475	2035144	2100802	rs2142391504	NC_000016.10:23630474:G:A	single nucleotide variant	intron variant	Likely benign	Oct 11, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-7T>A	PALB2		Familial cancer of breast	VCV001112232	16	23641797	16	23630476	1112232	1103706	rs1555460705	NC_000016.10:23630475:A:T	single nucleotide variant	intron variant	Likely benign	Feb 24, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-7T>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000492168	16	23641797	16	23630476	492168	485032	rs1555460705	NC_000016.10:23630475:A:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 28, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1685-9C>G	PALB2		Hereditary cancer-predisposing syndrome	VCV001691942	16	23641799	16	23630478	1691942	1684384	rs2142391529	NC_000016.10:23630477:G:C	single nucleotide variant	intron variant	Uncertain significance	May 20, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-9C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001111404	16	23641799	16	23630478	1111404	1103707	rs2142391529	NC_000016.10:23630477:G:A	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1685-10T>C	PALB2		Familial cancer of breast|Hereditary cancer|Hereditary cancer-predisposing syndrome	VCV000629999	16	23641800	16	23630479	629999	619624	rs1567219034	NC_000016.10:23630478:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1685-11T>C	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5	VCV003780081	16	23641801	16	23630480	3780081	3896048		NC_000016.10:23630479:A:G	single nucleotide variant	intron variant	Uncertain significance	Jul 13, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-14T>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000630629	16	23641804	16	23630483	630629	619534	rs780772404	NC_000016.10:23630482:A:G	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1685-14T>A	PALB2		not specified|Familial cancer of breast|PALB2-related cancer predisposition|Hereditary cancer-predisposing syndrome	VCV000389983	16	23641804	16	23630483	389983	374942	rs780772404	NC_000016.10:23630482:A:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1685-15A>G	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5	VCV003780082	16	23641805	16	23630484	3780082	3896049		NC_000016.10:23630483:T:C	single nucleotide variant	intron variant	Likely benign	Feb 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-15A>C	PALB2		Familial cancer of breast	VCV002766241	16	23641805	16	23630484	2766241	2932146	rs747646354	NC_000016.10:23630483:T:G	single nucleotide variant	intron variant	Likely benign	Oct 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-17T>C	PALB2		Familial cancer of breast	VCV003903629	16	23641807	16	23630486	3903629	4019502		NC_000016.10:23630485:A:G	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-17T>A	PALB2		Hereditary cancer-predisposing syndrome	VCV000629533	16	23641807	16	23630486	629533	619565	rs1567219043	NC_000016.10:23630485:A:T	single nucleotide variant	intron variant	Likely benign	Oct 12, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-18C>T	PALB2		not specified	VCV001802887	16	23641808	16	23630487	1802887	1859918	rs1401344071	NC_000016.10:23630486:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-20G>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492167	16	23641810	16	23630489	492167	484831	rs1555460707	NC_000016.10:23630488:C:T	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1685-28T>C	PALB2		Familial cancer of breast	VCV000803237	16	23641818	16	23630497	803237	791570	rs1597091553	NC_000016.10:23630496:A:G	single nucleotide variant	intron variant	Likely benign	May 28, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1685-29C>T	PALB2		not specified	VCV001802888	16	23641819	16	23630498	1802888	1859919	rs773252502	NC_000016.10:23630497:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+29A>G	PALB2		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000126616	16	23646154	16	23634833	126616	132126	rs74320059	NC_000016.10:23634832:T:C	single nucleotide variant	intron variant	Benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1684+20A>G	PALB2		Familial cancer of breast	VCV002046786	16	23646163	16	23634842	2046786	2093062	rs1966945622	NC_000016.10:23634841:T:C	single nucleotide variant	intron variant	Likely benign	May 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+19G>C	PALB2		Familial cancer of breast	VCV002753006	16	23646164	16	23634843	2753006	2909004	rs2142408998	NC_000016.10:23634842:C:G	single nucleotide variant	intron variant	Likely benign	Aug 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+17T>G	PALB2		Familial cancer of breast	VCV002086678	16	23646166	16	23634845	2086678	2140719	rs2142409017	NC_000016.10:23634844:A:C	single nucleotide variant	intron variant	Likely benign	Jan 17, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+15G>A	PALB2		Familial cancer of breast	VCV001925464	16	23646168	16	23634847	1925464	1986944	rs2142409040	NC_000016.10:23634846:C:T	single nucleotide variant	intron variant	Likely benign	Jul 16, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+13G>T	PALB2		Familial cancer of breast	VCV003701403	16	23646170	16	23634849	3701403	3826651		NC_000016.10:23634848:C:A	single nucleotide variant	intron variant	Likely benign	May 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+11A>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N	VCV000490070	16	23646172	16	23634851	490070	482931	rs201368043	NC_000016.10:23634850:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1684+10G>A	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000381871	16	23646173	16	23634852	381871	374949	rs1057517620	NC_000016.10:23634851:C:T	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1684+9A>G	PALB2		Familial cancer of breast	VCV003903729	16	23646174	16	23634853	3903729	4019602		NC_000016.10:23634852:T:C	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+7C>T	PALB2		Familial cancer of breast	VCV003903609	16	23646176	16	23634855	3903609	4019482		NC_000016.10:23634854:G:A	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+7C>G	PALB2		Familial cancer of breast	VCV001126795	16	23646176	16	23634855	1126795	1125119	rs1160398551	NC_000016.10:23634854:G:C	single nucleotide variant	intron variant	Likely benign	Jun 8, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+5A>G	PALB2		Hereditary cancer-predisposing syndrome	VCV003774412	16	23646178	16	23634857	3774412	3890559		NC_000016.10:23634856:T:C	single nucleotide variant	intron variant	Uncertain significance	Oct 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+4A>G	PALB2		Familial cancer of breast	VCV002770036	16	23646179	16	23634858	2770036	2929905	rs1057523145	NC_000016.10:23634857:T:C	single nucleotide variant	intron variant	Uncertain significance	Jun 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+4A>C	PALB2		not specified	VCV000388551	16	23646179	16	23634858	388551	375260	rs1057523145	NC_000016.10:23634857:T:G	single nucleotide variant	intron variant	Likely benign	Aug 15, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.1684+2T>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002043593	16	23646181	16	23634860	2043593	2102767	rs2142409238	NC_000016.10:23634859:A:T	single nucleotide variant	splice donor variant|intron variant	Conflicting classifications of pathogenicity	Aug 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1684+1G>A	PALB2		Familial cancer of breast	VCV000482029	16	23646182	16	23634861	482029	477590	rs1555461148	NC_000016.10:23634860:C:T	single nucleotide variant	splice donor variant|intron variant	Uncertain significance	Jan 5, 2024	reviewed by expert panel							
NM_024675.4(PALB2):c.1684+1G>T	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481027	16	23646182	16	23634861	481027	477585	rs1555461148	NC_000016.10:23634860:C:A	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Feb 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1684G>A (p.Gly562Arg)	PALB2	G562R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000185516	16	23646183	16	23634862	185516	184229	rs786202239	NC_000016.10:23634861:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1683A>G (p.Lys561=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003413399	16	23646184	16	23634863	3413399	3574622		NC_000016.10:23634862:T:C	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Nov 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1681A>G (p.Lys561Glu)	PALB2	K561E	Hereditary cancer-predisposing syndrome	VCV000819811	16	23646186	16	23634865	819811	812748	rs1597095176	NC_000016.10:23634864:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1680G>C (p.Val560=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001158229	16	23646187	16	23634866	1158229	1146011	rs2142409320	NC_000016.10:23634865:C:G	single nucleotide variant	synonymous variant	Likely benign	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1678G>A (p.Val560Met)	PALB2	V560M	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000852289	16	23646189	16	23634868	852289	843597	rs1966946608	NC_000016.10:23634867:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1677A>T (p.Gln559His)	PALB2	Q264H, Q559H, Q539H	Hereditary cancer-predisposing syndrome	VCV003927459	16	23646190	16	23634869	3927459	4047092		NC_000016.10:23634868:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 3, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1677A>G (p.Gln559=)	PALB2		Familial cancer of breast	VCV002093927	16	23646190	16	23634869	2093927	2153130	rs1966946695	NC_000016.10:23634868:T:C	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Feb 6, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1676A>T (p.Gln559Leu)	PALB2	Q264L, Q559L, Q539L	Familial cancer of breast	VCV002096498	16	23646191	16	23634870	2096498	2146649	rs152451	NC_000016.10:23634869:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1676A>G (p.Gln559Arg)	PALB2	Q559R	Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not specified|Hereditary breast ovarian cancer syndrome|not provided|Familial cancer of breast	VCV000126613	16	23646191	16	23634870	126613	132123	rs152451	NC_000016.10:23634869:T:C	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1675C>G (p.Gln559Glu)	PALB2	Q559E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001376312	16	23646192	16	23634871	1376312	1466845	rs1555461154	NC_000016.10:23634870:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1675C>T (p.Gln559Ter)	PALB2	Q559*	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000480240	16	23646192	16	23634871	480240	477634	rs1555461154	NC_000016.10:23634870:G:A	single nucleotide variant	nonsense	Pathogenic	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1674T>G (p.Ile558Met)	PALB2	I263M, I558M, I538M	Familial cancer of breast	VCV003697005	16	23646193	16	23634872	3697005	3822105		NC_000016.10:23634871:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 1, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1673T>G (p.Ile558Ser)	PALB2	I558S	Hereditary cancer-predisposing syndrome	VCV000629596	16	23646194	16	23634873	629596	618408	rs766583287	NC_000016.10:23634872:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1673T>C (p.Ile558Thr)	PALB2	I558T	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000619885	16	23646194	16	23634873	619885	611221	rs766583287	NC_000016.10:23634872:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1671T>C (p.Phe557=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000754407	16	23646196	16	23634875	754407	770779	rs1597095213	NC_000016.10:23634874:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 16, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1670T>C (p.Phe557Ser)	PALB2	F557S	Hereditary cancer-predisposing syndrome	VCV000233619	16	23646197	16	23634876	233619	235271	rs876660525	NC_000016.10:23634875:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.1669T>C (p.Phe557Leu)	PALB2	F557L	not provided|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000570662	16	23646198	16	23634877	570662	570189	rs1326785676	NC_000016.10:23634876:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1668A>G (p.Leu556=)	PALB2		Familial cancer of breast	VCV003903725	16	23646199	16	23634878	3903725	4019598		NC_000016.10:23634877:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1667T>C (p.Leu556Ser)	PALB2	L556S	Familial cancer of breast	VCV000864467	16	23646200	16	23634879	864467	843598	rs1966947813	NC_000016.10:23634878:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1665A>G (p.Lys555=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000794829	16	23646202	16	23634881	794829	785229	rs45518838	NC_000016.10:23634880:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1665A>T (p.Lys555Asn)	PALB2	K555N	Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast	VCV000650470	16	23646202	16	23634881	650470	644447	rs45518838	NC_000016.10:23634880:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1664A>G (p.Lys555Arg)	PALB2	K555R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484243	16	23646203	16	23634882	484243	477668	rs1555461163	NC_000016.10:23634881:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1662A>G (p.Glu554=)	PALB2		Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Familial cancer of breast|not provided	VCV000186099	16	23646205	16	23634884	186099	184230	rs786202692	NC_000016.10:23634883:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1661A>G (p.Glu554Gly)	PALB2	E554G	Familial cancer of breast	VCV000460906	16	23646206	16	23634885	460906	466449	rs1555461164	NC_000016.10:23634884:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1660G>T (p.Glu554Ter)	PALB2	E554*, E534*, E259*	Hereditary cancer-predisposing syndrome	VCV003304011	16	23646207	16	23634886	3304011	3470178		NC_000016.10:23634885:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1660G>A (p.Glu554Lys)	PALB2	E554K	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000481030	16	23646207	16	23634886	481030	477593	rs377486858	NC_000016.10:23634885:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1659C>T (p.His553=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000386502	16	23646208	16	23634887	386502	374950	rs370318597	NC_000016.10:23634886:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1659C>A (p.His553Gln)	PALB2	H553Q	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000188298	16	23646208	16	23634887	188298	186218	rs370318597	NC_000016.10:23634886:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1659C>G (p.His553Gln)	PALB2	H553Q	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000187175	16	23646208	16	23634887	187175	184231	rs370318597	NC_000016.10:23634886:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1658A>G (p.His553Arg)	PALB2	H553R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000642417	16	23646209	16	23634888	642417	644448	rs1482172344	NC_000016.10:23634887:T:C	single nucleotide variant	missense variant	Uncertain significance	May 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1657C>G (p.His553Asp)	PALB2	H553D	Hereditary cancer-predisposing syndrome	VCV000630435	16	23646210	16	23634889	630435	618409	rs1567220555	NC_000016.10:23634888:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1656G>C (p.Gln552His)	PALB2	Q532H, Q552H, Q257H	Familial cancer of breast	VCV003656242	16	23646211	16	23634890	3656242	3779052		NC_000016.10:23634889:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1656G>A (p.Gln552=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126612	16	23646211	16	23634890	126612	132122	rs180177104	NC_000016.10:23634889:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1655A>G (p.Gln552Arg)	PALB2	Q552R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000246365	16	23646212	16	23634891	246365	244966	rs375611746	NC_000016.10:23634890:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1653T>G (p.Tyr551Ter)	PALB2	Y551*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000819760	16	23646214	16	23634893	819760	812749	rs118203997	NC_000016.10:23634892:A:C	single nucleotide variant	nonsense	Pathogenic	Dec 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1653T>C (p.Tyr551=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000231586	16	23646214	16	23634893	231586	235272	rs118203997	NC_000016.10:23634892:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1653T>A (p.Tyr551Ter)	PALB2	Y551*	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000001243	16	23646214	16	23634893	1243	16282	rs118203997	NC_000016.10:23634892:A:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1652A>G (p.Tyr551Cys)	PALB2	Y551C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000856757	16	23646215	16	23634894	856757	843599	rs1966949762	NC_000016.10:23634893:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1651T>C (p.Tyr551His)	PALB2	Y531H, Y551H, Y256H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001777271	16	23646216	16	23634895	1777271	1831163	rs2506470274	NC_000016.10:23634894:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1650A>G (p.Lys550=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000415995	16	23646217	16	23634896	415995	401786	rs1060504716	NC_000016.10:23634895:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1649A>G (p.Lys550Arg)	PALB2	K530R, K550R, K255R	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001777202	16	23646218	16	23634897	1777202	1831094	rs2506470320	NC_000016.10:23634896:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1648A>T (p.Lys550Ter)	PALB2	K550*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000487009	16	23646219	16	23634898	487009	478138	rs1555461178	NC_000016.10:23634897:T:A	single nucleotide variant	nonsense	Pathogenic	Nov 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1648A>G (p.Lys550Glu)	PALB2	K550E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484245	16	23646219	16	23634898	484245	478143	rs1555461178	NC_000016.10:23634897:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1647C>T (p.His549=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830143	16	23646220	16	23634899	830143	818507	rs747842085	NC_000016.10:23634898:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1647C>G (p.His549Gln)	PALB2	H549Q	Familial cancer of breast	VCV000656191	16	23646220	16	23634899	656191	644449	rs747842085	NC_000016.10:23634898:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1647C>A (p.His549Gln)	PALB2	H549Q	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|not provided|Familial cancer of breast	VCV000220449	16	23646220	16	23634899	220449	222470	rs747842085	NC_000016.10:23634898:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1646A>T (p.His549Leu)	PALB2	H529L, H549L, H254L	Hereditary cancer-predisposing syndrome	VCV003885197	16	23646221	16	23634900	3885197	4005519		NC_000016.10:23634899:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1646A>G (p.His549Arg)	PALB2	H549R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000654612	16	23646221	16	23634900	654612	644450	rs1597095334	NC_000016.10:23634899:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1645C>T (p.His549Tyr)	PALB2	H549Y	Familial cancer of breast	VCV001009616	16	23646222	16	23634901	1009616	996806	rs1966950582	NC_000016.10:23634900:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1644A>G (p.Ser548=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000819716	16	23646223	16	23634902	819716	812750	rs1597095339	NC_000016.10:23634901:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 1, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1644A>C (p.Ser548=)	PALB2		Familial cancer of breast	VCV000754963	16	23646223	16	23634902	754963	770780	rs1597095339	NC_000016.10:23634901:T:G	single nucleotide variant	synonymous variant	Likely benign	Sep 29, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1643C>G (p.Ser548Ter)	PALB2	S548*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819733	16	23646224	16	23634903	819733	812751	rs1241049372	NC_000016.10:23634902:G:C	single nucleotide variant	nonsense	Pathogenic	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1643C>T (p.Ser548Leu)	PALB2	S548L	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000460904	16	23646224	16	23634903	460904	465503	rs1241049372	NC_000016.10:23634902:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 5, 2022	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1642T>C (p.Ser548Pro)	PALB2	S548P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000660721	16	23646225	16	23634904	660721	644451	rs1597095353	NC_000016.10:23634903:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1641C>G (p.Thr547=)	PALB2		Familial cancer of breast	VCV002130152	16	23646226	16	23634905	2130152	2189429	rs564514783	NC_000016.10:23634904:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 24, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1641C>T (p.Thr547=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000182752	16	23646226	16	23634905	182752	180733	rs564514783	NC_000016.10:23634904:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1640C>A (p.Thr547Asn)	PALB2	T547N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000920787	16	23646227	16	23634906	920787	913647	rs1597095364	NC_000016.10:23634905:G:T	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1640C>T (p.Thr547Ile)	PALB2	T547I	Hereditary cancer-predisposing syndrome	VCV000819726	16	23646227	16	23634906	819726	812752	rs1597095364	NC_000016.10:23634905:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1639A>G (p.Thr547Ala)	PALB2	T252A, T527A, T547A	Familial cancer of breast	VCV003667375	16	23646228	16	23634907	3667375	3795952		NC_000016.10:23634906:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 29, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1638C>T (p.Val546=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000232182	16	23646229	16	23634908	232182	235273	rs876659604	NC_000016.10:23634907:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1637T>C (p.Val546Ala)	PALB2	V546A	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000136129	16	23646230	16	23634909	136129	139841	rs148647206	NC_000016.10:23634908:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1635A>G (p.Glu545=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003304012	16	23646232	16	23634911	3304012	3470179		NC_000016.10:23634910:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1635A>C (p.Glu545Asp)	PALB2	E545D	Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome	VCV000819651	16	23646232	16	23634911	819651	812753	rs1597095388	NC_000016.10:23634910:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1634A>G (p.Glu545Gly)	PALB2	E545G	Hereditary cancer-predisposing syndrome	VCV000481043	16	23646233	16	23634912	481043	477594	rs1555461186	NC_000016.10:23634911:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1633G>A (p.Glu545Lys)	PALB2	E545K	Hereditary cancer-predisposing syndrome	VCV000486006	16	23646234	16	23634913	486006	477635	rs180177103	NC_000016.10:23634912:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2018	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1633G>T (p.Glu545Ter)	PALB2	E545*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000126611	16	23646234	16	23634913	126611	132121	rs180177103	NC_000016.10:23634912:C:A	single nucleotide variant	nonsense	Pathogenic	Jun 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1632A>G (p.Glu544=)	PALB2		Familial cancer of breast	VCV003903870	16	23646235	16	23634914	3903870	4019743		NC_000016.10:23634913:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1631A>G (p.Glu544Gly)	PALB2	E544G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000575792	16	23646236	16	23634915	575792	567989	rs1567220628	NC_000016.10:23634914:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1630G>A (p.Glu544Lys)	PALB2	E544K	Hereditary cancer-predisposing syndrome	VCV001332589	16	23646237	16	23634916	1332589	1323307	rs2142410635	NC_000016.10:23634915:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1629G>A (p.Lys543=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003227994	16	23646238	16	23634917	3227994	3387763	rs1274647317	NC_000016.10:23634916:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1629G>C (p.Lys543Asn)	PALB2	K543N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481157	16	23646238	16	23634917	481157	477598	rs1274647317	NC_000016.10:23634916:C:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1628A>G (p.Lys543Arg)	PALB2	K543R	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530201	16	23646239	16	23634918	530201	529839	rs370468259	NC_000016.10:23634917:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1628A>C (p.Lys543Thr)	PALB2	K543T	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000460903	16	23646239	16	23634918	460903	466228	rs370468259	NC_000016.10:23634917:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1627A>G (p.Lys543Glu)	PALB2	K543E	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000481158	16	23646240	16	23634919	481158	478145	rs770908238	NC_000016.10:23634918:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1626C>T (p.Ser542=)	PALB2		Familial cancer of breast	VCV003729700	16	23646241	16	23634920	3729700	3862478		NC_000016.10:23634919:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 28, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1623G>C (p.Arg541Ser)	PALB2	R541S	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480231	16	23646244	16	23634923	480231	478155	rs745665968	NC_000016.10:23634922:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1623G>T (p.Arg541Ser)	PALB2	R541S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410101	16	23646244	16	23634923	410101	401122	rs745665968	NC_000016.10:23634922:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1623G>A (p.Arg541=)	PALB2		not provided|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000183745	16	23646244	16	23634923	183745	184233	rs745665968	NC_000016.10:23634922:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1622G>C (p.Arg541Thr)	PALB2	R541T	Familial cancer of breast	VCV000861514	16	23646245	16	23634924	861514	843600	rs1597095450	NC_000016.10:23634923:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1622G>A (p.Arg541Lys)	PALB2	R541K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819679	16	23646245	16	23634924	819679	812755	rs1597095450	NC_000016.10:23634923:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1621A>C (p.Arg541=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000784777	16	23646246	16	23634925	784777	714812	rs1597095457	NC_000016.10:23634924:T:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1620C>T (p.Asn540=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480270	16	23646247	16	23634926	480270	478156	rs771815436	NC_000016.10:23634925:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1619A>G (p.Asn540Ser)	PALB2	N540S	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000419052	16	23646248	16	23634927	419052	409546	rs1064793609	NC_000016.10:23634926:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1618A>G (p.Asn540Asp)	PALB2	N540D, N245D, N520D	Hereditary cancer-predisposing syndrome	VCV001776528	16	23646249	16	23634928	1776528	1837758	rs2506471464	NC_000016.10:23634927:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1617T>C (p.Val539=)	PALB2		Familial cancer of breast	VCV001148941	16	23646250	16	23634929	1148941	1146012	rs776807758	NC_000016.10:23634928:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1615G>A (p.Val539Ile)	PALB2	V519I, V244I, V539I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002777763	16	23646252	16	23634931	2777763	2936759	rs2142411065	NC_000016.10:23634930:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 15, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1614T>G (p.Ile538Met)	PALB2	I538M	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001038784	16	23646253	16	23634932	1038784	1032526	rs1060504713	NC_000016.10:23634931:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1614T>C (p.Ile538=)	PALB2		not specified|Familial cancer of breast	VCV000415990	16	23646253	16	23634932	415990	401787	rs1060504713	NC_000016.10:23634931:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1613T>A (p.Ile538Asn)	PALB2	I538N, I243N, I518N	Familial cancer of breast	VCV003652830	16	23646254	16	23634933	3652830	3778219		NC_000016.10:23634932:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1613T>G (p.Ile538Ser)	PALB2	I243S, I538S, I518S	Hereditary cancer-predisposing syndrome	VCV001776449	16	23646254	16	23634933	1776449	1837679	rs2142411118	NC_000016.10:23634932:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1611G>T (p.Ser537=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001776411	16	23646256	16	23634935	1776411	1837641	rs730881874	NC_000016.10:23634934:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 29, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1611G>A (p.Ser537=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not specified|not provided|Fanconi anemia complementation group N	VCV000378317	16	23646256	16	23634935	378317	377394	rs730881874	NC_000016.10:23634934:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1611G>C (p.Ser537=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000182751	16	23646256	16	23634935	182751	180734	rs730881874	NC_000016.10:23634934:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1610C>A (p.Ser537Ter)	PALB2	S242*, S517*, S537*	Familial cancer of breast	VCV002674038	16	23646257	16	23634936	2674038	2836344	rs142103232	NC_000016.10:23634935:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic/Likely pathogenic	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1610C>T (p.Ser537Leu)	PALB2	S537L	Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|PALB2-related disorder|Familial cancer of breast|not provided	VCV000182791	16	23646257	16	23634936	182791	180735	rs142103232	NC_000016.10:23634935:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1607T>C (p.Leu536Pro)	PALB2	L536P	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000530144	16	23646260	16	23634939	530144	530362	rs1555461198	NC_000016.10:23634938:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 10, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1606C>T (p.Leu536=)	PALB2		Breast and/or ovarian cancer|not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000126610	16	23646261	16	23634940	126610	132120	rs151162255	NC_000016.10:23634939:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1605C>T (p.Ser535=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003413497	16	23646262	16	23634941	3413497	3574720		NC_000016.10:23634940:G:A	single nucleotide variant	intron variant|synonymous variant	Likely benign	Nov 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1604G>C (p.Ser535Thr)	PALB2	S535T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000918290	16	23646263	16	23634942	918290	913649	rs1966953852	NC_000016.10:23634941:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1603A>G (p.Ser535Gly)	PALB2	S240G, S535G, S515G	Hereditary cancer-predisposing syndrome|not specified	VCV001776218	16	23646264	16	23634943	1776218	1837448	rs2142411421	NC_000016.10:23634942:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1602T>C (p.Ser534=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001776207	16	23646265	16	23634944	1776207	1837437	rs2093129453	NC_000016.10:23634943:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1601C>G (p.Ser534Cys)	PALB2	S534C	Familial cancer of breast	VCV001440580	16	23646266	16	23634945	1440580	1461865	rs1555461200	NC_000016.10:23634944:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1601C>T (p.Ser534Phe)	PALB2	S534F	Hereditary cancer-predisposing syndrome	VCV000484216	16	23646266	16	23634945	484216	478161	rs1555461200	NC_000016.10:23634944:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1600T>A (p.Ser534Thr)	PALB2	S514T, S534T, S239T	Hereditary cancer-predisposing syndrome	VCV001776177	16	23646267	16	23634946	1776177	1837407	rs1064793824	NC_000016.10:23634945:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1600T>G (p.Ser534Ala)	PALB2	S534A	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000419370	16	23646267	16	23634946	419370	409547	rs1064793824	NC_000016.10:23634945:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 10, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1599T>C (p.Thr533=)	PALB2		not specified|Fanconi anemia complementation group N|Familial cancer of breast|Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome|not provided	VCV000183798	16	23646268	16	23634947	183798	184235	rs786201088	NC_000016.10:23634946:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1597A>G (p.Thr533Ala)	PALB2	T533A	not provided|Breast carcinoma|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000523534	16	23646270	16	23634949	523534	514061	rs1393117824	NC_000016.10:23634948:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 16, 2022	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1596A>G (p.Pro532=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003304000	16	23646271	16	23634950	3304000	3470167		NC_000016.10:23634949:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 1, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1596A>C (p.Pro532=)	PALB2		Familial cancer of breast	VCV002041770	16	23646271	16	23634950	2041770	2102242	rs2142411606	NC_000016.10:23634949:T:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1596A>T (p.Pro532=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001776010	16	23646271	16	23634950	1776010	1827809	rs2142411606	NC_000016.10:23634949:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 29, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1595C>T (p.Pro532Leu)	PALB2	P532L	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000490069	16	23646272	16	23634951	490069	482894	rs1555461202	NC_000016.10:23634950:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1594C>T (p.Pro532Ser)	PALB2	P532S	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000185637	16	23646273	16	23634952	185637	184236	rs763007754	NC_000016.10:23634951:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1592T>A (p.Leu531Ter)	PALB2	L236*, L511*, L531*	Familial cancer of breast	VCV002673844	16	23646275	16	23634954	2673844	2841346	rs540962715	NC_000016.10:23634953:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 11, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1592T>G (p.Leu531Trp)	PALB2	L511W, L531W, L236W	Hereditary cancer-predisposing syndrome	VCV002330162	16	23646275	16	23634954	2330162	2326826	rs540962715	NC_000016.10:23634953:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1591T>C (p.Leu531=)	PALB2		Familial cancer of breast	VCV001093906	16	23646276	16	23634955	1093906	1081892	rs2142411740	NC_000016.10:23634954:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1588C>T (p.Leu530Phe)	PALB2	L530F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000232283	16	23646279	16	23634958	232283	235274	rs876659671	NC_000016.10:23634957:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1587A>G (p.Pro529=)	PALB2		Familial cancer of breast	VCV001078175	16	23646280	16	23634959	1078175	1081893	rs1597095555	NC_000016.10:23634958:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1587A>C (p.Pro529=)	PALB2		Familial cancer of breast	VCV000760679	16	23646280	16	23634959	760679	770781	rs1597095555	NC_000016.10:23634958:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1586C>T (p.Pro529Leu)	PALB2	P529L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000819605	16	23646281	16	23634960	819605	812756	rs1597095559	NC_000016.10:23634959:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 13, 2020	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1585C>A (p.Pro529Thr)	PALB2	P234T, P509T, P529T	Familial cancer of breast	VCV001721168	16	23646282	16	23634961	1721168	1775150	rs560839514	NC_000016.10:23634960:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1585C>T (p.Pro529Ser)	PALB2	P529S	Familial cancer of breast	VCV001009693	16	23646282	16	23634961	1009693	996807	rs560839514	NC_000016.10:23634960:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1585C>G (p.Pro529Ala)	PALB2	P529A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000583344	16	23646282	16	23634961	583344	573949	rs560839514	NC_000016.10:23634960:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1584A>G (p.Glu528=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001775765	16	23646283	16	23634962	1775765	1827565	rs2142411913	NC_000016.10:23634961:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 18, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1583A>T (p.Glu528Val)	PALB2	E508V, E528V, E233V	Hereditary cancer-predisposing syndrome	VCV002453298	16	23646284	16	23634963	2453298	2430358	rs2506472616	NC_000016.10:23634962:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1583A>G (p.Glu528Gly)	PALB2	E508G, E233G, E528G	Familial cancer of breast	VCV002130048	16	23646284	16	23634963	2130048	2189325	rs2506472616	NC_000016.10:23634962:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1582G>C (p.Glu528Gln)	PALB2	E233Q, E508Q, E528Q	Familial cancer of breast	VCV002705578	16	23646285	16	23634964	2705578	2856715	rs1966955447	NC_000016.10:23634963:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1582G>T (p.Glu528Ter)	PALB2	E233*, E508*, E528*	Familial cancer of breast	VCV002673870	16	23646285	16	23634964	2673870	2841371	rs1966955447	NC_000016.10:23634963:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 11, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1582G>A (p.Glu528Lys)	PALB2	E528K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000921023	16	23646285	16	23634964	921023	913650	rs1966955447	NC_000016.10:23634963:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1581T>C (p.Cys527=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001691941	16	23646286	16	23634965	1691941	1684383	rs2142411961	NC_000016.10:23634964:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1580G>T (p.Cys527Phe)	PALB2	C527F, C232F, C507F	Familial cancer of breast	VCV002840332	16	23646287	16	23634966	2840332	3000156	rs1555461206	NC_000016.10:23634965:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1580G>A (p.Cys527Tyr)	PALB2	C527Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480934	16	23646287	16	23634966	480934	477669	rs1555461206	NC_000016.10:23634965:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1579T>C (p.Cys527Arg)	PALB2	C527R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819592	16	23646288	16	23634967	819592	812757	rs1597095571	NC_000016.10:23634966:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1578T>C (p.His526=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000795606	16	23646289	16	23634968	795606	785230	rs45603832	NC_000016.10:23634967:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1576C>T (p.His526Tyr)	PALB2	H231Y, H506Y, H526Y	Hereditary cancer-predisposing syndrome	VCV003885221	16	23646291	16	23634970	3885221	4005543		NC_000016.10:23634969:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1576C>G (p.His526Asp)	PALB2	H526D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460902	16	23646291	16	23634970	460902	465504	rs529894848	NC_000016.10:23634969:G:C	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1574A>G (p.Asp525Gly)	PALB2	D230G, D505G, D525G	Familial cancer of breast	VCV002753478	16	23646293	16	23634972	2753478	2919845	rs1966956081	NC_000016.10:23634971:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1574A>T (p.Asp525Val)	PALB2	D525V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000850362	16	23646293	16	23634972	850362	843601	rs1966956081	NC_000016.10:23634971:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1573G>T (p.Asp525Tyr)	PALB2	D525Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000231292	16	23646294	16	23634973	231292	235275	rs876659074	NC_000016.10:23634972:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 4, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1572A>G (p.Ser524=)	PALB2		Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|not provided|Fanconi anemia complementation group N|not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast	VCV000126608	16	23646295	16	23634974	126608	132118	rs45472400	NC_000016.10:23634973:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1571C>T (p.Ser524Leu)	PALB2	S229L, S504L, S524L	Hereditary cancer-predisposing syndrome	VCV003927426	16	23646296	16	23634975	3927426	4047059		NC_000016.10:23634974:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Apr 1, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1571C>G (p.Ser524Ter)	PALB2	S524*	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000143964	16	23646296	16	23634975	143964	153694	rs587776413	NC_000016.10:23634974:G:C	single nucleotide variant	nonsense	Pathogenic	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1569A>T (p.Ala523=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819540	16	23646298	16	23634977	819540	812758	rs1200825980	NC_000016.10:23634976:T:A	single nucleotide variant	synonymous variant	Likely benign	Jul 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1569A>G (p.Ala523=)	PALB2		not specified|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000633342	16	23646298	16	23634977	633342	621532	rs1200825980	NC_000016.10:23634976:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1568C>T (p.Ala523Val)	PALB2	A228V, A503V, A523V	not provided|Hereditary cancer-predisposing syndrome	VCV002567583	16	23646299	16	23634978	2567583	2731225	rs1966956742	NC_000016.10:23634977:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1568C>G (p.Ala523Gly)	PALB2	A523G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000864274	16	23646299	16	23634978	864274	843602	rs1966956742	NC_000016.10:23634977:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 26, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1567G>A (p.Ala523Thr)	PALB2	A228T, A523T, A503T	Familial cancer of breast	VCV002695114	16	23646300	16	23634979	2695114	2857821	rs2142412384	NC_000016.10:23634978:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 11, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1566A>G (p.Pro522=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000801237	16	23646301	16	23634980	801237	789603	rs1597095620	NC_000016.10:23634979:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1565C>A (p.Pro522Gln)	PALB2	P227Q, P502Q, P522Q	Hereditary cancer-predisposing syndrome	VCV003227993	16	23646302	16	23634981	3227993	3387762	rs2142412424	NC_000016.10:23634980:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	Jan 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1565C>T (p.Pro522Leu)	PALB2	P502L, P522L, P227L	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV001775354	16	23646302	16	23634981	1775354	1830551	rs2142412424	NC_000016.10:23634980:G:A	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1564C>G (p.Pro522Ala)	PALB2	P522A	Hereditary cancer-predisposing syndrome	VCV000484213	16	23646303	16	23634982	484213	478162	rs373876101	NC_000016.10:23634981:G:C	single nucleotide variant	missense variant	Likely benign	Apr 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1564C>T (p.Pro522Ser)	PALB2	P522S	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000128120	16	23646303	16	23634982	128120	133577	rs373876101	NC_000016.10:23634981:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1563C>A (p.Thr521=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001775310	16	23646304	16	23634983	1775310	1830507	rs864622170	NC_000016.10:23634982:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 6, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1563C>T (p.Thr521=)	PALB2		Familial cancer of breast	VCV000704079	16	23646304	16	23634983	704079	693830	rs864622170	NC_000016.10:23634982:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1563C>G (p.Thr521=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000219591	16	23646304	16	23634983	219591	222471	rs864622170	NC_000016.10:23634982:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1562C>A (p.Thr521Asn)	PALB2	T521N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000945319	16	23646305	16	23634984	945319	927727	rs1555461218	NC_000016.10:23634983:G:T	single nucleotide variant	missense variant	Uncertain significance	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1562C>T (p.Thr521Ile)	PALB2	T521I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480239	16	23646305	16	23634984	480239	478164	rs1555461218	NC_000016.10:23634983:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 19, 2022	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1561A>T (p.Thr521Ser)	PALB2	T521S, T501S, T226S	Familial cancer of breast	VCV003011589	16	23646306	16	23634985	3011589	3177021	rs2142412552	NC_000016.10:23634984:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1561A>G (p.Thr521Ala)	PALB2	T521A, T226A, T501A	Familial cancer of breast	VCV002699393	16	23646306	16	23634985	2699393	2865516	rs2142412552	NC_000016.10:23634984:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1560C>T (p.Cys520=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003227992	16	23646307	16	23634986	3227992	3387761	rs2142412586	NC_000016.10:23634985:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Apr 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1560C>A (p.Cys520Ter)	PALB2	C225*, C500*, C520*	Familial cancer of breast	VCV002573229	16	23646307	16	23634986	2573229	2738178	rs2142412586	NC_000016.10:23634985:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Feb 7, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1559G>A (p.Cys520Tyr)	PALB2	C520Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000857350	16	23646308	16	23634987	857350	843603	rs1966957419	NC_000016.10:23634986:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1557C>T (p.Ala519=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000402293	16	23646310	16	23634989	402293	389272	rs752349785	NC_000016.10:23634988:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1556C>T (p.Ala519Val)	PALB2	A519V	Familial cancer of breast|not provided	VCV001391309	16	23646311	16	23634990	1391309	1389989	rs1340452845	NC_000016.10:23634989:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1556C>A (p.Ala519Asp)	PALB2	A519D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001018289	16	23646311	16	23634990	1018289	1012036	rs1340452845	NC_000016.10:23634989:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 6, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1556C>G (p.Ala519Gly)	PALB2	A519G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000936649	16	23646311	16	23634990	936649	937367	rs1340452845	NC_000016.10:23634989:G:C	single nucleotide variant	missense variant	Uncertain significance	May 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1555G>T (p.Ala519Ser)	PALB2	A499S, A519S, A224S	Familial cancer of breast	VCV003647776	16	23646312	16	23634991	3647776	3777022		NC_000016.10:23634990:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1555G>A (p.Ala519Thr)	PALB2	A499T, A224T, A519T	Hereditary cancer-predisposing syndrome	VCV001775146	16	23646312	16	23634991	1775146	1833731	rs1597095651	NC_000016.10:23634990:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1555G>C (p.Ala519Pro)	PALB2	A519P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000659328	16	23646312	16	23634991	659328	644452	rs1597095651	NC_000016.10:23634990:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1554A>T (p.Ser518=)	PALB2		Familial cancer of breast	VCV003904283	16	23646313	16	23634992	3904283	4020156		NC_000016.10:23634991:T:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1553C>A (p.Ser518Ter)	PALB2	S518*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000842300	16	23646314	16	23634993	842300	843605	rs1060502805	NC_000016.10:23634992:G:T	single nucleotide variant	nonsense	Pathogenic	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1553C>T (p.Ser518Leu)	PALB2	S518L	Familial cancer of breast	VCV000835904	16	23646314	16	23634993	835904	843604	rs1060502805	NC_000016.10:23634992:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1553C>G (p.Ser518Ter)	PALB2	S518*	PALB2-related disorder|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410213	16	23646314	16	23634993	410213	401060	rs1060502805	NC_000016.10:23634992:G:C	single nucleotide variant	nonsense	Pathogenic	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1552T>C (p.Ser518Pro)	PALB2	S518P	not provided|Hereditary cancer-predisposing syndrome	VCV000142810	16	23646315	16	23634994	142810	152524	rs587782735	NC_000016.10:23634993:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1551A>G (p.Lys517=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000873419	16	23646316	16	23634995	873419	861541	rs755845383	NC_000016.10:23634994:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1549A>G (p.Lys517Glu)	PALB2	K222E, K497E, K517E	not provided	VCV003369747	16	23646318	16	23634997	3369747	3528938		NC_000016.10:23634996:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1549A>C (p.Lys517Gln)	PALB2	K222Q, K517Q, K497Q	Familial cancer of breast	VCV002769778	16	23646318	16	23634997	2769778	2933093	rs2506473795	NC_000016.10:23634996:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 18, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1549A>T (p.Lys517Ter)	PALB2	K222*, K517*, K497*	Familial cancer of breast	VCV002068264	16	23646318	16	23634997	2068264	2125788	rs2506473795	NC_000016.10:23634996:T:A	single nucleotide variant	nonsense	Pathogenic	Jan 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1547G>T (p.Arg516Ile)	PALB2	R516I, R221I, R496I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002012057	16	23646320	16	23634999	2012057	2067434	rs2506473872	NC_000016.10:23634998:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1545A>G (p.Lys515=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000187098	16	23646322	16	23635001	187098	184237	rs368503108	NC_000016.10:23635000:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1544A>G (p.Lys515Arg)	PALB2	K515R	Breast and/or ovarian cancer|not specified|not provided|Hereditary cancer|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126607	16	23646323	16	23635002	126607	132117	rs515726072	NC_000016.10:23635001:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1543A>G (p.Lys515Glu)	PALB2	K495E, K220E, K515E	Familial cancer of breast	VCV004056161	16	23646324	16	23635003	4056161	4170101		NC_000016.10:23635002:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1543A>T (p.Lys515Ter)	PALB2	K220*, K495*, K515*	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002578760	16	23646324	16	23635003	2578760	2743760	rs1188755325	NC_000016.10:23635002:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1542A>G (p.Gly514=)	PALB2		Familial cancer of breast	VCV001548751	16	23646325	16	23635004	1548751	1572866	rs2142413046	NC_000016.10:23635003:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1540G>A (p.Gly514Arg)	PALB2	G514R	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3	VCV000232748	16	23646327	16	23635006	232748	235276	rs756778249	NC_000016.10:23635005:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1539A>G (p.Thr513=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002567593	16	23646328	16	23635007	2567593	2731235	rs786202974	NC_000016.10:23635006:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1539A>T (p.Thr513=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000186465	16	23646328	16	23635007	186465	184238	rs786202974	NC_000016.10:23635006:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1538C>G (p.Thr513Arg)	PALB2	T493R, T513R, T218R	Familial cancer of breast	VCV003656082	16	23646329	16	23635008	3656082	3782949		NC_000016.10:23635007:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1538C>T (p.Thr513Ile)	PALB2	T513I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000490068	16	23646329	16	23635008	490068	482896	rs778890869	NC_000016.10:23635007:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1538C>A (p.Thr513Lys)	PALB2	T513K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480283	16	23646329	16	23635008	480283	478166	rs778890869	NC_000016.10:23635007:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1537A>C (p.Thr513Pro)	PALB2	T513P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484209	16	23646330	16	23635009	484209	478168	rs1060502741	NC_000016.10:23635008:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1537A>G (p.Thr513Ala)	PALB2	T513A	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3	VCV000410118	16	23646330	16	23635009	410118	401063	rs1060502741	NC_000016.10:23635008:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1536C>T (p.Tyr512=)	PALB2		Familial cancer of breast	VCV003903904	16	23646331	16	23635010	3903904	4019777		NC_000016.10:23635009:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1536C>G (p.Tyr512Ter)	PALB2	Y492*, Y512*, Y217*	Familial cancer of breast	VCV002031615	16	23646331	16	23635010	2031615	2089519	rs1567220802	NC_000016.10:23635009:G:C	single nucleotide variant	nonsense	Pathogenic	Sep 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1536C>A (p.Tyr512Ter)	PALB2	Y512*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628983	16	23646331	16	23635010	628983	618410	rs1567220802	NC_000016.10:23635009:G:T	single nucleotide variant	nonsense	Pathogenic	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1535A>G (p.Tyr512Cys)	PALB2	Y512C	Familial cancer of breast	VCV001038783	16	23646332	16	23635011	1038783	1032527	rs1966959384	NC_000016.10:23635010:T:C	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1534T>A (p.Tyr512Asn)	PALB2	Y512N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001434586	16	23646333	16	23635012	1434586	1494402	rs1966959567	NC_000016.10:23635011:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1534T>C (p.Tyr512His)	PALB2	Y512H	Familial cancer of breast	VCV001378403	16	23646333	16	23635012	1378403	1492833	rs1966959567	NC_000016.10:23635011:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1533A>G (p.Arg511=)	PALB2		Familial cancer of breast	VCV003903863	16	23646334	16	23635013	3903863	4019736		NC_000016.10:23635012:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1533A>T (p.Arg511Ser)	PALB2	R511S	not provided|Familial cancer of breast	VCV000969892	16	23646334	16	23635013	969892	957701	rs941787019	NC_000016.10:23635012:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1532G>T (p.Arg511Ile)	PALB2	R511I	Hereditary cancer-predisposing syndrome	VCV000628119	16	23646335	16	23635014	628119	618411	rs1555461231	NC_000016.10:23635013:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1532G>A (p.Arg511Lys)	PALB2	R511K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460900	16	23646335	16	23635014	460900	466453	rs1555461231	NC_000016.10:23635013:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1530A>G (p.Arg510=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001774607	16	23646337	16	23635016	1774607	1837145	rs1555461232	NC_000016.10:23635015:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 5, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1530A>C (p.Arg510Ser)	PALB2	R510S	Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484184	16	23646337	16	23635016	484184	477639	rs1555461232	NC_000016.10:23635015:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1529G>C (p.Arg510Thr)	PALB2	R510T, R215T, R490T	Familial cancer of breast	VCV003656546	16	23646338	16	23635017	3656546	3779356		NC_000016.10:23635016:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1528A>G (p.Arg510Gly)	PALB2	R510G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000658736	16	23646339	16	23635018	658736	644453	rs1597095753	NC_000016.10:23635017:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1527T>C (p.Gly509=)	PALB2		Familial cancer of breast	VCV003904102	16	23646340	16	23635019	3904102	4019975		NC_000016.10:23635018:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1526G>T (p.Gly509Val)	PALB2	G214V, G489V, G509V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002099401	16	23646341	16	23635020	2099401	2150722	rs786203176	NC_000016.10:23635019:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1526G>A (p.Gly509Asp)	PALB2	G509D	Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|Familial cancer of breast|not specified	VCV000186732	16	23646341	16	23635020	186732	184239	rs786203176	NC_000016.10:23635019:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 29, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1525G>C (p.Gly509Arg)	PALB2	G509R	Familial cancer of breast	VCV000642132	16	23646342	16	23635021	642132	644454	rs1567220815	NC_000016.10:23635020:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1525G>T (p.Gly509Cys)	PALB2	G509C	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000619883	16	23646342	16	23635021	619883	611223	rs1567220815	NC_000016.10:23635020:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1524T>C (p.Pro508=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819452	16	23646343	16	23635022	819452	812760	rs1597095768	NC_000016.10:23635021:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1523C>G (p.Pro508Arg)	PALB2	P213R, P488R, P508R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001709173	16	23646344	16	23635023	1709173	1707527	rs2142413565	NC_000016.10:23635022:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1523C>T (p.Pro508Leu)	PALB2	P508L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001513045	16	23646344	16	23635023	1513045	1381136	rs2142413565	NC_000016.10:23635022:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1523C>A (p.Pro508His)	PALB2	P508H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001380485	16	23646344	16	23635023	1380485	1421307	rs2142413565	NC_000016.10:23635022:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1522C>T (p.Pro508Ser)	PALB2	P508S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000652653	16	23646345	16	23635024	652653	644455	rs1597095773	NC_000016.10:23635023:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 17, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1521A>C (p.Ala507=)	PALB2		Hereditary cancer-predisposing syndrome	VCV002774009	16	23646346	16	23635025	2774009	2934740	rs2142413617	NC_000016.10:23635024:T:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1520C>G (p.Ala507Gly)	PALB2	A507G, A487G, A212G	Hereditary cancer-predisposing syndrome	VCV003885213	16	23646347	16	23635026	3885213	4005535		NC_000016.10:23635025:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 25, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1520C>A (p.Ala507Glu)	PALB2	A487E, A507E, A212E	Hereditary cancer-predisposing syndrome	VCV003413460	16	23646347	16	23635026	3413460	3574683		NC_000016.10:23635025:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1520C>T (p.Ala507Val)	PALB2	A212V, A487V, A507V	Familial cancer of breast	VCV002064662	16	23646347	16	23635026	2064662	2124775	rs2142413640	NC_000016.10:23635025:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1519G>A (p.Ala507Thr)	PALB2	A487T, A212T, A507T	Hereditary cancer-predisposing syndrome	VCV001774376	16	23646348	16	23635027	1774376	1836915	rs2142413664	NC_000016.10:23635026:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1518A>G (p.Gln506=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460899	16	23646349	16	23635028	460899	465509	rs1555461234	NC_000016.10:23635027:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1516C>G (p.Gln506Glu)	PALB2	Q211E, Q506E, Q486E	Familial cancer of breast	VCV003694031	16	23646351	16	23635030	3694031	3832133		NC_000016.10:23635029:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1515C>G (p.Ala505=)	PALB2		Familial cancer of breast	VCV002056072	16	23646352	16	23635031	2056072	2112655	rs745837198	NC_000016.10:23635030:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1515C>T (p.Ala505=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233501	16	23646352	16	23635031	233501	235277	rs745837198	NC_000016.10:23635030:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1513G>A (p.Ala505Thr)	PALB2	A210T, A505T, A485T	Hereditary cancer-predisposing syndrome	VCV001774270	16	23646354	16	23635033	1774270	1827376	rs2142413783	NC_000016.10:23635032:C:T	single nucleotide variant	missense variant	Likely benign	May 4, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1512T>C (p.Val504=)	PALB2		Familial cancer of breast	VCV002733526	16	23646355	16	23635034	2733526	2897861	rs2142413814	NC_000016.10:23635033:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1510G>C (p.Val504Leu)	PALB2	V484L, V504L, V209L	Familial cancer of breast	VCV002839783	16	23646357	16	23635036	2839783	2993220	rs771846754	NC_000016.10:23635035:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1510G>T (p.Val504Phe)	PALB2	V484F, V209F, V504F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002097878	16	23646357	16	23635036	2097878	2146734	rs771846754	NC_000016.10:23635035:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1510G>A (p.Val504Ile)	PALB2	V504I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000187090	16	23646357	16	23635036	187090	184240	rs771846754	NC_000016.10:23635035:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1509A>G (p.Ala503=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003413493	16	23646358	16	23635037	3413493	3574716		NC_000016.10:23635036:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1507G>A (p.Ala503Thr)	PALB2	A483T, A503T, A208T	Familial cancer of breast	VCV004056184	16	23646360	16	23635039	4056184	4170124		NC_000016.10:23635038:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 1, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1507G>C (p.Ala503Pro)	PALB2	A503P	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000460898	16	23646360	16	23635039	460898	466482	rs1555461243	NC_000016.10:23635038:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 7, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1506G>A (p.Lys502=)	PALB2		Familial cancer of breast	VCV000748005	16	23646361	16	23635040	748005	755030	rs371142570	NC_000016.10:23635039:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1506G>C (p.Lys502Asn)	PALB2	K502N	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000482009	16	23646361	16	23635040	482009	477603	rs371142570	NC_000016.10:23635039:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1505A>G (p.Lys502Arg)	PALB2	K502R	Hereditary cancer-predisposing syndrome	VCV000186124	16	23646362	16	23635041	186124	184241	rs786202711	NC_000016.10:23635040:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2014	criteria provided, single submitter							
NM_024675.4(PALB2):c.1503G>A (p.Arg501=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000415979	16	23646364	16	23635043	415979	401129	rs1060504705	NC_000016.10:23635042:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1502G>A (p.Arg501Lys)	PALB2	R501K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000935660	16	23646365	16	23635044	935660	937368	rs1966961470	NC_000016.10:23635043:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1501A>G (p.Arg501Gly)	PALB2	R501G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000845816	16	23646366	16	23635045	845816	843606	rs1966961551	NC_000016.10:23635044:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1500T>A (p.Ser500=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001774018	16	23646367	16	23635046	1774018	1827124	rs1555461248	NC_000016.10:23635045:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 8, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1500T>C (p.Ser500=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001126053	16	23646367	16	23635046	1126053	1125120	rs1555461248	NC_000016.10:23635045:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1500T>G (p.Ser500=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000492164	16	23646367	16	23635046	492164	484742	rs1555461248	NC_000016.10:23635045:A:C	single nucleotide variant	synonymous variant	Likely benign	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1499C>G (p.Ser500Cys)	PALB2	S500C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001024049	16	23646368	16	23635047	1024049	1012037	rs1966961724	NC_000016.10:23635046:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1499C>T (p.Ser500Phe)	PALB2	S500F	Familial cancer of breast	VCV000848642	16	23646368	16	23635047	848642	843607	rs1966961724	NC_000016.10:23635046:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1498T>C (p.Ser500Pro)	PALB2	S500P	Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not provided	VCV000221571	16	23646369	16	23635048	221571	223306	rs869025294	NC_000016.10:23635047:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1497G>T (p.Leu499Phe)	PALB2	L499F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000960149	16	23646370	16	23635049	960149	949313	rs748315431	NC_000016.10:23635048:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 24, 2022	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1497G>A (p.Leu499=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not provided	VCV000391674	16	23646370	16	23635049	391674	377402	rs748315431	NC_000016.10:23635048:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1496T>C (p.Leu499Ser)	PALB2	L499S	Hereditary cancer-predisposing syndrome	VCV000927865	16	23646371	16	23635050	927865	913651	rs886039620	NC_000016.10:23635049:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1496T>A (p.Leu499Ter)	PALB2	L499*	not provided|Familial cancer of breast	VCV000265553	16	23646371	16	23635050	265553	260104	rs886039620	NC_000016.10:23635049:A:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jun 30, 2018	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1495T>G (p.Leu499Val)	PALB2	L204V, L499V, L479V	Familial cancer of breast	VCV003646536	16	23646372	16	23635051	3646536	3787089		NC_000016.10:23635050:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1495T>C (p.Leu499=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819324	16	23646372	16	23635051	819324	812761	rs1597095836	NC_000016.10:23635050:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1494C>T (p.Asp498=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484189	16	23646373	16	23635052	484189	477650	rs1555461250	NC_000016.10:23635051:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1493A>T (p.Asp498Val)	PALB2	D498V	Familial cancer of breast	VCV000958704	16	23646374	16	23635053	958704	949314	rs1966962467	NC_000016.10:23635052:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1492G>A (p.Asp498Asn)	PALB2	D498N	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000410161	16	23646375	16	23635054	410161	401799	rs75023630	NC_000016.10:23635053:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1492G>T (p.Asp498Tyr)	PALB2	D498Y	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Fanconi anemia complementation group N	VCV000182790	16	23646375	16	23635054	182790	180736	rs75023630	NC_000016.10:23635053:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1491T>A (p.Asn497Lys)	PALB2	N497K	Familial cancer of breast	VCV001416310	16	23646376	16	23635055	1416310	1383133	rs374707677	NC_000016.10:23635054:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1491T>C (p.Asn497=)	PALB2		Familial cancer of breast	VCV001107356	16	23646376	16	23635055	1107356	1103708	rs374707677	NC_000016.10:23635054:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1491T>G (p.Asn497Lys)	PALB2	N497K	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000421287	16	23646376	16	23635055	421287	409548	rs374707677	NC_000016.10:23635054:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 31, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1490A>G (p.Asn497Ser)	PALB2	N497S, N202S, N477S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002056605	16	23646377	16	23635056	2056605	2109308	rs1966962812	NC_000016.10:23635055:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 21, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1490A>C (p.Asn497Thr)	PALB2	N497T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000923299	16	23646377	16	23635056	923299	913652	rs1966962812	NC_000016.10:23635055:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1489A>C (p.Asn497His)	PALB2	N497H	Hereditary cancer-predisposing syndrome	VCV000630711	16	23646378	16	23635057	630711	618412	rs1567220876	NC_000016.10:23635056:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1488T>A (p.Asp496Glu)	PALB2	D201E, D476E, D496E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001719783	16	23646379	16	23635058	1719783	1772439	rs1381339723	NC_000016.10:23635057:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1488T>C (p.Asp496=)	PALB2		Familial cancer of breast	VCV001561279	16	23646379	16	23635058	1561279	1554704	rs1381339723	NC_000016.10:23635057:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1487A>T (p.Asp496Val)	PALB2	D496V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000665184	16	23646380	16	23635059	665184	644456	rs786204228	NC_000016.10:23635058:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1487A>G (p.Asp496Gly)	PALB2	D496G	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000188343	16	23646380	16	23635059	188343	186219	rs786204228	NC_000016.10:23635058:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1485A>G (p.Glu495=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001773647	16	23646382	16	23635061	1773647	1830153	rs1567220888	NC_000016.10:23635060:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1485A>T (p.Glu495Asp)	PALB2	E495D	Familial cancer of breast	VCV000578549	16	23646382	16	23635061	578549	573950	rs1567220888	NC_000016.10:23635060:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1484A>T (p.Glu495Val)	PALB2	E495V, E200V, E475V	Hereditary cancer-predisposing syndrome	VCV003303992	16	23646383	16	23635062	3303992	3470159		NC_000016.10:23635061:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1482T>G (p.Thr494=)	PALB2		Familial cancer of breast	VCV003903877	16	23646385	16	23635064	3903877	4019750		NC_000016.10:23635063:A:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1482T>C (p.Thr494=)	PALB2		Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast	VCV001617379	16	23646385	16	23635064	1617379	1548456	rs2142414557	NC_000016.10:23635063:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1481C>A (p.Thr494Asn)	PALB2	T494N	Hereditary cancer-predisposing syndrome	VCV000186703	16	23646386	16	23635065	186703	184242	rs587782368	NC_000016.10:23635064:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2014	criteria provided, single submitter							
NM_024675.4(PALB2):c.1481C>T (p.Thr494Ile)	PALB2	T494I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000142300	16	23646386	16	23635065	142300	152014	rs587782368	NC_000016.10:23635064:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1480A>G (p.Thr494Ala)	PALB2	T494A	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Hereditary cancer	VCV000847840	16	23646387	16	23635066	847840	843608	rs1555461258	NC_000016.10:23635065:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 11, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1480A>C (p.Thr494Pro)	PALB2	T494P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482056	16	23646387	16	23635066	482056	477653	rs1555461258	NC_000016.10:23635065:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1479C>T (p.Pro493=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484204	16	23646388	16	23635067	484204	477609	rs1555461260	NC_000016.10:23635066:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1478C>T (p.Pro493Leu)	PALB2	P493L	Pilocytic astrocytoma|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000225853	16	23646389	16	23635068	225853	227671	rs770965402	NC_000016.10:23635067:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 31, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1477C>G (p.Pro493Ala)	PALB2	P493A	Familial cancer of breast	VCV000964148	16	23646390	16	23635069	964148	949315	rs1966964053	NC_000016.10:23635068:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1476G>T (p.Gly492=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000480264	16	23646391	16	23635070	480264	477675	rs1555461264	NC_000016.10:23635069:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1475G>A (p.Gly492Glu)	PALB2	G472E, G492E, G197E	Hereditary cancer-predisposing syndrome	VCV003885220	16	23646392	16	23635071	3885220	4005542		NC_000016.10:23635070:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 6, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1472C>T (p.Ala491Val)	PALB2	A491V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819315	16	23646395	16	23635074	819315	812762	rs1473779466	NC_000016.10:23635073:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1471G>T (p.Ala491Ser)	PALB2	A491S	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000665559	16	23646396	16	23635075	665559	644457	rs577969558	NC_000016.10:23635074:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1471G>A (p.Ala491Thr)	PALB2	A491T	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000460896	16	23646396	16	23635075	460896	466233	rs577969558	NC_000016.10:23635074:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1471G>C (p.Ala491Pro)	PALB2	A491P	not provided|Familial cancer of breast|PALB2-related disorder|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000182789	16	23646396	16	23635075	182789	180737	rs577969558	NC_000016.10:23635074:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1470C>G (p.Pro490=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484179	16	23646397	16	23635076	484179	478170	rs45612837	NC_000016.10:23635075:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1470C>T (p.Pro490=)	PALB2		Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|not specified|not provided	VCV000126604	16	23646397	16	23635076	126604	132114	rs45612837	NC_000016.10:23635075:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1469C>T (p.Pro490Leu)	PALB2	P490L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410202	16	23646398	16	23635077	410202	401544	rs1060502797	NC_000016.10:23635076:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1468C>T (p.Pro490Ser)	PALB2	P490S	Hereditary cancer-predisposing syndrome	VCV000492163	16	23646399	16	23635078	492163	484751	rs878855101	NC_000016.10:23635077:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1468C>G (p.Pro490Ala)	PALB2	P490A	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|not specified	VCV000241531	16	23646399	16	23635078	241531	242375	rs878855101	NC_000016.10:23635077:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1466C>T (p.Ser489Phe)	PALB2	S489F	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000819192	16	23646401	16	23635080	819192	812763	rs1597095944	NC_000016.10:23635079:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1465T>C (p.Ser489Pro)	PALB2	S489P	Familial cancer of breast	VCV001514807	16	23646402	16	23635081	1514807	1485850	rs538225556	NC_000016.10:23635080:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1464C>T (p.Ser488=)	PALB2		Familial cancer of breast	VCV003903957	16	23646403	16	23635082	3903957	4019830		NC_000016.10:23635081:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1464C>G (p.Ser488Arg)	PALB2	S193R, S468R, S488R	Familial cancer of breast	VCV002840180	16	23646403	16	23635082	2840180	3003401	rs2142415186	NC_000016.10:23635081:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1463G>C (p.Ser488Thr)	PALB2	S488T	Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000420536	16	23646404	16	23635083	420536	409550	rs767926590	NC_000016.10:23635082:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1463G>T (p.Ser488Ile)	PALB2	S488I	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000241530	16	23646404	16	23635083	241530	242376	rs767926590	NC_000016.10:23635082:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1462A>T (p.Ser488Cys)	PALB2	S193C, S468C, S488C	Hereditary cancer-predisposing syndrome	VCV002774010	16	23646405	16	23635084	2774010	2934741	rs753124503	NC_000016.10:23635083:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 26, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1462A>C (p.Ser488Arg)	PALB2	S488R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000579708	16	23646405	16	23635084	579708	573951	rs753124503	NC_000016.10:23635083:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1462A>G (p.Ser488Gly)	PALB2	S488G	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000418396	16	23646405	16	23635084	418396	409551	rs753124503	NC_000016.10:23635083:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1461C>A (p.Val487=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000482054	16	23646406	16	23635085	482054	478171	rs515726069	NC_000016.10:23635084:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 27, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1461C>T (p.Val487=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000126603	16	23646406	16	23635085	126603	132113	rs515726069	NC_000016.10:23635084:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 2, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1460T>G (p.Val487Gly)	PALB2	V467G, V192G, V487G	Hereditary cancer-predisposing syndrome	VCV001773154	16	23646407	16	23635086	1773154	1833049	rs2142415304	NC_000016.10:23635085:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1460T>A (p.Val487Asp)	PALB2	V487D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001506787	16	23646407	16	23635086	1506787	1426847	rs2142415304	NC_000016.10:23635085:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1459G>A (p.Val487Ile)	PALB2	V487I	Hereditary cancer-predisposing syndrome	VCV000819271	16	23646408	16	23635087	819271	812764	rs1597095975	NC_000016.10:23635086:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1458A>C (p.Lys486Asn)	PALB2	K191N, K466N, K486N	Familial cancer of breast	VCV002764542	16	23646409	16	23635088	2764542	2931745	rs1555461270	NC_000016.10:23635087:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 1, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1458A>G (p.Lys486=)	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000460895	16	23646409	16	23635088	460895	466484	rs1555461270	NC_000016.10:23635087:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1457A>C (p.Lys486Thr)	PALB2	K191T, K466T, K486T	Hereditary cancer-predisposing syndrome	VCV001773068	16	23646410	16	23635089	1773068	1832963	rs864622291	NC_000016.10:23635088:T:G	single nucleotide variant	missense variant	Uncertain significance	May 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1457A>T (p.Lys486Ile)	PALB2	K486I	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000219875	16	23646410	16	23635089	219875	222472	rs864622291	NC_000016.10:23635088:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 3, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1456A>G (p.Lys486Glu)	PALB2	K486E	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000231086	16	23646411	16	23635090	231086	235278	rs876658949	NC_000016.10:23635089:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 20, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1455T>G (p.Thr485=)	PALB2		Familial cancer of breast|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000241529	16	23646412	16	23635091	241529	242377	rs566105533	NC_000016.10:23635090:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1454C>T (p.Thr485Ile)	PALB2	T485I	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000186107	16	23646413	16	23635092	186107	184243	rs786202699	NC_000016.10:23635091:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1453A>C (p.Thr485Pro)	PALB2	T190P, T465P, T485P	Hereditary cancer-predisposing syndrome	VCV003304007	16	23646414	16	23635093	3304007	3470174		NC_000016.10:23635092:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1452A>T (p.Leu484Phe)	PALB2	L484F	Familial cancer of breast	VCV001376652	16	23646415	16	23635094	1376652	1479517	rs1262680014	NC_000016.10:23635093:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1451T>G (p.Leu484Ter)	PALB2	L484*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000819252	16	23646416	16	23635095	819252	812765	rs786203714	NC_000016.10:23635094:A:C	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Oct 21, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1451T>A (p.Leu484Ter)	PALB2	L484*	Familial cancer of breast|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000187412	16	23646416	16	23635095	187412	184244	rs786203714	NC_000016.10:23635094:A:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1449A>G (p.Ser483=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001772852	16	23646418	16	23635097	1772852	1836695	rs1597096030	NC_000016.10:23635096:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 20, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1449A>T (p.Ser483=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000819246	16	23646418	16	23635097	819246	812766	rs1597096030	NC_000016.10:23635096:T:A	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1448C>T (p.Ser483Leu)	PALB2	S483L	not provided|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000574201	16	23646419	16	23635098	574201	573955	rs1057520736	NC_000016.10:23635097:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1448C>A (p.Ser483Ter)	PALB2	S483*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000530155	16	23646419	16	23635098	530155	529905	rs1057520736	NC_000016.10:23635097:G:T	single nucleotide variant	nonsense	Pathogenic	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1448C>G (p.Ser483Ter)	PALB2	S483*	Hereditary cancer-predisposing syndrome|not provided	VCV000379792	16	23646419	16	23635098	379792	374276	rs1057520736	NC_000016.10:23635097:G:C	single nucleotide variant	nonsense	Pathogenic	Apr 7, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1446C>G (p.Leu482=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000509035	16	23646421	16	23635100	509035	505521	rs368759893	NC_000016.10:23635099:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1444C>T (p.Leu482Phe)	PALB2	L482F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000923896	16	23646423	16	23635102	923896	913654	rs753470554	NC_000016.10:23635101:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1443T>C (p.Leu481=)	PALB2		Familial cancer of breast	VCV002697041	16	23646424	16	23635103	2697041	2854611	rs2142415807	NC_000016.10:23635102:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1443T>A (p.Leu481=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001772755	16	23646424	16	23635103	1772755	1836599	rs2142415807	NC_000016.10:23635102:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1442T>G (p.Leu481Arg)	PALB2	L186R, L461R, L481R	Hereditary cancer-predisposing syndrome	VCV003227990	16	23646425	16	23635104	3227990	3387759	rs2142415827	NC_000016.10:23635103:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 26, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1442T>C (p.Leu481Pro)	PALB2	L481P	not provided	VCV001317091	16	23646425	16	23635104	1317091	1306909	rs2142415827	NC_000016.10:23635103:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1440A>G (p.Lys480=)	PALB2		Familial cancer of breast	VCV002700140	16	23646427	16	23635106	2700140	2858992	rs2142415876	NC_000016.10:23635105:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1438A>G (p.Lys480Glu)	PALB2	K480E	Familial cancer of breast	VCV000936534	16	23646429	16	23635108	936534	937369	rs1057520653	NC_000016.10:23635107:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1438A>T (p.Lys480Ter)	PALB2	K480*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000379581	16	23646429	16	23635108	379581	374956	rs1057520653	NC_000016.10:23635107:T:A	single nucleotide variant	nonsense	Pathogenic	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1436A>T (p.Gln479Leu)	PALB2	Q459L, Q184L, Q479L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001772622	16	23646431	16	23635110	1772622	1836466	rs1966968128	NC_000016.10:23635109:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1436A>C (p.Gln479Pro)	PALB2	Q479P	Hereditary cancer-predisposing syndrome	VCV000830139	16	23646431	16	23635110	830139	818511	rs1966968128	NC_000016.10:23635109:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1435C>G (p.Gln479Glu)	PALB2	Q479E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001009971	16	23646432	16	23635111	1009971	996808	rs1060502761	NC_000016.10:23635110:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1435C>A (p.Gln479Lys)	PALB2	Q479K	Hereditary cancer-predisposing syndrome	VCV000492161	16	23646432	16	23635111	492161	484674	rs1060502761	NC_000016.10:23635110:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1435C>T (p.Gln479Ter)	PALB2	Q479*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410147	16	23646432	16	23635111	410147	401133	rs1060502761	NC_000016.10:23635110:G:A	single nucleotide variant	nonsense	Pathogenic	Dec 22, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1434T>C (p.Ser478=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002567581	16	23646433	16	23635112	2567581	2731223	rs1394196009	NC_000016.10:23635111:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1433C>G (p.Ser478Cys)	PALB2	S478C	Familial cancer of breast	VCV001008992	16	23646434	16	23635113	1008992	996809	rs786203879	NC_000016.10:23635112:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1433C>T (p.Ser478Phe)	PALB2	S478F	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000187630	16	23646434	16	23635113	187630	184245	rs786203879	NC_000016.10:23635112:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1432T>C (p.Ser478Pro)	PALB2	S478P	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000642825	16	23646435	16	23635114	642825	644458	rs1597096071	NC_000016.10:23635113:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 4, 2022	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1431C>T (p.Thr477=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000126602	16	23646436	16	23635115	126602	132112	rs515726068	NC_000016.10:23635114:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1430C>T (p.Thr477Ile)	PALB2	T477I	Hereditary cancer-predisposing syndrome	VCV000819196	16	23646437	16	23635116	819196	812767	rs1567221020	NC_000016.10:23635115:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1430C>A (p.Thr477Asn)	PALB2	T477N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000627796	16	23646437	16	23635116	627796	618413	rs1567221020	NC_000016.10:23635115:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 5, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1429A>G (p.Thr477Ala)	PALB2	T477A	Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000460894	16	23646438	16	23635117	460894	466236	rs1555461285	NC_000016.10:23635116:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1426A>G (p.Arg476Gly)	PALB2	R181G, R456G, R476G	Familial cancer of breast	VCV003675916	16	23646441	16	23635120	3675916	3813532		NC_000016.10:23635119:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1425A>G (p.Ser475=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003718354	16	23646442	16	23635121	3718354	3849468		NC_000016.10:23635120:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1424C>T (p.Ser475Leu)	PALB2	S475L	Familial cancer of breast|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV001329322	16	23646443	16	23635122	1329322	1320009	rs886039479	NC_000016.10:23635121:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1424C>A (p.Ser475Ter)	PALB2	S475*	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000379622	16	23646443	16	23635122	379622	377404	rs886039479	NC_000016.10:23635121:G:T	single nucleotide variant	nonsense	Pathogenic	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1424C>G (p.Ser475Ter)	PALB2	S475*	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000265326	16	23646443	16	23635122	265326	260105	rs886039479	NC_000016.10:23635121:G:C	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Apr 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1422T>C (p.Ser474=)	PALB2		Familial cancer of breast	VCV000530251	16	23646445	16	23635124	530251	530368	rs878855100	NC_000016.10:23635123:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 12, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1422T>G (p.Ser474Arg)	PALB2	S474R	Familial cancer of breast	VCV000241528	16	23646445	16	23635124	241528	242378	rs878855100	NC_000016.10:23635123:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.1421G>A (p.Ser474Asn)	PALB2	S474N	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000184941	16	23646446	16	23635125	184941	184246	rs786201806	NC_000016.10:23635124:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1420A>G (p.Ser474Gly)	PALB2	S474G, S179G, S454G	Hereditary cancer-predisposing syndrome	VCV001772246	16	23646447	16	23635126	1772246	1826658	rs2142416507	NC_000016.10:23635125:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1419A>C (p.Pro473=)	PALB2		not provided|not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome	VCV000126601	16	23646448	16	23635127	126601	132111	rs62625275	NC_000016.10:23635126:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1418C>G (p.Pro473Arg)	PALB2	P473R, P178R, P453R	Hereditary cancer-predisposing syndrome	VCV003413502	16	23646449	16	23635128	3413502	3574725		NC_000016.10:23635127:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1418C>T (p.Pro473Leu)	PALB2	P473L	Familial cancer of breast	VCV001015217	16	23646449	16	23635128	1015217	1012038	rs1288887287	NC_000016.10:23635127:G:A	single nucleotide variant	missense variant	Uncertain significance	May 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1417C>G (p.Pro473Ala)	PALB2	P473A, P178A, P453A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002453288	16	23646450	16	23635129	2453288	2430348	rs1966970348	NC_000016.10:23635128:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1417C>T (p.Pro473Ser)	PALB2	P473S, P178S, P453S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001772160	16	23646450	16	23635129	1772160	1829971	rs1966970348	NC_000016.10:23635128:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1415A>G (p.Gln472Arg)	PALB2	Q472R	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N	VCV000232322	16	23646452	16	23635131	232322	235280	rs867817029	NC_000016.10:23635130:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1414C>T (p.Gln472Ter)	PALB2	Q177*, Q452*, Q472*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002673862	16	23646453	16	23635132	2673862	2841363	rs2142416694	NC_000016.10:23635131:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1414C>A (p.Gln472Lys)	PALB2	Q472K	Familial cancer of breast	VCV001050985	16	23646453	16	23635132	1050985	1049526	rs2142416694	NC_000016.10:23635131:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1413A>T (p.Gly471=)	PALB2		Familial cancer of breast	VCV002742830	16	23646454	16	23635133	2742830	2900593	rs1555461299	NC_000016.10:23635132:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1413A>G (p.Gly471=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492160	16	23646454	16	23635133	492160	484753	rs1555461299	NC_000016.10:23635132:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1411G>A (p.Gly471Arg)	PALB2	G471R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000969519	16	23646456	16	23635135	969519	957703	rs1966970790	NC_000016.10:23635134:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1411G>C (p.Gly471Arg)	PALB2	G471R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830138	16	23646456	16	23635135	830138	818512	rs1966970790	NC_000016.10:23635134:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 10, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1408A>G (p.Thr470Ala)	PALB2	T470A	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast|Inherited breast cancer and ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000185197	16	23646459	16	23635138	185197	184247	rs150636811	NC_000016.10:23635137:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1407C>T (p.Cys469=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001771922	16	23646460	16	23635139	1771922	1829734	rs730881883	NC_000016.10:23635138:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 10, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1407C>G (p.Cys469Trp)	PALB2	C469W	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000182761	16	23646460	16	23635139	182761	180738	rs730881883	NC_000016.10:23635138:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1406G>A (p.Cys469Tyr)	PALB2	C469Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000935651	16	23646461	16	23635140	935651	937370	rs1966970988	NC_000016.10:23635139:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1405T>C (p.Cys469Arg)	PALB2	C469R	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000410192	16	23646462	16	23635141	410192	401545	rs1060502789	NC_000016.10:23635140:A:G	single nucleotide variant	missense variant	Uncertain significance	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1404A>G (p.Thr468=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000819097	16	23646463	16	23635142	819097	812768	rs1567221054	NC_000016.10:23635141:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1402A>G (p.Thr468Ala)	PALB2	T468A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000941779	16	23646465	16	23635144	941779	937371	rs1966971242	NC_000016.10:23635143:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1401C>T (p.Gly467=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492159	16	23646466	16	23635145	492159	484759	rs1555461301	NC_000016.10:23635144:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1400G>C (p.Gly467Ala)	PALB2	G467A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000819115	16	23646467	16	23635146	819115	812769	rs730881906	NC_000016.10:23635145:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1400G>A (p.Gly467Asp)	PALB2	G467D	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000182788	16	23646467	16	23635146	182788	180739	rs730881906	NC_000016.10:23635145:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 15, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1399G>A (p.Gly467Ser)	PALB2	G467S	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000421651	16	23646468	16	23635147	421651	409552	rs45602239	NC_000016.10:23635146:C:T	single nucleotide variant	missense variant	Uncertain significance	May 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1399G>C (p.Gly467Arg)	PALB2	G467R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410112	16	23646468	16	23635147	410112	401066	rs45602239	NC_000016.10:23635146:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1398T>G (p.Ser466=)	PALB2		Familial cancer of breast|not provided|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000460892	16	23646469	16	23635148	460892	465520	rs780026905	NC_000016.10:23635147:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1397C>T (p.Ser466Phe)	PALB2	S171F, S446F, S466F	Hereditary cancer-predisposing syndrome	VCV003227988	16	23646470	16	23635149	3227988	3387757	rs2142417233	NC_000016.10:23635148:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 1, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1396T>A (p.Ser466Thr)	PALB2	S171T, S446T, S466T	Familial cancer of breast	VCV003669163	16	23646471	16	23635150	3669163	3796440		NC_000016.10:23635149:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1396T>G (p.Ser466Ala)	PALB2	S171A, S446A, S466A	Familial cancer of breast	VCV002726695	16	23646471	16	23635150	2726695	2885885	rs1966971889	NC_000016.10:23635149:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1396T>C (p.Ser466Pro)	PALB2	S171P, S466P, S446P	Hereditary cancer-predisposing syndrome	VCV002567560	16	23646471	16	23635150	2567560	2731202	rs1966971889	NC_000016.10:23635149:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 1, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1395G>A (p.Met465Ile)	PALB2	M465I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000186522	16	23646472	16	23635151	186522	184248	rs746805049	NC_000016.10:23635150:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1393A>G (p.Met465Val)	PALB2	M465V	Familial cancer of breast	VCV000460891	16	23646474	16	23635153	460891	466245	rs1170015107	NC_000016.10:23635152:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1392G>A (p.Arg464=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000231175	16	23646475	16	23635154	231175	235281	rs876659000	NC_000016.10:23635153:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1391G>A (p.Arg464Lys)	PALB2	R464K	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000950545	16	23646476	16	23635155	950545	927728	rs1966972231	NC_000016.10:23635154:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1390A>T (p.Arg464Trp)	PALB2	R464W	Familial cancer of breast	VCV001051042	16	23646477	16	23635156	1051042	1049527	rs1555461305	NC_000016.10:23635155:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1390A>G (p.Arg464Gly)	PALB2	R464G	Hereditary cancer-predisposing syndrome	VCV000480279	16	23646477	16	23635156	480279	478176	rs1555461305	NC_000016.10:23635155:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1389T>G (p.Ile463Met)	PALB2	I463M	not provided	VCV001319618	16	23646478	16	23635157	1319618	1309869	rs2142417519	NC_000016.10:23635156:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1388T>G (p.Ile463Ser)	PALB2	I463S	Familial cancer of breast	VCV000665101	16	23646479	16	23635158	665101	644459	rs1597096230	NC_000016.10:23635157:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1386A>G (p.Glu462=)	PALB2		Familial cancer of breast	VCV001613309	16	23646481	16	23635160	1613309	1578046	rs2142417622	NC_000016.10:23635159:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 25, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1385A>T (p.Glu462Val)	PALB2	E442V, E462V, E167V	Familial cancer of breast	VCV002014821	16	23646482	16	23635161	2014821	2071471	rs1966972534	NC_000016.10:23635160:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1385A>G (p.Glu462Gly)	PALB2	E462G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000834816	16	23646482	16	23635161	834816	843609	rs1966972534	NC_000016.10:23635160:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1384G>T (p.Glu462Ter)	PALB2	E462*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000819054	16	23646483	16	23635162	819054	812770	rs1597096243	NC_000016.10:23635161:C:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	May 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1383T>C (p.Ser461=)	PALB2		Familial cancer of breast	VCV002857840	16	23646484	16	23635163	2857840	3017887	rs768482110	NC_000016.10:23635162:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1383T>G (p.Ser461Arg)	PALB2	S461R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001389498	16	23646484	16	23635163	1389498	1376978	rs768482110	NC_000016.10:23635162:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1383T>A (p.Ser461Arg)	PALB2	S461R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not provided|Familial cancer of breast|not specified	VCV000410105	16	23646484	16	23635163	410105	401071	rs768482110	NC_000016.10:23635162:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 7, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1382G>A (p.Ser461Asn)	PALB2	S461N	Familial cancer of breast	VCV001387871	16	23646485	16	23635164	1387871	1374492	rs1966972801	NC_000016.10:23635163:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1382G>T (p.Ser461Ile)	PALB2	S461I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000947358	16	23646485	16	23635164	947358	927729	rs1966972801	NC_000016.10:23635163:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1381A>G (p.Ser461Gly)	PALB2	S166G, S441G, S461G	Familial cancer of breast	VCV004056176	16	23646486	16	23635165	4056176	4170116		NC_000016.10:23635164:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1381A>C (p.Ser461Arg)	PALB2	S166R, S461R, S441R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001771287	16	23646486	16	23635165	1771287	1836425	rs2142417777	NC_000016.10:23635164:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1380A>G (p.Gln460=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000126599	16	23646487	16	23635166	126599	132109	rs372641262	NC_000016.10:23635165:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Apr 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1379A>G (p.Gln460Arg)	PALB2	Q460R	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|not specified|Familial cancer of breast|not provided|Hereditary breast ovarian cancer syndrome	VCV000187141	16	23646488	16	23635167	187141	184249	rs749494645	NC_000016.10:23635166:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1378C>T (p.Gln460Ter)	PALB2	Q460*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000229742	16	23646489	16	23635168	229742	235282	rs876658166	NC_000016.10:23635167:G:A	single nucleotide variant	nonsense	Pathogenic	Sep 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1377C>T (p.Asp459=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001549895	16	23646490	16	23635169	1549895	1538849	rs771002573	NC_000016.10:23635168:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1377C>G (p.Asp459Glu)	PALB2	D459E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000567341	16	23646490	16	23635169	567341	567996	rs771002573	NC_000016.10:23635168:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1377C>A (p.Asp459Glu)	PALB2	D459E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000482024	16	23646490	16	23635169	482024	478189	rs771002573	NC_000016.10:23635168:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 18, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1376A>T (p.Asp459Val)	PALB2	D459V	Familial cancer of breast	VCV001046620	16	23646491	16	23635170	1046620	1032528	rs1031787378	NC_000016.10:23635169:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1376A>G (p.Asp459Gly)	PALB2	D459G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630621	16	23646491	16	23635170	630621	618414	rs1031787378	NC_000016.10:23635169:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 2, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1375G>A (p.Asp459Asn)	PALB2	D459N	Familial cancer of breast	VCV001353784	16	23646492	16	23635171	1353784	1495903	rs2142417951	NC_000016.10:23635170:C:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1374T>C (p.Thr458=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000241526	16	23646493	16	23635172	241526	242379	rs878855098	NC_000016.10:23635171:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 12, 2018	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1373C>T (p.Thr458Ile)	PALB2	T163I, T458I, T438I	Hereditary cancer-predisposing syndrome	VCV003885230	16	23646494	16	23635173	3885230	4005552		NC_000016.10:23635172:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 7, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1373C>G (p.Thr458Ser)	PALB2	T163S, T438S, T458S	Hereditary cancer-predisposing syndrome	VCV003303993	16	23646494	16	23635173	3303993	3470160		NC_000016.10:23635172:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1372A>G (p.Thr458Ala)	PALB2	T438A, T458A, T163A	Familial cancer of breast	VCV002823374	16	23646495	16	23635174	2823374	2985739	rs2142418039	NC_000016.10:23635173:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1371A>G (p.Glu457=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000921141	16	23646496	16	23635175	921141	913655	rs1555461314	NC_000016.10:23635174:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1371A>C (p.Glu457Asp)	PALB2	E457D	Hereditary cancer-predisposing syndrome	VCV000492158	16	23646496	16	23635175	492158	484841	rs1555461314	NC_000016.10:23635174:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1370A>G (p.Glu457Gly)	PALB2	E457G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001507414	16	23646497	16	23635176	1507414	1449704	rs774298150	NC_000016.10:23635175:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1369G>T (p.Glu457Ter)	PALB2	E457*	Familial cancer of breast	VCV000241527	16	23646498	16	23635177	241527	242380	rs878855099	NC_000016.10:23635176:C:A	single nucleotide variant	nonsense	Pathogenic	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1368G>T (p.Glu456Asp)	PALB2	E456D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000627995	16	23646499	16	23635178	627995	618415	rs1555461319	NC_000016.10:23635177:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1368G>A (p.Glu456=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492157	16	23646499	16	23635178	492157	484843	rs1555461319	NC_000016.10:23635177:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1366G>T (p.Glu456Ter)	PALB2	E456*	Familial cancer of breast	VCV000410186	16	23646501	16	23635180	410186	401546	rs1060502785	NC_000016.10:23635179:C:A	single nucleotide variant	nonsense	Pathogenic	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1365T>C (p.Asn455=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001770928	16	23646502	16	23635181	1770928	1836067	rs2506480141	NC_000016.10:23635180:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 18, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1364A>T (p.Asn455Ile)	PALB2	N455I	Hereditary cancer-predisposing syndrome	VCV000918342	16	23646503	16	23635182	918342	913656	rs587781824	NC_000016.10:23635181:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 7, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1364A>G (p.Asn455Ser)	PALB2	N455S	Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|not provided|Familial cancer of breast	VCV000141535	16	23646503	16	23635182	141535	151249	rs587781824	NC_000016.10:23635181:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1363A>C (p.Asn455His)	PALB2	N435H, N455H, N160H	Hereditary cancer-predisposing syndrome	VCV003413473	16	23646504	16	23635183	3413473	3574696		NC_000016.10:23635182:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1363A>T (p.Asn455Tyr)	PALB2	N160Y, N435Y, N455Y	Hereditary cancer-predisposing syndrome	VCV002774012	16	23646504	16	23635183	2774012	2934743	rs2506480193	NC_000016.10:23635182:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1363A>G (p.Asn455Asp)	PALB2	N435D, N455D, N160D	Hereditary cancer-predisposing syndrome	VCV001770882	16	23646504	16	23635183	1770882	1826582	rs2506480193	NC_000016.10:23635182:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1361C>T (p.Ser454Phe)	PALB2	S454F	Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000142948	16	23646506	16	23635185	142948	152662	rs587782842	NC_000016.10:23635184:G:A	single nucleotide variant	missense variant	Uncertain significance	May 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1360T>C (p.Ser454Pro)	PALB2	S454P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000818981	16	23646507	16	23635186	818981	812771	rs1597096304	NC_000016.10:23635185:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1359T>C (p.Leu453=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001770774	16	23646508	16	23635187	1770774	1826474	rs2142418360	NC_000016.10:23635186:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 10, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1358T>C (p.Leu453Pro)	PALB2	L453P, L158P, L433P	Familial cancer of breast	VCV002124478	16	23646509	16	23635188	2124478	2184939	rs2142418402	NC_000016.10:23635187:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1357C>A (p.Leu453Ile)	PALB2	L433I, L453I, L158I	Hereditary cancer-predisposing syndrome	VCV003927451	16	23646510	16	23635189	3927451	4047084		NC_000016.10:23635188:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	May 22, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1357C>T (p.Leu453Phe)	PALB2	L453F	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000419165	16	23646510	16	23635189	419165	409553	rs746328068	NC_000016.10:23635188:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1356C>A (p.Asn452Lys)	PALB2	N432K, N157K, N452K	Familial cancer of breast|not provided	VCV002710350	16	23646511	16	23635190	2710350	2871374	rs1555461327	NC_000016.10:23635189:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1356C>T (p.Asn452=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460890	16	23646511	16	23635190	460890	466488	rs1555461327	NC_000016.10:23635189:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1355A>G (p.Asn452Ser)	PALB2	N432S, N452S, N157S	Hereditary cancer-predisposing syndrome	VCV002453307	16	23646512	16	23635191	2453307	2430367	rs2142418462	NC_000016.10:23635190:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1353A>C (p.Leu451Phe)	PALB2	L451F, L431F, L156F	Hereditary cancer-predisposing syndrome	VCV001770640	16	23646514	16	23635193	1770640	1826341	rs1966974752	NC_000016.10:23635192:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1353A>G (p.Leu451=)	PALB2		Familial cancer of breast	VCV001082991	16	23646514	16	23635193	1082991	1081894	rs1966974752	NC_000016.10:23635192:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1352T>G (p.Leu451Ter)	PALB2	L451*	Familial cancer of breast	VCV001453991	16	23646515	16	23635194	1453991	1366600	rs1966974831	NC_000016.10:23635193:A:C	single nucleotide variant	nonsense	Pathogenic	Nov 17, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1352T>A (p.Leu451Ter)	PALB2	L451*	Hereditary cancer-predisposing syndrome	VCV000919094	16	23646515	16	23635194	919094	913657	rs1966974831	NC_000016.10:23635193:A:T	single nucleotide variant	nonsense	Pathogenic	Mar 2, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1351T>G (p.Leu451Val)	PALB2	L451V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000951843	16	23646516	16	23635195	951843	927730	rs772691867	NC_000016.10:23635194:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1351T>A (p.Leu451Ile)	PALB2	L451I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000818957	16	23646516	16	23635195	818957	812773	rs772691867	NC_000016.10:23635194:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1349A>C (p.Asn450Thr)	PALB2	N450T	Hereditary cancer-predisposing syndrome	VCV000818918	16	23646518	16	23635197	818918	812774	rs1597096335	NC_000016.10:23635196:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1348A>C (p.Asn450His)	PALB2	N450H	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|not provided	VCV000128119	16	23646519	16	23635198	128119	133576	rs62625274	NC_000016.10:23635197:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1347A>G (p.Lys449=)	PALB2		not provided|not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000128118	16	23646520	16	23635199	128118	133575	rs587780205	NC_000016.10:23635198:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1346A>C (p.Lys449Thr)	PALB2	K449T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000569088	16	23646521	16	23635200	569088	570195	rs876659152	NC_000016.10:23635199:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1346A>T (p.Lys449Ile)	PALB2	K449I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000231429	16	23646521	16	23635200	231429	235283	rs876659152	NC_000016.10:23635199:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1344T>C (p.Ser448=)	PALB2		Familial cancer of breast	VCV002040076	16	23646523	16	23635202	2040076	2101847	rs1452869606	NC_000016.10:23635201:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 11, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1344T>G (p.Ser448Arg)	PALB2	S448R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001362033	16	23646523	16	23635202	1362033	1376659	rs1452869606	NC_000016.10:23635201:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1343G>A (p.Ser448Asn)	PALB2	S448N	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000410204	16	23646524	16	23635203	410204	401801	rs956172059	NC_000016.10:23635202:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1342A>C (p.Ser448Arg)	PALB2	S153R, S428R, S448R	Familial cancer of breast	VCV003657037	16	23646525	16	23635204	3657037	3789893		NC_000016.10:23635203:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 19, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1342A>G (p.Ser448Gly)	PALB2	S448G	Familial cancer of breast	VCV000942759	16	23646525	16	23635204	942759	937372	rs1966975915	NC_000016.10:23635203:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1341A>T (p.Ala447=)	PALB2		Familial cancer of breast	VCV001576674	16	23646526	16	23635205	1576674	1587005	rs2142418889	NC_000016.10:23635204:T:A	single nucleotide variant	synonymous variant	Likely benign	Aug 10, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1340C>T (p.Ala447Val)	PALB2	A447V	not specified	VCV000830135	16	23646527	16	23635206	830135	818515	rs1555461334	NC_000016.10:23635205:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1340C>A (p.Ala447Glu)	PALB2	A447E	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000480285	16	23646527	16	23635206	480285	478191	rs1555461334	NC_000016.10:23635205:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1339G>A (p.Ala447Thr)	PALB2	A152T, A427T, A447T	Hereditary cancer-predisposing syndrome	VCV001770306	16	23646528	16	23635207	1770306	1829411	rs2142418942	NC_000016.10:23635206:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1338T>C (p.Asp446=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003885226	16	23646529	16	23635208	3885226	4005548		NC_000016.10:23635207:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 1, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1338T>G (p.Asp446Glu)	PALB2	D446E	Hereditary cancer-predisposing syndrome	VCV000818977	16	23646529	16	23635208	818977	812776	rs1597096377	NC_000016.10:23635207:A:C	single nucleotide variant	missense variant	Likely benign	Jun 4, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1337A>G (p.Asp446Gly)	PALB2	D446G	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000419431	16	23646530	16	23635209	419431	409554	rs146434474	NC_000016.10:23635208:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1337A>T (p.Asp446Val)	PALB2	D446V	not provided|Retinoblastoma|not specified|Familial cancer of breast|PALB2-related disorder|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3	VCV000216742	16	23646530	16	23635209	216742	213176	rs146434474	NC_000016.10:23635208:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1336G>C (p.Asp446His)	PALB2	D151H, D426H, D446H	Hereditary cancer-predisposing syndrome	VCV001770250	16	23646531	16	23635210	1770250	1829355	rs2142419030	NC_000016.10:23635209:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1336G>A (p.Asp446Asn)	PALB2	D426N, D151N, D446N	Hereditary cancer-predisposing syndrome	VCV001770247	16	23646531	16	23635210	1770247	1829352	rs2142419030	NC_000016.10:23635209:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1335G>A (p.Lys445=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001770233	16	23646532	16	23635211	1770233	1829338	rs1966976357	NC_000016.10:23635210:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1334A>C (p.Lys445Thr)	PALB2	K445T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480282	16	23646533	16	23635212	480282	478192	rs1555461337	NC_000016.10:23635211:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1332T>C (p.Asn444=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001630268	16	23646535	16	23635214	1630268	1649473	rs2142419145	NC_000016.10:23635213:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1331A>T (p.Asn444Ile)	PALB2	N149I, N444I, N424I	Hereditary cancer-predisposing syndrome	VCV001770149	16	23646536	16	23635215	1770149	1829254	rs764599493	NC_000016.10:23635214:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1331A>G (p.Asn444Ser)	PALB2	N444S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000580737	16	23646536	16	23635215	580737	569984	rs764599493	NC_000016.10:23635214:T:C	single nucleotide variant	missense variant	Uncertain significance	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1328A>G (p.Lys443Arg)	PALB2	K443R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000141002	16	23646539	16	23635218	141002	150716	rs587781429	NC_000016.10:23635217:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1327A>T (p.Lys443Ter)	PALB2	K443*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484160	16	23646540	16	23635219	484160	477612	rs1555461339	NC_000016.10:23635218:T:A	single nucleotide variant	nonsense	Pathogenic	Sep 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1326T>C (p.Asn442=)	PALB2		not specified|Familial cancer of breast	VCV000460888	16	23646541	16	23635220	460888	466496	rs1555461340	NC_000016.10:23635219:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2017	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1325A>T (p.Asn442Ile)	PALB2	N442I, N147I, N422I	Hereditary cancer-predisposing syndrome	VCV001769987	16	23646542	16	23635221	1769987	1832472	rs2142419299	NC_000016.10:23635220:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1323A>T (p.Lys441Asn)	PALB2	K421N, K441N, K146N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002848465	16	23646544	16	23635223	2848465	3015362	rs2142419361	NC_000016.10:23635222:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1321A>G (p.Lys441Glu)	PALB2	K146E, K421E, K441E	Hereditary cancer-predisposing syndrome	VCV003227987	16	23646546	16	23635225	3227987	3387756	rs2506481612	NC_000016.10:23635224:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 15, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1318T>C (p.Phe440Leu)	PALB2	F440L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast	VCV000818899	16	23646549	16	23635228	818899	812777	rs776294034	NC_000016.10:23635227:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1317G>T (p.Gly439=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001769819	16	23646550	16	23635229	1769819	1832304	rs515726066	NC_000016.10:23635228:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1317G>A (p.Gly439=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000126597	16	23646550	16	23635229	126597	132107	rs515726066	NC_000016.10:23635228:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1316G>A (p.Gly439Glu)	PALB2	G439E	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV001015637	16	23646551	16	23635230	1015637	1012039	rs537258442	NC_000016.10:23635229:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1316G>C (p.Gly439Ala)	PALB2	G439A	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000818890	16	23646551	16	23635230	818890	812778	rs537258442	NC_000016.10:23635229:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1316G>T (p.Gly439Val)	PALB2	G439V	Hereditary cancer-predisposing syndrome|not specified|not provided|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Familial cancer of breast	VCV000188096	16	23646551	16	23635230	188096	186220	rs537258442	NC_000016.10:23635229:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1315G>T (p.Gly439Trp)	PALB2	G144W, G419W, G439W	Familial cancer of breast	VCV002768587	16	23646552	16	23635231	2768587	2926738	rs764750338	NC_000016.10:23635230:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1315G>A (p.Gly439Arg)	PALB2	G439R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000852568	16	23646552	16	23635231	852568	843610	rs764750338	NC_000016.10:23635230:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 20, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1315G>C (p.Gly439Arg)	PALB2	G439R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000578132	16	23646552	16	23635231	578132	567999	rs764750338	NC_000016.10:23635230:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1314A>C (p.Lys438Asn)	PALB2	K143N, K438N, K418N	Familial cancer of breast	VCV002008179	16	23646553	16	23635232	2008179	2069991	rs2142419604	NC_000016.10:23635231:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1313A>G (p.Lys438Arg)	PALB2	K418R, K438R, K143R	Familial cancer of breast	VCV002862094	16	23646554	16	23635233	2862094	3025745	rs2142419663	NC_000016.10:23635232:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1313A>T (p.Lys438Ile)	PALB2	K418I, K143I, K438I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002751321	16	23646554	16	23635233	2751321	2908617	rs2142419663	NC_000016.10:23635232:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1312A>C (p.Lys438Gln)	PALB2	K143Q, K418Q, K438Q	Hereditary cancer-predisposing syndrome	VCV001769692	16	23646555	16	23635234	1769692	1832178	rs2506481937	NC_000016.10:23635233:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1311A>G (p.Lys437=)	PALB2		not specified|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Familial cancer of breast	VCV000184531	16	23646556	16	23635235	184531	184250	rs190489275	NC_000016.10:23635234:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1310A>G (p.Lys437Arg)	PALB2	K437R, K417R, K142R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast	VCV001769647	16	23646557	16	23635236	1769647	1832134	rs2142419695	NC_000016.10:23635235:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1309A>G (p.Lys437Glu)	PALB2	K437E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001015636	16	23646558	16	23635237	1015636	1012040	rs1597096438	NC_000016.10:23635236:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1309A>C (p.Lys437Gln)	PALB2	K437Q	Hereditary cancer-predisposing syndrome	VCV000818864	16	23646558	16	23635237	818864	812779	rs1597096438	NC_000016.10:23635236:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1308G>C (p.Lys436Asn)	PALB2	K436N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001357797	16	23646559	16	23635238	1357797	1367693	rs1258005167	NC_000016.10:23635237:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1307A>G (p.Lys436Arg)	PALB2	K436R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001039234	16	23646560	16	23635239	1039234	1032529	rs1966977995	NC_000016.10:23635238:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1306A>G (p.Lys436Glu)	PALB2	K416E, K141E, K436E	Hereditary cancer-predisposing syndrome	VCV001769519	16	23646561	16	23635240	1769519	1835954	rs2142419798	NC_000016.10:23635239:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1305C>A (p.Val435=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001769495	16	23646562	16	23635241	1769495	1835930	rs1597096444	NC_000016.10:23635240:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1305C>T (p.Val435=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000765766	16	23646562	16	23635241	765766	770782	rs1597096444	NC_000016.10:23635240:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1304T>C (p.Val435Ala)	PALB2	V140A, V415A, V435A	Hereditary cancer-predisposing syndrome	VCV003227986	16	23646563	16	23635242	3227986	3387755	rs2142419868	NC_000016.10:23635241:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Jan 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1303G>A (p.Val435Ile)	PALB2	V435I	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000420495	16	23646564	16	23635243	420495	409555	rs1064794517	NC_000016.10:23635242:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1302T>G (p.Asp434Glu)	PALB2	D434E, D414E, D139E	Familial cancer of breast	VCV002816076	16	23646565	16	23635244	2816076	2976746	rs2142419939	NC_000016.10:23635243:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1302T>C (p.Asp434=)	PALB2		Familial cancer of breast	VCV001108363	16	23646565	16	23635244	1108363	1103709	rs2142419939	NC_000016.10:23635243:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 20, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1301A>G (p.Asp434Gly)	PALB2	D139G, D414G, D434G	Familial cancer of breast	VCV003240008	16	23646566	16	23635245	3240008	3398996	rs757972600	NC_000016.10:23635244:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1301A>C (p.Asp434Ala)	PALB2	D434A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492156	16	23646566	16	23635245	492156	484844	rs757972600	NC_000016.10:23635244:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1300G>A (p.Asp434Asn)	PALB2	D414N, D139N, D434N	Hereditary cancer-predisposing syndrome	VCV002567576	16	23646567	16	23635246	2567576	2731218	rs2142420011	NC_000016.10:23635245:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 9, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1300G>C (p.Asp434His)	PALB2	D434H	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV001318662	16	23646567	16	23635246	1318662	1307174	rs2142420011	NC_000016.10:23635245:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1299G>A (p.Leu433=)	PALB2		Familial cancer of breast	VCV001135865	16	23646568	16	23635247	1135865	1125121	rs1966978476	NC_000016.10:23635246:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1299G>T (p.Leu433Phe)	PALB2	L433F	Pancreatic cancer, susceptibility to, 3|Breast cancer, susceptibility to	VCV000979137	16	23646568	16	23635247	979137	967208	rs1966978476	NC_000016.10:23635246:C:A	single nucleotide variant	missense variant	Uncertain significance		criteria provided, single submitter							
NM_024675.4(PALB2):c.1298T>G (p.Leu433Trp)	PALB2	L433W	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000656043	16	23646569	16	23635248	656043	644460	rs1597096465	NC_000016.10:23635247:A:C	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1297T>C (p.Leu433=)	PALB2		Familial cancer of breast	VCV003903660	16	23646570	16	23635249	3903660	4019533		NC_000016.10:23635248:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1297T>A (p.Leu433Met)	PALB2	L413M, L138M, L433M	Hereditary cancer-predisposing syndrome	VCV001769251	16	23646570	16	23635249	1769251	1835688	rs2142420096	NC_000016.10:23635248:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1296T>A (p.His432Gln)	PALB2	H432Q	Familial cancer of breast	VCV000830134	16	23646571	16	23635250	830134	818516	rs1567221194	NC_000016.10:23635249:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1296T>C (p.His432=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628426	16	23646571	16	23635250	628426	618416	rs1567221194	NC_000016.10:23635249:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1295A>G (p.His432Arg)	PALB2	H432R	Familial cancer of breast	VCV000651764	16	23646572	16	23635251	651764	644461	rs1597096474	NC_000016.10:23635250:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1294C>T (p.His432Tyr)	PALB2	H432Y	not provided|Familial cancer of breast	VCV000246417	16	23646573	16	23635252	246417	244970	rs879254250	NC_000016.10:23635251:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1293T>G (p.Ser431Arg)	PALB2	S431R	not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460887	16	23646574	16	23635253	460887	466247	rs1555461355	NC_000016.10:23635252:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1292G>A (p.Ser431Asn)	PALB2	S431N	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000482005	16	23646575	16	23635254	482005	478195	rs1555461357	NC_000016.10:23635253:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1291A>G (p.Ser431Gly)	PALB2	S411G, S431G, S136G	Familial cancer of breast	VCV001999256	16	23646576	16	23635255	1999256	2061049	rs2142420286	NC_000016.10:23635254:T:C	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1290G>A (p.Gln430=)	PALB2		Familial cancer of breast	VCV001123400	16	23646577	16	23635256	1123400	1125122	rs2142420314	NC_000016.10:23635255:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1288C>T (p.Gln430Ter)	PALB2	Q430*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000546012	16	23646579	16	23635258	546012	536462	rs1555461358	NC_000016.10:23635257:G:A	single nucleotide variant	nonsense	Pathogenic	Aug 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1287T>G (p.Ile429Met)	PALB2	I429M	Familial cancer of breast	VCV001468824	16	23646580	16	23635259	1468824	1359183	rs1966979451	NC_000016.10:23635258:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1286T>C (p.Ile429Thr)	PALB2	I429T	Hereditary cancer-predisposing syndrome	VCV000481105	16	23646581	16	23635260	481105	477678	rs1555461359	NC_000016.10:23635259:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1285A>G (p.Ile429Val)	PALB2	I429V	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000648799	16	23646582	16	23635261	648799	644462	rs1555461360	NC_000016.10:23635260:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1285A>C (p.Ile429Leu)	PALB2	I429L	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000480269	16	23646582	16	23635261	480269	478199	rs1555461360	NC_000016.10:23635260:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1284C>T (p.Val428=)	PALB2		Familial cancer of breast	VCV001103089	16	23646583	16	23635262	1103089	1103710	rs2142420475	NC_000016.10:23635261:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1283T>C (p.Val428Ala)	PALB2	V428A	Hereditary cancer-predisposing syndrome	VCV000924287	16	23646584	16	23635263	924287	913658	rs1966979781	NC_000016.10:23635262:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1282G>T (p.Val428Phe)	PALB2	V428F	Familial cancer of breast	VCV000853329	16	23646585	16	23635264	853329	843611	rs1966979857	NC_000016.10:23635263:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1281T>C (p.Ala427=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000138577	16	23646586	16	23635265	138577	142280	rs138697796	NC_000016.10:23635264:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1280C>G (p.Ala427Gly)	PALB2	A427G, A132G, A407G	Hereditary cancer-predisposing syndrome	VCV001767796	16	23646587	16	23635266	1767796	1818447	rs2142420597	NC_000016.10:23635265:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1280C>T (p.Ala427Val)	PALB2	A427V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001419147	16	23646587	16	23635266	1419147	1386826	rs2142420597	NC_000016.10:23635265:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1279G>A (p.Ala427Thr)	PALB2	A132T, A407T, A427T	not provided	VCV002500524	16	23646588	16	23635267	2500524	2523422	rs2142420634	NC_000016.10:23635266:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1279G>C (p.Ala427Pro)	PALB2	A132P, A407P, A427P	Familial cancer of breast	VCV002118390	16	23646588	16	23635267	2118390	2176172	rs2142420634	NC_000016.10:23635266:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1278G>T (p.Glu426Asp)	PALB2	E131D, E406D, E426D	Hereditary cancer-predisposing syndrome	VCV001767170	16	23646589	16	23635268	1767170	1821512	rs1555461362	NC_000016.10:23635267:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1278G>A (p.Glu426=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460886	16	23646589	16	23635268	460886	466249	rs1555461362	NC_000016.10:23635267:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1276G>A (p.Glu426Lys)	PALB2	E426K	Familial cancer of breast	VCV001380237	16	23646591	16	23635270	1380237	1506286	rs2142420693	NC_000016.10:23635269:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1275G>A (p.Val425=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000758972	16	23646592	16	23635271	758972	770783	rs1597096529	NC_000016.10:23635270:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1273G>T (p.Val425Leu)	PALB2	V130L, V425L, V405L	Hereditary cancer-predisposing syndrome	VCV003885196	16	23646594	16	23635273	3885196	4005518		NC_000016.10:23635272:C:A	single nucleotide variant	missense variant|intron variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1273G>C (p.Val425Leu)	PALB2	V405L, V130L, V425L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001766078	16	23646594	16	23635273	1766078	1818028	rs576081828	NC_000016.10:23635272:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1273G>A (p.Val425Met)	PALB2	V425M	Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|not provided	VCV000187458	16	23646594	16	23635273	187458	184252	rs576081828	NC_000016.10:23635272:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1272C>G (p.Ala424=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000186469	16	23646595	16	23635274	186469	184254	rs754720030	NC_000016.10:23635273:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1272C>T (p.Ala424=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|not specified|Familial cancer of breast	VCV000184383	16	23646595	16	23635274	184383	184253	rs754720030	NC_000016.10:23635273:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1271C>G (p.Ala424Gly)	PALB2	A129G, A424G, A404G	Hereditary cancer-predisposing syndrome	VCV001765546	16	23646596	16	23635275	1765546	1821186	rs2142420870	NC_000016.10:23635274:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1271C>T (p.Ala424Val)	PALB2	A424V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001171422	16	23646596	16	23635275	1171422	1161318	rs2142420870	NC_000016.10:23635274:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1270G>A (p.Ala424Thr)	PALB2	A129T, A404T, A424T	not specified|Familial cancer of breast	VCV001802889	16	23646597	16	23635276	1802889	1859920	rs2142420905	NC_000016.10:23635275:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1270G>T (p.Ala424Ser)	PALB2	A404S, A424S, A129S	Hereditary cancer-predisposing syndrome	VCV001765453	16	23646597	16	23635276	1765453	1821094	rs2142420905	NC_000016.10:23635275:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1268T>C (p.Val423Ala)	PALB2	V403A, V423A, V128A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002786778	16	23646599	16	23635278	2786778	2948783	rs2142420977	NC_000016.10:23635277:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1267G>A (p.Val423Ile)	PALB2	V423I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001021058	16	23646600	16	23635279	1021058	1012041	rs1966980569	NC_000016.10:23635278:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1266A>G (p.Lys422=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484171	16	23646601	16	23635280	484171	478227	rs1371849254	NC_000016.10:23635279:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1265A>C (p.Lys422Thr)	PALB2	K422T	Hereditary cancer-predisposing syndrome	VCV000818735	16	23646602	16	23635281	818735	812780	rs1597096566	NC_000016.10:23635280:T:G	single nucleotide variant	missense variant	Likely benign	Jun 3, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1263G>A (p.Arg421=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233366	16	23646604	16	23635283	233366	235284	rs876660359	NC_000016.10:23635282:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1262G>C (p.Arg421Thr)	PALB2	R421T	Familial cancer of breast	VCV001426534	16	23646605	16	23635284	1426534	1366207	rs2142421169	NC_000016.10:23635283:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1261A>G (p.Arg421Gly)	PALB2	R126G, R401G, R421G	not provided	VCV003340218	16	23646606	16	23635285	3340218	3499476		NC_000016.10:23635284:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 14, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1260G>C (p.Gln420His)	PALB2	Q125H, Q420H, Q400H	Hereditary cancer-predisposing syndrome	VCV003927449	16	23646607	16	23635286	3927449	4047082		NC_000016.10:23635285:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 17, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1258C>G (p.Gln420Glu)	PALB2	Q420E, Q400E, Q125E	Hereditary cancer-predisposing syndrome	VCV001762305	16	23646609	16	23635288	1762305	1820441	rs587782446	NC_000016.10:23635287:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1258C>T (p.Gln420Ter)	PALB2	Q420*	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000142412	16	23646609	16	23635288	142412	152126	rs587782446	NC_000016.10:23635287:G:A	single nucleotide variant	nonsense	Pathogenic	Jan 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1257C>A (p.Cys419Ter)	PALB2	C124*, C419*, C399*	Hereditary cancer-predisposing syndrome	VCV001762018	16	23646610	16	23635289	1762018	1823960	rs786201086	NC_000016.10:23635288:G:T	single nucleotide variant	nonsense	Pathogenic	Jun 21, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1257C>T (p.Cys419=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000183796	16	23646610	16	23635289	183796	184255	rs786201086	NC_000016.10:23635288:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1256G>T (p.Cys419Phe)	PALB2	C419F	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000246408	16	23646611	16	23635290	246408	244971	rs866387173	NC_000016.10:23635289:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1255T>C (p.Cys419Arg)	PALB2	C399R, C124R, C419R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001969578	16	23646612	16	23635291	1969578	2022384	rs2142421373	NC_000016.10:23635290:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1254T>C (p.Asn418=)	PALB2		Familial cancer of breast	VCV001103425	16	23646613	16	23635292	1103425	1103711	rs2142421399	NC_000016.10:23635291:A:G	single nucleotide variant	synonymous variant	Likely benign	May 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1253A>G (p.Asn418Ser)	PALB2	N418S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000923709	16	23646614	16	23635293	923709	913659	rs1784498384	NC_000016.10:23635292:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1252A>G (p.Asn418Asp)	PALB2	N418D	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000186426	16	23646615	16	23635294	186426	184256	rs786202943	NC_000016.10:23635293:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1251C>T (p.Ser417=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000230781	16	23646616	16	23635295	230781	235285	rs876658769	NC_000016.10:23635294:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 26, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1250C>T (p.Ser417Phe)	PALB2	S122F, S397F, S417F	Hereditary cancer-predisposing syndrome	VCV003227984	16	23646617	16	23635296	3227984	3387753	rs45510998	NC_000016.10:23635295:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1250C>G (p.Ser417Cys)	PALB2	S122C, S417C, S397C	Hereditary cancer-predisposing syndrome	VCV001760632	16	23646617	16	23635296	1760632	1820060	rs45510998	NC_000016.10:23635295:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1250C>A (p.Ser417Tyr)	PALB2	S417Y	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not provided|Hereditary breast ovarian cancer syndrome	VCV000126595	16	23646617	16	23635296	126595	132105	rs45510998	NC_000016.10:23635295:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1249T>C (p.Ser417Pro)	PALB2	S122P, S397P, S417P	not provided|Hereditary cancer-predisposing syndrome	VCV001801182	16	23646618	16	23635297	1801182	1858469	rs1966981850	NC_000016.10:23635296:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1246A>G (p.Met416Val)	PALB2	M416V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830131	16	23646621	16	23635300	830131	818519	rs1966982055	NC_000016.10:23635299:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1245C>T (p.Ser415=)	PALB2		Familial cancer of breast	VCV003643175	16	23646622	16	23635301	3643175	3776047		NC_000016.10:23635300:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1245C>A (p.Ser415Arg)	PALB2	S415R	Familial cancer of breast	VCV000830130	16	23646622	16	23635301	830130	818520	rs1966982144	NC_000016.10:23635300:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1244G>C (p.Ser415Thr)	PALB2	S415T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001495130	16	23646623	16	23635302	1495130	1368916	rs2142421697	NC_000016.10:23635301:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1243A>C (p.Ser415Arg)	PALB2	S415R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000486015	16	23646624	16	23635303	486015	477689	rs1555461376	NC_000016.10:23635302:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 21, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1243A>T (p.Ser415Cys)	PALB2	S415C	Hereditary cancer-predisposing syndrome	VCV000484234	16	23646624	16	23635303	484234	477620	rs1555461376	NC_000016.10:23635302:T:A	single nucleotide variant	missense variant	Uncertain significance	May 31, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1242A>G (p.Arg414=)	PALB2		Familial cancer of breast	VCV000530259	16	23646625	16	23635304	530259	529917	rs875989795	NC_000016.10:23635303:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1242A>C (p.Arg414=)	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000225858	16	23646625	16	23635304	225858	227672	rs875989795	NC_000016.10:23635303:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1241G>A (p.Arg414Gln)	PALB2	R414Q	Hereditary cancer-predisposing syndrome|Familial pancreatic carcinoma|Familial cancer of breast|not specified|not provided	VCV000188322	16	23646626	16	23635305	188322	186221	rs749461008	NC_000016.10:23635304:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1240C>T (p.Arg414Ter)	PALB2	R414*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Hereditary breast ovarian cancer syndrome	VCV000128117	16	23646627	16	23635306	128117	133574	rs180177100	NC_000016.10:23635305:G:A	single nucleotide variant	nonsense	Pathogenic	Mar 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1239A>G (p.Thr413=)	PALB2		Familial cancer of breast	VCV001145964	16	23646628	16	23635307	1145964	1146013	rs2142421859	NC_000016.10:23635306:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 5, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1238C>T (p.Thr413Ile)	PALB2	T118I, T393I, T413I	Breast-ovarian cancer, familial, susceptibility to, 5	VCV002573177	16	23646629	16	23635308	2573177	2738126	rs876660213	NC_000016.10:23635307:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1238C>G (p.Thr413Arg)	PALB2	T413R	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000496461	16	23646629	16	23635308	496461	487901	rs876660213	NC_000016.10:23635307:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1238C>A (p.Thr413Lys)	PALB2	T413K	Hereditary cancer-predisposing syndrome	VCV000233127	16	23646629	16	23635308	233127	235286	rs876660213	NC_000016.10:23635307:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1237A>G (p.Thr413Ala)	PALB2	T413A	Hereditary cancer-predisposing syndrome	VCV000919823	16	23646630	16	23635309	919823	913660	rs1335631200	NC_000016.10:23635308:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1237A>C (p.Thr413Pro)	PALB2	T413P	Familial cancer of breast	VCV000655733	16	23646630	16	23635309	655733	644463	rs1335631200	NC_000016.10:23635308:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1235C>T (p.Thr412Ile)	PALB2	T412I, T117I, T392I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003023777	16	23646632	16	23635311	3023777	3180070	rs2142421975	NC_000016.10:23635310:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1235C>A (p.Thr412Lys)	PALB2	T117K, T392K, T412K	Hereditary cancer-predisposing syndrome	VCV002774015	16	23646632	16	23635311	2774015	2934746	rs2142421975	NC_000016.10:23635310:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1235C>G (p.Thr412Arg)	PALB2	T412R, T117R, T392R	Hereditary cancer-predisposing syndrome	VCV002567555	16	23646632	16	23635311	2567555	2731197	rs2142421975	NC_000016.10:23635310:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1233A>G (p.Arg411=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001756054	16	23646634	16	23635313	1756054	1812232	rs2142422020	NC_000016.10:23635312:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 21, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1232G>A (p.Arg411Lys)	PALB2	R411K	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000449868	16	23646635	16	23635314	449868	445547	rs926278722	NC_000016.10:23635313:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1230T>C (p.Val410=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000136127	16	23646637	16	23635316	136127	139839	rs587780818	NC_000016.10:23635315:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1229T>G (p.Val410Gly)	PALB2	V115G, V390G, V410G	Hereditary cancer-predisposing syndrome	VCV002774016	16	23646638	16	23635317	2774016	2934747	rs2142422111	NC_000016.10:23635316:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1227T>A (p.Tyr409Ter)	PALB2	Y409*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000956282	16	23646640	16	23635319	956282	949317	rs1555461386	NC_000016.10:23635318:A:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1227T>C (p.Tyr409=)	PALB2		not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000492154	16	23646640	16	23635319	492154	484770	rs1555461386	NC_000016.10:23635318:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1226A>T (p.Tyr409Phe)	PALB2	Y409F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000859179	16	23646641	16	23635320	859179	843612	rs878855097	NC_000016.10:23635319:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1226A>G (p.Tyr409Cys)	PALB2	Y409C	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Hereditary cancer	VCV000241525	16	23646641	16	23635320	241525	242381	rs878855097	NC_000016.10:23635319:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1225T>G (p.Tyr409Asp)	PALB2	Y409D, Y114D, Y389D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001754206	16	23646642	16	23635321	1754206	1804761	rs1064793222	NC_000016.10:23635320:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1225T>C (p.Tyr409His)	PALB2	Y409H	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000418395	16	23646642	16	23635321	418395	409556	rs1064793222	NC_000016.10:23635320:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1224T>G (p.Tyr408Ter)	PALB2	Y113*, Y388*, Y408*	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome	VCV003075689	16	23646643	16	23635322	3075689	3234985	rs2142422250	NC_000016.10:23635321:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic/Likely pathogenic	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1224T>C (p.Tyr408=)	PALB2		Familial cancer of breast	VCV001117984	16	23646643	16	23635322	1117984	1103712	rs2142422250	NC_000016.10:23635321:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1223A>G (p.Tyr408Cys)	PALB2	Y408C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000863470	16	23646644	16	23635323	863470	843613	rs779251679	NC_000016.10:23635322:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1222T>G (p.Tyr408Asp)	PALB2	Y408D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000185091	16	23646645	16	23635324	185091	184257	rs515726064	NC_000016.10:23635323:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1222T>C (p.Tyr408His)	PALB2	Y408H	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000126594	16	23646645	16	23635324	126594	132104	rs515726064	NC_000016.10:23635323:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1221A>T (p.Glu407Asp)	PALB2	E407D	Hereditary cancer-predisposing syndrome	VCV000924882	16	23646646	16	23635325	924882	913661	rs1597096669	NC_000016.10:23635324:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1221A>G (p.Glu407=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000705165	16	23646646	16	23635325	705165	693831	rs1597096669	NC_000016.10:23635324:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1220A>G (p.Glu407Gly)	PALB2	E407G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000818622	16	23646647	16	23635326	818622	812781	rs1597096676	NC_000016.10:23635325:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1218A>C (p.Ala406=)	PALB2		Familial cancer of breast	VCV001616916	16	23646649	16	23635328	1616916	1579919	rs1480282493	NC_000016.10:23635327:T:G	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1217C>A (p.Ala406Glu)	PALB2	A406E	Hereditary cancer-predisposing syndrome	VCV000919015	16	23646650	16	23635329	919015	913662	rs1060502757	NC_000016.10:23635328:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1217C>T (p.Ala406Val)	PALB2	A406V	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000410142	16	23646650	16	23635329	410142	401141	rs1060502757	NC_000016.10:23635328:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 25, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1215T>G (p.Pro405=)	PALB2		Familial cancer of breast	VCV000793718	16	23646652	16	23635331	793718	785231	rs1597096698	NC_000016.10:23635330:A:C	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1214C>T (p.Pro405Leu)	PALB2	P405L	Familial cancer of breast	VCV001364168	16	23646653	16	23635332	1364168	1386107	rs1555461396	NC_000016.10:23635331:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1214C>G (p.Pro405Arg)	PALB2	P405R	Hereditary cancer-predisposing syndrome	VCV000482028	16	23646653	16	23635332	482028	477691	rs1555461396	NC_000016.10:23635331:G:C	single nucleotide variant	missense variant	Uncertain significance	May 10, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.1213C>G (p.Pro405Ala)	PALB2	P405A	PALB2-related disorder|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000410151	16	23646654	16	23635333	410151	401806	rs545119348	NC_000016.10:23635332:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1212T>A (p.Phe404Leu)	PALB2	F384L, F404L, F109L	Familial cancer of breast	VCV002036430	16	23646655	16	23635334	2036430	2090486	rs148921082	NC_000016.10:23635333:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1212T>G (p.Phe404Leu)	PALB2	F404L	not provided|PALB2-related disorder|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410195	16	23646655	16	23635334	410195	401142	rs148921082	NC_000016.10:23635333:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1210T>C (p.Phe404Leu)	PALB2	F404L	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000418394	16	23646657	16	23635336	418394	409557	rs1064793221	NC_000016.10:23635335:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1209G>C (p.Leu403=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001114256	16	23646658	16	23635337	1114256	1103713	rs786202452	NC_000016.10:23635336:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1209G>A (p.Leu403=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|not specified|Familial cancer of breast	VCV000185784	16	23646658	16	23635337	185784	184258	rs786202452	NC_000016.10:23635336:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1208T>G (p.Leu403Arg)	PALB2	L403R	Familial cancer of breast	VCV000577130	16	23646659	16	23635338	577130	573959	rs1567221341	NC_000016.10:23635337:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1207C>G (p.Leu403Val)	PALB2	L108V, L403V, L383V	Familial cancer of breast	VCV002112058	16	23646660	16	23635339	2112058	2160879	rs2142422741	NC_000016.10:23635338:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1207C>T (p.Leu403=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001749095	16	23646660	16	23635339	1749095	1803545	rs2142422741	NC_000016.10:23635338:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1206T>C (p.Leu402=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492153	16	23646661	16	23635340	492153	485044	rs1163836809	NC_000016.10:23635339:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1205T>G (p.Leu402Arg)	PALB2	L107R, L402R, L382R	Hereditary cancer-predisposing syndrome	VCV001748732	16	23646662	16	23635341	1748732	1803185	rs2142422785	NC_000016.10:23635340:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1204C>G (p.Leu402Val)	PALB2	L402V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001043636	16	23646663	16	23635342	1043636	1032530	rs1555461402	NC_000016.10:23635341:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1204C>A (p.Leu402Ile)	PALB2	L402I	Familial cancer of breast	VCV000568500	16	23646663	16	23635342	568500	569985	rs1555461402	NC_000016.10:23635341:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1204C>T (p.Leu402Phe)	PALB2	L402F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482059	16	23646663	16	23635342	482059	477693	rs1555461402	NC_000016.10:23635341:G:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1203C>T (p.Gly401=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001128869	16	23646664	16	23635343	1128869	1125123	rs1418142337	NC_000016.10:23635342:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1202G>A (p.Gly401Asp)	PALB2	G106D, G381D, G401D	Familial cancer of breast	VCV002744910	16	23646665	16	23635344	2744910	2897073	rs1462655583	NC_000016.10:23635343:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1202G>T (p.Gly401Val)	PALB2	G401V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000639246	16	23646665	16	23635344	639246	644464	rs1462655583	NC_000016.10:23635343:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1201G>A (p.Gly401Ser)	PALB2	G401S, G106S, G381S	Familial cancer of breast	VCV003645721	16	23646666	16	23635345	3645721	3780296		NC_000016.10:23635344:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1200A>C (p.Glu400Asp)	PALB2	E105D, E400D, E380D	Familial cancer of breast	VCV002759075	16	23646667	16	23635346	2759075	2917657	rs1966985747	NC_000016.10:23635345:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1200A>T (p.Glu400Asp)	PALB2	E400D	Familial cancer of breast	VCV001004053	16	23646667	16	23635346	1004053	996810	rs1966985747	NC_000016.10:23635345:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1199A>G (p.Glu400Gly)	PALB2	E400G	Familial cancer of breast	VCV001348806	16	23646668	16	23635347	1348806	1456194	rs2142422950	NC_000016.10:23635346:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1198G>A (p.Glu400Lys)	PALB2	E105K, E380K, E400K	Hereditary cancer-predisposing syndrome	VCV001746562	16	23646669	16	23635348	1746562	1806109	rs2142422984	NC_000016.10:23635347:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1197T>C (p.Pro399=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001746433	16	23646670	16	23635349	1746433	1809921	rs2506485667	NC_000016.10:23635348:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 4, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1196C>T (p.Pro399Leu)	PALB2	P399L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001047627	16	23646671	16	23635350	1047627	1032531	rs776115183	NC_000016.10:23635349:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 10, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1194G>T (p.Val398=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000225861	16	23646673	16	23635352	225861	227673	rs61755173	NC_000016.10:23635351:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1194G>A (p.Val398=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|not provided|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Breast and/or ovarian cancer|Familial cancer of breast	VCV000126592	16	23646673	16	23635352	126592	132102	rs61755173	NC_000016.10:23635351:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1193T>G (p.Val398Gly)	PALB2	V398G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000948085	16	23646674	16	23635353	948085	927731	rs1461956026	NC_000016.10:23635352:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1192G>C (p.Val398Leu)	PALB2	V103L, V378L, V398L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001715290	16	23646675	16	23635354	1715290	1775435	rs769097541	NC_000016.10:23635353:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1192G>A (p.Val398Met)	PALB2	V398M	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000460885	16	23646675	16	23635354	460885	466499	rs769097541	NC_000016.10:23635353:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1191A>C (p.Thr397=)	PALB2		Familial cancer of breast	VCV002825803	16	23646676	16	23635355	2825803	2979196	rs1597096781	NC_000016.10:23635354:T:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1191A>G (p.Thr397=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial pancreatic carcinoma|not provided	VCV000742734	16	23646676	16	23635355	742734	755031	rs1597096781	NC_000016.10:23635354:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1190C>T (p.Thr397Ile)	PALB2	T397I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000140850	16	23646677	16	23635356	140850	150564	rs587781319	NC_000016.10:23635355:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1189A>C (p.Thr397Pro)	PALB2	T397P	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast	VCV000818541	16	23646678	16	23635357	818541	812782	rs367578415	NC_000016.10:23635356:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1189A>G (p.Thr397Ala)	PALB2	T397A	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000246419	16	23646678	16	23635357	246419	244972	rs367578415	NC_000016.10:23635356:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1189A>T (p.Thr397Ser)	PALB2	T397S	not specified|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 5|Inherited breast cancer and ovarian cancer|Familial ovarian cancer|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000142048	16	23646678	16	23635357	142048	151762	rs367578415	NC_000016.10:23635356:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1188C>A (p.Cys396Ter)	PALB2	C396*	Fanconi anemia complementation group N|Familial cancer of breast	VCV001323412	16	23646679	16	23635358	1323412	1313697	rs587780817	NC_000016.10:23635357:G:T	single nucleotide variant	nonsense	Pathogenic	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1188C>G (p.Cys396Trp)	PALB2	C396W	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000841874	16	23646679	16	23635358	841874	843614	rs587780817	NC_000016.10:23635357:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1188C>T (p.Cys396=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000136126	16	23646679	16	23635358	136126	139838	rs587780817	NC_000016.10:23635357:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1187G>A (p.Cys396Tyr)	PALB2	C396Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001495101	16	23646680	16	23635359	1495101	1368887	rs2142423374	NC_000016.10:23635358:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1186T>C (p.Cys396Arg)	PALB2	C396R	Familial cancer of breast	VCV001513854	16	23646681	16	23635360	1513854	1469041	rs2142423404	NC_000016.10:23635359:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1184C>A (p.Ser395Tyr)	PALB2	S100Y, S375Y, S395Y	Hereditary cancer-predisposing syndrome	VCV003413421	16	23646683	16	23635362	3413421	3574644		NC_000016.10:23635361:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1184C>G (p.Ser395Cys)	PALB2	S395C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000923897	16	23646683	16	23635362	923897	913663	rs764796329	NC_000016.10:23635361:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1184C>T (p.Ser395Phe)	PALB2	S395F	Breast-ovarian cancer, familial, susceptibility to, 5|not provided	VCV000422703	16	23646683	16	23635362	422703	409558	rs764796329	NC_000016.10:23635361:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1183T>C (p.Ser395Pro)	PALB2	S395P	Familial cancer of breast	VCV001034580	16	23646684	16	23635363	1034580	1032532	rs1966987344	NC_000016.10:23635362:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1182T>C (p.His394=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460884	16	23646685	16	23635364	460884	466503	rs772960995	NC_000016.10:23635363:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1181A>C (p.His394Pro)	PALB2	H99P, H394P, H374P	Familial cancer of breast	VCV002693093	16	23646686	16	23635365	2693093	2857077	rs762430363	NC_000016.10:23635364:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1181A>T (p.His394Leu)	PALB2	H394L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000923898	16	23646686	16	23635365	923898	913664	rs762430363	NC_000016.10:23635364:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 7, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1180C>T (p.His394Tyr)	PALB2	H394Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000631056	16	23646687	16	23635366	631056	618417	rs1567221411	NC_000016.10:23635365:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1179A>C (p.Lys393Asn)	PALB2	K393N, K98N, K373N	Familial cancer of breast	VCV002695714	16	23646688	16	23635367	2695714	2864401	rs976340416	NC_000016.10:23635366:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1179A>G (p.Lys393=)	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000422052	16	23646688	16	23635367	422052	409559	rs976340416	NC_000016.10:23635366:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1178A>G (p.Lys393Arg)	PALB2	K393R	Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified	VCV000219990	16	23646689	16	23635368	219990	222473	rs765898856	NC_000016.10:23635367:T:C	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1177A>C (p.Lys393Gln)	PALB2	K393Q	not provided|Familial cancer of breast	VCV001364989	16	23646690	16	23635369	1364989	1502035	rs866787789	NC_000016.10:23635368:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1177A>G (p.Lys393Glu)	PALB2	K393E	Familial cancer of breast	VCV000965400	16	23646690	16	23635369	965400	957704	rs866787789	NC_000016.10:23635368:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1176A>T (p.Glu392Asp)	PALB2	E372D, E392D, E97D	Hereditary cancer-predisposing syndrome	VCV003893962	16	23646691	16	23635370	3893962	4009843		NC_000016.10:23635369:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 12, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1176A>C (p.Glu392Asp)	PALB2	E392D, E97D, E372D	Hereditary cancer-predisposing syndrome	VCV003413446	16	23646691	16	23635370	3413446	3574669		NC_000016.10:23635369:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1176A>G (p.Glu392=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000480265	16	23646691	16	23635370	480265	477699	rs1555461423	NC_000016.10:23635369:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1175A>G (p.Glu392Gly)	PALB2	E392G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492151	16	23646692	16	23635371	492151	485051	rs1555461424	NC_000016.10:23635370:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1174G>T (p.Glu392Ter)	PALB2	E97*, E372*, E392*	Hereditary cancer-predisposing syndrome	VCV001740412	16	23646693	16	23635372	1740412	1791443	rs2142423775	NC_000016.10:23635371:C:A	single nucleotide variant	nonsense	Pathogenic	Apr 12, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1173A>G (p.Ala391=)	PALB2		Familial cancer of breast	VCV001532244	16	23646694	16	23635373	1532244	1583164	rs1346057856	NC_000016.10:23635372:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 8, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1171G>T (p.Ala391Ser)	PALB2	A391S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001346251	16	23646696	16	23635375	1346251	1378540	rs2142423854	NC_000016.10:23635374:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1170T>C (p.Ser390=)	PALB2		Hereditary cancer-predisposing syndrome	VCV002774017	16	23646697	16	23635376	2774017	2934748	rs1597096863	NC_000016.10:23635375:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1170T>A (p.Ser390=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000818490	16	23646697	16	23635376	818490	812783	rs1597096863	NC_000016.10:23635375:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1169C>G (p.Ser390Cys)	PALB2	S370C, S390C, S95C	Familial cancer of breast	VCV002677445	16	23646698	16	23635377	2677445	2836316	rs1555461425	NC_000016.10:23635376:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1169C>T (p.Ser390Phe)	PALB2	S390F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630686	16	23646698	16	23635377	630686	618419	rs1555461425	NC_000016.10:23635376:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1169C>A (p.Ser390Tyr)	PALB2	S390Y	Familial cancer of breast	VCV000460883	16	23646698	16	23635377	460883	466239	rs1555461425	NC_000016.10:23635376:G:T	single nucleotide variant	missense variant	Uncertain significance	May 21, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1167T>C (p.Leu389=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001574258	16	23646700	16	23635379	1574258	1659443	rs2142423985	NC_000016.10:23635378:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1166T>C (p.Leu389Pro)	PALB2	L389P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000575692	16	23646701	16	23635380	575692	570201	rs1567221452	NC_000016.10:23635379:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1165C>T (p.Leu389Phe)	PALB2	L389F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000572383	16	23646702	16	23635381	572383	573961	rs1555461427	NC_000016.10:23635380:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1165C>G (p.Leu389Val)	PALB2	L389V	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000460882	16	23646702	16	23635381	460882	466509	rs1555461427	NC_000016.10:23635380:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1164T>C (p.Pro388=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not specified	VCV000517000	16	23646703	16	23635382	517000	506214	rs1205215998	NC_000016.10:23635381:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1163C>T (p.Pro388Leu)	PALB2	P388L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000818461	16	23646704	16	23635383	818461	812784	rs1597096898	NC_000016.10:23635382:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 19, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1162C>T (p.Pro388Ser)	PALB2	P388S	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000628804	16	23646705	16	23635384	628804	618420	rs1567221468	NC_000016.10:23635383:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1161T>G (p.Ser387=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000818454	16	23646706	16	23635385	818454	812785	rs1597096920	NC_000016.10:23635384:A:C	single nucleotide variant	synonymous variant	Likely benign	Aug 6, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1160C>G (p.Ser387Cys)	PALB2	S387C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000241524	16	23646707	16	23635386	241524	242382	rs587781863	NC_000016.10:23635385:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1160C>T (p.Ser387Phe)	PALB2	S387F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000141593	16	23646707	16	23635386	141593	151307	rs587781863	NC_000016.10:23635385:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1158C>T (p.Thr386=)	PALB2		Familial cancer of breast	VCV003903868	16	23646709	16	23635388	3903868	4019741		NC_000016.10:23635387:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1158C>G (p.Thr386=)	PALB2		Familial cancer of breast	VCV002765310	16	23646709	16	23635388	2765310	2926057	rs2142424262	NC_000016.10:23635387:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1157C>T (p.Thr386Ile)	PALB2	T366I, T91I, T386I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001735626	16	23646710	16	23635389	1735626	1790120	rs876660840	NC_000016.10:23635388:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1157C>G (p.Thr386Ser)	PALB2	T386S	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000234085	16	23646710	16	23635389	234085	235289	rs876660840	NC_000016.10:23635388:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1156A>C (p.Thr386Pro)	PALB2	T386P, T91P, T366P	Familial cancer of breast	VCV003689185	16	23646711	16	23635390	3689185	3827265		NC_000016.10:23635389:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1156A>T (p.Thr386Ser)	PALB2	T386S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000629942	16	23646711	16	23635390	629942	618421	rs148102335	NC_000016.10:23635389:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1156A>G (p.Thr386Ala)	PALB2	T386A	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000182787	16	23646711	16	23635390	182787	180740	rs148102335	NC_000016.10:23635389:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1155A>G (p.Ala385=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481018	16	23646712	16	23635391	481018	477666	rs1555461431	NC_000016.10:23635390:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1153G>A (p.Ala385Thr)	PALB2	A385T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000848519	16	23646714	16	23635393	848519	843616	rs1966990156	NC_000016.10:23635392:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1152A>C (p.Glu384Asp)	PALB2	E384D, E89D, E364D	Familial cancer of breast	VCV002813885	16	23646715	16	23635394	2813885	2965999	rs1567221490	NC_000016.10:23635393:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 12, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1152A>G (p.Glu384=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000584542	16	23646715	16	23635394	584542	575600	rs1567221490	NC_000016.10:23635393:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1150G>C (p.Glu384Gln)	PALB2	E384Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000937358	16	23646717	16	23635396	937358	937374	rs1567221497	NC_000016.10:23635395:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1150G>A (p.Glu384Lys)	PALB2	E384K	Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast	VCV000571957	16	23646717	16	23635396	571957	569991	rs1567221497	NC_000016.10:23635395:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1149G>T (p.Leu383=)	PALB2		Familial cancer of breast	VCV002028721	16	23646718	16	23635397	2028721	2085356	rs2142424481	NC_000016.10:23635396:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 3, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1149G>A (p.Leu383=)	PALB2		Familial cancer of breast	VCV001093577	16	23646718	16	23635397	1093577	1081895	rs2142424481	NC_000016.10:23635396:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 27, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1148T>C (p.Leu383Pro)	PALB2	L383P	Hereditary cancer-predisposing syndrome	VCV000492150	16	23646719	16	23635398	492150	484785	rs1555461432	NC_000016.10:23635397:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 5, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1147C>T (p.Leu383=)	PALB2		Familial cancer of breast	VCV003904152	16	23646720	16	23635399	3904152	4020025		NC_000016.10:23635398:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1147C>A (p.Leu383Met)	PALB2	L383M	Familial cancer of breast	VCV001509127	16	23646720	16	23635399	1509127	1452244	rs2142424566	NC_000016.10:23635398:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1145G>C (p.Ser382Thr)	PALB2	S87T, S362T, S382T	Familial cancer of breast	VCV002726119	16	23646722	16	23635401	2726119	2892624	rs515726063	NC_000016.10:23635400:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1145G>A (p.Ser382Asn)	PALB2	S87N, S362N, S382N	Hereditary cancer-predisposing syndrome	VCV001732388	16	23646722	16	23635401	1732388	1786075	rs515726063	NC_000016.10:23635400:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1145G>T (p.Ser382Ile)	PALB2	S382I	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000126591	16	23646722	16	23635401	126591	132101	rs515726063	NC_000016.10:23635400:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1144A>C (p.Ser382Arg)	PALB2	S382R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410114	16	23646723	16	23635402	410114	401146	rs1060502737	NC_000016.10:23635401:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 17, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1143T>C (p.Leu381=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003413438	16	23646724	16	23635403	3413438	3574661		NC_000016.10:23635402:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1142T>G (p.Leu381Arg)	PALB2	L361R, L381R, L86R	Familial cancer of breast	VCV003665810	16	23646725	16	23635404	3665810	3795683		NC_000016.10:23635403:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1141C>T (p.Leu381Phe)	PALB2	L381F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484221	16	23646726	16	23635405	484221	478245	rs1555461435	NC_000016.10:23635404:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1139G>A (p.Ser380Asn)	PALB2	S380N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460881	16	23646728	16	23635407	460881	466242	rs876659887	NC_000016.10:23635406:C:T	single nucleotide variant	missense variant	Uncertain significance	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1139G>C (p.Ser380Thr)	PALB2	S380T	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000232632	16	23646728	16	23635407	232632	235290	rs876659887	NC_000016.10:23635406:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1137G>A (p.Lys379=)	PALB2		not specified|Familial cancer of breast	VCV000415989	16	23646730	16	23635409	415989	401072	rs1060504712	NC_000016.10:23635408:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 29, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1135A>T (p.Lys379Ter)	PALB2	K359*, K379*, K84*	not provided	VCV002579933	16	23646732	16	23635411	2579933	2747443	rs2142424902	NC_000016.10:23635410:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1135A>G (p.Lys379Glu)	PALB2	K379E, K359E, K84E	Familial cancer of breast	VCV001941711	16	23646732	16	23635411	1941711	1994549	rs2142424902	NC_000016.10:23635410:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1134T>G (p.Pro378=)	PALB2		Familial cancer of breast	VCV001146165	16	23646733	16	23635412	1146165	1146014	rs2142424923	NC_000016.10:23635411:A:C	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.1133C>G (p.Pro378Arg)	PALB2	P378R	Familial cancer of breast	VCV001021187	16	23646734	16	23635413	1021187	1012042	rs1442895662	NC_000016.10:23635412:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1133C>T (p.Pro378Leu)	PALB2	P378L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000460880	16	23646734	16	23635413	460880	465531	rs1442895662	NC_000016.10:23635412:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1131A>G (p.Gln377=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001954914	16	23646736	16	23635415	1954914	2015056	rs2142425052	NC_000016.10:23635414:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1130A>C (p.Gln377Pro)	PALB2	Q377P	Familial cancer of breast|not specified|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome	VCV000490066	16	23646737	16	23635416	490066	482898	rs1358484245	NC_000016.10:23635415:T:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1129C>T (p.Gln377Ter)	PALB2	Q377*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000640023	16	23646738	16	23635417	640023	644466	rs929474806	NC_000016.10:23635416:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jul 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1128T>C (p.Ser376=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000923024	16	23646739	16	23635418	923024	913665	rs587780204	NC_000016.10:23635417:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1128T>A (p.Ser376Arg)	PALB2	S376R	Familial cancer of breast	VCV000643340	16	23646739	16	23635418	643340	644467	rs587780204	NC_000016.10:23635417:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1128T>G (p.Ser376Arg)	PALB2	S376R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not provided	VCV000128116	16	23646739	16	23635418	128116	133573	rs587780204	NC_000016.10:23635417:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1127G>C (p.Ser376Thr)	PALB2	S376T	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000142053	16	23646740	16	23635419	142053	151767	rs587782200	NC_000016.10:23635418:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1126A>T (p.Ser376Cys)	PALB2	S376C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000935953	16	23646741	16	23635420	935953	937375	rs1966991786	NC_000016.10:23635419:T:A	single nucleotide variant	missense variant	Uncertain significance	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1125A>T (p.Leu375=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003927443	16	23646742	16	23635421	3927443	4047076		NC_000016.10:23635420:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 7, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1125A>G (p.Leu375=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000766036	16	23646742	16	23635421	766036	770784	rs767284930	NC_000016.10:23635420:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1125A>C (p.Leu375=)	PALB2		Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|not specified|Hereditary cancer-predisposing syndrome	VCV000480932	16	23646742	16	23635421	480932	477672	rs767284930	NC_000016.10:23635420:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1123C>G (p.Leu375Val)	PALB2	L375V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000627850	16	23646744	16	23635423	627850	618422	rs373298267	NC_000016.10:23635422:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1123C>T (p.Leu375=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000386627	16	23646744	16	23635423	386627	375266	rs373298267	NC_000016.10:23635422:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1123C>A (p.Leu375Ile)	PALB2	L375I	not provided|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000187142	16	23646744	16	23635423	187142	184259	rs373298267	NC_000016.10:23635422:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 24, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1121T>G (p.Ile374Ser)	PALB2	I374S, I354S, I79S	Hereditary cancer-predisposing syndrome	VCV003927446	16	23646746	16	23635425	3927446	4047079		NC_000016.10:23635424:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1121T>C (p.Ile374Thr)	PALB2	I374T	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000633343	16	23646746	16	23635425	633343	621533	rs1567221558	NC_000016.10:23635424:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1119G>A (p.Glu373=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000484203	16	23646748	16	23635427	484203	478249	rs45623436	NC_000016.10:23635426:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1117G>A (p.Glu373Lys)	PALB2	E373K, E78K, E353K	Hereditary cancer-predisposing syndrome	VCV001796607	16	23646750	16	23635429	1796607	1855182	rs1597097072	NC_000016.10:23635428:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1117G>T (p.Glu373Ter)	PALB2	E373*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822210	16	23646750	16	23635429	822210	812786	rs1597097072	NC_000016.10:23635428:C:A	single nucleotide variant	nonsense	Pathogenic	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1115G>A (p.Ser372Asn)	PALB2	S372N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000955096	16	23646752	16	23635431	955096	949319	rs786204243	NC_000016.10:23635430:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 6, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1115G>T (p.Ser372Ile)	PALB2	S372I	Hereditary cancer-predisposing syndrome	VCV000919873	16	23646752	16	23635431	919873	913666	rs786204243	NC_000016.10:23635430:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1115G>C (p.Ser372Thr)	PALB2	S372T	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3	VCV000188377	16	23646752	16	23635431	188377	186222	rs786204243	NC_000016.10:23635430:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1114A>G (p.Ser372Gly)	PALB2	S372G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000142705	16	23646753	16	23635432	142705	152419	rs587782657	NC_000016.10:23635431:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1113A>G (p.Glu371=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001795612	16	23646754	16	23635433	1795612	1854271	rs2506488476	NC_000016.10:23635432:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1112A>G (p.Glu371Gly)	PALB2	E351G, E371G, E76G	Hereditary cancer-predisposing syndrome	VCV003227982	16	23646755	16	23635434	3227982	3387751	rs1555461445	NC_000016.10:23635433:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1112A>T (p.Glu371Val)	PALB2	E371V	Hereditary cancer-predisposing syndrome	VCV000492148	16	23646755	16	23635434	492148	484790	rs1555461445	NC_000016.10:23635433:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1111G>T (p.Glu371Ter)	PALB2	E351*, E371*, E76*	Familial cancer of breast	VCV002674086	16	23646756	16	23635435	2674086	2841576	rs1312378621	NC_000016.10:23635434:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 7, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1111G>A (p.Glu371Lys)	PALB2	E371K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000482017	16	23646756	16	23635435	482017	477621	rs1312378621	NC_000016.10:23635434:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1110G>A (p.Gln370=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000381360	16	23646757	16	23635436	381360	374958	rs756002989	NC_000016.10:23635435:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1109A>G (p.Gln370Arg)	PALB2	Q370R	Familial cancer of breast	VCV000460879	16	23646758	16	23635437	460879	465534	rs1555461447	NC_000016.10:23635436:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.1108C>A (p.Gln370Lys)	PALB2	Q370K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822189	16	23646759	16	23635438	822189	812787	rs587776411	NC_000016.10:23635437:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1108C>T (p.Gln370Ter)	PALB2	Q370*	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000143961	16	23646759	16	23635438	143961	153691	rs587776411	NC_000016.10:23635437:G:A	single nucleotide variant	nonsense	Pathogenic	Aug 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1106T>C (p.Leu369Pro)	PALB2	L369P	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001008162	16	23646761	16	23635440	1008162	996811	rs1966993516	NC_000016.10:23635439:A:G	single nucleotide variant	missense variant	Uncertain significance	May 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1104T>C (p.Asn368=)	PALB2		Familial cancer of breast	VCV003903845	16	23646763	16	23635442	3903845	4019718		NC_000016.10:23635441:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1104T>A (p.Asn368Lys)	PALB2	N368K	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast	VCV000818370	16	23646763	16	23635442	818370	812788	rs1348407391	NC_000016.10:23635441:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1103A>G (p.Asn368Ser)	PALB2	N368S	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410205	16	23646764	16	23635443	410205	401550	rs1060502799	NC_000016.10:23635442:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1101A>G (p.Glu367=)	PALB2		Familial cancer of breast	VCV002005598	16	23646766	16	23635445	2005598	2052362	rs2142425885	NC_000016.10:23635444:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1100A>G (p.Glu367Gly)	PALB2	E367G, E72G, E347G	Familial cancer of breast	VCV002057265	16	23646767	16	23635446	2057265	2106087	rs2142425917	NC_000016.10:23635445:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1099G>A (p.Glu367Lys)	PALB2	E367K	Familial cancer of breast	VCV000836680	16	23646768	16	23635447	836680	843617	rs1966993880	NC_000016.10:23635446:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1097A>G (p.Asn366Ser)	PALB2	N366S	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000185365	16	23646770	16	23635449	185365	184260	rs554849907	NC_000016.10:23635448:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1096A>G (p.Asn366Asp)	PALB2	N366D	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Inherited breast cancer and ovarian cancer	VCV000188117	16	23646771	16	23635450	188117	186223	rs786204080	NC_000016.10:23635449:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1095G>A (p.Arg365=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000187159	16	23646772	16	23635451	187159	184261	rs515726062	NC_000016.10:23635450:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1094G>A (p.Arg365Lys)	PALB2	R345K, R365K, R70K	Familial cancer of breast	VCV003667399	16	23646773	16	23635452	3667399	3795976		NC_000016.10:23635451:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1093A>C (p.Arg365=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000215926	16	23646774	16	23635453	215926	213177	rs773001248	NC_000016.10:23635452:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1093A>G (p.Arg365Gly)	PALB2	R365G	not provided|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000185438	16	23646774	16	23635453	185438	184262	rs773001248	NC_000016.10:23635452:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1092C>G (p.Gly364=)	PALB2		Familial cancer of breast	VCV002114079	16	23646775	16	23635454	2114079	2171974	rs1966994380	NC_000016.10:23635453:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1092C>T (p.Gly364=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001348529	16	23646775	16	23635454	1348529	1455917	rs1966994380	NC_000016.10:23635453:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1091G>A (p.Gly364Asp)	PALB2	G364D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822144	16	23646776	16	23635455	822144	812790	rs758500775	NC_000016.10:23635454:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1090G>A (p.Gly364Ser)	PALB2	G69S, G344S, G364S	Familial cancer of breast	VCV003656165	16	23646777	16	23635456	3656165	3783032		NC_000016.10:23635455:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1089T>C (p.Asp363=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000757862	16	23646778	16	23635457	757862	770785	rs1597097155	NC_000016.10:23635456:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1088A>T (p.Asp363Val)	PALB2	D68V, D343V, D363V	Hereditary cancer-predisposing syndrome	VCV003413481	16	23646779	16	23635458	3413481	3574704		NC_000016.10:23635457:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1086T>C (p.Leu362=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460877	16	23646781	16	23635460	460877	466510	rs1555461454	NC_000016.10:23635459:A:G	single nucleotide variant	synonymous variant	Likely benign	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1085T>G (p.Leu362Arg)	PALB2	L362R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000230940	16	23646782	16	23635461	230940	235291	rs875989793	NC_000016.10:23635460:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1085T>C (p.Leu362Pro)	PALB2	L362P	Familial cancer of breast	VCV000225852	16	23646782	16	23635461	225852	227674	rs875989793	NC_000016.10:23635460:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1084C>G (p.Leu362Val)	PALB2	L362V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410143	16	23646783	16	23635462	410143	401075	rs1060502758	NC_000016.10:23635461:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1083T>C (p.Thr361=)	PALB2		not specified|Familial cancer of breast	VCV000517001	16	23646784	16	23635463	517001	505271	rs1555461457	NC_000016.10:23635462:A:G	single nucleotide variant	synonymous variant	Likely benign	May 20, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1082C>T (p.Thr361Ile)	PALB2	T361I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001486386	16	23646785	16	23635464	1486386	1491487	rs1345668733	NC_000016.10:23635463:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1082C>A (p.Thr361Asn)	PALB2	T361N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001438948	16	23646785	16	23635464	1438948	1448672	rs1345668733	NC_000016.10:23635463:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1082C>G (p.Thr361Ser)	PALB2	T361S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460876	16	23646785	16	23635464	460876	466250	rs1345668733	NC_000016.10:23635463:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1081A>G (p.Thr361Ala)	PALB2	T361A	Familial cancer of breast	VCV000659477	16	23646786	16	23635465	659477	644469	rs111981798	NC_000016.10:23635464:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1081A>T (p.Thr361Ser)	PALB2	T361S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000482016	16	23646786	16	23635465	482016	477628	rs111981798	NC_000016.10:23635464:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1080C>T (p.Asp360=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000741704	16	23646787	16	23635466	741704	755032	rs1415958873	NC_000016.10:23635465:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1079A>C (p.Asp360Ala)	PALB2	D340A, D65A, D360A	Familial cancer of breast	VCV002846873	16	23646788	16	23635467	2846873	3015048	rs876659751	NC_000016.10:23635466:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 18, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1079A>G (p.Asp360Gly)	PALB2	D360G	not provided|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000232415	16	23646788	16	23635467	232415	235292	rs876659751	NC_000016.10:23635466:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 4, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1077T>C (p.Ser359=)	PALB2		Familial cancer of breast	VCV003903723	16	23646790	16	23635469	3903723	4019596		NC_000016.10:23635468:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1077T>G (p.Ser359Arg)	PALB2	S359R, S339R, S64R	not specified|Hereditary cancer-predisposing syndrome	VCV001785308	16	23646790	16	23635469	1785308	1840105	rs1280472090	NC_000016.10:23635468:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1076G>C (p.Ser359Thr)	PALB2	S339T, S359T, S64T	Familial cancer of breast	VCV002778016	16	23646791	16	23635470	2778016	2937011	rs1966995771	NC_000016.10:23635469:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1076G>A (p.Ser359Asn)	PALB2	S359N	not provided	VCV000830128	16	23646791	16	23635470	830128	818522	rs1966995771	NC_000016.10:23635469:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1075A>G (p.Ser359Gly)	PALB2	S339G, S359G, S64G	Hereditary cancer-predisposing syndrome	VCV001784636	16	23646792	16	23635471	1784636	1846696	rs2506489887	NC_000016.10:23635470:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1074C>G (p.Pro358=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003227979	16	23646793	16	23635472	3227979	3387748	rs1966995930	NC_000016.10:23635471:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1074C>T (p.Pro358=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001784422	16	23646793	16	23635472	1784422	1846483	rs1966995930	NC_000016.10:23635471:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1074C>A (p.Pro358=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001784325	16	23646793	16	23635472	1784325	1846387	rs1966995930	NC_000016.10:23635471:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.1073C>G (p.Pro358Arg)	PALB2	P63R, P358R, P338R	Hereditary cancer-predisposing syndrome	VCV003304009	16	23646794	16	23635473	3304009	3470176		NC_000016.10:23635472:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 26, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1073C>T (p.Pro358Leu)	PALB2	P358L	Hereditary cancer-predisposing syndrome	VCV000822122	16	23646794	16	23635473	822122	812791	rs1555461462	NC_000016.10:23635472:G:A	single nucleotide variant	missense variant	Likely benign	Mar 27, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1073C>A (p.Pro358His)	PALB2	P358H	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000482063	16	23646794	16	23635473	482063	477716	rs1555461462	NC_000016.10:23635472:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1072C>G (p.Pro358Ala)	PALB2	P358A	Familial cancer of breast	VCV001022820	16	23646795	16	23635474	1022820	1012043	rs876660876	NC_000016.10:23635473:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1072C>T (p.Pro358Ser)	PALB2	P358S	not provided|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000234140	16	23646795	16	23635474	234140	235293	rs876660876	NC_000016.10:23635473:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1070C>T (p.Ser357Phe)	PALB2	S357F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822111	16	23646797	16	23635476	822111	812792	rs1555461469	NC_000016.10:23635475:G:A	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1070C>G (p.Ser357Cys)	PALB2	S357C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530121	16	23646797	16	23635476	530121	530369	rs1555461469	NC_000016.10:23635475:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1068A>G (p.Lys356=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002792738	16	23646799	16	23635478	2792738	2957750	rs2142426828	NC_000016.10:23635477:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1067A>C (p.Lys356Thr)	PALB2	K336T, K356T, K61T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001782109	16	23646800	16	23635479	1782109	1835504	rs2142426883	NC_000016.10:23635478:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1066A>G (p.Lys356Glu)	PALB2	K356E	not provided|Familial cancer of breast|Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome|not specified	VCV000460875	16	23646801	16	23635480	460875	466252	rs1202130508	NC_000016.10:23635479:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 31, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1064T>A (p.Leu355Ter)	PALB2	L335*, L355*, L60*	Hereditary cancer-predisposing syndrome	VCV003227978	16	23646803	16	23635482	3227978	3387747	rs1597097263	NC_000016.10:23635481:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1064T>C (p.Leu355Ser)	PALB2	L355S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000818312	16	23646803	16	23635482	818312	812793	rs1597097263	NC_000016.10:23635481:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1063T>G (p.Leu355Val)	PALB2	L355V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484199	16	23646804	16	23635483	484199	477673	rs1555461473	NC_000016.10:23635482:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1062T>A (p.Ser354=)	PALB2		Familial cancer of breast	VCV003724847	16	23646805	16	23635484	3724847	3854626		NC_000016.10:23635483:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1061C>A (p.Ser354Tyr)	PALB2	S354Y	Familial cancer of breast	VCV000846243	16	23646806	16	23635485	846243	843618	rs1555461474	NC_000016.10:23635484:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1061C>G (p.Ser354Cys)	PALB2	S354C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460874	16	23646806	16	23635485	460874	466251	rs1555461474	NC_000016.10:23635484:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1060T>A (p.Ser354Thr)	PALB2	S354T	Familial cancer of breast	VCV000940471	16	23646807	16	23635486	940471	937376	rs1567221680	NC_000016.10:23635485:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1060T>G (p.Ser354Ala)	PALB2	S354A	Familial cancer of breast	VCV000581317	16	23646807	16	23635486	581317	568009	rs1567221680	NC_000016.10:23635485:A:C	single nucleotide variant	missense variant	Uncertain significance	May 31, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.1059A>G (p.Lys353=)	PALB2		Familial cancer of breast|not specified	VCV000509399	16	23646808	16	23635487	509399	505524	rs1213280805	NC_000016.10:23635486:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1058A>T (p.Lys353Ile)	PALB2	K333I, K353I, K58I	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3	VCV003891896	16	23646809	16	23635488	3891896	4007785		NC_000016.10:23635487:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 27, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1058A>G (p.Lys353Arg)	PALB2	K353R	Hereditary cancer-predisposing syndrome	VCV000629432	16	23646809	16	23635488	629432	618423	rs1567221700	NC_000016.10:23635487:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1057A>G (p.Lys353Glu)	PALB2	K353E	Familial cancer of breast	VCV000241523	16	23646810	16	23635489	241523	242383	rs878855096	NC_000016.10:23635488:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.1056G>C (p.Glu352Asp)	PALB2	E352D, E57D, E332D	Familial cancer of breast	VCV003663147	16	23646811	16	23635490	3663147	3801544		NC_000016.10:23635489:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1054G>C (p.Glu352Gln)	PALB2	E352Q	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000132751	16	23646813	16	23635492	132751	136499	rs201035780	NC_000016.10:23635491:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1053A>C (p.Thr351=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001121943	16	23646814	16	23635493	1121943	1125124	rs1555461480	NC_000016.10:23635492:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1053A>G (p.Thr351=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000460873	16	23646814	16	23635493	460873	466514	rs1555461480	NC_000016.10:23635492:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1052C>T (p.Thr351Ile)	PALB2	T351I	Familial cancer of breast	VCV000460872	16	23646815	16	23635494	460872	465539	rs876658656	NC_000016.10:23635493:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1052C>G (p.Thr351Arg)	PALB2	T351R	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000419253	16	23646815	16	23635494	419253	409562	rs876658656	NC_000016.10:23635493:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1052C>A (p.Thr351Lys)	PALB2	T351K	Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000230592	16	23646815	16	23635494	230592	235294	rs876658656	NC_000016.10:23635493:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 11, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1051A>C (p.Thr351Pro)	PALB2	T351P, T331P, T56P	Hereditary cancer-predisposing syndrome	VCV001777195	16	23646816	16	23635495	1777195	1831087	rs1555461483	NC_000016.10:23635494:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1051A>G (p.Thr351Ala)	PALB2	T351A	Hereditary cancer-predisposing syndrome	VCV000482011	16	23646816	16	23635495	482011	478251	rs1555461483	NC_000016.10:23635494:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1049A>T (p.Gln350Leu)	PALB2	Q350L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630025	16	23646818	16	23635497	630025	618424	rs1567221732	NC_000016.10:23635496:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1048C>A (p.Gln350Lys)	PALB2	Q330K, Q55K, Q350K	Familial cancer of breast	VCV002701476	16	23646819	16	23635498	2701476	2862470	rs1060502788	NC_000016.10:23635497:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1048C>G (p.Gln350Glu)	PALB2	Q350E	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000920408	16	23646819	16	23635498	920408	913668	rs1060502788	NC_000016.10:23635497:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1048C>T (p.Gln350Ter)	PALB2	Q350*	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410191	16	23646819	16	23635498	410191	401810	rs1060502788	NC_000016.10:23635497:G:A	single nucleotide variant	nonsense	Pathogenic	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1046A>C (p.Asn349Thr)	PALB2	N349T	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000619882	16	23646821	16	23635500	619882	611224	rs1567221740	NC_000016.10:23635499:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 11, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1044A>G (p.Gln348=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000818309	16	23646823	16	23635502	818309	812794	rs1597097374	NC_000016.10:23635501:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1043A>G (p.Gln348Arg)	PALB2	Q348R, Q53R, Q328R	Familial cancer of breast	VCV003675338	16	23646824	16	23635503	3675338	3806666		NC_000016.10:23635502:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1042C>G (p.Gln348Glu)	PALB2	Q328E, Q348E, Q53E	Hereditary cancer-predisposing syndrome	VCV003894318	16	23646825	16	23635504	3894318	4010198		NC_000016.10:23635503:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1042C>T (p.Gln348Ter)	PALB2	Q348*	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000221914	16	23646825	16	23635504	221914	223602	rs375699023	NC_000016.10:23635503:G:A	single nucleotide variant	nonsense	Pathogenic	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1042C>A (p.Gln348Lys)	PALB2	Q348K	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000141588	16	23646825	16	23635504	141588	151302	rs375699023	NC_000016.10:23635503:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 15, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1041A>G (p.Glu347=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492144	16	23646826	16	23635505	492144	484797	rs1555461486	NC_000016.10:23635504:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1040A>G (p.Glu347Gly)	PALB2	E347G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001359588	16	23646827	16	23635506	1359588	1370768	rs2142427838	NC_000016.10:23635505:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1039G>C (p.Glu347Gln)	PALB2	E347Q	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000942377	16	23646828	16	23635507	942377	937377	rs1060499812	NC_000016.10:23635506:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1039G>T (p.Glu347Ter)	PALB2	E347*	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000402286	16	23646828	16	23635507	402286	389277	rs1060499812	NC_000016.10:23635506:C:A	single nucleotide variant	nonsense	Pathogenic	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1038A>C (p.Lys346Asn)	PALB2	K346N	Hereditary cancer-predisposing syndrome	VCV001171639	16	23646829	16	23635508	1171639	1161320	rs515726059	NC_000016.10:23635507:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1038A>G (p.Lys346=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000126584	16	23646829	16	23635508	126584	132094	rs515726059	NC_000016.10:23635507:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1037A>G (p.Lys346Arg)	PALB2	K346R, K326R, K51R	Familial cancer of breast	VCV003724739	16	23646830	16	23635509	3724739	3854519		NC_000016.10:23635508:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1035A>G (p.Leu345=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002774018	16	23646832	16	23635511	2774018	2934749	rs876658634	NC_000016.10:23635510:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1035A>C (p.Leu345Phe)	PALB2	L345F	Hereditary cancer-predisposing syndrome	VCV000230560	16	23646832	16	23635511	230560	235295	rs876658634	NC_000016.10:23635510:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.1034T>C (p.Leu345Ser)	PALB2	L345S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822051	16	23646833	16	23635512	822051	812795	rs781757934	NC_000016.10:23635511:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1033T>C (p.Leu345=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000184305	16	23646834	16	23635513	184305	184264	rs786201393	NC_000016.10:23635512:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1032C>T (p.Asn344=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001332040	16	23646835	16	23635514	1332040	1322760	rs2142428036	NC_000016.10:23635513:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1031A>C (p.Asn344Thr)	PALB2	N344T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630536	16	23646836	16	23635515	630536	618425	rs1567221791	NC_000016.10:23635514:T:G	single nucleotide variant	missense variant	Uncertain significance	May 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1030A>G (p.Asn344Asp)	PALB2	N344D	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000186306	16	23646837	16	23635516	186306	184265	rs786202850	NC_000016.10:23635515:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1029A>G (p.Gln343=)	PALB2		Familial cancer of breast	VCV003653276	16	23646838	16	23635517	3653276	3788710		NC_000016.10:23635516:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 14, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1028A>G (p.Gln343Arg)	PALB2	Q343R, Q48R, Q323R	Familial cancer of breast	VCV002006813	16	23646839	16	23635518	2006813	2066048	rs1567221796	NC_000016.10:23635517:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.1027C>T (p.Gln343Ter)	PALB2	Q343*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000126583	16	23646840	16	23635519	126583	132093	rs180177097	NC_000016.10:23635518:G:A	single nucleotide variant	nonsense	Pathogenic	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1026C>T (p.Asn342=)	PALB2		Familial cancer of breast	VCV003903887	16	23646841	16	23635520	3903887	4019760		NC_000016.10:23635519:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1026C>G (p.Asn342Lys)	PALB2	N342K	Hereditary cancer-predisposing syndrome	VCV000186776	16	23646841	16	23635520	186776	184266	rs786203211	NC_000016.10:23635519:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2014	criteria provided, single submitter							
NM_024675.4(PALB2):c.1021G>T (p.Glu341Ter)	PALB2	E341*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001423799	16	23646846	16	23635525	1423799	1418858	rs2142428256	NC_000016.10:23635524:C:A	single nucleotide variant	nonsense	Pathogenic	Jul 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1020T>C (p.Asn340=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000232989	16	23646847	16	23635526	232989	235296	rs748432666	NC_000016.10:23635525:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1018A>T (p.Asn340Tyr)	PALB2	N45Y, N320Y, N340Y	Familial cancer of breast	VCV003646698	16	23646849	16	23635528	3646698	3787251		NC_000016.10:23635527:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 19, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1018A>G (p.Asn340Asp)	PALB2	N45D, N320D, N340D	Hereditary cancer-predisposing syndrome	VCV002567554	16	23646849	16	23635528	2567554	2731196	rs2142428331	NC_000016.10:23635527:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1017A>G (p.Ala339=)	PALB2		Familial cancer of breast	VCV002769726	16	23646850	16	23635529	2769726	2933041	rs2142428345	NC_000016.10:23635528:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1017A>C (p.Ala339=)	PALB2		Familial cancer of breast	VCV002089442	16	23646850	16	23635529	2089442	2144772	rs2142428345	NC_000016.10:23635528:T:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1016C>A (p.Ala339Glu)	PALB2	A44E, A339E, A319E	Familial cancer of breast	VCV003666354	16	23646851	16	23635530	3666354	3792158		NC_000016.10:23635529:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1016C>T (p.Ala339Val)	PALB2	A44V, A319V, A339V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002702002	16	23646851	16	23635530	2702002	2859585	rs2142428364	NC_000016.10:23635529:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1015G>A (p.Ala339Thr)	PALB2	A339T, A319T, A44T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002102449	16	23646852	16	23635531	2102449	2165494	rs2142428379	NC_000016.10:23635530:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1014A>G (p.Pro338=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000184397	16	23646853	16	23635532	184397	184267	rs540622230	NC_000016.10:23635531:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1013C>T (p.Pro338Leu)	PALB2	P338L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628383	16	23646854	16	23635533	628383	618426	rs1316239336	NC_000016.10:23635532:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1012C>T (p.Pro338Ser)	PALB2	P338S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001003623	16	23646855	16	23635534	1003623	996812	rs560853558	NC_000016.10:23635533:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 16, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1012C>G (p.Pro338Ala)	PALB2	P338A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492142	16	23646855	16	23635534	492142	484808	rs560853558	NC_000016.10:23635533:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1012C>A (p.Pro338Thr)	PALB2	P338T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482053	16	23646855	16	23635534	482053	477683	rs560853558	NC_000016.10:23635533:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 20, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1011A>T (p.Leu337Phe)	PALB2	L337F, L317F, L42F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002857511	16	23646856	16	23635535	2857511	3021408	rs2506492406	NC_000016.10:23635534:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1010T>G (p.Leu337Ter)	PALB2	L337*	Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Familial cancer of breast	VCV000822009	16	23646857	16	23635536	822009	812796	rs45494092	NC_000016.10:23635535:A:C	single nucleotide variant	nonsense	Pathogenic	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1010T>A (p.Leu337Ter)	PALB2	L337*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000641318	16	23646857	16	23635536	641318	644472	rs45494092	NC_000016.10:23635535:A:T	single nucleotide variant	nonsense	Pathogenic	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1010T>C (p.Leu337Ser)	PALB2	L337S	Breast and/or ovarian cancer|not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N	VCV000126582	16	23646857	16	23635536	126582	132092	rs45494092	NC_000016.10:23635535:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1008C>T (p.Asn336=)	PALB2		Familial cancer of breast	VCV001107203	16	23646859	16	23635538	1107203	1103714	rs2142428659	NC_000016.10:23635537:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 26, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.1006A>C (p.Asn336His)	PALB2	N336H	not provided|not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000578696	16	23646861	16	23635540	578696	570203	rs1060502774	NC_000016.10:23635539:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 18, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1006A>G (p.Asn336Asp)	PALB2	N336D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410169	16	23646861	16	23635540	410169	401814	rs1060502774	NC_000016.10:23635539:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1005T>A (p.Asn335Lys)	PALB2	N315K, N40K, N335K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003413471	16	23646862	16	23635541	3413471	3574694		NC_000016.10:23635540:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1004A>T (p.Asn335Ile)	PALB2	N335I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000492141	16	23646863	16	23635542	492141	484861	rs1368473544	NC_000016.10:23635541:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1004A>G (p.Asn335Ser)	PALB2	N335S	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000460869	16	23646863	16	23635542	460869	465550	rs1368473544	NC_000016.10:23635541:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1002C>T (p.Tyr334=)	PALB2		Familial cancer of breast	VCV003904036	16	23646865	16	23635544	3904036	4019909		NC_000016.10:23635543:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1002C>G (p.Tyr334Ter)	PALB2	Y314*, Y334*, Y39*	Familial cancer of breast	VCV002674066	16	23646865	16	23635544	2674066	2841556	rs1967002667	NC_000016.10:23635543:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 7, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.1002C>A (p.Tyr334Ter)	PALB2	Y334*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000850899	16	23646865	16	23635544	850899	843621	rs1967002667	NC_000016.10:23635543:G:T	single nucleotide variant	nonsense	Pathogenic	Jan 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1001A>G (p.Tyr334Cys)	PALB2	Y334C	Hereditary cancer-predisposing syndrome|not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Breast and/or ovarian cancer|Familial cancer of breast|Hereditary breast ovarian cancer syndrome	VCV000126581	16	23646866	16	23635545	126581	132091	rs200620434	NC_000016.10:23635544:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 18, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.1000T>G (p.Tyr334Asp)	PALB2	Y334D	Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000126580	16	23646867	16	23635546	126580	132090	rs202241382	NC_000016.10:23635545:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.999C>A (p.Thr333=)	PALB2		Familial cancer of breast	VCV003904104	16	23646868	16	23635547	3904104	4019977		NC_000016.10:23635546:G:T	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.999C>G (p.Thr333=)	PALB2		Familial cancer of breast	VCV000461038	16	23646868	16	23635547	461038	465552	rs180177096	NC_000016.10:23635546:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 17, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.999C>T (p.Thr333=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000126783	16	23646868	16	23635547	126783	132293	rs180177096	NC_000016.10:23635546:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.998C>A (p.Thr333Asn)	PALB2	T333N	Ovarian neoplasm|Familial cancer of breast	VCV000951770	16	23646869	16	23635548	951770	927732	rs1567221840	NC_000016.10:23635547:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.998C>T (p.Thr333Ile)	PALB2	T333I	Familial cancer of breast	VCV000571259	16	23646869	16	23635548	571259	573962	rs1567221840	NC_000016.10:23635547:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.997A>G (p.Thr333Ala)	PALB2	T333A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000142488	16	23646870	16	23635549	142488	152202	rs587782498	NC_000016.10:23635548:T:C	single nucleotide variant	missense variant	Uncertain significance	May 8, 2017	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.996C>G (p.Leu332=)	PALB2		Familial cancer of breast	VCV003904341	16	23646871	16	23635550	3904341	4020213		NC_000016.10:23635549:G:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.996C>A (p.Leu332=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001768756	16	23646871	16	23635550	1768756	1825756	rs2142428966	NC_000016.10:23635549:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 22, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.995T>C (p.Leu332Pro)	PALB2	L332P	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000461037	16	23646872	16	23635551	461037	465554	rs377149139	NC_000016.10:23635550:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.995T>A (p.Leu332His)	PALB2	L332H	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000143019	16	23646872	16	23635551	143019	152733	rs377149139	NC_000016.10:23635550:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.994C>T (p.Leu332Phe)	PALB2	L332F	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000565864	16	23646873	16	23635552	565864	570008	rs1567221866	NC_000016.10:23635551:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.993A>G (p.Glu331=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000186886	16	23646874	16	23635553	186886	184268	rs760362870	NC_000016.10:23635552:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.992A>C (p.Glu331Ala)	PALB2	E331A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823555	16	23646875	16	23635554	823555	812797	rs1597097586	NC_000016.10:23635553:T:G	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.991G>T (p.Glu331Ter)	PALB2	E311*, E331*, E36*	Familial cancer of breast	VCV002583217	16	23646876	16	23635555	2583217	2750788	rs878855126	NC_000016.10:23635554:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.991G>C (p.Glu331Gln)	PALB2	E331Q	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000241574	16	23646876	16	23635555	241574	242384	rs878855126	NC_000016.10:23635554:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.990T>C (p.Asn330=)	PALB2		Familial cancer of breast	VCV001097725	16	23646877	16	23635556	1097725	1081896	rs2142429127	NC_000016.10:23635555:A:G	single nucleotide variant	synonymous variant	Likely benign	May 7, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.989A>G (p.Asn330Ser)	PALB2	N310S, N330S, N35S	not provided|Hereditary cancer-predisposing syndrome	VCV003228052	16	23646878	16	23635557	3228052	3387821	rs1967003935	NC_000016.10:23635556:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.988A>G (p.Asn330Asp)	PALB2	N330D	Familial cancer of breast	VCV000662523	16	23646879	16	23635558	662523	644473	rs1597097599	NC_000016.10:23635557:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.987A>T (p.Leu329=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823527	16	23646880	16	23635559	823527	812798	rs1258396517	NC_000016.10:23635558:T:A	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.987A>G (p.Leu329=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492229	16	23646880	16	23635559	492229	484871	rs1258396517	NC_000016.10:23635558:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.986T>C (p.Leu329Pro)	PALB2	L329P	Familial cancer of breast	VCV001402090	16	23646881	16	23635560	1402090	1453900	rs2142429260	NC_000016.10:23635559:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.985C>T (p.Leu329=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001086526	16	23646882	16	23635561	1086526	1081897	rs863224792	NC_000016.10:23635560:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.985C>G (p.Leu329Val)	PALB2	L329V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000216763	16	23646882	16	23635561	216763	213178	rs863224792	NC_000016.10:23635560:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.983C>G (p.Ser328Cys)	PALB2	S308C, S328C, S33C	Familial cancer of breast|not specified	VCV002573616	16	23646884	16	23635563	2573616	2738560	rs1567221893	NC_000016.10:23635562:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.983C>A (p.Ser328Tyr)	PALB2	S328Y	Familial cancer of breast	VCV001055325	16	23646884	16	23635563	1055325	1049528	rs1567221893	NC_000016.10:23635562:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.983C>T (p.Ser328Phe)	PALB2	S328F	Hereditary cancer-predisposing syndrome	VCV000628269	16	23646884	16	23635563	628269	618427	rs1567221893	NC_000016.10:23635562:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.981T>G (p.Cys327Trp)	PALB2	C307W, C327W, C32W	not provided	VCV001809915	16	23646886	16	23635565	1809915	1866919	rs1967004526	NC_000016.10:23635564:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.980G>A (p.Cys327Tyr)	PALB2	C327Y	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000185906	16	23646887	16	23635566	185906	184269	rs786202550	NC_000016.10:23635565:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.979T>C (p.Cys327Arg)	PALB2	C307R, C32R, C327R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001768241	16	23646888	16	23635567	1768241	1825674	rs2142429442	NC_000016.10:23635566:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.978A>G (p.Ser326=)	PALB2		Familial cancer of breast	VCV003706862	16	23646889	16	23635568	3706862	3846348		NC_000016.10:23635567:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.977C>T (p.Ser326Leu)	PALB2	S326L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000572696	16	23646890	16	23635569	572696	570209	rs1282291340	NC_000016.10:23635568:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.975T>G (p.Ile325Met)	PALB2	I325M	Hereditary cancer-predisposing syndrome	VCV000925959	16	23646892	16	23635571	925959	913670	rs1967005065	NC_000016.10:23635570:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.974T>A (p.Ile325Asn)	PALB2	I325N, I30N, I305N	Hereditary cancer-predisposing syndrome	VCV003413510	16	23646893	16	23635572	3413510	3574733		NC_000016.10:23635571:A:T	single nucleotide variant	missense variant|intron variant	Likely benign	Dec 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.974T>C (p.Ile325Thr)	PALB2	I30T, I305T, I325T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001768076	16	23646893	16	23635572	1768076	1825509	rs2142429594	NC_000016.10:23635571:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.972T>C (p.Asn324=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001768020	16	23646895	16	23635574	1768020	1825453	rs2506493833	NC_000016.10:23635573:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.971A>C (p.Asn324Thr)	PALB2	N324T	Hereditary cancer-predisposing syndrome	VCV000490088	16	23646896	16	23635575	490088	482949	rs1555461520	NC_000016.10:23635574:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.970A>G (p.Asn324Asp)	PALB2	N29D, N304D, N324D	Hereditary cancer-predisposing syndrome	VCV003228051	16	23646897	16	23635576	3228051	3387820	rs2142429646	NC_000016.10:23635575:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Feb 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.969A>G (p.Ala323=)	PALB2		Familial cancer of breast	VCV003903442	16	23646898	16	23635577	3903442	4019316		NC_000016.10:23635576:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.968C>T (p.Ala323Val)	PALB2	A323V	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|not specified	VCV000482023	16	23646899	16	23635578	482023	477688	rs730881882	NC_000016.10:23635577:G:A	single nucleotide variant	missense variant	Uncertain significance	May 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.968C>A (p.Ala323Glu)	PALB2	A323E	not provided|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome	VCV000182760	16	23646899	16	23635578	182760	180742	rs730881882	NC_000016.10:23635577:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.967G>T (p.Ala323Ser)	PALB2	A28S, A303S, A323S	not provided	VCV003360866	16	23646900	16	23635579	3360866	3520077		NC_000016.10:23635578:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.966G>C (p.Glu322Asp)	PALB2	E322D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000842820	16	23646901	16	23635580	842820	843622	rs1246010785	NC_000016.10:23635579:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.965A>G (p.Glu322Gly)	PALB2	E322G	Hereditary cancer-predisposing syndrome	VCV000481113	16	23646902	16	23635581	481113	477690	rs1555461523	NC_000016.10:23635580:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.964G>C (p.Glu322Gln)	PALB2	E27Q, E302Q, E322Q	Hereditary cancer-predisposing syndrome	VCV003774411	16	23646903	16	23635582	3774411	3890558		NC_000016.10:23635581:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.964G>T (p.Glu322Ter)	PALB2	E27*, E302*, E322*	Familial cancer of breast	VCV002673880	16	23646903	16	23635582	2673880	2841380	rs1597097656	NC_000016.10:23635581:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 7, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.964G>A (p.Glu322Lys)	PALB2	E322K	Familial cancer of breast	VCV000654774	16	23646903	16	23635582	654774	644474	rs1597097656	NC_000016.10:23635581:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.962T>G (p.Leu321Ter)	PALB2	L301*, L321*, L26*	Familial cancer of breast	VCV002017905	16	23646905	16	23635584	2017905	2075822	rs2142429833	NC_000016.10:23635583:A:C	single nucleotide variant	nonsense	Pathogenic	Sep 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.962T>C (p.Leu321Ser)	PALB2	L26S, L301S, L321S	Hereditary cancer-predisposing syndrome	VCV001767613	16	23646905	16	23635584	1767613	1818264	rs2142429833	NC_000016.10:23635583:A:G	single nucleotide variant	missense variant	Uncertain significance	May 5, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.961T>C (p.Leu321=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000920163	16	23646906	16	23635585	920163	913671	rs1967005997	NC_000016.10:23635584:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.961T>G (p.Leu321Val)	PALB2	L321V	Familial cancer of breast	VCV000849137	16	23646906	16	23635585	849137	843623	rs1967005997	NC_000016.10:23635584:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.958A>C (p.Asn320His)	PALB2	N320H, N25H, N300H	Familial cancer of breast	VCV002121261	16	23646909	16	23635588	2121261	2180443	rs2142429933	NC_000016.10:23635587:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.957T>C (p.Ser319=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000186605	16	23646910	16	23635589	186605	184270	rs786203082	NC_000016.10:23635588:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.956C>T (p.Ser319Phe)	PALB2	S319F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000402312	16	23646911	16	23635590	402312	389279	rs200144401	NC_000016.10:23635589:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.956C>A (p.Ser319Tyr)	PALB2	S319Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000126782	16	23646911	16	23635590	126782	132292	rs200144401	NC_000016.10:23635589:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.955T>C (p.Ser319Pro)	PALB2	S319P	Familial cancer of breast	VCV000461035	16	23646912	16	23635591	461035	466518	rs1555461524	NC_000016.10:23635590:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.952A>G (p.Ser318Gly)	PALB2	S318G, S23G, S298G	Familial cancer of breast	VCV003666413	16	23646915	16	23635594	3666413	3792217		NC_000016.10:23635593:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.952A>C (p.Ser318Arg)	PALB2	S318R	Hereditary cancer-predisposing syndrome	VCV000823316	16	23646915	16	23635594	823316	812799	rs1597097692	NC_000016.10:23635593:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.951A>G (p.Thr317=)	PALB2		Familial cancer of breast	VCV003903892	16	23646916	16	23635595	3903892	4019765		NC_000016.10:23635594:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.951A>T (p.Thr317=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000918291	16	23646916	16	23635595	918291	913672	rs1967006687	NC_000016.10:23635594:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.950C>T (p.Thr317Ile)	PALB2	T317I	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000185396	16	23646917	16	23635596	185396	184271	rs45548638	NC_000016.10:23635595:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.949A>C (p.Thr317Pro)	PALB2	T317P	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000128150	16	23646918	16	23635597	128150	133607	rs587780223	NC_000016.10:23635596:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.948C>T (p.Pro316=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000461034	16	23646919	16	23635598	461034	465555	rs1555461528	NC_000016.10:23635597:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.947C>T (p.Pro316Leu)	PALB2	P316L	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000230958	16	23646920	16	23635599	230958	235298	rs876658867	NC_000016.10:23635598:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.946C>G (p.Pro316Ala)	PALB2	P21A, P296A, P316A	Hereditary cancer-predisposing syndrome	VCV001767057	16	23646921	16	23635600	1767057	1821399	rs751688374	NC_000016.10:23635599:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.945G>A (p.Leu315=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001133194	16	23646922	16	23635601	1133194	1125125	rs1555461529	NC_000016.10:23635600:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.945G>T (p.Leu315=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480272	16	23646922	16	23635601	480272	477641	rs1555461529	NC_000016.10:23635600:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.944T>C (p.Leu315Pro)	PALB2	L20P, L315P, L295P	Hereditary cancer-predisposing syndrome	VCV003885217	16	23646923	16	23635602	3885217	4005539		NC_000016.10:23635601:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 31, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.943C>T (p.Leu315=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000627990	16	23646924	16	23635603	627990	618428	rs1567221961	NC_000016.10:23635602:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.942A>T (p.Gln314His)	PALB2	Q19H, Q314H, Q294H	Hereditary cancer-predisposing syndrome	VCV001766920	16	23646925	16	23635604	1766920	1825163	rs1156931572	NC_000016.10:23635603:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.942A>C (p.Gln314His)	PALB2	Q314H	Familial cancer of breast	VCV001665488	16	23646925	16	23635604	1665488	1589872	rs1156931572	NC_000016.10:23635603:T:G	single nucleotide variant	missense variant	Likely benign	Jun 11, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.942A>G (p.Gln314=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000928081	16	23646925	16	23635604	928081	913673	rs1156931572	NC_000016.10:23635603:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.940C>T (p.Gln314Ter)	PALB2	Q314*	not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000187557	16	23646927	16	23635606	187557	184272	rs786203821	NC_000016.10:23635605:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.939C>T (p.Gly313=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001152872	16	23646928	16	23635607	1152872	1146015	rs2142430444	NC_000016.10:23635606:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.938G>A (p.Gly313Asp)	PALB2	G313D	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000580823	16	23646929	16	23635608	580823	570009	rs1555461531	NC_000016.10:23635607:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 22, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.938G>T (p.Gly313Val)	PALB2	G313V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000481179	16	23646929	16	23635608	481179	478256	rs1555461531	NC_000016.10:23635607:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.937G>A (p.Gly313Ser)	PALB2	G18S, G293S, G313S	Hereditary cancer-predisposing syndrome	VCV003228049	16	23646930	16	23635609	3228049	3387818	rs2142430509	NC_000016.10:23635608:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.936T>C (p.Ser312=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481119	16	23646931	16	23635610	481119	477727	rs1555461534	NC_000016.10:23635609:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.935G>C (p.Ser312Thr)	PALB2	S312T, S292T, S17T	Hereditary cancer-predisposing syndrome	VCV001766680	16	23646932	16	23635611	1766680	1824923	rs1407319475	NC_000016.10:23635610:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.935G>A (p.Ser312Asn)	PALB2	S312N	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000461033	16	23646932	16	23635611	461033	466256	rs1407319475	NC_000016.10:23635610:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 24, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.934A>G (p.Ser312Gly)	PALB2	S17G, S292G, S312G	Hereditary cancer-predisposing syndrome	VCV003228048	16	23646933	16	23635612	3228048	3387817	rs1401541483	NC_000016.10:23635611:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.934A>T (p.Ser312Cys)	PALB2	S17C, S292C, S312C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001766648	16	23646933	16	23635612	1766648	1824891	rs1401541483	NC_000016.10:23635611:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.933A>C (p.Lys311Asn)	PALB2	K16N, K291N, K311N	Ovarian cancer	VCV002445316	16	23646934	16	23635613	2445316	2419042	rs2506495029	NC_000016.10:23635612:T:G	single nucleotide variant	missense variant	Benign	Jan 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.932A>G (p.Lys311Arg)	PALB2	K311R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000530210	16	23646935	16	23635614	530210	529920	rs755129205	NC_000016.10:23635613:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.932A>C (p.Lys311Thr)	PALB2	K311T	Familial cancer of breast	VCV000461032	16	23646935	16	23635614	461032	465559	rs755129205	NC_000016.10:23635613:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.931A>G (p.Lys311Glu)	PALB2	K311E	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000461031	16	23646936	16	23635615	461031	466253	rs1060499831	NC_000016.10:23635614:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.931A>T (p.Lys311Ter)	PALB2	K311*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000402311	16	23646936	16	23635615	402311	389280	rs1060499831	NC_000016.10:23635614:T:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jun 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.930T>C (p.Ser310=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000924272	16	23646937	16	23635616	924272	913675	rs1967008319	NC_000016.10:23635615:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.929G>A (p.Ser310Asn)	PALB2	S310N	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000216762	16	23646938	16	23635617	216762	213179	rs370887726	NC_000016.10:23635616:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.928A>G (p.Ser310Gly)	PALB2	S310G	Hereditary cancer-predisposing syndrome|PALB2-related disorder|not specified|Familial cancer of breast|not provided|Breast and/or ovarian cancer	VCV000128149	16	23646939	16	23635618	128149	133606	rs45561331	NC_000016.10:23635617:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 24, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.927A>T (p.Ile309=)	PALB2		Familial cancer of breast	VCV003904205	16	23646940	16	23635619	3904205	4020078		NC_000016.10:23635618:T:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.927A>G (p.Ile309Met)	PALB2	I289M, I309M, I14M	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002813691	16	23646940	16	23635619	2813691	2969641	rs1326253995	NC_000016.10:23635618:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.927A>C (p.Ile309=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000461030	16	23646940	16	23635619	461030	466258	rs1326253995	NC_000016.10:23635618:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.926T>C (p.Ile309Thr)	PALB2	I309T, I14T, I289T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002122363	16	23646941	16	23635620	2122363	2173788	rs201588519	NC_000016.10:23635619:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.926T>A (p.Ile309Lys)	PALB2	I309K	Familial cancer of breast	VCV000964376	16	23646941	16	23635620	964376	949320	rs201588519	NC_000016.10:23635619:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.926T>G (p.Ile309Arg)	PALB2	I309R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530130	16	23646941	16	23635620	530130	530148	rs201588519	NC_000016.10:23635619:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.925A>G (p.Ile309Val)	PALB2	I309V	Familial cancer of breast|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000126780	16	23646942	16	23635621	126780	132290	rs3809683	NC_000016.10:23635620:T:C	single nucleotide variant	missense variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.924T>C (p.Ala308=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001128326	16	23646943	16	23635622	1128326	1125126	rs2142430881	NC_000016.10:23635621:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.923C>G (p.Ala308Gly)	PALB2	A13G, A288G, A308G	Hereditary cancer-predisposing syndrome	VCV003228047	16	23646944	16	23635623	3228047	3387816	rs1967009067	NC_000016.10:23635622:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.923C>T (p.Ala308Val)	PALB2	A308V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001043474	16	23646944	16	23635623	1043474	1032534	rs1967009067	NC_000016.10:23635622:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 18, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.922G>T (p.Ala308Ser)	PALB2	A13S, A308S, A288S	Hereditary cancer-predisposing syndrome	VCV003303985	16	23646945	16	23635624	3303985	3470152		NC_000016.10:23635623:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.921A>G (p.Lys307=)	PALB2		Familial cancer of breast	VCV000530062	16	23646946	16	23635625	530062	529921	rs1555461544	NC_000016.10:23635624:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.920A>C (p.Lys307Thr)	PALB2	K307T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001481061	16	23646947	16	23635626	1481061	1451499	rs2142430999	NC_000016.10:23635625:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.918T>G (p.Asn306Lys)	PALB2	N306K	Hereditary cancer-predisposing syndrome	VCV000823085	16	23646949	16	23635628	823085	812800	rs114428350	NC_000016.10:23635627:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.916A>C (p.Asn306His)	PALB2	N11H, N306H, N286H	Familial cancer of breast	VCV002825083	16	23646951	16	23635630	2825083	2986168	rs2142431094	NC_000016.10:23635629:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 30, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.915A>G (p.Val305=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001559003	16	23646952	16	23635631	1559003	1563668	rs748881930	NC_000016.10:23635630:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.915A>T (p.Val305=)	PALB2		Familial cancer of breast	VCV000766628	16	23646952	16	23635631	766628	770786	rs748881930	NC_000016.10:23635630:T:A	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.913G>A (p.Val305Ile)	PALB2	V285I, V10I, V305I	Familial cancer of breast	VCV002751210	16	23646954	16	23635633	2751210	2913248	rs2142431165	NC_000016.10:23635632:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.912T>C (p.Leu304=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001765915	16	23646955	16	23635634	1765915	1817865	rs1967009790	NC_000016.10:23635633:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 21, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.911T>C (p.Leu304Pro)	PALB2	L284P, L9P, L304P	Familial cancer of breast	VCV002845523	16	23646956	16	23635635	2845523	3011722	rs2142431212	NC_000016.10:23635634:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.911T>G (p.Leu304Arg)	PALB2	L9R, L304R, L284R	Familial cancer of breast	VCV002099312	16	23646956	16	23635635	2099312	2150633	rs2142431212	NC_000016.10:23635634:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.909C>T (p.Leu303=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified|Fanconi anemia complementation group N|not provided	VCV000126778	16	23646958	16	23635637	126778	132288	rs145788619	NC_000016.10:23635636:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.908T>C (p.Leu303Pro)	PALB2	L303P	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000231978	16	23646959	16	23635638	231978	235299	rs774057025	NC_000016.10:23635637:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.908T>A (p.Leu303His)	PALB2	L303H	Hereditary cancer-predisposing syndrome	VCV000231920	16	23646959	16	23635638	231920	235300	rs774057025	NC_000016.10:23635637:A:T	single nucleotide variant	missense variant	Uncertain significance	May 19, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.907C>A (p.Leu303Ile)	PALB2	L283I, L8I, L303I	Hereditary cancer-predisposing syndrome	VCV001765694	16	23646960	16	23635639	1765694	1821334	rs878855125	NC_000016.10:23635638:G:T	single nucleotide variant	missense variant	Likely benign	Apr 23, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.907C>T (p.Leu303Phe)	PALB2	L303F	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822987	16	23646960	16	23635639	822987	812801	rs878855125	NC_000016.10:23635638:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.907C>G (p.Leu303Val)	PALB2	L303V	Familial cancer of breast	VCV000241573	16	23646960	16	23635639	241573	242385	rs878855125	NC_000016.10:23635638:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.906C>G (p.Asn302Lys)	PALB2	N282K, N302K, N7K	not specified	VCV002576373	16	23646961	16	23635640	2576373	2741269	rs1967010410	NC_000016.10:23635639:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.906C>A (p.Asn302Lys)	PALB2	N302K	Hereditary cancer-predisposing syndrome	VCV000927826	16	23646961	16	23635640	927826	913676	rs1967010410	NC_000016.10:23635639:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.905A>G (p.Asn302Ser)	PALB2	N7S, N282S, N302S	Familial cancer of breast	VCV002768793	16	23646962	16	23635641	2768793	2926943	rs2142431444	NC_000016.10:23635640:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.904A>T (p.Asn302Tyr)	PALB2	N302Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001171627	16	23646963	16	23635642	1171627	1161321	rs2142431479	NC_000016.10:23635641:T:A	single nucleotide variant	missense variant	Uncertain significance	May 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.903T>C (p.Asp301=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000382713	16	23646964	16	23635643	382713	377415	rs1057521432	NC_000016.10:23635642:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.902A>T (p.Asp301Val)	PALB2	D301V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001332123	16	23646965	16	23635644	1332123	1322843	rs759014440	NC_000016.10:23635643:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.902A>G (p.Asp301Gly)	PALB2	D301G	not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000231781	16	23646965	16	23635644	231781	235301	rs759014440	NC_000016.10:23635643:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.901G>C (p.Asp301His)	PALB2	D301H	Familial cancer of breast	VCV001474357	16	23646966	16	23635645	1474357	1410888	rs1967010825	NC_000016.10:23635644:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.900A>G (p.Thr300=)	PALB2		Familial cancer of breast|not provided|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000187401	16	23646967	16	23635646	187401	184273	rs771660444	NC_000016.10:23635645:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.899C>G (p.Thr300Arg)	PALB2	T300R	Hereditary cancer-predisposing syndrome	VCV000484220	16	23646968	16	23635647	484220	478260	rs528541334	NC_000016.10:23635646:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.899C>T (p.Thr300Ile)	PALB2	T300I	not specified|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000126777	16	23646968	16	23635647	126777	132287	rs528541334	NC_000016.10:23635646:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.898A>G (p.Thr300Ala)	PALB2	T280A, T5A, T300A	not provided|Hereditary cancer-predisposing syndrome	VCV003413492	16	23646969	16	23635648	3413492	3574715		NC_000016.10:23635647:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.897T>C (p.Ser299=)	PALB2		Breast and/or ovarian cancer|Familial cancer of breast|Fanconi anemia complementation group N|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000126776	16	23646970	16	23635649	126776	132286	rs180177095	NC_000016.10:23635648:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.896C>T (p.Ser299Phe)	PALB2	S299F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001004029	16	23646971	16	23635650	1004029	996813	rs1967011427	NC_000016.10:23635649:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.895T>A (p.Ser299Thr)	PALB2	S279T, S299T, S4T	Hereditary cancer-predisposing syndrome	VCV003228045	16	23646972	16	23635651	3228045	3387814	rs2142431778	NC_000016.10:23635650:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.894C>A (p.Val298=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001765210	16	23646973	16	23635652	1765210	1824704	rs1597097899	NC_000016.10:23635651:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 25, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.894C>T (p.Val298=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000822830	16	23646973	16	23635652	822830	812802	rs1597097899	NC_000016.10:23635651:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.893T>C (p.Val298Ala)	PALB2	V298A	Hereditary cancer-predisposing syndrome	VCV000482058	16	23646974	16	23635653	482058	477745	rs763726703	NC_000016.10:23635652:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.892G>A (p.Val298Ile)	PALB2	V298I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not provided	VCV000461029	16	23646975	16	23635654	461029	466257	rs1060502765	NC_000016.10:23635653:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 11, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.892G>C (p.Val298Leu)	PALB2	V298L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410153	16	23646975	16	23635654	410153	401552	rs1060502765	NC_000016.10:23635653:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.891T>C (p.Thr297=)	PALB2		Familial cancer of breast	VCV003903461	16	23646976	16	23635655	3903461	4019335		NC_000016.10:23635654:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.890C>T (p.Thr297Ile)	PALB2	T297I	Familial cancer of breast	VCV001364135	16	23646977	16	23635656	1364135	1386074	rs1967012032	NC_000016.10:23635655:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.887T>A (p.Met296Lys)	PALB2	M1K, M296K, M276K	Hereditary cancer-predisposing syndrome	VCV003413501	16	23646980	16	23635659	3413501	3574724		NC_000016.10:23635658:A:T	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.887T>G (p.Met296Arg)	PALB2	M296R	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000461028	16	23646980	16	23635659	461028	466520	rs1555461566	NC_000016.10:23635658:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.886A>T (p.Met296Leu)	PALB2	M1L, M276L, M296L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001764939	16	23646981	16	23635660	1764939	1824433	rs2142432039	NC_000016.10:23635659:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.885A>G (p.Lys295=)	PALB2		Familial cancer of breast	VCV001553471	16	23646982	16	23635661	1553471	1553255	rs2142432107	NC_000016.10:23635660:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.882A>G (p.Lys294=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000514890	16	23646985	16	23635664	514890	505728	rs1415955458	NC_000016.10:23635663:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.880A>T (p.Lys294Ter)	PALB2	K294*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001075018	16	23646987	16	23635666	1075018	1063602	rs753676934	NC_000016.10:23635665:T:A	single nucleotide variant	nonsense	Pathogenic	Sep 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.880A>G (p.Lys294Glu)	PALB2	K294E	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000410190	16	23646987	16	23635666	410190	401083	rs753676934	NC_000016.10:23635665:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 25, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.879C>G (p.Gly293=)	PALB2		Familial cancer of breast	VCV001116909	16	23646988	16	23635667	1116909	1103715	rs1461078801	NC_000016.10:23635666:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.878G>A (p.Gly293Asp)	PALB2	G293D	not specified|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233423	16	23646989	16	23635668	233423	235302	rs876660398	NC_000016.10:23635667:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.877G>A (p.Gly293Ser)	PALB2	G293S	Hereditary cancer-predisposing syndrome	VCV000822728	16	23646990	16	23635669	822728	812804	rs1392587904	NC_000016.10:23635668:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.876A>C (p.Gln292His)	PALB2	Q292H	Familial cancer of breast	VCV001025795	16	23646991	16	23635670	1025795	1012044	rs1408180894	NC_000016.10:23635669:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.876A>G (p.Gln292=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000920578	16	23646991	16	23635670	920578	913678	rs1408180894	NC_000016.10:23635669:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 2, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.875A>G (p.Gln292Arg)	PALB2	Q292R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482031	16	23646992	16	23635671	482031	477692	rs1328100544	NC_000016.10:23635670:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.874C>T (p.Gln292Ter)	PALB2	Q272*, Q292*	Familial cancer of breast|Hereditary breast ovarian cancer syndrome	VCV002573617	16	23646993	16	23635672	2573617	2738561	rs1335897946	NC_000016.10:23635671:G:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.874C>A (p.Gln292Lys)	PALB2	Q292K	Familial cancer of breast	VCV000803238	16	23646993	16	23635672	803238	791571	rs1335897946	NC_000016.10:23635671:G:T	single nucleotide variant	missense variant	Uncertain significance	May 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.873A>C (p.Ala291=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001764488	16	23646994	16	23635673	1764488	1817615	rs1567222128	NC_000016.10:23635672:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Aug 28, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.873A>G (p.Ala291=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001139819	16	23646994	16	23635673	1139819	1125127	rs1567222128	NC_000016.10:23635672:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.872C>T (p.Ala291Val)	PALB2	A291V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000647738	16	23646995	16	23635674	647738	644475	rs1411140246	NC_000016.10:23635673:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.871G>T (p.Ala291Ser)	PALB2	A291S, A271S	Hereditary cancer-predisposing syndrome	VCV001764443	16	23646996	16	23635675	1764443	1817570	rs878855124	NC_000016.10:23635674:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.871G>A (p.Ala291Thr)	PALB2	A291T	Familial cancer of breast	VCV000241572	16	23646996	16	23635675	241572	242386	rs878855124	NC_000016.10:23635674:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.870G>A (p.Glu290=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000230954	16	23646997	16	23635676	230954	235303	rs761771287	NC_000016.10:23635675:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.868G>T (p.Glu290Ter)	PALB2	E290*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000584472	16	23646999	16	23635678	584472	575601	rs1567222143	NC_000016.10:23635677:C:A	single nucleotide variant	nonsense	Pathogenic	Mar 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.867G>C (p.Leu289Phe)	PALB2	L269F, L289F	Familial cancer of breast	VCV003707172	16	23647000	16	23635679	3707172	3846658		NC_000016.10:23635678:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jun 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.867G>A (p.Leu289=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000822654	16	23647000	16	23635679	822654	812805	rs1597098004	NC_000016.10:23635678:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.866T>G (p.Leu289Trp)	PALB2	L289W	Familial cancer of breast	VCV001472482	16	23647001	16	23635680	1472482	1397864	rs1555461574	NC_000016.10:23635679:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.866T>C (p.Leu289Ser)	PALB2	L289S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822641	16	23647001	16	23635680	822641	812806	rs1555461574	NC_000016.10:23635679:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.866T>A (p.Leu289Ter)	PALB2	L289*	Familial cancer of breast	VCV000487421	16	23647001	16	23635680	487421	480479	rs1555461574	NC_000016.10:23635679:A:T	single nucleotide variant	nonsense	Pathogenic	Mar 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.865T>A (p.Leu289Met)	PALB2	L289M	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000840704	16	23647002	16	23635681	840704	843624	rs1967014008	NC_000016.10:23635680:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.863G>A (p.Ser288Asn)	PALB2	S288N	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000928055	16	23647004	16	23635683	928055	913679	rs1967014090	NC_000016.10:23635682:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.860T>C (p.Val287Ala)	PALB2	V287A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000461027	16	23647007	16	23635686	461027	466263	rs1555461576	NC_000016.10:23635685:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.859G>T (p.Val287Leu)	PALB2	V287L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001027006	16	23647008	16	23635687	1027006	1012045	rs1967014349	NC_000016.10:23635686:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.858T>G (p.Pro286=)	PALB2		Familial cancer of breast	VCV000963924	16	23647009	16	23635688	963924	949321	rs1060504709	NC_000016.10:23635687:A:C	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.858T>C (p.Pro286=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000415984	16	23647009	16	23635688	415984	401822	rs1060504709	NC_000016.10:23635687:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.857C>T (p.Pro286Leu)	PALB2	P286L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822579	16	23647010	16	23635689	822579	812807	rs1597098031	NC_000016.10:23635688:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.856C>T (p.Pro286Ser)	PALB2	P286S	Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000128147	16	23647011	16	23635690	128147	133604	rs45585833	NC_000016.10:23635689:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.855A>T (p.Ser285=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003885229	16	23647012	16	23635691	3885229	4005551		NC_000016.10:23635690:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.855A>C (p.Ser285=)	PALB2		Familial cancer of breast	VCV002039809	16	23647012	16	23635691	2039809	2091271	rs2142432748	NC_000016.10:23635690:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.855A>G (p.Ser285=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001997606	16	23647012	16	23635691	1997606	2056826	rs2142432748	NC_000016.10:23635690:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.854C>A (p.Ser285Ter)	PALB2	S265*, S285*	Familial cancer of breast	VCV002431307	16	23647013	16	23635692	2431307	2404811	rs180177094	NC_000016.10:23635691:G:T	single nucleotide variant	nonsense	Pathogenic	Jan 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.854C>G (p.Ser285Ter)	PALB2	S285*	Hereditary cancer-predisposing syndrome	VCV000486026	16	23647013	16	23635692	486026	477696	rs180177094	NC_000016.10:23635691:G:C	single nucleotide variant	nonsense	Pathogenic	Jun 29, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.854C>T (p.Ser285Leu)	PALB2	S285L	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000126775	16	23647013	16	23635692	126775	132285	rs180177094	NC_000016.10:23635691:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.853T>C (p.Ser285Pro)	PALB2	S285P	Familial cancer of breast	VCV000410172	16	23647014	16	23635693	410172	401824	rs1060502776	NC_000016.10:23635692:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.852T>A (p.Thr284=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001763763	16	23647015	16	23635694	1763763	1820629	rs2142432796	NC_000016.10:23635693:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 31, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.851C>T (p.Thr284Ile)	PALB2	T284I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000461026	16	23647016	16	23635695	461026	466259	rs1555461583	NC_000016.10:23635694:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.850A>G (p.Thr284Ala)	PALB2	T284A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481019	16	23647017	16	23635696	481019	477746	rs1555461584	NC_000016.10:23635695:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.847T>C (p.Phe283Leu)	PALB2	F263L, F283L	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome	VCV001763541	16	23647020	16	23635699	1763541	1824265	rs2142432879	NC_000016.10:23635698:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.846A>T (p.Arg282Ser)	PALB2	R282S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530186	16	23647021	16	23635700	530186	530167	rs1555461587	NC_000016.10:23635699:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.845G>A (p.Arg282Lys)	PALB2	R282K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530198	16	23647022	16	23635701	530198	530374	rs1555461590	NC_000016.10:23635700:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.844A>G (p.Arg282Gly)	PALB2	R282G	Breast and/or ovarian cancer|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000231184	16	23647023	16	23635702	231184	235304	rs45447991	NC_000016.10:23635701:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 18, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.843T>A (p.Ile281=)	PALB2		Familial cancer of breast	VCV001148720	16	23647024	16	23635703	1148720	1146016	rs786201408	NC_000016.10:23635702:A:T	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.843T>C (p.Ile281=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000184334	16	23647024	16	23635703	184334	184275	rs786201408	NC_000016.10:23635702:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.842T>G (p.Ile281Ser)	PALB2	I281S	Familial cancer of breast	VCV001524975	16	23647025	16	23635704	1524975	1363315	rs950480706	NC_000016.10:23635703:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.841A>G (p.Ile281Val)	PALB2	I281V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530108	16	23647026	16	23635705	530108	529933	rs751882053	NC_000016.10:23635704:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.841A>T (p.Ile281Phe)	PALB2	I281F	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000216761	16	23647026	16	23635705	216761	213180	rs751882053	NC_000016.10:23635704:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.840C>T (p.Asn280=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000461025	16	23647027	16	23635706	461025	466521	rs375258299	NC_000016.10:23635705:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.839A>G (p.Asn280Ser)	PALB2	N280S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001376823	16	23647028	16	23635707	1376823	1479687	rs1597098100	NC_000016.10:23635706:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.839A>T (p.Asn280Ile)	PALB2	N280I	Hereditary cancer-predisposing syndrome	VCV000822376	16	23647028	16	23635707	822376	812809	rs1597098100	NC_000016.10:23635706:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.838A>C (p.Asn280His)	PALB2	N280H	Familial cancer of breast	VCV000568879	16	23647029	16	23635708	568879	570010	rs1567222209	NC_000016.10:23635707:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.836A>C (p.Lys279Thr)	PALB2	K279T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000921971	16	23647031	16	23635710	921971	913680	rs1967016594	NC_000016.10:23635709:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.834A>T (p.Leu278=)	PALB2		Hereditary cancer-predisposing syndrome|not provided	VCV000822318	16	23647033	16	23635712	822318	812810	rs199919863	NC_000016.10:23635711:T:A	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.834A>G (p.Leu278=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000508712	16	23647033	16	23635712	508712	505530	rs199919863	NC_000016.10:23635711:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.833T>C (p.Leu278Pro)	PALB2	L258P, L278P	Familial cancer of breast	VCV001919119	16	23647034	16	23635713	1919119	1971559	rs200843485	NC_000016.10:23635712:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.833T>A (p.Leu278Gln)	PALB2	L278Q	Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome	VCV000822315	16	23647034	16	23635713	822315	812811	rs200843485	NC_000016.10:23635712:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 13, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.832C>T (p.Leu278=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000386503	16	23647035	16	23635714	386503	377417	rs515726128	NC_000016.10:23635713:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.831C>T (p.Asp277=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000230252	16	23647036	16	23635715	230252	235305	rs62625273	NC_000016.10:23635714:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.829G>T (p.Asp277Tyr)	PALB2	D277Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000582336	16	23647038	16	23635717	582336	573968	rs778309339	NC_000016.10:23635716:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.829G>A (p.Asp277Asn)	PALB2	D277N	Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000186811	16	23647038	16	23635717	186811	184276	rs778309339	NC_000016.10:23635716:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.828C>A (p.His276Gln)	PALB2	H276Q, H256Q	Hereditary cancer-predisposing syndrome	VCV003885231	16	23647039	16	23635718	3885231	4005553		NC_000016.10:23635717:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Mar 8, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.828C>G (p.His276Gln)	PALB2	H276Q, H256Q	Familial cancer of breast	VCV003729639	16	23647039	16	23635718	3729639	3858968		NC_000016.10:23635717:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 26, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.828C>T (p.His276=)	PALB2		Fanconi anemia complementation group N|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000461024	16	23647039	16	23635718	461024	466261	rs911713488	NC_000016.10:23635717:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.827A>C (p.His276Pro)	PALB2	H276P	Hereditary cancer-predisposing syndrome	VCV000922232	16	23647040	16	23635719	922232	913681	rs1967017695	NC_000016.10:23635718:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.826C>T (p.His276Tyr)	PALB2	H276Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000230863	16	23647041	16	23635720	230863	235306	rs876658815	NC_000016.10:23635719:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.825T>G (p.Thr275=)	PALB2		Familial cancer of breast	VCV002033176	16	23647042	16	23635721	2033176	2100108	rs2142433506	NC_000016.10:23635720:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Sep 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.824C>T (p.Thr275Ile)	PALB2	T275I	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000185844	16	23647043	16	23635722	185844	184277	rs786202499	NC_000016.10:23635721:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.823A>T (p.Thr275Ser)	PALB2	T275S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000949929	16	23647044	16	23635723	949929	927733	rs1555461608	NC_000016.10:23635722:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.823A>G (p.Thr275Ala)	PALB2	T275A	Hereditary cancer-predisposing syndrome	VCV000918502	16	23647044	16	23635723	918502	913682	rs1555461608	NC_000016.10:23635722:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.823A>C (p.Thr275Pro)	PALB2	T275P	Hereditary cancer-predisposing syndrome	VCV000480235	16	23647044	16	23635723	480235	477753	rs1555461608	NC_000016.10:23635722:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.822T>C (p.Thr274=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003413475	16	23647045	16	23635724	3413475	3574698		NC_000016.10:23635723:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.821C>A (p.Thr274Asn)	PALB2	T274N, T254N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001762502	16	23647046	16	23635725	1762502	1816901	rs867994747	NC_000016.10:23635724:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.821C>T (p.Thr274Ile)	PALB2	T274I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001430378	16	23647046	16	23635725	1430378	1470913	rs867994747	NC_000016.10:23635724:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 24, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.821C>G (p.Thr274Ser)	PALB2	T274S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530200	16	23647046	16	23635725	530200	530375	rs867994747	NC_000016.10:23635724:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.820A>C (p.Thr274Pro)	PALB2	T274P	Familial cancer of breast	VCV000580842	16	23647047	16	23635726	580842	568012	rs1567222260	NC_000016.10:23635725:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.817C>T (p.Leu273Phe)	PALB2	L273F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001038466	16	23647050	16	23635729	1038466	1032535	rs537723251	NC_000016.10:23635728:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.816A>G (p.Glu272=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000827486	16	23647051	16	23635730	827486	812812	rs1597098200	NC_000016.10:23635729:T:C	single nucleotide variant	synonymous variant	Likely benign	May 17, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.814G>T (p.Glu272Ter)	PALB2	E272*	Hereditary cancer-predisposing syndrome	VCV000482043	16	23647053	16	23635732	482043	478266	rs515726127	NC_000016.10:23635731:C:A	single nucleotide variant	nonsense	Pathogenic	Nov 3, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.814G>A (p.Glu272Lys)	PALB2	E272K	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000126772	16	23647053	16	23635732	126772	132282	rs515726127	NC_000016.10:23635731:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.813T>C (p.Ser271=)	PALB2		Familial cancer of breast	VCV003904113	16	23647054	16	23635733	3904113	4019986		NC_000016.10:23635732:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.813T>G (p.Ser271Arg)	PALB2	S271R	Familial cancer of breast	VCV000410176	16	23647054	16	23635733	410176	401086	rs786203246	NC_000016.10:23635732:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.813T>A (p.Ser271Arg)	PALB2	S271R	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|not specified	VCV000186821	16	23647054	16	23635733	186821	184278	rs786203246	NC_000016.10:23635732:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.812G>A (p.Ser271Asn)	PALB2	S271N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830121	16	23647055	16	23635734	830121	818529	rs1167051191	NC_000016.10:23635733:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 17, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.811A>G (p.Ser271Gly)	PALB2	S271G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001042012	16	23647056	16	23635735	1042012	1032536	rs1289027047	NC_000016.10:23635734:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.810C>T (p.Ser270=)	PALB2		Familial cancer of breast	VCV003903880	16	23647057	16	23635736	3903880	4019753		NC_000016.10:23635735:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.810C>A (p.Ser270Arg)	PALB2	S270R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628876	16	23647057	16	23635736	628876	618429	rs1567222286	NC_000016.10:23635735:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.809G>A (p.Ser270Asn)	PALB2	S270N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000827449	16	23647058	16	23635737	827449	812813	rs1597098223	NC_000016.10:23635736:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 25, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.808A>T (p.Ser270Cys)	PALB2	S250C, S270C	Hereditary cancer-predisposing syndrome	VCV003413509	16	23647059	16	23635738	3413509	3574732		NC_000016.10:23635737:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.808A>G (p.Ser270Gly)	PALB2	S270G	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481112	16	23647059	16	23635738	481112	477706	rs1347076714	NC_000016.10:23635737:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 24, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.807T>A (p.Gly269=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000827436	16	23647060	16	23635739	827436	812814	rs180177093	NC_000016.10:23635738:A:T	single nucleotide variant	synonymous variant	Likely benign	Sep 25, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.807T>C (p.Gly269=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000126771	16	23647060	16	23635739	126771	132281	rs180177093	NC_000016.10:23635738:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.806G>A (p.Gly269Asp)	PALB2	G269D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000944127	16	23647061	16	23635740	944127	927734	rs1431508303	NC_000016.10:23635739:C:T	single nucleotide variant	missense variant	Uncertain significance	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.806G>T (p.Gly269Val)	PALB2	G269V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000942396	16	23647061	16	23635740	942396	937378	rs1431508303	NC_000016.10:23635739:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.805G>T (p.Gly269Cys)	PALB2	G269C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000665845	16	23647062	16	23635741	665845	644477	rs1597098242	NC_000016.10:23635740:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.804A>G (p.Lys268=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000958741	16	23647063	16	23635742	958741	949322	rs1967019844	NC_000016.10:23635741:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.804A>C (p.Lys268Asn)	PALB2	K268N	Familial cancer of breast	VCV000955686	16	23647063	16	23635742	955686	949323	rs1967019844	NC_000016.10:23635741:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.803A>C (p.Lys268Thr)	PALB2	K248T, K268T	Familial cancer of breast	VCV002854199	16	23647064	16	23635743	2854199	3010565	rs1967019966	NC_000016.10:23635742:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.803A>G (p.Lys268Arg)	PALB2	K268R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000924986	16	23647064	16	23635743	924986	913683	rs1967019966	NC_000016.10:23635742:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.802A>G (p.Lys268Glu)	PALB2	K268E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000568536	16	23647065	16	23635744	568536	570018	rs1347572821	NC_000016.10:23635743:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.801T>G (p.Pro267=)	PALB2		Familial cancer of breast	VCV002771246	16	23647066	16	23635745	2771246	2933262	rs2142434157	NC_000016.10:23635744:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.800C>T (p.Pro267Leu)	PALB2	P267L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000960795	16	23647067	16	23635746	960795	949324	rs1967020152	NC_000016.10:23635745:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.799C>T (p.Pro267Ser)	PALB2	P267S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001352600	16	23647068	16	23635747	1352600	1505809	rs2142434198	NC_000016.10:23635746:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.798T>C (p.Pro266=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003885209	16	23647069	16	23635748	3885209	4005531		NC_000016.10:23635747:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.797C>G (p.Pro266Arg)	PALB2	P266R, P246R	Hereditary cancer-predisposing syndrome	VCV003304003	16	23647070	16	23635749	3304003	3470170		NC_000016.10:23635748:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.797C>T (p.Pro266Leu)	PALB2	P266L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482040	16	23647070	16	23635749	482040	477707	rs1555461619	NC_000016.10:23635748:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.796C>A (p.Pro266Thr)	PALB2	P266T, P246T	Familial cancer of breast	VCV002780987	16	23647071	16	23635750	2780987	2940840	rs1967020348	NC_000016.10:23635749:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.796C>T (p.Pro266Ser)	PALB2	P266S	Familial cancer of breast	VCV000830120	16	23647071	16	23635750	830120	818530	rs1967020348	NC_000016.10:23635749:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.793A>T (p.Ile265Phe)	PALB2	I245F, I265F	Hereditary cancer-predisposing syndrome	VCV003927444	16	23647074	16	23635753	3927444	4047077		NC_000016.10:23635752:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.793A>G (p.Ile265Val)	PALB2	I265V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000461022	16	23647074	16	23635753	461022	466268	rs1555461620	NC_000016.10:23635752:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.792C>T (p.His264=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000530237	16	23647075	16	23635754	530237	530169	rs1310569612	NC_000016.10:23635753:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.791A>G (p.His264Arg)	PALB2	H264R, H244R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001761207	16	23647076	16	23635755	1761207	1813515	rs2142434378	NC_000016.10:23635754:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.790C>G (p.His264Asp)	PALB2	H264D, H244D	Hereditary cancer-predisposing syndrome	VCV003885176	16	23647077	16	23635756	3885176	4005499		NC_000016.10:23635755:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 11, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.790C>T (p.His264Tyr)	PALB2	H264Y, H244Y	Hereditary cancer-predisposing syndrome	VCV001761175	16	23647077	16	23635756	1761175	1813484	rs1967020660	NC_000016.10:23635755:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.790C>A (p.His264Asn)	PALB2	H264N	Familial cancer of breast	VCV000964252	16	23647077	16	23635756	964252	949325	rs1967020660	NC_000016.10:23635755:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.789A>T (p.Glu263Asp)	PALB2	E263D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410123	16	23647078	16	23635757	410123	401827	rs1060502743	NC_000016.10:23635756:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.788A>G (p.Glu263Gly)	PALB2	E263G	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|not provided	VCV000185553	16	23647079	16	23635758	185553	184279	rs745553724	NC_000016.10:23635757:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.787G>A (p.Glu263Lys)	PALB2	E243K, E263K	not provided	VCV003781299	16	23647080	16	23635759	3781299	3897258		NC_000016.10:23635758:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.787G>T (p.Glu263Ter)	PALB2	E263*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001392941	16	23647080	16	23635759	1392941	1402669	rs2142434483	NC_000016.10:23635758:C:A	single nucleotide variant	nonsense	Pathogenic	Feb 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.785T>C (p.Leu262Pro)	PALB2	L262P, L242P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003654616	16	23647082	16	23635761	3654616	3778711		NC_000016.10:23635760:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.785T>G (p.Leu262Arg)	PALB2	L262R	Familial cancer of breast	VCV000410104	16	23647082	16	23635761	410104	401834	rs1060502732	NC_000016.10:23635760:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.784C>G (p.Leu262Val)	PALB2	L262V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000933591	16	23647083	16	23635762	933591	937379	rs1967021118	NC_000016.10:23635761:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.782A>T (p.His261Leu)	PALB2	H261L, H241L	Familial cancer of breast	VCV002126187	16	23647085	16	23635764	2126187	2185355	rs2142434612	NC_000016.10:23635763:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.782A>G (p.His261Arg)	PALB2	H241R, H261R	Familial cancer of breast	VCV002001842	16	23647085	16	23635764	2001842	2055043	rs2142434612	NC_000016.10:23635763:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.781C>A (p.His261Asn)	PALB2	H261N	Familial cancer of breast	VCV000530217	16	23647086	16	23635765	530217	529844	rs1555461626	NC_000016.10:23635764:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.780G>A (p.Gln260=)	PALB2		Familial cancer of breast	VCV000830118	16	23647087	16	23635766	830118	818532	rs1967021342	NC_000016.10:23635765:C:T	single nucleotide variant	synonymous variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.779A>G (p.Gln260Arg)	PALB2	Q260R	Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000827257	16	23647088	16	23635767	827257	812815	rs1597098293	NC_000016.10:23635766:T:C	single nucleotide variant	missense variant	Uncertain significance	May 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.778C>T (p.Gln260Ter)	PALB2	Q260*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000560018	16	23647089	16	23635768	560018	550737	rs1555461627	NC_000016.10:23635767:G:A	single nucleotide variant	nonsense	Pathogenic	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.777T>A (p.Ser259Arg)	PALB2	S259R	Familial cancer of breast	VCV000999663	16	23647090	16	23635769	999663	996814	rs975045312	NC_000016.10:23635768:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.776G>A (p.Ser259Asn)	PALB2	S259N	not provided|Hereditary cancer-predisposing syndrome	VCV001321734	16	23647091	16	23635770	1321734	1312015	rs2142434773	NC_000016.10:23635769:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.775A>C (p.Ser259Arg)	PALB2	S239R, S259R	Familial cancer of breast	VCV003654132	16	23647092	16	23635771	3654132	3782283		NC_000016.10:23635770:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.775A>G (p.Ser259Gly)	PALB2	S259G	Familial cancer of breast	VCV001474119	16	23647092	16	23635771	1474119	1410651	rs2142434805	NC_000016.10:23635770:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.774T>C (p.Ser258=)	PALB2		Familial cancer of breast	VCV000762152	16	23647093	16	23635772	762152	770787	rs1597098315	NC_000016.10:23635771:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.773G>A (p.Ser258Asn)	PALB2	S258N	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000229922	16	23647094	16	23635773	229922	235307	rs371289600	NC_000016.10:23635772:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.772A>G (p.Ser258Gly)	PALB2	S238G, S258G	Familial cancer of breast	VCV002725338	16	23647095	16	23635774	2725338	2881957	rs2142434905	NC_000016.10:23635773:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.770G>A (p.Gly257Asp)	PALB2	G237D, G257D	Familial cancer of breast	VCV003728988	16	23647097	16	23635776	3728988	3861923		NC_000016.10:23635775:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.770G>T (p.Gly257Val)	PALB2	G237V, G257V	Familial cancer of breast	VCV003725496	16	23647097	16	23635776	3725496	3861004		NC_000016.10:23635775:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.769G>T (p.Gly257Cys)	PALB2	G257C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000631455	16	23647098	16	23635777	631455	618430	rs587780824	NC_000016.10:23635776:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.769G>C (p.Gly257Arg)	PALB2	G257R	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000420829	16	23647098	16	23635777	420829	409563	rs587780824	NC_000016.10:23635776:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.769G>A (p.Gly257Ser)	PALB2	G257S	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000136139	16	23647098	16	23635777	136139	139851	rs587780824	NC_000016.10:23635776:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 31, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.768C>A (p.Ser256Arg)	PALB2	S256R, S236R	Hereditary cancer-predisposing syndrome	VCV001760138	16	23647099	16	23635778	1760138	1823374	rs45487491	NC_000016.10:23635777:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.768C>T (p.Ser256=)	PALB2		Breast and/or ovarian cancer|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Familial cancer of breast	VCV000184338	16	23647099	16	23635778	184338	184280	rs45487491	NC_000016.10:23635777:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.767G>C (p.Ser256Thr)	PALB2	S236T, S256T	Breast-ovarian cancer, familial, susceptibility to, 5	VCV003780095	16	23647100	16	23635779	3780095	3896062		NC_000016.10:23635778:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 9, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.767G>A (p.Ser256Asn)	PALB2	S236N, S256N	Hereditary cancer-predisposing syndrome	VCV003228043	16	23647100	16	23635779	3228043	3387812	rs935956250	NC_000016.10:23635778:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.766A>G (p.Ser256Gly)	PALB2	S256G	PALB2-related disorder|not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001044990	16	23647101	16	23635780	1044990	1032537	rs1967022496	NC_000016.10:23635779:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.765T>C (p.Asp255=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast and/or ovarian cancer|Fanconi anemia|not provided|Familial cancer of breast|not specified	VCV000126770	16	23647102	16	23635781	126770	132280	rs45465299	NC_000016.10:23635780:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.764A>G (p.Asp255Gly)	PALB2	D255G	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000410210	16	23647103	16	23635782	410210	401841	rs776753788	NC_000016.10:23635781:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.763G>C (p.Asp255His)	PALB2	D255H	Familial cancer of breast	VCV000578286	16	23647104	16	23635783	578286	570021	rs1567222367	NC_000016.10:23635782:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.761C>T (p.Ser254Leu)	PALB2	S234L, S254L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001905856	16	23647106	16	23635785	1905856	1964793	rs864622695	NC_000016.10:23635784:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.761C>G (p.Ser254Ter)	PALB2	S254*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000632930	16	23647106	16	23635785	632930	621534	rs864622695	NC_000016.10:23635784:G:C	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	May 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.761C>A (p.Ser254Ter)	PALB2	S254*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000220919	16	23647106	16	23635785	220919	222475	rs864622695	NC_000016.10:23635784:G:T	single nucleotide variant	nonsense	Pathogenic	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.759A>G (p.Leu253=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000461021	16	23647108	16	23635787	461021	466523	rs367842489	NC_000016.10:23635786:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.758T>C (p.Leu253Pro)	PALB2	L233P, L253P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001709034	16	23647109	16	23635788	1709034	1707388	rs2142435363	NC_000016.10:23635787:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 10, 2021	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.758T>G (p.Leu253Arg)	PALB2	L253R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001366107	16	23647109	16	23635788	1366107	1399097	rs2142435363	NC_000016.10:23635787:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 24, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.757C>T (p.Leu253=)	PALB2		Familial cancer of breast	VCV003904003	16	23647110	16	23635789	3904003	4019876		NC_000016.10:23635788:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.757C>A (p.Leu253Ile)	PALB2	L253I, L233I	Familial cancer of breast	VCV003658592	16	23647110	16	23635789	3658592	3797013		NC_000016.10:23635788:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 3, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.757C>G (p.Leu253Val)	PALB2	L253V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410217	16	23647110	16	23635789	410217	401087	rs565005049	NC_000016.10:23635788:G:C	single nucleotide variant	missense variant	Uncertain significance	May 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.756T>C (p.Thr252=)	PALB2		Familial cancer of breast	VCV003717222	16	23647111	16	23635790	3717222	3855632		NC_000016.10:23635789:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.756T>G (p.Thr252=)	PALB2		Familial cancer of breast	VCV003625003	16	23647111	16	23635790	3625003	3754951		NC_000016.10:23635789:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 3, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.755C>T (p.Thr252Ile)	PALB2	T252I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000987875	16	23647112	16	23635791	987875	975831	rs1967023769	NC_000016.10:23635790:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.754A>T (p.Thr252Ser)	PALB2	T252S	Hereditary cancer-predisposing syndrome	VCV000827114	16	23647113	16	23635792	827114	812816	rs1597098387	NC_000016.10:23635791:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.753G>A (p.Gln251=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001652991	16	23647114	16	23635793	1652991	1579491	rs863224791	NC_000016.10:23635792:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.753G>C (p.Gln251His)	PALB2	Q251H	Familial cancer of breast	VCV000216760	16	23647114	16	23635793	216760	213181	rs863224791	NC_000016.10:23635792:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.752A>G (p.Gln251Arg)	PALB2	Q251R	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000421653	16	23647115	16	23635794	421653	409564	rs1064795275	NC_000016.10:23635793:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.751C>T (p.Gln251Ter)	PALB2	Q251*	Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Familial cancer of breast	VCV000126767	16	23647116	16	23635795	126767	132277	rs180177091	NC_000016.10:23635794:G:A	single nucleotide variant	nonsense	Pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.750A>T (p.Leu250Phe)	PALB2	L230F, L250F	Hereditary cancer-predisposing syndrome	VCV002453292	16	23647117	16	23635796	2453292	2430352	rs2142435624	NC_000016.10:23635795:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.750A>G (p.Leu250=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001136208	16	23647117	16	23635796	1136208	1125128	rs2142435624	NC_000016.10:23635795:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.749T>C (p.Leu250Ser)	PALB2	L250S	Breast and/or ovarian cancer|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000827085	16	23647118	16	23635797	827085	812817	rs774675771	NC_000016.10:23635796:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.748T>C (p.Leu250=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000827080	16	23647119	16	23635798	827080	812818	rs1597098419	NC_000016.10:23635797:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.747T>C (p.Pro249=)	PALB2		Familial cancer of breast	VCV001151183	16	23647120	16	23635799	1151183	1146017	rs1967024501	NC_000016.10:23635798:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 29, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.746C>T (p.Pro249Leu)	PALB2	P249L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000830115	16	23647121	16	23635800	830115	818535	rs759810283	NC_000016.10:23635799:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.743T>C (p.Val248Ala)	PALB2	V248A	Hereditary cancer-predisposing syndrome	VCV000628604	16	23647124	16	23635803	628604	618431	rs1567222424	NC_000016.10:23635802:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.742G>C (p.Val248Leu)	PALB2	V248L	Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000418891	16	23647125	16	23635804	418891	409565	rs572102702	NC_000016.10:23635803:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 10, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.741A>G (p.Thr247=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001758818	16	23647126	16	23635805	1758818	1819529	rs2142435893	NC_000016.10:23635804:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 28, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.740C>T (p.Thr247Ile)	PALB2	T247I	not specified	VCV000830113	16	23647127	16	23635806	830113	818537	rs587782658	NC_000016.10:23635805:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.740C>G (p.Thr247Arg)	PALB2	T247R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000142706	16	23647127	16	23635806	142706	152420	rs587782658	NC_000016.10:23635805:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.739A>G (p.Thr247Ala)	PALB2	T247A	Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|Familial cancer of breast	VCV000186559	16	23647128	16	23635807	186559	184281	rs786203040	NC_000016.10:23635806:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.738T>A (p.Thr246=)	PALB2		Familial cancer of breast	VCV003641994	16	23647129	16	23635808	3641994	3772716		NC_000016.10:23635807:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 19, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.737C>T (p.Thr246Ile)	PALB2	T246I	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000827001	16	23647130	16	23635809	827001	812819	rs1597098443	NC_000016.10:23635808:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.736A>T (p.Thr246Ser)	PALB2	T246S	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481033	16	23647131	16	23635810	481033	477711	rs1555461659	NC_000016.10:23635809:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.735G>C (p.Ala245=)	PALB2		Familial cancer of breast	VCV003904448	16	23647132	16	23635811	3904448	4020320		NC_000016.10:23635810:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.735G>T (p.Ala245=)	PALB2		Familial cancer of breast	VCV001547974	16	23647132	16	23635811	1547974	1537792	rs371612049	NC_000016.10:23635810:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.735G>A (p.Ala245=)	PALB2		Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not provided|Familial cancer of breast	VCV000215938	16	23647132	16	23635811	215938	213182	rs371612049	NC_000016.10:23635810:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.734C>G (p.Ala245Gly)	PALB2	A225G, A245G	Familial cancer of breast	VCV002830394	16	23647133	16	23635812	2830394	2997872	rs571063157	NC_000016.10:23635811:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.734C>T (p.Ala245Val)	PALB2	A245V	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|not provided|not specified|Familial cancer of breast	VCV000142078	16	23647133	16	23635812	142078	151792	rs571063157	NC_000016.10:23635811:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.733G>T (p.Ala245Ser)	PALB2	A245S, A225S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003708264	16	23647134	16	23635813	3708264	3836541		NC_000016.10:23635812:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.733G>C (p.Ala245Pro)	PALB2	A245P	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N	VCV000318560	16	23647134	16	23635813	318560	334406	rs886051831	NC_000016.10:23635812:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.732G>C (p.Arg244Ser)	PALB2	R224S, R244S	Familial cancer of breast	VCV002104591	16	23647135	16	23635814	2104591	2162354	rs2142436158	NC_000016.10:23635813:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.732G>A (p.Arg244=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001636818	16	23647135	16	23635814	1636818	1612107	rs2142436158	NC_000016.10:23635813:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 28, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.731G>A (p.Arg244Lys)	PALB2	R244K, R224K	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV002828293	16	23647136	16	23635815	2828293	2990231	rs764553978	NC_000016.10:23635814:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.731G>C (p.Arg244Thr)	PALB2	R244T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000958845	16	23647136	16	23635815	958845	949326	rs764553978	NC_000016.10:23635814:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.730A>G (p.Arg244Gly)	PALB2	R244G, R224G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002796077	16	23647137	16	23635816	2796077	2958496	rs2142436206	NC_000016.10:23635815:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.730A>C (p.Arg244=)	PALB2		Familial cancer of breast	VCV001132663	16	23647137	16	23635816	1132663	1125129	rs2142436206	NC_000016.10:23635815:T:G	single nucleotide variant	synonymous variant	Likely benign	Oct 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.729C>T (p.Thr243=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001758154	16	23647138	16	23635817	1758154	1813035	rs2142436221	NC_000016.10:23635816:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.728C>G (p.Thr243Ser)	PALB2	T223S, T243S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002431386	16	23647139	16	23635818	2431386	2404890	rs1967025917	NC_000016.10:23635817:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.728C>T (p.Thr243Ile)	PALB2	T243I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000848078	16	23647139	16	23635818	848078	843625	rs1967025917	NC_000016.10:23635817:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.727A>G (p.Thr243Ala)	PALB2	T223A, T243A	Familial cancer of breast	VCV003602687	16	23647140	16	23635819	3602687	3735381		NC_000016.10:23635818:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 5, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.727A>C (p.Thr243Pro)	PALB2	T243P	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410127	16	23647140	16	23635819	410127	401554	rs1060502747	NC_000016.10:23635818:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 3, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.724T>C (p.Phe242Leu)	PALB2	F242L, F222L	Hereditary cancer-predisposing syndrome	VCV001757919	16	23647143	16	23635822	1757919	1812800	rs1555461663	NC_000016.10:23635821:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.724T>G (p.Phe242Val)	PALB2	F242V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000461020	16	23647143	16	23635822	461020	465562	rs1555461663	NC_000016.10:23635821:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.722A>G (p.Asn241Ser)	PALB2	N241S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000136138	16	23647145	16	23635824	136138	139850	rs587780823	NC_000016.10:23635823:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.721A>T (p.Asn241Tyr)	PALB2	N241Y	Hereditary cancer-predisposing syndrome	VCV000923000	16	23647146	16	23635825	923000	913684	rs113217267	NC_000016.10:23635824:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.721A>C (p.Asn241His)	PALB2	N241H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410215	16	23647146	16	23635825	410215	401848	rs113217267	NC_000016.10:23635824:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.721A>G (p.Asn241Asp)	PALB2	N241D	Familial cancer of breast	VCV000126765	16	23647146	16	23635825	126765	132275	rs113217267	NC_000016.10:23635824:T:C	single nucleotide variant	missense variant	Benign	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.720T>G (p.Pro240=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002716310	16	23647147	16	23635826	2716310	2879856	rs2506501835	NC_000016.10:23635825:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Nov 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.720T>C (p.Pro240=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001757727	16	23647147	16	23635826	1757727	1815925	rs2506501835	NC_000016.10:23635825:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jan 17, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.719C>A (p.Pro240His)	PALB2	P220H, P240H	Familial cancer of breast	VCV002086415	16	23647148	16	23635827	2086415	2144330	rs1466115155	NC_000016.10:23635826:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.719C>G (p.Pro240Arg)	PALB2	P240R	Familial cancer of breast	VCV001401410	16	23647148	16	23635827	1401410	1379397	rs1466115155	NC_000016.10:23635826:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.719C>T (p.Pro240Leu)	PALB2	P240L	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV001189343	16	23647148	16	23635827	1189343	1181358	rs1466115155	NC_000016.10:23635826:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.718C>A (p.Pro240Thr)	PALB2	P240T	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N	VCV000461019	16	23647149	16	23635828	461019	466269	rs757567654	NC_000016.10:23635827:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.717A>T (p.Arg239Ser)	PALB2	R219S, R239S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001757507	16	23647150	16	23635829	1757507	1815705	rs1967026649	NC_000016.10:23635828:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.717A>G (p.Arg239=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001757504	16	23647150	16	23635829	1757504	1815702	rs1967026649	NC_000016.10:23635828:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jan 25, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.716G>A (p.Arg239Lys)	PALB2	R219K, R239K	Hereditary cancer-predisposing syndrome	VCV003927431	16	23647151	16	23635830	3927431	4047064		NC_000016.10:23635829:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 5, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.715A>T (p.Arg239Ter)	PALB2	R239*, R219*	Familial cancer of breast	VCV002031162	16	23647152	16	23635831	2031162	2078804	rs1967026821	NC_000016.10:23635830:T:A	single nucleotide variant	nonsense	Pathogenic	Sep 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.715A>G (p.Arg239Gly)	PALB2	R239G	Familial cancer of breast	VCV001046821	16	23647152	16	23635831	1046821	1032538	rs1967026821	NC_000016.10:23635830:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.713G>C (p.Arg238Thr)	PALB2	R238T	Hereditary cancer-predisposing syndrome	VCV000826863	16	23647154	16	23635833	826863	812820	rs1567222480	NC_000016.10:23635832:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.713G>A (p.Arg238Lys)	PALB2	R238K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000631027	16	23647154	16	23635833	631027	618432	rs1567222480	NC_000016.10:23635832:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.712A>T (p.Arg238Ter)	PALB2	R238*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000826857	16	23647155	16	23635834	826857	812821	rs779278389	NC_000016.10:23635833:T:A	single nucleotide variant	nonsense	Pathogenic	Sep 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.712A>G (p.Arg238Gly)	PALB2	R238G	Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000233268	16	23647155	16	23635834	233268	235309	rs779278389	NC_000016.10:23635833:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.711A>C (p.Leu237=)	PALB2		Familial cancer of breast	VCV002034979	16	23647156	16	23635835	2034979	2100637	rs1967027262	NC_000016.10:23635834:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 10, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.710T>A (p.Leu237Gln)	PALB2	L217Q, L237Q	Familial cancer of breast	VCV001721199	16	23647157	16	23635836	1721199	1775181	rs2142436672	NC_000016.10:23635835:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.709C>T (p.Leu237=)	PALB2		Familial cancer of breast	VCV003903830	16	23647158	16	23635837	3903830	4019703		NC_000016.10:23635836:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.709C>G (p.Leu237Val)	PALB2	L237V	not specified|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000927562	16	23647158	16	23635837	927562	913685	rs1064794118	NC_000016.10:23635836:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.709C>A (p.Leu237Ile)	PALB2	L237I	not provided	VCV000419806	16	23647158	16	23635837	419806	409566	rs1064794118	NC_000016.10:23635836:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.706T>G (p.Phe236Val)	PALB2	F236V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000826817	16	23647161	16	23635840	826817	812822	rs1196649458	NC_000016.10:23635839:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.706T>A (p.Phe236Ile)	PALB2	F236I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000461018	16	23647161	16	23635840	461018	466524	rs1196649458	NC_000016.10:23635839:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.705A>C (p.Thr235=)	PALB2		Familial cancer of breast	VCV003725436	16	23647162	16	23635841	3725436	3860944		NC_000016.10:23635840:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Nov 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.705A>G (p.Thr235=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001756917	16	23647162	16	23635841	1756917	1818922	rs2142436806	NC_000016.10:23635840:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.704C>G (p.Thr235Arg)	PALB2	T215R, T235R	Familial cancer of breast	VCV002752862	16	23647163	16	23635842	2752862	2913603	rs1385914265	NC_000016.10:23635841:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.704C>A (p.Thr235Lys)	PALB2	T235K	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000566781	16	23647163	16	23635842	566781	570024	rs1385914265	NC_000016.10:23635841:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.704C>T (p.Thr235Ile)	PALB2	T235I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000461017	16	23647163	16	23635842	461017	466270	rs1385914265	NC_000016.10:23635841:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.703A>G (p.Thr235Ala)	PALB2	T235A, T215A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001756821	16	23647164	16	23635843	1756821	1822632	rs2142436855	NC_000016.10:23635842:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 4, 2022	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.701A>T (p.Asp234Val)	PALB2	D234V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000858261	16	23647166	16	23635845	858261	843627	rs1967027890	NC_000016.10:23635844:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.700G>A (p.Asp234Asn)	PALB2	D234N	not specified|Hereditary cancer-predisposing syndrome	VCV001696390	16	23647167	16	23635846	1696390	1688795	rs868149939	NC_000016.10:23635845:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.700G>C (p.Asp234His)	PALB2	D234H	Familial cancer of breast	VCV000851992	16	23647167	16	23635846	851992	843628	rs868149939	NC_000016.10:23635845:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.699T>C (p.Val233=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001756539	16	23647168	16	23635847	1756539	1822352	rs2142436995	NC_000016.10:23635846:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 25, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.696T>C (p.Gly232=)	PALB2		Familial cancer of breast	VCV000762647	16	23647171	16	23635850	762647	770788	rs1597098550	NC_000016.10:23635849:A:G	single nucleotide variant	synonymous variant	Likely benign	May 30, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.695G>C (p.Gly232Ala)	PALB2	G232A, G212A	Familial cancer of breast	VCV002002560	16	23647172	16	23635851	2002560	2061784	rs1365024903	NC_000016.10:23635850:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.695G>T (p.Gly232Val)	PALB2	G232V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000826727	16	23647172	16	23635851	826727	812823	rs1365024903	NC_000016.10:23635850:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.694G>T (p.Gly232Cys)	PALB2	G232C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000946750	16	23647173	16	23635852	946750	927735	rs1967028555	NC_000016.10:23635851:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.693A>T (p.Lys231Asn)	PALB2	K231N	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000230928	16	23647174	16	23635853	230928	235311	rs876658847	NC_000016.10:23635852:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.692A>T (p.Lys231Ile)	PALB2	K231I	Hereditary cancer-predisposing syndrome	VCV000826710	16	23647175	16	23635854	826710	812824	rs745443201	NC_000016.10:23635853:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.691A>T (p.Lys231Ter)	PALB2	K231*	Familial cancer of breast	VCV001075100	16	23647176	16	23635855	1075100	1063606	rs2142437289	NC_000016.10:23635854:T:A	single nucleotide variant	nonsense	Pathogenic	Dec 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.689A>G (p.Glu230Gly)	PALB2	E230G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001022251	16	23647178	16	23635857	1022251	1012046	rs1567222506	NC_000016.10:23635856:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.689A>C (p.Glu230Ala)	PALB2	E230A	Familial cancer of breast	VCV000863216	16	23647178	16	23635857	863216	843629	rs1567222506	NC_000016.10:23635856:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.689A>T (p.Glu230Val)	PALB2	E230V	Hereditary cancer-predisposing syndrome	VCV000826686	16	23647178	16	23635857	826686	812825	rs1567222506	NC_000016.10:23635856:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.688G>T (p.Glu230Ter)	PALB2	E230*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000182786	16	23647179	16	23635858	182786	180745	rs730881905	NC_000016.10:23635857:C:A	single nucleotide variant	nonsense	Pathogenic	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.687A>G (p.Pro229=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002018019	16	23647180	16	23635859	2018019	2075936	rs2506502991	NC_000016.10:23635858:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.686C>G (p.Pro229Arg)	PALB2	P209R, P229R	Familial cancer of breast	VCV002068342	16	23647181	16	23635860	2068342	2125866	rs368477874	NC_000016.10:23635859:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.686C>T (p.Pro229Leu)	PALB2	P209L, P229L	Hereditary cancer-predisposing syndrome	VCV001755881	16	23647181	16	23635860	1755881	1815376	rs368477874	NC_000016.10:23635859:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.685C>T (p.Pro229Ser)	PALB2	P229S, P209S	Familial cancer of breast	VCV003728673	16	23647182	16	23635861	3728673	3852004		NC_000016.10:23635860:G:A	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Uncertain significance	Jan 8, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.684A>G (p.Gln228=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000923179	16	23647183	16	23635862	923179	913687	rs1967029347	NC_000016.10:23635861:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.682C>T (p.Gln228Ter)	PALB2	Q228*	Familial cancer of breast	VCV000484222	16	23647185	16	23635864	484222	477758	rs1327399690	NC_000016.10:23635863:G:A	single nucleotide variant	nonsense	Pathogenic	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.681C>T (p.Ala227=)	PALB2		Familial cancer of breast	VCV002127460	16	23647186	16	23635865	2127460	2174998	rs2142437477	NC_000016.10:23635864:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 17, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.681C>G (p.Ala227=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001691955	16	23647186	16	23635865	1691955	1684397	rs2142437477	NC_000016.10:23635864:G:C	single nucleotide variant	intron variant|synonymous variant|5 prime UTR variant	Likely benign	Nov 19, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.679G>T (p.Ala227Ser)	PALB2	A207S, A227S	Familial cancer of breast	VCV002054360	16	23647188	16	23635867	2054360	2112242	rs1555461678	NC_000016.10:23635866:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.679G>A (p.Ala227Thr)	PALB2	A227T	Familial cancer of breast|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000461015	16	23647188	16	23635867	461015	466275	rs1555461678	NC_000016.10:23635866:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.678T>A (p.Thr226=)	PALB2		Familial cancer of breast	VCV000840852	16	23647189	16	23635868	840852	843630	rs1967029721	NC_000016.10:23635867:A:T	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.677C>T (p.Thr226Ile)	PALB2	T206I, T226I	Hereditary cancer-predisposing syndrome	VCV002567565	16	23647190	16	23635869	2567565	2731207	rs1967029792	NC_000016.10:23635868:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 3, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.676A>G (p.Thr226Ala)	PALB2	T226A	not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000490087	16	23647191	16	23635870	490087	482901	rs1555461680	NC_000016.10:23635869:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.675A>G (p.Pro225=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000461014	16	23647192	16	23635871	461014	466272	rs1555461681	NC_000016.10:23635870:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.674C>G (p.Pro225Arg)	PALB2	P205R, P225R	Familial cancer of breast	VCV003726955	16	23647193	16	23635872	3726955	3851576		NC_000016.10:23635871:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.673C>T (p.Pro225Ser)	PALB2	P225S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410129	16	23647194	16	23635873	410129	401089	rs1060502749	NC_000016.10:23635872:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.672A>G (p.Pro224=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002774021	16	23647195	16	23635874	2774021	2934752	rs2142437718	NC_000016.10:23635873:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.671C>T (p.Pro224Leu)	PALB2	P204L, P224L	Familial cancer of breast	VCV002109807	16	23647196	16	23635875	2109807	2163682	rs1597098606	NC_000016.10:23635874:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.671C>G (p.Pro224Arg)	PALB2	P224R	Hereditary cancer-predisposing syndrome	VCV000826575	16	23647196	16	23635875	826575	812826	rs1597098606	NC_000016.10:23635874:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.668T>C (p.Ile223Thr)	PALB2	I223T	not provided|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000245749	16	23647199	16	23635878	245749	244973	rs150517167	NC_000016.10:23635877:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.665T>A (p.Leu222Ter)	PALB2	L222*	Familial cancer of breast	VCV001437019	16	23647202	16	23635881	1437019	1435590	rs2142437926	NC_000016.10:23635880:A:T	single nucleotide variant	nonsense	Pathogenic	Feb 8, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.665T>C (p.Leu222Ser)	PALB2	L222S	Familial cancer of breast	VCV001058856	16	23647202	16	23635881	1058856	1049529	rs2142437926	NC_000016.10:23635880:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.663A>T (p.Val221=)	PALB2		Familial cancer of breast	VCV002700708	16	23647204	16	23635883	2700708	2855707	rs876659721	NC_000016.10:23635882:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 3, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.663A>G (p.Val221=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000232361	16	23647204	16	23635883	232361	235312	rs876659721	NC_000016.10:23635882:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.662T>C (p.Val221Ala)	PALB2	V221A	Familial cancer of breast	VCV001046832	16	23647205	16	23635884	1046832	1032539	rs1967030851	NC_000016.10:23635883:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.661G>A (p.Val221Ile)	PALB2	V221I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000410168	16	23647206	16	23635885	410168	401853	rs1060502773	NC_000016.10:23635884:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.660T>G (p.Ser220Arg)	PALB2	S200R, S220R	not provided	VCV003234652	16	23647207	16	23635886	3234652	3393774	rs571762192	NC_000016.10:23635885:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 1, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.660T>C (p.Ser220=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000221034	16	23647207	16	23635886	221034	222476	rs571762192	NC_000016.10:23635885:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.659G>C (p.Ser220Thr)	PALB2	S220T	Familial cancer of breast	VCV001379241	16	23647208	16	23635887	1379241	1486470	rs2142438106	NC_000016.10:23635886:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.659G>A (p.Ser220Asn)	PALB2	S220N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001377104	16	23647208	16	23635887	1377104	1394719	rs2142438106	NC_000016.10:23635886:C:T	single nucleotide variant	missense variant	Uncertain significance	May 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.658A>C (p.Ser220Arg)	PALB2	S200R, S220R	Hereditary cancer-predisposing syndrome	VCV001754338	16	23647209	16	23635888	1754338	1811796	rs2142438155	NC_000016.10:23635887:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.658A>G (p.Ser220Gly)	PALB2	S220G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001397505	16	23647209	16	23635888	1397505	1438071	rs2142438155	NC_000016.10:23635887:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.657C>T (p.Asp219=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002075411	16	23647210	16	23635889	2075411	2130760	rs1467537798	NC_000016.10:23635888:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.656A>G (p.Asp219Gly)	PALB2	D219G	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer	VCV000126763	16	23647211	16	23635890	126763	132273	rs45594034	NC_000016.10:23635889:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.653A>G (p.Glu218Gly)	PALB2	E198G, E218G	Hereditary cancer-predisposing syndrome	VCV001754095	16	23647214	16	23635893	1754095	1804650	rs2142438331	NC_000016.10:23635892:T:C	single nucleotide variant	missense variant	Likely benign	Dec 18, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.653A>T (p.Glu218Val)	PALB2	E218V	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV001171463	16	23647214	16	23635893	1171463	1161322	rs2142438331	NC_000016.10:23635892:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.652G>A (p.Glu218Lys)	PALB2	E218K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001365657	16	23647215	16	23635894	1365657	1402524	rs2142438340	NC_000016.10:23635893:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.652G>T (p.Glu218Ter)	PALB2	E218*	Familial cancer of breast	VCV001360701	16	23647215	16	23635894	1360701	1360267	rs2142438340	NC_000016.10:23635893:C:A	single nucleotide variant	nonsense	Pathogenic	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.651T>C (p.Asn217=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486025	16	23647216	16	23635895	486025	477646	rs1555461692	NC_000016.10:23635894:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.650A>G (p.Asn217Ser)	PALB2	N217S, N197S	Hereditary cancer-predisposing syndrome	VCV003413402	16	23647217	16	23635896	3413402	3574625		NC_000016.10:23635895:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.648T>A (p.Ile216=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001691954	16	23647219	16	23635898	1691954	1684396	rs1597098670	NC_000016.10:23635897:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.648T>G (p.Ile216Met)	PALB2	I216M	Familial cancer of breast	VCV000649494	16	23647219	16	23635898	649494	644478	rs1597098670	NC_000016.10:23635897:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.647T>C (p.Ile216Thr)	PALB2	I216T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000838226	16	23647220	16	23635899	838226	843632	rs1967031858	NC_000016.10:23635898:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 16, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.643G>A (p.Glu215Lys)	PALB2	E215K	Familial cancer of breast	VCV000934547	16	23647224	16	23635903	934547	937380	rs1555461693	NC_000016.10:23635902:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.643G>T (p.Glu215Ter)	PALB2	E215*	Familial cancer of breast|Breast neoplasm	VCV000430594	16	23647224	16	23635903	430594	423242	rs1555461693	NC_000016.10:23635902:C:A	single nucleotide variant	nonsense	Pathogenic	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.642A>G (p.Thr214=)	PALB2		Familial cancer of breast	VCV000794923	16	23647225	16	23635904	794923	785232	rs1597098691	NC_000016.10:23635903:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.641C>A (p.Thr214Lys)	PALB2	T214K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830109	16	23647226	16	23635905	830109	818541	rs1967032138	NC_000016.10:23635904:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.640A>C (p.Thr214Pro)	PALB2	T214P	Hereditary cancer-predisposing syndrome	VCV000484181	16	23647227	16	23635906	484181	477713	rs1555461694	NC_000016.10:23635905:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.639T>A (p.Val213=)	PALB2		Familial cancer of breast	VCV003659500	16	23647228	16	23635907	3659500	3790440		NC_000016.10:23635906:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.638T>A (p.Val213Asp)	PALB2	V213D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000947316	16	23647229	16	23635908	947316	927736	rs1967032445	NC_000016.10:23635907:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.637G>C (p.Val213Leu)	PALB2	V213L	Familial cancer of breast|not specified|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000187626	16	23647230	16	23635909	187626	184282	rs786203875	NC_000016.10:23635908:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.636A>G (p.Pro212=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480230	16	23647231	16	23635910	480230	477648	rs1555461696	NC_000016.10:23635909:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.635C>G (p.Pro212Arg)	PALB2	P212R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410121	16	23647232	16	23635911	410121	401090	rs1060502742	NC_000016.10:23635910:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.634C>T (p.Pro212Ser)	PALB2	P212S, P192S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002447306	16	23647233	16	23635912	2447306	2422428	rs1967032913	NC_000016.10:23635911:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.634C>G (p.Pro212Ala)	PALB2	P212A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001039454	16	23647233	16	23635912	1039454	1032540	rs1967032913	NC_000016.10:23635911:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.632A>G (p.Glu211Gly)	PALB2	E211G	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000126762	16	23647235	16	23635914	126762	132272	rs180177089	NC_000016.10:23635913:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.631G>C (p.Glu211Gln)	PALB2	E191Q, E211Q	Familial cancer of breast|not specified	VCV001722457	16	23647236	16	23635915	1722457	1779967	rs2142438741	NC_000016.10:23635914:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.630A>C (p.Pro210=)	PALB2		Familial cancer of breast	VCV003903857	16	23647237	16	23635916	3903857	4019730		NC_000016.10:23635915:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.630A>G (p.Pro210=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480253	16	23647237	16	23635916	480253	477649	rs1234068504	NC_000016.10:23635915:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.629C>T (p.Pro210Leu)	PALB2	P210L	Fanconi anemia complementation group N|Familial cancer of breast|Breast and/or ovarian cancer|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000126761	16	23647238	16	23635917	126761	132271	rs57605939	NC_000016.10:23635916:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.628C>A (p.Pro210Thr)	PALB2	P210T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001362077	16	23647239	16	23635918	1362077	1376703	rs878976819	NC_000016.10:23635917:G:T	single nucleotide variant	missense variant	Uncertain significance	May 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.628C>G (p.Pro210Ala)	PALB2	P210A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000826297	16	23647239	16	23635918	826297	812829	rs878976819	NC_000016.10:23635917:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.626C>T (p.Ser209Phe)	PALB2	S209F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000578550	16	23647241	16	23635920	578550	573976	rs1567222610	NC_000016.10:23635919:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.623A>G (p.Asp208Gly)	PALB2	D208G, D188G	Familial cancer of breast	VCV002850424	16	23647244	16	23635923	2850424	3016032	rs1555461702	NC_000016.10:23635922:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.623A>C (p.Asp208Ala)	PALB2	D208A	Familial cancer of breast	VCV000530182	16	23647244	16	23635923	530182	530180	rs1555461702	NC_000016.10:23635922:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.623A>T (p.Asp208Val)	PALB2	D208V	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480262	16	23647244	16	23635923	480262	478270	rs1555461702	NC_000016.10:23635922:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.622G>C (p.Asp208His)	PALB2	D208H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000826260	16	23647245	16	23635924	826260	812830	rs1597098746	NC_000016.10:23635923:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.621A>T (p.Pro207=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000925048	16	23647246	16	23635925	925048	913688	rs1555461703	NC_000016.10:23635924:T:A	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.621A>G (p.Pro207=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000482055	16	23647246	16	23635925	482055	478280	rs1555461703	NC_000016.10:23635924:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 23, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.620C>T (p.Pro207Leu)	PALB2	P207L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630036	16	23647247	16	23635926	630036	618435	rs515726125	NC_000016.10:23635925:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.620C>G (p.Pro207Arg)	PALB2	P207R	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000126760	16	23647247	16	23635926	126760	132270	rs515726125	NC_000016.10:23635925:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 18, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.619C>A (p.Pro207Thr)	PALB2	P207T	Familial cancer of breast	VCV000410111	16	23647248	16	23635927	410111	401558	rs374090568	NC_000016.10:23635926:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.619C>T (p.Pro207Ser)	PALB2	P207S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000233315	16	23647248	16	23635927	233315	235314	rs374090568	NC_000016.10:23635926:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.618T>A (p.Leu206=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000757168	16	23647249	16	23635928	757168	770789	rs180177088	NC_000016.10:23635927:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.617T>C (p.Leu206Pro)	PALB2	L206P, L186P	Familial cancer of breast	VCV003673116	16	23647250	16	23635929	3673116	3803954		NC_000016.10:23635928:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.617T>G (p.Leu206Arg)	PALB2	L186R, L206R	Familial cancer of breast	VCV002747522	16	23647250	16	23635929	2747522	2904415	rs2142439081	NC_000016.10:23635928:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.616C>T (p.Leu206Phe)	PALB2	L206F	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000246502	16	23647251	16	23635930	246502	244974	rs776664411	NC_000016.10:23635929:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.615A>C (p.Glu205Asp)	PALB2	E205D	Familial cancer of breast	VCV001489935	16	23647252	16	23635931	1489935	1514928	rs748128739	NC_000016.10:23635930:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.615A>G (p.Glu205=)	PALB2		Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000461012	16	23647252	16	23635931	461012	466279	rs748128739	NC_000016.10:23635930:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.613G>T (p.Glu205Ter)	PALB2	E205*	not provided	VCV000619711	16	23647254	16	23635933	619711	611225	rs1567222636	NC_000016.10:23635932:C:A	single nucleotide variant	nonsense	Likely pathogenic	Mar 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.612T>G (p.Ser204=)	PALB2		Familial cancer of breast	VCV003648978	16	23647255	16	23635934	3648978	3780987		NC_000016.10:23635933:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.611C>A (p.Ser204Tyr)	PALB2	S184Y, S204Y	Hereditary cancer-predisposing syndrome	VCV001751715	16	23647256	16	23635935	1751715	1807396	rs1567222638	NC_000016.10:23635934:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.611C>G (p.Ser204Cys)	PALB2	S204C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000571496	16	23647256	16	23635935	571496	570210	rs1567222638	NC_000016.10:23635934:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.610T>G (p.Ser204Ala)	PALB2	S204A	Hereditary cancer-predisposing syndrome	VCV000187023	16	23647257	16	23635936	187023	184283	rs786203412	NC_000016.10:23635935:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.608A>C (p.Lys203Thr)	PALB2	K183T, K203T	Familial cancer of breast	VCV001995051	16	23647259	16	23635938	1995051	2049551	rs2142439295	NC_000016.10:23635937:T:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.607A>G (p.Lys203Glu)	PALB2	K203E, K183E	Familial cancer of breast	VCV002844352	16	23647260	16	23635939	2844352	3007993	rs2506505934	NC_000016.10:23635938:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.605T>C (p.Leu202Pro)	PALB2	L202P	not provided	VCV001321054	16	23647262	16	23635941	1321054	1311298	rs2142439333	NC_000016.10:23635940:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 25, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.604C>G (p.Leu202Val)	PALB2	L202V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000955761	16	23647263	16	23635942	955761	949327	rs1597098794	NC_000016.10:23635941:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.604C>T (p.Leu202Phe)	PALB2	L202F	Familial cancer of breast	VCV000660614	16	23647263	16	23635942	660614	644479	rs1597098794	NC_000016.10:23635941:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.603T>G (p.Ser201Arg)	PALB2	S181R, S201R	Hereditary cancer-predisposing syndrome	VCV003885195	16	23647264	16	23635943	3885195	4005517		NC_000016.10:23635942:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.603T>C (p.Ser201=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001751238	16	23647264	16	23635943	1751238	1800967	rs769647912	NC_000016.10:23635942:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Mar 28, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.603T>A (p.Ser201Arg)	PALB2	S201R	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000482025	16	23647264	16	23635943	482025	477724	rs769647912	NC_000016.10:23635942:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.602G>A (p.Ser201Asn)	PALB2	S201N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410193	16	23647265	16	23635944	410193	401571	rs1060502790	NC_000016.10:23635943:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.601A>C (p.Ser201Arg)	PALB2	S201R, S181R	Familial cancer of breast	VCV001994311	16	23647266	16	23635945	1994311	2056111	rs2142439443	NC_000016.10:23635944:T:G	single nucleotide variant	missense variant	Uncertain significance	May 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.600A>G (p.Leu200=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484230	16	23647267	16	23635946	484230	477774	rs1555461714	NC_000016.10:23635945:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.599T>C (p.Leu200Ser)	PALB2	L200S	Familial cancer of breast	VCV000946433	16	23647268	16	23635947	946433	927737	rs1967035557	NC_000016.10:23635946:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.597T>C (p.Leu199=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003303989	16	23647270	16	23635949	3303989	3470156		NC_000016.10:23635948:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.596T>A (p.Leu199His)	PALB2	L199H, L179H	Familial cancer of breast	VCV002000882	16	23647271	16	23635950	2000882	2061386	rs2142439574	NC_000016.10:23635949:A:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.596T>G (p.Leu199Arg)	PALB2	L179R, L199R	Hereditary cancer-predisposing syndrome	VCV001750785	16	23647271	16	23635950	1750785	1803935	rs2142439574	NC_000016.10:23635949:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.595C>A (p.Leu199Ile)	PALB2	L179I, L199I	Familial cancer of breast	VCV002717370	16	23647272	16	23635951	2717370	2873194	rs876660851	NC_000016.10:23635950:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.595C>T (p.Leu199Phe)	PALB2	L199F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000234104	16	23647272	16	23635951	234104	235315	rs876660851	NC_000016.10:23635950:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 14, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.594C>T (p.His198=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492227	16	23647273	16	23635952	492227	484817	rs1555461716	NC_000016.10:23635951:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.593A>C (p.His198Pro)	PALB2	H178P, H198P	Hereditary cancer-predisposing syndrome	VCV002587414	16	23647274	16	23635953	2587414	2754090	rs2142439669	NC_000016.10:23635952:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.592C>T (p.His198Tyr)	PALB2	H198Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001035297	16	23647275	16	23635954	1035297	1032541	rs1967036024	NC_000016.10:23635953:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.591T>A (p.Thr197=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001750504	16	23647276	16	23635955	1750504	1803654	rs773073532	NC_000016.10:23635954:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.591T>C (p.Thr197=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000798101	16	23647276	16	23635955	798101	785233	rs773073532	NC_000016.10:23635954:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.590C>G (p.Thr197Ser)	PALB2	T177S, T197S	Hereditary cancer-predisposing syndrome	VCV003228041	16	23647277	16	23635956	3228041	3387810	rs367945485	NC_000016.10:23635955:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Dec 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.590C>T (p.Thr197Ile)	PALB2	T197I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000582007	16	23647277	16	23635956	582007	570212	rs367945485	NC_000016.10:23635955:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.587G>T (p.Arg196Ile)	PALB2	R196I, R176I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002087944	16	23647280	16	23635959	2087944	2154903	rs730881904	NC_000016.10:23635958:C:A	single nucleotide variant	missense variant	Uncertain significance	May 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.587G>A (p.Arg196Lys)	PALB2	R196K	Familial cancer of breast|PALB2-related disorder|Hereditary cancer-predisposing syndrome|not provided	VCV000182785	16	23647280	16	23635959	182785	180746	rs730881904	NC_000016.10:23635958:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.586A>C (p.Arg196=)	PALB2		Familial cancer of breast	VCV002805548	16	23647281	16	23635960	2805548	2964074	rs2142439819	NC_000016.10:23635959:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Mar 3, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.585A>T (p.Ile195=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000461011	16	23647282	16	23635961	461011	466283	rs767775306	NC_000016.10:23635960:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.584T>C (p.Ile195Thr)	PALB2	I195T	Familial cancer of breast	VCV000861576	16	23647283	16	23635962	861576	843633	rs587782260	NC_000016.10:23635961:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.584T>G (p.Ile195Arg)	PALB2	I195R	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000142133	16	23647283	16	23635962	142133	151847	rs587782260	NC_000016.10:23635961:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.583A>G (p.Ile195Val)	PALB2	I195V	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast	VCV000231652	16	23647284	16	23635963	231652	235316	rs760784181	NC_000016.10:23635962:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 28, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.580G>A (p.Glu194Lys)	PALB2	E194K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000945709	16	23647287	16	23635966	945709	927738	rs1967036814	NC_000016.10:23635965:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.579T>G (p.Thr193=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003885185	16	23647288	16	23635967	3885185	4005507		NC_000016.10:23635966:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.578C>A (p.Thr193Asn)	PALB2	T193N, T173N	Familial cancer of breast	VCV003721987	16	23647289	16	23635968	3721987	3860091		NC_000016.10:23635967:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 1, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.578C>T (p.Thr193Ile)	PALB2	T193I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000232531	16	23647289	16	23635968	232531	235317	rs876659823	NC_000016.10:23635967:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.577A>G (p.Thr193Ala)	PALB2	T193A	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000968926	16	23647290	16	23635969	968926	957707	rs1967037000	NC_000016.10:23635968:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.576A>G (p.Val192=)	PALB2		Familial cancer of breast	VCV001630413	16	23647291	16	23635970	1630413	1649618	rs2142440064	NC_000016.10:23635969:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.574G>A (p.Val192Ile)	PALB2	V172I, V192I	Hereditary cancer-predisposing syndrome	VCV001749430	16	23647293	16	23635972	1749430	1800458	rs2142440108	NC_000016.10:23635971:C:T	single nucleotide variant	missense variant	Uncertain significance	May 10, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.573A>G (p.Pro191=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003927464	16	23647294	16	23635973	3927464	4047097		NC_000016.10:23635972:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.572C>G (p.Pro191Arg)	PALB2	P171R, P191R	Familial cancer of breast	VCV002745605	16	23647295	16	23635974	2745605	2907663	rs1001733949	NC_000016.10:23635973:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 21, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.572C>T (p.Pro191Leu)	PALB2	P191L	Familial cancer of breast	VCV001382968	16	23647295	16	23635974	1382968	1509564	rs1001733949	NC_000016.10:23635973:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.571C>T (p.Pro191Ser)	PALB2	P171S, P191S	Familial cancer of breast	VCV002901670	16	23647296	16	23635975	2901670	3064374	rs587780221	NC_000016.10:23635974:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.571C>A (p.Pro191Thr)	PALB2	P191T	not specified|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000439236	16	23647296	16	23635975	439236	432880	rs587780221	NC_000016.10:23635974:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.571C>G (p.Pro191Ala)	PALB2	P191A	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000128146	16	23647296	16	23635975	128146	133603	rs587780221	NC_000016.10:23635974:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.570A>C (p.Ser190=)	PALB2		Familial cancer of breast	VCV001149075	16	23647297	16	23635976	1149075	1146018	rs1967037408	NC_000016.10:23635975:T:G	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.570A>G (p.Ser190=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000921504	16	23647297	16	23635976	921504	913689	rs1967037408	NC_000016.10:23635975:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 14, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.568T>A (p.Ser190Thr)	PALB2	S190T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000839779	16	23647299	16	23635978	839779	843634	rs1967037502	NC_000016.10:23635977:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.567A>G (p.Arg189=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001152247	16	23647300	16	23635979	1152247	1146019	rs1597098858	NC_000016.10:23635978:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 26, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.567A>C (p.Arg189Ser)	PALB2	R189S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000825890	16	23647300	16	23635979	825890	812831	rs1597098858	NC_000016.10:23635978:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.566G>C (p.Arg189Thr)	PALB2	R169T, R189T	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV002873849	16	23647301	16	23635980	2873849	3040669	rs764180110	NC_000016.10:23635979:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.566G>A (p.Arg189Lys)	PALB2	R189K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000864430	16	23647301	16	23635980	864430	843635	rs764180110	NC_000016.10:23635979:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.566G>T (p.Arg189Ile)	PALB2	R189I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000461010	16	23647301	16	23635980	461010	466277	rs764180110	NC_000016.10:23635979:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 17, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.565A>G (p.Arg189Gly)	PALB2	R189G	Familial cancer of breast	VCV000961499	16	23647302	16	23635981	961499	949328	rs1967037808	NC_000016.10:23635980:T:C	single nucleotide variant	missense variant	Uncertain significance	May 27, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.563C>G (p.Ala188Gly)	PALB2	A188G	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000141738	16	23647304	16	23635983	141738	151452	rs587781975	NC_000016.10:23635982:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.562G>T (p.Ala188Ser)	PALB2	A188S	Familial cancer of breast	VCV001002669	16	23647305	16	23635984	1002669	996815	rs1967038001	NC_000016.10:23635983:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.560C>A (p.Pro187His)	PALB2	P187H	not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000481010	16	23647307	16	23635986	481010	477729	rs371582757	NC_000016.10:23635985:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.560C>T (p.Pro187Leu)	PALB2	P187L	Hereditary cancer-predisposing syndrome	VCV000142699	16	23647307	16	23635986	142699	152413	rs371582757	NC_000016.10:23635985:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.559C>T (p.Pro187Ser)	PALB2	P187S	Familial cancer of breast	VCV000653253	16	23647308	16	23635987	653253	644480	rs1597098885	NC_000016.10:23635986:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.557A>G (p.Asn186Ser)	PALB2	N186S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001062064	16	23647310	16	23635989	1062064	1049530	rs587782164	NC_000016.10:23635988:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 27, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.557A>C (p.Asn186Thr)	PALB2	N186T	Familial cancer of breast	VCV001034786	16	23647310	16	23635989	1034786	1032542	rs587782164	NC_000016.10:23635988:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.557A>T (p.Asn186Ile)	PALB2	N186I	not specified|Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3	VCV000141993	16	23647310	16	23635989	141993	151707	rs587782164	NC_000016.10:23635988:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.554A>C (p.Lys185Thr)	PALB2	K185T	Hereditary cancer-predisposing syndrome	VCV000482032	16	23647313	16	23635992	482032	478283	rs864622667	NC_000016.10:23635991:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.554A>G (p.Lys185Arg)	PALB2	K185R	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000220827	16	23647313	16	23635992	220827	222477	rs864622667	NC_000016.10:23635991:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.553A>G (p.Lys185Glu)	PALB2	K185E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001039308	16	23647314	16	23635993	1039308	1032543	rs1967038738	NC_000016.10:23635992:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 22, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.551G>C (p.Ser184Thr)	PALB2	S184T	Familial cancer of breast|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000128145	16	23647316	16	23635995	128145	133602	rs587780220	NC_000016.10:23635994:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 6, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.550A>G (p.Ser184Gly)	PALB2	S184G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000825792	16	23647317	16	23635996	825792	812832	rs1597098904	NC_000016.10:23635995:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.549T>A (p.Ser183Arg)	PALB2	S183R	Hereditary cancer-predisposing syndrome	VCV000825774	16	23647318	16	23635997	825774	812833	rs1597098910	NC_000016.10:23635996:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.546C>G (p.Ile182Met)	PALB2	I182M	Hereditary cancer-predisposing syndrome	VCV000922381	16	23647321	16	23636000	922381	913690	rs1597098917	NC_000016.10:23635999:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.546C>T (p.Ile182=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000825759	16	23647321	16	23636000	825759	812834	rs1597098917	NC_000016.10:23635999:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.545T>G (p.Ile182Ser)	PALB2	I162S, I182S	Hereditary cancer-predisposing syndrome	VCV003228038	16	23647322	16	23636001	3228038	3387807	rs1967039388	NC_000016.10:23636000:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.545T>C (p.Ile182Thr)	PALB2	I182T	Familial cancer of breast	VCV001014830	16	23647322	16	23636001	1014830	1012047	rs1967039388	NC_000016.10:23636000:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.544A>G (p.Ile182Val)	PALB2	I182V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000629262	16	23647323	16	23636002	629262	618436	rs1567222712	NC_000016.10:23636001:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.543A>G (p.Glu181=)	PALB2		Familial cancer of breast	VCV002758439	16	23647324	16	23636003	2758439	2910538	rs2142440854	NC_000016.10:23636002:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	May 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.541G>T (p.Glu181Ter)	PALB2	E181*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast	VCV000229757	16	23647326	16	23636005	229757	235318	rs864622280	NC_000016.10:23636004:C:A	single nucleotide variant	nonsense	Pathogenic	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.541G>C (p.Glu181Gln)	PALB2	E181Q	Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000219855	16	23647326	16	23636005	219855	222478	rs864622280	NC_000016.10:23636004:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.539A>C (p.Glu180Ala)	PALB2	E160A, E180A	Familial cancer of breast	VCV003655095	16	23647328	16	23636007	3655095	3789238		NC_000016.10:23636006:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 31, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.538G>T (p.Glu180Ter)	PALB2	E180*	not provided|Familial cancer of breast	VCV000830107	16	23647329	16	23636008	830107	818543	rs750782778	NC_000016.10:23636007:C:A	single nucleotide variant	nonsense	Pathogenic	Jul 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.538G>A (p.Glu180Lys)	PALB2	E180K	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000186268	16	23647329	16	23636008	186268	184284	rs750782778	NC_000016.10:23636007:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.535C>T (p.Gln179Ter)	PALB2	Q179*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001459981	16	23647332	16	23636011	1459981	1481338	rs730881903	NC_000016.10:23636010:G:A	single nucleotide variant	nonsense	Pathogenic	Jul 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.535C>G (p.Gln179Glu)	PALB2	Q179E	not specified|Familial cancer of breast|not provided	VCV000182784	16	23647332	16	23636011	182784	180747	rs730881903	NC_000016.10:23636010:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.534A>G (p.Glu178=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001746970	16	23647333	16	23636012	1746970	1806514	rs758733690	NC_000016.10:23636011:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Sep 20, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.532G>T (p.Glu178Ter)	PALB2	E158*, E178*	Familial cancer of breast	VCV002673859	16	23647335	16	23636014	2673859	2836337	rs1597098960	NC_000016.10:23636013:C:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic/Likely pathogenic	Sep 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.532G>A (p.Glu178Lys)	PALB2	E178K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000825657	16	23647335	16	23636014	825657	812836	rs1597098960	NC_000016.10:23636013:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.531G>A (p.Lys177=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484227	16	23647336	16	23636015	484227	478285	rs779739454	NC_000016.10:23636014:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.530A>C (p.Lys177Thr)	PALB2	K157T, K177T	Hereditary cancer-predisposing syndrome	VCV003885193	16	23647337	16	23636016	3885193	4005515		NC_000016.10:23636015:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.527T>C (p.Leu176Pro)	PALB2	L176P	Familial cancer of breast	VCV000570587	16	23647340	16	23636019	570587	573977	rs1567222733	NC_000016.10:23636018:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.526C>A (p.Leu176Ile)	PALB2	L156I, L176I	Hereditary cancer-predisposing syndrome	VCV001746489	16	23647341	16	23636020	1746489	1809977	rs1211622922	NC_000016.10:23636019:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.526C>T (p.Leu176=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000922820	16	23647341	16	23636020	922820	913691	rs1211622922	NC_000016.10:23636019:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.526C>G (p.Leu176Val)	PALB2	L176V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530141	16	23647341	16	23636020	530141	530376	rs1211622922	NC_000016.10:23636019:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.525A>G (p.Arg175=)	PALB2		not specified|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000461009	16	23647342	16	23636021	461009	466525	rs1555461747	NC_000016.10:23636020:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.524G>C (p.Arg175Thr)	PALB2	R155T, R175T	Hereditary cancer-predisposing syndrome	VCV003774410	16	23647343	16	23636022	3774410	3890557		NC_000016.10:23636021:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.524G>A (p.Arg175Lys)	PALB2	R155K, R175K	Familial cancer of breast	VCV002713927	16	23647343	16	23636022	2713927	2872350	rs2506508864	NC_000016.10:23636021:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 28, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.522A>G (p.Lys174=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530244	16	23647345	16	23636024	530244	530377	rs1555461754	NC_000016.10:23636023:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.521A>G (p.Lys174Arg)	PALB2	K174R	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000182783	16	23647346	16	23636025	182783	180748	rs730881902	NC_000016.10:23636024:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.520A>C (p.Lys174Gln)	PALB2	K154Q, K174Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002141200	16	23647347	16	23636026	2141200	1872191	rs2142441340	NC_000016.10:23636025:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.520A>G (p.Lys174Glu)	PALB2	K174E	Familial cancer of breast	VCV001054128	16	23647347	16	23636026	1054128	1049531	rs2142441340	NC_000016.10:23636025:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.519G>C (p.Gly173=)	PALB2		Familial cancer of breast	VCV003903911	16	23647348	16	23636027	3903911	4019784		NC_000016.10:23636026:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.519G>A (p.Gly173=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000825533	16	23647348	16	23636027	825533	812838	rs1597099004	NC_000016.10:23636026:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 25, 2019	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.517G>T (p.Gly173Trp)	PALB2	G153W, G173W	Familial cancer of breast	VCV001718067	16	23647350	16	23636029	1718067	1772043	rs878855121	NC_000016.10:23636028:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.517G>A (p.Gly173Arg)	PALB2	G173R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000241569	16	23647350	16	23636029	241569	242387	rs878855121	NC_000016.10:23636028:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.516T>C (p.Ser172=)	PALB2		Familial cancer of breast	VCV003627510	16	23647351	16	23636030	3627510	3752690		NC_000016.10:23636029:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.515C>G (p.Ser172Cys)	PALB2	S152C, S172C	Familial cancer of breast	VCV003240013	16	23647352	16	23636031	3240013	3399001	rs1597099026	NC_000016.10:23636030:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.515C>T (p.Ser172Phe)	PALB2	S172F	Familial cancer of breast	VCV000665980	16	23647352	16	23636031	665980	644482	rs1597099026	NC_000016.10:23636030:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.514T>G (p.Ser172Ala)	PALB2	S172A	Hereditary cancer-predisposing syndrome	VCV000924775	16	23647353	16	23636032	924775	913692	rs1967041594	NC_000016.10:23636031:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.514T>C (p.Ser172Pro)	PALB2	S172P	Familial cancer of breast	VCV000861582	16	23647353	16	23636032	861582	843636	rs1967041594	NC_000016.10:23636031:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.513G>C (p.Leu171Phe)	PALB2	L151F, L171F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002088474	16	23647354	16	23636033	2088474	2151548	rs1251724216	NC_000016.10:23636032:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.513G>A (p.Leu171=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000481131	16	23647354	16	23636033	481131	477785	rs1251724216	NC_000016.10:23636032:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.512T>C (p.Leu171Ser)	PALB2	L171S	Hereditary cancer-predisposing syndrome	VCV000825469	16	23647355	16	23636034	825469	812839	rs876658979	NC_000016.10:23636033:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.512T>A (p.Leu171Ter)	PALB2	L171*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000644238	16	23647355	16	23636034	644238	644483	rs876658979	NC_000016.10:23636033:A:T	single nucleotide variant	nonsense	Pathogenic	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.512T>G (p.Leu171Trp)	PALB2	L171W	Hereditary cancer-predisposing syndrome	VCV000231142	16	23647355	16	23636034	231142	235320	rs876658979	NC_000016.10:23636033:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.511T>C (p.Leu171=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000628127	16	23647356	16	23636035	628127	618437	rs863224790	NC_000016.10:23636034:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 3, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.511T>A (p.Leu171Met)	PALB2	L171M	Familial cancer of breast	VCV000216759	16	23647356	16	23636035	216759	213183	rs863224790	NC_000016.10:23636034:A:T	single nucleotide variant	missense variant	Uncertain significance	May 28, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.510A>T (p.Arg170Ser)	PALB2	R150S, R170S	Familial cancer of breast	VCV002066151	16	23647357	16	23636036	2066151	2128836	rs1060502796	NC_000016.10:23636035:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.510A>G (p.Arg170=)	PALB2		Familial cancer of breast	VCV001539358	16	23647357	16	23636036	1539358	1660284	rs1060502796	NC_000016.10:23636035:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.510A>C (p.Arg170Ser)	PALB2	R170S	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|not provided	VCV000410201	16	23647357	16	23636036	410201	401854	rs1060502796	NC_000016.10:23636035:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.509G>T (p.Arg170Ile)	PALB2	R170I	Familial cancer of breast	VCV001382792	16	23647358	16	23636037	1382792	1513266	rs898765598	NC_000016.10:23636036:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.509G>C (p.Arg170Thr)	PALB2	R170T	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000484210	16	23647358	16	23636037	484210	477733	rs898765598	NC_000016.10:23636036:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.508A>C (p.Arg170=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530257	16	23647359	16	23636038	530257	530181	rs864622622	NC_000016.10:23636037:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.508A>G (p.Arg170Gly)	PALB2	R170G	not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000220654	16	23647359	16	23636038	220654	222479	rs864622622	NC_000016.10:23636037:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.507C>A (p.Leu169=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001745195	16	23647360	16	23636039	1745195	1806041	rs1375166092	NC_000016.10:23636038:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Nov 14, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.507C>G (p.Leu169=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000763764	16	23647360	16	23636039	763764	770790	rs1375166092	NC_000016.10:23636038:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.507C>T (p.Leu169=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000629255	16	23647360	16	23636039	629255	618438	rs1375166092	NC_000016.10:23636038:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.506T>C (p.Leu169Pro)	PALB2	L169P	Familial cancer of breast	VCV001428525	16	23647361	16	23636040	1428525	1379815	rs2142441769	NC_000016.10:23636039:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.505C>G (p.Leu169Val)	PALB2	L169V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484170	16	23647362	16	23636041	484170	478286	rs180177086	NC_000016.10:23636040:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 10, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.505C>T (p.Leu169Phe)	PALB2	L169F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000461008	16	23647362	16	23636041	461008	466284	rs180177086	NC_000016.10:23636040:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.505C>A (p.Leu169Ile)	PALB2	L169I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000126755	16	23647362	16	23636041	126755	132265	rs180177086	NC_000016.10:23636040:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 19, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.504A>G (p.Ser168=)	PALB2		Familial cancer of breast	VCV000830106	16	23647363	16	23636042	830106	818544	rs754500464	NC_000016.10:23636041:T:C	single nucleotide variant	synonymous variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.504A>C (p.Ser168=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000629856	16	23647363	16	23636042	629856	618439	rs754500464	NC_000016.10:23636041:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.503C>G (p.Ser168Ter)	PALB2	S168*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000925447	16	23647364	16	23636043	925447	913693	rs515726122	NC_000016.10:23636042:G:C	single nucleotide variant	nonsense	Pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.503C>T (p.Ser168Leu)	PALB2	S168L	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000187261	16	23647364	16	23636043	187261	184285	rs515726122	NC_000016.10:23636042:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.503C>A (p.Ser168Ter)	PALB2	S168*	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000126754	16	23647364	16	23636043	126754	132264	rs515726122	NC_000016.10:23636042:G:T	single nucleotide variant	nonsense	Pathogenic	Mar 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.502T>G (p.Ser168Ala)	PALB2	S168A	Familial cancer of breast	VCV001053479	16	23647365	16	23636044	1053479	1049532	rs2142441892	NC_000016.10:23636043:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.499G>A (p.Asp167Asn)	PALB2	D147N, D167N	Familial cancer of breast	VCV002714075	16	23647368	16	23636047	2714075	2868613	rs2142441963	NC_000016.10:23636046:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.498T>A (p.Thr166=)	PALB2		Familial cancer of breast	VCV001487440	16	23647369	16	23636048	1487440	1485333	rs1597099121	NC_000016.10:23636047:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.498T>C (p.Thr166=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000755488	16	23647369	16	23636048	755488	770791	rs1597099121	NC_000016.10:23636047:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.497C>T (p.Thr166Ile)	PALB2	T146I, T166I	not provided	VCV002502634	16	23647370	16	23636049	2502634	2667740	rs2142442014	NC_000016.10:23636048:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.495C>T (p.Gly165=)	PALB2		Fanconi anemia complementation group N|Familial cancer of breast|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000186120	16	23647372	16	23636051	186120	184286	rs200937538	NC_000016.10:23636050:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.494G>C (p.Gly165Ala)	PALB2	G145A, G165A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003304001	16	23647373	16	23636052	3304001	3470168		NC_000016.10:23636051:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.494G>A (p.Gly165Asp)	PALB2	G165D	Familial cancer of breast	VCV000571916	16	23647373	16	23636052	571916	570213	rs1567222798	NC_000016.10:23636051:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.493G>A (p.Gly165Ser)	PALB2	G165S	Familial cancer of breast	VCV000935626	16	23647374	16	23636053	935626	937381	rs1967043594	NC_000016.10:23636052:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.492T>G (p.Phe164Leu)	PALB2	F144L, F164L	Hereditary cancer-predisposing syndrome	VCV003413457	16	23647375	16	23636054	3413457	3574680		NC_000016.10:23636053:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.491T>G (p.Phe164Cys)	PALB2	F144C, F164C	Familial cancer of breast	VCV002805722	16	23647376	16	23636055	2805722	2974084	rs2142442158	NC_000016.10:23636054:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.489C>T (p.Val163=)	PALB2		Familial cancer of breast	VCV003904186	16	23647378	16	23636057	3904186	4020059		NC_000016.10:23636056:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.489C>G (p.Val163=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000926299	16	23647378	16	23636057	926299	913694	rs1967043668	NC_000016.10:23636056:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.488T>G (p.Val163Gly)	PALB2	V163G, V143G	Familial cancer of breast	VCV002756848	16	23647379	16	23636058	2756848	2910249	rs2142442214	NC_000016.10:23636057:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.485G>C (p.Cys162Ser)	PALB2	C162S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000846942	16	23647382	16	23636061	846942	843637	rs1555461779	NC_000016.10:23636060:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 21, 2020	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.485G>A (p.Cys162Tyr)	PALB2	C162Y	Familial cancer of breast	VCV000461006	16	23647382	16	23636061	461006	466291	rs1555461779	NC_000016.10:23636060:C:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.484T>G (p.Cys162Gly)	PALB2	C162G, C142G	Familial cancer of breast	VCV002858551	16	23647383	16	23636062	2858551	3028472	rs2142442315	NC_000016.10:23636061:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 3, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.484T>C (p.Cys162Arg)	PALB2	C142R, C162R	Familial cancer of breast	VCV002816511	16	23647383	16	23636062	2816511	2984014	rs2142442315	NC_000016.10:23636061:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 24, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.483C>T (p.Asp161=)	PALB2		Familial cancer of breast	VCV001152112	16	23647384	16	23636063	1152112	1146020	rs371627753	NC_000016.10:23636062:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.483C>G (p.Asp161Glu)	PALB2	D161E	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000849998	16	23647384	16	23636063	849998	843638	rs371627753	NC_000016.10:23636062:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 10, 2021	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.482A>T (p.Asp161Val)	PALB2	D141V, D161V	Familial cancer of breast	VCV002060817	16	23647385	16	23636064	2060817	2127386	rs748042783	NC_000016.10:23636063:T:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.482A>G (p.Asp161Gly)	PALB2	D161G	Hereditary cancer-predisposing syndrome	VCV000630688	16	23647385	16	23636064	630688	618440	rs748042783	NC_000016.10:23636063:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.481G>C (p.Asp161His)	PALB2	D161H	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000480258	16	23647386	16	23636065	480258	477658	rs769841151	NC_000016.10:23636064:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.480A>G (p.Arg160=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484169	16	23647387	16	23636066	484169	478295	rs1555461782	NC_000016.10:23636065:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.479G>A (p.Arg160Lys)	PALB2	R160K	not provided|Familial cancer of breast	VCV001320923	16	23647388	16	23636067	1320923	1311167	rs2142442427	NC_000016.10:23636066:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.477G>C (p.Glu159Asp)	PALB2	E139D, E159D	Hereditary cancer-predisposing syndrome	VCV003906175	16	23647390	16	23636069	3906175	4022047		NC_000016.10:23636068:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 3, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.477G>A (p.Glu159=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5	VCV001537623	16	23647390	16	23636069	1537623	1649902	rs1163253431	NC_000016.10:23636068:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.476A>G (p.Glu159Gly)	PALB2	E159G	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000492223	16	23647391	16	23636070	492223	484680	rs1555461786	NC_000016.10:23636069:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.475G>T (p.Glu159Ter)	PALB2	E159*	Familial cancer of breast	VCV000548756	16	23647392	16	23636071	548756	539344	rs1555461788	NC_000016.10:23636070:C:A	single nucleotide variant	nonsense	Pathogenic	Mar 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.474G>C (p.Gln158His)	PALB2	Q158H	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000649100	16	23647393	16	23636072	649100	644484	rs878855119	NC_000016.10:23636071:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.474G>A (p.Gln158=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000241565	16	23647393	16	23636072	241565	242388	rs878855119	NC_000016.10:23636071:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.473A>G (p.Gln158Arg)	PALB2	Q158R	Familial cancer of breast	VCV001477764	16	23647394	16	23636073	1477764	1436643	rs1349641343	NC_000016.10:23636072:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.473A>T (p.Gln158Leu)	PALB2	Q158L	Hereditary cancer-predisposing syndrome	VCV000925724	16	23647394	16	23636073	925724	913695	rs1349641343	NC_000016.10:23636072:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.472C>T (p.Gln158Ter)	PALB2	Q158*	not provided|Familial cancer of breast	VCV000246291	16	23647395	16	23636074	246291	244975	rs879254197	NC_000016.10:23636073:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.470C>A (p.Ser157Ter)	PALB2	S137*, S157*	Familial cancer of breast	VCV002673861	16	23647397	16	23636076	2673861	2841362	rs749078410	NC_000016.10:23636075:G:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.470C>T (p.Ser157Leu)	PALB2	S157L	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410140	16	23647397	16	23636076	410140	401101	rs749078410	NC_000016.10:23636075:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.467T>C (p.Ile156Thr)	PALB2	I136T, I156T	Familial cancer of breast	VCV001719751	16	23647400	16	23636079	1719751	1772407	rs2142442688	NC_000016.10:23636078:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.466A>G (p.Ile156Val)	PALB2	I156V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000651711	16	23647401	16	23636080	651711	644485	rs1597099200	NC_000016.10:23636079:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.465T>G (p.Phe155Leu)	PALB2	F135L, F155L	Familial cancer of breast	VCV003660953	16	23647402	16	23636081	3660953	3790612		NC_000016.10:23636080:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.465T>C (p.Phe155=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000928036	16	23647402	16	23636081	928036	913696	rs1967045486	NC_000016.10:23636080:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 11, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.464T>C (p.Phe155Ser)	PALB2	F155S	Familial cancer of breast	VCV001522519	16	23647403	16	23636082	1522519	1369462	rs1167005475	NC_000016.10:23636081:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.464T>G (p.Phe155Cys)	PALB2	F155C	Familial cancer of breast	VCV000946917	16	23647403	16	23636082	946917	927739	rs1167005475	NC_000016.10:23636081:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.463T>C (p.Phe155Leu)	PALB2	F155L, F135L	Familial cancer of breast	VCV003666370	16	23647404	16	23636083	3666370	3792174		NC_000016.10:23636082:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.462A>C (p.Thr154=)	PALB2		Familial cancer of breast	VCV003903855	16	23647405	16	23636084	3903855	4019728		NC_000016.10:23636083:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.462A>T (p.Thr154=)	PALB2		Familial cancer of breast	VCV002893331	16	23647405	16	23636084	2893331	3055837	rs1057522196	NC_000016.10:23636083:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.462A>G (p.Thr154=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000385336	16	23647405	16	23636084	385336	374959	rs1057522196	NC_000016.10:23636083:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.459G>A (p.Arg153=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000230558	16	23647408	16	23636087	230558	235322	rs876658633	NC_000016.10:23636086:C:T	single nucleotide variant	synonymous variant	Likely benign	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.458G>A (p.Arg153Lys)	PALB2	R153K	Familial cancer of breast	VCV001003608	16	23647409	16	23636088	1003608	996816	rs1967045901	NC_000016.10:23636087:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.457A>C (p.Arg153=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001049129	16	23647410	16	23636089	1049129	1038420	rs1375458252	NC_000016.10:23636088:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.456G>A (p.Lys152=)	PALB2		Familial cancer of breast	VCV001122183	16	23647411	16	23636090	1122183	1125130	rs2142442964	NC_000016.10:23636089:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 11, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.454A>T (p.Lys152Ter)	PALB2	K132*, K152*	Familial cancer of breast	VCV001713227	16	23647413	16	23636092	1713227	1770739	rs2506511810	NC_000016.10:23636091:T:A	single nucleotide variant	nonsense	Pathogenic	Sep 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.452A>T (p.Gln151Leu)	PALB2	Q151L	Familial cancer of breast	VCV000935876	16	23647415	16	23636094	935876	937382	rs1967046234	NC_000016.10:23636093:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.451C>A (p.Gln151Lys)	PALB2	Q151K	Familial cancer of breast	VCV001477964	16	23647416	16	23636095	1477964	1436842	rs587776407	NC_000016.10:23636094:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.451C>T (p.Gln151Ter)	PALB2	Q151*	Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000143977	16	23647416	16	23636095	143977	153707	rs587776407	NC_000016.10:23636094:G:A	single nucleotide variant	nonsense	Pathogenic	Mar 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.450G>C (p.Gln150His)	PALB2	Q150H	Familial cancer of breast	VCV001489239	16	23647417	16	23636096	1489239	1498731	rs2142443097	NC_000016.10:23636095:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.450G>T (p.Gln150His)	PALB2	Q150H	Familial cancer of breast	VCV001368150	16	23647417	16	23636096	1368150	1424688	rs2142443097	NC_000016.10:23636095:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.448C>A (p.Gln150Lys)	PALB2	Q130K, Q150K	Familial cancer of breast	VCV002015357	16	23647419	16	23636098	2015357	2068155	rs1597099241	NC_000016.10:23636097:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.448C>G (p.Gln150Glu)	PALB2	Q150E	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000665078	16	23647419	16	23636098	665078	644486	rs1597099241	NC_000016.10:23636097:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.447G>T (p.Lys149Asn)	PALB2	K149N	Hereditary cancer-predisposing syndrome	VCV000484193	16	23647420	16	23636099	484193	478299	rs1555461793	NC_000016.10:23636098:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.445A>C (p.Lys149Gln)	PALB2	K149Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000629857	16	23647422	16	23636101	629857	618441	rs770680919	NC_000016.10:23636100:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.444G>T (p.Lys148Asn)	PALB2	K148N	Hereditary cancer-predisposing syndrome	VCV000921558	16	23647423	16	23636102	921558	913697	rs1060502782	NC_000016.10:23636101:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.444G>A (p.Lys148=)	PALB2		Familial cancer of breast	VCV000761582	16	23647423	16	23636102	761582	770792	rs1060502782	NC_000016.10:23636101:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.444G>C (p.Lys148Asn)	PALB2	K148N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410181	16	23647423	16	23636102	410181	401580	rs1060502782	NC_000016.10:23636101:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.443A>G (p.Lys148Arg)	PALB2	K148R	Hereditary cancer-predisposing syndrome	VCV000830105	16	23647424	16	23636103	830105	818545	rs1967047110	NC_000016.10:23636102:T:C	single nucleotide variant	missense variant	Likely benign	Jun 3, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.442A>T (p.Lys148Ter)	PALB2	K148*, K128*	Familial cancer of breast	VCV002709974	16	23647425	16	23636104	2709974	2874872	rs2142443334	NC_000016.10:23636103:T:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.442A>G (p.Lys148Glu)	PALB2	K148E, K128E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002587422	16	23647425	16	23636104	2587422	2754098	rs2142443334	NC_000016.10:23636103:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.442A>C (p.Lys148Gln)	PALB2	K148Q	Familial cancer of breast	VCV001420084	16	23647425	16	23636104	1420084	1502864	rs2142443334	NC_000016.10:23636103:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.440G>T (p.Arg147Ile)	PALB2	R147I, R127I	Familial cancer of breast	VCV003663573	16	23647427	16	23636106	3663573	3798164		NC_000016.10:23636105:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.440G>A (p.Arg147Lys)	PALB2	R147K	Familial cancer of breast	VCV001499335	16	23647427	16	23636106	1499335	1389038	rs1597099275	NC_000016.10:23636105:C:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.438A>C (p.Arg146Ser)	PALB2	R146S	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000141105	16	23647429	16	23636108	141105	150819	rs587781498	NC_000016.10:23636107:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.437G>C (p.Arg146Thr)	PALB2	R146T, R126T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001740149	16	23647430	16	23636109	1740149	1791182	rs2142443443	NC_000016.10:23636108:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.437G>A (p.Arg146Lys)	PALB2	R146K	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV001321058	16	23647430	16	23636109	1321058	1311302	rs2142443443	NC_000016.10:23636108:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.435C>G (p.Ser145Arg)	PALB2	S125R, S145R	Hereditary cancer-predisposing syndrome	VCV002587410	16	23647432	16	23636111	2587410	2754086	rs2142443491	NC_000016.10:23636110:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.435C>T (p.Ser145=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002567574	16	23647432	16	23636111	2567574	2731216	rs2142443491	NC_000016.10:23636110:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.433A>G (p.Ser145Gly)	PALB2	S145G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001485997	16	23647434	16	23636113	1485997	1468475	rs2142443524	NC_000016.10:23636112:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 10, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.432A>G (p.Pro144=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486017	16	23647435	16	23636114	486017	477793	rs1555461797	NC_000016.10:23636113:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.431C>T (p.Pro144Leu)	PALB2	P144L	Familial cancer of breast	VCV001389094	16	23647436	16	23636115	1389094	1476674	rs2142443551	NC_000016.10:23636114:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.430C>G (p.Pro144Ala)	PALB2	P144A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000486016	16	23647437	16	23636116	486016	478300	rs1555461798	NC_000016.10:23636115:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.429G>T (p.Leu143=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000389745	16	23647438	16	23636117	389745	374279	rs1057523525	NC_000016.10:23636116:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.427C>T (p.Leu143=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000824750	16	23647440	16	23636119	824750	812842	rs1597099297	NC_000016.10:23636118:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.426G>A (p.Lys142=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830104	16	23647441	16	23636120	830104	818546	rs1967047677	NC_000016.10:23636119:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.424A>T (p.Lys142Ter)	PALB2	K142*	Malignant tumor of breast|PALB2-related disorder|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Breast cancer, susceptibility to	VCV000141779	16	23647443	16	23636122	141779	151493	rs587782005	NC_000016.10:23636121:T:A	single nucleotide variant	nonsense	Pathogenic	May 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.423G>A (p.Gln141=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000186083	16	23647444	16	23636123	186083	184287	rs786202680	NC_000016.10:23636122:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.422A>C (p.Gln141Pro)	PALB2	Q121P, Q141P	Hereditary cancer-predisposing syndrome	VCV003413484	16	23647445	16	23636124	3413484	3574707		NC_000016.10:23636123:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 19, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.422A>G (p.Gln141Arg)	PALB2	Q121R, Q141R	Familial cancer of breast	VCV002815053	16	23647445	16	23636124	2815053	2973583	rs2142443782	NC_000016.10:23636123:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.421C>T (p.Gln141Ter)	PALB2	Q141*	Familial cancer of breast|not provided	VCV000265636	16	23647446	16	23636125	265636	260109	rs886039686	NC_000016.10:23636124:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Sep 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.419A>C (p.Lys140Thr)	PALB2	K140T, K120T	Familial cancer of breast	VCV003644256	16	23647448	16	23636127	3644256	3765741		NC_000016.10:23636126:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 3, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.416A>C (p.Gln139Pro)	PALB2	Q139P	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000923417	16	23647451	16	23636130	923417	913698	rs1555461800	NC_000016.10:23636129:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.416A>G (p.Gln139Arg)	PALB2	Q139R	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000485995	16	23647451	16	23636130	485995	477735	rs1555461800	NC_000016.10:23636129:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.413A>C (p.Glu138Ala)	PALB2	E138A	Familial cancer of breast|not provided	VCV000496468	16	23647454	16	23636133	496468	487778	rs1322095182	NC_000016.10:23636132:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.412G>T (p.Glu138Ter)	PALB2	E118*, E138*	Familial cancer of breast	VCV002673850	16	23647455	16	23636134	2673850	2841352	rs1967048357	NC_000016.10:23636133:C:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.410G>T (p.Gly137Val)	PALB2	G137V	Familial cancer of breast	VCV000571608	16	23647457	16	23636136	571608	573979	rs1567222904	NC_000016.10:23636135:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.409G>A (p.Gly137Ser)	PALB2	G137S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628639	16	23647458	16	23636137	628639	618442	rs1397816581	NC_000016.10:23636136:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.408T>C (p.Ser136=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001949506	16	23647459	16	23636138	1949506	2003208	rs112202375	NC_000016.10:23636137:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	May 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.408T>G (p.Ser136Arg)	PALB2	S136R	Familial cancer of breast	VCV000946635	16	23647459	16	23636138	946635	927740	rs112202375	NC_000016.10:23636137:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.407G>A (p.Ser136Asn)	PALB2	S116N, S136N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002893256	16	23647460	16	23636139	2893256	3055762	rs2142444123	NC_000016.10:23636138:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.406A>G (p.Ser136Gly)	PALB2	S136G	Familial cancer of breast	VCV001368667	16	23647461	16	23636140	1368667	1340259	rs144496685	NC_000016.10:23636139:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.406A>T (p.Ser136Cys)	PALB2	S136C	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000461001	16	23647461	16	23636140	461001	466303	rs144496685	NC_000016.10:23636139:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.405T>C (p.Pro135=)	PALB2		not provided|not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000184637	16	23647462	16	23636141	184637	184288	rs786201586	NC_000016.10:23636140:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.404C>G (p.Pro135Arg)	PALB2	P135R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001379288	16	23647463	16	23636142	1379288	1486517	rs1597099361	NC_000016.10:23636141:G:C	single nucleotide variant	missense variant	Uncertain significance	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.404C>T (p.Pro135Leu)	PALB2	P135L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000824537	16	23647463	16	23636142	824537	812844	rs1597099361	NC_000016.10:23636141:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.402C>T (p.Asp134=)	PALB2		Familial cancer of breast	VCV002011244	16	23647465	16	23636144	2011244	2074318	rs1967049086	NC_000016.10:23636143:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.402C>A (p.Asp134Glu)	PALB2	D134E, D114E	Hereditary cancer-predisposing syndrome	VCV001737172	16	23647465	16	23636144	1737172	1790371	rs1967049086	NC_000016.10:23636143:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.400G>A (p.Asp134Asn)	PALB2	D134N	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified|not provided|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome	VCV000126749	16	23647467	16	23636146	126749	132259	rs139555085	NC_000016.10:23636145:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.399T>C (p.Ser133=)	PALB2		Familial cancer of breast	VCV002016381	16	23647468	16	23636147	2016381	2075587	rs2142444314	NC_000016.10:23636146:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 12, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.398G>C (p.Ser133Thr)	PALB2	S133T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000837352	16	23647469	16	23636148	837352	843639	rs864622411	NC_000016.10:23636147:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 25, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.398G>A (p.Ser133Asn)	PALB2	S133N	Hereditary cancer-predisposing syndrome|not provided|not specified|Familial cancer of breast	VCV000246217	16	23647469	16	23636148	246217	244976	rs864622411	NC_000016.10:23636147:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.398G>T (p.Ser133Ile)	PALB2	S133I	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000220173	16	23647469	16	23636148	220173	222480	rs864622411	NC_000016.10:23636147:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 30, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.397A>G (p.Ser133Gly)	PALB2	S133G	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000182759	16	23647470	16	23636149	182759	180749	rs730881881	NC_000016.10:23636148:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 26, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.396C>T (p.Val132=)	PALB2		not specified	VCV003896439	16	23647471	16	23636150	3896439	4012308		NC_000016.10:23636149:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 7, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.396C>A (p.Val132=)	PALB2		Familial cancer of breast	VCV001662877	16	23647471	16	23636150	1662877	1555683	rs1567222949	NC_000016.10:23636149:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.394G>T (p.Val132Phe)	PALB2	V112F, V132F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001736429	16	23647473	16	23636152	1736429	1796962	rs1555461807	NC_000016.10:23636151:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.394G>A (p.Val132Ile)	PALB2	V132I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001481862	16	23647473	16	23636152	1481862	1367380	rs1555461807	NC_000016.10:23636151:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.394G>C (p.Val132Leu)	PALB2	V132L	Hereditary cancer-predisposing syndrome	VCV000486019	16	23647473	16	23636152	486019	477676	rs1555461807	NC_000016.10:23636151:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.393G>A (p.Arg131=)	PALB2		Familial cancer of breast	VCV002984374	16	23647474	16	23636153	2984374	3145986	rs864622461	NC_000016.10:23636152:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Nov 29, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.393G>C (p.Arg131Ser)	PALB2	R131S	Familial cancer of breast	VCV000220289	16	23647474	16	23636153	220289	222481	rs864622461	NC_000016.10:23636152:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.392G>A (p.Arg131Lys)	PALB2	R131K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000652945	16	23647475	16	23636154	652945	644487	rs1597099403	NC_000016.10:23636153:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.391A>C (p.Arg131=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003927458	16	23647476	16	23636155	3927458	4047091		NC_000016.10:23636154:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 2, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.391A>G (p.Arg131Gly)	PALB2	R111G, R131G	Hereditary cancer-predisposing syndrome	VCV003894454	16	23647476	16	23636155	3894454	4010334		NC_000016.10:23636154:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.390C>T (p.His130=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001736101	16	23647477	16	23636156	1736101	1787260	rs2142444553	NC_000016.10:23636155:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Sep 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.389A>C (p.His130Pro)	PALB2	H130P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000846272	16	23647478	16	23636157	846272	843640	rs1967050224	NC_000016.10:23636156:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.388C>T (p.His130Tyr)	PALB2	H130Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N	VCV000824342	16	23647479	16	23636158	824342	812845	rs1555461809	NC_000016.10:23636157:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 25, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.388C>A (p.His130Asn)	PALB2	H130N	Familial cancer of breast	VCV000530135	16	23647479	16	23636158	530135	529934	rs1555461809	NC_000016.10:23636157:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.387C>T (p.Pro129=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV001100880	16	23647480	16	23636159	1100880	1103716	rs1253286227	NC_000016.10:23636158:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.386C>T (p.Pro129Leu)	PALB2	P109L, P129L	Hereditary cancer-predisposing syndrome	VCV001735678	16	23647481	16	23636160	1735678	1790172	rs1555461810	NC_000016.10:23636159:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.386C>G (p.Pro129Arg)	PALB2	P129R	Hereditary cancer-predisposing syndrome	VCV000482020	16	23647481	16	23636160	482020	478306	rs1555461810	NC_000016.10:23636159:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.385C>T (p.Pro129Ser)	PALB2	P129S	Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001046827	16	23647482	16	23636161	1046827	1032544	rs1174443228	NC_000016.10:23636160:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 22, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.380A>T (p.His127Leu)	PALB2	H127L	Familial cancer of breast	VCV000834836	16	23647487	16	23636166	834836	843641	rs863224789	NC_000016.10:23636165:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.380A>G (p.His127Arg)	PALB2	H127R	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000216758	16	23647487	16	23636166	216758	213184	rs863224789	NC_000016.10:23636165:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.379C>T (p.His127Tyr)	PALB2	H127Y	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000619709	16	23647488	16	23636167	619709	611226	rs1056494105	NC_000016.10:23636166:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.378A>T (p.Glu126Asp)	PALB2	E126D, E106D	Hereditary cancer-predisposing syndrome	VCV001734916	16	23647489	16	23636168	1734916	1793255	rs2142444796	NC_000016.10:23636167:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.378A>G (p.Glu126=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001106878	16	23647489	16	23636168	1106878	1103717	rs2142444796	NC_000016.10:23636167:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.377A>G (p.Glu126Gly)	PALB2	E106G, E126G	Familial cancer of breast	VCV002973583	16	23647490	16	23636169	2973583	3140002	rs1597099431	NC_000016.10:23636168:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.376G>A (p.Glu126Lys)	PALB2	E106K, E126K	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001734751	16	23647491	16	23636170	1734751	1796543	rs577006107	NC_000016.10:23636169:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.375A>G (p.Gln125=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000461000	16	23647492	16	23636171	461000	466530	rs531307676	NC_000016.10:23636170:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.373C>T (p.Gln125Ter)	PALB2	Q105*, Q125*	Familial cancer of breast	VCV002574092	16	23647494	16	23636173	2574092	2739038	rs2142444897	NC_000016.10:23636172:G:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic/Likely pathogenic	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.372C>T (p.Thr124=)	PALB2		not specified|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000185066	16	23647495	16	23636174	185066	184289	rs786201904	NC_000016.10:23636173:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.371C>T (p.Thr124Ile)	PALB2	T124I	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000487020	16	23647496	16	23636175	487020	477677	rs45457297	NC_000016.10:23636174:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.371C>A (p.Thr124Asn)	PALB2	T124N	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000449580	16	23647496	16	23636175	449580	445548	rs45457297	NC_000016.10:23636174:G:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.369C>T (p.Asp123=)	PALB2		Familial cancer of breast	VCV000830102	16	23647498	16	23636177	830102	818548	rs1967051605	NC_000016.10:23636176:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.368A>G (p.Asp123Gly)	PALB2	D103G, D123G	Familial cancer of breast	VCV003721358	16	23647499	16	23636178	3721358	3853724		NC_000016.10:23636177:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 23, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.368A>T (p.Asp123Val)	PALB2	D123V	Familial cancer of breast	VCV001485274	16	23647499	16	23636178	1485274	1394000	rs2142445019	NC_000016.10:23636177:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.367G>T (p.Asp123Tyr)	PALB2	D123Y, D103Y	Hereditary cancer-predisposing syndrome	VCV002453306	16	23647500	16	23636179	2453306	2430366	rs1967051717	NC_000016.10:23636178:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.366T>C (p.Asp122=)	PALB2		Familial cancer of breast	VCV003903689	16	23647501	16	23636180	3903689	4019562		NC_000016.10:23636179:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.365A>G (p.Asp122Gly)	PALB2	D122G	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000241567	16	23647502	16	23636181	241567	242389	rs866367185	NC_000016.10:23636180:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 1, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.364G>C (p.Asp122His)	PALB2	D122H, D102H	Familial cancer of breast	VCV003640120	16	23647503	16	23636182	3640120	3775134		NC_000016.10:23636181:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 11, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.364G>A (p.Asp122Asn)	PALB2	D122N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480271	16	23647503	16	23636182	480271	477736	rs730881880	NC_000016.10:23636181:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.364G>T (p.Asp122Tyr)	PALB2	D122Y	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000182758	16	23647503	16	23636182	182758	180750	rs730881880	NC_000016.10:23636181:C:A	single nucleotide variant	missense variant	Uncertain significance	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.363A>T (p.Thr121=)	PALB2		Familial cancer of breast	VCV002848016	16	23647504	16	23636183	2848016	3005259	rs1555461816	NC_000016.10:23636182:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Mar 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.363A>G (p.Thr121=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492221	16	23647504	16	23636183	492221	484685	rs1555461816	NC_000016.10:23636182:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.362C>G (p.Thr121Arg)	PALB2	T101R, T121R	Familial cancer of breast	VCV003694322	16	23647505	16	23636184	3694322	3828531		NC_000016.10:23636183:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.361A>G (p.Thr121Ala)	PALB2	T121A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001040505	16	23647506	16	23636185	1040505	1032545	rs1967052155	NC_000016.10:23636184:T:C	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.359G>C (p.Arg120Thr)	PALB2	R120T	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast	VCV000946075	16	23647508	16	23636187	946075	927741	rs1251150895	NC_000016.10:23636186:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.358A>G (p.Arg120Gly)	PALB2	R120G, R100G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001732971	16	23647509	16	23636188	1732971	1796045	rs2142445228	NC_000016.10:23636187:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 31, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.357A>G (p.Gln119=)	PALB2		Familial cancer of breast	VCV003903606	16	23647510	16	23636189	3903606	4019479		NC_000016.10:23636188:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.353T>C (p.Ile118Thr)	PALB2	I118T	not provided|not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000128143	16	23647514	16	23636193	128143	133600	rs370404126	NC_000016.10:23636192:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.352A>G (p.Ile118Val)	PALB2	I118V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628278	16	23647515	16	23636194	628278	618443	rs1567223015	NC_000016.10:23636193:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.351T>C (p.Pro117=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000215937	16	23647516	16	23636195	215937	213185	rs763330757	NC_000016.10:23636194:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.350C>T (p.Pro117Leu)	PALB2	P117L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000582553	16	23647517	16	23636196	582553	573986	rs1567223025	NC_000016.10:23636195:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.349C>G (p.Pro117Ala)	PALB2	P117A, P97A	Familial cancer of breast	VCV002101685	16	23647518	16	23636197	2101685	2147943	rs1413238389	NC_000016.10:23636196:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.349C>T (p.Pro117Ser)	PALB2	P117S	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001317269	16	23647518	16	23636197	1317269	1307086	rs1413238389	NC_000016.10:23636196:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.349C>A (p.Pro117Thr)	PALB2	P117T	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480248	16	23647518	16	23636197	480248	478309	rs1413238389	NC_000016.10:23636196:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.347T>C (p.Leu116Ser)	PALB2	L116S	Familial cancer of breast	VCV000838629	16	23647520	16	23636199	838629	843642	rs876660465	NC_000016.10:23636198:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.347T>A (p.Leu116Ter)	PALB2	L116*	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000233528	16	23647520	16	23636199	233528	235323	rs876660465	NC_000016.10:23636198:A:T	single nucleotide variant	nonsense	Pathogenic	Mar 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.346T>C (p.Leu116=)	PALB2		Familial cancer of breast	VCV002117019	16	23647521	16	23636200	2117019	2172326	rs2142445481	NC_000016.10:23636199:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Mar 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.345A>T (p.Gly115=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823796	16	23647522	16	23636201	823796	812846	rs1597099510	NC_000016.10:23636200:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.344G>T (p.Gly115Val)	PALB2	G115V	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000126743	16	23647523	16	23636202	126743	132253	rs145598272	NC_000016.10:23636201:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.343G>T (p.Gly115Ter)	PALB2	G115*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823773	16	23647524	16	23636203	823773	812847	rs1597099523	NC_000016.10:23636202:C:A	single nucleotide variant	nonsense	Pathogenic	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.342A>G (p.Gly114=)	PALB2		Familial cancer of breast	VCV003903544	16	23647525	16	23636204	3903544	4019417		NC_000016.10:23636203:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.342A>T (p.Gly114=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000920825	16	23647525	16	23636204	920825	913699	rs1967053280	NC_000016.10:23636203:T:A	single nucleotide variant	synonymous variant	Likely benign	Dec 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.341G>A (p.Gly114Glu)	PALB2	G114E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630067	16	23647526	16	23636205	630067	618444	rs1567223045	NC_000016.10:23636204:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.340G>A (p.Gly114Arg)	PALB2	G94R, G114R	Familial cancer of breast	VCV003709462	16	23647527	16	23636206	3709462	3840322		NC_000016.10:23636205:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.339A>G (p.Pro113=)	PALB2		Familial cancer of breast	VCV003903541	16	23647528	16	23636207	3903541	4019414		NC_000016.10:23636206:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.339A>C (p.Pro113=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000187567	16	23647528	16	23636207	187567	184290	rs376182266	NC_000016.10:23636206:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.338C>T (p.Pro113Leu)	PALB2	P113L	Familial cancer of breast	VCV000492220	16	23647529	16	23636208	492220	484828	rs374425261	NC_000016.10:23636207:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.338C>G (p.Pro113Arg)	PALB2	P113R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000232582	16	23647529	16	23636208	232582	235324	rs374425261	NC_000016.10:23636207:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.337C>G (p.Pro113Ala)	PALB2	P113A	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000492219	16	23647530	16	23636209	492219	484833	rs1352495486	NC_000016.10:23636208:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.336C>A (p.Gly112=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000755230	16	23647531	16	23636210	755230	770793	rs1293127133	NC_000016.10:23636209:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.336C>T (p.Gly112=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484167	16	23647531	16	23636210	484167	478310	rs1293127133	NC_000016.10:23636209:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.333T>A (p.Asp111Glu)	PALB2	D111E, D91E	Familial cancer of breast	VCV002753394	16	23647534	16	23636213	2753394	2909392	rs1597099553	NC_000016.10:23636212:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.333T>C (p.Asp111=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000766746	16	23647534	16	23636213	766746	770794	rs1597099553	NC_000016.10:23636212:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.332A>G (p.Asp111Gly)	PALB2	D111G	Familial cancer of breast|not provided	VCV001316478	16	23647535	16	23636214	1316478	1307572	rs2142445830	NC_000016.10:23636213:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.331G>C (p.Asp111His)	PALB2	D111H, D91H	Familial cancer of breast	VCV002162818	16	23647536	16	23636215	2162818	1891235	rs1597099556	NC_000016.10:23636214:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.331G>A (p.Asp111Asn)	PALB2	D111N	Familial cancer of breast	VCV000658802	16	23647536	16	23636215	658802	644488	rs1597099556	NC_000016.10:23636214:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.330A>C (p.Gly110=)	PALB2		Familial cancer of breast	VCV002837270	16	23647537	16	23636216	2837270	2999649	rs876660773	NC_000016.10:23636215:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.330A>G (p.Gly110=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233981	16	23647537	16	23636216	233981	235325	rs876660773	NC_000016.10:23636215:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.329G>C (p.Gly110Ala)	PALB2	G110A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628066	16	23647538	16	23636217	628066	618445	rs1341395298	NC_000016.10:23636216:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.329G>A (p.Gly110Glu)	PALB2	G110E	Familial cancer of breast	VCV000572069	16	23647538	16	23636217	572069	568027	rs1341395298	NC_000016.10:23636216:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.328G>C (p.Gly110Arg)	PALB2	G110R, G90R	Familial cancer of breast	VCV001992718	16	23647539	16	23636218	1992718	2059239	rs2142445918	NC_000016.10:23636217:C:G	single nucleotide variant	missense variant	Uncertain significance	May 10, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.328G>A (p.Gly110Arg)	PALB2	G110R	not provided|Familial cancer of breast	VCV001318634	16	23647539	16	23636218	1318634	1308418	rs2142445918	NC_000016.10:23636217:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.327T>C (p.Pro109=)	PALB2		Familial cancer of breast	VCV002849599	16	23647540	16	23636219	2849599	3009388	rs2142445932	NC_000016.10:23636218:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Mar 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.326C>T (p.Pro109Leu)	PALB2	P109L, P89L	Hereditary cancer-predisposing syndrome	VCV001729608	16	23647541	16	23636220	1729608	1795283	rs2142445960	NC_000016.10:23636219:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.325C>A (p.Pro109Thr)	PALB2	P109T, P89T	Familial cancer of breast	VCV003717221	16	23647542	16	23636221	3717221	3855631		NC_000016.10:23636220:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 15, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.325C>G (p.Pro109Ala)	PALB2	P109A	Familial cancer of breast	VCV000530064	16	23647542	16	23636221	530064	530379	rs1555461831	NC_000016.10:23636220:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.324C>G (p.Asn108Lys)	PALB2	N108K, N88K	not provided	VCV002444714	16	23647543	16	23636222	2444714	2418444	rs1967054646	NC_000016.10:23636221:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.324C>T (p.Asn108=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830099	16	23647543	16	23636222	830099	818551	rs1967054646	NC_000016.10:23636221:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.322A>C (p.Asn108His)	PALB2	N108H	Familial cancer of breast	VCV001421665	16	23647545	16	23636224	1421665	1423081	rs1240552147	NC_000016.10:23636223:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.322A>T (p.Asn108Tyr)	PALB2	N108Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000952331	16	23647545	16	23636224	952331	927742	rs1240552147	NC_000016.10:23636223:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.321T>C (p.Phe107=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823231	16	23647546	16	23636225	823231	812848	rs781049663	NC_000016.10:23636224:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.321T>G (p.Phe107Leu)	PALB2	F107L	Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome	VCV000582054	16	23647546	16	23636225	582054	568028	rs781049663	NC_000016.10:23636224:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.319T>A (p.Phe107Ile)	PALB2	F107I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460979	16	23647548	16	23636227	460979	466305	rs752251774	NC_000016.10:23636226:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.318C>G (p.Ser106=)	PALB2		Familial cancer of breast	VCV003657738	16	23647549	16	23636228	3657738	3789956		NC_000016.10:23636227:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.318C>A (p.Ser106=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001728629	16	23647549	16	23636228	1728629	1788264	rs2142446163	NC_000016.10:23636227:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 22, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.318C>T (p.Ser106=)	PALB2		Familial cancer of breast	VCV001125475	16	23647549	16	23636228	1125475	1125131	rs2142446163	NC_000016.10:23636227:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.317C>G (p.Ser106Cys)	PALB2	S106C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000926117	16	23647550	16	23636229	926117	913701	rs1484403594	NC_000016.10:23636228:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.317C>T (p.Ser106Phe)	PALB2	S106F	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000922654	16	23647550	16	23636229	922654	913700	rs1484403594	NC_000016.10:23636228:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.315G>C (p.Glu105Asp)	PALB2	E105D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not specified|not provided	VCV000126718	16	23647552	16	23636231	126718	132228	rs515726108	NC_000016.10:23636230:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.313G>T (p.Glu105Ter)	PALB2	E105*, E85*	Familial cancer of breast	VCV002673854	16	23647554	16	23636233	2673854	2841356	rs1307895700	NC_000016.10:23636232:C:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.313G>C (p.Glu105Gln)	PALB2	E105Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000486028	16	23647554	16	23636233	486028	477740	rs1307895700	NC_000016.10:23636232:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.312T>A (p.Pro104=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003885216	16	23647555	16	23636234	3885216	4005538		NC_000016.10:23636233:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jan 31, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.312T>C (p.Pro104=)	PALB2		Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided	VCV000184298	16	23647555	16	23636234	184298	184291	rs749203259	NC_000016.10:23636233:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.311C>T (p.Pro104Leu)	PALB2	P104L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484197	16	23647556	16	23636235	484197	477795	rs1555461835	NC_000016.10:23636234:G:A	single nucleotide variant	missense variant	Uncertain significance	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.310C>G (p.Pro104Ala)	PALB2	P84A, P104A	Familial cancer of breast	VCV002754368	16	23647557	16	23636236	2754368	2913810	rs1967055763	NC_000016.10:23636235:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 22, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.310C>T (p.Pro104Ser)	PALB2	P104S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000920668	16	23647557	16	23636236	920668	913702	rs1967055763	NC_000016.10:23636235:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.309G>A (p.Gly103=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000384593	16	23647558	16	23636237	384593	374960	rs546015723	NC_000016.10:23636236:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.308G>C (p.Gly103Ala)	PALB2	G103A, G83A	Familial cancer of breast	VCV003687205	16	23647559	16	23636238	3687205	3830466		NC_000016.10:23636237:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.308G>A (p.Gly103Glu)	PALB2	G103E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000234012	16	23647559	16	23636238	234012	235326	rs876660794	NC_000016.10:23636237:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 2, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.307G>C (p.Gly103Arg)	PALB2	G103R, G83R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002721706	16	23647560	16	23636239	2721706	2884795	rs2142446440	NC_000016.10:23636238:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.305T>C (p.Val102Ala)	PALB2	V102A	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000460975	16	23647562	16	23636241	460975	466535	rs1313838988	NC_000016.10:23636240:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.304G>A (p.Val102Ile)	PALB2	V102I	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410149	16	23647563	16	23636242	410149	401102	rs778573607	NC_000016.10:23636241:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.303T>C (p.Asp101=)	PALB2		Familial cancer of breast	VCV003903589	16	23647564	16	23636243	3903589	4019462		NC_000016.10:23636242:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.303T>G (p.Asp101Glu)	PALB2	D101E	Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not specified|Hereditary cancer-predisposing syndrome	VCV000492208	16	23647564	16	23636243	492208	484873	rs1417779335	NC_000016.10:23636242:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.301G>A (p.Asp101Asn)	PALB2	D101N, D81N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002453294	16	23647566	16	23636245	2453294	2430354	rs794727654	NC_000016.10:23636244:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.301G>C (p.Asp101His)	PALB2	D101H	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000197352	16	23647566	16	23636245	197352	194513	rs794727654	NC_000016.10:23636244:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.300T>C (p.Leu100=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002035150	16	23647567	16	23636246	2035150	2100808	rs1169777505	NC_000016.10:23636245:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.299T>G (p.Leu100Arg)	PALB2	L100R	Familial cancer of breast	VCV000662678	16	23647568	16	23636247	662678	644489	rs1597099643	NC_000016.10:23636246:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.298C>G (p.Leu100Val)	PALB2	L100V	Familial cancer of breast	VCV000850218	16	23647569	16	23636248	850218	843644	rs61756147	NC_000016.10:23636247:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.298C>T (p.Leu100Phe)	PALB2	L100F	Familial cancer of breast|Breast and/or ovarian cancer|Fanconi anemia complementation group N|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000126698	16	23647569	16	23636248	126698	132208	rs61756147	NC_000016.10:23636247:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.297A>G (p.Thr99=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000389716	16	23647570	16	23636249	389716	375268	rs1057523513	NC_000016.10:23636248:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.296C>T (p.Thr99Ile)	PALB2	T99I	Familial cancer of breast	VCV001006218	16	23647571	16	23636250	1006218	996818	rs1967056981	NC_000016.10:23636249:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.295A>C (p.Thr99Pro)	PALB2	T99P	not provided	VCV000419481	16	23647572	16	23636251	419481	409568	rs1064793902	NC_000016.10:23636250:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.294C>T (p.Ile98=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001798031	16	23647573	16	23636252	1798031	1853650	rs1060502730	NC_000016.10:23636251:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Sep 13, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.294C>G (p.Ile98Met)	PALB2	I98M	Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410102	16	23647573	16	23636252	410102	401864	rs1060502730	NC_000016.10:23636251:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.293T>C (p.Ile98Thr)	PALB2	I78T, I98T	Hereditary cancer-predisposing syndrome	VCV003602624	16	23647574	16	23636253	3602624	3735300		NC_000016.10:23636252:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 20, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.292A>G (p.Ile98Val)	PALB2	I98V	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000142935	16	23647575	16	23636254	142935	152649	rs587782831	NC_000016.10:23636253:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.291T>C (p.Ser97=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003303997	16	23647576	16	23636255	3303997	3470164		NC_000016.10:23636254:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.291T>G (p.Ser97=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001148626	16	23647576	16	23636255	1148626	1146021	rs2142446803	NC_000016.10:23636254:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.290C>T (p.Ser97Phe)	PALB2	S97F	Familial cancer of breast	VCV000845621	16	23647577	16	23636256	845621	843645	rs776902295	NC_000016.10:23636255:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 6, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.290C>A (p.Ser97Tyr)	PALB2	S97Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460968	16	23647577	16	23636256	460968	466547	rs776902295	NC_000016.10:23636255:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 5, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.289T>C (p.Ser97Pro)	PALB2	S97P	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000630137	16	23647578	16	23636257	630137	618446	rs1456296764	NC_000016.10:23636256:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.288A>G (p.Thr96=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001136211	16	23647579	16	23636258	1136211	1125132	rs878855114	NC_000016.10:23636257:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.288A>C (p.Thr96=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000241555	16	23647579	16	23636258	241555	242390	rs878855114	NC_000016.10:23636257:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.287C>T (p.Thr96Ile)	PALB2	T96I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000927236	16	23647580	16	23636259	927236	913704	rs1967057796	NC_000016.10:23636258:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.286A>T (p.Thr96Ser)	PALB2	T76S, T96S	Hereditary cancer-predisposing syndrome	VCV002453297	16	23647581	16	23636260	2453297	2430357	rs2142446940	NC_000016.10:23636259:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 2, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.286A>G (p.Thr96Ala)	PALB2	T76A, T96A	Familial cancer of breast	VCV001718428	16	23647581	16	23636260	1718428	1778788	rs2142446940	NC_000016.10:23636259:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.285G>C (p.Lys95Asn)	PALB2	K75N, K95N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001796941	16	23647582	16	23636261	1796941	1855516	rs1043578258	NC_000016.10:23636260:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.283A>T (p.Lys95Ter)	PALB2	K75*, K95*	Hereditary cancer-predisposing syndrome	VCV003413451	16	23647584	16	23636263	3413451	3574674		NC_000016.10:23636262:T:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Aug 23, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.283A>G (p.Lys95Glu)	PALB2	K95E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000821795	16	23647584	16	23636263	821795	812849	rs1597099704	NC_000016.10:23636262:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.282A>C (p.Glu94Asp)	PALB2	E74D, E94D	Hereditary cancer-predisposing syndrome	VCV003228021	16	23647585	16	23636264	3228021	3387790	rs2142447037	NC_000016.10:23636263:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Feb 23, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.280G>T (p.Glu94Ter)	PALB2	E74*, E94*	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV002453308	16	23647587	16	23636266	2453308	2430368	rs45602040	NC_000016.10:23636265:C:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.280G>C (p.Glu94Gln)	PALB2	E94Q	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486001	16	23647587	16	23636266	486001	477796	rs45602040	NC_000016.10:23636265:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 17, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.279A>T (p.Gly93=)	PALB2		Familial cancer of breast	VCV000658333	16	23647588	16	23636267	658333	644490	rs1286951503	NC_000016.10:23636266:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.278G>A (p.Gly93Glu)	PALB2	G93E	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000482006	16	23647589	16	23636268	482006	477682	rs761863504	NC_000016.10:23636267:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.277G>A (p.Gly93Arg)	PALB2	G93R	not provided|Familial cancer of breast	VCV001199614	16	23647590	16	23636269	1199614	1191788	rs2142447132	NC_000016.10:23636268:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.276T>A (p.Thr92=)	PALB2		Familial cancer of breast	VCV001101090	16	23647591	16	23636270	1101090	1103718	rs1555461850	NC_000016.10:23636269:A:T	single nucleotide variant	synonymous variant	Likely benign	Jan 28, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.276T>C (p.Thr92=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001083579	16	23647591	16	23636270	1083579	1081898	rs1555461850	NC_000016.10:23636269:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.276T>G (p.Thr92=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000460957	16	23647591	16	23636270	460957	466306	rs1555461850	NC_000016.10:23636269:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.275C>T (p.Thr92Ile)	PALB2	T72I, T92I	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002888210	16	23647592	16	23636271	2888210	3050954	rs2142447179	NC_000016.10:23636270:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.274A>G (p.Thr92Ala)	PALB2	T92A, T72A	Hereditary cancer-predisposing syndrome	VCV003413490	16	23647593	16	23636272	3413490	3574713		NC_000016.10:23636271:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 3, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.273A>G (p.Glu91=)	PALB2		Hereditary cancer-predisposing syndrome	VCV002453291	16	23647594	16	23636273	2453291	2430351	rs2506518201	NC_000016.10:23636272:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.271G>T (p.Glu91Ter)	PALB2	E71*, E91*	Hereditary cancer-predisposing syndrome	VCV003927425	16	23647596	16	23636275	3927425	4047058		NC_000016.10:23636274:C:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Mar 15, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.270A>G (p.Glu90=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001795028	16	23647597	16	23636276	1795028	1849237	rs2506518246	NC_000016.10:23636275:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.269A>G (p.Glu90Gly)	PALB2	E90G	Familial cancer of breast	VCV000410216	16	23647598	16	23636277	410216	401107	rs1060502807	NC_000016.10:23636276:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.268G>T (p.Glu90Ter)	PALB2	E70*, E90*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002673872	16	23647599	16	23636278	2673872	2841373	rs2142447291	NC_000016.10:23636277:C:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.266A>G (p.Asp89Gly)	PALB2	D89G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000184918	16	23647601	16	23636280	184918	184292	rs786201790	NC_000016.10:23636279:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.265G>C (p.Asp89His)	PALB2	D89H	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000571084	16	23647602	16	23636281	571084	573988	rs769790850	NC_000016.10:23636280:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.263T>G (p.Leu88Arg)	PALB2	L88R	Familial cancer of breast	VCV000846327	16	23647604	16	23636283	846327	843646	rs876660270	NC_000016.10:23636282:A:C	single nucleotide variant	missense variant	Uncertain significance	May 13, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.263T>C (p.Leu88Pro)	PALB2	L88P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233224	16	23647604	16	23636283	233224	235327	rs876660270	NC_000016.10:23636282:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.262C>T (p.Leu88Phe)	PALB2	L88F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492194	16	23647605	16	23636284	492194	484837	rs730881901	NC_000016.10:23636283:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.262C>G (p.Leu88Val)	PALB2	L88V	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000182782	16	23647605	16	23636284	182782	180751	rs730881901	NC_000016.10:23636283:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.261T>A (p.His87Gln)	PALB2	H87Q, H67Q	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003304008	16	23647606	16	23636285	3304008	3470175		NC_000016.10:23636284:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.261T>C (p.His87=)	PALB2		Familial cancer of breast	VCV001639892	16	23647606	16	23636285	1639892	1571312	rs2142447442	NC_000016.10:23636284:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.260A>T (p.His87Leu)	PALB2	H67L, H87L	Hereditary cancer-predisposing syndrome	VCV002774023	16	23647607	16	23636286	2774023	2934754	rs1251028803	NC_000016.10:23636285:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.259C>T (p.His87Tyr)	PALB2	H67Y, H87Y	Hereditary cancer-predisposing syndrome	VCV001793616	16	23647608	16	23636287	1793616	1845741	rs2506518652	NC_000016.10:23636286:G:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.258C>G (p.Thr86=)	PALB2		Familial cancer of breast	VCV003904190	16	23647609	16	23636288	3904190	4020063		NC_000016.10:23636287:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.258C>T (p.Thr86=)	PALB2		Familial cancer of breast	VCV001544969	16	23647609	16	23636288	1544969	1644375	rs2142447498	NC_000016.10:23636287:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.257C>T (p.Thr86Ile)	PALB2	T86I, T66I	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001793353	16	23647610	16	23636289	1793353	1848866	rs1967059270	NC_000016.10:23636288:G:A	single nucleotide variant	missense variant	Uncertain significance	May 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.257C>G (p.Thr86Ser)	PALB2	T86S	Familial cancer of breast	VCV001514021	16	23647610	16	23636289	1514021	1491836	rs1967059270	NC_000016.10:23636288:G:C	single nucleotide variant	missense variant	Uncertain significance	May 8, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.256A>C (p.Thr86Pro)	PALB2	T86P, T66P	Familial cancer of breast	VCV003008608	16	23647611	16	23636290	3008608	3162436	rs2142447541	NC_000016.10:23636289:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.254A>G (p.Lys85Arg)	PALB2	K85R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000638977	16	23647613	16	23636292	638977	644491	rs1597099769	NC_000016.10:23636291:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.253A>G (p.Lys85Glu)	PALB2	K85E	Familial cancer of breast	VCV000851737	16	23647614	16	23636293	851737	843647	rs1967059440	NC_000016.10:23636292:T:C	single nucleotide variant	missense variant	Uncertain significance	May 27, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.252C>T (p.Ile84=)	PALB2		Familial cancer of breast	VCV002800838	16	23647615	16	23636294	2800838	2962818	rs1967059537	NC_000016.10:23636293:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Aug 1, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.252C>A (p.Ile84=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001792647	16	23647615	16	23636294	1792647	1851697	rs1967059537	NC_000016.10:23636293:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jan 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.252C>G (p.Ile84Met)	PALB2	I84M	Familial cancer of breast	VCV000853267	16	23647615	16	23636294	853267	843648	rs1967059537	NC_000016.10:23636293:G:C	single nucleotide variant	missense variant	Uncertain significance	May 31, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.251T>C (p.Ile84Thr)	PALB2	I64T, I84T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5	VCV002580957	16	23647616	16	23636295	2580957	2748542	rs1967059657	NC_000016.10:23636294:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.251T>A (p.Ile84Asn)	PALB2	I84N	Hereditary cancer-predisposing syndrome	VCV000830097	16	23647616	16	23636295	830097	818553	rs1967059657	NC_000016.10:23636294:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.250A>G (p.Ile84Val)	PALB2	I64V, I84V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002567580	16	23647617	16	23636296	2567580	2731222	rs2142447670	NC_000016.10:23636295:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.249C>T (p.His83=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000389287	16	23647618	16	23636297	389287	374282	rs1057523390	NC_000016.10:23636296:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.248A>C (p.His83Pro)	PALB2	H83P	Familial cancer of breast	VCV001516025	16	23647619	16	23636298	1516025	1407303	rs2142447708	NC_000016.10:23636297:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.248A>G (p.His83Arg)	PALB2	H83R	Familial cancer of breast	VCV001467119	16	23647619	16	23636298	1467119	1346746	rs2142447708	NC_000016.10:23636297:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.247C>T (p.His83Tyr)	PALB2	H83Y	Familial cancer of breast	VCV000952843	16	23647620	16	23636299	952843	927744	rs773732106	NC_000016.10:23636298:G:A	single nucleotide variant	missense variant	Uncertain significance	May 9, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.247C>A (p.His83Asn)	PALB2	H83N	Familial cancer of breast	VCV000830096	16	23647620	16	23636299	830096	818554	rs773732106	NC_000016.10:23636298:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.244T>C (p.Leu82=)	PALB2		Familial cancer of breast	VCV000530234	16	23647623	16	23636302	530234	529846	rs763378141	NC_000016.10:23636301:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.243G>A (p.Lys81=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000629282	16	23647624	16	23636303	629282	618447	rs1060502775	NC_000016.10:23636302:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.243G>C (p.Lys81Asn)	PALB2	K81N	Familial cancer of breast	VCV000410171	16	23647624	16	23636303	410171	401153	rs1060502775	NC_000016.10:23636302:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.242A>G (p.Lys81Arg)	PALB2	K81R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000187058	16	23647625	16	23636304	187058	184293	rs786203440	NC_000016.10:23636303:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.240C>G (p.Asp80Glu)	PALB2	D80E	Familial cancer of breast	VCV001018309	16	23647627	16	23636306	1018309	1012048	rs1597099799	NC_000016.10:23636305:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.240C>A (p.Asp80Glu)	PALB2	D80E	Familial cancer of breast	VCV000642776	16	23647627	16	23636306	642776	644492	rs1597099799	NC_000016.10:23636305:G:T	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.238G>A (p.Asp80Asn)	PALB2	D80N	Familial cancer of breast	VCV001054474	16	23647629	16	23636308	1054474	1049533	rs2142447895	NC_000016.10:23636307:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.237T>G (p.Tyr79Ter)	PALB2	Y79*, Y59*	Hereditary cancer-predisposing syndrome	VCV003413458	16	23647630	16	23636309	3413458	3574681		NC_000016.10:23636308:A:C	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 3, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.237T>C (p.Tyr79=)	PALB2		Hereditary cancer-predisposing syndrome	VCV001790430	16	23647630	16	23636309	1790430	1841331	rs2142447916	NC_000016.10:23636308:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 4, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.236A>G (p.Tyr79Cys)	PALB2	Y79C	Hereditary cancer-predisposing syndrome	VCV000927829	16	23647631	16	23636310	927829	913705	rs766710382	NC_000016.10:23636309:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 6, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.235T>C (p.Tyr79His)	PALB2	Y79H	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000410117	16	23647632	16	23636311	410117	401109	rs1060502740	NC_000016.10:23636310:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.233T>C (p.Val78Ala)	PALB2	V78A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482026	16	23647634	16	23636313	482026	477798	rs1313634930	NC_000016.10:23636312:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 13, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.232G>A (p.Val78Ile)	PALB2	V78I	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|Breast and/or ovarian cancer	VCV000126647	16	23647635	16	23636314	126647	132157	rs515726085	NC_000016.10:23636313:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.231T>A (p.Cys77Ter)	PALB2	C57*, C77*	Familial cancer of breast	VCV003648282	16	23647636	16	23636315	3648282	3787561		NC_000016.10:23636314:A:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Apr 1, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.230G>C (p.Cys77Ser)	PALB2	C57S, C77S	not provided	VCV003384263	16	23647637	16	23636316	3384263	3543413		NC_000016.10:23636315:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jun 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.230G>T (p.Cys77Phe)	PALB2	C57F, C77F	Familial cancer of breast	VCV002808819	16	23647637	16	23636316	2808819	2964770	rs1597099850	NC_000016.10:23636315:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 1, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.230G>A (p.Cys77Tyr)	PALB2	C77Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000821070	16	23647637	16	23636316	821070	812850	rs1597099850	NC_000016.10:23636315:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.229T>G (p.Cys77Gly)	PALB2	C77G	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000663100	16	23647638	16	23636317	663100	644493	rs760045493	NC_000016.10:23636316:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.229T>C (p.Cys77Arg)	PALB2	C77R	Familial cancer of breast|not provided|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000233693	16	23647638	16	23636317	233693	235328	rs760045493	NC_000016.10:23636316:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.228A>G (p.Ile76Met)	PALB2	I76M	Familial cancer of breast|not provided	VCV000460935	16	23647639	16	23636318	460935	466280	rs1555461872	NC_000016.10:23636317:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.227T>C (p.Ile76Thr)	PALB2	I76T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830095	16	23647640	16	23636319	830095	818555	rs1967061407	NC_000016.10:23636318:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 16, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.226A>G (p.Ile76Val)	PALB2	I76V	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not provided|not specified	VCV000220168	16	23647641	16	23636320	220168	222482	rs541028076	NC_000016.10:23636319:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.225A>T (p.Lys75Asn)	PALB2	K75N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001040748	16	23647642	16	23636321	1040748	1032546	rs1250453452	NC_000016.10:23636320:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.225A>C (p.Lys75Asn)	PALB2	K75N	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000631010	16	23647642	16	23636321	631010	618448	rs1250453452	NC_000016.10:23636320:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.223A>T (p.Lys75Ter)	PALB2	K75*	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000460933	16	23647644	16	23636323	460933	465567	rs1555461875	NC_000016.10:23636322:T:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Apr 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.220A>G (p.Asn74Asp)	PALB2	N54D, N74D	Familial cancer of breast	VCV001721472	16	23647647	16	23636326	1721472	1772806	rs2506519799	NC_000016.10:23636325:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.219A>C (p.Lys73Asn)	PALB2	K53N, K73N	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001787541	16	23647648	16	23636327	1787541	1850522	rs1172090595	NC_000016.10:23636326:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.218A>G (p.Lys73Arg)	PALB2	K73R	Familial cancer of breast	VCV001406767	16	23647649	16	23636328	1406767	1486825	rs2142448330	NC_000016.10:23636327:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.215C>G (p.Pro72Arg)	PALB2	P72R	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000998796	16	23647652	16	23636331	998796	996819	rs1967062090	NC_000016.10:23636330:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.214C>T (p.Pro72Ser)	PALB2	P72S	Familial cancer of breast	VCV001440188	16	23647653	16	23636332	1440188	1368638	rs2142448436	NC_000016.10:23636331:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.213A>G (p.Glu71=)	PALB2		Familial cancer of breast	VCV000958813	16	23647654	16	23636333	958813	949329	rs1967062173	NC_000016.10:23636332:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.213A>C (p.Glu71Asp)	PALB2	E71D	Hereditary cancer-predisposing syndrome	VCV000830094	16	23647654	16	23636333	830094	818556	rs1967062173	NC_000016.10:23636332:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.212A>G (p.Glu71Gly)	PALB2	E71G	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000530031	16	23647655	16	23636334	530031	530384	rs1555461877	NC_000016.10:23636333:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.212-1G>C	PALB2		Hereditary cancer-predisposing syndrome	VCV002567552	16	23647656	16	23636335	2567552	2731194	rs1597099910	NC_000016.10:23636334:C:G	single nucleotide variant	splice acceptor variant|intron variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-1G>A	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000921112	16	23647656	16	23636335	921112	915946	rs1597099910	NC_000016.10:23636334:C:T	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.212-1G>T	PALB2		Familial cancer of breast	VCV000803240	16	23647656	16	23636335	803240	791573	rs1597099910	NC_000016.10:23636334:C:A	single nucleotide variant	splice acceptor variant|intron variant	Uncertain significance	May 28, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-2A>C	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000640795	16	23647657	16	23636336	640795	652557	rs730881879	NC_000016.10:23636335:T:G	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.212-2A>G	PALB2		Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia complementation group N|Familial cancer of breast|Hereditary breast ovarian cancer syndrome	VCV000182757	16	23647657	16	23636336	182757	180752	rs730881879	NC_000016.10:23636335:T:C	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Apr 14, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.212-3C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000241540	16	23647658	16	23636337	241540	242391	rs878855106	NC_000016.10:23636336:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.212-4T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV003927461	16	23647659	16	23636338	3927461	4047094		NC_000016.10:23636337:A:C	single nucleotide variant	intron variant	Likely benign	Jun 11, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-5C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000820767	16	23647660	16	23636339	820767	815633	rs1597099922	NC_000016.10:23636338:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.212-6C>G	PALB2		Familial cancer of breast	VCV003904056	16	23647661	16	23636340	3904056	4019929		NC_000016.10:23636339:G:C	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-6C>T	PALB2		Familial cancer of breast	VCV000803241	16	23647661	16	23636340	803241	791574	rs1416424510	NC_000016.10:23636339:G:A	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.212-7T>C	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000385771	16	23647662	16	23636341	385771	374964	rs755601819	NC_000016.10:23636340:A:G	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.212-8C>T	PALB2		Familial cancer of breast	VCV000768761	16	23647663	16	23636342	768761	778246	rs1387711045	NC_000016.10:23636341:G:A	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.212-9C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000516519	16	23647664	16	23636343	516519	506216	rs1555461884	NC_000016.10:23636342:G:A	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.212-10T>C	PALB2		Familial cancer of breast	VCV003903928	16	23647665	16	23636344	3903928	4019801		NC_000016.10:23636343:A:G	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-13T>C	PALB2		Hereditary cancer-predisposing syndrome	VCV003076164	16	23647668	16	23636347	3076164	3235450	rs2506520226	NC_000016.10:23636346:A:G	single nucleotide variant	intron variant	Uncertain significance	Feb 25, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-14T>G	PALB2		Familial cancer of breast	VCV003904299	16	23647669	16	23636348	3904299	4020171		NC_000016.10:23636347:A:C	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-14T>A	PALB2		Familial cancer of breast	VCV003903727	16	23647669	16	23636348	3903727	4019600		NC_000016.10:23636347:A:T	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-15T>G	PALB2		Familial cancer of breast	VCV003904098	16	23647670	16	23636349	3904098	4019971		NC_000016.10:23636348:A:C	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-16T>A	PALB2		Familial cancer of breast	VCV003904138	16	23647671	16	23636350	3904138	4020011		NC_000016.10:23636349:A:T	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-16T>C	PALB2		Familial cancer of breast	VCV003903479	16	23647671	16	23636350	3903479	4019352		NC_000016.10:23636349:A:G	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-16T>G	PALB2		Familial cancer of breast	VCV001545441	16	23647671	16	23636350	1545441	1559162	rs1435563021	NC_000016.10:23636349:A:C	single nucleotide variant	intron variant	Likely benign	Dec 13, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-17A>C	PALB2		Familial cancer of breast	VCV003903899	16	23647672	16	23636351	3903899	4019772		NC_000016.10:23636350:T:G	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-17A>G	PALB2		Familial cancer of breast	VCV003903697	16	23647672	16	23636351	3903697	4019570		NC_000016.10:23636350:T:C	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-17A>T	PALB2		Familial cancer of breast	VCV001547129	16	23647672	16	23636351	1547129	1571672	rs1322250562	NC_000016.10:23636350:T:A	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.212-18C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492178	16	23647673	16	23636352	492178	485069	rs1555461886	NC_000016.10:23636351:G:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.212-19A>G	PALB2		Familial cancer of breast	VCV002904890	16	23647674	16	23636353	2904890	3069084	rs2142448709	NC_000016.10:23636352:T:C	single nucleotide variant	intron variant	Likely benign	Oct 9, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-25T>G	PALB2		not specified	VCV003256300	16	23647680	16	23636359	3256300	3415063		NC_000016.10:23636358:A:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.212-33A>C	PALB2		Familial cancer of breast	VCV000126634	16	23647688	16	23636367	126634	132144	rs515726079	NC_000016.10:23636366:T:G	single nucleotide variant	intron variant	Likely benign	Jun 15, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.212-45T>C	PALB2		Hereditary breast ovarian cancer syndrome|not specified	VCV001678972	16	23647700	16	23636379	1678972	1670766	rs528563270	NC_000016.10:23636378:A:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.212-58A>C	PALB2		not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 5	VCV000126635	16	23647713	16	23636392	126635	132145	rs80291632	NC_000016.10:23636391:T:G	single nucleotide variant	intron variant	Benign/Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.212-183T>G	PALB2		not provided	VCV000677009	16	23647838	16	23636517	677009	667448	rs60253267	NC_000016.10:23636516:A:C	single nucleotide variant	intron variant	Likely benign	Jun 15, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+320G>A	PALB2		not provided	VCV001248658	16	23648851	16	23637530	1248658	1239027	rs377343	NC_000016.10:23637529:C:T	single nucleotide variant	intron variant	Benign	Mar 6, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+274C>T	PALB2		not provided	VCV000679723	16	23648897	16	23637576	679723	668444	rs13332044	NC_000016.10:23637575:G:A	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+272C>T	PALB2		Familial cancer of breast	VCV002677450	16	23648899	16	23637578	2677450	2836321	rs2506529969	NC_000016.10:23637577:G:A	single nucleotide variant	intron variant	Uncertain significance	Jun 12, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+191A>T	PALB2		not provided	VCV000677858	16	23648980	16	23637659	677858	667450	rs150117355	NC_000016.10:23637658:T:A	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+166T>C	PALB2		not provided	VCV000677008	16	23649005	16	23637684	677008	668259	rs116577988	NC_000016.10:23637683:A:G	single nucleotide variant	intron variant	Likely benign	Jun 15, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+64T>C	PALB2		Hereditary breast ovarian cancer syndrome	VCV001678974	16	23649107	16	23637786	1678974	1670768	rs1967096537	NC_000016.10:23637785:A:G	single nucleotide variant	intron variant	Likely benign	Apr 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+19C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000492176	16	23649152	16	23637831	492176	485078	rs1555462022	NC_000016.10:23637830:G:A	single nucleotide variant	intron variant	Likely benign	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.211+18A>G	PALB2		Familial cancer of breast	VCV002101259	16	23649153	16	23637832	2101259	2151279	rs1967097856	NC_000016.10:23637831:T:C	single nucleotide variant	intron variant	Likely benign	Feb 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+17C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000627982	16	23649154	16	23637833	627982	619537	rs1567223868	NC_000016.10:23637832:G:A	single nucleotide variant	intron variant	Likely benign	May 25, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.211+15T>C	PALB2		Familial cancer of breast	VCV002813584	16	23649156	16	23637835	2813584	2969534	rs2142455155	NC_000016.10:23637834:A:G	single nucleotide variant	intron variant	Likely benign	Dec 2, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+14A>G	PALB2		Familial cancer of breast|not specified	VCV000378316	16	23649157	16	23637836	378316	374965	rs1057520341	NC_000016.10:23637835:T:C	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.211+13C>T	PALB2		Familial cancer of breast	VCV002075028	16	23649158	16	23637837	2075028	2123826	rs2142455173	NC_000016.10:23637836:G:A	single nucleotide variant	intron variant	Likely benign	Jan 5, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+12C>T	PALB2		Familial cancer of breast	VCV002899799	16	23649159	16	23637838	2899799	3067886	rs1967098029	NC_000016.10:23637837:G:A	single nucleotide variant	intron variant	Likely benign	Jan 5, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+10G>T	PALB2		Familial cancer of breast	VCV001115426	16	23649161	16	23637840	1115426	1103719	rs1555462023	NC_000016.10:23637839:C:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.211+10G>A	PALB2		Familial cancer of breast	VCV000530248	16	23649161	16	23637840	530248	530190	rs1555462023	NC_000016.10:23637839:C:T	single nucleotide variant	intron variant	Likely benign	Dec 14, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+9A>G	PALB2		Familial cancer of breast	VCV000759041	16	23649162	16	23637841	759041	776525	rs1597101242	NC_000016.10:23637840:T:C	single nucleotide variant	intron variant	Likely benign	Oct 19, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+7C>G	PALB2		Familial cancer of breast	VCV002815525	16	23649164	16	23637843	2815525	2970196	rs2142455258	NC_000016.10:23637842:G:C	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.211+7C>A	PALB2		Familial cancer of breast	VCV001082089	16	23649164	16	23637843	1082089	1081899	rs2142455258	NC_000016.10:23637842:G:T	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.211+6T>A	PALB2		Familial cancer of breast	VCV000530213	16	23649165	16	23637844	530213	530386	rs1555462024	NC_000016.10:23637843:A:T	single nucleotide variant	intron variant	Uncertain significance	Dec 13, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+4A>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000487005	16	23649167	16	23637846	487005	477686	rs1555462025	NC_000016.10:23637845:T:C	single nucleotide variant	intron variant	Likely benign	Nov 8, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+3A>G	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001017791	16	23649168	16	23637847	1017791	1012049	rs1324112672	NC_000016.10:23637846:T:C	single nucleotide variant	intron variant	Uncertain significance	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.211+2T>C	PALB2		Familial cancer of breast	VCV000835687	16	23649169	16	23637848	835687	852649	rs1967098495	NC_000016.10:23637847:A:G	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Nov 20, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+1G>C	PALB2		Familial cancer of breast	VCV003772921	16	23649170	16	23637849	3772921	3889071		NC_000016.10:23637848:C:G	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Oct 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.211+1G>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Hereditary breast ovarian cancer syndrome	VCV000650958	16	23649170	16	23637849	650958	652725	rs1555462026	NC_000016.10:23637848:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.211+1G>A	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000492177	16	23649170	16	23637849	492177	484691	rs1555462026	NC_000016.10:23637848:C:T	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.211G>A (p.Glu71Lys)	PALB2	E71K, E51K	Familial cancer of breast	VCV002111364	16	23649171	16	23637850	2111364	2163939	rs2142455366	NC_000016.10:23637849:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.210A>G (p.Ser70=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482003	16	23649172	16	23637851	482003	477741	rs786202650	NC_000016.10:23637850:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.210A>C (p.Ser70=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000186040	16	23649172	16	23637851	186040	184294	rs786202650	NC_000016.10:23637850:T:G	single nucleotide variant	synonymous variant	Likely benign	Aug 9, 2014	criteria provided, single submitter							
NM_024675.4(PALB2):c.209C>G (p.Ser70Ter)	PALB2	S70*	Familial cancer of breast	VCV001351078	16	23649173	16	23637852	1351078	1407428	rs763745734	NC_000016.10:23637851:G:C	single nucleotide variant	nonsense	Pathogenic	Sep 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.208T>G (p.Ser70Ala)	PALB2	S70A, S50A	Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast	VCV003666202	16	23649174	16	23637853	3666202	3792008		NC_000016.10:23637852:A:C	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.208T>C (p.Ser70Pro)	PALB2	S70P	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000182781	16	23649174	16	23637853	182781	180753	rs730881900	NC_000016.10:23637852:A:G	single nucleotide variant	missense variant	Uncertain significance	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.207C>T (p.His69=)	PALB2		Hereditary cancer-predisposing syndrome	VCV000830093	16	23649175	16	23637854	830093	818557	rs1567223897	NC_000016.10:23637853:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.207C>A (p.His69Gln)	PALB2	H69Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628559	16	23649175	16	23637854	628559	618449	rs1567223897	NC_000016.10:23637853:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.206A>G (p.His69Arg)	PALB2	H69R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001508019	16	23649176	16	23637855	1508019	1442673	rs749443090	NC_000016.10:23637854:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.206A>C (p.His69Pro)	PALB2	H69P	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000480241	16	23649176	16	23637855	480241	477694	rs749443090	NC_000016.10:23637854:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.206A>T (p.His69Leu)	PALB2	H69L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not provided	VCV000410167	16	23649176	16	23637855	410167	401586	rs749443090	NC_000016.10:23637854:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 27, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.205C>T (p.His69Tyr)	PALB2	H69Y	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|not specified|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000245654	16	23649177	16	23637856	245654	244977	rs879253891	NC_000016.10:23637855:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.204A>G (p.Lys68=)	PALB2		not provided|Familial cancer of breast	VCV002028010	16	23649178	16	23637857	2028010	2078221	rs2142455551	NC_000016.10:23637856:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Aug 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.201A>G (p.Leu67=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000378315	16	23649181	16	23637860	378315	375271	rs1057520340	NC_000016.10:23637859:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.200T>C (p.Leu67Pro)	PALB2	L67P	Familial cancer of breast	VCV001467117	16	23649182	16	23637861	1467117	1346744	rs2142455603	NC_000016.10:23637860:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.199C>T (p.Leu67=)	PALB2		Familial cancer of breast	VCV003903943	16	23649183	16	23637862	3903943	4019816		NC_000016.10:23637861:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.199C>G (p.Leu67Val)	PALB2	L67V	Hereditary cancer-predisposing syndrome	VCV000820504	16	23649183	16	23637862	820504	812851	rs1597101301	NC_000016.10:23637861:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.197A>G (p.Gln66Arg)	PALB2	Q66R	Familial cancer of breast	VCV001020048	16	23649185	16	23637864	1020048	1012050	rs1967099408	NC_000016.10:23637863:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.196C>T (p.Gln66Ter)	PALB2	Q66*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|not provided|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Hereditary breast ovarian cancer syndrome	VCV000126629	16	23649186	16	23637865	126629	132139	rs180177083	NC_000016.10:23637864:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.195G>T (p.Pro65=)	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000506807	16	23649187	16	23637866	506807	505532	rs751176316	NC_000016.10:23637865:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.195G>A (p.Pro65=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|not specified	VCV000184751	16	23649187	16	23637866	184751	184295	rs751176316	NC_000016.10:23637865:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.194C>G (p.Pro65Arg)	PALB2	P65R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000233066	16	23649188	16	23637867	233066	235329	rs62625272	NC_000016.10:23637866:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.194C>T (p.Pro65Leu)	PALB2	P65L	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000128124	16	23649188	16	23637867	128124	133581	rs62625272	NC_000016.10:23637866:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 11, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.193C>T (p.Pro65Ser)	PALB2	P65S, P45S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001783034	16	23649189	16	23637868	1783034	1842979	rs1229828972	NC_000016.10:23637867:G:A	single nucleotide variant	missense variant	Uncertain significance	May 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.193C>G (p.Pro65Ala)	PALB2	P65A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000482012	16	23649189	16	23637868	482012	477744	rs1229828972	NC_000016.10:23637867:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 27, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.192A>C (p.Ser64=)	PALB2		Familial cancer of breast	VCV003903851	16	23649190	16	23637869	3903851	4019724		NC_000016.10:23637868:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.192A>G (p.Ser64=)	PALB2		Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000484192	16	23649190	16	23637869	484192	477701	rs1555462038	NC_000016.10:23637868:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 6, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.191C>A (p.Ser64Ter)	PALB2	S44*, S64*	Familial cancer of breast	VCV002584302	16	23649191	16	23637870	2584302	2751868	rs1567223942	NC_000016.10:23637869:G:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Apr 26, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.191C>T (p.Ser64Leu)	PALB2	S64L	PALB2-related disorder|Hereditary cancer|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000630469	16	23649191	16	23637870	630469	618450	rs1567223942	NC_000016.10:23637869:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.189C>T (p.Leu63=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002784762	16	23649193	16	23637872	2784762	2938564	rs1788725990	NC_000016.10:23637871:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.188T>C (p.Leu63Pro)	PALB2	L63P	Familial cancer of breast	VCV000946683	16	23649194	16	23637873	946683	927746	rs1967100204	NC_000016.10:23637872:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.187C>G (p.Leu63Val)	PALB2	L63V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000484196	16	23649195	16	23637874	484196	478313	rs730881899	NC_000016.10:23637873:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 25, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.187C>T (p.Leu63Phe)	PALB2	L63F	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000182780	16	23649195	16	23637874	182780	180754	rs730881899	NC_000016.10:23637873:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.184G>T (p.Asp62Tyr)	PALB2	D62Y, D42Y	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5	VCV002761273	16	23649198	16	23637877	2761273	2925039	rs1967100410	NC_000016.10:23637876:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.184G>A (p.Asp62Asn)	PALB2	D62N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000946024	16	23649198	16	23637877	946024	927747	rs1967100410	NC_000016.10:23637876:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.182A>G (p.Gln61Arg)	PALB2	Q41R, Q61R	Familial cancer of breast	VCV002149927	16	23649200	16	23637879	2149927	1881393	rs1354687901	NC_000016.10:23637878:T:C	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.182A>T (p.Gln61Leu)	PALB2	Q41L, Q61L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001983037	16	23649200	16	23637879	1983037	2035795	rs1354687901	NC_000016.10:23637878:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 4, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.181C>T (p.Gln61Ter)	PALB2	Q61*	Familial cancer of breast	VCV000934287	16	23649201	16	23637880	934287	937384	rs1967100637	NC_000016.10:23637879:G:A	single nucleotide variant	nonsense	Pathogenic	Sep 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.180G>A (p.Gln60=)	PALB2		Familial cancer of breast	VCV001093170	16	23649202	16	23637881	1093170	1081900	rs1354445034	NC_000016.10:23637880:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 27, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.178C>T (p.Gln60Ter)	PALB2	Q60*	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000265704	16	23649204	16	23637883	265704	260110	rs886039747	NC_000016.10:23637882:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Oct 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.177T>A (p.Ser59=)	PALB2		Familial cancer of breast	VCV002111963	16	23649205	16	23637884	2111963	2160784	rs1060504707	NC_000016.10:23637883:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.177T>C (p.Ser59=)	PALB2		Familial cancer of breast	VCV000415982	16	23649205	16	23637884	415982	401870	rs1060504707	NC_000016.10:23637883:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.176C>T (p.Ser59Phe)	PALB2	S59F	Hereditary cancer-predisposing syndrome	VCV000921699	16	23649206	16	23637885	921699	913706	rs1967100960	NC_000016.10:23637884:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.175T>A (p.Ser59Thr)	PALB2	S39T, S59T	Familial cancer of breast	VCV003664315	16	23649207	16	23637886	3664315	3795474		NC_000016.10:23637885:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 3, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.174G>T (p.Leu58Phe)	PALB2	L58F, L38F	Familial cancer of breast	VCV001993884	16	23649208	16	23637887	1993884	2059546	rs775243719	NC_000016.10:23637886:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.174G>C (p.Leu58Phe)	PALB2	L58F, L38F	Familial cancer of breast	VCV001990714	16	23649208	16	23637887	1990714	2044653	rs775243719	NC_000016.10:23637886:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.173T>C (p.Leu58Ser)	PALB2	L58S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000570960	16	23649209	16	23637888	570960	568034	rs1567223972	NC_000016.10:23637887:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.172T>G (p.Leu58Val)	PALB2	L58V	Familial cancer of breast	VCV001464148	16	23649210	16	23637889	1464148	1435819	rs1597101395	NC_000016.10:23637888:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.172T>C (p.Leu58=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000743919	16	23649210	16	23637889	743919	755033	rs1597101395	NC_000016.10:23637888:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.170G>C (p.Cys57Ser)	PALB2	C57S	Hereditary cancer-predisposing syndrome	VCV000630448	16	23649212	16	23637891	630448	618451	rs876660029	NC_000016.10:23637890:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.170G>A (p.Cys57Tyr)	PALB2	C57Y	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000241532	16	23649212	16	23637891	241532	242392	rs876660029	NC_000016.10:23637890:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.170G>T (p.Cys57Phe)	PALB2	C57F	Hereditary cancer-predisposing syndrome	VCV000232856	16	23649212	16	23637891	232856	235330	rs876660029	NC_000016.10:23637890:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.169T>A (p.Cys57Ser)	PALB2	C57S	Hereditary cancer-predisposing syndrome	VCV000185393	16	23649213	16	23637892	185393	184296	rs786202140	NC_000016.10:23637891:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2014	criteria provided, single submitter							
NM_024675.4(PALB2):c.168T>G (p.Asp56Glu)	PALB2	D56E	Familial cancer of breast	VCV000972629	16	23649214	16	23637893	972629	957709	rs1203135643	NC_000016.10:23637892:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.168T>C (p.Asp56=)	PALB2		Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000629043	16	23649214	16	23637893	629043	618452	rs1203135643	NC_000016.10:23637892:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.167A>G (p.Asp56Gly)	PALB2	D56G	Familial cancer of breast	VCV000572118	16	23649215	16	23637894	572118	573990	rs1567223986	NC_000016.10:23637893:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.166G>T (p.Asp56Tyr)	PALB2	D36Y, D56Y	Familial cancer of breast	VCV001718525	16	23649216	16	23637895	1718525	1778885	rs2142456520	NC_000016.10:23637894:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.165A>G (p.Gln55=)	PALB2		Familial cancer of breast	VCV003903848	16	23649217	16	23637896	3903848	4019721		NC_000016.10:23637895:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.164A>T (p.Gln55Leu)	PALB2	Q55L	Familial cancer of breast	VCV000460905	16	23649218	16	23637897	460905	465572	rs1555462056	NC_000016.10:23637896:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.163C>A (p.Gln55Lys)	PALB2	Q55K	not specified	VCV001697762	16	23649219	16	23637898	1697762	1690146	rs1064793772	NC_000016.10:23637897:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.163C>G (p.Gln55Glu)	PALB2	Q55E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628347	16	23649219	16	23637898	628347	618453	rs1064793772	NC_000016.10:23637897:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.163C>T (p.Gln55Ter)	PALB2	Q55*	not provided|Hereditary cancer-predisposing syndrome	VCV000419287	16	23649219	16	23637898	419287	409570	rs1064793772	NC_000016.10:23637897:G:A	single nucleotide variant	nonsense	Pathogenic	Dec 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.162A>G (p.Glu54=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002774024	16	23649220	16	23637899	2774024	2934755	rs2142456617	NC_000016.10:23637898:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.161A>G (p.Glu54Gly)	PALB2	E54G	Familial cancer of breast|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000182779	16	23649221	16	23637900	182779	180755	rs730881898	NC_000016.10:23637899:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.160G>T (p.Glu54Ter)	PALB2	E54*, E34*	Hereditary cancer-predisposing syndrome	VCV003927436	16	23649222	16	23637901	3927436	4047069		NC_000016.10:23637900:C:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	May 13, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.160G>A (p.Glu54Lys)	PALB2	E34K, E54K	Hereditary cancer-predisposing syndrome	VCV003927428	16	23649222	16	23637901	3927428	4047061		NC_000016.10:23637900:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Apr 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.160G>C (p.Glu54Gln)	PALB2	E54Q	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000628348	16	23649222	16	23637901	628348	618454	rs1567224004	NC_000016.10:23637900:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.159A>T (p.Glu53Asp)	PALB2	E33D, E53D	Hereditary cancer-predisposing syndrome	VCV001776078	16	23649223	16	23637902	1776078	1827877	rs2142456717	NC_000016.10:23637901:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.157G>C (p.Glu53Gln)	PALB2	E33Q, E53Q	Hereditary cancer-predisposing syndrome	VCV001775666	16	23649225	16	23637904	1775666	1827466	rs1184603042	NC_000016.10:23637903:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.157G>A (p.Glu53Lys)	PALB2	E53K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530120	16	23649225	16	23637904	530120	529852	rs1184603042	NC_000016.10:23637903:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.156A>T (p.Val52=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003927456	16	23649226	16	23637905	3927456	4047089		NC_000016.10:23637904:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 1, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.156A>G (p.Val52=)	PALB2		Familial cancer of breast	VCV002005053	16	23649226	16	23637905	2005053	2055681	rs2142456776	NC_000016.10:23637904:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.155T>C (p.Val52Ala)	PALB2	V52A	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000246458	16	23649227	16	23637906	246458	244978	rs373970237	NC_000016.10:23637905:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.154G>A (p.Val52Ile)	PALB2	V52I	Hereditary cancer-predisposing syndrome|not provided	VCV000231918	16	23649228	16	23637907	231918	235332	rs876659444	NC_000016.10:23637906:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 29, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.153A>G (p.Thr51=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001774791	16	23649229	16	23637908	1774791	1833377	rs1555462061	NC_000016.10:23637907:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jan 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.153A>T (p.Thr51=)	PALB2		not specified	VCV000517010	16	23649229	16	23637908	517010	506218	rs1555462061	NC_000016.10:23637907:T:A	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.152C>A (p.Thr51Lys)	PALB2	T51K, T31K	Hereditary cancer-predisposing syndrome	VCV002567577	16	23649230	16	23637909	2567577	2731219	rs1967102805	NC_000016.10:23637908:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 23, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.151A>T (p.Thr51Ser)	PALB2	T51S	Familial cancer of breast	VCV001060329	16	23649231	16	23637910	1060329	1049534	rs2142456898	NC_000016.10:23637909:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.150A>G (p.Lys50=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003413410	16	23649232	16	23637911	3413410	3574633		NC_000016.10:23637910:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Sep 30, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.150A>T (p.Lys50Asn)	PALB2	K50N	Familial cancer of breast	VCV001007419	16	23649232	16	23637911	1007419	996820	rs1967102886	NC_000016.10:23637910:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.149A>C (p.Lys50Thr)	PALB2	K50T	Familial cancer of breast|not specified|not provided|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000220112	16	23649233	16	23637912	220112	222483	rs763598472	NC_000016.10:23637911:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.148A>G (p.Lys50Glu)	PALB2	K50E	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000928094	16	23649234	16	23637913	928094	913707	rs1967103124	NC_000016.10:23637912:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.147G>A (p.Lys49=)	PALB2		Familial cancer of breast	VCV003904218	16	23649235	16	23637914	3904218	4020091		NC_000016.10:23637913:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.145A>G (p.Lys49Glu)	PALB2	K49E	Familial cancer of breast	VCV001413358	16	23649237	16	23637916	1413358	1461400	rs2142457092	NC_000016.10:23637915:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.143T>G (p.Ile48Ser)	PALB2	I28S, I48S	Familial cancer of breast	VCV003729069	16	23649239	16	23637918	3729069	3862004		NC_000016.10:23637917:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 16, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.142A>T (p.Ile48Phe)	PALB2	I48F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV001344535	16	23649240	16	23637919	1344535	1336238	rs786203134	NC_000016.10:23637918:T:A	single nucleotide variant	missense variant	Uncertain significance		criteria provided, single submitter							
NM_024675.4(PALB2):c.142A>G (p.Ile48Val)	PALB2	I48V	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000186676	16	23649240	16	23637919	186676	184297	rs786203134	NC_000016.10:23637918:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.141T>C (p.Ser47=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003227989	16	23649241	16	23637920	3227989	3387758	rs2142457174	NC_000016.10:23637919:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 24, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.140C>T (p.Ser47Phe)	PALB2	S47F, S27F	Familial cancer of breast	VCV003695580	16	23649242	16	23637921	3695580	3821987		NC_000016.10:23637920:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.140C>A (p.Ser47Tyr)	PALB2	S47Y	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000231887	16	23649242	16	23637921	231887	235333	rs876659427	NC_000016.10:23637920:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.137A>G (p.His46Arg)	PALB2	H46R	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530102	16	23649245	16	23637924	530102	529857	rs1290624507	NC_000016.10:23637923:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.136C>T (p.His46Tyr)	PALB2	H26Y, H46Y	Familial cancer of breast	VCV002677452	16	23649246	16	23637925	2677452	2836324	rs2142457282	NC_000016.10:23637924:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.135G>C (p.Lys45Asn)	PALB2	K45N	Familial cancer of breast	VCV000951617	16	23649247	16	23637926	951617	927748	rs753270291	NC_000016.10:23637925:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.135G>A (p.Lys45=)	PALB2		Familial cancer of breast	VCV000230997	16	23649247	16	23637926	230997	235334	rs753270291	NC_000016.10:23637925:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.133A>C (p.Lys45Gln)	PALB2	K45Q	Hereditary cancer-predisposing syndrome	VCV000484214	16	23649249	16	23637928	484214	477749	rs1555462067	NC_000016.10:23637927:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.132T>G (p.Ile44Met)	PALB2	I44M	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast	VCV000460889	16	23649250	16	23637929	460889	466312	rs756856792	NC_000016.10:23637928:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.130A>T (p.Ile44Phe)	PALB2	I24F, I44F	Hereditary cancer-predisposing syndrome	VCV003927453	16	23649252	16	23637931	3927453	4047086		NC_000016.10:23637930:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 31, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.130A>G (p.Ile44Val)	PALB2	I44V, I24V	Familial cancer of breast	VCV001964731	16	23649252	16	23637931	1964731	2031193	rs2506535892	NC_000016.10:23637930:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.129G>C (p.Lys43Asn)	PALB2	K23N, K43N	Hereditary cancer-predisposing syndrome	VCV001769328	16	23649253	16	23637932	1769328	1835765	rs551111938	NC_000016.10:23637931:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.129G>A (p.Lys43=)	PALB2		Familial cancer of breast	VCV001122488	16	23649253	16	23637932	1122488	1125133	rs551111938	NC_000016.10:23637931:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.129G>T (p.Lys43Asn)	PALB2	K43N	Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Breast and/or ovarian cancer|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480233	16	23649253	16	23637932	480233	477806	rs551111938	NC_000016.10:23637931:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.127A>G (p.Lys43Glu)	PALB2	K43E	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3	VCV000410107	16	23649255	16	23637934	410107	401593	rs765125459	NC_000016.10:23637933:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.123T>A (p.Ala41=)	PALB2		Familial cancer of breast	VCV001540614	16	23649259	16	23637938	1540614	1598630	rs1967104067	NC_000016.10:23637937:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.122C>T (p.Ala41Val)	PALB2	A41V	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000818650	16	23649260	16	23637939	818650	812852	rs1597101507	NC_000016.10:23637938:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.121G>C (p.Ala41Pro)	PALB2	A41P	Familial cancer of breast	VCV001403275	16	23649261	16	23637940	1403275	1470498	rs2142457610	NC_000016.10:23637939:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.120A>T (p.Arg40Ser)	PALB2	R20S, R40S	Hereditary cancer-predisposing syndrome	VCV003413498	16	23649262	16	23637941	3413498	3574721		NC_000016.10:23637940:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.120A>G (p.Arg40=)	PALB2		Hereditary cancer-predisposing syndrome	VCV002774025	16	23649262	16	23637941	2774025	2934756	rs1362378434	NC_000016.10:23637940:T:C	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Likely benign	Sep 8, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.119G>T (p.Arg40Ile)	PALB2	R20I, R40I	Hereditary cancer-predisposing syndrome	VCV003413499	16	23649263	16	23637942	3413499	3574722		NC_000016.10:23637941:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 17, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.119G>C (p.Arg40Thr)	PALB2	R40T	not provided|Hereditary cancer-predisposing syndrome	VCV000830090	16	23649263	16	23637942	830090	818560	rs573118236	NC_000016.10:23637941:C:G	single nucleotide variant	missense variant	Uncertain significance	May 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.119G>A (p.Arg40Lys)	PALB2	R40K	Breast-ovarian cancer, familial, susceptibility to, 5|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000449888	16	23649263	16	23637942	449888	445549	rs573118236	NC_000016.10:23637941:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 1, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.117A>G (p.Gln39=)	PALB2		Familial cancer of breast	VCV001022163	16	23649265	16	23637944	1022163	1012051	rs1967104762	NC_000016.10:23637943:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.116A>G (p.Gln39Arg)	PALB2	Q19R, Q39R	Familial cancer of breast	VCV001881170	16	23649266	16	23637945	1881170	1946978	rs1555462083	NC_000016.10:23637944:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.116A>T (p.Gln39Leu)	PALB2	Q39L	Familial cancer of breast	VCV000530084	16	23649266	16	23637945	530084	530387	rs1555462083	NC_000016.10:23637944:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.115C>G (p.Gln39Glu)	PALB2	Q19E, Q39E	Familial cancer of breast|not provided	VCV002776456	16	23649267	16	23637946	2776456	2946247	rs876659319	NC_000016.10:23637945:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.115C>T (p.Gln39Ter)	PALB2	Q39*	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000231718	16	23649267	16	23637946	231718	235335	rs876659319	NC_000016.10:23637945:G:A	single nucleotide variant	nonsense	Pathogenic	Feb 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.114C>T (p.Ala38=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000509400	16	23649268	16	23637947	509400	506223	rs1555462085	NC_000016.10:23637946:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.113C>T (p.Ala38Val)	PALB2	A38V	Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Ovarian cancer|Familial cancer of breast	VCV000572721	16	23649269	16	23637948	572721	570025	rs371875379	NC_000016.10:23637947:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.113C>G (p.Ala38Gly)	PALB2	A38G	not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N	VCV000318561	16	23649269	16	23637948	318561	334409	rs371875379	NC_000016.10:23637947:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.112G>T (p.Ala38Ser)	PALB2	A18S, A38S	Familial cancer of breast	VCV003725630	16	23649270	16	23637949	3725630	3861138		NC_000016.10:23637948:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 19, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.112G>C (p.Ala38Pro)	PALB2	A38P, A18P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002699119	16	23649270	16	23637949	2699119	2865242	rs2142457890	NC_000016.10:23637948:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jun 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.111T>A (p.Arg37=)	PALB2		Familial cancer of breast	VCV001114722	16	23649271	16	23637950	1114722	1103720	rs1555462089	NC_000016.10:23637949:A:T	single nucleotide variant	synonymous variant	Likely benign	Nov 2, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.111T>C (p.Arg37=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000484168	16	23649271	16	23637950	484168	477704	rs1555462089	NC_000016.10:23637949:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.110G>T (p.Arg37Leu)	PALB2	R37L	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000490065	16	23649272	16	23637951	490065	482906	rs202194596	NC_000016.10:23637950:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.110G>A (p.Arg37His)	PALB2	R37H	Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000126590	16	23649272	16	23637951	126590	132100	rs202194596	NC_000016.10:23637950:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 25, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.109C>G (p.Arg37Gly)	PALB2	R37G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460878	16	23649273	16	23637952	460878	466316	rs200048921	NC_000016.10:23637951:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109C>T (p.Arg37Cys)	PALB2	R37C	not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000220218	16	23649273	16	23637952	220218	222484	rs200048921	NC_000016.10:23637951:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.109C>A (p.Arg37Ser)	PALB2	R37S	Familial cancer of breast	VCV000185108	16	23649273	16	23637952	185108	184298	rs200048921	NC_000016.10:23637951:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.109-1G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002673827	16	23649274	16	23637953	2673827	2841330	rs2142458017	NC_000016.10:23637952:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-2A>T	PALB2		Familial cancer of breast	VCV002673826	16	23649275	16	23637954	2673826	2836322	rs730881897	NC_000016.10:23637953:T:A	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Sep 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-2A>C	PALB2		Hereditary cancer-predisposing syndrome	VCV000822146	16	23649275	16	23637954	822146	815634	rs730881897	NC_000016.10:23637953:T:G	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Mar 30, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.109-2A>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|not provided	VCV000182778	16	23649275	16	23637954	182778	180756	rs730881897	NC_000016.10:23637953:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-4C>T	PALB2		Familial cancer of breast	VCV001648539	16	23649277	16	23637956	1648539	1600692	rs778124229	NC_000016.10:23637955:G:A	single nucleotide variant	intron variant	Likely benign	Apr 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.109-4C>G	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified	VCV000390614	16	23649277	16	23637956	390614	374971	rs778124229	NC_000016.10:23637955:G:C	single nucleotide variant	intron variant	Likely benign	Mar 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-5T>C	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000530241	16	23649278	16	23637957	530241	530389	rs749299119	NC_000016.10:23637956:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.109-7C>A	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000516436	16	23649280	16	23637959	516436	505272	rs368705933	NC_000016.10:23637958:G:T	single nucleotide variant	intron variant	Likely benign	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-7C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492147	16	23649280	16	23637959	492147	485081	rs368705933	NC_000016.10:23637958:G:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-8T>C	PALB2		Familial cancer of breast	VCV000749423	16	23649281	16	23637960	749423	760303	rs1597101610	NC_000016.10:23637959:A:G	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-9C>T	PALB2		Familial cancer of breast	VCV003903494	16	23649282	16	23637961	3903494	4019367		NC_000016.10:23637960:G:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.109-11G>A	PALB2		Familial cancer of breast	VCV003904067	16	23649284	16	23637963	3904067	4019940		NC_000016.10:23637962:C:T	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.109-11G>T	PALB2		Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome	VCV002101452	16	23649284	16	23637963	2101452	2147710	rs2506536955	NC_000016.10:23637962:C:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-12T>C	PALB2		Familial cancer of breast	VCV003904019	16	23649285	16	23637964	3904019	4019892		NC_000016.10:23637963:A:G	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.109-12T>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|PALB2-related cancer predisposition	VCV000490064	16	23649285	16	23637964	490064	482937	rs774949203	NC_000016.10:23637963:A:T	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Apr 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-13T>C	PALB2		Hereditary cancer-predisposing syndrome	VCV001170971	16	23649286	16	23637965	1170971	1161323	rs1445277569	NC_000016.10:23637964:A:G	single nucleotide variant	intron variant	Likely benign	May 9, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.109-16T>A	PALB2		Familial cancer of breast	VCV002850604	16	23649289	16	23637968	2850604	3012960	rs2142458255	NC_000016.10:23637967:A:T	single nucleotide variant	intron variant	Likely benign	Mar 31, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.109-18T>G	PALB2		Familial cancer of breast	VCV002189295	16	23649291	16	23637970	2189295	1911638	rs1555462094	NC_000016.10:23637969:A:C	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.109-18T>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492146	16	23649291	16	23637970	492146	484839	rs1555462094	NC_000016.10:23637969:A:G	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-20G>A	PALB2		Familial cancer of breast	VCV003660810	16	23649293	16	23637972	3660810	3794525		NC_000016.10:23637971:C:T	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.109-39A>C	PALB2		Familial cancer of breast	VCV002677449	16	23649312	16	23637991	2677449	2836320	rs2142458575	NC_000016.10:23637990:T:G	single nucleotide variant	intron variant	Uncertain significance	Jul 2, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+21A>G	PALB2		not specified	VCV002576374	16	23649370	16	23638049	2576374	2741270	rs751308824	NC_000016.10:23638048:T:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+17C>T	PALB2		Familial cancer of breast	VCV002197248	16	23649374	16	23638053	2197248	1926830	rs1967108386	NC_000016.10:23638052:G:A	single nucleotide variant	intron variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+15T>A	PALB2		Familial cancer of breast	VCV001968360	16	23649376	16	23638055	1968360	2032235	rs544611459	NC_000016.10:23638054:A:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+13T>G	PALB2		Familial cancer of breast	VCV003650831	16	23649378	16	23638057	3650831	3781561		NC_000016.10:23638056:A:C	single nucleotide variant	intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+12G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified	VCV000492145	16	23649379	16	23638058	492145	485092	rs558824045	NC_000016.10:23638057:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.108+11C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000919858	16	23649380	16	23638059	919858	916426	rs754110994	NC_000016.10:23638058:G:A	single nucleotide variant	intron variant	Likely benign	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.108+9A>T	PALB2		Familial cancer of breast	VCV003904640	16	23649382	16	23638061	3904640	4020512		NC_000016.10:23638060:T:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+9A>G	PALB2		not provided|Familial cancer of breast	VCV000422441	16	23649382	16	23638061	422441	409572	rs1064795783	NC_000016.10:23638060:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 12, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.108+8A>G	PALB2		Familial cancer of breast	VCV000530260	16	23649383	16	23638062	530260	530193	rs1419065219	NC_000016.10:23638061:T:C	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.108+6T>G	PALB2		Familial cancer of breast	VCV000655921	16	23649385	16	23638064	655921	652994	rs1567224136	NC_000016.10:23638063:A:C	single nucleotide variant	intron variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+5G>A	PALB2		Familial cancer of breast	VCV000568096	16	23649386	16	23638065	568096	573991	rs1567224137	NC_000016.10:23638064:C:T	single nucleotide variant	intron variant	Likely benign	Oct 3, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+4A>G	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480935	16	23649387	16	23638066	480935	477809	rs1555462100	NC_000016.10:23638065:T:C	single nucleotide variant	intron variant	Uncertain significance	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.108+3A>G	PALB2		Familial cancer of breast	VCV003723837	16	23649388	16	23638067	3723837	3860653		NC_000016.10:23638066:T:C	single nucleotide variant	intron variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+2T>G	PALB2		Familial cancer of breast	VCV002573252	16	23649389	16	23638068	2573252	2738200	rs2142459705	NC_000016.10:23638067:A:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.108+2T>C	PALB2		Familial cancer of breast	VCV000995903	16	23649389	16	23638068	995903	983603	rs2142459705	NC_000016.10:23638067:A:G	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Dec 15, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+1G>C	PALB2		Hereditary cancer-predisposing syndrome	VCV003227980	16	23649390	16	23638069	3227980	3387749	rs1060499814	NC_000016.10:23638068:C:G	single nucleotide variant	splice donor variant|intron variant	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.108+1G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 3|Breast cancer, susceptibility to|not provided	VCV000402289	16	23649390	16	23638069	402289	389282	rs1060499814	NC_000016.10:23638068:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Mar 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.108G>C (p.Gln36His)	PALB2	Q36H	Familial cancer of breast	VCV002815056	16	23649391	16	23638070	2815056	2973586	rs1567224146	NC_000016.10:23638069:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.108G>A (p.Gln36=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000634802	16	23649391	16	23638070	634802	622560	rs1567224146	NC_000016.10:23638069:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Jun 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.107A>G (p.Gln36Arg)	PALB2	Q36R	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV003208092	16	23649392	16	23638071	3208092	3367684	rs2142459764	NC_000016.10:23638070:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.106C>A (p.Gln36Lys)	PALB2	Q36K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001489813	16	23649393	16	23638072	1489813	1507806	rs757369748	NC_000016.10:23638071:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.106C>T (p.Gln36Ter)	PALB2	Q36*	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000402288	16	23649393	16	23638072	402288	389283	rs757369748	NC_000016.10:23638071:G:A	single nucleotide variant	nonsense	Pathogenic	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.105T>C (p.Leu35=)	PALB2		Familial cancer of breast	VCV001962645	16	23649394	16	23638073	1962645	2010292	rs2142459825	NC_000016.10:23638072:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Sep 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.104T>C (p.Leu35Pro)	PALB2	L35P	Familial cancer of breast	VCV000657328	16	23649395	16	23638074	657328	644494	rs141047069	NC_000016.10:23638073:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.103C>T (p.Leu35Phe)	PALB2	L35F	Hereditary cancer-predisposing syndrome	VCV002774026	16	23649396	16	23638075	2774026	2934757	rs2142459867	NC_000016.10:23638074:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 5, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.102C>T (p.Arg34=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000460870	16	23649397	16	23638076	460870	465574	rs1555462102	NC_000016.10:23638075:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.101G>T (p.Arg34Leu)	PALB2	R34L	Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000186920	16	23649398	16	23638077	186920	184299	rs144944814	NC_000016.10:23638076:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.101G>A (p.Arg34His)	PALB2	R34H	Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|not specified	VCV000141256	16	23649398	16	23638077	141256	150970	rs144944814	NC_000016.10:23638076:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.100C>T (p.Arg34Cys)	PALB2	R34C	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided|Inherited breast cancer and ovarian cancer	VCV000185273	16	23649399	16	23638078	185273	184300	rs373483056	NC_000016.10:23638077:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.98C>A (p.Ala33Asp)	PALB2	A33D	not provided|Familial cancer of breast	VCV001483345	16	23649401	16	23638080	1483345	1380464	rs780769645	NC_000016.10:23638079:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.98C>T (p.Ala33Val)	PALB2	A33V	Familial cancer of breast	VCV001051599	16	23649401	16	23638080	1051599	1049535	rs780769645	NC_000016.10:23638079:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.97G>C (p.Ala33Pro)	PALB2	A33P	Familial cancer of breast|Hereditary breast ovarian cancer syndrome	VCV000569340	16	23649402	16	23638081	569340	568035	rs747302288	NC_000016.10:23638080:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.97G>A (p.Ala33Thr)	PALB2	A33T	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000490089	16	23649402	16	23638081	490089	482943	rs747302288	NC_000016.10:23638080:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.96A>G (p.Leu32=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV003702487	16	23649403	16	23638082	3702487	3838538		NC_000016.10:23638081:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.96A>T (p.Leu32=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003228050	16	23649403	16	23638082	3228050	3387819	rs2142460102	NC_000016.10:23638081:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 1, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.95T>C (p.Leu32Pro)	PALB2	L32P	Familial cancer of breast|not specified	VCV001000626	16	23649404	16	23638083	1000626	996821	rs1967110180	NC_000016.10:23638082:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.94C>A (p.Leu32Ile)	PALB2	L32I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV001041146	16	23649405	16	23638084	1041146	1032547	rs151316635	NC_000016.10:23638083:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.94C>T (p.Leu32=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000507815	16	23649405	16	23638084	507815	505535	rs151316635	NC_000016.10:23638083:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.94C>G (p.Leu32Val)	PALB2	L32V	Breast-ovarian cancer, familial, susceptibility to, 5|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast|Fanconi anemia complementation group N	VCV000126781	16	23649405	16	23638084	126781	132291	rs151316635	NC_000016.10:23638083:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.93A>C (p.Thr31=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001606315	16	23649406	16	23638085	1606315	1625455	rs1597101837	NC_000016.10:23638084:T:G	single nucleotide variant	synonymous variant	Likely benign	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.93A>G (p.Thr31=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000751195	16	23649406	16	23638085	751195	770795	rs1597101837	NC_000016.10:23638084:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.92C>T (p.Thr31Ile)	PALB2	T31I	Familial cancer of breast	VCV000567901	16	23649407	16	23638086	567901	570027	rs1567224182	NC_000016.10:23638085:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.91A>T (p.Thr31Ser)	PALB2	T31S	Familial cancer of breast	VCV002123106	16	23649408	16	23638087	2123106	2181000	rs1967110664	NC_000016.10:23638086:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.91A>G (p.Thr31Ala)	PALB2	T31A	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000850927	16	23649408	16	23638087	850927	843649	rs1967110664	NC_000016.10:23638086:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2020	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.90G>A (p.Lys30=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480242	16	23649409	16	23638088	480242	478324	rs515726130	NC_000016.10:23638087:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.88A>G (p.Lys30Glu)	PALB2	K30E	Familial cancer of breast	VCV001025014	16	23649411	16	23638090	1025014	1012052	rs1967110881	NC_000016.10:23638089:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.87C>T (p.Ser29=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002006812	16	23649412	16	23638091	2006812	2066047	rs2142460349	NC_000016.10:23638090:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.87C>G (p.Ser29Arg)	PALB2	S29R	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001513097	16	23649412	16	23638091	1513097	1381188	rs2142460349	NC_000016.10:23638090:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.86G>T (p.Ser29Ile)	PALB2	S29I	Hereditary cancer-predisposing syndrome	VCV001764364	16	23649413	16	23638092	1764364	1817491	rs1967110973	NC_000016.10:23638091:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.86G>C (p.Ser29Thr)	PALB2	S29T	Hereditary cancer-predisposing syndrome	VCV000830089	16	23649413	16	23638092	830089	818561	rs1967110973	NC_000016.10:23638091:C:G	single nucleotide variant	missense variant	Likely benign	Mar 14, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.85A>G (p.Ser29Gly)	PALB2	S29G	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000188076	16	23649414	16	23638093	188076	186224	rs776110440	NC_000016.10:23638092:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.84C>G (p.Tyr28Ter)	PALB2	Y28*	Familial cancer of breast	VCV001454606	16	23649415	16	23638094	1454606	1444945	rs761533286	NC_000016.10:23638093:G:C	single nucleotide variant	nonsense	Pathogenic	Jun 1, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.84C>A (p.Tyr28Ter)	PALB2	Y28*	Familial cancer of breast	VCV001351198	16	23649415	16	23638094	1351198	1407548	rs761533286	NC_000016.10:23638093:G:T	single nucleotide variant	nonsense	Pathogenic	Mar 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.84C>T (p.Tyr28=)	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5|not specified|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000184820	16	23649415	16	23638094	184820	184301	rs761533286	NC_000016.10:23638093:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.83A>G (p.Tyr28Cys)	PALB2	Y28C	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000126774	16	23649416	16	23638095	126774	132284	rs515726129	NC_000016.10:23638094:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.82T>C (p.Tyr28His)	PALB2	Y28H	not provided|Familial cancer of breast	VCV003360863	16	23649417	16	23638096	3360863	3520074		NC_000016.10:23638095:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.82T>A (p.Tyr28Asn)	PALB2	Y28N	Familial cancer of breast	VCV000410148	16	23649417	16	23638096	410148	401878	rs1060502762	NC_000016.10:23638095:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.81A>G (p.Glu27=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001539349	16	23649418	16	23638097	1539349	1660275	rs2142460493	NC_000016.10:23638096:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.80A>G (p.Glu27Gly)	PALB2	E27G	Familial cancer of breast	VCV001373153	16	23649419	16	23638098	1373153	1452871	rs2142460509	NC_000016.10:23638097:T:C	single nucleotide variant	missense variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.79G>T (p.Glu27Ter)	PALB2	E27*	Familial cancer of breast|not provided|Malignant tumor of breast|Fanconi anemia complementation group N|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome	VCV000241570	16	23649420	16	23638099	241570	242393	rs878855122	NC_000016.10:23638098:C:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.78G>C (p.Arg26Ser)	PALB2	R26S	Hereditary cancer-predisposing syndrome	VCV001761132	16	23649421	16	23638100	1761132	1816747	rs45572434	NC_000016.10:23638099:C:G	single nucleotide variant	missense variant	Uncertain significance	May 12, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.78G>A (p.Arg26=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000379621	16	23649421	16	23638100	379621	375274	rs45572434	NC_000016.10:23638099:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.77G>T (p.Arg26Met)	PALB2	R26M	Familial cancer of breast	VCV000942426	16	23649422	16	23638101	942426	937386	rs1967111702	NC_000016.10:23638100:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.74A>G (p.Lys25Arg)	PALB2	K25R	not specified	VCV000987832	16	23649425	16	23638104	987832	975832	rs1967111893	NC_000016.10:23638103:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.73A>C (p.Lys25Gln)	PALB2	K25Q	Hereditary cancer-predisposing syndrome	VCV000830088	16	23649426	16	23638105	830088	818562	rs1248579792	NC_000016.10:23638104:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.73A>T (p.Lys25Ter)	PALB2	K25*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000628424	16	23649426	16	23638105	628424	618455	rs1248579792	NC_000016.10:23638104:T:A	single nucleotide variant	nonsense	Pathogenic	Jun 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.72G>T (p.Leu24Phe)	PALB2	L24F	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001758207	16	23649427	16	23638106	1758207	1822724	rs587781986	NC_000016.10:23638105:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.72G>A (p.Leu24=)	PALB2		Familial cancer of breast	VCV001152172	16	23649427	16	23638106	1152172	1146022	rs587781986	NC_000016.10:23638105:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.72G>C (p.Leu24Phe)	PALB2	L24F	not provided|Hereditary cancer-predisposing syndrome	VCV000141755	16	23649427	16	23638106	141755	151469	rs587781986	NC_000016.10:23638105:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.71T>G (p.Leu24Trp)	PALB2	L24W	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001757662	16	23649428	16	23638107	1757662	1815860	rs876658653	NC_000016.10:23638106:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.71T>C (p.Leu24Ser)	PALB2	L24S	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000230588	16	23649428	16	23638107	230588	235336	rs876658653	NC_000016.10:23638106:A:G	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.70T>C (p.Leu24=)	PALB2		Familial cancer of breast	VCV003654167	16	23649429	16	23638108	3654167	3782318		NC_000016.10:23638107:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	May 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.66A>T (p.Ala22=)	PALB2		Hereditary cancer-predisposing syndrome	VCV003894435	16	23649433	16	23638112	3894435	4010315		NC_000016.10:23638111:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jan 14, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.66A>G (p.Ala22=)	PALB2		not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N	VCV000381230	16	23649433	16	23638112	381230	374972	rs1057520982	NC_000016.10:23638111:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.65C>T (p.Ala22Val)	PALB2	A22V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000830087	16	23649434	16	23638113	830087	818563	rs1967112519	NC_000016.10:23638112:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.64G>C (p.Ala22Pro)	PALB2	A22P	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001040425	16	23649435	16	23638114	1040425	1032548	rs1473970758	NC_000016.10:23638113:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.63A>G (p.Leu21=)	PALB2		Breast-ovarian cancer, familial, susceptibility to, 5	VCV003780093	16	23649436	16	23638115	3780093	3896060		NC_000016.10:23638114:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.62T>A (p.Leu21Ter)	PALB2	L21*	Breast-ovarian cancer, familial, susceptibility to, 5	VCV002683825	16	23649437	16	23638116	2683825	2844863	rs769240800	NC_000016.10:23638115:A:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Jan 8, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.62T>C (p.Leu21Ser)	PALB2	L21S	Familial cancer of breast	VCV000830086	16	23649437	16	23638116	830086	818564	rs769240800	NC_000016.10:23638115:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.62T>G (p.Leu21Ter)	PALB2	L21*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000439237	16	23649437	16	23638116	439237	432881	rs769240800	NC_000016.10:23638115:A:C	single nucleotide variant	nonsense	Pathogenic	Apr 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.61T>G (p.Leu21Val)	PALB2	L21V	Familial cancer of breast	VCV002693108	16	23649438	16	23638117	2693108	2857092	rs2142461023	NC_000016.10:23638116:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 4, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.60A>G (p.Lys20=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000826186	16	23649439	16	23638118	826186	812855	rs1196162944	NC_000016.10:23638117:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.59A>T (p.Lys20Ile)	PALB2	K20I	Hereditary cancer-predisposing syndrome	VCV000233311	16	23649440	16	23638119	233311	235337	rs876660327	NC_000016.10:23638118:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.58A>T (p.Lys20Ter)	PALB2	K20*	Familial cancer of breast	VCV001677249	16	23649441	16	23638120	1677249	1668881	rs2142461082	NC_000016.10:23638119:T:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Sep 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.57G>A (p.Glu19=)	PALB2		Familial cancer of breast	VCV003903978	16	23649442	16	23638121	3903978	4019851		NC_000016.10:23638120:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.57G>T (p.Glu19Asp)	PALB2	E19D	Hereditary cancer-predisposing syndrome	VCV003228040	16	23649442	16	23638121	3228040	3387809	rs1967112979	NC_000016.10:23638120:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 2, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.57G>C (p.Glu19Asp)	PALB2	E19D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001444734	16	23649442	16	23638121	1444734	1384824	rs1967112979	NC_000016.10:23638120:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.56A>G (p.Glu19Gly)	PALB2	E19G	Hereditary cancer-predisposing syndrome	VCV002567566	16	23649443	16	23638122	2567566	2731208	rs2142461139	NC_000016.10:23638121:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 13, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.55G>A (p.Glu19Lys)	PALB2	E19K	Hereditary cancer-predisposing syndrome	VCV003228039	16	23649444	16	23638123	3228039	3387808	rs2142461160	NC_000016.10:23638122:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.55G>T (p.Glu19Ter)	PALB2	E19*	Familial cancer of breast	VCV002673855	16	23649444	16	23638123	2673855	2841357	rs2142461160	NC_000016.10:23638122:C:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.53A>G (p.Lys18Arg)	PALB2	K18R	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000126758	16	23649446	16	23638125	126758	132268	rs138789658	NC_000016.10:23638124:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.52A>G (p.Lys18Glu)	PALB2	K18E	not specified	VCV002576375	16	23649447	16	23638126	2576375	2741271	rs2142461206	NC_000016.10:23638125:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.52A>C (p.Lys18Gln)	PALB2	K18Q	Familial cancer of breast	VCV001060687	16	23649447	16	23638126	1060687	1049536	rs2142461206	NC_000016.10:23638125:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.51A>G (p.Leu17=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001746006	16	23649448	16	23638127	1746006	1799603	rs2142461231	NC_000016.10:23638126:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.50T>A (p.Leu17Ter)	PALB2	L17*	Familial cancer of breast	VCV002814546	16	23649449	16	23638128	2814546	2976499	rs1567224232	NC_000016.10:23638127:A:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Nov 15, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.50T>G (p.Leu17Ter)	PALB2	L17*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000584911	16	23649449	16	23638128	584911	575967	rs1567224232	NC_000016.10:23638127:A:C	single nucleotide variant	nonsense	Pathogenic	Mar 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.49-1G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000584471	16	23649451	16	23638130	584471	575602	rs1440838364	NC_000016.10:23638129:C:T	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Jun 13, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.49-2A>G	PALB2		Familial cancer of breast	VCV002677460	16	23649452	16	23638131	2677460	2836332	rs786203245	NC_000016.10:23638130:T:C	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Sep 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.49-2A>T	PALB2		Familial cancer of breast	VCV000186820	16	23649452	16	23638131	186820	184302	rs786203245	NC_000016.10:23638130:T:A	single nucleotide variant	splice acceptor variant|intron variant	Uncertain significance	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.49-3C>A	PALB2		Familial cancer of breast	VCV002677453	16	23649453	16	23638132	2677453	2836325	rs2506541178	NC_000016.10:23638131:G:T	single nucleotide variant	intron variant	Uncertain significance	Mar 31, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-3C>T	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001744261	16	23649453	16	23638132	1744261	1799157	rs2506541178	NC_000016.10:23638131:G:A	single nucleotide variant	intron variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.49-4C>A	PALB2		Familial cancer of breast	VCV003723502	16	23649454	16	23638133	3723502	3850713		NC_000016.10:23638132:G:T	single nucleotide variant	intron variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-4C>T	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000386697	16	23649454	16	23638133	386697	374975	rs762518243	NC_000016.10:23638132:G:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.49-7C>T	PALB2		Familial cancer of breast	VCV003903787	16	23649457	16	23638136	3903787	4019660		NC_000016.10:23638135:G:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-10C>T	PALB2		Familial cancer of breast	VCV002862612	16	23649460	16	23638139	2862612	3022661	rs2506541270	NC_000016.10:23638138:G:A	single nucleotide variant	intron variant	Likely benign	May 8, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-12T>C	PALB2		Familial cancer of breast	VCV003903738	16	23649462	16	23638141	3903738	4019611		NC_000016.10:23638140:A:G	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-13T>C	PALB2		Familial cancer of breast	VCV001564029	16	23649463	16	23638142	1564029	1589050	rs2142461422	NC_000016.10:23638141:A:G	single nucleotide variant	intron variant	Likely benign	Sep 18, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-15T>C	PALB2		Familial cancer of breast	VCV003666171	16	23649465	16	23638144	3666171	3791978		NC_000016.10:23638143:A:G	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.49-15T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000628233	16	23649465	16	23638144	628233	619629	rs1567224243	NC_000016.10:23638143:A:C	single nucleotide variant	intron variant	Likely benign	Apr 25, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-16G>A	PALB2		Familial cancer of breast	VCV003716961	16	23649466	16	23638145	3716961	3848666		NC_000016.10:23638144:C:T	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.49-17T>G	PALB2		Familial cancer of breast	VCV002957260	16	23649467	16	23638146	2957260	3122358	rs2142461487	NC_000016.10:23638145:A:C	single nucleotide variant	intron variant	Likely benign	May 19, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-18G>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000629177	16	23649468	16	23638147	629177	619545	rs1567224246	NC_000016.10:23638146:C:G	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.49-19G>T	PALB2		Familial cancer of breast	VCV003903691	16	23649469	16	23638148	3903691	4019564		NC_000016.10:23638147:C:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-54C>T	PALB2		not provided	VCV000126753	16	23649504	16	23638183	126753	132263	rs515726121	NC_000016.10:23638182:G:A	single nucleotide variant	intron variant	Likely benign		criteria provided, single submitter							
NM_024675.4(PALB2):c.49-75G>A	PALB2		Hereditary breast ovarian cancer syndrome	VCV001678975	16	23649525	16	23638204	1678975	1670769	rs959085284	NC_000016.10:23638203:C:T	single nucleotide variant	intron variant	Likely benign	Apr 19, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-165C>G	PALB2		not provided	VCV000677857	16	23649615	16	23638294	677857	667456	rs7198601	NC_000016.10:23638293:G:C	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.49-344T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV001744213	16	23649794	16	23638473	1744213	1799109	rs1967121549	NC_000016.10:23638472:A:C	single nucleotide variant	intron variant	Uncertain significance	Aug 23, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-432A>G	PALB2		Familial cancer of breast	VCV000803243	16	23649882	16	23638561	803243	791576	rs1597102250	NC_000016.10:23638560:T:C	single nucleotide variant	intron variant	Likely benign	May 28, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.49-1123C>G	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001470642	16	23650573	16	23639252	1470642	1394869	rs2142467185	NC_000016.10:23639251:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 21, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.48+50C>T	PALB2		not specified	VCV001697763	16	23652381	16	23641060	1697763	1690147	rs1227997015	NC_000016.10:23641059:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+39C>A	PALB2		not specified	VCV001697764	16	23652392	16	23641071	1697764	1690148	rs768839390	NC_000016.10:23641070:G:T	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+29A>G	PALB2		not specified	VCV002691971	16	23652402	16	23641081	2691971	2852974	rs748522775	NC_000016.10:23641080:T:C	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+26C>A	PALB2		not specified	VCV002576376	16	23652405	16	23641084	2576376	2741272	rs748775669	NC_000016.10:23641083:G:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+20G>C	PALB2		Familial cancer of breast	VCV003672819	16	23652411	16	23641090	3672819	3804956		NC_000016.10:23641089:C:G	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	May 26, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+20G>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492224	16	23652411	16	23641090	492224	484697	rs201765609	NC_000016.10:23641089:C:T	single nucleotide variant	intron variant	Likely benign	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.48+19G>C	PALB2		not specified|Familial cancer of breast	VCV000392982	16	23652412	16	23641091	392982	374979	rs1057523580	NC_000016.10:23641090:C:G	single nucleotide variant	intron variant	Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.48+19G>A	PALB2		Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000389913	16	23652412	16	23641091	389913	374287	rs1057523580	NC_000016.10:23641090:C:T	single nucleotide variant	intron variant	Likely benign	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.48+18A>G	PALB2		Familial cancer of breast	VCV002036763	16	23652413	16	23641092	2036763	2101130	rs2142480375	NC_000016.10:23641091:T:C	single nucleotide variant	intron variant	Likely benign	Oct 25, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+16G>C	PALB2		Familial cancer of breast	VCV002770618	16	23652415	16	23641094	2770618	2927468	rs759520257	NC_000016.10:23641093:C:G	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Mar 4, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+16G>A	PALB2		Familial cancer of breast|not specified	VCV000387180	16	23652415	16	23641094	387180	374290	rs759520257	NC_000016.10:23641093:C:T	single nucleotide variant	intron variant	Likely benign	Sep 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.48+15G>A	PALB2		Familial cancer of breast	VCV001613240	16	23652416	16	23641095	1613240	1567595	rs2142480406	NC_000016.10:23641094:C:T	single nucleotide variant	intron variant	Likely benign	May 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+14G>C	PALB2		Familial cancer of breast	VCV002751193	16	23652417	16	23641096	2751193	2913231	rs2142480424	NC_000016.10:23641095:C:G	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Apr 9, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+13C>G	PALB2		Familial cancer of breast	VCV003723259	16	23652418	16	23641097	3723259	3850471		NC_000016.10:23641096:G:C	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Oct 19, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+13C>T	PALB2		Familial cancer of breast	VCV001617585	16	23652418	16	23641097	1617585	1614438	rs1226428051	NC_000016.10:23641096:G:A	single nucleotide variant	intron variant	Likely benign	Nov 16, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+13C>A	PALB2		Familial cancer of breast	VCV001513516	16	23652418	16	23641097	1513516	1472571	rs1226428051	NC_000016.10:23641096:G:T	single nucleotide variant	intron variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+10G>C	PALB2		not specified|Familial cancer of breast	VCV001147095	16	23652421	16	23641100	1147095	1146023	rs1311681895	NC_000016.10:23641099:C:G	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.48+10G>T	PALB2		Familial cancer of breast	VCV001082375	16	23652421	16	23641100	1082375	1081902	rs1311681895	NC_000016.10:23641099:C:A	single nucleotide variant	intron variant	Likely benign	May 29, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+10G>A	PALB2		not provided|PALB2-related cancer predisposition|Familial cancer of breast	VCV000619710	16	23652421	16	23641100	619710	611329	rs1311681895	NC_000016.10:23641099:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.48+9G>C	PALB2		Familial cancer of breast	VCV003904496	16	23652422	16	23641101	3904496	4020368		NC_000016.10:23641100:C:G	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+9G>T	PALB2		Familial cancer of breast	VCV002018575	16	23652422	16	23641101	2018575	2072658	rs1782502330	NC_000016.10:23641100:C:A	single nucleotide variant	intron variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+9G>A	PALB2		Familial cancer of breast	VCV001086506	16	23652422	16	23641101	1086506	1081903	rs1782502330	NC_000016.10:23641100:C:T	single nucleotide variant	intron variant	Likely benign	Apr 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+8G>C	PALB2		Familial cancer of breast	VCV002008164	16	23652423	16	23641102	2008164	2069976	rs2142480527	NC_000016.10:23641101:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.48+8G>A	PALB2		Familial cancer of breast	VCV001658495	16	23652423	16	23641102	1658495	1563872	rs2142480527	NC_000016.10:23641101:C:T	single nucleotide variant	intron variant	Likely benign	Oct 23, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+7G>A	PALB2		Familial cancer of breast	VCV002133895	16	23652424	16	23641103	2133895	2188441	rs190626072	NC_000016.10:23641102:C:T	single nucleotide variant	intron variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+7G>C	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000241568	16	23652424	16	23641103	241568	242394	rs190626072	NC_000016.10:23641102:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.48+6G>C	PALB2		Familial cancer of breast|not specified	VCV000508169	16	23652425	16	23641104	508169	505731	rs1555462487	NC_000016.10:23641103:C:G	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.48+6G>A	PALB2		Familial cancer of breast	VCV000461005	16	23652425	16	23641104	461005	466319	rs1555462487	NC_000016.10:23641103:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+5C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000492225	16	23652426	16	23641105	492225	484702	rs1555462488	NC_000016.10:23641104:G:A	single nucleotide variant	intron variant	Likely benign	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.48+4C>A	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002762991	16	23652427	16	23641106	2762991	2928052	rs876659843	NC_000016.10:23641105:G:T	single nucleotide variant	5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.48+4C>T	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000232567	16	23652427	16	23641106	232567	235338	rs876659843	NC_000016.10:23641105:G:A	single nucleotide variant	intron variant	Uncertain significance	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.48+3G>T	PALB2		Hereditary cancer-predisposing syndrome	VCV003228037	16	23652428	16	23641107	3228037	3387806	rs748854938	NC_000016.10:23641106:C:A	single nucleotide variant	5 prime UTR variant|intron variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+3G>C	PALB2		Familial cancer of breast	VCV002677463	16	23652428	16	23641107	2677463	2836335	rs748854938	NC_000016.10:23641106:C:G	single nucleotide variant	5 prime UTR variant|intron variant	Uncertain significance	Jun 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+3G>A	PALB2		Familial cancer of breast	VCV002098580	16	23652428	16	23641107	2098580	2157776	rs748854938	NC_000016.10:23641106:C:T	single nucleotide variant	intron variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+2T>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000232295	16	23652429	16	23641108	232295	235339	rs876659679	NC_000016.10:23641107:A:C	single nucleotide variant	5 prime UTR variant|intron variant|splice donor variant	Likely pathogenic	Jun 8, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.48+1G>T	PALB2		not provided|Familial cancer of breast	VCV000871587	16	23652430	16	23641109	871587	860243	rs515726118	NC_000016.10:23641108:C:A	single nucleotide variant	5 prime UTR variant|intron variant|splice donor variant	Pathogenic/Likely pathogenic	Sep 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.48+1G>A	PALB2		Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000482019	16	23652430	16	23641109	482019	478325	rs515726118	NC_000016.10:23641108:C:T	single nucleotide variant	5 prime UTR variant|intron variant|splice donor variant	Likely pathogenic	Sep 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.48+1G>C	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV000126750	16	23652430	16	23641109	126750	132260	rs515726118	NC_000016.10:23641108:C:G	single nucleotide variant	5 prime UTR variant|intron variant|splice donor variant	Conflicting classifications of pathogenicity	Mar 1, 2023	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.48G>A (p.Lys16=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N	VCV000143978	16	23652431	16	23641110	143978	153708	rs587776405	NC_000016.10:23641109:C:T	single nucleotide variant	synonymous variant	Pathogenic/Likely pathogenic	Apr 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.47A>C (p.Lys16Thr)	PALB2	K16T	not provided	VCV001713226	16	23652432	16	23641111	1713226	1770738	rs1064795514	NC_000016.10:23641110:T:G	single nucleotide variant	missense variant	Likely pathogenic	May 27, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.47A>G (p.Lys16Arg)	PALB2	K16R	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000422035	16	23652432	16	23641111	422035	409573	rs1064795514	NC_000016.10:23641110:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.45A>G (p.Glu15=)	PALB2		not provided|Familial cancer of breast|Familial pancreatic carcinoma|Hereditary cancer-predisposing syndrome	VCV000415998	16	23652434	16	23641113	415998	401111	rs1060504718	NC_000016.10:23641112:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.44A>T (p.Glu15Val)	PALB2	E15V	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000486013	16	23652435	16	23641114	486013	477708	rs1555462501	NC_000016.10:23641113:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.43G>C (p.Glu15Gln)	PALB2	E15Q	Familial cancer of breast	VCV002126658	16	23652436	16	23641115	2126658	2181958	rs730881884	NC_000016.10:23641114:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.43G>A (p.Glu15Lys)	PALB2	E15K	Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000480291	16	23652436	16	23641115	480291	477709	rs730881884	NC_000016.10:23641114:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.43G>T (p.Glu15Ter)	PALB2	E15*	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000182762	16	23652436	16	23641115	182762	180757	rs730881884	NC_000016.10:23641114:C:A	single nucleotide variant	nonsense	Pathogenic	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.42G>A (p.Lys14=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000461003	16	23652437	16	23641116	461003	466322	rs1555462505	NC_000016.10:23641115:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.41A>G (p.Lys14Arg)	PALB2	K14R	Familial cancer of breast	VCV000461002	16	23652438	16	23641117	461002	466550	rs1555462506	NC_000016.10:23641116:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.40A>G (p.Lys14Glu)	PALB2	K14E	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000185246	16	23652439	16	23641118	185246	184303	rs786202029	NC_000016.10:23641117:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.39G>C (p.Glu13Asp)	PALB2	E13D	Familial cancer of breast	VCV001059709	16	23652440	16	23641119	1059709	1049537	rs876660538	NC_000016.10:23641118:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.39G>A (p.Glu13=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000233636	16	23652440	16	23641119	233636	235340	rs876660538	NC_000016.10:23641118:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.38A>T (p.Glu13Val)	PALB2	E13V	Familial cancer of breast	VCV001035198	16	23652441	16	23641120	1035198	1032549	rs876658288	NC_000016.10:23641119:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.38A>C (p.Glu13Ala)	PALB2	E13A	Hereditary cancer-predisposing syndrome	VCV000490086	16	23652441	16	23641120	490086	482950	rs876658288	NC_000016.10:23641119:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.38A>G (p.Glu13Gly)	PALB2	E13G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000229943	16	23652441	16	23641120	229943	235342	rs876658288	NC_000016.10:23641119:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.37G>T (p.Glu13Ter)	PALB2	E13*	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000920082	16	23652442	16	23641121	920082	913710	rs373287455	NC_000016.10:23641120:C:A	single nucleotide variant	nonsense	Pathogenic	Dec 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.37G>C (p.Glu13Gln)	PALB2	E13Q	Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	VCV000824235	16	23652442	16	23641121	824235	812856	rs373287455	NC_000016.10:23641120:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.37G>A (p.Glu13Lys)	PALB2	E13K	not provided|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000182792	16	23652442	16	23641121	182792	180758	rs373287455	NC_000016.10:23641120:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.36G>C (p.Glu12Asp)	PALB2	E12D	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000492222	16	23652443	16	23641122	492222	485103	rs760609798	NC_000016.10:23641121:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.36G>A (p.Glu12=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000185575	16	23652443	16	23641122	185575	184304	rs760609798	NC_000016.10:23641121:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.35A>C (p.Glu12Ala)	PALB2	E12A	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000232401	16	23652444	16	23641123	232401	235343	rs876659744	NC_000016.10:23641122:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.34G>C (p.Glu12Gln)	PALB2	E12Q	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000823856	16	23652445	16	23641124	823856	812857	rs765520187	NC_000016.10:23641123:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.34G>A (p.Glu12Lys)	PALB2	E12K	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000410184	16	23652445	16	23641124	410184	401156	rs765520187	NC_000016.10:23641123:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.33T>A (p.Cys11Ter)	PALB2	C11*	Familial cancer of breast	VCV002673886	16	23652446	16	23641125	2673886	2841384	rs2142481060	NC_000016.10:23641124:A:T	single nucleotide variant	nonsense|5 prime UTR variant|splice donor variant	Pathogenic	Sep 5, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.32G>A (p.Cys11Tyr)	PALB2	C11Y	Familial cancer of breast	VCV002917569	16	23652447	16	23641126	2917569	3074811	rs750720488	NC_000016.10:23641125:C:T	single nucleotide variant	missense variant|5 prime UTR variant|splice donor variant	Uncertain significance	May 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.30C>G (p.Ser10Arg)	PALB2	S10R	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001497470	16	23652449	16	23641128	1497470	1476091	rs758500749	NC_000016.10:23641127:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.30C>T (p.Ser10=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000822895	16	23652449	16	23641128	822895	812858	rs758500749	NC_000016.10:23641127:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.29G>A (p.Ser10Asn)	PALB2	S10N	Hereditary cancer-predisposing syndrome	VCV002453302	16	23652450	16	23641129	2453302	2430362	rs876659643	NC_000016.10:23641128:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Jan 17, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.29G>C (p.Ser10Thr)	PALB2	S10T	Hereditary cancer-predisposing syndrome	VCV000822498	16	23652450	16	23641129	822498	812859	rs876659643	NC_000016.10:23641128:C:G	single nucleotide variant	missense variant	Uncertain significance	May 17, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.29G>T (p.Ser10Ile)	PALB2	S10I	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Fanconi anemia complementation group N|Familial cancer of breast|not specified|not provided	VCV000232241	16	23652450	16	23641129	232241	235345	rs876659643	NC_000016.10:23641128:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.28A>G (p.Ser10Gly)	PALB2	S10G	Hereditary cancer-predisposing syndrome	VCV002567557	16	23652451	16	23641130	2567557	2731199	rs2142481164	NC_000016.10:23641129:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 14, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.28A>T (p.Ser10Cys)	PALB2	S10C	Hereditary cancer-predisposing syndrome	VCV001797409	16	23652451	16	23641130	1797409	1854327	rs2142481164	NC_000016.10:23641129:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.27C>T (p.Leu9=)	PALB2		Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV002431652	16	23652452	16	23641131	2431652	2405156	rs749298208	NC_000016.10:23641130:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.27C>G (p.Leu9=)	PALB2		not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000232080	16	23652452	16	23641131	232080	235346	rs749298208	NC_000016.10:23641130:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.26T>C (p.Leu9Pro)	PALB2	L9P	Hereditary cancer-predisposing syndrome	VCV001171171	16	23652453	16	23641132	1171171	1161325	rs515726092	NC_000016.10:23641131:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.25C>T (p.Leu9Phe)	PALB2	L9F	Familial pancreatic carcinoma|Hereditary breast ovarian cancer syndrome|not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000410124	16	23652454	16	23641133	410124	401115	rs1060502744	NC_000016.10:23641132:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.24C>T (p.Pro8=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001103443	16	23652455	16	23641134	1103443	1103721	rs766487850	NC_000016.10:23641133:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.24C>A (p.Pro8=)	PALB2		Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV000629367	16	23652455	16	23641134	629367	618456	rs766487850	NC_000016.10:23641133:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.23C>T (p.Pro8Leu)	PALB2	P8L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome	VCV000126652	16	23652456	16	23641135	126652	132162	rs150390726	NC_000016.10:23641134:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 1, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.22C>A (p.Pro8Thr)	PALB2	P8T	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|Hereditary cancer-predisposing syndrome	VCV000629191	16	23652457	16	23641136	629191	618457	rs876660586	NC_000016.10:23641135:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 21, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.22C>T (p.Pro8Ser)	PALB2	P8S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480289	16	23652457	16	23641136	480289	477710	rs876660586	NC_000016.10:23641135:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.22C>G (p.Pro8Ala)	PALB2	P8A	Hereditary cancer-predisposing syndrome	VCV000233707	16	23652457	16	23641136	233707	235347	rs876660586	NC_000016.10:23641135:G:C	single nucleotide variant	missense variant	Uncertain significance	May 11, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.21G>A (p.Lys7=)	PALB2		not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000480284	16	23652458	16	23641137	480284	477714	rs1424944402	NC_000016.10:23641136:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.21G>C (p.Lys7Asn)	PALB2	K7N	Familial cancer of breast	VCV000460931	16	23652458	16	23641137	460931	466326	rs1424944402	NC_000016.10:23641136:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.20A>T (p.Lys7Met)	PALB2	K7M	Familial cancer of breast	VCV001018417	16	23652459	16	23641138	1018417	1012053	rs947155109	NC_000016.10:23641137:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.20A>G (p.Lys7Arg)	PALB2	K7R	PALB2-related disorder|not provided|not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000421024	16	23652459	16	23641138	421024	409574	rs947155109	NC_000016.10:23641137:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.18G>A (p.Gly6=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia complementation group N|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast	VCV000460917	16	23652461	16	23641140	460917	466285	rs587782462	NC_000016.10:23641139:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.18G>T (p.Gly6=)	PALB2		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast	VCV000142432	16	23652461	16	23641140	142432	152146	rs587782462	NC_000016.10:23641139:C:A	single nucleotide variant	synonymous variant	Pathogenic/Likely pathogenic	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.16G>T (p.Gly6Trp)	PALB2	G6W	Familial cancer of breast	VCV001499611	16	23652463	16	23641142	1499611	1389313	rs1967234587	NC_000016.10:23641141:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.16G>A (p.Gly6Arg)	PALB2	G6R	Familial cancer of breast	VCV001022586	16	23652463	16	23641142	1022586	1012054	rs1967234587	NC_000016.10:23641141:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2020	criteria provided, single submitter							
NM_024675.4(PALB2):c.15C>G (p.Pro5=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000819611	16	23652464	16	23641143	819611	812860	rs876658438	NC_000016.10:23641142:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.15C>T (p.Pro5=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided	VCV000230191	16	23652464	16	23641143	230191	235348	rs876658438	NC_000016.10:23641142:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.14C>T (p.Pro5Leu)	PALB2	P5L	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000918643	16	23652465	16	23641144	918643	913712	rs1967234897	NC_000016.10:23641143:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.13C>G (p.Pro5Ala)	PALB2	P5A	Familial cancer of breast	VCV002757708	16	23652466	16	23641145	2757708	2917580	rs377085677	NC_000016.10:23641144:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.13C>T (p.Pro5Ser)	PALB2	P5S	not specified|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|not provided	VCV000126600	16	23652466	16	23641145	126600	132110	rs377085677	NC_000016.10:23641144:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.12T>A (p.Pro4=)	PALB2		Familial cancer of breast	VCV003904491	16	23652467	16	23641146	3904491	4020363		NC_000016.10:23641145:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign	Jan 9, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.12T>C (p.Pro4=)	PALB2		not specified|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group N|Familial cancer of breast|not provided	VCV000136128	16	23652467	16	23641146	136128	139840	rs567706422	NC_000016.10:23641145:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.11C>T (p.Pro4Leu)	PALB2	P4L	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided|Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Esophageal atresia/tracheoesophageal fistula|Fanconi anemia complementation group N	VCV000126593	16	23652468	16	23641147	126593	132103	rs45619737	NC_000016.10:23641146:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 2, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.10C>G (p.Pro4Ala)	PALB2	P4A	Familial cancer of breast	VCV002840985	16	23652469	16	23641148	2840985	2996973	rs587782483	NC_000016.10:23641147:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.10C>A (p.Pro4Thr)	PALB2	P4T	Familial cancer of breast	VCV000582378	16	23652469	16	23641148	582378	573992	rs587782483	NC_000016.10:23641147:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.10C>T (p.Pro4Ser)	PALB2	P4S	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000142468	16	23652469	16	23641148	142468	152182	rs587782483	NC_000016.10:23641147:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.9G>T (p.Glu3Asp)	PALB2	E3D	Hereditary cancer-predisposing syndrome|not provided|not specified|Familial cancer of breast	VCV000186265	16	23652470	16	23641149	186265	184305	rs786202325	NC_000016.10:23641148:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.9G>A (p.Glu3=)	PALB2		Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast	VCV000185627	16	23652470	16	23641149	185627	184306	rs786202325	NC_000016.10:23641148:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.8A>T (p.Glu3Val)	PALB2	E3V	Hereditary cancer-predisposing syndrome	VCV003927457	16	23652471	16	23641150	3927457	4047090		NC_000016.10:23641149:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 1, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.7G>A (p.Glu3Lys)	PALB2	E3K	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000480296	16	23652472	16	23641151	480296	477813	rs878855123	NC_000016.10:23641150:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.7G>C (p.Glu3Gln)	PALB2	E3Q	Familial cancer of breast	VCV000410170	16	23652472	16	23641151	410170	401596	rs878855123	NC_000016.10:23641150:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2016	criteria provided, single submitter							
NM_024675.4(PALB2):c.7G>T (p.Glu3Ter)	PALB2	E3*	Familial cancer of breast	VCV000241571	16	23652472	16	23641151	241571	242395	rs878855123	NC_000016.10:23641150:C:A	single nucleotide variant	nonsense	Pathogenic	Apr 5, 2023	reviewed by expert panel							
NM_024675.4(PALB2):c.6C>A (p.Asp2Glu)	PALB2	D2E	Hereditary cancer-predisposing syndrome	VCV002774028	16	23652473	16	23641152	2774028	2934759	rs1302088447	NC_000016.10:23641151:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 25, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.6C>T (p.Asp2=)	PALB2		Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000461016	16	23652473	16	23641152	461016	466329	rs1302088447	NC_000016.10:23641151:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.5A>G (p.Asp2Gly)	PALB2	D2G	Familial cancer of breast|Pancreatic cancer, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 5|Fanconi anemia complementation group N	VCV003730305	16	23652474	16	23641153	3730305	3862371		NC_000016.10:23641152:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.4G>A (p.Asp2Asn)	PALB2	D2N	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV001744704	16	23652475	16	23641154	1744704	1809484	rs1224301730	NC_000016.10:23641153:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.3G>T (p.Met1Ile)	PALB2	M1I	Familial cancer of breast	VCV002673831	16	23652476	16	23641155	2673831	2841334	rs1057517585	NC_000016.10:23641154:C:A	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Likely pathogenic	Sep 6, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.3G>A (p.Met1Ile)	PALB2	M1I	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5|not provided	VCV000371919	16	23652476	16	23641155	371919	358911	rs1057517585	NC_000016.10:23641154:C:T	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic/Likely pathogenic	Aug 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2T>G (p.Met1Arg)	PALB2	M1R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided	VCV001798683	16	23652477	16	23641156	1798683	1855953	rs756519825	NC_000016.10:23641155:A:C	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic/Likely pathogenic	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.2T>C (p.Met1Thr)	PALB2	M1T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000241558	16	23652477	16	23641156	241558	242396	rs756519825	NC_000016.10:23641155:A:G	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic/Likely pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.1A>T (p.Met1Leu)	PALB2	M1L	Hereditary cancer-predisposing syndrome	VCV003927445	16	23652478	16	23641157	3927445	4047078		NC_000016.10:23641156:T:A	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Likely pathogenic	May 21, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.1A>C (p.Met1Leu)	PALB2	M1L	Hereditary cancer-predisposing syndrome	VCV001784166	16	23652478	16	23641157	1784166	1849725	rs879254144	NC_000016.10:23641156:T:G	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic	Sep 5, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.1A>G (p.Met1Val)	PALB2	M1V	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	VCV000246182	16	23652478	16	23641157	246182	244980	rs879254144	NC_000016.10:23641156:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic/Likely pathogenic	Apr 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.-1G>A	PALB2		Hereditary cancer-predisposing syndrome	VCV000918635	16	23652479	16	23641158	918635	913713	rs1341292125	NC_000016.10:23641157:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.-1G>C	PALB2		not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000668267	16	23652479	16	23641158	668267	656360	rs1341292125	NC_000016.10:23641157:C:G	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.-1G>T	PALB2		not specified	VCV000496463	16	23652479	16	23641158	496463	487669	rs1341292125	NC_000016.10:23641157:C:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jun 20, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.-2C>A	PALB2		Hereditary cancer-predisposing syndrome	VCV003303998	16	23652480	16	23641159	3303998	3470165		NC_000016.10:23641158:G:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	May 10, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.-2C>G	PALB2		Hereditary cancer-predisposing syndrome	VCV000830082	16	23652480	16	23641159	830082	818567	rs587781902	NC_000016.10:23641158:G:C	single nucleotide variant	5 prime UTR variant	Uncertain significance	Sep 22, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.-2C>T	PALB2		Hereditary cancer-predisposing syndrome|not provided	VCV000141643	16	23652480	16	23641159	141643	151357	rs587781902	NC_000016.10:23641158:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.-5G>A	PALB2		Hereditary cancer-predisposing syndrome	VCV003228042	16	23652483	16	23641162	3228042	3387811	rs730881875	NC_000016.10:23641161:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Oct 27, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.-5G>T	PALB2		Hereditary cancer-predisposing syndrome|not specified	VCV000182753	16	23652483	16	23641162	182753	180759	rs730881875	NC_000016.10:23641161:C:A	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 10, 2025	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.-7C>G	PALB2		Familial cancer of breast	VCV004056289	16	23652485	16	23641164	4056289	4170227		NC_000016.10:23641163:G:C	single nucleotide variant	5 prime UTR variant	Uncertain significance	Apr 23, 2024	criteria provided, single submitter							
NM_024675.4(PALB2):c.-7C>T	PALB2		not provided	VCV002682038	16	23652485	16	23641164	2682038	2843071	rs377315640	NC_000016.10:23641163:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_024675.4(PALB2):c.-9G>C	PALB2		Hereditary cancer-predisposing syndrome	VCV002774029	16	23652487	16	23641166	2774029	2934760	rs1391314143	NC_000016.10:23641165:C:G	single nucleotide variant	5 prime UTR variant	Likely benign	Nov 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.-10C>T	PALB2		PALB2-related cancer predisposition|Hereditary cancer-predisposing syndrome|not provided	VCV000492140	16	23652488	16	23641167	492140	484842	rs1038099508	NC_000016.10:23641166:G:A	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 2, 2024	criteria provided, conflicting classifications							
NM_024675.4(PALB2):c.-17G>A	PALB2		Hereditary cancer-predisposing syndrome	VCV000631069	16	23652495	16	23641174	631069	618458	rs897865845	NC_000016.10:23641173:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Nov 7, 2022	criteria provided, single submitter							
NM_024675.4(PALB2):c.-23C>T	PALB2		Familial cancer of breast	VCV000803244	16	23652501	16	23641180	803244	791577	rs1597106322	NC_000016.10:23641179:G:A	single nucleotide variant	5 prime UTR variant	Likely benign	May 28, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.-36G>A	PALB2		not specified	VCV000516434	16	23652514	16	23641193	516434	505733	rs775325716	NC_000016.10:23641192:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Mar 21, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.-36G>C	PALB2		not specified	VCV000512991	16	23652514	16	23641193	512991	505278	rs775325716	NC_000016.10:23641192:C:G	single nucleotide variant	5 prime UTR variant	Likely benign	Oct 24, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.-37C>T	PALB2		Fanconi anemia complementation group N	VCV000888489	16	23652515	16	23641194	888489	874992	rs1403573232	NC_000016.10:23641193:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.-39G>T	PALB2		not specified	VCV000516312	16	23652517	16	23641196	516312	505538	rs1175612919	NC_000016.10:23641195:C:A	single nucleotide variant	5 prime UTR variant	Likely benign	Sep 28, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.-45C>G	PALB2		not specified	VCV001697765	16	23652523	16	23641202	1697765	1690149	rs556490497	NC_000016.10:23641201:G:C	single nucleotide variant	5 prime UTR variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_024675.4(PALB2):c.-47G>A	PALB2		Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000126578	16	23652525	16	23641204	126578	132088	rs8053188	NC_000016.10:23641203:C:T	single nucleotide variant	5 prime UTR variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_024675.4(PALB2):c.-48A>G	PALB2		not provided	VCV001227729	16	23652526	16	23641205	1227729	1215121	rs1271474783	NC_000016.10:23641204:T:C	single nucleotide variant	5 prime UTR variant	Benign	Jul 14, 2015	criteria provided, single submitter							
NM_024675.4(PALB2):c.-49C>A	PALB2		not specified	VCV000512727	16	23652527	16	23641206	512727	506231	rs376865021	NC_000016.10:23641205:G:T	single nucleotide variant	5 prime UTR variant	Likely benign	Oct 12, 2017	criteria provided, single submitter							
NM_024675.4(PALB2):c.-66C>T	PALB2		Familial cancer of breast	VCV000803245	16	23652544	16	23641223	803245	791578	rs1597106467	NC_000016.10:23641222:G:A	single nucleotide variant	5 prime UTR variant	Likely benign	May 28, 2019	criteria provided, single submitter							
NM_024675.4(PALB2):c.-108C>A	PALB2		Fanconi anemia complementation group N	VCV000888490	16	23652586	16	23641265	888490	874993	rs180177140	NC_000016.10:23641264:G:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_024675.4(PALB2):c.-132G>C	PALB2		Hereditary cancer-predisposing syndrome	VCV001691940	16	23652610	16	23641289	1691940	1684382	rs1434219502	NC_000016.10:23641288:C:G	single nucleotide variant	5 prime UTR variant	Uncertain significance	Aug 24, 2021	criteria provided, single submitter							
NM_024675.4(PALB2):c.-149G>A	PALB2		Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome	VCV000318562	16	23652627	16	23641306	318562	342534	rs886051832	NC_000016.10:23641305:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NC_000016.10:g.23641315C>G	PALB2		Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia complementation group N	VCV000126571	16	23652636	16	23641315	126571	132081	rs138200248	NC_000016.10:23641314:C:G	single nucleotide variant		Conflicting classifications of pathogenicity	May 1, 2025	criteria provided, conflicting classifications							
NC_000016.10:g.23641699A>G	DCTN5|PALB2		not provided	VCV001236229	16	23653020	16	23641699	1236229	1227938	rs8058061	NC_000016.10:23641698:A:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, multiple submitters, no conflicts							
